@ARTICLE{Hinton2006-pm,
  title    = "Reducing the dimensionality of data with neural networks",
  author   = "Hinton, G E and Salakhutdinov, R R",
  abstract = "High-dimensional data can be converted to low-dimensional codes
              by training a multilayer neural network with a small central
              layer to reconstruct high-dimensional input vectors. Gradient
              descent can be used for fine-tuning the weights in such
              ``autoencoder'' networks, but this works well only if the initial
              weights are close to a good solution. We describe an effective
              way of initializing the weights that allows deep autoencoder
              networks to learn low-dimensional codes that work much better
              than principal components analysis as a tool to reduce the
              dimensionality of data.",
  journal  = "Science",
  volume   =  313,
  number   =  5786,
  pages    = "504--507",
  month    =  jul,
  year     =  2006,
  keywords = "Autoencoders",
  language = "en"
}

@MISC{noauthor_2017-ff,
  title        = "Top 100 Lab Procedures Ranked by Service",
  booktitle    = "www.cms.gov",
  year         =  2017,
  howpublished = "\url{www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports}",
  note         = "Accessed: 2019-11-4"
}

@ARTICLE{Muller2010-go,
  title    = "Analyses of treatment variables for patients with childhood
              craniopharyngioma--results of the multicenter prospective trial
              {KRANIOPHARYNGEOM} 2000 after three years of follow-up",
  author   = "M{\"u}ller, Hermann L and Gebhardt, Ursel and Schr{\"o}der,
              Sabine and Pohl, Fabian and Kortmann, Rolf-Dieter and Faldum,
              Andreas and Zwiener, Isabella and Warmuth-Metz, Monika and
              Pietsch, Torsten and Calaminus, Gabriele and Kolb, Reinhard and
              Wiegand, Christoph and S{\"o}rensen, Niels and {study committee
              of KRANIOPHARYNGEOM 2000/2007}",
  abstract = "BACKGROUND: Controversies surround various treatment variables
              for patients with childhood craniopharyngioma such as growth
              hormone (GH) replacement, which some believe can exacerbate
              recurrence/progression. We prospectively assessed the risk of
              tumor recurrence/progression in survivors of childhood
              craniopharyngioma. METHODS: Multivariable analyses of risk
              factors (age at diagnosis, degree of resection, irradiation, GH
              treatment and gender) and descriptive analyses of overall
              survival (OS) and event-free survival (EFS) rates were performed
              in 117 patients, recruited prospectively and evaluated after 3
              years of follow-up in the German, Austrian and Swiss multicenter
              trial KRANIOPHARYNGEOM 2000. RESULTS: We observed a 3-year OS of
              0.97 and a 3-year EFS of 0.46, indicating high recurrence rates
              after complete resection (CR) (n = 47; 3-year-EFS: 0.64) and high
              progression rates after incomplete resection (IR) (n = 64; 3-year
              EFS: 0.31). The risk of an event decreased by 80\% after CR
              compared to IR (hazard ratio = 0.20; p < 0.001). Irradiation had
              protective effects on EFS: irradiated patients had an 88\% lower
              risk of recurrence/progression compared to patients
              without/before irradiation (hazard ratio = 0.12; p < 0.001). GH
              treatment had no impact on 3-year EFS rates. CONCLUSIONS: Tumor
              recurrences/progressions are frequent and occur early after
              initial treatment of childhood craniopharyngioma. A radical
              resection preserving the integrity of hypothalamic structures
              appears optimal at original diagnosis. Irradiation was efficient
              in preventing recurrences/progressions. GH treatment had no
              impact on the low 3-year EFS observed in our study. However,
              further conclusions on the influence of GH on recurrence rates
              have to be refined to long-term follow-up studies of patients
              with childhood craniopharyngioma.",
  journal  = "Horm. Res. Paediatr.",
  volume   =  73,
  number   =  3,
  pages    = "175--180",
  month    =  mar,
  year     =  2010,
  language = "en"
}

@ARTICLE{Weng2017-ts,
  title    = "Combining deep learning and coherent anti-Stokes Raman scattering
              imaging for automated differential diagnosis of lung cancer",
  author   = "Weng, Sheng and Xu, Xiaoyun and Li, Jiasong and Wong, Stephen T C",
  abstract = "Lung cancer is the most prevalent type of cancer and the leading
              cause of cancer-related deaths worldwide. Coherent anti-Stokes
              Raman scattering (CARS) is capable of providing cellular-level
              images and resolving pathologically related features on human
              lung tissues. However, conventional means of analyzing CARS
              images requires extensive image processing, feature engineering,
              and human intervention. This study demonstrates the feasibility
              of applying a deep learning algorithm to automatically
              differentiate normal and cancerous lung tissue images acquired by
              CARS. We leverage the features learned by pretrained deep neural
              networks and retrain the model using CARS images as the input. We
              achieve 89.2\% accuracy in classifying normal, small-cell
              carcinoma, adenocarcinoma, and squamous cell carcinoma lung
              images. This computational method is a step toward on-the-spot
              diagnosis of lung cancer and can be further strengthened by the
              efforts aimed at miniaturizing the CARS technique for fiber-based
              microendoscopic imaging.",
  journal  = "J. Biomed. Opt.",
  volume   =  22,
  number   =  10,
  pages    = "1--10",
  month    =  oct,
  year     =  2017,
  keywords = "artificial intelligence; classification; deep learning; lung
              cancer; medical imaging; nonlinear microscopy",
  language = "en"
}

@ARTICLE{Chen2018-zn,
  title         = "Neural Ordinary Differential Equations",
  author        = "Chen, Ricky T Q and Rubanova, Yulia and Bettencourt, Jesse
                   and Duvenaud, David",
  abstract      = "We introduce a new family of deep neural network models.
                   Instead of specifying a discrete sequence of hidden layers,
                   we parameterize the derivative of the hidden state using a
                   neural network. The output of the network is computed using
                   a black-box differential equation solver. These
                   continuous-depth models have constant memory cost, adapt
                   their evaluation strategy to each input, and can explicitly
                   trade numerical precision for speed. We demonstrate these
                   properties in continuous-depth residual networks and
                   continuous-time latent variable models. We also construct
                   continuous normalizing flows, a generative model that can
                   train by maximum likelihood, without partitioning or
                   ordering the data dimensions. For training, we show how to
                   scalably backpropagate through any ODE solver, without
                   access to its internal operations. This allows end-to-end
                   training of ODEs within larger models.",
  month         =  jun,
  year          =  2018,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "1806.07366"
}

@ARTICLE{Sanai2011-yn,
  title    = "An extent of resection threshold for newly diagnosed
              glioblastomas",
  author   = "Sanai, Nader and Polley, Mei-Yin and McDermott, Michael W and
              Parsa, Andrew T and Berger, Mitchel S",
  abstract = "OBJECT: The value of extent of resection (EOR) in improving
              survival in patients with glioblastoma multiforme (GBM) remains
              controversial. Specifically, it is unclear what proportion of
              contrast-enhancing tumor must be resected for a survival
              advantage and how much survival improves beyond this threshold.
              The authors attempt to define these values for the patient with
              newly diagnosed GBM in the modern neurosurgical era. METHODS: The
              authors identified 500 consecutive newly diagnosed patients with
              supratentorial GBM treated at the University of California, San
              Francisco between 1997 and 2009. Clinical, radiographic, and
              outcome parameters were measured for each case, including MR
              imaging-based volumetric tumor analysis. RESULTS: The patients
              had a median age of 60 years and presented with a median
              Karnofsky Performance Scale (KPS) score of 80. The mean clinical
              follow-up period was 15.3 months, and no patient was unaccounted
              for. All patients underwent resection followed by chemotherapy
              and radiation therapy. The median postoperative tumor volume was
              2.3 cm(3), equating to a 96\% EOR. The median overall survival
              was 12.2 months. Using Cox proportional hazards analysis, age,
              KPS score, and EOR were predictive of survival (p < 0.0001). A
              significant survival advantage was seen with as little as 78\%
              EOR, and stepwise improvement in survival was evident even in the
              95\%-100\% EOR range. A recursive partitioning analysis validated
              these findings and provided additional risk stratification
              parameters related to age, EOR, and tumor burden. CONCLUSIONS:
              For patients with newly diagnosed GBMs, aggressive EOR equates to
              improvement in overall survival, even at the highest levels of
              resection. Interestingly, subtotal resections as low as 78\% also
              correspond to a survival benefit.",
  journal  = "J. Neurosurg.",
  volume   =  115,
  number   =  1,
  pages    = "3--8",
  month    =  jul,
  year     =  2011,
  language = "en"
}

@ARTICLE{Bloch2012-sb,
  title    = "Impact of extent of resection for recurrent glioblastoma on
              overall survival: clinical article",
  author   = "Bloch, Orin and Han, Seunggu J and Cha, Soonmee and Sun, Matthew
              Z and Aghi, Manish K and McDermott, Michael W and Berger, Mitchel
              S and Parsa, Andrew T",
  abstract = "OBJECT: Extent of resection (EOR) has been shown to be an
              important prognostic factor for survival in patients undergoing
              initial resection of glioblastoma (GBM), but the significance of
              EOR at repeat craniotomy for recurrence remains unclear. In this
              study the authors investigate the impact of EOR at initial and
              repeat resection of GBM on overall survival. METHODS: Medical
              records were reviewed for all patients undergoing craniotomy for
              GBM at the University of California San Francisco Medical Center
              from January 1, 2005, through August 15, 2009. Patients who had a
              second craniotomy for pathologically confirmed recurrence
              following radiation and chemotherapy were evaluated. Volumetric
              EOR was measured and classified as gross-total resection (GTR, >
              95\% by volume) or subtotal resection (STR, $\leq$ 95\% by
              volume) after independent radiological review. Overall survival
              was compared between groups using univariate and multivariate
              analysis accounting for known prognostic factors, including age,
              eloquent location, Karnofsky Performance Status (KPS), and
              adjuvant therapies. RESULTS: Multiple resections were performed
              in 107 patients. Fifty-two patients had initial GTR, of whom 31
              (60\%) had GTR at recurrence, with a median survival of 20.4
              months (standard error [SE] 1.0 months), and 21 (40\%) had STR at
              recurrence, with a median survival of 18.4 months (SE 0.5 months)
              (difference not statistically significant). Initial STR was
              performed in 55 patients, of whom 26 (47\%) had GTR at
              recurrence, with a median survival of 19.0 months (SE 1.2
              months), and 29 (53\%) had STR, with a median survival of 15.9
              months (SE 1.2 months) (p = 0.004). A Cox proportional hazards
              model was constructed demonstrating that age (HR 1.03, p =
              0.004), KPS score at recurrence (HR 2.4, p = 0.02), and EOR at
              repeat resection (HR 0.62, p = 0.02) were independent predictors
              of survival. Extent of initial resection was not a statistically
              significant factor (p = 0.13) when repeat EOR was included in the
              model, suggesting that GTR at second craniotomy could overcome
              the effect of an initial STR. CONCLUSIONS: Extent of resection at
              recurrence is an important predictor of overall survival. If GTR
              is achieved at recurrence, overall survival is maximized
              regardless of initial EOR, suggesting that patients with initial
              STR may benefit from surgery with a GTR at recurrence.",
  journal  = "J. Neurosurg.",
  volume   =  117,
  number   =  6,
  pages    = "1032--1038",
  month    =  dec,
  year     =  2012,
  language = "en"
}

@UNPUBLISHED{noauthor_undated-cp,
  title    = "[No title]"
}

@ARTICLE{Wilson1905-vt,
  title     = "A {METHOD} {FOR} {THE} {RAPID} {PREPARATION} {OF} {FRESH}
               {TISSUES} {FOR} {THE} {MICROSCOPE}",
  author    = "Wilson, Louis B",
  abstract  = "While engaged in general pathologic work I shared the common
               distrust of frozen sections of fresh tissues for microscopic
               diagnosis. On taking charge recently of the laboratories of the
               Drs. Mayo, surgeons, I carefully tested the various methods
               hitherto published and found them either too slow for results
               while the patient waits under the anesthetic or else giving
               poorly differentiated cell detail. After considerable
               experimentation the following technic was discovered, and for
               the last six months it has given uniformly excellent
               preparations:Bits of fresh tissue not more than
               2$\times$10$\times$10 mm. are frozen in dextrin solution and cut
               in sections of from 10 to 15 microns thick.The sections are
               removed from the knife with the tip of the finger and allowed to
               thaw thereon.The sections are unrolled with camel's-hair brushes
               in 1 per cent. NaCl solution.The sections are stained from 10 to
               20 seconds in neutral Unna's",
  journal   = "JAMA",
  publisher = "American Medical Association",
  volume    = "XLV",
  number    =  23,
  pages     = "1737--1737",
  month     =  dec,
  year      =  1905
}

@MISC{Chollet2015-na,
  title  = "Keras",
  author = "Chollet, Fran{\c c}ois and {Others}",
  year   =  2015
}

@ARTICLE{Hinni2013-hc,
  title    = "Surgical margins in head and neck cancer: a contemporary review",
  author   = "Hinni, Michael L and Ferlito, Alfio and Brandwein-Gensler,
              Margaret S and Takes, Robert P and Silver, Carl E and Westra,
              William H and Seethala, Raja R and Rodrigo, Juan P and Corry,
              June and Bradford, Carol R and Hunt, Jennifer L and Strojan,
              Primo{\v z} and Devaney, Kenneth O and Gnepp, Douglas R and
              Hartl, Dana M and Kowalski, Luiz P and Rinaldo, Alessandra and
              Barnes, Leon",
  abstract = "Adequate resection margins are critical to the treatment
              decisions and prognosis of patients with head and neck squamous
              cell carcinoma (HNSCC). However, there are numerous controversies
              regarding reporting and interpretation of the status of resection
              margins. Fundamental issues relating to the basic definition of
              margin adequacy, uniform reporting standards for margins, optimal
              method of specimen dissection, and the role of intraoperative
              frozen section evaluation, all require further clarification and
              standardization. Future horizons for margin surveillance offer
              the possible use of novel methods such as ``molecular margins''
              and contact microscopic endoscopy, However, the limitations of
              these approaches need to be understood. The goal of this review
              was to evaluate these issues to define a more rational,
              standardized approach for achieving resection margin adequacy for
              patients with HNSCC undergoing curative resection.",
  journal  = "Head Neck",
  volume   =  35,
  number   =  9,
  pages    = "1362--1370",
  month    =  sep,
  year     =  2013,
  keywords = "frozen section; head neck cancer; molecular factors; pattern of
              invasion; surgical margins",
  language = "en"
}

@ARTICLE{Hollon2018-hl,
  title    = "Rapid Intraoperative Diagnosis of Pediatric Brain Tumors Using
              Stimulated Raman Histology",
  author   = "Hollon, Todd C and Lewis, Spencer and Pandian, Balaji and
              Niknafs, Yashar S and Garrard, Mia R and Garton, Hugh and Maher,
              Cormac O and McFadden, Kathryn and Snuderl, Matija and Lieberman,
              Andrew P and Muraszko, Karin and Camelo-Piragua, Sandra and
              Orringer, Daniel A",
  abstract = "Accurate histopathologic diagnosis is essential for providing
              optimal surgical management of pediatric brain tumors. Current
              methods for intraoperative histology are time- and
              labor-intensive and often introduce artifact that limit
              interpretation. Stimulated Raman histology (SRH) is a novel
              label-free imaging technique that provides intraoperative
              histologic images of fresh, unprocessed surgical specimens. Here
              we evaluate the capacity of SRH for use in the intraoperative
              diagnosis of pediatric type brain tumors. SRH revealed key
              diagnostic features in fresh tissue specimens collected from 33
              prospectively enrolled pediatric type brain tumor patients,
              preserving tumor cytology and histoarchitecture in all specimens.
              We simulated an intraoperative consultation for 25 patients with
              specimens imaged using both SRH and standard hematoxylin and
              eosin histology. SRH-based diagnoses achieved near-perfect
              diagnostic concordance (Cohen's kappa, $\kappa$ > 0.90) and an
              accuracy of 92\% to 96\%. We then developed a quantitative
              histologic method using SRH images based on rapid image feature
              extraction. Nuclear density, tumor-associated macrophage
              infiltration, and nuclear morphology parameters from 3337 SRH
              fields of view were used to develop and validate a decision-tree
              machine-learning model. Using SRH image features, our model
              correctly classified 25 fresh pediatric type surgical specimens
              into normal versus lesional tissue and low-grade versus
              high-grade tumors with 100\% accuracy. Our results provide
              insight into how SRH can deliver rapid diagnostic histologic data
              that could inform the surgical management of pediatric brain
              tumors.Significance: A new imaging method simplifies diagnosis
              and informs decision making during pediatric brain tumor surgery.
              Cancer Res; 78(1); 278-89. \copyright{}2017 AACR.",
  journal  = "Cancer Res.",
  volume   =  78,
  number   =  1,
  pages    = "278--289",
  month    =  jan,
  year     =  2018,
  keywords = "SRS\_imaging;My\_papers",
  language = "en"
}

@INPROCEEDINGS{Szegedy2017-ie,
  title     = "Inception-v4, inception-resnet and the impact of residual
               connections on learning",
  booktitle = "{AAAI}",
  author    = "Szegedy, Christian and Ioffe, Sergey and Vanhoucke, Vincent and
               Alemi, Alexander A",
  volume    =  4,
  pages     = "12",
  year      =  2017,
  keywords  = "ConvNets"
}

@ARTICLE{Erhan2009-qb,
  title    = "Visualizing higher-layer features of a deep network",
  author   = "Erhan, Dumitru and Bengio, Yoshua and Courville, Aaron and
              Vincent, Pascal",
  journal  = "University of Montreal",
  volume   =  1341,
  number   =  3,
  pages    = "1",
  year     =  2009,
  keywords = "Visualization\_neuralnets"
}

@ARTICLE{Esteva2017-ae,
  title    = "Dermatologist-level classification of skin cancer with deep
              neural networks",
  author   = "Esteva, Andre and Kuprel, Brett and Novoa, Roberto A and Ko,
              Justin and Swetter, Susan M and Blau, Helen M and Thrun,
              Sebastian",
  abstract = "Skin cancer, the most common human malignancy, is primarily
              diagnosed visually, beginning with an initial clinical screening
              and followed potentially by dermoscopic analysis, a biopsy and
              histopathological examination. Automated classification of skin
              lesions using images is a challenging task owing to the
              fine-grained variability in the appearance of skin lesions. Deep
              convolutional neural networks (CNNs) show potential for general
              and highly variable tasks across many fine-grained object
              categories. Here we demonstrate classification of skin lesions
              using a single CNN, trained end-to-end from images directly,
              using only pixels and disease labels as inputs. We train a CNN
              using a dataset of 129,450 clinical images-two orders of
              magnitude larger than previous datasets-consisting of 2,032
              different diseases. We test its performance against 21
              board-certified dermatologists on biopsy-proven clinical images
              with two critical binary classification use cases: keratinocyte
              carcinomas versus benign seborrheic keratoses; and malignant
              melanomas versus benign nevi. The first case represents the
              identification of the most common cancers, the second represents
              the identification of the deadliest skin cancer. The CNN achieves
              performance on par with all tested experts across both tasks,
              demonstrating an artificial intelligence capable of classifying
              skin cancer with a level of competence comparable to
              dermatologists. Outfitted with deep neural networks, mobile
              devices can potentially extend the reach of dermatologists
              outside of the clinic. It is projected that 6.3 billion
              smartphone subscriptions will exist by the year 2021 (ref. 13)
              and can therefore potentially provide low-cost universal access
              to vital diagnostic care.",
  journal  = "Nature",
  volume   =  542,
  number   =  7639,
  pages    = "115--118",
  month    =  feb,
  year     =  2017,
  keywords = "AI\_healthcare",
  language = "en"
}

@ARTICLE{Titano2018-mx,
  title    = "Automated deep-neural-network surveillance of cranial images for
              acute neurologic events",
  author   = "Titano, Joseph J and Badgeley, Marcus and Schefflein, Javin and
              Pain, Margaret and Su, Andres and Cai, Michael and Swinburne,
              Nathaniel and Zech, John and Kim, Jun and Bederson, Joshua and
              Mocco, J and Drayer, Burton and Lehar, Joseph and Cho, Samuel and
              Costa, Anthony and Oermann, Eric K",
  abstract = "Rapid diagnosis and treatment of acute neurological illnesses
              such as stroke, hemorrhage, and hydrocephalus are critical to
              achieving positive outcomes and preserving neurologic
              function-'time is brain'1-5. Although these disorders are often
              recognizable by their symptoms, the critical means of their
              diagnosis is rapid imaging6-10. Computer-aided surveillance of
              acute neurologic events in cranial imaging has the potential to
              triage radiology workflow, thus decreasing time to treatment and
              improving outcomes. Substantial clinical work has focused on
              computer-assisted diagnosis (CAD), whereas technical work in
              volumetric image analysis has focused primarily on segmentation.
              3D convolutional neural networks (3D-CNNs) have primarily been
              used for supervised classification on 3D modeling and light
              detection and ranging (LiDAR) data11-15. Here, we demonstrate a
              3D-CNN architecture that performs weakly supervised
              classification to screen head CT images for acute neurologic
              events. Features were automatically learned from a clinical
              radiology dataset comprising 37,236 head CTs and were annotated
              with a semisupervised natural-language processing (NLP)
              framework16. We demonstrate the effectiveness of our approach to
              triage radiology workflow and accelerate the time to diagnosis
              from minutes to seconds through a randomized, double-blinded,
              prospective trial in a simulated clinical environment.",
  journal  = "Nat. Med.",
  volume   =  24,
  number   =  9,
  pages    = "1337--1341",
  month    =  sep,
  year     =  2018,
  keywords = "AI\_healthcare",
  language = "en"
}

@MISC{Tyc2016-qt,
  title        = "imreg\_dft",
  author       = "T{\'y}{\v c}, Mat{\v e}j and Gohlke, Christoph",
  publisher    = "GitHub",
  year         =  2016,
  howpublished = "\url{https://github.com/matejak/imreg_dft}"
}

@ARTICLE{Carter1989-of,
  title    = "Relation of tumor size, lymph node status, and survival in 24,740
              breast cancer cases",
  author   = "Carter, C L and Allen, C and Henson, D E",
  abstract = "Two of the most important prognostic indicators for breast cancer
              are tumor size and extent of axillary lymph node involvement.
              Data on 24,740 cases recorded in the Surveillance, Epidemiology,
              and End Results (SEER) Program of the National Cancer Institute
              were used to evaluate the breast cancer survival experience in a
              representative sample of women from the United States. Actuarial
              (life table) methods were used to investigate the 5-year relative
              survival rates in cases with known operative/pathologic axillary
              lymph node status and primary tumor diameter. Survival rates
              varied from 45.5\% for tumor diameters equal to or greater than 5
              cm with positive axillary nodes to 96.3\% for tumors less than 2
              cm and with no involved nodes. The relation between tumor size
              and lymph node status was investigated in detail. Tumor diameter
              and lymph node status were found to act as independent but
              additive prognostic indicators. As tumor size increased, survival
              decreased regardless of lymph node status; and as lymph node
              involvement increased, survival status also decreased regardless
              of tumor size. A linear relation was found between tumor diameter
              and the percent of cases with positive lymph node involvement.
              The results of our analyses suggest that disease progression to
              distant sites does not occur exclusively via the axillary lymph
              nodes, but rather that lymph node status serves as an indicator
              of the tumor's ability to spread.",
  journal  = "Cancer",
  volume   =  63,
  number   =  1,
  pages    = "181--187",
  month    =  jan,
  year     =  1989,
  language = "en"
}

@ARTICLE{Sabour2017-xe,
  title         = "Dynamic Routing Between Capsules",
  author        = "Sabour, Sara and Frosst, Nicholas and Hinton, Geoffrey E",
  abstract      = "A capsule is a group of neurons whose activity vector
                   represents the instantiation parameters of a specific type
                   of entity such as an object or an object part. We use the
                   length of the activity vector to represent the probability
                   that the entity exists and its orientation to represent the
                   instantiation parameters. Active capsules at one level make
                   predictions, via transformation matrices, for the
                   instantiation parameters of higher-level capsules. When
                   multiple predictions agree, a higher level capsule becomes
                   active. We show that a discrimininatively trained,
                   multi-layer capsule system achieves state-of-the-art
                   performance on MNIST and is considerably better than a
                   convolutional net at recognizing highly overlapping digits.
                   To achieve these results we use an iterative
                   routing-by-agreement mechanism: A lower-level capsule
                   prefers to send its output to higher level capsules whose
                   activity vectors have a big scalar product with the
                   prediction coming from the lower-level capsule.",
  month         =  oct,
  year          =  2017,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1710.09829"
}

@ARTICLE{Sullivan2015-we,
  title    = "Global cancer surgery: delivering safe, affordable, and timely
              cancer surgery",
  author   = "Sullivan, Richard and Alatise, Olusegun Isaac and Anderson,
              Benjamin O and Audisio, Riccardo and Autier, Philippe and
              Aggarwal, Ajay and Balch, Charles and Brennan, Murray F and Dare,
              Anna and D'Cruz, Anil and Eggermont, Alexander M M and Fleming,
              Kenneth and Gueye, Serigne Magueye and Hagander, Lars and
              Herrera, Cristian A and Holmer, Hampus and Ilbawi, Andr{\'e} M
              and Jarnheimer, Anton and Ji, Jia-Fu and Kingham, T Peter and
              Liberman, Jonathan and Leather, Andrew J M and Meara, John G and
              Mukhopadhyay, Swagoto and Murthy, Shilpa S and Omar, Sherif and
              Parham, Groesbeck P and Pramesh, C S and Riviello, Robert and
              Rodin, Danielle and Santini, Luiz and Shrikhande, Shailesh V and
              Shrime, Mark and Thomas, Robert and Tsunoda, Audrey T and van de
              Velde, Cornelis and Veronesi, Umberto and Vijaykumar,
              Dehannathparambil Kottarathil and Watters, David and Wang, Shan
              and Wu, Yi-Long and Zeiton, Moez and Purushotham, Arnie",
  abstract = "Surgery is essential for global cancer care in all resource
              settings. Of the 15.2 million new cases of cancer in 2015, over
              80\% of cases will need surgery, some several times. By 2030, we
              estimate that annually 45 million surgical procedures will be
              needed worldwide. Yet, less than 25\% of patients with cancer
              worldwide actually get safe, affordable, or timely surgery. This
              Commission on global cancer surgery, building on Global Surgery
              2030, has examined the state of global cancer surgery through an
              analysis of the burden of surgical disease and breadth of cancer
              surgery, economics and financing, factors for strengthening
              surgical systems for cancer with multiple-country studies, the
              research agenda, and the political factors that frame policy
              making in this area. We found wide equity and economic gaps in
              global cancer surgery. Many patients throughout the world do not
              have access to cancer surgery, and the failure to train more
              cancer surgeons and strengthen systems could result in as much as
              US \$6.2 trillion in lost cumulative gross domestic product by
              2030. Many of the key adjunct treatment modalities for cancer
              surgery--e.g., pathology and imaging--are also inadequate. Our
              analysis identified substantial issues, but also highlights
              solutions and innovations. Issues of access, a paucity of
              investment in public surgical systems, low investment in
              research, and training and education gaps are remarkably
              widespread. Solutions include better regulated public systems,
              international partnerships, super-centralisation of surgical
              services, novel surgical clinical trials, and new approaches to
              improve quality and scale up cancer surgical systems through
              education and training. Our key messages are directed at many
              global stakeholders, but the central message is that to deliver
              safe, affordable, and timely cancer surgery to all, surgery must
              be at the heart of global and national cancer control planning.",
  journal  = "Lancet Oncol.",
  volume   =  16,
  number   =  11,
  pages    = "1193--1224",
  month    =  sep,
  year     =  2015,
  language = "en"
}

@INPROCEEDINGS{Do2010-fc,
  title     = "Neural conditional random fields",
  booktitle = "Proceedings of the Thirteenth International Conference on
               Artificial Intelligence and Statistics",
  author    = "Do, Trinh--minh--tri and Artieres, Thierry",
  editor    = "Teh, Yee Whye and Titterington, Mike",
  abstract  = "We propose a non-linear graphical model for structured
               prediction. It combines the power of deep neural networks to
               extract high level features with the graphical framework of
               Markov networks, yielding a powerful and scalable probabilistic
               model that we apply to signal labeling tasks.",
  publisher = "PMLR",
  volume    =  9,
  pages     = "177--184",
  series    = "Proceedings of Machine Learning Research",
  year      =  2010,
  address   = "Chia Laguna Resort, Sardinia, Italy"
}

@ARTICLE{Novis1997-gy,
  title    = "Interinstitutional comparison of frozen section turnaround time.
              A College of American Pathologists {Q-Probes} study of 32868
              frozen sections in 700 hospitals",
  author   = "Novis, D A and Zarbo, R J",
  abstract = "OBJECTIVES: To study the intraoperative turnaround time for
              performing a frozen section (FS) and to examine pathology
              practice variables that influence it. DESIGN: Over a 4-month
              period in 1995, participants in the College of American
              Pathologists Q-Probes laboratory quality improvement program
              prospectively collected data on up to 30 FS procedures performed
              on elective inpatient surgical cases and completed questionnaires
              profiling their FS practice characteristics. SETTING: Surgical
              pathology laboratories serving private and public hospitals.
              PARTICIPANTS: Seven hundred institutions located in North America
              (667), Australia (12), New Zealand (1), the United Kingdom (3),
              Hong Kong (1), Mexico (1), and Norway (1). MAIN OUTCOME MEASURES:
              The 90\% FS block completion time defined as the time interval,
              in minutes, within which the fastest 90\% of all FS blocks were
              completed, measured from the time pathologists received FS
              specimens to the time they communicated FS results to the
              surgeon. RESULTS: Participants submitted data on 32868 FS blocks.
              Ninety percent of FS procedures were completed within 20 minutes.
              Frozen section turnaround times exceeding 20 minutes, termed
              outlier turnaround times, were more likely to occur when more
              than one pathologist participated in the FS diagnosis, pathology
              residents and medical students participated in the FS procedure,
              the pathologist had to retrieve and review previous case material
              during the FS procedure, the pathologist simultaneously received
              additional specimens from other FS cases, the pathologist was
              unable to reach a final FS diagnosis, and when technical problems
              occurred during the FS procedure. Seventy percent of all
              participating hospitals completed 90\% of their frozen sections
              within 20 minutes. The institutional 90\% completion times were
              shorter for hospitals containing 300 or fewer occupied beds than
              for those containing more than 300 occupied beds. CONCLUSIONS:
              The data suggest that 90\% of FS block turnaround times can be
              performed within 20 minutes, measured from the time that
              pathologists receive FS specimens to the time that pathologists
              return FS diagnoses to surgeons.",
  journal  = "Arch. Pathol. Lab. Med.",
  volume   =  121,
  number   =  6,
  pages    = "559--567",
  month    =  jun,
  year     =  1997,
  language = "en"
}

@ARTICLE{Gal2005-na,
  title    = "The 100-year anniversary of the description of the frozen section
              procedure",
  author   = "Gal, Anthony A and Cagle, Philip T",
  journal  = "JAMA",
  volume   =  294,
  number   =  24,
  pages    = "3135--3137",
  month    =  dec,
  year     =  2005,
  language = "en"
}

@ARTICLE{Kuzmin2016-gh,
  title    = "Third harmonic generation imaging for fast, label-free pathology
              of human brain tumors",
  author   = "Kuzmin, N V and Wesseling, P and Hamer, P C de Witt and Noske, D
              P and Galgano, G D and Mansvelder, H D and Baayen, J C and Groot,
              M L",
  abstract = "In brain tumor surgery, recognition of tumor boundaries is key.
              However, intraoperative assessment of tumor boundaries by the
              neurosurgeon is difficult. Therefore, there is an urgent need for
              tools that provide the neurosurgeon with pathological information
              during the operation. We show that third harmonic generation
              (THG) microscopy provides label-free, real-time images of
              histopathological quality; increased cellularity, nuclear
              pleomorphism, and rarefaction of neuropil in fresh, unstained
              human brain tissue could be clearly recognized. We further
              demonstrate THG images taken with a GRIN objective, as a step
              toward in situ THG microendoscopy of tumor boundaries. THG
              imaging is thus a promising tool for optical biopsies.",
  journal  = "Biomed. Opt. Express",
  volume   =  7,
  number   =  5,
  pages    = "1889--1904",
  month    =  may,
  year     =  2016,
  keywords = "(170.1530) Cell analysis; (170.2150) Endoscopic imaging;
              (170.4730) Optical pathology; (170.6935) Tissue characterization;
              (180.4315) Nonlinear microscopy; (190.4160) Multiharmonic
              generation",
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Jermyn2016-cv,
  title     = "Raman spectroscopy detects distant invasive brain cancer cells
               centimeters beyond {MRI} capability in humans",
  author    = "Jermyn, Michael and Desroches, Joannie and Mercier, Jeanne and
               St-Arnaud, Karl and Guiot, Marie-Christine and Leblond, Frederic
               and Petrecca, Kevin",
  abstract  = "Surgical treatment of brain cancer is limited by the inability
               of current imaging capabilities such as magnetic resonance
               imaging (MRI) to detect the entirety of this locally invasive
               cancer. This results in residual cancer cells remaining
               following surgery, leading to recurrence and death. We
               demonstrate that intraoperative Raman spectroscopy can detect
               invasive cancer cells centimeters beyond pathological
               T1-contrast-enhanced and T2- weighted MRI signals. This
               intraoperative optical guide can be used to detect invasive â€¦",
  journal   = "Biomed. Opt. Express",
  publisher = "Optical Society of America",
  volume    =  7,
  number    =  12,
  pages     = "5129--5137",
  year      =  2016
}

@ARTICLE{Wen2010-op,
  title    = "Updated response assessment criteria for high-grade gliomas:
              response assessment in neuro-oncology working group",
  author   = "Wen, Patrick Y and Macdonald, David R and Reardon, David A and
              Cloughesy, Timothy F and Sorensen, A Gregory and Galanis,
              Evanthia and Degroot, John and Wick, Wolfgang and Gilbert, Mark R
              and Lassman, Andrew B and Tsien, Christina and Mikkelsen, Tom and
              Wong, Eric T and Chamberlain, Marc C and Stupp, Roger and
              Lamborn, Kathleen R and Vogelbaum, Michael A and van den Bent,
              Martin J and Chang, Susan M",
  abstract = "Currently, the most widely used criteria for assessing response
              to therapy in high-grade gliomas are based on two-dimensional
              tumor measurements on computed tomography (CT) or magnetic
              resonance imaging (MRI), in conjunction with clinical assessment
              and corticosteroid dose (the Macdonald Criteria). It is
              increasingly apparent that there are significant limitations to
              these criteria, which only address the contrast-enhancing
              component of the tumor. For example, chemoradiotherapy for newly
              diagnosed glioblastomas results in transient increase in tumor
              enhancement (pseudoprogression) in 20\% to 30\% of patients,
              which is difficult to differentiate from true tumor progression.
              Antiangiogenic agents produce high radiographic response rates,
              as defined by a rapid decrease in contrast enhancement on CT/MRI
              that occurs within days of initiation of treatment and that is
              partly a result of reduced vascular permeability to contrast
              agents rather than a true antitumor effect. In addition, a subset
              of patients treated with antiangiogenic agents develop tumor
              recurrence characterized by an increase in the nonenhancing
              component depicted on T2-weighted/fluid-attenuated inversion
              recovery sequences. The recognition that contrast enhancement is
              nonspecific and may not always be a true surrogate of tumor
              response and the need to account for the nonenhancing component
              of the tumor mandate that new criteria be developed and validated
              to permit accurate assessment of the efficacy of novel therapies.
              The Response Assessment in Neuro-Oncology Working Group is an
              international effort to develop new standardized response
              criteria for clinical trials in brain tumors. In this proposal,
              we present the recommendations for updated response criteria for
              high-grade gliomas.",
  journal  = "J. Clin. Oncol.",
  volume   =  28,
  number   =  11,
  pages    = "1963--1972",
  month    =  apr,
  year     =  2010,
  language = "en"
}

@ARTICLE{Sanai2011-op,
  title    = "Intraoperative confocal microscopy for brain tumors: a
              feasibility analysis in humans",
  author   = "Sanai, Nader and Eschbacher, Jennifer and Hattendorf, Guido and
              Coons, Stephen W and Preul, Mark C and Smith, Kris A and Nakaji,
              Peter and Spetzler, Robert F",
  abstract = "BACKGROUND: The ability to diagnose brain tumors intraoperatively
              and identify tumor margins during resection could maximize
              resection and minimize morbidity. Advances in optical imaging
              enabled production of a handheld intraoperative confocal
              microscope. OBJECTIVE: To present a feasibility analysis of the
              intraoperative confocal microscope for brain tumor resection.
              METHODS: Thirty-three patients with brain tumor treated at Barrow
              Neurological Institute were examined. All patients received an
              intravenous bolus of sodium fluorescein before confocal imaging
              with the Optiscan FIVE 1 system probe. Optical biopsies were
              obtained within each tumor and along the tumor-brain interfaces.
              Corresponding pathologic specimens were then excised and
              processed. These data was compared by a neuropathologist to
              identify the concordance for tumor histology, grade, and margins.
              RESULTS: Thirty-one of 33 lesions were tumors (93.9\%) and 2
              cases were identified as radiation necrosis (6.1\%). Of the
              former, 25 (80.6\%) were intra-axial and 6 (19.4\%) were
              extra-axial. Intra-axial tumors were most commonly gliomas and
              metastases, while all extra-axial tumors were meningiomas. Among
              high-grade gliomas, vascular neoproliferation, as well as tumor
              margins, were identifiable using confocal imaging. Meningothelial
              and fibrous meningiomas were distinct on confocal microscopy--the
              latter featured spindle-shaped cells distinguishable from
              adjacent parenchyma. Other tumor histologies correlated well with
              standard neuropathology tissue preparations. CONCLUSION:
              Intraoperative confocal microscopy is a practicable technology
              for the resection of human brain tumors. Preliminary analysis
              demonstrates reliability for a variety of lesions in identifying
              tumor cells and the tumor-brain interface. Further refinement of
              this technology depends upon the approval of tumor-specific
              fluorescent contrast agents for human use.",
  journal  = "Neurosurgery",
  volume   =  68,
  number   = "2 Suppl Operative",
  pages    = "282--90; discussion 290",
  month    =  jun,
  year     =  2011,
  language = "en"
}

@ARTICLE{Lau2016-rx,
  title    = "A prospective Phase {II} clinical trial of 5-aminolevulinic acid
              to assess the correlation of intraoperative fluorescence
              intensity and degree of histologic cellularity during resection
              of high-grade gliomas",
  author   = "Lau, Darryl and Hervey-Jumper, Shawn L and Chang, Susan and
              Molinaro, Annette M and McDermott, Michael W and Phillips, Joanna
              J and Berger, Mitchel S",
  abstract = "OBJECT There is evidence that 5-aminolevulinic acid (ALA)
              facilitates greater extent of resection and improves 6-month
              progression-free survival in patients with high-grade gliomas.
              But there remains a paucity of studies that have examined whether
              the intensity of ALA fluorescence correlates with tumor
              cellularity. Therefore, a Phase II clinical trial was undertaken
              to examine the correlation of intensity of ALA fluorescence with
              the degree of tumor cellularity. METHODS A single-center,
              prospective, single-arm, open-label Phase II clinical trial of
              ALA fluorescence-guided resection of high-grade gliomas (Grade
              III and IV) was held over a 43-month period (August 2010 to
              February 2014). ALA was administered at a dose of 20 mg/kg body
              weight. Intraoperative biopsies from resection cavities were
              collected. The biopsies were graded on a 4-point scale (0 to 3)
              based on ALA fluorescence intensity by the surgeon and
              independently based on tumor cellularity by a neuropathologist.
              The primary outcome of interest was the correlation of ALA
              fluorescence intensity to tumor cellularity. The secondary
              outcome of interest was ALA adverse events. Sensitivities,
              specificities, positive predictive values (PPVs), negative
              predictive values (NPVs), and Spearman correlation coefficients
              were calculated. RESULTS A total of 211 biopsies from 59 patients
              were included. Mean age was 53.3 years and 59.5\% were male. The
              majority of biopsies were glioblastoma (GBM) (79.7\%). Slightly
              more than half (52.5\%) of all tumors were recurrent. ALA
              intensity of 3 correlated with presence of tumor 97.4\% (PPV) of
              the time. However, absence of ALA fluorescence (intensity 0)
              correlated with the absence of tumor only 37.7\% (NPV) of the
              time. For all tumor types, GBM, Grade III gliomas, and recurrent
              tumors, ALA intensity 3 correlated strongly with cellularity
              Grade 3; Spearman correlation coefficients (r) were 0.65, 0.66,
              0.65, and 0.62, respectively. The specificity and PPV of ALA
              intensity 3 correlating with cellularity Grade 3 ranged from 95\%
              to 100\% and 86\% to 100\%, respectively. In biopsies without
              tumor (cellularity Grade 0), 35.4\% still demonstrated ALA
              fluorescence. Of those biopsies, 90.9\% contained abnormal brain
              tissue, characterized by reactive astrocytes, scattered atypical
              cells, or inflammation, and 8.1\% had normal brain. In
              nonfluorescent (ALA intensity 0) biopsies, 62.3\% had tumor cells
              present. The ALA-associated complication rate among the study
              cohort was 3.4\%. CONCLUSIONS The PPV of utilizing the most
              robust ALA fluorescence intensity (lava-like orange) as a
              predictor of tumor presence is high. However, the NPV of
              utilizing the absence of fluorescence as an indicator of no tumor
              is poor. ALA intensity is a strong predictor for degree of tumor
              cellularity for the most fluorescent areas but less so for lower
              ALA intensities. Even in the absence of tumor cells, reactive
              changes may lead to ALA fluorescence.",
  journal  = "J. Neurosurg.",
  volume   =  124,
  number   =  5,
  pages    = "1300--1309",
  month    =  may,
  year     =  2016,
  keywords = "ALA = 5-aminolevulinic acid; EOR = extent of resection; GBM =
              glioblastoma; GTR = gross-total resection; H \& E = hematoxylin
              and eosin; LFT = liver function test; NPV = negative predictive
              value; PPV = positive predictive value; WHO = World Health
              Organization; aminolevulinic acid; cellularity; fluorescence;
              glioblastoma; high-grade glioma; oncology",
  language = "en"
}

@ARTICLE{Calligaris2015-mu,
  title    = "{MALDI} mass spectrometry imaging analysis of pituitary adenomas
              for near-real-time tumor delineation",
  author   = "Calligaris, David and Feldman, Daniel R and Norton, Isaiah and
              Olubiyi, Olutayo and Changelian, Armen N and Machaidze, Revaz and
              Vestal, Matthew L and Laws, Edward R and Dunn, Ian F and
              Santagata, Sandro and Agar, Nathalie Y R",
  abstract = "We present a proof of concept study designed to support the
              clinical development of mass spectrometry imaging (MSI) for the
              detection of pituitary tumors during surgery. We analyzed by
              matrix-assisted laser desorption/ionization (MALDI) MSI six
              nonpathological (NP) human pituitary glands and 45 hormone
              secreting and nonsecreting (NS) human pituitary adenomas. We show
              that the distribution of pituitary hormones such as prolactin
              (PRL), growth hormone (GH), adrenocorticotropic hormone (ACTH),
              and thyroid stimulating hormone (TSH) in both normal and tumor
              tissues can be assessed by using this approach. The presence of
              most of the pituitary hormones was confirmed by using MS/MS and
              pseudo-MS/MS methods, and subtyping of pituitary adenomas was
              performed by using principal component analysis (PCA) and support
              vector machine (SVM). Our proof of concept study demonstrates
              that MALDI MSI could be used to directly detect excessive
              hormonal production from functional pituitary adenomas and
              generally classify pituitary adenomas by using statistical and
              machine learning analyses. The tissue characterization can be
              completed in fewer than 30 min and could therefore be applied for
              the near-real-time detection and delineation of pituitary tumors
              for intraoperative surgical decision-making.",
  journal  = "Proc. Natl. Acad. Sci. U. S. A.",
  volume   =  112,
  number   =  32,
  pages    = "9978--9983",
  month    =  aug,
  year     =  2015,
  keywords = "in-source decay; intrasurgical diagnosis; mass spectrometry
              imaging; molecular pathology; pituitary",
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Santagata2013-ko,
  title     = "Metabolite-imaging Mass Spectrometry to Guide Brain Surgery",
  author    = "Santagata, S and Eberlin, L and Norton, I and {others}",
  journal   = "JOURNAL OF",
  publisher = "LIPPINCOTT WILLIAMS \& WILKINS â€¦",
  year      =  2013
}

@INCOLLECTION{Lee2008-zr,
  title     = "Sparse deep belief net model for visual area {V2}",
  booktitle = "Advances in Neural Information Processing Systems 20",
  author    = "Lee, Honglak and Ekanadham, Chaitanya and Ng, Andrew Y",
  editor    = "Platt, J C and Koller, D and Singer, Y and Roweis, S T",
  publisher = "Curran Associates, Inc.",
  pages     = "873--880",
  year      =  2008
}

@ARTICLE{Brichard2018-rs,
  title    = "Outcome of Transsphenoidal Surgery for Cushing Disease: A
              {Single-Center} Experience over 20 Years",
  author   = "Brichard, Camille and Costa, Emmanuel and Fomekong, Edward and
              Maiter, Dominique and Raftopoulos, Christian",
  abstract = "BACKGROUND: This study investigated the outcome of
              transsphenoidal surgery (TSS) for Cushing disease (CD) and the
              influence of our surgical strategy on remission rates and
              postoperative pituitary function. PATIENTS AND METHODS: We
              retrospectively reviewed data from 71 patients with CD who
              underwent microscope navigation TSS (MN-TSS) in Saint-Luc
              Hospital between 1996 and 2017. True remission was defined as
              normal fasting cortisol level, normal 24-hour urinary free
              cortisol, or continued need for hydrocortisone replacement for 1
              year after surgery. RESULTS: Overall remission rate after 1 or
              repeated MN-TSS was 83\%. Highest remission rate was found in
              patients with macroadenomas (92\%). Successful first MN-TSS was
              correlated with a high final remission rate (95\%), whereas
              failed first MN-TSS was correlated with a low final remission
              rate (36\%). Although day 1 cortisol levels were significantly
              lower in patients with long-term remission, high levels were
              still observed in a few patients, especially those who had had CD
              for many years. We found a low rate of postoperative pituitary
              long-term hypofunction (9.7\%). CONCLUSIONS: MN-TSS is a safe and
              effective procedure to treat CD, allowing remission rates of
              83\%. One-year remission period after first surgery is correlated
              with a final remission rate of 95\%. Although day 1 morning
              cortisol value is the most significant predictor for long-term
              remission, some patients with CD for many years may keep high
              postoperative cortisol levels and be in later remission, likely
              because of secondary adrenal hyperplasia. Our focused approach
              with microscope navigation resulted in low rates of postoperative
              pituitary hypofunction and kept a recurrence rate comparable to
              that in the literature.",
  journal  = "World Neurosurg.",
  volume   =  119,
  pages    = "e106--e117",
  month    =  nov,
  year     =  2018,
  keywords = "ACTH; Cortisol; Cushing disease; Hypercorticism; Macroadenoma;
              Microadenoma; Microscope navigation; Remission; Transsphenoidal
              surgery",
  language = "en"
}

@ARTICLE{Hollon2019-bc,
  title    = "Surgical Adjuncts to Increase the Extent of Resection:
              Intraoperative {MRI}, Fluorescence, and Raman Histology",
  author   = "Hollon, Todd and Stummer, Walter and Orringer, Daniel and Suero
              Molina, Eric",
  abstract = "In low-grade glioma surgery, depicting tumor margins is
              challenging. 7 - Bowden 2018 - Sodium Fluorescein Facilitates
              Guided Sampling of Diagnostic Tumor Tissue.pdf Several tools have
              emerged to assist surgical decision-making. Intraoperative MRI,
              albeit expensive and time-consuming, can provide useful
              information during surgery. Fluorescence-guidance with
              5-aminolevulinic acid (5-ALA) helps provide real-time information
              during surgery regardless of brain-shift, assists in finding
              anaplastic foci in low-grade tumors, and enables diagnosis of
              malignant tissue. Raman histology has potential for detecting
              viable tumor in biopsied tissue and for identifying tumor
              infiltration in vivo. This article analyzes and discusses these
              surgical adjuncts.",
  journal  = "Neurosurg. Clin. N. Am.",
  volume   =  30,
  number   =  1,
  pages    = "65--74",
  month    =  jan,
  year     =  2019,
  keywords = "5-Aminolevulnic acid; Fluorescence-guided resections;
              Intraoperative MRI; Low-grade glioma; Raman spectroscopy;
              Stimulated Raman histology;My\_papers",
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Hollon2016-zg,
  title     = "Surgical Management of Skull Base {Rosai--Dorfman} Disease",
  author    = "Hollon, T and Camelo-Piragua, S I and McKean, E L and {others}",
  abstract  = "Background and Importance Rosai--Dorfman disease is a rare
               benign histiocytic proliferative disorder with a self-limiting
               clinical course. Skull base Rosai--Dorfman disease presents with
               intracranial lesions that often mimic meningiomas and other
               benign skull base tumors. The â€¦",
  journal   = "World Neurosurg.",
  publisher = "Elsevier",
  year      =  2016,
  keywords  = "My\_papers"
}

@ARTICLE{Saadeh2018-oc,
  title    = "Primary diffuse leptomeningeal melanomatosis: Description and
              recommendations",
  author   = "Saadeh, Yamaan S and Hollon, Todd C and Fisher-Hubbard, Amanda
              and Savastano, Luis E and McKeever, Paul E and Orringer, Daniel A",
  abstract = "Primary melanocytic disease of the central nervous system is a
              rarely encountered condition currently without consensus on
              treatment and lacking major guidelines for management.
              Understanding the nature of the disease and differentiating
              primary melanocytic disease from the much more commonly
              encountered secondary (metastatic) melanoma is important in
              identifying the condition and pursuing appropriate treatment.",
  journal  = "J. Clin. Neurosci.",
  volume   =  50,
  pages    = "139--143",
  month    =  apr,
  year     =  2018,
  keywords = "Central nervous system; Hydrocephalus; Leptomeningeal
              melanomatosis; Melanocytic disease;My\_papers",
  language = "en"
}

@ARTICLE{Hollon2018-vt,
  title    = "Microvascular Brainstem Ischemia After Vestibular Schwannoma
              Surgery: A Clinical and Microanatomic Study",
  author   = "Hollon, Todd C and Savastano, Luis E and Argersinger, Davis P and
              Quint, Douglas J and Thompson, B Gregory",
  abstract = "OBJECTIVE: To identify a potential microvascular etiology in
              patients who underwent vestibular schwannoma surgery (VSS)
              complicated by postoperative microvascular brainstem ischemia.
              METHODS: Charts were retrospectively reviewed of all patients who
              had an MRI within 14 days of VSS in years 2005-2016. Patient
              characteristics, preoperative and postoperative imaging features,
              clinical course and potential predictors of brainstem ischemia
              were recorded. Cadaveric dissections of 4 cerebellopontine angle
              (CPA) cisterns with focus on the anterior inferior cerebellar
              artery (AICA) microvascular were also performed to identify
              candidate vessels and potential etiology. RESULTS: Fifty-four of
              258 patients had an MRI within 14 days of VSS. Retrosigmoid
              approach was used in 61.1\% of patients, translabyrinthine
              approach in 25.9\%, and middle fossa approach in 13.0\%. Four
              patients (7.4\%) had acute microvascular ischemia involving the
              middle cerebellar peduncle (MCP) adjacent to the cranial nerve
              (CN) VII-VIII complex demonstrated on postoperative MRI. A
              statistically significant association was found between the
              translabyrinthine approach and acute brainstem ischemia (odds
              ratio, 10.6; 95\% confidence interval, 1.004-112.7). Dissection
              of CPAs revealed 10-20 perforating arteries per specimen
              originating from the lateral pontine and the flocculopeduncular
              segments of the AICA. Most microvessels travelled in retrograde
              fashion along the anteroinferior surface of the CN VII-VIII
              complex to perforate the cisternal surface of the MCP. No patient
              had residual or delayed neurologic deficits related to brainstem
              ischemia at final follow-up. CONCLUSIONS: While effort should be
              made to preserve perforating vessels, microvascular brainstem
              ischemia is often asymptomatic and did not lead to permanent
              neurologic deficits in our series.",
  journal  = "World Neurosurg.",
  volume   =  112,
  pages    = "e415--e424",
  month    =  apr,
  year     =  2018,
  keywords = "Anterior inferior cerebellar artery; Brainstem; Cerebellopontine
              angle cistern; Middle cerebellar peduncle; Vestibular schwannoma
              surgery;My\_papers",
  language = "en"
}

@ARTICLE{Hollon2018-vp,
  title    = "Ventriculoscopic Surgery for Cystic Retrochiasmatic
              Craniopharyngiomas: Indications, Surgical Technique, and
              {Short-Term} Patient Outcomes",
  author   = "Hollon, Todd C and Savastano, Luis E and Altshuler, David and
              Barkan, Ariel L and Sullivan, Stephen E",
  abstract = "BACKGROUND: Attempted gross-total resection for the management of
              cystic retrochiasmatic craniopharyngiomas can cause severe
              hypothalamic dysfunction and decrease overall survival.
              Ventriculoscopic surgery is a minimally invasive alternative;
              however, potential indications and technique have not been well
              defined. OBJECTIVE: To present our indications and technique for
              the ventriculoscopic treatment of cystic retrochiasmatic
              craniopharyngiomas. METHODS: We evaluated all patients with
              retrochiasmatic craniopharyngiomas for ventriculoscopic surgery.
              Indications and operative technique were developed to minimize
              operative morbidity, relieve mass effect, and optimize functional
              outcome. Cyst size and functional outcomes were statistically
              evaluated to determine radiographic and short-term clinical
              outcome. RESULTS: Indications for ventriculoscopic surgery
              included (1) radiographic evidence of hypothalamic involvement
              and (2) major cystic component. Ten patients met indications, and
              mean follow-up was 2.5 $\pm$ 1.6 yr. The surgical technique
              included wide cyst fenestration at the foramen of Monro, and
              fenestration of inferior cyst wall/third ventriculostomy
              (``through-and-through'' technique). Preoperative Karnofsky
              performance status was 70 $\pm$ 15 and was inversely correlated
              with preoperative cyst size (13 $\pm$ 13 cm3). A statistically
              significant reduction in cyst size was found on early
              postoperative imaging (2.1 $\pm$ 4.3 cm3). Seven patients
              received postoperative radiotherapy. Postoperative performance
              scores (81 $\pm$ 8.3) had improved; no patient suffered
              functional decline. Pre- and postoperative body mass indices were
              similar. No patient had short-term hypothalamic obesity.
              CONCLUSION: Ventriculoscopic surgery, with or without adjuvant
              treatments, can reduce early postoperative tumor volume and
              improve short-term functional status in cystic retrochiasmatic
              craniopharyngiomas with hypothalamic involvement; it should be
              considered a minimally invasive option in the multimodal
              treatment of craniopharyngiomas. Further studies are needed to
              determine long-term efficacy.",
  journal  = "Oper Neurosurg (Hagerstown)",
  volume   =  15,
  number   =  2,
  pages    = "109--119",
  month    =  aug,
  year     =  2018,
  keywords = "My\_papers",
  language = "en"
}

@ARTICLE{Khalsa2017-nm,
  title    = "Spontaneous subarachnoid hemorrhage due to ruptured cavernous
              internal carotid artery aneurysm after medical prolactinoma
              treatment",
  author   = "Khalsa, Siri Sahib and Hollon, Todd C and Shastri, Ravi and
              Trobe, Jonathan D and Gemmete, Joseph J and Pandey, Aditya S",
  abstract = "Aneurysms of the cavernous segment of the internal carotid artery
              (ICA) are believed to have a low risk of subarachnoid haemorrhage
              (SAH), given the confines of the dural rings and the anterior
              clinoid process. The risk may be greater when the bony and dural
              protection has been eroded. We report a case of spontaneous SAH
              from rupture of a cavernous ICA aneurysm in a patient whose large
              prolactinoma had markedly decreased in size as the result of
              cabergoline treatment. After passing a balloon test occlusion,
              the patient underwent successful endovascular vessel
              deconstruction. This case suggests that an eroding skull base
              lesion may distort normal anterior cranial base anatomy and allow
              communication between the cavernous ICA and subarachnoid space.
              The potential for SAH due to cavernous ICA aneurysm rupture
              should be recognised in patients with previous pituitary or other
              skull base lesions adjacent to the cavernous sinus.",
  journal  = "J. Neurointerv. Surg.",
  volume   =  9,
  number   =  3,
  pages    = "e9",
  month    =  mar,
  year     =  2017,
  keywords = "Aneurysm; Hemorrhage; Stroke; Subarachnoid;My\_papers",
  language = "en"
}

@ARTICLE{Franko2018-wi,
  title    = "Clinical Factors Associated With {ICU-Specific} Care Following
              Supratentoral Brain Tumor Resection and Validation of a Risk
              Prediction Score",
  author   = "Franko, Lynze R and Hollon, Todd and Linzey, Joseph and Roark,
              Christopher and Rajajee, Venkatakrishna and Sheehan, Kyle and
              Teig, Magnus and Hervey-Jumper, Shawn and Heth, Jason and
              Orringer, Daniel and Williamson, Craig A",
  abstract = "OBJECTIVES: The postoperative management of patients who undergo
              brain tumor resection frequently occurs in an ICU. However, the
              routine admission of all patients to an ICU following surgery is
              controversial. This study seeks to identify the frequency with
              which patients undergoing elective supratentorial tumor resection
              require care, aside from frequent neurologic checks, that is
              specific to an ICU and to determine the frequency of new
              complications during ICU admission. Additionally, clinical
              predictors of ICU-specific care are identified, and a scoring
              system to discriminate patients most likely to require
              ICU-specific treatment is validated. DESIGN: Retrospective
              observational cohort study. SETTING: Academic neurosurgical
              center. PATIENTS: Two-hundred consecutive adult patients who
              underwent supratentorial brain tumor surgery. An additional 100
              consecutive patients were used to validate the prediction score.
              INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Univariate
              statistics and multivariable logistic regression were used to
              identify clinical characteristics associated with ICU-specific
              treatment. Eighteen patients (9\%) received ICU-specific care,
              and 19 (9.5\%) experienced new complications or underwent
              emergent imaging while in the ICU. Factors significantly
              associated with ICU-specific care included nonelective admission,
              preoperative Glasgow Coma Scale, and volume of IV fluids. A
              simple clinical scoring system that included Karnofsky
              Performance Status less than 70 (1 point), general endotracheal
              anesthesia (1 point), and any early postoperative complications
              (2 points) demonstrated excellent ability to discriminate
              patients who required ICU-specific care in both the derivation
              and validation cohorts. CONCLUSIONS: Less than 10\% of patients
              required ICU-specific care following supratentorial tumor
              resection. A simple clinical scoring system may aid clinicians in
              stratifying the risk of requiring ICU care and could inform
              triage decisions when ICU bed availability is limited.",
  journal  = "Crit. Care Med.",
  volume   =  46,
  number   =  8,
  pages    = "1302--1308",
  month    =  aug,
  year     =  2018,
  language = "en"
}

@ARTICLE{Savastano2018-ts,
  title    = "Korsakoff syndrome from retrochiasmatic suprasellar lesions:
              rapid reversal after relief of cerebral compression in 4 cases",
  author   = "Savastano, Luis E and Hollon, Todd C and Barkan, Ariel L and
              Sullivan, Stephen E",
  abstract = "Korsakoff syndrome is a chronic memory disorder caused by a
              severe deficiency of thiamine that is most commonly observed in
              alcoholics. However, some have proposed that focal structural
              lesions disrupting memory circuits-in particular, the mammillary
              bodies, the mammillothalamic tract, and the anterior thalamus-can
              give rise to this amnestic syndrome. Here, the authors present 4
              patients with reversible Korsakoff syndromes caused by
              suprasellar retrochiasmatic lesions compressing the mammillary
              bodies and adjacent caudal hypothalamic structures. Three of the
              patients were found to have large pituitary macroadenomas in
              their workup for memory deficiency and cognitive decline with
              minimal visual symptoms. These tumors extended superiorly into
              the suprasellar region in a retrochiasmatic position and caused
              significant mass effect in the bilateral mammillary bodies in the
              base of the brain. These 3 patients had complete and rapid
              resolution of amnestic problems shortly after initiation of
              treatment, consisting of resection in 1 case of nonfunctioning
              pituitary adenoma or cabergoline therapy in 2 cases of
              prolactinoma. The fourth patient presented with bizarre and
              hostile behavior along with significant memory deficits and was
              found to have a large cystic craniopharyngioma filling the third
              ventricle and compressing the midline diencephalic structures.
              This patient underwent cyst fenestration and tumor debulking,
              with a rapid improvement in his mental status. The rapid and
              dramatic memory improvement observed in all of these cases is
              probably due to a reduction in the pressure imposed by the
              lesions on structures contiguous to the third ventricle, rather
              than a direct destructive effect of the tumor, and highlights the
              essential role of the caudal diencephalic structures-mainly the
              mammillary bodies-in memory function. In summary, large pituitary
              lesions with suprasellar retrochiasmatic extension and third
              ventricular craniopharyngiomas can cause severe Korsakoff-like
              amnestic syndromes, probably because of bilateral pressure on or
              damage to mammillary bodies, anterior thalamic nuclei, or their
              major connections. Neuropsychiatric symptoms may rapidly and
              completely reverse shortly after initiation of therapy via
              surgical decompression of tumors or pharmacological treatment of
              prolactinomas. Early identification of these lesions with timely
              treatment can lead to a favorable prognosis for this severe
              neuropsychiatric disorder.",
  journal  = "J. Neurosurg.",
  volume   =  128,
  number   =  6,
  pages    = "1731--1736",
  month    =  jun,
  year     =  2018,
  keywords = "IGF-1 = insulin-like growth factor 1; Korsakoff syndrome;
              Korsakoff-like amnestic syndrome; craniopharyngioma; mammillary
              body compression; oncology; pituitary macroadenoma; pituitary
              surgery;My\_papers",
  language = "en"
}

@ARTICLE{Wertz2016-xj,
  title    = "Surgical Treatment of Esthesioneuroblastoma: Major Complication
              Rates, Progression Free and Overall Survival",
  author   = "Wertz, Aileen and Hollon, Todd and Marentette, Lawrence and
              Sullivan, Stephen and Mckean, Erin",
  abstract = "Thieme E-Books \& E-Journals",
  journal  = "J. Neurol. Surg. B Skull Base",
  volume   =  77,
  number   = "S 01",
  pages    = "A003",
  month    =  mar,
  year     =  2016,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Juarez-Chambi2019-ue,
  title     = "{AI-Assisted} In Situ Detection of Human Glioma Infiltration
               Using a Novel Computational Method for Optical Coherence
               Tomography",
  author    = "Juarez-Chambi, Ronald M and Kut, Carmen and Rico-Jimenez, Jose J
               and Chaichana, Kaisorn L and Xi, Jiefeng and Campos-Delgado,
               Daniel U and Rodriguez, Fausto J and Quinones-Hinojosa, Alfredo
               and Li, Xingde and Jo, Javier A",
  abstract  = "PURPOSE: In glioma surgery, it is critical to maximize tumor
               resection without compromising adjacent noncancerous brain
               tissue. Optical coherence tomography (OCT) is a noninvasive,
               label-free, real-time, high-resolution imaging modality that has
               been explored for glioma infiltration detection. Here, we report
               a novel artificial intelligence (AI)-assisted method for
               automated, real-time, in situ detection of glioma infiltration
               at high spatial resolution. EXPERIMENTAL DESIGN: Volumetric OCT
               datasets were intraoperatively obtained from resected brain
               tissue specimens of 21 patients with glioma tumors of different
               stages and labeled as either noncancerous or glioma-infiltrated
               on the basis of histopathology evaluation of the tissue
               specimens (gold standard). Labeled OCT images from 12 patients
               were used as the training dataset to develop the AI-assisted
               OCT-based method for automated detection of glioma-infiltrated
               brain tissue. Unlabeled OCT images from the other 9 patients
               were used as the validation dataset to quantify the method
               detection performance. RESULTS: Our method achieved excellent
               levels of sensitivity (âˆ¼100\%) and specificity (âˆ¼85\%) for
               detecting glioma-infiltrated tissue with high spatial resolution
               (16 $\mu$m laterally) and processing speed (âˆ¼100,020 OCT
               A-lines/second). CONCLUSIONS: Previous methods for OCT-based
               detection of glioma-infiltrated brain tissue rely on estimating
               the tissue optical attenuation coefficient from the OCT signal,
               which requires sacrificing spatial resolution to increase signal
               quality, and performing systematic calibration procedures using
               tissue phantoms. By overcoming these major challenges, our
               AI-assisted method will enable implementing practical OCT-guided
               surgical tools for continuous, real-time, and accurate
               intraoperative detection of glioma-infiltrated brain tissue,
               facilitating maximal glioma resection and superior surgical
               outcomes for patients with glioma.",
  journal   = "Clin. Cancer Res.",
  publisher = "AACR",
  month     =  jul,
  year      =  2019,
  language  = "en"
}

@ARTICLE{Topol2019-oc,
  title    = "High-performance medicine: the convergence of human and
              artificial intelligence",
  author   = "Topol, Eric J",
  abstract = "The use of artificial intelligence, and the deep-learning subtype
              in particular, has been enabled by the use of labeled big data,
              along with markedly enhanced computing power and cloud storage,
              across all sectors. In medicine, this is beginning to have an
              impact at three levels: for clinicians, predominantly via rapid,
              accurate image interpretation; for health systems, by improving
              workflow and the potential for reducing medical errors; and for
              patients, by enabling them to process their own data to promote
              health. The current limitations, including bias, privacy and
              security, and lack of transparency, along with the future
              directions of these applications will be discussed in this
              article. Over time, marked improvements in accuracy,
              productivity, and workflow will likely be actualized, but whether
              that will be used to improve the patient-doctor relationship or
              facilitate its erosion remains to be seen.",
  journal  = "Nat. Med.",
  volume   =  25,
  number   =  1,
  pages    = "44--56",
  month    =  jan,
  year     =  2019,
  language = "en"
}

@ARTICLE{Evans2008-wq,
  title    = "Coherent anti-stokes Raman scattering microscopy: chemical
              imaging for biology and medicine",
  author   = "Evans, Conor L and Xie, X Sunney",
  abstract = "Coherent anti-Stokes Raman scattering (CARS) microscopy is a
              label-free imaging technique that is capable of real-time,
              nonperturbative examination of living cells and organisms based
              on molecular vibrational spectroscopy. Recent advances in
              detection schemes, understanding of contrast mechanisms, and
              developments of laser sources have enabled superb sensitivity and
              high time resolution. Emerging applications, such as metabolite
              and drug imaging and tumor identification, raise many exciting
              new possibilities for biology and medicine.",
  journal  = "Annu. Rev. Anal. Chem.",
  volume   =  1,
  pages    = "883--909",
  year     =  2008,
  language = "en"
}

@ARTICLE{Mahe2013-rq,
  title    = "Intraoperative pathology consultation: error, cause and impact",
  author   = "Mahe, Etienne and Ara, Shamim and Bishara, Mona and Kurian, Annie
              and Tauqir, Syeda and Ursani, Nafisa and Vasudev, Pooja and Aziz,
              Tariq and Ross, Cathy and Lytwyn, Alice",
  abstract = "BACKGROUND: Correlation of intraoperative frozen section
              diagnosis with final diagnosis can be an important component of
              an institution's quality assurance process. METHODS: We performed
              a quality assurance review of 1207 frozen section diagnoses from
              812 surgical cases performed in the Hamilton Regional Laboratory
              Medicine Programme during a 6-month period in 2007. We reviewed
              the frozen section and permanent slides from all potentially
              discordant cases using a multiheaded microscope to arrive at a
              consensus pertaining to the type and reason for error. We
              reviewed the clinical record to determine whether there had been
              a potential adverse impact on immediate clinical management.
              RESULTS: Frozen sections were most commonly requested for head
              and neck, nervous system and female genital tract specimens.
              Twenty-eight frozen sections (3\%) were deferred. We identified
              24 discordant diagnoses involving 3\% of cases and 2\% of
              specimens. The organ systems showing the greatest frequency of
              discordance relative to the total number from that system were
              the nervous system, head and neck, and the lungs. Of the errors
              identified, most occurred owing to diagnostic misinterpretation,
              followed by problems related to tissue sampling. There was a
              potential adverse impact on immediate clinical management in 14
              cases. CONCLUSION: Our results add to the Canadian data on the
              correlation between frozen sections and permanent sections; we
              note comparability to the concordance rates reported in the
              literature.",
  journal  = "Can. J. Surg.",
  volume   =  56,
  number   =  3,
  pages    = "E13--8",
  month    =  jun,
  year     =  2013,
  language = "en"
}

@ARTICLE{Somerset2011-eu,
  title    = "Approach to the intraoperative consultation for neurosurgical
              specimens",
  author   = "Somerset, Hilary Lynch and Kleinschmidt-DeMasters, Bette Kay",
  abstract = "Intraoperative consultation remains an invaluable tool in the
              initial evaluation of surgically excised specimens. Good
              communication is required between the pathologist and surgeon to
              obtain the best care for their mutual patient. Intraoperative
              consultation (frozen section, FS) provides a preliminary
              diagnosis for the surgeon and aids in guiding his/her subsequent
              surgical approach. For the pathologist, it serves to assess
              tissue adequacy in the context of the clinical and imaging
              features of the patient. FS can guarantee that the surgeon is in
              the desired anatomic location, but most often serves to ensure
              that adequate amounts of abnormal, and likely diagnostic, tissue
              will be available to the pathologist to render a final diagnosis
              on permanent sections. The preliminary evaluation of tissue at
              the time of intraoperative FS also guides the pathologist in the
              ordering of ancillary studies, some of which need to be performed
              on fresh or frozen tissues and must be sent at the time of the
              intraoperative consultation. This brief review will specifically
              focus on the role of the pathologist who is called to perform a
              FS for a neurosurgical specimen. We will discuss (1) the goals of
              the neurosurgeon for the intraoperative consultation, (2) how to
              achieve optimal communication between neurosurgeon and
              pathologist at the time of the FS, (3) what constitutes
              reasonable and unreasonable expectations by the neurosurgeon for
              the FS, (4) choices of techniques that can be used by the
              pathologist, (5) what tissue should be triaged, and (6) common
              discrepancies between FS and permanent section diagnoses in
              central nervous system disorders. The published literature on FS
              and permanent section discrepancies will be briefly reviewed so
              that pathologists will understand that some difficulties are
              inherent in neurosurgical specimens and are not specific to their
              practice, or to a given pathologist. Hopefully, this knowledge
              will enhance pathologists' confidence as they negotiate how best
              to handle this time-sensitive, and sometimes angst-producing,
              task.",
  journal  = "Adv. Anat. Pathol.",
  volume   =  18,
  number   =  6,
  pages    = "446--449",
  month    =  nov,
  year     =  2011,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Galli2017-fx,
  title    = "Assessing the efficacy of coherent anti-Stokes Raman scattering
              microscopy for the detection of infiltrating glioblastoma in
              fresh brain samples",
  author   = "Galli, Roberta and Uckermann, Ortrud and Temme, Achim and
              Leipnitz, Elke and Meinhardt, Matthias and Koch, Edmund and
              Schackert, Gabriele and Steiner, Gerald and Kirsch, Matthias",
  abstract = "Coherent anti-Stokes Raman scattering (CARS) microscopy is an
              emerging technique for identification of brain tumors. However,
              tumor identification by CARS microscopy on bulk samples and in
              vivo has been so far verified retrospectively on histological
              sections, which only provide a gross reference for the
              interpretation of CARS images without matching at cellular level.
              Therefore, fluorescent labels were exploited for direct
              assessment of the interpretation of CARS images of solid and
              infiltrative tumors. Glioblastoma cells expressing green
              fluorescent protein (GFP) were used for induction of tumors in
              mice (n = 7). The neoplastic nature of cells imaged by CARS
              microscopy was unequivocally verified by addressing two-photon
              fluorescence of GFP on fresh brain slices and in vivo. In fresh
              unfixed biopsies of human glioblastoma (n = 10), the fluorescence
              of 5-aminolevulinic acid-induced protoporphyrin IX was used for
              identification of tumorous tissue. Distinctive morphological
              features of glioblastoma cells, i.e. larger nuclei, evident
              nuclear membrane and nucleolus, were identified in the CARS
              images of both mouse and human brain tumors. This approach
              demonstrates that the chemical contrast provided by CARS allows
              the localization of infiltrating tumor cells in fresh tissue and
              that the cell morphology in CARS images is useful for tumor
              recognition. Experimental glioblastoma expressing green
              fluorescent protein.",
  journal  = "J. Biophotonics",
  volume   =  10,
  number   =  3,
  pages    = "404--414",
  month    =  mar,
  year     =  2017,
  keywords = "brain tumors; coherent antiâ€Stokes Raman scattering;
              glioblastoma; green fluorescent protein; human biopsies; native
              tissue; twoâ€photon fluorescence",
  language = "en"
}

@ARTICLE{Galli2014-fl,
  title    = "Effects of tissue fixation on coherent anti-Stokes Raman
              scattering images of brain",
  author   = "Galli, Roberta and Uckermann, Ortrud and Koch, Edmund and
              Schackert, Gabriele and Kirsch, Matthias and Steiner, Gerald",
  abstract = "Coherent anti-Stokes Raman scattering (CARS) microscopy is an
              emerging multiphoton technique for the label-free histopathology
              of the central nervous system, by imaging the lipid content
              within the tissue. In order to apply the technique on standard
              histology sections, it is important to know the effects of tissue
              fixation on the CARS image. Here, we report the effects of two
              common fixation methods, namely with formalin and
              methanol-acetone, on mouse brain and human glioblastoma tissue.
              The variations induced by fixation on the CARS contrast and
              intensity were compared and interpreted using Raman
              microspectroscopy. The results show that, whenever unfixed
              cryosections cannot be used, fixation with formalin constitutes
              an alternative which does not deteriorate substantially the
              contrast generated by the different brain structures in the CARS
              image. Fixation with methanol-acetone strongly modifies the
              tissue lipid content and is therefore incompatible with the CARS
              imaging.",
  journal  = "J. Biomed. Opt.",
  volume   =  19,
  number   =  7,
  pages    = "071402",
  month    =  jul,
  year     =  2014,
  language = "en"
}

@ARTICLE{Upchurch2018-sk,
  title    = "An update on the use of Raman spectroscopy in molecular cancer
              diagnostics: current challenges and further prospects",
  author   = "Upchurch, Emma and Isabelle, Martin and Lloyd, Gavin Rhys and
              Kendall, Catherine and Barr, Hugh",
  abstract = "INTRODUCTION: Cancer is responsible for an extraordinary burden
              of disease, affecting 90.5 million people worldwide in 2015.
              Outcomes for these patients are improved when the disease is
              diagnosed at an early, or even precancerous, stage. Raman
              spectroscopy is demonstrating results that show its ability to
              detect the molecular changes that are diagnostic of precancerous
              and cancerous tissue. This review highlights the new advances
              occurring in this domain. Areas covered: PubMed searches were
              undertaken to identify new research in the utilisation of Raman
              spectroscopy in cancer diagnostics. The areas in which Raman
              spectroscopy is showing promise are covered, including improving
              the accuracy of identifying precancerous changes, using the
              technology in real time, in vivo modalities, the search for a
              biomarker to aid potential screening and predicting the response
              of the cancer to the treatment regimen. Expert commentary: Many
              of the examples in this review are focused on Barrett's
              oesophagus and oesophageal adenocarcinoma as this is my area of
              expertise and perfectly exemplifies where Raman spectroscopy
              could be utilised in clinical practise. The authors discuss the
              areas where they believe current knowledge is lacking and how
              Raman spectroscopy could answer the dilemmas that are still faced
              in the management of cancer.",
  journal  = "Expert Rev. Mol. Diagn.",
  volume   =  18,
  number   =  3,
  pages    = "245--258",
  month    =  mar,
  year     =  2018,
  keywords = "Molecular changes; Raman spectroscopy; biomarkers;
              dysplasia/early cancer; early diagnosis",
  language = "en"
}

@ARTICLE{Uckermann2018-ce,
  title    = "{IDH1} mutation in human glioma induces chemical alterations that
              are amenable to optical Raman spectroscopy",
  author   = "Uckermann, Ortrud and Yao, Wenmin and Juratli, Tareq A and Galli,
              Roberta and Leipnitz, Elke and Meinhardt, Matthias and Koch,
              Edmund and Schackert, Gabriele and Steiner, Gerald and Kirsch,
              Matthias",
  abstract = "INTRODUCTION: Mutations in the isocytrate dehydrogenase 1 (IDH1)
              gene are early genetic events in glioma pathogenesis and cause
              profound metabolic changes. Because this genotype is found in
              virtually every tumor cell, therapies targeting mutant IDH1
              protein are being developed. The intraoperative administration of
              those therapies would require fast technologies for the
              determination of IDH1 genotype. As of today, there is no such
              diagnostic test available. Recently, infrared spectroscopy was
              shown to bridge this gap. Here, we tested Raman spectroscopy for
              analysis of IDH1 genotype in glioma, which constitutes an
              alternative contact-free technique with the potential of being
              applicable in situ. METHODS: Human glioma samples (n = 36) were
              obtained during surgery and cryosections were prepared. IDH1
              mutations were assessed using DNA sequencing and 100 Raman
              spectra were obtained for each sample. RESULTS: Analysis of Raman
              spectra revealed increased intensities in spectral bands related
              to DNA in IDH1 mutant glioma while bands assigned to molecular
              vibrations of lipids were significantly decreased. Moreover,
              intensities of Raman bands assigned to proteins differed in IDH1
              mutant and IDH1 wild-type glioma, suggesting alterations in the
              protein profile. The selection of five bands (498, 826, 1003,
              1174 and 1337 cm-1) allowed the classification of Raman spectra
              according to IDH1 genotype with a correct rate of 89\%.
              CONCLUSION: Raman spectroscopy constitutes a simple, rapid and
              safe procedure for determination of the IDH1 mutation that shows
              great promise for clinically relevant in situ diagnostics.",
  journal  = "J. Neurooncol.",
  volume   =  139,
  number   =  2,
  pages    = "261--268",
  month    =  sep,
  year     =  2018,
  keywords = "Brain tumor; Intraoperative; Personalized medicine; Vibrational
              spectroscopy",
  language = "en"
}

@ARTICLE{Evans2007-fy,
  title    = "Chemically-selective imaging of brain structures with {CARS}
              microscopy",
  author   = "Evans, Conor L and Xu, Xiaoyin and Kesari, Santosh and Xie, X
              Sunney and Wong, Steven T C and Young, Geoffrey S",
  abstract = "We demonstrate the use of coherent anti-Stokes Raman scattering
              (CARS) microscopy to image brain structure and pathology ex vivo.
              Although non-invasive clinical brain imaging with CT, MRI and PET
              has transformed the diagnosis of neurologic disease, definitive
              pre-operative distinction of neoplastic and benign pathologies
              remains elusive. Definitive diagnosis still requires brain biopsy
              in a significant number of cases. CARS microscopy, a nonlinear,
              vibrationally-sensitive technique, is capable of high-sensitivity
              chemically-selective three-dimensional imaging without exogenous
              labeling agents. Like MRI, CARS can be tuned to provide a wide
              variety of possible tissue contrasts, but with sub-cellular
              spatial resolution and near real time temporal resolution. These
              attributes make CARS an ideal technique for fast, minimally
              invasive, non-destructive, molecularly specific intraoperative
              optical diagnosis of brain lesions. This promises significant
              clinical benefit to neurosurgical patients by providing
              definitive diagnosis of neoplasia prior to tissue biopsy or
              resection. CARS imaging can augment the diagnostic accuracy of
              traditional frozen section histopathology in needle biopsy and
              dynamically define the margins of tumor resection during brain
              surgery. This report illustrates the feasibility of in vivo CARS
              vibrational histology as a clinical tool for neuropathological
              diagnosis by demonstrating the use of CARS microscopy in
              identifying normal brain structures and primary glioma in fresh
              unfixed and unstained ex vivo brain tissue.",
  journal  = "Opt. Express",
  volume   =  15,
  number   =  19,
  pages    = "12076--12087",
  month    =  sep,
  year     =  2007,
  language = "en"
}

@ARTICLE{Ji2015-pn,
  title    = "Detection of human brain tumor infiltration with quantitative
              stimulated Raman scattering microscopy",
  author   = "Ji, Minbiao and Lewis, Spencer and Camelo-Piragua, Sandra and
              Ramkissoon, Shakti H and Snuderl, Matija and Venneti, Sriram and
              Fisher-Hubbard, Amanda and Garrard, Mia and Fu, Dan and Wang,
              Anthony C and Heth, Jason A and Maher, Cormac O and Sanai, Nader
              and Johnson, Timothy D and Freudiger, Christian W and Sagher,
              Oren and Xie, Xiaoliang Sunney and Orringer, Daniel A",
  abstract = "Differentiating tumor from normal brain is a major barrier to
              achieving optimal outcome in brain tumor surgery. New imaging
              techniques for visualizing tumor margins during surgery are
              needed to improve surgical results. We recently demonstrated the
              ability of stimulated Raman scattering (SRS) microscopy, a
              nondestructive, label-free optical method, to reveal glioma
              infiltration in animal models. We show that SRS reveals human
              brain tumor infiltration in fresh, unprocessed surgical specimens
              from 22 neurosurgical patients. SRS detects tumor infiltration in
              near-perfect agreement with standard hematoxylin and eosin light
              microscopy ($\kappa$ = 0.86). The unique chemical contrast
              specific to SRS microscopy enables tumor detection by revealing
              quantifiable alterations in tissue cellularity, axonal density,
              and protein/lipid ratio in tumor-infiltrated tissues. To ensure
              that SRS microscopic data can be easily used in brain tumor
              surgery, without the need for expert interpretation, we created a
              classifier based on cellularity, axonal density, and
              protein/lipid ratio in SRS images capable of detecting tumor
              infiltration with 97.5\% sensitivity and 98.5\% specificity.
              Quantitative SRS microscopy detects the spread of tumor cells,
              even in brain tissue surrounding a tumor that appears grossly
              normal. By accurately revealing tumor infiltration, quantitative
              SRS microscopy holds potential for improving the accuracy of
              brain tumor surgery.",
  journal  = "Sci. Transl. Med.",
  volume   =  7,
  number   =  309,
  pages    = "309ra163",
  month    =  oct,
  year     =  2015,
  language = "en"
}

@ARTICLE{Tashibu1990-nb,
  title    = "[Analysis of water content in rat brain using Raman spectroscopy]",
  author   = "Tashibu, K",
  abstract = "Laser Raman spectroscopy has not been applied to brain tissue.
              However, this method can possibly analyze the constituent
              elements of living tissue of cellular and molecular level easily,
              and this might be essential for further brain research. I
              attempted to analyze the water content of brain tissues, which
              was measured by Raman spectrum of CH and OH groups, in normal and
              edematous rat brain tissues. The experimental results indicated
              that the peak intensity of CH group originated from protein, 2935
              cm-1 in wave number, was constant in normal, dried and edematous
              brain tissue. Therefore it could be used as internal standard. As
              the peak intensity of OH group, 3390 cm-1 in wave number, was
              originated from water, the relative amount of water content in
              the brain tissues could be evaluated by OH/CH value. The OH/CH
              value was not significantly different between the cortex and the
              thalamus, but it was significantly higher in the gray matter
              (thalamus) than in the white matter (pons). The OH/CH value was
              decreased in dried specimens. In experimental edematous brain
              tissues, which was produced by intraperitoneal injection of
              organic tin, the OH/CH value was evidently increased in the
              thalamus but not much changed in the pons. This results were well
              compatible with cytotoxic edema, which was reported to be
              produced by organic tin. It is suggested that laser Raman
              spectroscopy can be used for brain edema research as one of the
              strong weapon, in analyzing water content of brain tissues on a
              cellular level.",
  journal  = "No To Shinkei",
  volume   =  42,
  number   =  10,
  pages    = "999--1004",
  month    =  oct,
  year     =  1990,
  language = "ja"
}

@ARTICLE{Koljenovic2002-hr,
  title    = "Discriminating vital tumor from necrotic tissue in human
              glioblastoma tissue samples by Raman spectroscopy",
  author   = "Koljenovi{\'c}, Senada and Choo-Smith, Lin-P'ing and Bakker
              Schut, Tom C and Kros, Johan M and van den Berge, Herbert J and
              Puppels, Gerwin J",
  abstract = "Vital and necrotic glioblastoma tissues were studied by Raman
              microspectroscopy to identify possibilities for the development
              of an in vivo Raman method for real-time intraoperative brain
              biopsy guidance. The histologic malignancy grade of gliomas
              depends on the presence of parameters such as endothelial
              proliferation and necrosis, which are often not evenly
              distributed within the tumor. Because tissue samples obtained by
              stereotactic surgery are relatively small, sampling errors may
              easily occur by missing these crucial features. Although necrosis
              is important for grading, specimens containing only necrosis are
              diagnostically useless. Raman microspectroscopic mapping
              experiments were performed on unfixed cryosections of
              glioblastoma, obtained from 20 patients. After spectral
              acquisition, a clustering analysis was performed, resulting in
              groups of similar spectra. Each cluster was assigned a color, and
              pseudo-color Raman maps of the tissue sections were constructed.
              After the Raman experiments, the tissue sections were stained for
              histopathologic analysis, enabling identification of the
              histologic origin of the Raman spectra and assignment of the
              Raman spectral clusters to either vital or necrotic tissue. A
              classification model for discrimination between vital and
              necrotic tumor tissue based on linear discriminant analysis was
              developed. The classification model was evaluated using
              independent Raman data obtained from nine other tissue sections
              and yielded 100\% accuracy. Information about the biochemical
              differences between necrosis and vital tumor was obtained by the
              analysis of difference spectra. Necrotic tissue was found to
              consistently contain higher levels of cholesterol (-esters). This
              in vitro result indicates that Raman spectra contain the
              information to distinguish vital glioblastoma from necrosis and
              makes Raman spectroscopy a powerful candidate for guidance of
              stereotactic brain biopsy.",
  journal  = "Lab. Invest.",
  volume   =  82,
  number   =  10,
  pages    = "1265--1277",
  month    =  oct,
  year     =  2002,
  language = "en"
}

@ARTICLE{Hervey-Jumper2014-uf,
  title    = "Reoperation for recurrent high-grade glioma: a current
              perspective of the literature",
  author   = "Hervey-Jumper, Shawn L and Berger, Mitchel S",
  abstract = "Optimal treatment for recurrent high-grade glioma continues to
              evolve. Currently, however, there is no consensus in the
              literature on the role of reoperation in the management of these
              patients. In this analysis, we reviewed the literature to examine
              the role of reoperation in patients with World Health
              Organization grade III or IV recurrent gliomas, focusing on how
              reoperation affects outcome, perioperative complications, and
              quality of life. An extensive literature review was performed
              through the use of the PubMed and Ovid Medline databases for
              January 1980 through August 2013. A total 31 studies were
              included in the final analysis. Of the 31 studies with
              significant data from single or multiple institutions, 29
              demonstrated a survival benefit or improved functional status
              after reoperation for recurrent high-grade glioma. Indications
              for reoperation included new focal neurological deficits, tumor
              mass effect, signs of elevated intracranial pressure, headaches,
              increased seizure frequency, and radiographic evidence of tumor
              progression. Age was not a contraindication to reoperation. Time
              interval of at least 6 months between operations and favorable
              performance status (Karnofsky Performance Status score $\geq$70)
              were important predictors of benefit from reoperation. Extent of
              resection at reoperation improved survival, even in patients with
              subtotal resection at initial operation. Careful patient
              selection such as avoiding those individuals with poor
              performance status and bevacizumab within 4 weeks of surgery is
              important. Although limited to retrospective analysis and patient
              selection bias, mounting evidence suggests a survival benefit in
              patients receiving a reoperation at the time of high-grade glioma
              recurrence.",
  journal  = "Neurosurgery",
  volume   =  75,
  number   =  5,
  pages    = "491--9; discussion 498--9",
  month    =  nov,
  year     =  2014,
  language = "en"
}

@INPROCEEDINGS{Szegedy2015-bw,
  title     = "Going deeper with convolutions",
  booktitle = "2015 {IEEE} Conference on Computer Vision and Pattern
               Recognition ({CVPR})",
  author    = "Szegedy, C and Liu, Wei and Jia, Yangqing and Sermanet, P and
               Reed, S and Anguelov, D and Erhan, D and Vanhoucke, V and
               Rabinovich, A",
  abstract  = "We propose a deep convolutional neural network architecture
               codenamed Inception that achieves the new state of the art for
               classification and detection in the ImageNet Large-Scale Visual
               Recognition Challenge 2014 (ILSVRC14). The main hallmark of this
               architecture is the improved utilization of the computing
               resources inside the network. By a carefully crafted design, we
               increased the depth and width of the network while keeping the
               computational budget constant. To optimize quality, the
               architectural decisions were based on the Hebbian principle and
               the intuition of multi-scale processing. One particular
               incarnation used in our submission for ILSVRC14 is called
               GoogLeNet, a 22 layers deep network, the quality of which is
               assessed in the context of classification and detection.",
  pages     = "1--9",
  month     =  jun,
  year      =  2015,
  keywords  = "convolution;decision making;feature extraction;Hebbian
               learning;image classification;neural net architecture;resource
               allocation;convolutional neural network architecture;resource
               utilization;architectural decision;Hebbian principle;object
               classification;object detection;Computer
               architecture;Convolutional codes;Sparse matrices;Neural
               networks;Visualization;Object detection;Computer vision;ConvNets"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Van_Dijken2017-tn,
  title    = "Diagnostic accuracy of magnetic resonance imaging techniques for
              treatment response evaluation in patients with high-grade glioma,
              a systematic review and meta-analysis",
  author   = "van Dijken, Bart R J and van Laar, Peter Jan and Holtman, Gea A
              and van der Hoorn, Anouk",
  abstract = "OBJECTIVE: Treatment response assessment in high-grade gliomas
              uses contrast enhanced T1-weighted MRI, but is unreliable. Novel
              advanced MRI techniques have been studied, but the accuracy is
              not well known. Therefore, we performed a systematic
              meta-analysis to assess the diagnostic accuracy of anatomical and
              advanced MRI for treatment response in high-grade gliomas.
              METHODS: Databases were searched systematically. Study selection
              and data extraction were done by two authors independently.
              Meta-analysis was performed using a bivariate random effects
              model when $\geq$5 studies were included. RESULTS: Anatomical MRI
              (five studies, 166 patients) showed a pooled sensitivity and
              specificity of 68\% (95\%CI 51-81) and 77\% (45-93),
              respectively. Pooled apparent diffusion coefficients (seven
              studies, 204 patients) demonstrated a sensitivity of 71\% (60-80)
              and specificity of 87\% (77-93). DSC-perfusion (18 studies, 708
              patients) sensitivity was 87\% (82-91) with a specificity of 86\%
              (77-91). DCE-perfusion (five studies, 207 patients) sensitivity
              was 92\% (73-98) and specificity was 85\% (76-92). The
              sensitivity of spectroscopy (nine studies, 203 patients) was 91\%
              (79-97) and specificity was 95\% (65-99). CONCLUSION: Advanced
              techniques showed higher diagnostic accuracy than anatomical MRI,
              the highest for spectroscopy, supporting the use in treatment
              response assessment in high-grade gliomas. KEY POINTS: â€¢
              Treatment response assessment in high-grade gliomas with
              anatomical MRI is unreliable â€¢ Novel advanced MRI techniques have
              been studied, but diagnostic accuracy is unknown â€¢ Meta-analysis
              demonstrates that advanced MRI showed higher diagnostic accuracy
              than anatomical MRI â€¢ Highest diagnostic accuracy for
              spectroscopy and perfusion MRI â€¢ Supports the incorporation of
              advanced MRI in high-grade glioma treatment response assessment.",
  journal  = "Eur. Radiol.",
  volume   =  27,
  number   =  10,
  pages    = "4129--4144",
  month    =  oct,
  year     =  2017,
  keywords = "Glioma; Magnetic resonance imaging; Magnetic resonance
              spectroscopy; Meta-analysis; Treatment response",
  language = "en"
}

@INPROCEEDINGS{Lee2018-xq,
  title     = "A Simple Unified Framework for Detecting Out-of-distribution
               Samples and Adversarial Attacks",
  booktitle = "Proceedings of the 32Nd International Conference on Neural
               Information Processing Systems",
  author    = "Lee, Kimin and Lee, Kibok and Lee, Honglak and Shin, Jinwoo",
  publisher = "Curran Associates Inc.",
  pages     = "7167--7177",
  series    = "NIPS'18",
  year      =  2018,
  address   = "USA",
  location  = "Montr{\'e}al, Canada"
}

@INPROCEEDINGS{Yosinski2014-eh,
  title     = "How Transferable Are Features in Deep Neural Networks?",
  booktitle = "Proceedings of the 27th International Conference on Neural
               Information Processing Systems - Volume 2",
  author    = "Yosinski, Jason and Clune, Jeff and Bengio, Yoshua and Lipson,
               Hod",
  publisher = "MIT Press",
  pages     = "3320--3328",
  series    = "NIPS'14",
  year      =  2014,
  address   = "Cambridge, MA, USA",
  location  = "Montreal, Canada"
}

@ARTICLE{Patel2012-kh,
  title     = "Molecular targeted therapy in recurrent glioblastoma: current
               challenges and future directions",
  author    = "Patel, Mital and Vogelbaum, Michael A and Barnett, Gene H and
               Jalali, Rakesh and Ahluwalia, Manmeet S",
  abstract  = "INTRODUCTION: The survival of patients with glioblastoma (GBM),
               which is the most common primary brain malignancy, remains poor
               with current treatment modalities. However, an enhanced
               understanding of gliomagenesis is supporting the development of
               targeted molecular therapies with the potential for improving
               clinical outcomes. AREAS COVERED: Epidermal growth factor
               receptor (EGFR) and vascular endothelial growth factor receptor
               (VEGFR) initiate key signaling pathways in GBM; however, trials
               with anti-EGFR agents have failed to show improved outcomes.
               Bevacizumab, a monoclonal antibody targeting VEGF, remains the
               only FDA-approved molecular drug in GBM; yet its use has only
               improved progression-free survival without any improvement in
               overall survival. We review the evidence supporting the
               continued evaluation of targeted molecular therapies in
               recurrent GBM. In addition, newer potential therapies targeting
               other signaling pathways, heat shock proteins and proteosomes,
               as well as the concept of targeting glioma stem cells are
               discussed. EXPERT OPINION: The complex genetic origin of GBM
               makes it challenging to identify molecular subsets that may
               benefit from specific targeted therapies. Pathway inhibition,
               via multisite kinase inhibitors or a carefully selected
               combination of molecular drugs with or without cytotoxic agents,
               is currently undergoing evaluation in clinical trials and may
               improve outcomes in these patients.",
  journal   = "Expert Opin. Investig. Drugs",
  publisher = "Taylor \& Francis",
  volume    =  21,
  number    =  9,
  pages     = "1247--1266",
  month     =  sep,
  year      =  2012,
  language  = "en"
}

@ARTICLE{Suzuki2015-xe,
  title    = "Mutational landscape and clonal architecture in grade {II} and
              {III} gliomas",
  author   = "Suzuki, Hiromichi and Aoki, Kosuke and Chiba, Kenichi and Sato,
              Yusuke and Shiozawa, Yusuke and Shiraishi, Yuichi and Shimamura,
              Teppei and Niida, Atsushi and Motomura, Kazuya and Ohka, Fumiharu
              and Yamamoto, Takashi and Tanahashi, Kuniaki and Ranjit, Melissa
              and Wakabayashi, Toshihiko and Yoshizato, Tetsuichi and Kataoka,
              Keisuke and Yoshida, Kenichi and Nagata, Yasunobu and
              Sato-Otsubo, Aiko and Tanaka, Hiroko and Sanada, Masashi and
              Kondo, Yutaka and Nakamura, Hideo and Mizoguchi, Masahiro and
              Abe, Tatsuya and Muragaki, Yoshihiro and Watanabe, Reiko and Ito,
              Ichiro and Miyano, Satoru and Natsume, Atsushi and Ogawa, Seishi",
  abstract = "Grade II and III gliomas are generally slowly progressing brain
              cancers, many of which eventually transform into more aggressive
              tumors. Despite recent findings of frequent mutations in IDH1 and
              other genes, knowledge about their pathogenesis is still
              incomplete. Here, combining two large sets of high-throughput
              sequencing data, we delineate the entire picture of genetic
              alterations and affected pathways in these glioma types, with
              sensitive detection of driver genes. Grade II and III gliomas
              comprise three distinct subtypes characterized by discrete sets
              of mutations and distinct clinical behaviors. Mutations showed
              significant positive and negative correlations and a
              chronological hierarchy, as inferred from different allelic
              burdens among coexisting mutations, suggesting that there is
              functional interplay between the mutations that drive clonal
              selection. Extensive serial and multi-regional sampling analyses
              further supported this finding and also identified a high degree
              of temporal and spatial heterogeneity generated during tumor
              expansion and relapse, which is likely shaped by the complex but
              ordered processes of multiple clonal selection and evolutionary
              events.",
  journal  = "Nat. Genet.",
  volume   =  47,
  number   =  5,
  pages    = "458--468",
  month    =  may,
  year     =  2015,
  language = "en"
}

@ARTICLE{Hollon2018-js,
  title    = "A machine learning approach to predict early outcomes after
              pituitary adenoma surgery",
  author   = "Hollon, Todd C and Parikh, Adish and Pandian, Balaji and Tarpeh,
              Jamaal and Orringer, Daniel A and Barkan, Ariel L and McKean,
              Erin L and Sullivan, Stephen E",
  abstract = "OBJECTIVEPituitary adenomas occur in a heterogeneous patient
              population with diverse perioperative risk factors,
              endocrinopathies, and other tumor-related comorbidities. This
              heterogeneity makes predicting postoperative outcomes challenging
              when using traditional scoring systems. Modern machine learning
              algorithms can automatically identify the most predictive risk
              factors and learn complex risk-factor interactions using training
              data to build a robust predictive model that can generalize to
              new patient cohorts. The authors sought to build a predictive
              model using supervised machine learning to accurately predict
              early outcomes of pituitary adenoma surgery.METHODSA
              retrospective cohort of 400 consecutive pituitary adenoma
              patients was used. Patient variables/predictive features were
              limited to common patient characteristics to improve model
              implementation. Univariate and multivariate odds ratio analysis
              was performed to identify individual risk factors for common
              postoperative complications and to compare risk factors with
              model predictors. The study population was split into 300
              training/validation patients and 100 testing patients to train
              and evaluate four machine learning models using binary
              classification accuracy for predicting early outcomes.RESULTSThe
              study included a total of 400 patients. The mean $\pm$ SD patient
              age was 53.9 $\pm$ 16.3 years, 59.8\% of patients had
              nonfunctioning adenomas and 84.7\% had macroadenomas, and the
              mean body mass index (BMI) was 32.6 $\pm$ 7.8 (58.0\% obesity
              rate). Multivariate odds ratio analysis demonstrated that age <
              40 years was associated with a 2.86 greater odds of postoperative
              diabetes insipidus and that nonobese patients (BMI < 30) were 2.2
              times more likely to develop postoperative hyponatremia. Using
              broad criteria for a poor early postoperative outcome-major
              medical and early surgical complications, extended length of
              stay, emergency department admission, inpatient readmission, and
              death-31.0\% of patients met criteria for a poor early outcome.
              After model training, a logistic regression model with elastic
              net (LR-EN) regularization best predicted early postoperative
              outcomes of pituitary adenoma surgery on the 100-patient testing
              set-sensitivity 68.0\%, specificity 93.3\%, overall accuracy
              87.0\%. The receiver operating characteristic and
              precision-recall curves for the LR-EN model had areas under the
              curve of 82.7 and 69.5, respectively. The most important
              predictive variables were lowest perioperative sodium, age, BMI,
              highest perioperative sodium, and Cushing's
              disease.CONCLUSIONSEarly postoperative outcomes of pituitary
              adenoma surgery can be predicted with 87\% accuracy using a
              machine learning approach. These results provide insight into how
              predictive modeling using machine learning can be used to improve
              the perioperative management of pituitary adenoma patients.",
  journal  = "Neurosurg. Focus",
  volume   =  45,
  number   =  5,
  pages    = "E8",
  month    =  nov,
  year     =  2018,
  keywords = "AUC = area under the curve; BMI = body mass index; DVT = deep
              vein thrombosis; LR-EN = logistic regression with elastic net; PE
              = pulmonary embolism; PR = precision recall; ROC = receiver
              operating characteristic; machine learning; obesity; outcome
              prediction; pituitary adenoma; predictive modeling; risk
              stratification;My\_papers",
  language = "en"
}

@ARTICLE{Hollon2020-ez,
  title    = "Near real-time intraoperative brain tumor diagnosis using
              stimulated Raman histology and deep neural networks",
  author   = "Hollon, Todd C and Pandian, Balaji and Adapa, Arjun R and Urias,
              Esteban and Save, Akshay V and Khalsa, Siri Sahib S and Eichberg,
              Daniel G and D'Amico, Randy S and Farooq, Zia U and Lewis,
              Spencer and Petridis, Petros D and Marie, Tamara and Shah, Ashish
              H and Garton, Hugh J L and Maher, Cormac O and Heth, Jason A and
              McKean, Erin L and Sullivan, Stephen E and Hervey-Jumper, Shawn L
              and Patil, Parag G and Thompson, B Gregory and Sagher, Oren and
              McKhann, 2nd, Guy M and Komotar, Ricardo J and Ivan, Michael E
              and Snuderl, Matija and Otten, Marc L and Johnson, Timothy D and
              Sisti, Michael B and Bruce, Jeffrey N and Muraszko, Karin M and
              Trautman, Jay and Freudiger, Christian W and Canoll, Peter and
              Lee, Honglak and Camelo-Piragua, Sandra and Orringer, Daniel A",
  abstract = "Intraoperative diagnosis is essential for providing safe and
              effective care during cancer surgery1. The existing workflow for
              intraoperative diagnosis based on hematoxylin and eosin staining
              of processed tissue is time, resource and labor intensive2,3.
              Moreover, interpretation of intraoperative histologic images is
              dependent on a contracting, unevenly distributed, pathology
              workforce4. In the present study, we report a parallel workflow
              that combines stimulated Raman histology (SRH)5-7, a label-free
              optical imaging method and deep convolutional neural networks
              (CNNs) to predict diagnosis at the bedside in near real-time in
              an automated fashion. Specifically, our CNNs, trained on over 2.5
              million SRH images, predict brain tumor diagnosis in the
              operating room in under 150 s, an order of magnitude faster than
              conventional techniques (for example, 20-30 min)2. In a
              multicenter, prospective clinical trial (n = 278), we
              demonstrated that CNN-based diagnosis of SRH images was
              noninferior to pathologist-based interpretation of conventional
              histologic images (overall accuracy, 94.6\% versus 93.9\%). Our
              CNNs learned a hierarchy of recognizable histologic feature
              representations to classify the major histopathologic classes of
              brain tumors. In addition, we implemented a semantic segmentation
              method to identify tumor-infiltrated diagnostic regions within
              SRH images. These results demonstrate how intraoperative cancer
              diagnosis can be streamlined, creating a complementary pathway
              for tissue diagnosis that is independent of a traditional
              pathology laboratory.",
  journal  = "Nat. Med.",
  month    =  jan,
  year     =  2020,
  keywords = "My\_papers",
  language = "en"
}

@ARTICLE{Farquhar2016-zl,
  title    = "Propensity score analysis of endoscopic and open approaches to
              malignant paranasal and anterior skull base tumor outcomes",
  author   = "Farquhar, Douglas and Kim, Luke and Worrall, Douglas and Chiu,
              Alexander and Lee, John Y K and Khalili, Sammy and Grady, Sean
              and O'Malley, Jr, Bert W and Kennedy, David W and Newman, Jason G
              and Palmer, James N and Adappa, Nithin D",
  abstract = "OBJECTIVES/HYPOTHESIS: Malignant sinonasal and skull base tumors
              are now being resected using an endoscopic technique, but there
              has been controversy regarding the oncologic safety of this
              approach. Various studies have compared the outcomes from
              endoscopic surgery to those from open techniques; however, all
              have been limited by substantial differences in the patient
              populations receiving each approach. In this study we compare
              outcomes of open and endoscopic techniques and use propensity
              score matching to control for these differences in the patient
              populations. STUDY DESIGN: Retrospective cohort study including
              all patients > 18 years old receiving primary surgery for
              malignant sinonasal or skull base tumors at our institution from
              2002 to 2013. RESULTS: One hundred twenty-four patients met
              criteria; 82 received endoscopic-only surgery, and 42 had an open
              component to their approach. There was an 86\% 3-year overall
              survival and a 74\% disease-free survival. Without controlling
              for differences in the groups, the endoscopic patients fared
              significantly better in survival, recurrence rates, wound
              infections, and length of hospital stay. When using propensity
              score matching to account for patient comorbidities and tumor
              size, there were no significant differences in any outcomes
              except length of the hospital stay. A multivariate regression
              analysis yielded the same results. CONCLUSION: In this study,
              endoscopic surgery was shown to be a safe alternative to the open
              technique, even when controlling for the favorable patient and
              tumor characteristics in endoscopic patients. This is the first
              study to account for these differences with a rigorous
              statistical methodology. LEVEL OF EVIDENCE: 4. Laryngoscope,
              126:1724-1729, 2016.",
  journal  = "Laryngoscope",
  volume   =  126,
  number   =  8,
  pages    = "1724--1729",
  month    =  aug,
  year     =  2016,
  keywords = "Skull base tumor; endoscopic surgery; propensity score; sinonasal
              malignancy",
  language = "en"
}

@ARTICLE{Molinaro2020-qs,
  title    = "Association of Maximal Extent of Resection of {Contrast-Enhanced}
              and {Non-Contrast-Enhanced} Tumor With Survival Within Molecular
              Subgroups of Patients With Newly Diagnosed Glioblastoma",
  author   = "Molinaro, Annette M and Hervey-Jumper, Shawn and Morshed, Ramin A
              and Young, Jacob and Han, Seunggu J and Chunduru, Pranathi and
              Zhang, Yalan and Phillips, Joanna J and Shai, Anny and
              Lafontaine, Marisa and Crane, Jason and Chandra, Ankush and
              Flanigan, Patrick and Jahangiri, Arman and Cioffi, Gino and
              Ostrom, Quinn and Anderson, John E and Badve, Chaitra and
              Barnholtz-Sloan, Jill and Sloan, Andrew E and Erickson, Bradley J
              and Decker, Paul A and Kosel, Matthew L and LaChance, Daniel and
              Eckel-Passow, Jeanette and Jenkins, Robert and Villanueva-Meyer,
              Javier and Rice, Terri and Wrensch, Margaret and Wiencke, John K
              and Oberheim Bush, Nancy Ann and Taylor, Jennie and Butowski,
              Nicholas and Prados, Michael and Clarke, Jennifer and Chang,
              Susan and Chang, Edward and Aghi, Manish and Theodosopoulos,
              Philip and McDermott, Michael and Berger, Mitchel S",
  abstract = "Importance: Per the World Health Organization 2016 integrative
              classification, newly diagnosed glioblastomas are separated into
              isocitrate dehydrogenase gene 1 or 2 (IDH)-wild-type and
              IDH-mutant subtypes, with median patient survival of 1.2 and 3.6
              years, respectively. Although maximal resection of
              contrast-enhanced (CE) tumor is associated with longer survival,
              the prognostic importance of maximal resection within molecular
              subgroups and the potential importance of resection of
              non-contrast-enhanced (NCE) disease is poorly understood.
              Objective: To assess the association of resection of CE and NCE
              tumors in conjunction with molecular and clinical information to
              develop a new road map for cytoreductive surgery. Design,
              Setting, and Participants: This retrospective, multicenter cohort
              study included a development cohort from the University of
              California, San Francisco (761 patients diagnosed from January 1,
              1997, through December 31, 2017, with 9.6 years of follow-up) and
              validation cohorts from the Mayo Clinic (107 patients diagnosed
              from January 1, 2004, through December 31, 2014, with 5.7 years
              of follow-up) and the Cleveland Clinic's Ohio Brain Tumor Study
              (99 patients with data collected from January 1, 2008, through
              December 31, 2011, with a median follow-up of 10.9 months). Image
              accessors were blinded to patient groupings. Eligible patients
              underwent surgical resection for newly diagnosed glioblastoma and
              had available survival, molecular, and clinical data and
              preoperative and postoperative magnetic resonance images. Data
              were analyzed from November 15, 2018, to March 15, 2019. Main
              Outcomes and Measures: Overall survival. Results: Among the 761
              patients included in the development cohort (468 [61.5\%] men;
              median age, 60 [interquartile range, 51.6-67.7] years), younger
              patients with IDH-wild-type tumors and aggressive resection of CE
              and NCE tumors had survival similar to that of patients with
              IDH-mutant tumors (median overall survival [OS], 37.3 [95\% CI,
              31.6-70.7] months). Younger patients with IDH-wild-type tumors
              and reduction of CE tumor but residual NCE tumors fared worse
              (median OS, 16.5 [95\% CI, 14.7-18.3] months). Older patients
              with IDH-wild-type tumors benefited from reduction of CE tumor
              (median OS, 12.4 [95\% CI, 11.4-14.0] months). The results were
              validated in the 2 external cohorts. The association between
              aggressive CE and NCE in patients with IDH-wild-type tumors was
              not attenuated by the methylation status of the promoter region
              of the DNA repair enzyme O6-methylguanine-DNA methyltransferase.
              Conclusions and Relevance: This study confirms an association
              between maximal resection of CE tumor and OS in patients with
              glioblastoma across all subgroups. In addition, maximal resection
              of NCE tumor was associated with longer OS in younger patients,
              regardless of IDH status, and among patients with IDH-wild-type
              glioblastoma regardless of the methylation status of the promoter
              region of the DNA repair enzyme O6-methylguanine-DNA
              methyltransferase. These conclusions may help reassess surgical
              strategies for individual patients with newly diagnosed
              glioblastoma.",
  journal  = "JAMA Oncol",
  month    =  feb,
  year     =  2020,
  language = "en"
}

@ARTICLE{Patel2018-jp,
  title    = "The Role of Extent of Resection in {IDH1} {Wild-Type} or Mutant
              {Low-Grade} Gliomas",
  author   = "Patel, Toral and Bander, Evan D and Venn, Rachael A and Powell,
              Tiffany and Cederquist, Gustav Young-Min and Schaefer, Peter M
              and Puchi, Luis A and Akhmerov, Akbarshakh and Ogilvie, Shahiba
              and Reiner, Anne S and Moussazadeh, Nelson and Tabar, Viviane",
  abstract = "BACKGROUND: Maximizing extent of resection (EOR) improves
              outcomes in adults with World Health Organization (WHO) grade II
              low-grade gliomas (LGG). However, recent studies demonstrate that
              LGGs bearing a mutation in the isocitrate dehydrogenase 1 (IDH1)
              gene are a distinct molecular and clinical entity. It remains
              unclear whether maximizing EOR confers an equivalent clinical
              benefit in IDH mutated (mtIDH) and IDH wild-type (wtIDH) LGGs.
              OBJECTIVE: To assess the impact of EOR on malignant
              progression-free survival (MPFS) and overall survival (OS) in
              mtIDH and wtIDH LGGs. METHODS: We performed a retrospective
              review of 74 patients with WHO grade II gliomas and known IDH
              mutational status undergoing resection at a single institution.
              EOR was assessed with quantitative 3-dimensional volumetric
              analysis. The effect of predictor variables on MPFS and OS was
              analyzed with Cox regression models and the Kaplan-Meier method.
              RESULTS: Fifty-two (70\%) mtIDH patients and 22 (30\%) wtIDH
              patients were included. Median preoperative tumor volume was 37.4
              cm3; median EOR of 57.6\% was achieved. Univariate Cox regression
              analysis confirmed EOR as a prognostic factor for the entire
              cohort. However, stratifying by IDH status demonstrates that
              greater EOR independently prolonged MPFS and OS for wtIDH
              patients (hazard ratio [HR] = 0.002 [95\% confidence interval
              \{CI\} 0.000-0.074] and HR = 0.001 [95\% CI 0.00-0.108],
              respectively), but not for mtIDH patients (HR = 0.84 [95\% CI
              0.17-4.13] and HR = 2.99 [95\% CI 0.15-61.66], respectively).
              CONCLUSION: Increasing EOR confers oncologic and survival
              benefits in IDH1 wtLGGs, but the impact on IDH1 mtLGGs requires
              further study.",
  journal  = "Neurosurgery",
  volume   =  82,
  number   =  6,
  pages    = "808--814",
  month    =  jun,
  year     =  2018,
  language = "en"
}

@ARTICLE{Harary2020-pw,
  title    = "Predictors and early survival outcomes of maximal resection in
              {WHO} grade {II} 1p/19q-codeleted oligodendrogliomas",
  author   = "Harary, Maya and Kavouridis, Vasileios K and Torre, Matthew and
              Zaidi, Hasan A and Chukwueke, Ugonma N and Reardon, David A and
              Smith, Timothy R and Iorgulescu, J Bryan",
  abstract = "BACKGROUND: Although surgery plays a crucial diagnostic role in
              World Health Organization (WHO) grade II 1p/19q-codeleted
              oligodendrogliomas, the role of maximal tumor surgical resection
              remains unclear, with early retrospective series limited by lack
              of molecular classification or appropriate control groups.
              METHODS: The characteristics, management, and overall survival
              (OS) of patients $\geq$20 years old presenting with
              histology-proven WHO grade II 1p/19q-codeleted oligodendrogliomas
              during 2010-2016 were evaluated using the National Cancer
              Database and validated using multi-institutional data. Patients
              were stratified by watchful waiting (biopsy only) versus surgical
              resection. OS was analyzed using Kaplan-Meier methods and
              risk-adjusted proportional hazards. RESULTS: Five hundred ninety
              adults met inclusion criteria, of whom 79.0\% (n = 466) underwent
              surgical resection. Of patient and tumor characteristics, younger
              patients were more likely to be resected. Achieving gross total
              resection (GTR; n = 320) was significantly associated with
              smaller tumors, management at integrated network cancer programs
              (vs community cancer programs), and Medicare insurance (as
              compared with no, private, or Medicaid/other government
              insurance) and independent of other patient or tumor
              characteristics. In risk-adjusted analyses, GTR, but not subtotal
              resection (STR), demonstrated improved OS (vs biopsy only: hazard
              ratio 0.28, 95\% CI: 0.09-0.85, P = 0.02). CONCLUSIONS: WHO grade
              II 1p/19q-codeleted oligodendrogliomas amenable to resection
              demonstrated improved OS with GTR, but not STR, compared with
              biopsy-only watchful waiting. The OS benefits of GTR were
              independent of age, tumor size, or tumor location.
              Medicare-insured and integrated network cancer program patients
              were significantly more likely to have GTR than other patients,
              suggesting that insurance status and care setting may play
              important roles in access to timely diagnosis or innovations that
              improve maximal resection.",
  journal  = "Neuro. Oncol.",
  volume   =  22,
  number   =  3,
  pages    = "369--380",
  month    =  mar,
  year     =  2020,
  keywords = "WHO grade II; diffuse oligodendroglioma; extent of resection;
              surgery; watchful waiting",
  language = "en"
}

@ARTICLE{Shin2019-pl,
  title    = "Intraoperative assessment of skull base tumors using stimulated
              Raman scattering microscopy",
  author   = "Shin, Kseniya S and Francis, Andrew T and Hill, Andrew H and
              Laohajaratsang, Mint and Cimino, Patrick J and Latimer, Caitlin S
              and Gonzalez-Cuyar, Luis F and Sekhar, Laligam N and
              Juric-Sekhar, Gordana and Fu, Dan",
  abstract = "Intraoperative consultations, used to guide tumor resection, can
              present histopathological findings that are challenging to
              interpret due to artefacts from tissue cryosectioning and
              conventional staining. Stimulated Raman histology (SRH), a
              label-free imaging technique for unprocessed biospecimens, has
              demonstrated promise in a limited subset of tumors. Here, we
              target unexplored skull base tumors using a fast simultaneous
              two-channel stimulated Raman scattering (SRS) imaging technique
              and a new pseudo-hematoxylin and eosin (H\&E) recoloring
              methodology. To quantitatively evaluate the efficacy of our
              approach, we use modularized assessment of diagnostic accuracy
              beyond cancer/non-cancer determination and neuropathologist
              confidence for SRH images contrasted to H\&E-stained frozen and
              formalin-fixed paraffin-embedded (FFPE) tissue sections. Our
              results reveal that SRH is effective for establishing a diagnosis
              using fresh tissue in most cases with 87\% accuracy relative to
              H\&E-stained FFPE sections. Further analysis of discrepant case
              interpretation suggests that pseudo-H\&E recoloring underutilizes
              the rich chemical information offered by SRS imaging, and an
              improved diagnosis can be achieved if full SRS information is
              used. In summary, our findings show that pseudo-H\&E recolored
              SRS images in combination with lipid and protein chemical
              information can maximize the use of SRS during intraoperative
              pathologic consultation with implications for tissue preservation
              and augmented diagnostic utility.",
  journal  = "Sci. Rep.",
  volume   =  9,
  number   =  1,
  pages    = "20392",
  month    =  dec,
  year     =  2019,
  language = "en"
}

@ARTICLE{Poplin2018-aq,
  title     = "Predicting Cardiovascular Risk Factors in Retinal Fundus
               Photographs using Deep Learning",
  author    = "Poplin, Ryan and Varadarajan, Avinash Vaidyanathan and Blumer,
               Katy and Liu, Yun and McConnell, Mike and Corrado, Greg and
               Peng, Lily and Webster, Dale",
  publisher = "Google Research",
  year      =  2018
}

@ARTICLE{Ouyang2020-yl,
  title    = "Video-based {AI} for beat-to-beat assessment of cardiac function",
  author   = "Ouyang, David and He, Bryan and Ghorbani, Amirata and Yuan, Neal
              and Ebinger, Joseph and Langlotz, Curtis P and Heidenreich, Paul
              A and Harrington, Robert A and Liang, David H and Ashley, Euan A
              and Zou, James Y",
  abstract = "Accurate assessment of cardiac function is crucial for the
              diagnosis of cardiovascular disease1, screening for
              cardiotoxicity2 and decisions regarding the clinical management
              of patients with a critical illness3. However, human assessment
              of cardiac function focuses on a limited sampling of cardiac
              cycles and has considerable inter-observer variability despite
              years of training4,5. Here, to overcome this challenge, we
              present a video-based deep learning
              algorithm-EchoNet-Dynamic-that surpasses the performance of human
              experts in the critical tasks of segmenting the left ventricle,
              estimating ejection fraction and assessing cardiomyopathy.
              Trained on echocardiogram videos, our model accurately segments
              the left ventricle with a Dice similarity coefficient of 0.92,
              predicts ejection fraction with a mean absolute error of 4.1\%
              and reliably classifies heart failure with reduced ejection
              fraction (area under the curve of 0.97). In an external dataset
              from another healthcare system, EchoNet-Dynamic predicts the
              ejection fraction with a mean absolute error of 6.0\% and
              classifies heart failure with reduced ejection fraction with an
              area under the curve of 0.96. Prospective evaluation with
              repeated human measurements confirms that the model has variance
              that is comparable to or less than that of human experts. By
              leveraging information across multiple cardiac cycles, our model
              can rapidly identify subtle changes in ejection fraction, is more
              reproducible than human evaluation and lays the foundation for
              precise diagnosis of cardiovascular disease in real time. As a
              resource to promote further innovation, we also make publicly
              available a large dataset of 10,030 annotated echocardiogram
              videos.",
  journal  = "Nature",
  volume   =  580,
  number   =  7802,
  pages    = "252--256",
  month    =  apr,
  year     =  2020,
  language = "en"
}

@ARTICLE{Waterhouse2019-wj,
  title    = "A roadmap for the clinical implementation of optical-imaging
              biomarkers",
  author   = "Waterhouse, Dale J and Fitzpatrick, Catherine R M and Pogue,
              Brian W and O'Connor, James P B and Bohndiek, Sarah E",
  abstract = "Clinical workflows for the non-invasive detection and
              characterization of disease states could benefit from
              optical-imaging biomarkers. In this Perspective, we discuss
              opportunities and challenges towards the clinical implementation
              of optical-imaging biomarkers for the early detection of cancer
              by analysing two case studies: the assessment of skin lesions in
              primary care, and the surveillance of patients with Barrett's
              oesophagus in specialist care. We stress the importance of
              technical and biological validations and clinical-utility
              assessments, and the need to address implementation bottlenecks.
              In addition, we define a translational roadmap for the widespread
              clinical implementation of optical-imaging technologies.",
  journal  = "Nat Biomed Eng",
  volume   =  3,
  number   =  5,
  pages    = "339--353",
  month    =  may,
  year     =  2019,
  language = "en"
}

@ARTICLE{Stummer2006-da,
  title    = "Fluorescence-guided surgery with 5-aminolevulinic acid for
              resection of malignant glioma: a randomised controlled
              multicentre phase {III} trial",
  author   = "Stummer, Walter and Pichlmeier, Uwe and Meinel, Thomas and
              Wiestler, Otmar Dieter and Zanella, Friedhelm and Reulen,
              Hans-J{\"u}rgen and {ALA-Glioma Study Group}",
  abstract = "BACKGROUND: 5-Aminolevulinic acid is a non-fluorescent prodrug
              that leads to intracellular accumulation of fluorescent
              porphyrins in malignant gliomas-a finding that is under
              investigation for intraoperative identification and resection of
              these tumours. We aimed to assess the effect of
              fluorescence-guided resection with 5-aminolevulinic acid on
              surgical radicality, progression-free survival, overall survival,
              and morbidity. METHODS: 322 patients aged 23-73 years with
              suspected malignant glioma amenable to complete resection of
              contrast-enhancing tumour were randomly assigned to 20 mg/kg
              bodyweight 5-aminolevulinic acid for fluorescence-guided
              resection (n=161) or to conventional microsurgery with white
              light (n=161). The primary endpoints were the number of patients
              without contrast-enhancing tumour on early MRI (ie, that obtained
              within 72 h after surgery) and 6-month progression-free survival
              as assessed by MRI. Secondary endpoints were volume of residual
              tumour on postoperative MRI, overall survival, neurological
              deficit, and toxic effects. We report the results of an interim
              analysis with 270 patients in the full-analysis population (139
              assigned 5-aminolevulinic acid, 131 assigned white light), which
              excluded patients with ineligible histological and radiological
              findings as assessed by central reviewers who were masked as to
              treatment allocation; the interim analysis resulted in
              termination of the study as defined by the protocol. Primary and
              secondary endpoints were analysed by intention to treat in the
              full-analysis population. The study is registered at
              http://www.clinicaltrials.gov as NCT00241670. FINDINGS: Median
              follow-up was 35.4 months (95\% CI 1.0-56.7). Contrast-enhancing
              tumour was resected completely in 90 (65\%) of 139 patients
              assigned 5-aminolevulinic acid compared with 47 (36\%) of 131
              assigned white light (difference between groups 29\% [95\% CI
              17-40], p<0.0001). Patients allocated 5-aminolevulinic acid had
              higher 6-month progression free survival than did those allocated
              white light (41.0\% [32.8-49.2] vs 21.1\% [14.0-28.2]; difference
              between groups 19.9\% [9.1-30.7], p=0.0003, Z test). Groups did
              not differ in the frequency of severe adverse events or adverse
              events in any organ system class reported within 7 days after
              surgery. INTERPRETATION: Tumour fluorescence derived from
              5-aminolevulinic acid enables more complete resections of
              contrast-enhancing tumour, leading to improved progression-free
              survival in patients with malignant glioma.",
  journal  = "Lancet Oncol.",
  volume   =  7,
  number   =  5,
  pages    = "392--401",
  month    =  may,
  year     =  2006,
  language = "en"
}

@ARTICLE{Fereidouni2017-za,
  title    = "Microscopy with ultraviolet surface excitation for rapid
              slide-free histology",
  author   = "Fereidouni, Farzad and Harmany, Zachary T and Tian, Miao and
              Todd, Austin and Kintner, John A and McPherson, John D and
              Borowsky, Alexander D and Bishop, John and Lechpammer, Mirna and
              Demos, Stavros G and Levenson, Richard",
  abstract = "Histological examination of tissues is central to the diagnosis
              and management of neoplasms and many other diseases and is a
              foundational technique for preclinical and basic research.
              However, commonly used bright-field microscopy requires prior
              preparation of micrometre-thick tissue sections mounted on glass
              slides-a process that can require hours or days, contributes to
              cost and delays access to critical information. Here, we
              introduce a simple, non-destructive slide-free technique that,
              within minutes, provides high-resolution diagnostic histological
              images resembling those obtained from conventional haematoxylin
              and eosin histology. The approach, which we named microscopy with
              ultraviolet surface excitation (MUSE), can also generate shape
              and colour-contrast information. MUSE relies on ~280 nm
              ultraviolet light to restrict the excitation of conventional
              fluorescent stains to tissue surfaces and it has no significant
              effects on downstream molecular assays (including fluorescence in
              situ hybridization and RNA sequencing). MUSE promises to improve
              the speed and efficiency of patient care in both state-of-the-art
              and low-resource settings and to provide opportunities for rapid
              histology in research.",
  journal  = "Nat Biomed Eng",
  volume   =  1,
  number   =  12,
  pages    = "957--966",
  month    =  dec,
  year     =  2017,
  language = "en"
}

@ARTICLE{Rumelhart1986-px,
  title    = "Learning representations by back-propagating errors",
  author   = "Rumelhart, David E and Hinton, Geoffrey E and Williams, Ronald J",
  abstract = "We describe a new learning procedure, back-propagation, for
              networks of neurone-like units. The procedure repeatedly adjusts
              the weights of the connections in the network so as to minimize a
              measure of the difference between the actual output vector of the
              net and the desired output vector. As a result of the weight
              adjustments, internal `hidden' units which are not part of the
              input or output come to represent important features of the task
              domain, and the regularities in the task are captured by the
              interactions of these units. The ability to create useful new
              features distinguishes back-propagation from earlier, simpler
              methods such as the perceptron-convergence procedure1.",
  journal  = "Nature",
  volume   =  323,
  number   =  6088,
  pages    = "533--536",
  month    =  oct,
  year     =  1986
}

@ARTICLE{Hochreiter1997-ri,
  title    = "Long short-term memory",
  author   = "Hochreiter, S and Schmidhuber, J",
  abstract = "Learning to store information over extended time intervals by
              recurrent backpropagation takes a very long time, mostly because
              of insufficient, decaying error backflow. We briefly review
              Hochreiter's (1991) analysis of this problem, then address it by
              introducing a novel, efficient, gradient-based method called long
              short-term memory (LSTM). Truncating the gradient where this does
              not do harm, LSTM can learn to bridge minimal time lags in excess
              of 1000 discrete-time steps by enforcing constant error flow
              through constant error carousels within special units.
              Multiplicative gate units learn to open and close access to the
              constant error flow. LSTM is local in space and time; its
              computational complexity per time step and weight is O(1). Our
              experiments with artificial data involve local, distributed,
              real-valued, and noisy pattern representations. In comparisons
              with real-time recurrent learning, back propagation through time,
              recurrent cascade correlation, Elman nets, and neural sequence
              chunking, LSTM leads to many more successful runs, and learns
              much faster. LSTM also solves complex, artificial long-time-lag
              tasks that have never been solved by previous recurrent network
              algorithms.",
  journal  = "Neural Comput.",
  volume   =  9,
  number   =  8,
  pages    = "1735--1780",
  month    =  nov,
  year     =  1997,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Brem1995-kt,
  title    = "Placebo-controlled trial of safety and efficacy of intraoperative
              controlled delivery by biodegradable polymers of chemotherapy for
              recurrent gliomas",
  author   = "Brem, H and Piantadosi, S and Burger, P C and Walker, M and
              Selker, R and Vick, N A and Black, K and Sisti, M and Brem, S and
              Mohr, G and Muller, P and Morawetz, R and Schold, S C",
  abstract = "Chemotherapy for brain tumours has been limited because of
              difficulty in achieving adequate exposure to the tumour without
              systemic toxicity. We have developed a method for local sustained
              release of chemotherapeutic agents by their incorporation into
              biodegradable polymers. Implantation of the drug-impregnated
              polymer at the tumour site allows prolonged local exposure with
              minimal systemic exposure. We conducted a randomised,
              placebo-controlled, prospective study to evaluate the
              effectiveness of biodegradable polymers impregnated with
              carmustine to treat recurrent malignant gliomas. In 27 medical
              centres, 222 patients with recurrent malignant brain tumours
              requiring re-operation were randomly assigned to receive
              surgically implanted biodegradable polymer discs with or without
              3Â·85\% carmustine. Randomisation balanced the treatment groups
              for all of the prognostic factors examined. Median survival of
              the 110 patients who received carmustine polymers was 31 weeks
              compared with 23 weeks for the 112 patients who received only
              placebo polymers (hazard ratio=0Â·67, p=0Â·006, after accounting
              for the effects of prognostic factors). Among patients with
              glioblastoma, 6-month survival in those treated with
              carmustine-polymer discs was 50\% greater than in those treated
              with placebo (mortality=32 of 72 [44\%] vs 47 of 73 [64\%],
              p=0Â·02). There were no clinically important adverse reactions
              related to the carmustine polymer, either in the brain or
              systemically. Interstitial chemotherapy delivered with polymers
              directly to brain tumours at the time of surgery seems to be a
              safe and effective treatment for recurrent malignant gliomas",
  journal  = "Lancet",
  volume   =  345,
  number   =  8956,
  pages    = "1008--1012",
  month    =  apr,
  year     =  1995
}

@INPROCEEDINGS{Guo2017-iv,
  title     = "Deep Clustering with Convolutional Autoencoders",
  booktitle = "Neural Information Processing",
  author    = "Guo, Xifeng and Liu, Xinwang and Zhu, En and Yin, Jianping",
  abstract  = "Deep clustering utilizes deep neural networks to learn feature
               representation that is suitable for clustering tasks. Though
               demonstrating promising performance in various applications, we
               observe that existing deep clustering algorithms either do not
               well take advantage of convolutional neural networks or do not
               considerably preserve the local structure of data generating
               distribution in the learned feature space. To address this
               issue, we propose a deep convolutional embedded clustering
               algorithm in this paper. Specifically, we develop a
               convolutional autoencoders structure to learn embedded features
               in an end-to-end way. Then, a clustering oriented loss is
               directly built on embedded features to jointly perform feature
               refinement and cluster assignment. To avoid feature space being
               distorted by the clustering loss, we keep the decoder remained
               which can preserve local structure of data in feature space. In
               sum, we simultaneously minimize the reconstruction loss of
               convolutional autoencoders and the clustering loss. The
               resultant optimization problem can be effectively solved by
               mini-batch stochastic gradient descent and back-propagation.
               Experiments on benchmark datasets empirically validate the power
               of convolutional autoencoders for feature learning and the
               effectiveness of local structure preservation.",
  publisher = "Springer International Publishing",
  pages     = "373--382",
  year      =  2017
}

@ARTICLE{Wiwie2015-oj,
  title    = "Comparing the performance of biomedical clustering methods",
  author   = "Wiwie, Christian and Baumbach, Jan and R{\"o}ttger, Richard",
  abstract = "Identifying groups of similar objects is a popular first step in
              biomedical data analysis, but it is error-prone and impossible to
              perform manually. Many computational methods have been developed
              to tackle this problem. Here we assessed 13 well-known methods
              using 24 data sets ranging from gene expression to protein
              domains. Performance was judged on the basis of 13 common cluster
              validity indices. We developed a clustering analysis platform,
              ClustEval (http://clusteval.mpi-inf.mpg.de), to promote
              streamlined evaluation, comparison and reproducibility of
              clustering results in the future. This allowed us to objectively
              evaluate the performance of all tools on all data sets with up to
              1,000 different parameter sets each, resulting in a total of more
              than 4 million calculated cluster validity indices. We observed
              that there was no universal best performer, but on the basis of
              this wide-ranging comparison we were able to develop a short
              guideline for biomedical clustering tasks. ClustEval allows
              biomedical researchers to pick the appropriate tool for their
              data type and allows method developers to compare their tool to
              the state of the art.",
  journal  = "Nat. Methods",
  volume   =  12,
  number   =  11,
  pages    = "1033--1038",
  month    =  nov,
  year     =  2015,
  language = "en"
}

@INPROCEEDINGS{Zhu2017-pi,
  title     = "{WSISA}: Making Survival Prediction from Whole Slide
               Histopathological Images",
  booktitle = "2017 {IEEE} Conference on Computer Vision and Pattern
               Recognition ({CVPR})",
  author    = "Zhu, X and Yao, J and Zhu, F and Huang, J",
  abstract  = "Image-based precision medicine techniques can be used to better
               treat cancer patients. However, the gigapixel resolution of
               Whole Slide Histopathological Images (WSIs) makes traditional
               survival models computationally impossible. These models usually
               adopt manually labeled discriminative patches from region of
               interests (ROIs) and are unable to directly learn discriminative
               patches from WSIs. We argue that only a small set of patches
               cannot fully represent the patients survival status due to the
               heterogeneity of tumor. Another challenge is that survival
               prediction usually comes with insufficient training patient
               samples. In this paper, we propose an effective Whole Slide
               Histopathological Images Survival Analysis framework (WSISA) to
               overcome above challenges. To exploit survival-discriminative
               patterns from WSIs, we first extract hundreds of patches from
               each WSI by adaptive sampling and then group these images into
               different clusters. Then we propose to train an aggregation
               model to make patient-level predictions based on cluster-level
               Deep Convolutional Survival (DeepConvSurv) prediction results.
               Different from existing state-of-the-arts image-based survival
               models which extract features using some patches from small
               regions of WSIs, the proposed framework can efficiently exploit
               and utilize all discriminative patterns in WSIs to predict
               patients survival status. To the best of our knowledge, this has
               not been shown before. We apply our method to the survival
               predictions of glioma and non-small-cell lung cancer using three
               datasets. Results demonstrate the proposed framework can
               significantly improve the prediction performance compared with
               the existing state-of-the-arts survival methods.",
  pages     = "6855--6863",
  month     =  jul,
  year      =  2017,
  keywords  = "biomedical optical imaging;cancer;feature extraction;learning
               (artificial intelligence);lung;medical image processing;patient
               treatment;tumours;WSISA;survival-discriminative
               patterns;aggregation model;patient-level predictions;prediction
               performance;cancer patient treatment;patient survival
               status;image-based precision medicine techniques;whole slide
               histopathological images survival analysis framework;adaptive
               sampling;cluster-level deep convolutional survival
               prediction;cluster-level DeepConvSurv;feature
               extraction;glioma;nonsmall-cell lung
               cancer;Tumors;Cancer;Computational modeling;Training;Feature
               extraction;Lungs"
}

@INPROCEEDINGS{Muhammad2019-po,
  title     = "Unsupervised Subtyping of Cholangiocarcinoma Using a Deep
               Clustering Convolutional Autoencoder",
  booktitle = "Medical Image Computing and Computer Assisted Intervention --
               {MICCAI} 2019",
  author    = "Muhammad, Hassan and Sigel, Carlie S and Campanella, Gabriele
               and Boerner, Thomas and Pak, Linda M and B{\"u}ttner, Stefan and
               IJzermans, Jan N M and Koerkamp, Bas Groot and Doukas, Michael
               and Jarnagin, William R and Simpson, Amber L and Fuchs, Thomas J",
  abstract  = "Unlike common cancers, such as those of the prostate and breast,
               tumor grading in rare cancers is difficult and largely undefined
               because of small sample sizes, the sheer volume of time and
               experience needed to undertake such a task, and the inherent
               difficulty of extracting human-observed patterns. One of the
               most challenging examples is intrahepatic cholangiocarcinoma
               (ICC), a primary liver cancer arising from the biliary system,
               for which there is well-recognized tumor heterogeneity and no
               grading paradigm or prognostic biomarkers. In this paper, we
               propose a new unsupervised deep convolutional autoencoder-based
               clustering model that groups together cellular and structural
               morphologies of tumor in 246 digitized whole slides, based on
               visual similarity. Clusters based on this visual dictionary of
               histologic patterns are interpreted as new ICC subtypes and
               evaluated by training Cox-proportional hazard survival models,
               resulting in statistically significant patient stratification.",
  publisher = "Springer International Publishing",
  pages     = "604--612",
  year      =  2019
}

@ARTICLE{Ramaswamy2016-wz,
  title    = "Fall of the Optical Wall: Freedom from the Tyranny of the
              Microscope Improves Glioma Risk Stratification",
  author   = "Ramaswamy, Vijay and Taylor, Michael D",
  abstract = "A recent study uses an integrated genomic approach to identify
              biologically defined subgroups of adult diffuse glioma. These
              results further lay the foundation for a pathological
              classification scheme for gliomas that incorporates both
              histology and molecular biomarkers, which appears far more robust
              than the current scheme, based solely on morphology.",
  journal  = "Cancer Cell",
  volume   =  29,
  number   =  2,
  pages    = "137--138",
  month    =  feb,
  year     =  2016,
  language = "en"
}

@ARTICLE{Wiens2019-mh,
  title    = "Do no harm: a roadmap for responsible machine learning for health
              care",
  author   = "Wiens, Jenna and Saria, Suchi and Sendak, Mark and Ghassemi,
              Marzyeh and Liu, Vincent X and Doshi-Velez, Finale and Jung,
              Kenneth and Heller, Katherine and Kale, David and Saeed, Mohammed
              and Ossorio, Pilar N and Thadaney-Israni, Sonoo and Goldenberg,
              Anna",
  abstract = "Interest in machine-learning applications within medicine has
              been growing, but few studies have progressed to deployment in
              patient care. We present a framework, context and ultimately
              guidelines for accelerating the translation of
              machine-learning-based interventions in health care. To be
              successful, translation will require a team of engaged
              stakeholders and a systematic process from beginning (problem
              formulation) to end (widespread deployment).",
  journal  = "Nat. Med.",
  volume   =  25,
  number   =  9,
  pages    = "1337--1340",
  month    =  sep,
  year     =  2019,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Krogager2019-os,
  title     = "Safe handling of veins in the pineal region---a mixed method
               study",
  author    = "Krogager, M E and Jakola, A S and Poulsgaard, L and {others}",
  abstract  = "Surgical experience in pineal surgery is largely confined to a
               few experienced surgeons and may be lost when they stop their
               practice. The objective of this study is to systematically
               preserve and analyze valuable practical knowledge of pineal
               region surgical venous â€¦",
  journal   = "Neurosurgical",
  publisher = "Springer",
  year      =  2019
}

@ARTICLE{Gozal2020-ua,
  title    = "Outcomes of decompressive surgery for cavernous sinus
              meningiomas: long-term follow-up in 50 patients",
  author   = "Gozal, Yair M and Alzhrani, Gmaan and Abou-Al-Shaar, Hussam and
              Azab, Mohammed A and Walsh, Michael T and Couldwell, William T",
  abstract = "OBJECTIVE: Cavernous sinus meningiomas are complex tumors that
              offer a perpetual challenge to skull base surgeons. The senior
              author has employed a management strategy for these lesions aimed
              at maximizing tumor control while minimizing neurological
              morbidity. This approach emphasizes combining ``safe'' tumor
              resection and direct decompression of the roof and lateral wall
              of the cavernous sinus as well as the optic nerve. Here, the
              authors review their experience with the application of this
              technique for the management of cavernous sinus meningiomas over
              the past 15 years. METHODS: A retrospective analysis was
              performed for patients with cavernous sinus meningiomas treated
              over a 15-year period (2002-2017) with this approach. Patient
              outcomes, including cranial nerve function, tumor control, and
              surgical complications were recorded. RESULTS: The authors
              identified 50 patients who underwent subtotal resection via
              frontotemporal craniotomy concurrently with decompression of the
              cavernous sinus and ipsilateral optic nerve. Of these, 25 (50\%)
              underwent adjuvant radiation to the remaining tumor within the
              cavernous sinus. Patients most commonly presented with a cranial
              nerve (CN) palsy involving CN III-VI (70\%), a visual deficit
              (62\%), headaches (52\%), or proptosis (44\%). Thirty-five
              patients had cranial nerve deficits preoperatively. In 52\% of
              these cases, the neuropathy improved postoperatively; it remained
              stable in 46\%; and it worsened in only 2\%. Similarly, 97\% of
              preoperative visual deficits either improved or were stable
              postoperatively. Notably, 12 new cranial nerve deficits occurred
              postoperatively in 10 patients. Of these, half were transient and
              ultimately resolved. Finally, radiographic recurrence was noted
              in 5 patients (10\%), with a median time to recurrence of 4.6
              years. CONCLUSIONS: The treatment of cavernous sinus meningiomas
              using surgical decompression with or without adjuvant radiation
              is an effective oncological strategy, achieving excellent tumor
              control rates with low risk of neurological morbidity.",
  journal  = "J. Neurosurg.",
  volume   =  132,
  number   =  2,
  pages    = "380--387",
  month    =  feb,
  year     =  2020,
  keywords = "CN = cranial nerve; KPS = Karnofsky Performance Status; SOF =
              superior orbital fissure; SRS = stereotactic radiosurgery; SRT =
              stereotactic radiotherapy; cavernous sinus; cranial nerve;
              cytoreduction; meningioma; oculoparesis; oncology; skull base
              approach",
  language = "en"
}

@ARTICLE{Karsy2017-eu,
  title    = "Assessment of Cost Drivers in Transsphenoidal Approaches for
              Resection of Pituitary Tumors Using the {Value-Driven} Outcome
              Database",
  author   = "Karsy, Michael and Brock, Andrea A and Guan, Jian and Bisson,
              Erica F and Couldwell, William T",
  abstract = "BACKGROUND: Reducing health care costs while improving quality of
              care has become imperative in neurosurgical care. The
              Value-Driven Outcome database at the University of Utah
              identifies cost drivers and tracks changes over time. METHODS:
              Retrospective review was performed for transsphenoidal resections
              of pituitary adenomas from July 2012 to September 2016. Total
              cost, subcategory costs, and potential cost drivers were
              evaluated. RESULTS: There were 272 patients (mean age 51.5 years
              $\pm$ 17.7, 45.6\% male) with mean length of stay of 4 days $\pm$
              4 evaluated. Total costs included facility utilization (60\%),
              physician professional fees (16\%), pharmacy (11\%), supplies and
              implants (7\%), laboratory studies (5\%), and imaging (1\%).
              Facility costs were driven by neurocritical care unit (30.7\%),
              neurosurgical operating room (16.6\%), and neurosurgical floor
              (11.2\%) costs. Multivariable linear regression, after adjusting
              for length of stay and American Society of Anesthesiologists
              grade, showed that overall cost was heavily influenced by
              facility utilization ($\rho$ = 0.98, P = 0.001), pharmacy ($\rho$
              = 0.71, P = 0.001), supplies and implants ($\rho$ = 0.51, P =
              0.0001), imaging ($\rho$ = 0.51, P = 0.0001), and laboratory
              ($\rho$ = 0.79, P = 0.001) costs. The top 10 outlier patients
              accounted for 18.7\% of total costs (mean cost for all patients
              0.24\% $\pm$ 0.29). CONCLUSIONS: Our results highlight the
              importance of facility utilization and pharmaceutical,
              supply/implant, imaging, and laboratory costs as overall cost
              drivers during transsphenoidal pituitary tumor resection.
              Facility utilization was a stronger cost driver than any other
              aspect of care. Strategies to mitigate cost include stratifying
              low-risk patients to an intermediate care unit and reducing
              length of stay.",
  journal  = "World Neurosurg.",
  volume   =  105,
  pages    = "818--823",
  month    =  sep,
  year     =  2017,
  keywords = "Cost-effectiveness; Pituitary tumor; Transsphenoidal surgery;
              Value-driven outcome",
  language = "en"
}

@ARTICLE{Couldwell1996-cv,
  title    = "Petroclival meningiomas: surgical experience in 109 cases",
  author   = "Couldwell, W T and Fukushima, T and Giannotta, S L and Weiss, M H",
  abstract = "The surgical removal of petroclival meningiomas has historically
              been associated with a high incidence of morbidity and mortality.
              The 109 consecutive patients included in the present
              retrospective study represent a combined series of tumors
              operated on by the four authors during a period from 1980 to
              1992. The series is composed of 40 men and 69 women ranging in
              age from 25 to 75 years (mean 51 years). Surgical approaches to
              tumors in this series included simple retromastoid (60 cases),
              combined supra- and infratentorial petrosal (22), transtemporal
              (primary transsigmoid retrolabyrinthine, translabyrinthine, or
              transcochlear (12), subtemporal (11), and frontotemporal
              transcavernous (eight). Gross-total removal was achieved in 75
              patients (69\%). Recurrence or progression of disease occurred in
              14 patients (13\%) over a 6.1-year mean follow-up period, and it
              was found within the cavernous sinus in 12 of these cases. Four
              recurrent cases demonstrated histological compatibility with
              malignant meningioma. Perioperative death occurred in four
              patients, and there were 56 significant complications in 35 other
              patients. Review of this series, with the attendant
              complications, has facilitated the authors' decision-making when
              considering the risk of gross-total removal in selected patients
              with asymptomatic cavernous sinus invasion or tumor adherent to
              the brainstem.",
  journal  = "J. Neurosurg.",
  volume   =  84,
  number   =  1,
  pages    = "20--28",
  month    =  jan,
  year     =  1996,
  language = "en"
}

@ARTICLE{Samii1997-ed,
  title    = "Management of 1000 vestibular schwannomas (acoustic neuromas):
              surgical management and results with an emphasis on complications
              and how to avoid them",
  author   = "Samii, M and Matthies, C",
  abstract = "OBJECTIVE: To identify the actual benefits and persisting
              problems in treating vestibular schwannomas by the suboccipital
              approach, the results and complications in a consecutive series
              of 1000 tumors surgically treated by the senior author were
              analyzed and compared with experiences involving other treatment
              modalities. METHODS: Pre- and postoperative clinical statuses
              were determined and radiological and surgical findings were
              collected and evaluated in a large database for 962 patients
              undergoing 1000 vestibular schwannoma operations at Nordstadt's
              neurosurgical department from 1978 to 1993. RESULTS: By the
              suboccipital transmeatal approach, 979 tumors were completely
              removed; in 21 cases, deliberate partial removal was performed
              either in severely ill patients for decompression of the brain
              stem or in an attempt to preserve hearing in the last hearing
              ear. Anatomic preservation of the facial nerve was achieved in
              93\% of the patients and of the cochlear nerve in 68\%. Major
              neurological complications included 1 case of tetraparesis, 10
              cases of hemiparesis, and caudal cranial nerve palsies in 5.5\%
              of the cases. Surgical complications included hematomas in 2.2\%
              of the cases, cerebrospinal fluid fistulas in 9.2\%,
              hydrocephalus in 2.3\%, bacterial meningitis in 1.2\%, and wound
              revisions in 1.1\%. There were 11 deaths occurring at 2 to 69
              days postoperatively (1.1\%). The techniques that were developed
              for avoidance of complications are reported. The analysis
              identifies preexisting severe general and/or neurological
              morbidity, cystic tumor formation, and major caudal cranial nerve
              deficits as relevant risk factors. CONCLUSION: The current
              treatment options of complete tumor resection with ongoing
              reduction of morbidity are well fulfilled by the suboccipital
              approach. By careful patient selection, the mortality rate should
              be further reduced to below 1\%.",
  journal  = "Neurosurgery",
  volume   =  40,
  number   =  1,
  pages    = "11--21; discussion 21--3",
  month    =  jan,
  year     =  1997,
  language = "en"
}

@ARTICLE{Harvey2017-jh,
  title    = "Survival outcomes for stage-matched endoscopic and open resection
              of olfactory neuroblastoma",
  author   = "Harvey, Richard J and Nalavenkata, Sunny and Sacks, Raymond and
              Adappa, Nithin D and Palmer, James N and Purkey, Michael T and
              Schlosser, Rodney J and Snyderman, Carl and Wang, Eric W and
              Woodworth, Bradford A and Smee, Robert and Havas, Tom and
              Gallagher, Richard",
  abstract = "BACKGROUND: Advanced-stage olfactory neuroblastoma requires
              multimodal therapy for optimal outcomes. Debate exists over
              endoscopic endonasal surgery in this situation. Stage-matched
              open and endoscopic surgical therapy were compared. METHODS:
              Patients from 6 cancer institutions were assessed. Stratification
              included dural involvement, Kadish stage, nodal disease, Hyams'
              grade, approach, and margin status. At follow-up, local control,
              nodal status, and evidence of distant metastases were recorded
              with any subsequent therapy. Statistical analyses to identify
              risk factors for developing recurrence and survival differences
              were performed. RESULTS: One hundred nine patients were assessed
              (age 49.2 $\pm$ 13.0 years; 46\% women) representing Kadish A
              stage (10\%), Kadish B stage (25\%), and Kadish C stage (65\%).
              The majority of the patients (61.5\%) underwent endoscopic
              resection, 53.5\% within Kadish C stage. Within-stage survival
              analysis favored endoscopic subgroup for Kadish C stage (log-rank
              P = .017) nonsignificant for Kadish B stage (log-rank P = .39).
              CONCLUSION: Stage-matched survival was better for the
              endoscopically treated group compared to the open surgery group,
              with high negative margin resections obtained.",
  journal  = "Head Neck",
  volume   =  39,
  number   =  12,
  pages    = "2425--2432",
  month    =  dec,
  year     =  2017,
  keywords = "endoscopy; esthesioneuroblastoma; metastases; outcomes;
              radiotherapy; surgery; survival",
  language = "en"
}

@ARTICLE{Wolfe2020-ik,
  title    = "Clinical Outcomes and Multidisciplinary Patterns of Failure for
              Olfactory Neuroblastoma: The Ohio State Experience",
  author   = "Wolfe, Adam R and Blakaj, Dukagjin and London, Nyall and Blakaj,
              Adriana and Klamer, Brett and Pan, Jeff and Wakely, Paul and
              Prevedello, Luciano and Bonomi, Marcelo and Bhatt, Aashish and
              Raval, Raju and Palmer, Joshua and Prevedello, Daniel and Gamez,
              Mauricio and Carrau, Ricardo",
  abstract = "Purpose Olfactory neuroblastoma (ONB) is a rare head and neck
              cancer believed to be originated from neural crest cells of the
              olfactory membrane located in the roof of the nasal fossa. This
              study evaluates clinical outcomes and failure patterns in ONB
              patients of those patients treated with surgical resection at a
              high-volume tertiary cancer center. Methods and Materials
              Thirty-nine ONB patients who underwent surgical resection at our
              institution from 1996 to 2017 were retrospectively identified.
              Univariate, multivariate, and survival analysis were calculated
              using Cox regression analysis and Kaplan-Meier log-rank. Results
              Median follow-up time was 59 months (range: 5.2-236 months). The
              median overall survival (OS) and disease-free survival (DFS) for
              the entire cohort were 15 and 7.6 years, respectively. The 5-year
              cumulative OS and DFS were 83 and 72\%, respectively. The 5-year
              OS for low Hyams grade (LHG) versus high Hyams grade (HHG) was 95
              versus 61\% ( p = 0.041). LHG was found in 66\% of the early
              Kadish stage patients compared with 28\% in the advanced Kadish
              stage patients ( p = 0.057). On multivariate analysis, HHG and
              positive node status predicted for worse OS and only HHG
              predicted for worse DFS. Of note, five patients (all Kadish stage
              A) who received surgical resection alone had no observed deaths
              or recurrences with a median follow-up of 44 months (range: 5-235
              months). Conclusion In this retrospective cohort, patients with
              positive nodes or HHG have significantly worse clinical outcomes.
              Future studies should explore treatment intensification for HHG
              or positive nodes.",
  journal  = "J. Neurol. Surg. B Skull Base",
  volume   =  81,
  number   =  3,
  pages    = "287--294",
  month    =  jun,
  year     =  2020,
  keywords = "IMRT; olfactory neuroblastoma; radiation therapy",
  language = "en"
}

@ARTICLE{Hendrix2017-se,
  title    = "Neurocognitive Function Surrounding the Resection of Frontal
              {WHO} Grade {I} Meningiomas: A Prospective {Matched-Control}
              Study",
  author   = "Hendrix, Philipp and Hans, Elisa and Griessenauer, Christoph J
              and Simgen, Andreas and Oertel, Joachim and Karbach, Julia",
  abstract = "OBJECTIVE: Patients with intracranial meningiomas can experience
              neurocognitive dysfunctions in specific cognitive domains
              depending on tumor location and size. The literature regarding
              cognitive function surrounding the resection of frontal
              meningiomas is sparse. METHODS: We performed a prospective
              matched-control study to investigate the cognitive performance of
              frontal meningioma patients undergoing resection. The
              neurocognitive status 1 week and 2 months after resection was
              compared with the preoperative status and matched-controls.
              Matching was performed for age, sex, handedness, education, and
              profession. An extensive test battery was used to assess
              perceptual speed, executive function, visual-spatial and verbal
              working memory, short- and long-term memory, verbal fluency,
              fluid intelligence, anxiety, and depression. RESULTS: Twelve
              patients with frontal World Health Organization grade I
              meningioma and 12 matched-controls underwent cognitive testing.
              Macroscopically, complete removal was achieved in all cases.
              Comparison of patients and controls revealed significant
              cognitive impairments in perceptual speed, executive function,
              short-term memory, and verbal fluency preoperatively and
              postoperatively. At 2 months' follow-up, perceptual speed and
              verbal fluency were still significantly impaired, whereas
              executive function and short-term memory were equal to that in
              the control group. None of the patients experienced cognitive
              deterioration after surgical therapy. CONCLUSION: Patients with
              frontal meningiomas display preoperative and postoperative
              deficits in perceptual speed, executive function, short-term
              memory, and verbal fluency. The risk for cognitive deterioration
              owing to surgical resection is low. Within the first two months
              after surgery, executive function and short-term memory appear to
              recover.",
  journal  = "World Neurosurg.",
  volume   =  98,
  pages    = "203--210",
  month    =  feb,
  year     =  2017,
  keywords = "Cognition; Frontal; Meningioma; Neurocognitive assessment",
  language = "en"
}

@INPROCEEDINGS{Hadsell2006-kv,
  title     = "Dimensionality Reduction by Learning an Invariant Mapping",
  booktitle = "2006 {IEEE} Computer Society Conference on Computer Vision and
               Pattern Recognition ({CVPR'06})",
  author    = "Hadsell, R and Chopra, S and LeCun, Y",
  abstract  = "Dimensionality reduction involves mapping a set of high
               dimensional input points onto a low dimensional manifold so that
               'similar`` points in input space are mapped to nearby points on
               the manifold. We present a method - called Dimensionality
               Reduction by Learning an Invariant Mapping (DrLIM) - for
               learning a globally coherent nonlinear function that maps the
               data evenly to the output manifold. The learning relies solely
               on neighborhood relationships and does not require any
               distancemeasure in the input space. The method can learn
               mappings that are invariant to certain transformations of the
               inputs, as is demonstrated with a number of experiments.
               Comparisons are made to other techniques, in particular LLE.",
  publisher = "ieeexplore.ieee.org",
  volume    =  2,
  pages     = "1735--1742",
  month     =  jun,
  year      =  2006,
  keywords  = "Extraterrestrial measurements;Image
               generation;Biology;Geoscience;Astronomy;Service
               robots;Manufacturing industries;Image analysis;Feature
               extraction;Data visualization"
}

@ARTICLE{Ratliff2000-vc,
  title    = "Multiple pituitary adenomas in Cushing's disease",
  author   = "Ratliff, J K and Oldfield, E H",
  abstract = "OBJECT: Clinically evident multiple pituitary adenomas rarely
              occur. The authors assess the incidence and clinical relevance of
              multiple adenomas in Cushing's disease. METHODS: A prospective
              clinical database of 660 pituitary surgeries was analyzed to
              assess the incidence of multiple pituitary adenomas in Cushing's
              disease. Relevant radiographic scans, medical records, and
              histopathological reports were reviewed. Thirteen patients with
              at least two separate histopathologically confirmed pituitary
              adenomas were identified. Prolactinomas (nine patients) were the
              most common incidental tumors. Other incidental tumors included
              secretors of growth hormone ([GH], one patient) and GH and
              prolactin (two patients), and a null-cell tumor (one patient). In
              two patients, early repeated surgery was performed because the
              initial operation failed to correct hypercortisolism, in one
              instance because the tumor excised at the initial surgery was a
              prolactinoma, not an adrenocorticotropic hormone-secreting tumor.
              One patient had three distinct tumors. CONCLUSIONS: Multiple
              pituitary adenomas are rare, but may complicate management of
              patients with pituitary disease.",
  journal  = "J. Neurosurg.",
  volume   =  93,
  number   =  5,
  pages    = "753--761",
  month    =  nov,
  year     =  2000,
  language = "en"
}

@ARTICLE{Yamada2012-zz,
  title    = "Surgical management and outcomes in patients with Cushing disease
              with negative pituitary magnetic resonance imaging",
  author   = "Yamada, Shozo and Fukuhara, Noriaki and Nishioka, Hiroshi and
              Takeshita, Akira and Inoshita, Naoko and Ito, Junko and Takeuchi,
              Yasuhiro",
  abstract = "OBJECTIVE: To analyze our experience with transsphenoidal surgery
              (TSS) in patients with Cushing disease (CD) with no visible
              adenoma on magnetic resonance imaging (MRI). METHODS: Between
              January 1988 and October 2010, 183 patients with CD underwent TSS
              at Toranomon Hospital. We retrospectively analyzed data in 18
              patients without visible adenomas on MRI and compared them with
              106 patients with microadenomas. RESULTS: Of 106 patients with
              MRI-visible microadenomas, postoperative remission was achieved
              in 104 patients (98.1\%) and recurrence of CD was observed in 4
              patients (3.8\%) during a mean follow-up of 5.2 years. Of the 18
              patients with negative MRI, postoperative remission was achieved
              in 0 of the 3 patients with negative inferior petrosal sinus
              sampling (IPSS), in 50\% of those with positive IPSS (7 of 14
              patients), and in 1 patient with inconclusive IPSS. No disease
              recurrence has been observed during a mean follow-up of 3.3 years
              in the 8 patients with remission, and no tumor has emerged on MRI
              in 10 patients with failed surgery during a mean follow-up of 4.2
              years. No major perioperative complications, including
              hypopituitarism, occurred in this series. CONCLUSIONS: When the
              pituitary origin of adrenocorticotropic hormone secretion is
              established by IPSS in patients with normal MRI findings, we
              recommend TSS as the first-line treatment for CD, although chance
              of surgical cure (50\% in this series) is lower than that of
              MRI-visible microadenomas. In contrast, other therapeutic options
              must be considered in patients with negative MRI and IPSS
              findings.",
  journal  = "World Neurosurg.",
  volume   =  77,
  number   = "3-4",
  pages    = "525--532",
  month    =  mar,
  year     =  2012,
  language = "en"
}

@ARTICLE{Oldfield1985-ye,
  title    = "Preoperative lateralization of {ACTH-secreting} pituitary
              microadenomas by bilateral and simultaneous inferior petrosal
              venous sinus sampling",
  author   = "Oldfield, E H and Chrousos, G P and Schulte, H M and Schaaf, M
              and McKeever, P E and Krudy, A G and Cutler, Jr, G B and Loriaux,
              D L and Doppman, J L",
  journal  = "N. Engl. J. Med.",
  volume   =  312,
  number   =  2,
  pages    = "100--103",
  month    =  jan,
  year     =  1985,
  language = "en"
}

@ARTICLE{McCrea2015-cs,
  title    = "Sex, Age, Anatomic Location, and Extent of Resection Influence
              Outcomes in Children With High-grade Glioma",
  author   = "McCrea, Heather J and Bander, Evan D and Venn, Rachael A and
              Reiner, Anne S and Iorgulescu, J Bryan and Puchi, Luis A and
              Schaefer, Peter M and Cederquist, Gustav and Greenfield, Jeffrey
              P",
  abstract = "BACKGROUND: Survival duration and prognostic factors in adult
              high-grade glioma have been comprehensively analyzed, but less is
              known about factors contributing to overall survival (OS) and
              progression-free survival (PFS) in pediatric patients. OBJECTIVE:
              To identify these factors in the pediatric population. METHODS:
              We retrospectively reviewed institutional databases evaluating
              all patients $\leq$21 years with high-grade glioma treated
              between 1988 and 2010. Kaplan-Meier curves and log-rank
              statistics were used to compare groups univariately. Multivariate
              analyses were completed using Cox proportional hazards regression
              models. RESULTS: Ninety-seven patients were identified with a
              median age of 11 years. Median OS was 1.7 years, and median PFS
              was 272 days. Location was significant for OS (P < .001).
              Patients with gross total resection (GTR) had a median OS of 3.4
              years vs 1.6 years for subtotal resection and 1.3 years for
              biopsy patients (P < .001). Female patients had improved OS (P =
              .01). Female patients with GTR had a mean OS of 8.1 years vs 2.4
              years for male patients with GTR and 1.4 years for all other
              female patients and male patients (P = .001). PFS favored
              patients $\leq$3 and $\geq$13 years and females (P = .003 and
              .001). CONCLUSION: OS was significantly correlated with the
              location of the tumor and the extent of resection. GTR
              significantly improved overall survival for both glioblastoma
              multiforme and anaplastic astrocytoma patients, and female
              patients showed a much larger survival benefit from GTR than male
              patients.",
  journal  = "Neurosurgery",
  volume   =  77,
  number   =  3,
  pages    = "443--52; discussion 452--3",
  month    =  sep,
  year     =  2015,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Souweidane2018-at,
  title    = "Convection-enhanced delivery for diffuse intrinsic pontine
              glioma: a single-centre, dose-escalation, phase 1 trial",
  author   = "Souweidane, Mark M and Kramer, Kim and Pandit-Taskar, Neeta and
              Zhou, Zhiping and Haque, Sofia and Zanzonico, Pat and
              Carrasquillo, Jorge A and Lyashchenko, Serge K and Thakur,
              Sunitha B and Donzelli, Maria and Turner, Ryan S and Lewis, Jason
              S and Cheung, Nai-Kong V and Larson, Steven M and Dunkel, Ira J",
  abstract = "BACKGROUND: Diffuse intrinsic pontine glioma is one of the
              deadliest central nervous system tumours of childhood, with a
              median overall survival of less than 12 months.
              Convection-enhanced delivery has been proposed as a means to
              efficiently deliver therapeutic agents directly into the
              brainstem while minimising systemic exposure and associated toxic
              effects. We did this study to evaluate the safety of
              convection-enhanced delivery of a radioimmunotherapy agent
              targeting the glioma-associated B7-H3 antigen in children with
              diffuse intrinsic pontine glioma. METHODS: We did a phase 1,
              single-arm, single-centre, dose-escalation study at the Memorial
              Sloan Kettering Cancer Center (New York, NY, USA). Eligible
              patients were aged 3-21 years and had diffuse intrinsic pontine
              glioma as diagnosed by consensus of a multidisciplinary
              paediatric neuro-oncology team; a Lansky (patients <16 years of
              age) or Karnofsky (patients $\geq$16 years) performance score of
              at least 50 at study entry; a minimum weight of 8 kg; and had
              completed external beam radiation therapy (54Â·0-59Â·4 Gy at 1Â·8 Gy
              per fraction over 30-33 fractions) at least 4 weeks but no more
              than 14 weeks before enrolment. Seven dose-escalation cohorts
              were planned based on standard 3 + 3 rules: patients received a
              single infusion of 9Â·25, 18Â·5, 27Â·75, 37, 92Â·5, 120Â·25, or 148
              MBq, respectively, at a concentration of about 37 MBq/mL by
              convection-enhanced delivery of the radiolabelled antibody
              [124I]-8H9. The primary endpoint was identification of the
              maximum tolerated dose. The analysis of the primary endpoint was
              done in the per-protocol population (patients who received the
              full planned dose of treatment), and all patients who received
              any dose of study treatment were included in the safety analysis.
              This study is registered with ClinicalTrials.gov, number
              NCT01502917, and is ongoing with an expanded cohort. FINDINGS:
              From April 5, 2012, to Oct 8, 2016, 28 children were enrolled and
              treated in the trial, of whom 25 were evaluable for the primary
              endpoint. The maximum tolerated dose was not reached as no
              dose-limiting toxicities were observed. One (4\%) of 28 patients
              had treatment-related transient grade 3 hemiparesis and one (4\%)
              had grade 3 skin infection. No treatment-related grade 4 adverse
              events or deaths occurred. Estimated volumes of distribution (Vd)
              were linearly dependent on volumes of infusion (Vi) and ranged
              from 1Â·5 to 20Â·1 cm3, with a mean Vd/Vi ratio of 3Â·4 (SD 1Â·2).
              The mean lesion absorbed dose was 0Â·39 Gy/MBq 124I (SD 0Â·20).
              Systemic exposure was negligible, with an average lesion-to-whole
              body ratio of radiation absorbed dose higher than 1200.
              INTERPRETATION: Convection-enhanced delivery in the brainstem of
              children with diffuse intrinsic pontine glioma who have
              previously received radiation therapy seems to be a rational and
              safe therapeutic strategy. PET-based dosimetry of the
              radiolabelled antibody [124I]-8H9 validated the principle of
              using convection-enhanced delivery in the brain to achieve high
              intra-lesional dosing with negligible systemic exposure. This
              therapeutic strategy warrants further development for children
              with diffuse intrinsic pontine glioma. FUNDING: National
              Institutes of Health, The Dana Foundation, The Cure Starts Now,
              Solving Kids' Cancer, The Lyla Nsouli Foundation, Cookies for
              Kids' Cancer, The Cristian Rivera Foundation, Battle for a Cure,
              Cole Foundation, Meryl \& Charles Witmer Charitable Foundation,
              Tuesdays with Mitch Charitable Foundation, and Memorial Sloan
              Kettering Cancer Center.",
  journal  = "Lancet Oncol.",
  volume   =  19,
  number   =  8,
  pages    = "1040--1050",
  month    =  aug,
  year     =  2018,
  language = "en"
}

@ARTICLE{Jones2017-is,
  title    = "Pediatric high-grade glioma: biologically and clinically in need
              of new thinking",
  author   = "Jones, Chris and Karajannis, Matthias A and Jones, David T W and
              Kieran, Mark W and Monje, Michelle and Baker, Suzanne J and
              Becher, Oren J and Cho, Yoon-Jae and Gupta, Nalin and Hawkins,
              Cynthia and Hargrave, Darren and Haas-Kogan, Daphne A and Jabado,
              Nada and Li, Xiao-Nan and Mueller, Sabine and Nicolaides, Theo
              and Packer, Roger J and Persson, Anders I and Phillips, Joanna J
              and Simonds, Erin F and Stafford, James M and Tang, Yujie and
              Pfister, Stefan M and Weiss, William A",
  abstract = "High-grade gliomas in children are different from those that
              arise in adults. Recent collaborative molecular analyses of these
              rare cancers have revealed previously unappreciated connections
              among chromatin regulation, developmental signaling, and
              tumorigenesis. As we begin to unravel the unique developmental
              origins and distinct biological drivers of this heterogeneous
              group of tumors, clinical trials need to keep pace. It is
              important to avoid therapeutic strategies developed purely using
              data obtained from studies on adult glioblastoma. This approach
              has resulted in repetitive trials and ineffective treatments
              being applied to these children, with limited improvement in
              clinical outcome. The authors of this perspective, comprising
              biology and clinical expertise in the disease, recently convened
              to discuss the most effective ways to translate the emerging
              molecular insights into patient benefit. This article reviews our
              current understanding of pediatric high-grade glioma and suggests
              approaches for innovative clinical management.",
  journal  = "Neuro. Oncol.",
  volume   =  19,
  number   =  2,
  pages    = "153--161",
  month    =  feb,
  year     =  2017,
  keywords = "DIPG; clinical trials; genomics; glioma; pediatric",
  language = "en"
}

@ARTICLE{Mendez2020-cd,
  title    = "Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and
              fms-like Tyrosine Kinase 3 Ligand ({TK/Flt3L}) Gene Therapy in a
              Mouse Model of {High-Grade} Brainstem Glioma",
  author   = "Mendez, Flor and Kadiyala, Padma and Nunez, Felipe J and Carney,
              Stephen and Nunez, Fernando M and Gauss, Jessica C and Ravindran,
              Ramya and Pawar, Sheeba and Edwards, Marta and Garcia-Fabiani,
              Maria Belen and Haase, Santiago and Lowenstein, Pedro R and
              Castro, Maria G",
  abstract = "PURPOSE: Diffuse intrinsic pontine glioma (DIPG) bears a dismal
              prognosis. A genetically engineered brainstem glioma model
              harboring the recurrent DIPG mutation, Activin A receptor type I
              (ACVR1)-G328V (mACVR1), was developed for testing an
              immune-stimulatory gene therapy. EXPERIMENTAL DESIGN: We utilized
              the Sleeping Beauty transposase system to generate an endogenous
              mouse model of mACVR1 brainstem glioma. Histology was used to
              characterize and validate the model. We performed RNA-sequencing
              analysis on neurospheres harboring mACVR1. mACVR1 neurospheres
              were implanted into the pons of immune-competent mice to test the
              therapeutic efficacy and toxicity of immune-stimulatory gene
              therapy using adenoviruses expressing thymidine kinase (TK) and
              fms-like tyrosine kinase 3 ligand (Flt3L). mACVR1 neurospheres
              expressing the surrogate tumor antigen ovalbumin were generated
              to investigate whether TK/Flt3L treatment induces the recruitment
              of tumor antigen-specific T cells. RESULTS: Histologic analysis
              of mACVR1 tumors indicates that they are localized in the
              brainstem and have increased downstream signaling of bone
              morphogenetic pathway as demonstrated by increased
              phospho-smad1/5 and Id1 levels. Transcriptome analysis of mACVR1
              neurosphere identified an increase in the TGF$\beta$ signaling
              pathway and the regulation of cell differentiation. Adenoviral
              delivery of TK/Flt3L in mice bearing brainstem gliomas resulted
              in antitumor immunity, recruitment of antitumor-specific T cells,
              and increased median survival (MS). CONCLUSIONS: This study
              provides insights into the phenotype and function of the tumor
              immune microenvironment in a mouse model of brainstem glioma
              harboring mACVR1. Immune-stimulatory gene therapy targeting the
              hosts' antitumor immune response inhibits tumor progression and
              increases MS of mice bearing mACVR1 tumors.",
  journal  = "Clin. Cancer Res.",
  volume   =  26,
  number   =  15,
  pages    = "4080--4092",
  month    =  aug,
  year     =  2020,
  language = "en"
}

@ARTICLE{Niazi2019-hl,
  title    = "Digital pathology and artificial intelligence",
  author   = "Niazi, Muhammad Khalid Khan and Parwani, Anil V and Gurcan, Metin
              N",
  abstract = "In modern clinical practice, digital pathology has a crucial role
              and is increasingly a technological requirement in the scientific
              laboratory environment. The advent of whole-slide imaging,
              availability of faster networks, and cheaper storage solutions
              has made it easier for pathologists to manage digital slide
              images and share them for clinical use. In parallel,
              unprecedented advances in machine learning have enabled the
              synergy of artificial intelligence and digital pathology, which
              offers image-based diagnosis possibilities that were once limited
              only to radiology and cardiology. Integration of digital slides
              into the pathology workflow, advanced algorithms, and
              computer-aided diagnostic techniques extend the frontiers of the
              pathologist's view beyond a microscopic slide and enable true
              utilisation and integration of knowledge that is beyond human
              limits and boundaries, and we believe there is clear potential
              for artificial intelligence breakthroughs in the pathology
              setting. In this Review, we discuss advancements in digital
              slide-based image diagnosis for cancer along with some challenges
              and opportunities for artificial intelligence in digital
              pathology.",
  journal  = "Lancet Oncol.",
  volume   =  20,
  number   =  5,
  pages    = "e253--e261",
  month    =  may,
  year     =  2019,
  language = "en"
}

@BOOK{Hastie2009-cc,
  title     = "The Elements of Statistical Learning: Data Mining, Inference,
               and Prediction",
  author    = "Hastie, Trevor and Tibshirani, Robert and Friedman, Jerome",
  publisher = "Springer, New York, NY",
  year      =  2009
}

@ARTICLE{Oya2021-mk,
  title    = "Effect of adjuvant radiotherapy after subtotal resection for
              {WHO} grade {I} meningioma: a propensity score matching analysis
              of the Brain Tumor Registry of Japan",
  author   = "Oya, Soichi and Ikawa, Fusao and Ichihara, Nao and Wanibuchi,
              Masahiko and Akiyama, Yukinori and Nakatomi, Hirofumi and Mikuni,
              Nobuhiro and Narita, Yoshitaka",
  abstract = "PURPOSE: This study aimed to improve the understanding of the
              role of adjuvant radiotherapy (AR) after subtotal resection (STR)
              of World Health Organization (WHO) grade I meningiomas. METHODS:
              We retrospectively reviewed the Brain Tumor Registry of Japan
              database. Among 7341 patients diagnosed with intracranial
              meningioma during 2001-2008, we identified 406 patients with WHO
              grade I meningioma treated with STR as initial treatment. Data on
              progression-free survival (PFS) were assessed for their relevance
              to clinical factors including age, sex, tumor location and size,
              presence of preoperative symptoms, and AR. RESULTS: AR was
              administered for 73 patients (18.0\%). Regrowth occurred in 90
              cases (22.2\%) during the median follow-up period of 6.0 years
              (interquartile range, 2.7-7.7 years). Multivariate Cox regression
              analysis of the entire cohort showed that no AR was associated
              with significantly shorter PFS (hazard ratio [HR] 2.52, 95\%
              confidence interval [CI] 1.33-5.42, p = 0.004). The therapeutic
              effect of AR was confirmed for skull base, but not non-skull
              base, meningiomas (p = 0.003 and 0.69, respectively). Propensity
              score matching analysis balanced the influence of confounding
              factors to generate AR+ and AR- cohorts of 73 patients each. PFS
              was significantly longer in the AR+ cohort than in the AR- cohort
              (HR 3.46, 95\% CI 1.53-8.59, p = 0.003). Subgroup analysis
              demonstrated the favorable effect of AR only for skull base
              meningiomas. CONCLUSIONS: Our study revealed that AR improves
              tumor control after STR in WHO grade I meningiomas. However, this
              beneficial effect might be limited to skull base meningiomas.",
  journal  = "J. Neurooncol.",
  month    =  may,
  year     =  2021,
  keywords = "Adjuvant radiotherapy; Brain tumor registry; Meningioma;
              Recurrence; Skull base",
  language = "en"
}

@ARTICLE{Hendrix2017-tw,
  title    = "Cognitive function surrounding resection of nonfunctioning
              pituitary adenomas with suprasellar extension: A prospective
              matched-control study",
  author   = "Hendrix, Philipp and Griessenauer, Christoph J and Hans, Elisa
              and Simgen, Andreas and Oertel, Joachim and Karbach, Julia",
  abstract = "OBJECTIVE: Patients suffering from pituitary adenomas may
              experience cognitive dysfunctions due to hormonal imbalance or
              suprasellar tumor extension displacing neural structures.
              Progressively enlarging or symptomatic nonfunctioning pituitary
              adenomas with suprasellar extension are frequently resected. The
              literature on neurocognitive performance surrounding resection of
              these lesions is sparse. METHODS: A prospective matched-control
              study was conducted to investigate the impact of nonfunctioning
              pituitary adenomas with suprasellar extension on preoperative and
              postoperative cognitive performance. Controls were matched for
              age, sex, handedness, education, and profession. The
              neurocognitive test battery included perceptual speed, executive
              function, visual-spatial and verbal working memory, short- and
              long-term memory, verbal fluency, fluid intelligence, anxiety,
              and depression. RESULTS: Ten patients and 10 healthy controls
              were matched. Median suprasellar tumor extension scored 8mm,
              compression of frontal lobe parenchyma was present in all cases.
              Median sagittal tumor diameter was 21mm. Preoperatively, patients
              scored worse in perceptual speed and short-term memory tasks. All
              patients underwent surgical resection either through a
              transnasal, transsphenoidal approach or a supraorbital
              frontolateral keyhole approach. The short-term memory deficit
              disappeared one week after surgery. Perceptual speed recovered
              within two months after surgical therapy. None of the patients
              experienced worsening of cognitive function. Routine
              postoperative imaging at six months did not reveal displacement
              of neural structures or surgery-related complications in any of
              the patients. CONCLUSION: Patients suffering from nonfunctioning
              pituitary adenomas with suprasellar extension may experience
              preoperative impairments in some neurocognitive domains that
              resolve within two months after surgery. The risk for cognitive
              deterioration with surgery appears to be low.",
  journal  = "J. Clin. Neurosci.",
  volume   =  40,
  pages    = "109--114",
  month    =  jun,
  year     =  2017,
  keywords = "Cognition; Neurocognitive assessment; Neuropsychology; Pituitary
              adenoma",
  language = "en"
}

@ARTICLE{Dufour2001-kp,
  title    = "Long-term tumor control and functional outcome in patients with
              cavernous sinus meningiomas treated by radiotherapy with or
              without previous surgery: is there an alternative to aggressive
              tumor removal?",
  author   = "Dufour, H and Muracciole, X and M{\'e}tellus, P and R{\'e}gis, J
              and Chinot, O and Grisoli, F",
  abstract = "OBJECTIVE: We report the long-term follow-up of 31 patients with
              cavernous sinus meningiomas who were treated either with surgery
              and radiotherapy (RT) or with RT alone. This retrospective review
              was undertaken to compare long-term efficacy and morbidity of RT
              with or without previous surgery versus complete, aggressive
              surgical removal. METHODS: Between 1980 and 1997, we performed a
              retrospective study of 31 patients harboring cavernous sinus
              meningiomas. The patient group comprised 25 women and 6 men.
              Patients were divided into two therapeutic categories: patients
              treated with surgery and RT (Group I, 17 patients) and patients
              treated with RT alone (Group II, 14 patients). Twenty-five
              patients (14 in Group I and 11 in Group II) were treated for
              primary tumors, and 6 patients (3 in Group I and 3 in Group II)
              were treated for recurrent disease. All three patients who were
              treated by RT alone at the time of recurrent disease had had
              previous surgery as initial treatment. Tumor control, treatment
              morbidity, and functional outcomes were evaluated for all
              patients. Twenty-eight patients were alive at the time of
              analysis, with a median follow-up period of 6.1 years. RESULTS:
              The progression-free survival rate was 92.8\% at 10-year
              follow-up. Only two patients exhibited tumor progression after
              initial treatment. One of the patients who experienced tumor
              regrowth 4 years after surgery and RT benefited from additional
              conventional external beam radiation, and this patient exhibited
              no evidence of tumor progression at the last follow-up
              examination 6 years later. Two patients experienced cranial nerve
              impairment after surgery, and no patients developed late
              radiation toxicity. Follow-up status as measured by the Karnofsky
              Performance Scale deteriorated in 7\% of patients and was the
              same or improved in 93\% of patients. CONCLUSION: The results of
              combined surgery and RT or RT alone indicated a high rate of
              tumor control and a low risk of complications. Complete
              aggressive surgical removal of cavernous sinus meningiomas is
              associated with an increased incidence of morbidity and mortality
              and does not demonstrate a better rate of tumor control.
              Conventional external beam radiation seems to be an efficient and
              safe initial or adjuvant treatment of these lesions, and these
              findings should serve as a basis for evaluating new alternatives
              such as radiosurgery or stereotactic RT.",
  journal  = "Neurosurgery",
  volume   =  48,
  number   =  2,
  pages    = "285--94; discussion 294--6",
  month    =  feb,
  year     =  2001,
  language = "en"
}

@ARTICLE{Raheja2020-af,
  title    = "Cavernous sinus meningioma",
  author   = "Raheja, Amol and Couldwell, William T",
  abstract = "Cavernous sinus meningioma (CSM) presents a management challenge
              to present-day neurosurgeons. Lack of adequate understanding of
              the natural history of these lesions, the early involvement of
              vital neurovascular structures, the absence of clear tissue
              planes with normal surrounding structures, and a high rate of
              aggressive surgery-related morbidity each pose management
              dilemmas for neurosurgeons. Over the past few decades, the
              enthusiasm of the neurosurgical community has shifted from
              aggressive microsurgical resection to maximal safe resection and
              institution of adjuvant radiotherapy, if necessary. This paradigm
              shift has ensured better functional outcome in treated patients.
              This chapter has been designed to discuss the current treatment
              algorithm and the importance of multimodality management for
              optimal outcome in patients with CSM. The technical aspects of
              this approach to management are presented, and the various
              treatment options are compared.",
  journal  = "Handb. Clin. Neurol.",
  volume   =  170,
  pages    = "69--85",
  year     =  2020,
  keywords = "Cavernous sinus; Fractionated stereotactic radiation therapy;
              Meningioma; Multimodality management; Skull base; Stereotactic
              radiosurgery; Surgery; Treatment algorithm; Tumor",
  language = "en"
}

@ARTICLE{Yasargil1990-rz,
  title    = "Total removal of craniopharyngiomas. Approaches and long-term
              results in 144 patients",
  author   = "Ya{\c s}argil, M G and Curcic, M and Kis, M and Siegenthaler, G
              and Teddy, P J and Roth, P",
  abstract = "The clinical features, perioperative course, and postoperative
              outcomes of 144 patients who underwent microsurgical resection of
              craniopharyngioma were reviewed. Overall, 90\% of the tumors were
              completely resected and 7\% recurred. Evaluation of those
              patients who underwent primary resection revealed much better
              results. The operative techniques and approaches are reviewed in
              detail. The results of this series suggest that primary total
              removal of craniopharyngiomas yields the best long-term outcome
              for the patient. Experience has shown that the larger the tumor
              the greater will be the damage, both preoperatively and
              intraoperatively, to vital intracranial structures. Consequently,
              early diagnosis, at a stage when the tumor is still small,
              improves the chances of accomplishing complete removal and of
              achieving good operative results. The early diagnosis of
              craniopharyngioma, before it can produce devastating neurological
              defects, continues to be the principal goal of our medical and
              pediatric colleagues.",
  journal  = "J. Neurosurg.",
  volume   =  73,
  number   =  1,
  pages    = "3--11",
  month    =  jul,
  year     =  1990,
  language = "en"
}

@ARTICLE{Alaoui-Ismaili2021-zj,
  title    = "Surgeons' experience of venous risk with {CPA} surgery",
  author   = "Alaoui-Ismaili, Adam and Krogager, M E and Jakola, A S and
              Poulsgaard, L and Couldwell, W and Mathiesen, T",
  abstract = "The study aims to systematize neurosurgeons' practical knowledge
              of venous sacrifice as applied to the posterior fossa region and
              to analyze the collected data to present and preserve relevant
              experience and expert knowledge for current and future practicing
              neurosurgeons. The venous structures assessed were the superior
              petrosal vein (SPV), sigmoid sinus (SS), and the tentorial veins
              (TV). The survey is constructed to obtain surgeons' idea of
              assessed risk when sacrificing specific venous structures during
              posterior fossa surgery. They were asked how they prep for
              surgery, number of operations conducted, and their basis of
              knowledge. Collected data were mainly qualitative and analyzed
              with a mixed-method approach. A mean absolute deviation was
              calculated measuring rate of disagreement for a given
              substructure. Consensus existed among the participating surgeons
              that sacrificing the SPV and the TV was considered safe.
              Although, the risk of death when occluding major structures like
              the main trunk of the SPV, one of the SS' and or a total
              occlusion of all TV yielded high risk of death. The risk of
              infarction was often too apparent to discredit even with low risk
              of death among an experienced class of surgeons. Our findings
              provide an overview of surgical risk associated with venous
              sacrifice. This will minimize cases where indispensable practical
              knowledge on safe handling veins in the cerebellopontine angle is
              either to be lost or taught among few when the neurosurgeons
              retire. This will lower the disagreement regarding risks and
              increase the quality of surgical decision-making.",
  journal  = "Neurosurg. Rev.",
  volume   =  44,
  number   =  3,
  pages    = "1675--1685",
  month    =  jun,
  year     =  2021,
  keywords = "CPA; Fossa; Risk; Sacrifice; Surgery; Vein",
  language = "en"
}

@ARTICLE{Little2020-sb,
  title    = "Evaluation of Surgical Resection Goal and Its Relationship to
              Extent of Resection and Patient Outcomes in a Multicenter
              Prospective Study of Patients With Surgically Treated,
              Nonfunctioning Pituitary Adenomas: A Case Series",
  author   = "Little, Andrew S and Chicoine, Michael R and Kelly, Daniel F and
              Sarris, Christina E and Mooney, Michael A and White, William L
              and Gardner, Paul A and Fernandez-Miranda, Juan C and
              Barkhoudarian, Garni and Chandler, James P and Prevedello, Daniel
              M and Liebelt, Brandon D and Sfondouris, John and Mayberg, Marc R
              and {TRANSSPHER Study Group}",
  abstract = "BACKGROUND: The influence of the surgeon's preoperative goal
              regarding the extent of tumor resection on patient outcomes has
              not been carefully studied among patients with nonfunctioning
              pituitary adenomas. OBJECTIVE: To analyze the relationship
              between surgical tumor removal goal and patient outcomes in a
              prospective multicenter study. METHODS: Centrally adjudicated
              extent of tumor resection (gross total resection [GTR] and
              subtotal resection [STR]) data were analyzed using standard
              univariate and multivariable analyses. RESULTS: GTR was
              accomplished in 148 of 171 (86.5\%) patients with planned GTR and
              32 of 50 (64.0\%) patients with planned STR (P = .001).
              Sensitivity, specificity, positive predictive value, and negative
              predictive value of GTR goal were 82.2, 43.9, 86.5, and 36.0\%,
              respectively. Knosp grade 0-2, first surgery, and being an
              experienced surgeon were associated with surgeons choosing GTR as
              the goal (P < .01). There was no association between surgical
              goal and presence of pituitary deficiency at 6 mo (P = .31).
              Tumor Knosp grade (P = .004) and size (P = .001) were stronger
              predictors of GTR than was surgical goal (P = .014). The most
              common site of residual tumor was the cavernous sinus (29 of 41
              patients; 70.1\%). CONCLUSION: This is the first pituitary
              surgery study to examine surgical goal regarding extent of tumor
              resection and associated patient outcomes. Surgical goal is a
              poor predictor of actual tumor resection. A more aggressive
              surgical goal does not correlate with pituitary gland
              dysfunction. A better understanding of the ability of surgeons to
              meet their expectations and of the factors associated with
              surgical result should improve prognostication and preoperative
              counseling.",
  journal  = "Oper Neurosurg (Hagerstown)",
  volume   =  18,
  number   =  1,
  pages    = "26--33",
  month    =  jan,
  year     =  2020,
  keywords = "Endoscopic surgery; Extent of resection; Microscopic surgery;
              Nonfunctioning adenoma; Transsphenoidal surgery",
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Little2019-ak,
  title    = "Results of a prospective multicenter controlled study comparing
              surgical outcomes of microscopic versus fully endoscopic
              transsphenoidal surgery for nonfunctioning pituitary adenomas:
              the Transsphenoidal Extent of Resection ({TRANSSPHER}) Study",
  author   = "Little, Andrew S and Kelly, Daniel F and White, William L and
              Gardner, Paul A and Fernandez-Miranda, Juan C and Chicoine,
              Michael R and Barkhoudarian, Garni and Chandler, James P and
              Prevedello, Daniel M and Liebelt, Brandon D and Sfondouris, John
              and Mayberg, Marc R and {TRANSSPHER Study Group}",
  abstract = "OBJECTIVE: Many surgeons have adopted fully endoscopic over
              microscopic transsphenoidal surgery for nonfunctioning pituitary
              tumors, although no high-quality evidence demonstrates superior
              patient outcomes with endoscopic surgery. The goal of this
              analysis was to compare these techniques in a prospective
              multicenter controlled study. METHODS: Extent of tumor resection
              was compared after endoscopic or microscopic transsphenoidal
              surgery in adults with nonfunctioning adenomas. The primary end
              point was gross-total tumor resection determined by postoperative
              MRI. Secondary end points included volumetric extent of tumor
              resection, pituitary hormone outcomes, and standard quality
              measures. RESULTS: Seven pituitary centers and 15 surgeons
              participated in the study. Of the 530 patients screened, 260 were
              enrolled (82 who underwent microscopic procedures, 177 who
              underwent endoscopic procedures, and 1 who cancelled surgery)
              between February 2015 and June 2017. Surgeons who used the
              microscopic technique were more experienced than the surgeons who
              used the endoscopic technique in terms of years in practice and
              number of transsphenoidal surgeries performed (p 0.2). New
              hormone deficiency was present at 6 months in 28.4\% (19/67) of
              the microscopic surgery patients and 9.7\% (14/145) of the
              endoscopic surgery patients (p < 0.001, OR 3.7, 95\% CI 1.7-7.7).
              Microscopic surgery cases were significantly shorter in duration
              than endoscopic surgery cases (p < 0.001). CONCLUSIONS:
              Experienced surgeons who performed microscopic surgery and less
              experienced surgeons who performed endoscopic surgery achieved
              similar extents of tumor resection and quality outcomes in
              patients with nonfunctioning pituitary adenomas. The endoscopic
              technique may be associated with lower rates of postoperative
              pituitary gland dysfunction. This study generally supports the
              transition to endoscopic pituitary surgery when the procedure is
              performed by proficient surgeons, although both techniques yield
              overall acceptable surgical outcomes.â–  CLASSIFICATION OF EVIDENCE
              Type of question: therapeutic; study design: prospective cohort
              trial; evidence: class III.Clinical trial registration no.:
              NCT02357498 (clinicaltrials.gov).",
  journal  = "J. Neurosurg.",
  volume   =  132,
  number   =  4,
  pages    = "1043--1053",
  month    =  mar,
  year     =  2019,
  keywords = "endoscopic surgery; extent of resection; microscopic surgery;
              nonfunctioning adenoma; pituitary surgery; transsphenoidal
              surgery",
  language = "en"
}

@ARTICLE{Di_Maio2011-ej,
  title    = "Current comprehensive management of cranial base chordomas:
              10-year meta-analysis of observational studies",
  author   = "Di Maio, Salvatore and Temkin, Nancy and Ramanathan, Dinesh and
              Sekhar, Laligam N",
  abstract = "OBJECT: The role of surgery and adjuvant radiation therapy for
              cranial base chordomas is not well established. This
              meta-analysis measures the relationship of complete resection and
              type of adjuvant radiation therapy to 5-year progression-free
              survival (PFS) and overall survival (OS) of cranial base
              chordomas. METHODS: A systematic MEDLINE search (1999-present)
              yielded 23 observational studies and 807 patients who fit
              inclusion criteria. The following analyses were performed: 1)
              Kaplan-Meier 5-year PFS and OS compared based on the extent of
              resection and type of adjuvant radiation therapy using the
              log-rank method; 2) a random-effects model comparing 5-year PFS
              with complete or incomplete resection; and 3) paired z-test
              comparisons of weighted average 5-year OS and PFS grouped by type
              of adjuvant radiation therapy. RESULTS: The weighted average
              follow-up was 53.6 months. The weighted average 5-year PFS and OS
              were 50.8\% and 78.4\%, respectively. Complete resection
              conferred a higher 5-year PFS than incomplete resection from the
              random effects model (mean difference in PFS 20.7\%; 95\% CI
              6.57\%-34.91\%). Patients with incomplete resection were 3.83
              times more likely to experience a recurrence (95\% CI 1.63-9.00)
              and 5.85 times more likely to die (95\% CI 1.40-24.5) at 5 years
              versus patients with complete resection. There was no difference
              in 5-year OS by type of adjuvant radiation, although 5-year PFS
              was lower in patients receiving Gamma Knife surgery relative to
              carbon ion radiotherapy (p = 0.042) on paired z-test. No survival
              difference occurred between radiation therapy techniques on
              Kaplan-Meier analysis of compiled patient data. CONCLUSIONS:
              Patients with complete resection of cranial base chordomas have a
              prolonged 5-year PFS and OS. Adjuvant proton-beam, carbon ion,
              and modern fractionated photon radiation therapy techniques
              offered a similar rate of PFS and OS at 5 years.",
  journal  = "J. Neurosurg.",
  volume   =  115,
  number   =  6,
  pages    = "1094--1105",
  month    =  dec,
  year     =  2011,
  language = "en"
}

@ARTICLE{Passer2021-sv,
  title    = "Surgical Management of Skull Base and Spine Chordomas",
  author   = "Passer, Joel Z and Alvarez-Breckenridge, Christopher and Rhines,
              Laurence and DeMonte, Franco and Tatsui, Claudio and Raza, Shaan
              M",
  abstract = "OPINION STATEMENT: Management of chordoma along the
              cranial-spinal axis is a major challenge for both skull base and
              spinal surgeons. Although chordoma remains a rare tumor,
              occurring in approximately 1 per 1 million individuals, its
              treatment poses several challenges. These tumors are generally
              poorly responsive to radiation and chemotherapy, leading to
              surgical resection as the mainstay of treatment. Due to anatomic
              constraints and unique challenges associated with each primary
              site of disease, gross total resection is often not feasible and
              is associated with high rates of morbidity. Additionally,
              chordoma is associated with high rates of recurrence due to the
              tumor's aggressive biologic features, and postoperative radiation
              is increasingly incorporated as a treatment option for these
              patients. Despite these challenges, modern-day surgical
              techniques in both skull base and spinal surgery have facilitated
              improved patient outcomes. For example, endoscopic endonasal
              techniques have become the mainstay in resection of skull base
              chordomas, improving the ability to achieve gross total
              resection, while reducing associated morbidity of open
              transfacial techniques. Resection of spinal chordomas has been
              facilitated by emerging techniques in preoperative imaging,
              intraoperative navigation, spinal reconstruction, and
              radiotherapy. Taken collectively, the treatment of chordoma
              affecting the skull base and spinal requires a multidisciplinary
              team of surgeons, radiation oncologists, and medical oncologists
              who specialize in the treatment of this challenging disease.",
  journal  = "Curr. Treat. Options Oncol.",
  volume   =  22,
  number   =  5,
  pages    = "40",
  month    =  mar,
  year     =  2021,
  keywords = "Chordoma; Chordoma surgery; Endoscopic endonasal approach;
              Enneking classification; Primary bone tumor; Sacrectomy",
  language = "en"
}

@ARTICLE{Abdel-Aziz2004-al,
  title    = "Large sphenoid wing meningiomas involving the cavernous sinus:
              conservative surgical strategies for better functional outcomes",
  author   = "Abdel-Aziz, Khaled M and Froelich, Sebastien C and Dagnew, Elias
              and Jean, Walter and Breneman, John C and Zuccarello, Mario and
              van Loveren, Harry R and Tew, Jr, John M",
  abstract = "OBJECTIVE: The ability to resect meningiomas that involve the
              medial and anterior compartments of the cavernous sinus has been
              refuted. In this retrospective study, we determined the efficacy
              of total resection of meningiomas that invade the cavernous sinus
              but are restricted to the lateral compartment. METHODS: We
              reviewed the charts of 38 consecutive patients with
              sphenocavernous, clinoidocavernous, and sphenoclinoidocavernous
              meningiomas who underwent surgical treatment. We assessed early
              and late cranial nerve morbidity, extent of resection, and
              long-term outcome (mean, 96 mo). RESULTS: In all patients, tumors
              exceeded 3 cm diameter. In 22 of 24 patients, total microscopic
              excision was achieved in tumors that involved only the lateral
              compartment of the cavernous sinus and touched or partially
              encased the cavernous internal carotid artery (i.e., modified
              Hirsch Grades 0 and 1, respectively). In 2 of 24 patients,
              remaining tumor infiltrated the superior orbital fissure. All 14
              patients who had tumors that encased (with or without narrowing)
              the cavernous segment of the internal carotid artery (Hirsch
              Grades 2-4) underwent incomplete resection. Among 38 patients,
              mortality was 0\%, late cranial nerve deficits remained in 6
              (16\%), and late Karnofsky Performance Scale scores exceeded 90
              in 34 patients (90\%). Four patients (10.5\%) developed a
              recurrence or regrowth. Of 20 patients who were treated with
              either linear accelerator-based stereotactic radiosurgery or
              fractionated conformal radiotherapy, 11 had residual tumor and a
              moderate to high proliferative index, 4 had atypical tumors and 1
              had angioblastic meningioma after total excision, 2 had regrowth,
              and 2 had recurrent tumors. In 18 (90\%) of the 20 patients who
              underwent radiation, tumor size was reduced or controlled.
              CONCLUSION: On the basis of this study and a review of the
              literature, we demonstrate that sphenocavernous,
              clinoidocavernous, and sphenoclinoidocavernous meningiomas of
              Hirsch Grades 0 and 1 can be excised from the lateral compartment
              of the cavernous sinus without postoperative mortality and with
              acceptable rates of morbidity. Residual tumor in the medial
              compartment (Hirsch Grades 2-4) may be treated with some form of
              radiation therapy or observation.",
  journal  = "Neurosurgery",
  volume   =  54,
  number   =  6,
  pages    = "1375--83; discussion 1383--4",
  month    =  jun,
  year     =  2004,
  language = "en"
}

@ARTICLE{Abdel-Aziz2004-zo,
  title    = "Large sphenoid wing meningiomas involving the cavernous sinus:
              conservative surgical strategies for better functional outcomes",
  author   = "Abdel-Aziz, Khaled M and Froelich, Sebastien C and Dagnew, Elias
              and Jean, Walter and Breneman, John C and Zuccarello, Mario and
              van Loveren, Harry R and Tew, Jr, John M",
  abstract = "OBJECTIVE: The ability to resect meningiomas that involve the
              medial and anterior compartments of the cavernous sinus has been
              refuted. In this retrospective study, we determined the efficacy
              of total resection of meningiomas that invade the cavernous sinus
              but are restricted to the lateral compartment. METHODS: We
              reviewed the charts of 38 consecutive patients with
              sphenocavernous, clinoidocavernous, and sphenoclinoidocavernous
              meningiomas who underwent surgical treatment. We assessed early
              and late cranial nerve morbidity, extent of resection, and
              long-term outcome (mean, 96 mo). RESULTS: In all patients, tumors
              exceeded 3 cm diameter. In 22 of 24 patients, total microscopic
              excision was achieved in tumors that involved only the lateral
              compartment of the cavernous sinus and touched or partially
              encased the cavernous internal carotid artery (i.e., modified
              Hirsch Grades 0 and 1, respectively). In 2 of 24 patients,
              remaining tumor infiltrated the superior orbital fissure. All 14
              patients who had tumors that encased (with or without narrowing)
              the cavernous segment of the internal carotid artery (Hirsch
              Grades 2-4) underwent incomplete resection. Among 38 patients,
              mortality was 0\%, late cranial nerve deficits remained in 6
              (16\%), and late Karnofsky Performance Scale scores exceeded 90
              in 34 patients (90\%). Four patients (10.5\%) developed a
              recurrence or regrowth. Of 20 patients who were treated with
              either linear accelerator-based stereotactic radiosurgery or
              fractionated conformal radiotherapy, 11 had residual tumor and a
              moderate to high proliferative index, 4 had atypical tumors and 1
              had angioblastic meningioma after total excision, 2 had regrowth,
              and 2 had recurrent tumors. In 18 (90\%) of the 20 patients who
              underwent radiation, tumor size was reduced or controlled.
              CONCLUSION: On the basis of this study and a review of the
              literature, we demonstrate that sphenocavernous,
              clinoidocavernous, and sphenoclinoidocavernous meningiomas of
              Hirsch Grades 0 and 1 can be excised from the lateral compartment
              of the cavernous sinus without postoperative mortality and with
              acceptable rates of morbidity. Residual tumor in the medial
              compartment (Hirsch Grades 2-4) may be treated with some form of
              radiation therapy or observation.",
  journal  = "Neurosurgery",
  volume   =  54,
  number   =  6,
  pages    = "1375--83; discussion 1383--4",
  month    =  jun,
  year     =  2004,
  language = "en"
}

@ARTICLE{Rutkowski2020-op,
  title    = "Development and clinical validation of a grading system for
              pituitary adenoma consistency",
  author   = "Rutkowski, Martin J and Chang, Ki-Eun and Cardinal, Tyler and Du,
              Robin and Tafreshi, Ali R and Donoho, Daniel A and Brunswick,
              Andrew and Micko, Alexander and Liu, Chia-Shang J and Shiroishi,
              Mark S and Carmichael, John D and Zada, Gabriel",
  abstract = "OBJECTIVE: Pituitary adenoma (PA) consistency, or texture, is an
              important intraoperative characteristic that may dictate
              operative dissection techniques and/or instruments used for tumor
              removal during endoscopic endonasal approaches (EEAs). The impact
              of PA consistency on surgical outcomes has yet to be elucidated.
              METHODS: The authors developed an objective 5-point grading scale
              for PA consistency based on intraoperative characteristics,
              including ease of tumor debulking, manipulation, and instrument
              selection, ranging from cystic/hemorrhagic tumors (grade 1) to
              calcified tumors (grade 5). The proposed grading system was
              prospectively assessed in 306 consecutive patients who underwent
              an EEA for PAs, and who were subsequently analyzed for
              associations with surgical outcomes, including extent of
              resection (EOR) and complication profiles. RESULTS: Institutional
              database review identified 306 patients who underwent
              intraoperative assessment of PA consistency, of which 96\% were
              macroadenomas, 70\% had suprasellar extension, and 44\% had
              cavernous sinus invasion (CSI). There were 214 (69.9\%)
              nonfunctional PAs and 92 functional PAs (31.1\%). Distribution of
              scores included 15 grade 1 tumors (4.9\%), 112 grade 2 tumors
              (36.6\%), 125 grade 3 tumors (40.8\%), 52 grade 4 tumors (17\%),
              and 2 grade 5 tumors (0.7\%). Compared to grade 1/2 and grade 3
              PAs, grade 4/5 PAs were significantly larger (22.5 vs 26.6 vs
              27.4 mm, p < 0.01), more likely to exhibit CSI (39\% vs 42\% vs
              59\%, p < 0.05), and trended toward nonfunctionality (67\% vs
              68\% vs 82\%, p = 0.086). Although there was no association
              between PA consistency and preoperative headaches or visual
              dysfunction, grade 4/5 PAs trended toward preoperative (p =
              0.058) and postoperative panhypopituitarism (p = 0.066). Patients
              with preoperative visual dysfunction experienced greater
              improvement if they had a grade 1/2 PA (p < 0.05). Intraoperative
              CSF leaks were noted in 32\% of cases and were more common with
              higher-consistency-grade tumors (p = 0.048), although this
              difference did not translate to postoperative CSF leaks.
              Gross-total resection (\%) was more likely with lower PA
              consistency score as follows: grade 1/2 (60\%), grade 3 (50\%),
              grade 4/5 (44\%; p = 0.045). Extracapsular techniques were almost
              exclusively performed in grade 4/5 PAs. Assignment of scores
              showed low variance and high reproducibility, with an intraclass
              correlation coefficient of 0.905 (95\% CI 0.815-0.958),
              indicating excellent interrater reliability. CONCLUSIONS: These
              findings demonstrate clinical validity of the proposed
              intraoperative grading scale with respect to PA subtype,
              neuroimaging features, EOR, and endocrine complications. Future
              studies will assess the relation of PA consistency to
              preoperative MRI findings to accurately predict consistency,
              thereby allowing the surgeon to tailor the exposure and prepare
              for varying resection strategies.",
  journal  = "J. Neurosurg.",
  pages    = "1--8",
  month    =  jun,
  year     =  2020,
  keywords = "CSI = cavernous sinus invasion; DI = diabetes insipidus; EEA =
              endoscopic endonasal approach; EOR = extent of resection; GH =
              growth hormone; GTR = gross-total resection; IGF = insulin-like
              growth factor; PA = pituitary adenoma; USC = University of
              Southern California; adenoma; consistency; endoscopic; extent of
              resection; pituitary surgery; recurrence; transsphenoidal",
  language = "en"
}

@ARTICLE{Przybylowski2020-bs,
  title    = "Prognostic value of the Simpson grading scale in modern
              meningioma surgery: Barrow Neurological Institute experience",
  author   = "Przybylowski, Colin J and Hendricks, Benjamin K and Frisoli,
              Fabio A and Zhao, Xiaochun and Cavallo, Claudio and Borba
              Moreira, Leandro and Gandhi, Sirin and Sanai, Nader and Almefty,
              Kaith K and Lawton, Michael T and Little, Andrew S",
  abstract = "OBJECTIVE: Recently, the prognostic value of the Simpson
              resection grading scale has been called into question for modern
              meningioma surgery. In this study, the authors analyzed the
              relationship between Simpson resection grade and meningioma
              recurrence in their institutional experience. METHODS: This study
              is a retrospective review of all patients who underwent resection
              of a WHO grade I intracranial meningioma at the authors'
              institution from 2007 to 2017. Binary logistic regression
              analysis was used to assess for predictors of Simpson grade IV
              resection and postoperative neurological morbidity. Cox
              multivariate analysis was used to assess for predictors of tumor
              recurrence. Kaplan-Meier analysis and log-rank tests were used to
              assess and compare recurrence-free survival (RFS) of Simpson
              resection grades, respectively. RESULTS: A total of 492 patients
              with evaluable data were included for analysis, including 394
              women (80.1\%) and 98 men (19.9\%) with a mean (SD) age of 58.7
              (12.8) years. The tumors were most commonly located at the skull
              base (n = 302; 61.4\%) or the convexity/parasagittal region (n =
              139; 28.3\%). The median (IQR) tumor volume was 6.8 (14.3) cm3.
              Simpson grade I, II, III, or IV resection was achieved in 105
              (21.3\%), 155 (31.5\%), 52 (10.6\%), and 180 (36.6\%) patients,
              respectively. Sixty-three of 180 patients (35.0\%) with Simpson
              grade IV resection were treated with adjuvant radiosurgery. In
              the multivariate analysis, increasing largest tumor dimension (p
              < 0.01) and sinus invasion (p < 0.01) predicted Simpson grade IV
              resection, whereas skull base location predicted neurological
              morbidity (p = 0.02). Tumor recurrence occurred in 63 patients
              (12.8\%) at a median (IQR) of 36 (40.3) months from surgery.
              Simpson grade I resection resulted in superior RFS compared with
              Simpson grade II resection (p = 0.02), Simpson grade III
              resection (p = 0.01), and Simpson grade IV resection with
              adjuvant radiosurgery (p = 0.01) or without adjuvant radiosurgery
              (p < 0.01). In the multivariate analysis, Simpson grade I
              resection was independently associated with no tumor recurrence
              (p = 0.04). Simpson grade II and III resections resulted in
              superior RFS compared with Simpson grade IV resection without
              adjuvant radiosurgery (p < 0.01) but similar RFS compared with
              Simpson grade IV resection with adjuvant radiosurgery (p = 0.82).
              Simpson grade IV resection with adjuvant radiosurgery resulted in
              superior RFS compared with Simpson grade IV resection without
              adjuvant radiosurgery (p < 0.01). CONCLUSIONS: The Simpson
              resection grading scale continues to hold substantial prognostic
              value in the modern neurosurgical era. When feasible, Simpson
              grade I resection should remain the goal of intracranial
              meningioma surgery. Simpson grade IV resection with adjuvant
              radiosurgery resulted in similar RFS compared with Simpson grade
              II and III resections.",
  journal  = "J. Neurosurg.",
  pages    = "1--9",
  month    =  oct,
  year     =  2020,
  keywords = "RFS = recurrence-free survival; Simpson grading scale; mRS =
              modified Rankin Scale; meningioma; oncology; prognosis;
              recurrence",
  language = "en"
}

@ARTICLE{Savardekar2018-lp,
  title    = "Differential Tumor Progression Patterns in Skull Base Versus
              {Non-Skull} Base Meningiomas: A Critical Analysis from a
              {Long-Term} {Follow-Up} Study and Review of Literature",
  author   = "Savardekar, Amey R and Patra, Devi Prasad and Bir, Shyamal and
              Thakur, Jai Deep and Mohammed, Nasser and Bollam, Papireddy and
              Georgescu, Maria-Magdalena and Nanda, Anil",
  abstract = "BACKGROUND: To analyze the differences in tumor progression
              patterns and histopathologic characteristics between skull base
              meningiomas (SBMs) and non-skull base meningiomas (NSBMs).
              METHODS: Retrospective data of 382 patients with SBMs and 200
              patients with NSBMs who underwent primary microsurgical resection
              between January 1995 and December 2016 were analyzed. Data
              related to clinical history, neuroimaging, surgical technique,
              and follow-up were reviewed. A separate prospective cohort of 78
              meningiomas operated on from June 2016 to July 2017 was analyzed
              (World Health Organization [WHO] grade and Ki-67 proliferation
              index) for biologic comparison. RESULTS: Skull base location, WHO
              grade II tumor, and subtotal resection were independent
              predictors of unfavorable outcome. The overall tumor progression
              rate in the SBM group (33\%) was higher than in the NSBM group
              (19.7\%) (P = 0.006) (mean follow-up period, 51 months). The
              3-year, 5-year, and 10-year progression-free survival (PFS) was
              78\%, 60\%, and 45\% in the SBM group, whereas it was 90\%, 80\%,
              and 53\% in the NSBM group, respectively. Interestingly, there
              was no difference in the median PFS after 10 years of follow-up
              (SBMs 210 months vs. NSBM 212 months, P = 0.93). In the
              prospective cohort of 78 meningiomas, there was no statistically
              significant difference in the proportion of WHO grade I tumors
              and in the mean Ki-67 index of WHO grade I meningiomas between
              the 2 groups. CONCLUSION: There is a divergent tumor progression
              pattern for surgically treated SBMs vis-{\`a}-vis NSBMs.
              Differences in tumor biology and the proportion of Simpson grade
              I resections are likely attributable factors.",
  journal  = "World Neurosurg.",
  volume   =  112,
  pages    = "e74--e83",
  month    =  apr,
  year     =  2018,
  keywords = "Intracranial meningioma; Long-term follow-up; Meningioma surgery;
              Non--skull base meningiomas; Progression-free survival;
              Recurrence; Skull base meningiomas; Tumor progression rate",
  language = "en"
}

@ARTICLE{McGovern2010-fd,
  title    = "A comparison of World Health Organization tumor grades at
              recurrence in patients with non-skull base and skull base
              meningiomas",
  author   = "McGovern, Susan L and Aldape, Kenneth D and Munsell, Mark F and
              Mahajan, Anita and DeMonte, Franco and Woo, Shiao Y",
  abstract = "OBJECT: Despite a favorable outcome for most patients with WHO
              Grade I meningiomas, a subset of these patients will have
              recurrent or progressive disease that advances to a higher grade
              and requires increasingly aggressive therapy. The goal of this
              study was to identify clinical characteristics associated with
              the recurrence of benign meningiomas and their acceleration to
              atypical and malignant histological types. METHODS: Records of
              216 patients with WHO Grade I, II, or III meningioma that were
              initially treated between 1965 and 2001 were retrospectively
              reviewed. Median follow-up was 7.2 years. RESULTS: Patients with
              non-skull base cranial meningiomas (82 of 105 [78\%]) were more
              likely to have undergone a gross-total resection than patients
              with skull base meningiomas (32 of 78 [41\%]; p < 0.001).
              Consequently, patients with Grade I non-skull base cranial
              meningiomas had better 5-year recurrence-free survival (69\%)
              than patients with Grade I skull base meningiomas (56\%) or Grade
              II or III tumors at any site (50\%; p = 0.005). Unexpectedly,
              patients with non-skull base tumors who experienced a recurrence
              (8 of 22 [36\%]) were more likely than patients with skull base
              tumors (1 of 19 [5\%]) to have a higher grade tumor at recurrence
              (p = 0.024). Furthermore, the median MIB-1 labeling index of
              Grade I non-skull base cranial meningiomas (2.60\%) was
              significantly higher than that of Grade I skull base tumors
              (1.35\%; p = 0.016). CONCLUSIONS: Cranial meningiomas that occur
              outside of the skull base are more likely to have a higher MIB-1
              labeling index and recur with a higher grade than those within
              the skull base, suggesting that non-skull base cranial tumors may
              have a more aggressive biology than skull base tumors.",
  journal  = "J. Neurosurg.",
  volume   =  112,
  number   =  5,
  pages    = "925--933",
  month    =  may,
  year     =  2010,
  language = "en"
}

@ARTICLE{Schwartz2013-nc,
  title    = "Evaluation of the increased use of partial resection of large
              vestibular schwanommas: facial nerve outcomes and
              recurrence/regrowth rates",
  author   = "Schwartz, Marc S and Kari, Elina and Strickland, Brian M and
              Berliner, Karen and Brackmann, Derald E and House, John W and
              Friedman, Rick A",
  abstract = "OBJECTIVE: To determine whether partial tumor removal in large
              vestibular schwannoma improves facial nerve outcomes while
              maintaining a low risk of tumor regrowth/recurrence. STUDY
              DESIGN: Retrospective chart review and prospective database.
              SETTING: Tertiary neurotologic referral center. PATIENTS: Four
              hundred patients with a vestibular schwannoma of 2.5 cm or
              greater in maximum diameter undergoing translabyrinthine
              microsurgical resection from 2001 to 2011. There were 325 gross
              total resections (GTR), 44 near total resections (NTR), and 31
              subtotal resections (STR), with an overall mean tumor size of 3.2
              cm (standard deviation, 0.7). INTERVENTION(S): Translabyrinthine
              surgical tumor resection. MAIN OUTCOME MEASURES: House-Brackmann
              (H-B) facial nerve grade postoperatively and at 1 year, tumor
              regrowth/recurrence ($\geq$2 mm), additional treatment, and
              complications. RESULTS: Higher rates of H-B facial nerve Grades I
              and II were achieved at both the postoperative and 1-year
              follow-ups in the NTR (78\%, 97\%) and STR (71\%, 96\%) groups
              compared with GTR (53\%, 77\%) (p $\leq$ 0.001). Eye treatment,
              medical or surgical, was required more often in GTR (28.0\%) than
              NTR and STR (8\% and 21\%, respectively, p $\leq$ 0.04), with no
              other differences in complications. The NTR and STR groups had a
              significantly higher rate of regrowth than GTR resection (21\%
              and 22\% versus 3\%) (p $\leq$ 0.001) at average follow-up times
              of 3.7, 3.7, and 5.1 years, respectively, and need for further
              treatment occurred at a higher rate, although infrequently, in
              NTR and STR (2\% and 10\% versus 0\%) (p $\leq$ 0.001).
              CONCLUSION: Near total and subtotal removal in large tumors are
              viable treatment options to maintain facial nerve function.
              During the follow-up period examined in this study, there was a
              low risk of need for further treatment. Longer-term follow-up is
              needed to better assess the need for retreatment in patients
              treated with NTR and STR.",
  journal  = "Otol. Neurotol.",
  volume   =  34,
  number   =  8,
  pages    = "1456--1464",
  month    =  oct,
  year     =  2013,
  language = "en"
}

@ARTICLE{Gejman2008-mi,
  title     = "Role of Ki-67 proliferation index and p53 expression in
               predicting progression of pituitary adenomas",
  author    = "Gejman, Roger and Swearingen, Brooke and Hedley-Whyte, E Tessa",
  abstract  = "Pituitary adenomas sometimes progress after surgery and can be
               locally invasive. Ki-67 and p53 expression are referred to as
               indicators of aggressive behavior in the World Health
               Organization Classification of Endocrine Tumors. The real value
               of these markers including an appropriate threshold for Ki-67
               labeling index correlating with tumor progression is
               controversial. We identified 24 consecutive pituitary adenomas
               from patients who required surgery for recurrence within 5 years
               of their first procedure and 31 consecutive adenomas with no
               evidence of postsurgical progression within 5 years of first
               surgery. Case selection was based upon availability of complete
               clinical information, blocks, and slides for study.
               Immunohistochemistry for Ki-67 revealed that the tumors without
               progression had a proliferation index of 0.41\% +/- 0.01\% (mean
               +/- SEM) (n = 31) (range, 0.08\%-1.2\%) and the first biopsy
               from those tumors which progressed had a mean proliferation
               index of 1.45\% +/- 0.09\% (mean +/- SEM) (n = 24) (range,
               0.1\%-10.6\%) (P = .01). With the use of ROC analysis, a
               threshold level of Ki-67 expression greater than 1.3\% predicts
               progression with a high specificity. The group with progression
               had a higher proportion of nonfunctioning tumors (P < .005,
               chi(2)). There was no significant difference between the 2
               groups with regard to invasion, suprasellar extension, size,
               tumor type, postoperative radiotherapy, extent of resection,
               sex, and age. Ki-67 labeling index was an independent predictor
               of progression (multivariate analysis, P < .011). p53 was
               positive in 12.5\% of cases with surgical progression and in
               9.6\% of cases without progression, but the difference was not
               significant (P = .7; chi(2), 0.11).",
  journal   = "Hum. Pathol.",
  publisher = "Elsevier",
  volume    =  39,
  number    =  5,
  pages     = "758--766",
  month     =  may,
  year      =  2008,
  language  = "en"
}

@ARTICLE{Horbinski2010-uv,
  title    = "The prognostic value of Ki-67, p53, epidermal growth factor
              receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas",
  author   = "Horbinski, Craig and Oakley, Gerard J and Cieply, Kathleen and
              Mantha, Geeta S and Nikiforova, Marina N and Dacic, Sanja and
              Seethala, Raja R",
  abstract = "CONTEXT: Skull base chordomas are rare, locally aggressive,
              notochord-derived neoplasms for which prognostically relevant
              biomarkers are not well established. OBJECTIVE: To evaluate
              whether newly discovered molecular alterations in chordomas have
              prognostic significance similar to what has been described
              regarding Ki-67 proliferation index. DESIGN: We conducted a
              retrospective study of 28 cases of primary clival chordomas.
              RESULTS: Ki-67 proliferation index 5\% or more, p53 accumulation,
              and epidermal growth factor receptor expression were seen in
              32\%, 44\%, and 8\% of chordomas, respectively. 1p loss of
              heterozygosity (LOH) and/or 1p36 hemizygous deletion was seen in
              30\% of tumors, while 9p LOH and/or 9p21 homozygous deletion was
              seen in 21\% of cases. Loss of heterozygosity at 10q23 and 17p13
              were identified in 57\% and 52\% of cases, respectively. Ki-67
              proliferation index 5\% or more and 9p LOH were significantly
              associated with a shorter overall survival, while homozygous
              deletion at 9p21 via fluorescence in situ hybridization
              approached significance. No correlation with survival was found
              for p53 or epidermal growth factor receptor expression, 1p36
              hemizygous deletion, or LOH at 1p, 10q23, or 17p13. CONCLUSIONS:
              Chordomas with elevated Ki-67 proliferation index or deletion at
              9p21 may be at risk for a more aggressive clinical course and
              shorter survival. These biomarkers may thus be used to improve
              therapeutic stratification.",
  journal  = "Arch. Pathol. Lab. Med.",
  volume   =  134,
  number   =  8,
  pages    = "1170--1176",
  month    =  aug,
  year     =  2010,
  language = "en"
}

@ARTICLE{Schwartz2020-cs,
  title    = "The Simpson grade: abandon the scale but preserve the message",
  author   = "Schwartz, Theodore H and McDermott, Michael W",
  abstract = "The Simpson grading scale, developed in 1957 by Donald Simpson,
              has been considered the gold standard for defining the surgical
              extent of resection for WHO grade I meningiomas. Since its
              introduction, the scale and its modifications have generated
              enormous controversy. The Simpson grade is based on an
              intraoperative visual assessment of resection, which is
              subjective and notoriously inaccurate. The majority of studies in
              which the grading system was used were performed before routine
              postoperative MRI surveillance was employed, rendering
              assessments of extent of resection and the definition of
              recurrence inconsistent. The infiltration and proliferation
              potential of tumor components such as hyperostotic bone and dural
              tail vary widely based on tumor location, as does the molecular
              biology of the tumor, rendering a universal scale for all
              meningiomas unfeasible. While extent of resection is clearly
              important at reducing recurrence rates, achieving the highest
              Simpson grade resection should not always be the goal of
              surgery.Donald Simpson's name and his scale deserve to be
              recognized and preserved in the historical pantheon of pioneering
              and transformative neurosurgical concepts. Nevertheless, his
              eponymous scale is no longer relevant in modern meningioma
              surgery. While his message of maximizing extent of resection and
              minimizing morbidity is still germane, a single measure using
              subjective criteria cannot be applied universally to all
              meningiomas, regardless of location. Meningioma surgery should be
              performed with the goal of achieving maximal safe resection,
              ideally guided by molecularly tagged fluorescent labeling and
              assessed using objective criteria, including postoperative MRI as
              well as molecularly tagged scans such as [68Ga]-DOTATATE-PET.",
  journal  = "J. Neurosurg.",
  pages    = "1--8",
  month    =  oct,
  year     =  2020,
  keywords = "Simpson grade; dural tail; extent of resection; hyperostosis;
              meningioma; oncology; recurrence; skull base; surgery",
  language = "en"
}

@ARTICLE{Ueberschaer2020-jg,
  title    = "Simpson Grade Revisited - Intraoperative Estimation of the Extent
              of Resection in Meningiomas Versus Postoperative Somatostatin
              Receptor Positron Emission {Tomography/Computed} Tomography and
              Magnetic Resonance Imaging",
  author   = "Ueberschaer, Moritz and Vettermann, Franziska Jill and Forbrig,
              Robert and Unterrainer, Marcus and Siller, Sebastian and Biczok,
              Anna-Maria and Thorsteinsdottir, Jun and Cyran, Clemens C and
              Bartenstein, Peter and Tonn, J{\"o}rg-Christian and Albert,
              Nathalie Lisa and Schichor, Christian",
  abstract = "BACKGROUND: Surgeon's intraoperative estimation of meningioma
              extent of resection (Simpson Grade, SG) is widely used as a
              prognostic factor for recurrence. However, the validity of SG is
              still a matter of debate. In preoperative imaging,
              68Ga-DOTATATE/PET-CT has been shown to detect meningioma tissue
              even more sensitively than magnetic resonance imaging (MRI).
              OBJECTIVE: To evaluate the Simpson grading within the framework
              of modern postoperative imaging techniques (MRI; PET-CT).
              METHODS: At first, patients with WHO grade I meningioma, surgical
              resection, and postoperative 68Ga-DOTATATE/PET-CT within 6 mo
              after surgery were retrospectively analyzed. Second, an analogous
              prospective cohort of patients with WHO grade I meningioma was
              investigated by comparing SG after meningioma removal with
              postoperative MRI and 68Ga-DOTATATE/PET-CT within 6 mo after
              surgery. RESULTS: A total of 37 patients were retrospectively
              analyzed. In total, 5/8 patients with SG-I and II resections
              showed tumor remnants according to postoperative PET-CT (SG
              62.5\% false negative). In the prospective cohort of 52 tumors,
              PET-CT displayed tracer uptake in 15/37 SG-I or II resections
              indicating unexpected tumor remnants (SG 40.5\% false negative).
              MRI was false negative in 7 of these 15 cases (MRI 18.9\% false
              negative) (P = .037). Discordant results according to PET-CT were
              more often found in convexity (40\%) and falcine (46.7\%)
              meningiomas than in skull base meningiomas (18.2\%). CONCLUSION:
              Intraoperative Simpson grading is at risk to underestimate tumor
              remnants, predominantly in grade I and II resections.
              Postoperative PET-CT improves detection rates compared to MRI.
              Prognostic impact of postoperative meningioma remnants according
              to PET-CT needs to be investigated prospectively.",
  journal  = "Neurosurgery",
  volume   =  88,
  number   =  1,
  pages    = "140--146",
  month    =  dec,
  year     =  2020,
  keywords = "Extent of resection; MRI; Meningioma; PET; Simpson grade",
  language = "en"
}

@ARTICLE{Samii1997-pj,
  title    = "Management of vestibular schwannomas (acoustic neuromas):
              auditory and facial nerve function after resection of 120
              vestibular schwannomas in patients with neurofibromatosis 2",
  author   = "Samii, M and Matthies, C and Tatagiba, M",
  abstract = "OBJECTIVE: Vestibular schwannomas (VSs) affect young patients
              with Neurofibromatosis 2 (NF-2) and cause very serious problems
              for hearing, facial expression, and brain stem function. Our
              objective was to determine a therapy concept for the right timing
              and indication of neurosurgical therapy. METHODS: In 1000
              consecutive VS resections, 120 tumors in 82 patients with NF-2
              were surgically treated by the same surgeon (MS) at the
              Department of Neurosurgery at Nordstadt Hospital from 1978 to
              1993. The mean age of the patients was 27.5 years. Sixty tumors
              were surgically treated in 41 male patients, and 60 tumors were
              surgically treated in 41 female patients. Bilateral tumor
              resection was performed in 38 patients (76 operations, after
              previous partial surgery in 15 cases elsewhere), and unilateral
              operations were performed in 44 patients, 5 of whom had undergone
              ipsi- or contralateral surgery that was performed elsewhere. The
              operative and clinical findings are evaluated and compared with
              the data of patients without NF-2. RESULTS: In 105 cases,
              complete tumor resections were achieved. In 15 cases, deliberate
              subtotal resections were performed. These were for brain stem
              decompression in 4 cases and for hearing preservation in the last
              hearing ear in 11 cases, with successful preservation in 8 of the
              11. Pre- and postoperative hearing rates were higher in male than
              in female patients (70\% in male versus 65\% in female patients
              before surgery and 40.5 versus 31\%, respectively, after
              surgery). Hearing was preserved in 29 of 81 ears (36\%). The rate
              of preservation was 24\% in cases of large tumors and 57\% in
              cases of small tumors (<30 mm). Twenty-one of 82 patients (26\%)
              were bilaterally deaf before surgery. Twenty-five patients had
              uni- or bilateral hearing after surgery (i.e., 41 \% of those
              with preoperative hearing or 30.5\% of the whole group). Anatomic
              facial nerve preservation was achieved in 85\%. The facial nerve
              was reconstructed intracranially at the cerebellopontine angle by
              sural grafting in 17 cases and by hypoglossal-facial reanimation
              in 5. Two deaths occurred 1 and 3 months postsurgically as a
              result of malignant tumor growth with brain stem dysfunction and
              respiratory problems. In summary, for patients with NF-2, the
              presentation ages are lower, tumor progression is faster, the
              chances of anatomic and functional nerve preservation are lower,
              the chances of good outcomes are best when surgery is performed
              early and when there is good preoperative hearing function, and
              the danger of sudden hearing loss is higher. The chances and
              danger often differ from side to side among individual patients.
              CONCLUSION: The indication and the timing of tumor resections are
              in some respects different from normal VS handling and are
              dependent on the tumor extension and related necessity of brain
              stem decompression and on the auditory function. As an optimal
              goal, completeness of resection with functional cochlear nerve
              preservation is formulated, and as an acceptable compromise,
              subtotal microsurgical resection with functional cochlear nerve
              preservation in the last hearing ear is suggested.",
  journal  = "Neurosurgery",
  volume   =  40,
  number   =  4,
  pages    = "696--705; discussion 705--6",
  month    =  apr,
  year     =  1997,
  language = "en"
}

@ARTICLE{Pollock2006-wg,
  title     = "{PATIENT} {OUTCOMES} {AFTER} {VESTIBULAR} {SCHWANNOMA}
               {MANAGEMENTA} {PROSPECTIVE} {COMPARISON} {OF} {MICROSURGICAL}
               {RESECTION} {AND} {STEREOTACTIC} {RADIOSURGERY}",
  author    = "Pollock, Bruce E and Driscoll, Colin L W and Foote, Robert L and
               Link, Michael J and Gorman, Deborah A and Bauch, Christopher D
               and Mandrekar, Jayawant N and Krecke, Karl N and Johnson, Craig
               H",
  abstract  = "AbstractOBJECTIVE. The best management for patients with small-
               to medium-sized vestibular schwannomas (versus) is
               controversial.METHODS. Prospective cohort stu",
  journal   = "Neurosurgery",
  publisher = "Oxford Academic",
  volume    =  59,
  number    =  1,
  pages     = "77--85",
  month     =  jul,
  year      =  2006,
  keywords  = "acoustic neuroma; radiosurgery; follow-up; excision; surgical
               procedures, operative; neoplasms; face; patient-focused
               outcomes; microsurgery"
}

@ARTICLE{Lunsford2005-jf,
  title    = "Radiosurgery of vestibular schwannomas: summary of experience in
              829 cases",
  author   = "Lunsford, L Dade and Niranjan, Ajay and Flickinger, John C and
              Maitz, Ann and Kondziolka, Douglas",
  abstract = "OBJECT: Management options for vestibular schwannomas (VSs) have
              greatly expanded since the introduction of stereotactic
              radiosurgery. Optimal outcomes reflect long-term tumor control,
              preservation of cranial nerve function, and retention of quality
              of life. The authors review their 15-year experience. METHODS:
              Between 1987 and 2002, some 829 patients with VSs underwent gamma
              knife surgery (GKS). Dose selection, imaging, and dose planning
              techniques evolved between 1987 and 1992 but thereafter remained
              stable for 10 years. The average tumor volume was 2.5 cm3. The
              median margin dose to the tumor was 13 Gy (range 10-20 Gy). No
              patient sustained significant perioperative morbidity. The
              average duration of hospital stay was less than 1 day. Unchanged
              hearing preservation was possible in 50 to 77\% of patients (up
              to 90\% in those with intracanalicular tumors). Facial neuropathy
              risks were reduced to less than 1\%. Trigeminal symptoms were
              detected in less than 3\% of patients whose tumors reached the
              level of the trigeminal nerve. Tumor control rates at 10 years
              were 97\% (no additional treatment needed). CONCLUSIONS: Superior
              imaging, multiple isocenter volumetric conformal dose planning,
              and optimal precision and dose delivery contributed to the
              long-term success of GKS, including in those patients in whom
              initial microsurgery had failed. Gamma knife surgery provides a
              low risk, minimally invasive treatment option for patients with
              newly diagnosed or residual VS. Cranial nerve preservation and
              quality of life maintenance are possible in long-term follow up.",
  journal  = "J. Neurosurg.",
  volume   = "102 Suppl",
  pages    = "195--199",
  month    =  jan,
  year     =  2005,
  language = "en"
}

@ARTICLE{Ierokomos1985-ls,
  title    = "Primary {CNS} lymphoma in the cerebellopontine angle. Report of a
              case",
  author   = "Ierokomos, A and Goin, D W",
  abstract = "We report a case of primary CNS lymphoma that appeared as a
              cerebellopontine angle lesion, an initial observation not
              previously reported, to our knowledge. In general, primary CNS
              lymphoma remains localized to the CNS, with death occurring from
              localized recurrence. Radiation therapy after open biopsy is the
              treatment of choice, and achieves a good three-year outcome.
              However, five-year outcome with this treatment is poor.",
  journal  = "Arch. Otolaryngol.",
  volume   =  111,
  number   =  1,
  pages    = "50--52",
  month    =  jan,
  year     =  1985,
  language = "en"
}

@ARTICLE{Hollon2021-sq,
  title    = "Label-free brain tumor imaging using Raman-based methods",
  author   = "Hollon, Todd and Orringer, Daniel A",
  abstract = "INTRODUCTION: Label-free Raman-based imaging techniques create
              the possibility of bringing chemical and histologic data into the
              operation room. Relying on the intrinsic biochemical properties
              of tissues to generate image contrast and optical tissue
              sectioning, Raman-based imaging methods can be used to detect
              microscopic tumor infiltration and diagnose brain tumor subtypes.
              METHODS: Here, we review the application of three Raman-based
              imaging methods to neurosurgical oncology: Raman spectroscopy,
              coherent anti-Stokes Raman scattering (CARS) microscopy, and
              stimulated Raman histology (SRH). RESULTS: Raman spectroscopy
              allows for chemical characterization of tissue and can
              differentiate normal and tumor-infiltrated tissue based on
              variations in macromolecule content, both ex vivo and in vivo. To
              improve signal-to-noise ratio compared to conventional Raman
              spectroscopy, a second pulsed excitation laser can be used to
              coherently drive the vibrational frequency of specific Raman
              active chemical bonds (i.e. symmetric stretching of -CH2 bonds).
              Coherent Raman imaging, including CARS and stimulated Raman
              scattering microscopy, has been shown to detect microscopic brain
              tumor infiltration in fresh brain tumor specimens with submicron
              image resolution. Advances in fiber-laser technology have allowed
              for the development of intraoperative SRH as well as artificial
              intelligence algorithms to facilitate interpretation of SRH
              images. With molecular diagnostics becoming an essential part of
              brain tumor classification, preliminary studies have demonstrated
              that Raman-based methods can be used to diagnose glioma molecular
              classes intraoperatively. CONCLUSIONS: These results demonstrate
              how label-free Raman-based imaging methods can be used to improve
              the management of brain tumor patients by detecting tumor
              infiltration, guiding tumor biopsy/resection, and providing
              images for histopathologic and molecular diagnosis.",
  journal  = "J. Neurooncol.",
  volume   =  151,
  number   =  3,
  pages    = "393--402",
  month    =  feb,
  year     =  2021,
  keywords = "Coherent Raman imaging; Coherent anti-Stokes Raman scattering
              microscopy; Intraoperative pathology; Label-free imaging;
              Molecular imaging; Raman spectroscopy; Stimulated Raman
              histology; Stimulated Raman scattering microscopy",
  language = "en"
}

@ARTICLE{Hollon2020-cl,
  title    = "Rapid, label-free detection of diffuse glioma recurrence using
              intraoperative stimulated Raman histology and deep neural
              networks",
  author   = "Hollon, Todd C and Pandian, Balaji and Urias, Esteban and Save,
              Akshay V and Adapa, Arjun R and Srinivasan, Sudharsan and
              Jairath, Neil K and Farooq, Zia and Marie, Tamara and Al-Holou,
              Wajd N and Eddy, Karen and Heth, Jason A and Khalsa, Siri Sahib S
              and Conway, Kyle and Sagher, Oren and Bruce, Jeffrey N and
              Canoll, Peter and Freudiger, Christian W and Camelo-Piragua,
              Sandra and Lee, Honglak and Orringer, Daniel A",
  abstract = "BACKGROUND: Detection of glioma recurrence remains a challenge in
              modern neuro-oncology. Noninvasive radiographic imaging is unable
              to definitively differentiate true recurrence versus
              pseudoprogression. Even in biopsied tissue, it can be challenging
              to differentiate recurrent tumor and treatment effect. We
              hypothesized that intraoperative stimulated Raman histology (SRH)
              and deep neural networks can be used to improve the
              intraoperative detection of glioma recurrence. METHODS: We used
              fiber-laser-based SRH, a label-free, non-consumptive,
              high-resolution microscopy method (<60 secs per 1 x 1 mm2) to
              image a cohort of patients (n = 35) with suspected recurrent
              gliomas who underwent biopsy or resection. The SRH images were
              then used to train a convolutional neural network (CNN) and
              develop an inference algorithm to detect viable recurrent glioma.
              Following network training, the performance of the CNN was tested
              for diagnostic accuracy in a retrospective cohort (n = 48).
              RESULTS: Using patch-level CNN predictions, the inference
              algorithm returned a single Bernoulli distribution for the
              probability of tumor recurrence for each surgical specimen or
              patient. The external SRH validation dataset consisted of 48
              patients (recurrent, 30; pseudoprogression, 18), and we achieved
              a diagnostic accuracy of 95.8\%. CONCLUSION: SRH with CNN-based
              diagnosis can be used to improve the intraoperative detection of
              glioma recurrence in near-real time. Our results provide insight
              into how optical imaging and computer vision can be combined to
              augment conventional diagnostic methods and improve the quality
              of specimen sampling at glioma recurrence.",
  journal  = "Neuro. Oncol.",
  month    =  jul,
  year     =  2020,
  keywords = "deep learning; frozen section; intraoperative pathology;
              label-free imaging; neural networks; stimulated Raman histology",
  language = "en"
}

@ARTICLE{Hou2021-om,
  title    = "Molecular subtype impacts surgical resection in low-grade
              gliomas: A Chinese Glioma Genome Atlas database analysis",
  author   = "Hou, Ziming and Zhang, Kenan and Liu, Xing and Fang, Shengyu and
              Li, Lianwang and Wang, Yinyan and Jiang, Tao",
  abstract = "Surgeons have considered extending the resection margins for
              better outcomes in gliomas, but have not considered molecular
              pathology. We investigated the impact of molecular pathology on
              the surgical benefit in gliomas. Herein, we collected the
              clinical and pathological information of 449 patients with glioma
              from the Chinese Glioma Genome Atlas database, and enrolled those
              who underwent surgical resection. We measured the impact of the
              extent of resection on survival time in subgroups classified by
              clinical characteristics. We found that gross total resection
              (GTR) was associated with longer survival times in the entire
              cohort, and each of the three molecular subtypes. Even after age
              stratification, there was no survival benefit from GTR in those
              with a Karnofsky performance score (KPS) $\leq$ 80. In patients
              aged >45 years with a KPS >80, extensive resection resulted in
              longer survival times in isocitrate dehydrogenase-mutated
              astrocytomas. Additionally, GTR was associated with longer
              overall survival times in patients aged $\leq$45 years with a KPS
              >80. In conclusion, extensive resection does not always prolong
              survival in patients with glioma. Along with clinical
              characteristics, molecular pathology positively impacts survival
              in gliomas. Neurosurgeons may consider our findings when planning
              surgery in the future.",
  journal  = "Cancer Lett.",
  volume   =  522,
  pages    = "14--21",
  month    =  sep,
  year     =  2021,
  keywords = "Chinese glioma genome atlas; Extent of resection; Glioma;
              Molecular pathology; Survival",
  language = "en"
}

@ARTICLE{Fortin_Ensign2021-cr,
  title    = "Assessing the utility and attitudes toward molecular testing in
              neuro-oncology: a survey of the Society for {Neuro-Oncology}
              members",
  author   = "Fortin Ensign, Shannon and Hrachova, Maya and Chang, Susan and
              Mrugala, Maciej M",
  abstract = "Background: Molecular testing (MT) is utilized in neuro-oncology
              with increasing frequency. The aim of this study was to determine
              clinical practice patterns to acquire this information, interpret
              and utilize MT for patient care, and identify unmet needs in the
              practical clinical application of MT. Methods: We conducted a
              voluntary online survey of providers within the Society for
              Neuro-Oncology (SNO) membership database between March and April
              2019. Results: We received 152 responses out of 2022 SNO members
              (7.5\% of membership). 88.8\% of respondents routinely order MT
              for newly diagnosed gliomas. Of those who do not, testing is
              preferentially performed in younger patients or those with
              midline tumors. 82.8\% use MT in recurrent gliomas. Other common
              indications included: metastatic tumors, meningioma, and
              medulloblastoma. Many providers utilize more than one resource
              (36.0\%), most frequently using in-house (41.8\%) over
              commercially available panels. 78.1\% used the results for
              clinical decision-making, with BRAF, EGFR, ALK, and H3K27
              mutations most commonly directing treatment decisions.
              Approximately, half (48.5\%) of respondents have molecular tumor
              boards at their institutions. Respondents would like to see
              SNO-endorsed guidelines on MT, organized lists of targeted agents
              available for specific mutations, a database of targetable
              mutations and clinical trials, and more educational programs on
              MT. Conclusion: This survey was marked by several limitations
              including response rate and interpretation of MT. Among
              respondents, there is routine use of MT in Neuro-Oncology,
              however, there remains a need for increased guidance for
              providers to effectively incorporate the expanding genomic data
              resulting from MT into daily Neuro-Oncology practice.",
  journal  = "Neurooncol Pract",
  volume   =  8,
  number   =  3,
  pages    = "310--316",
  month    =  jun,
  year     =  2021,
  keywords = "CNS tumors; genomic classification; molecular testing;
              neuro-oncology practice patterns",
  language = "en"
}

@ARTICLE{Zhao2021-gy,
  title    = "Chinese Glioma Genome Atlas ({CGGA)}: A Comprehensive Resource
              with Functional Genomic Data from Chinese Glioma Patients",
  author   = "Zhao, Zheng and Zhang, Ke-Nan and Wang, Qiangwei and Li,
              Guanzhang and Zeng, Fan and Zhang, Ying and Wu, Fan and Chai,
              Ruichao and Wang, Zheng and Zhang, Chuanbao and Zhang, Wei and
              Bao, Zhaoshi and Jiang, Tao",
  abstract = "Gliomas are the most common and malignant intracranial tumors in
              adults. Recent studies have revealed the significance of
              functional genomics for glioma pathophysiological studies and
              treatments. However, access to comprehensive genomic data and
              analytical platforms is often limited. Here, we developed the
              Chinese Glioma Genome Atlas (CGGA), a user-friendly data portal
              for the storage and interactive exploration of cross-omics data,
              including nearly 2000 primary and recurrent glioma samples from
              Chinese cohort. Currently, open access is provided to whole-exome
              sequencing data (286 samples), mRNA sequencing (1018 samples) and
              microarray data (301 samples), DNA methylation microarray data
              (159 samples), and microRNA microarray data (198 samples), and to
              detailed clinical information (age, gender, chemoradiotherapy
              status, WHO grade, histological type, critical molecular
              pathological information, and survival data). In addition, we
              have developed several tools for users to analyze the mutation
              profiles, mRNA/microRNA expression, and DNA methylation profiles,
              and to perform survival and gene correlation analyses of specific
              glioma subtypes. This database removes the barriers for
              researchers, providing rapid and convenient access to
              high-quality functional genomic data resources for biological
              studies and clinical applications. CGGA is available at
              http://www.cgga.org.cn.",
  journal  = "Genomics Proteomics Bioinformatics",
  month    =  mar,
  year     =  2021,
  keywords = "Chinese Glioma Genome Atlas; Chinese cohort; Database; Functional
              genomics; Glioma",
  language = "en"
}

@ARTICLE{Sayed2018-ng,
  title    = "Improving pathology and laboratory medicine in low-income and
              middle-income countries: roadmap to solutions",
  author   = "Sayed, Shahin and Cherniak, William and Lawler, Mark and Tan, Soo
              Yong and El Sadr, Wafaa and Wolf, Nicholas and Silkensen, Shannon
              and Brand, Nathan and Looi, Lai Meng and Pai, Sanjay A and
              Wilson, Michael L and Milner, Danny and Flanigan, John and
              Fleming, Kenneth A",
  abstract = "Insufficient awareness of the centrality of pathology and
              laboratory medicine (PALM) to a functioning health-care system at
              policy and governmental level, with the resultant inadequate
              investment, has meant that efforts to enhance PALM in low-income
              and middle-income countries have been local, fragmented, and
              mostly unsustainable. Responding to the four major barriers in
              PALM service delivery that were identified in the first paper of
              this Series (workforce, infrastructure, education and training,
              and quality assurance), this second paper identifies potential
              solutions that can be applied in low-income and middle-income
              countries (LMICs). Increasing and retaining a quality PALM
              workforce requires access to mentorship and continuing
              professional development, task sharing, and the development of
              short-term visitor programmes. Opportunities to enhance the
              training of pathologists and allied PALM personnel by increasing
              and improving education provision must be explored and
              implemented. PALM infrastructure must be strengthened by
              addressing supply chain barriers, and ensuring laboratory
              information systems are in place. New technologies, including
              telepathology and point-of-care testing, can have a substantial
              role in PALM service delivery, if used appropriately. We
              emphasise the crucial importance of maintaining PALM quality and
              posit that all laboratories in LMICs should participate in
              quality assurance and accreditation programmes. A potential role
              for public-private partnerships in filling PALM services gaps
              should also be investigated. Finally, to deliver these solutions
              and ensure equitable access to essential services in LMICs, we
              propose a PALM package focused on these countries, integrated
              within a nationally tiered laboratory system, as part of an
              overarching national laboratory strategic plan.",
  journal  = "Lancet",
  volume   =  391,
  number   =  10133,
  pages    = "1939--1952",
  month    =  may,
  year     =  2018,
  language = "en"
}

@ARTICLE{Wilson2018-cn,
  title    = "Access to pathology and laboratory medicine services: a crucial
              gap",
  author   = "Wilson, Michael L and Fleming, Kenneth A and Kuti, Modupe A and
              Looi, Lai Meng and Lago, Nestor and Ru, Kun",
  abstract = "As global efforts accelerate to implement the Sustainable
              Development Goals and, in particular, universal health coverage,
              access to high-quality and timely pathology and laboratory
              medicine (PALM) services will be needed to support health-care
              systems that are tasked with achieving these goals. This access
              will be most challenging to achieve in low-income and
              middle-income countries (LMICs), which have a disproportionately
              large share of the global burden of disease but a
              disproportionately low share of global health-care resources,
              particularly PALM services. In this first in a Series of three
              papers on PALM in LMICs, we describe the crucial and central
              roles of PALM services in the accurate diagnosis and detection of
              disease, informing prognosis and guiding treatment, contributing
              to disease screening, public health surveillance and disease
              registries, and supporting medical-legal systems. We also
              describe how, even though data are sparse, these services are of
              both insufficient scope and inadequate quality to play their key
              role in health-care systems in LMICs. Lastly, we identify four
              key barriers to the provision of optimal PALM services in
              resource-limited settings: insufficient human resources or
              workforce capacity, inadequate education and training, inadequate
              infrastructure, and insufficient quality, standards, and
              accreditation.",
  journal  = "Lancet",
  volume   =  391,
  number   =  10133,
  pages    = "1927--1938",
  month    =  may,
  year     =  2018,
  language = "en"
}

@ARTICLE{Reddy1996-zl,
  title    = "An {FFT-based} technique for translation, rotation, and
              scale-invariant image registration",
  author   = "Reddy, B S and Chatterji, B N",
  abstract = "This correspondence discusses an extension of the well-known
              phase correlation technique to cover translation, rotation, and
              scaling. Fourier scaling properties and Fourier rotational
              properties are used to find scale and rotational movement. The
              phase correlation technique determines the translational
              movement. This method shows excellent robustness against random
              noise.",
  journal  = "IEEE Trans. Image Process.",
  volume   =  5,
  number   =  8,
  pages    = "1266--1271",
  month    =  aug,
  year     =  1996,
  keywords = "Image registration;Fourier transforms;Frequency domain
              analysis;Noise robustness;Image
              processing;Pixel;Correlation;Optimal matching;Phase
              noise;Computational efficiency"
}

@INPROCEEDINGS{Huiping2003-ak,
  title     = "Analysis to the relationship of classification accuracy,
               segmentation scale, image resolution",
  booktitle = "{IGARSS} 2003. 2003 {IEEE} International Geoscience and Remote
               Sensing Symposium. Proceedings ({IEEE} Cat. {No.03CH37477})",
  author    = "Huiping, Huang and Bingfang, Wu and Jinlong, Fan",
  abstract  = "Information extraction encountered a new challenge while the
               spatial resolution is increasing quickly. People suppose that
               the higher the spatial resolution is, the better is the result
               of classification. To prove this guess we use two approaches:
               pixel-based classification and object-oriented classification.
               The former site test shows one class has different accuracy from
               various resolution images. The object-oriented approach is an
               advanced solution for image analysis. The accuracy of
               object-oriented approach is much higher than those of the
               pixel-based approach. The site result shows that each class has
               its optimal image segmentation scale.",
  volume    =  6,
  pages     = "3671--3673 vol.6",
  month     =  jul,
  year      =  2003,
  keywords  = "Image analysis;Image segmentation;Image resolution;Spatial
               resolution;Image color analysis;Remote
               sensing;Pixel;Testing;Maximum likelihood detection;Image
               generation"
}

@INPROCEEDINGS{Zhou2021-ss,
  title     = "Improving {Low-Resolution} Image Classification by
               {Super-Resolution} with Enhancing {High-Frequency} Content",
  booktitle = "2020 25th International Conference on Pattern Recognition
               ({ICPR})",
  author    = "Zhou, Liguo and Chen, Guang and Feng, Mingyue and Knoll, Alois",
  abstract  = "With the prosperous development of Convolutional Neural
               Networks, currently they can perform excellently on visual
               understanding tasks when the input images are high quality and
               common quality images. However, large degradation in performance
               always occur when the input images are low quality images. In
               this paper, we propose a new super-resolution method in order to
               improve the classification performance for low-resolution
               images. In an image, the regions in which pixel values vary
               dramatically contain more abundant high frequency contents
               compared to other parts. Based on this fact, we design a weight
               map and integrate it with a super-resolution CNN training
               framework. During the process of training, this weight map can
               find out positions of the high frequency pixels in ground truth
               high-resolution images. After that, the pixel-level loss
               function takes effect only at these found positions to minimize
               the difference between reconstructed high-resolution images and
               ground truth high-resolution images. Compared with other
               state-of-the-art super-resolution methods, the experiment
               results show that our method can recover more high frequency
               contents in high-resolution image reconstructing, and better
               improve the classification accuracy after low-resolution image
               preprocessing.",
  pages     = "1972--1978",
  month     =  jan,
  year      =  2021,
  keywords  = "Training;Degradation;Visualization;Superresolution;Noise
               reduction;Pattern recognition;High frequency"
}

@ARTICLE{Jiang2022-ea,
  title    = "Rapid Automated Analysis of Skull Base Tumor Specimens Using
              Intraoperative Optical Imaging and Artificial Intelligence",
  author   = "Jiang, Cheng and Bhattacharya, Abhishek and Linzey, Joseph R and
              Joshi, Rushikesh S and Cha, Sung Jik and Srinivasan, Sudharsan
              and Alber, Daniel and Kondepudi, Akhil and Urias, Esteban and
              Pandian, Balaji and Al-Holou, Wajd N and Sullivan, Stephen E and
              Thompson, B Gregory and Heth, Jason A and Freudiger, Christian W
              and Khalsa, Siri Sahib S and Pacione, Donato R and Golfinos, John
              G and Camelo-Piragua, Sandra and Orringer, Daniel A and Lee,
              Honglak and Hollon, Todd C",
  abstract = "BACKGROUND: Accurate specimen analysis of skull base tumors is
              essential for providing personalized surgical treatment
              strategies. Intraoperative specimen interpretation can be
              challenging because of the wide range of skull base pathologies
              and lack of intraoperative pathology resources. OBJECTIVE: To
              develop an independent and parallel intraoperative workflow that
              can provide rapid and accurate skull base tumor specimen analysis
              using label-free optical imaging and artificial intelligence.
              METHODS: We used a fiber laser-based, label-free, nonconsumptive,
              high-resolution microscopy method (<60 seconds per 1 $\times$ 1
              mm2), called stimulated Raman histology (SRH), to image a
              consecutive, multicenter cohort of patients with skull base
              tumor. SRH images were then used to train a convolutional neural
              network model using 3 representation learning strategies:
              cross-entropy, self-supervised contrastive learning, and
              supervised contrastive learning. Our trained convolutional neural
              network models were tested on a held-out, multicenter SRH data
              set. RESULTS: SRH was able to image the diagnostic features of
              both benign and malignant skull base tumors. Of the 3
              representation learning strategies, supervised contrastive
              learning most effectively learned the distinctive and diagnostic
              SRH image features for each of the skull base tumor types. In our
              multicenter testing set, cross-entropy achieved an overall
              diagnostic accuracy of 91.5\%, self-supervised contrastive
              learning 83.9\%, and supervised contrastive learning 96.6\%. Our
              trained model was able to segment tumor-normal margins and detect
              regions of microscopic tumor infiltration in meningioma SRH
              images. CONCLUSION: SRH with trained artificial intelligence
              models can provide rapid and accurate intraoperative analysis of
              skull base tumor specimens to inform surgical decision-making.",
  journal  = "Neurosurgery",
  month    =  mar,
  year     =  2022,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Freudiger2014-at,
  title     = "Stimulated Raman scattering microscopy with a robust fibre laser
               source",
  author    = "Freudiger, Christian W and Yang, Wenlong and Holtom, Gary R and
               Peyghambarian, Nasser and Xie, X Sunney and Kieu, Khanh Q",
  abstract  = "Stimulated Raman scattering microscopy allows label-free
               chemical imaging and has enabled exciting applications in
               biology, material science and medicine. It provides a major
               advantage in imaging speed over spontaneous Raman scattering and
               has improved image contrast and spectral fidelity compared to
               coherent anti-Stokes Raman scattering. Wider adoption of the
               technique has, however, been hindered by the need for a costly
               and environmentally sensitive tunable ultrafast dual-wavelength
               source. We present the development of an optimized all-fibre
               laser system based on the optical synchronization of two
               picosecond power amplifiers. To circumvent the high-frequency
               laser noise intrinsic to amplified fibre lasers, we have further
               developed a high-speed noise cancellation system based on
               voltage-subtraction autobalanced detection. We demonstrate
               uncompromised imaging performance of our fibre-laser-based
               stimulated Raman scattering microscope with shot-noise-limited
               sensitivity and an imaging speed up to 1 frame sâˆ’1. A
               dual-wavelength fibre laser source has been developed for
               stimulated Raman scattering microscopy. It is precisely tunable
               over the entire high-wavenumber region of Raman spectra, where
               most stimulated Raman scattering imaging is performed. Imaging
               speeds of up to 1 frame sâˆ’1 with shot-noise-limited sensitivity
               were achieved.",
  journal   = "Nat. Photonics",
  publisher = "Nature Publishing Group",
  volume    =  8,
  number    =  2,
  pages     = "153--159",
  month     =  jan,
  year      =  2014,
  language  = "en"
}

@ARTICLE{Di2022-pa,
  title    = "Radical supramaximal resection for newly diagnosed left-sided
              eloquent glioblastoma: safety and improved survival over
              gross-total resection",
  author   = "Di, Long and Shah, Ashish H and Mahavadi, Anil and Eichberg,
              Daniel G and Reddy, Raghuram and Sanjurjo, Alexander D and
              Morell, Alexis A and Lu, Victor M and Ampie, Leonel and Luther,
              Evan M and Komotar, Ricardo J and Ivan, Michael E",
  abstract = "OBJECTIVE: Supramaximal resection (SMR) has arisen as a possible
              surrogate to gross-total resection (GTR) to improve survival in
              newly diagnosed glioblastoma (nGBM). However, SMR has
              traditionally been limited to noneloquent regions and its
              feasibility in eloquent nGBM remains unclear. The authors
              conducted a retrospective multivariate propensity-matched
              analysis comparing survival outcomes for patients with left-sided
              eloquent nGBM undergoing SMR versus GTR. METHODS: A retrospective
              review was performed of all patients at our institution who
              underwent SMR or GTR of a left-sided eloquent nGBM during the
              period from 2011 to 2020. All patients underwent some form of
              preoperative or intraoperative functional mapping and underwent
              awake or asleep craniotomy (craniotomy under general anesthesia);
              however, awake craniotomy was performed in the majority of
              patients and the focus of the study was SMR achieved via awake
              craniotomy and functional mapping with lesionectomy and
              additional peritumoral fluid attenuated inversion recovery
              (FLAIR) resection. Propensity scores were generated controlling
              for age, tumor location, and preoperative Karnofsky Performance
              Status (KPS) score with the nearest-neighbor algorithm. RESULTS:
              A total of 102 patients (48 SMR, 54 GTR) were included in this
              study. The median overall survival (OS) and progression-free
              survival (PFS) for patients receiving SMR were 22.9 and 5.1
              months, respectively. Propensity matching resulted in a final
              cohort of 27 SMR versus 27 GTR patients. SMR conferred improved
              OS (21.55 vs 15.49 months, p = 0.0098) and PFS (4.51 vs 3.59
              months, p = 0.041) compared to GTR. There was no significant
              difference in postoperative complication rates or KPS score in
              SMR compared with GTR patients (p = 0.236 and p = 0.736,
              respectively). In patients receiving SMR, improved OS and PFS
              showed a dose-dependent relationship with extent of FLAIR
              resection (EOFR) on log-rank test for trend (p < 0.001).
              CONCLUSIONS: SMR by means of awake craniotomy with functional
              mapping for left-sided eloquent nGBM is safe and confers a
              survival benefit compared to GTR obtained with lesionectomy alone
              while preserving postoperative neurological integrity. When
              tolerated, greater EOFR with SMR may be associated with improved
              survival.",
  journal  = "J. Neurosurg.",
  pages    = "1--8",
  month    =  may,
  year     =  2022,
  keywords = "GBM; awake craniotomy; glioblastoma; gross-total resection;
              mapping; oncology; supramaximal resection",
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Fitzgerald2022-ld,
  title    = "Stimulated Raman Histology for Rapid {Intra-Operative} Diagnosis
              of Sinonasal and Skull Base Tumors",
  author   = "Fitzgerald, Conall W R and Dogan, Snjezana and Bou-Nassif, Rabih
              and Mclean, Tim and Woods, Robbie and Cracchiolo, Jennifer R and
              Ganly, Ian and Tabar, Viviane and Cohen, Marc A",
  abstract = "OBJECTIVE: Intra-operative stimulated Raman histology (SRH) is a
              novel technology that uses laser spectroscopy and color-matching
              algorithms to create images similar to the formalin-fixed
              paraffin-embedded (FFPE) section. We aim to assess the accuracy
              of SRH in a novel range of sinonasal and skull base tumors.
              METHODS: Select patients undergoing sinonasal and skull base
              surgery using the Invenio Imagingâ„¢ Nioâ„¢ Laser Imaging SRH system
              between June 2020 and September 2021 were assessed. The SRH
              images were reviewed for pathologic features similar to frozen
              section (FS) and FFPE. Time taken for results and diagnostic
              concordance was assessed. RESULTS: Sixty-seven SRH images from 7
              tumor types in 12 patients were assessed. Pathologies included
              squamous cell carcinoma, rhabdomyosarcoma, inverted papilloma,
              adenoid cystic carcinoma, SMARCB1-deficient sinonasal carcinoma,
              mucosal melanoma, metastatic colonic adenocarcinoma, and
              meningioma. Tumor was identified in 100\% of lesional specimens,
              with characteristic diagnostic features readily appreciable on
              SRH. Median time for diagnosis was significantly faster for SRH
              (4.3 min) versus FS (44.5 min; p = <.0001). Where SRH sample site
              matched precisely to FS (n = 32/67, 47.8\%), the same diagnosis
              was confirmed in 93.8\%. Sensitivity, specificity, precision, and
              overall accuracy of SRH were 93.3\%, 94.1\%, 93.8\%, and 93.3\%,
              respectively. Near-perfect concordance was seen between SRH and
              FS (Cohen's kappa [$\kappa$] = 0.89). CONCLUSION: Stimulated
              Raman histology can rapidly produce images similar to FFPE H\&E
              in sinonasal and skull base tumors. This technology has the
              potential to act as an adjunct or alternative to standard FS.
              LEVEL OF EVIDENCE: 4 Laryngoscope, 2022.",
  journal  = "Laryngoscope",
  month    =  may,
  year     =  2022,
  keywords = "histology; sinonasal; skull base; stimulated Raman histology",
  language = "en"
}

@MISC{Wightman2019-tk,
  title  = "Pytorch image models",
  author = "Wightman, Ross",
  year   =  2019
}

@ARTICLE{Smith2008-ga,
  title    = "Role of extent of resection in the long-term outcome of low-grade
              hemispheric gliomas",
  author   = "Smith, Justin S and Chang, Edward F and Lamborn, Kathleen R and
              Chang, Susan M and Prados, Michael D and Cha, Soonmee and Tihan,
              Tarik and Vandenberg, Scott and McDermott, Michael W and Berger,
              Mitchel S",
  abstract = "PURPOSE: The prognostic role of extent of resection (EOR) of
              low-grade gliomas (LGGs) is a major controversy. We designed a
              retrospective study to assess the influence of EOR on long-term
              outcomes of LGGs. PATIENTS AND METHODS: The study population (N =
              216) included adults undergoing initial resection of hemispheric
              LGG. Region-of-interest analysis was performed to measure tumor
              volumes based on fluid-attenuated inversion-recovery (FLAIR)
              imaging. RESULTS: Median preoperative and postoperative tumor
              volumes and EOR were 36.6 cm(3) (range, 0.7 to 246.1 cm(3)), 3.7
              cm(3) (range, 0 to 197.8 cm(3)) and 88.0\% (range, 5\% to 100\%),
              respectively. There was no operative mortality. New postoperative
              deficits were noted in 36 patients (17\%); however, all but four
              had complete recovery. There were 34 deaths (16\%; median
              follow-up, 4.4 years). Progression and malignant progression were
              identified in 95 (44\%) and 44 (20\%) cases, respectively.
              Patients with at least 90\% EOR had 5- and 8-year overall
              survival (OS) rates of 97\% and 91\%, respectively, whereas
              patients with less than 90\% EOR had 5- and 8-year OS rates of
              76\% and 60\%, respectively. After adjusting each measure of
              tumor burden for age, Karnofsky performance score (KPS), tumor
              location, and tumor subtype, OS was predicted by EOR (hazard
              ratio [HR] = 0.972; 95\% CI, 0.960 to 0.983; P < .001), log
              preoperative tumor volume (HR = 4.442; 95\% CI, 1.601 to 12.320;
              P = .004), and postoperative tumor volume (HR = 1.010; 95\% CI,
              1.001 to 1.019; P = .03), progression-free survival was predicted
              by log preoperative tumor volume (HR = 2.711; 95\% CI, 1.590 to
              4.623; P <or= .001) and postoperative tumor volume (HR = 1.007;
              95\% CI, 1.001 to 1.014; P = .035), and malignant
              progression-free survival was predicted by EOR (HR = 0.983; 95\%
              CI, 0.972 to 0.995; P = .005) and log preoperative tumor volume
              (HR = 3.826; 95\% CI, 1.632 to 8.969; P = .002). CONCLUSION:
              Improved outcome among adult patients with hemispheric LGG is
              predicted by greater EOR.",
  journal  = "J. Clin. Oncol.",
  volume   =  26,
  number   =  8,
  pages    = "1338--1345",
  month    =  mar,
  year     =  2008,
  language = "en"
}

@ARTICLE{Burns2011-sm,
  title    = "The levels of evidence and their role in evidence-based medicine",
  author   = "Burns, Patricia B and Rohrich, Rod J and Chung, Kevin C",
  journal  = "Plast. Reconstr. Surg.",
  volume   =  128,
  number   =  1,
  pages    = "305--310",
  month    =  jul,
  year     =  2011,
  language = "en"
}

@ARTICLE{Lacroix2001-td,
  title    = "A multivariate analysis of 416 patients with glioblastoma
              multiforme: prognosis, extent of resection, and survival",
  author   = "Lacroix, M and Abi-Said, D and Fourney, D R and Gokaslan, Z L and
              Shi, W and DeMonte, F and Lang, F F and McCutcheon, I E and
              Hassenbusch, S J and Holland, E and Hess, K and Michael, C and
              Miller, D and Sawaya, R",
  abstract = "OBJECT: The extent of tumor resection that should be undertaken
              in patients with glioblastoma multiforme (GBM) remains
              controversial. The purpose of this study was to identify
              significant independent predictors of survival in these patients
              and to determine whether the extent of resection was associated
              with increased survival time. METHODS: The authors
              retrospectively analyzed 416 consecutive patients with
              histologically proven GBM who underwent tumor resection at the
              authors' institution between June 1993 and June 1999. Volumetric
              data and other tumor characteristics identified on magnetic
              resonance (MR) imaging were collected prospectively. CONCLUSIONS:
              Five independent predictors of survival were identified: age,
              Karnofsky Performance Scale (KPS) score, extent of resection, and
              the degree of necrosis and enhancement on preoperative MR imaging
              studies. A significant survival advantage was associated with
              resection of 98\% or more of the tumor volume (median survival 13
              months, 95\% confidence interval [CI] 11.4-14.6 months), compared
              with 8.8 months (95\% CI 7.4-10.2 months; p < 0.0001) for
              resections of less than 98\%. Using an outcome scale ranging from
              0 to 5 based on age, KPS score, and tumor necrosis on MR imaging,
              we observed significantly longer survival in patients with lower
              scores (1-3) who underwent aggressive resections, and a trend
              toward slightly longer survival was found in patients with higher
              scores (4-5). Gross-total tumor resection is associated with
              longer survival in patients with GBM, especially when other
              predictive variables are favorable.",
  journal  = "J. Neurosurg.",
  volume   =  95,
  number   =  2,
  pages    = "190--198",
  month    =  aug,
  year     =  2001,
  language = "en"
}

@ARTICLE{Van_West2017-ne,
  title    = "Incidence of pseudoprogression in low-grade gliomas treated with
              radiotherapy",
  author   = "van West, Sophie E and de Bruin, Hein G and van de Langerijt,
              Bart and Swaak-Kragten, Annemarie T and van den Bent, Martin J
              and Taal, Walter",
  abstract = "Background: As the incidence of pseudo-progressive disease
              (psPD), or pseudoprogression, in low-grade glioma (LGG) is
              unknown, we retrospectively investigated this phenomenon in a
              cohort of LGG patients given radiotherapy (RT). Methods: All MRI
              scans and clinical data from patients with histologically proven
              LGG treated with radiation between 2000 and 2011 were reviewed.
              PsPD was scored when a new enhancing lesion occurred after RT and
              subsequently disappeared or remained stable for at least a year
              without therapy, including dexamethasone. Results: Sixty-three
              out of 71 patients who received RT for LGG were deemed eligible
              for evaluation of psPD. The median follow-up was 5 years (range
              1-10 y). PsPD was seen in 13 patients (20.6\%). PsPD occurred
              after a median of 12 months with a range of 3-78 months. The
              median duration of psPD was 6 months, with a range of 2-26 months
              and always occurred within the RT high dose fields of at least 45
              Gy. The area of the enhancement at the time of psPD was
              significantly smaller compared with the area of enhancement
              during ``true'' progression (median size 54mm2 [range 12-340mm2]
              vs 270mm2 [range 30-3420mm2], respectively; P = .009).
              Conclusions: PsPD occurs frequently in LGG patients receiving RT.
              This supports the policy to postpone a new line of treatment
              until progression is evident, especially when patients have small
              contrast enhancing lesions within the RT field.",
  journal  = "Neuro. Oncol.",
  volume   =  19,
  number   =  5,
  pages    = "719--725",
  month    =  may,
  year     =  2017,
  keywords = "LGG; glioma; low-grade glioma; pseudoprogression; radiotherapy",
  language = "en"
}

@ARTICLE{Drexler2022-qy,
  title    = "{DNA} methylation subclasses predict the benefit from gross total
              tumor resection in {IDH-wildtype} glioblastoma patients",
  author   = "Drexler, Richard and Sch{\"u}ller, Ulrich and Eckhardt, Alicia
              and Filipski, Katharina and Hartung, Tabea I and Harter, Patrick
              N and Div{\'e}, Iris and Forster, Marie-Therese and Czabanka,
              Marcus and Jelgersma, Claudius and Onken, Julia and Vajkoczy,
              Peter and Capper, David and Siewert, Christin and Sauvigny,
              Thomas and Lamszus, Katrin and Westphal, Manfred and D{\"u}hrsen,
              Lasse and Ricklefs, Franz L",
  abstract = "BACKGROUND: DNA methylation-based tumor classification allows an
              enhanced distinction into subgroups of glioblastoma. However, the
              clinical benefit of DNA methylation-based stratification of
              glioblastomas remains inconclusive. METHODS: Multicentric cohort
              study including 430 patients with newly diagnosed glioblastoma
              subjected to global DNA methylation profiling. Outcome measures
              included overall survival (OS), progression-free survival (PFS),
              prognostic relevance of EOR and MGMT promoter methylation status
              as well as surgical benefit for recurrent glioblastoma. RESULTS:
              345 patients (80.2\%) fulfilled the inclusion criteria. DNA
              methylation subclasses RTK I, RTK II, and mesenchymal (MES)
              revealed no significant survival differences (p = 0.06). 305
              Patients receiving combined adjuvant therapy (RTK I: Ref.; RTK
              II: HR 0.9 [95\% CI, 0.64-1.28]; p = 0.56; MES: 0.69 [0.47-1.02];
              p = 0.06). RTK I (GTR/near GTR: Ref.; PR: HR 2.87 [95\% CI,
              1.36-6.08]; p < 0.01) or RTK II (GTR/near GTR: Ref.; PR: HR 5.09
              [95\% CI, 2.80-9.26]; p < 0.01) tumors who underwent gross-total
              resection (GTR) or near GTR had a longer OS and PFS than
              partially resected patients. The MES subclass showed no survival
              benefit for a maximized EOR (GTR/near GTR: Ref.; PR: HR 1.45
              [95\% CI, 0.68-3.09]; p = 0.33). Therapy response-predictive
              value of MGMT promoter methylation was evident for RTK I (HR 0.37
              [95\% CI, 0.19-0.71]; p < 0.01) and RTK II (HR 0.56 [95\% CI,
              0.34-0.91]; p = 0.02) but not the MES subclass (HR 0.52 [95\% CI,
              0.27-1.02]; p = 0.06). For local recurrence (n=112), re-resection
              conveyed a progression-to-overall survival (POS) benefit (p <
              0.01), which was evident in RTK I (p = 0.03) and RTK II (p <
              0.01) tumors, but not in MES tumors (p = 0.33). CONCLUSION: We
              demonstrate a survival benefit from maximized EOR for newly
              diagnosed and recurrent glioblastomas of the RTK I and RTK II but
              not the MES subclass. Hence, it needs to be debated whether the
              MES subclass should be treated with maximal surgical resection,
              especially when located in eloquent areas and at time of
              recurrence.",
  journal  = "Neuro. Oncol.",
  month    =  jul,
  year     =  2022,
  language = "en"
}

@INCOLLECTION{Krizhevsky2012-cv,
  title     = "{ImageNet} Classification with Deep Convolutional Neural
               Networks",
  booktitle = "Advances in Neural Information Processing Systems 25",
  author    = "Krizhevsky, Alex and Sutskever, Ilya and Hinton, Geoffrey E",
  editor    = "Pereira, F and Burges, C J C and Bottou, L and Weinberger, K Q",
  publisher = "Curran Associates, Inc.",
  pages     = "1097--1105",
  year      =  2012
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Srivastava2014-cw,
  title     = "Dropout: a simple way to prevent neural networks from
               overfitting",
  author    = "Srivastava, N and Hinton, G and Krizhevsky, A and {others}",
  abstract  = "Deep neural nets with a large number of parameters are very
               powerful machine learning systems. However, overfitting is a
               serious problem in such networks. Large networks are also slow
               to use, making it difficult to deal with overfitting by
               combining the predictions of â€¦",
  journal   = "The Journal of Machine",
  publisher = "jmlr.org",
  year      =  2014,
  keywords  = "Classic\_papers"
}

@ARTICLE{Lu2016-he,
  title    = "{Label-Free} Neurosurgical Pathology with Stimulated Raman
              Imaging",
  author   = "Lu, Fa-Ke and Calligaris, David and Olubiyi, Olutayo I and
              Norton, Isaiah and Yang, Wenlong and Santagata, Sandro and Xie, X
              Sunney and Golby, Alexandra J and Agar, Nathalie Y R",
  abstract = "The goal of brain tumor surgery is to maximize tumor removal
              without injuring critical brain structures. Achieving this goal
              is challenging as it can be difficult to distinguish tumor from
              nontumor tissue. While standard histopathology provides
              information that could assist tumor delineation, it cannot be
              performed iteratively during surgery as freezing, sectioning, and
              staining of the tissue require too much time. Stimulated Raman
              scattering (SRS) microscopy is a powerful label-free chemical
              imaging technology that enables rapid mapping of lipids and
              proteins within a fresh specimen. This information can be
              rendered into pathology-like images. Although this approach has
              been used to assess the density of glioma cells in murine
              orthotopic xenografts models and human brain tumors, tissue
              heterogeneity in clinical brain tumors has not yet been fully
              evaluated with SRS imaging. Here we profile 41 specimens resected
              from 12 patients with a range of brain tumors. By evaluating
              large-scale stimulated Raman imaging data and correlating this
              data with current clinical gold standard of histopathology for
              4,422 fields of view, we capture many essential diagnostic
              hallmarks for glioma classification. Notably, in fresh tumor
              samples, we observe additional features, not seen by conventional
              methods, including extensive lipid droplets within glioma cells,
              collagen deposition in gliosarcoma, and irregularity and
              disruption of myelinated fibers in areas infiltrated by
              oligodendroglioma cells. The data are freely available in a
              public resource to foster diagnostic training and to permit
              additional interrogation. Our work establishes the methodology
              and provides a significant collection of reference images for
              label-free neurosurgical pathology. Cancer Res; 76(12); 3451-62.
              \copyright{}2016 AACR.",
  journal  = "Cancer Res.",
  volume   =  76,
  number   =  12,
  pages    = "3451--3462",
  month    =  jun,
  year     =  2016,
  keywords = "SRS\_imaging",
  language = "en"
}

@ARTICLE{Louis2016-jf,
  title    = "The 2016 World Health Organization Classification of Tumors of
              the Central Nervous System: a summary",
  author   = "Louis, David N and Perry, Arie and Reifenberger, Guido and von
              Deimling, Andreas and Figarella-Branger, Dominique and Cavenee,
              Webster K and Ohgaki, Hiroko and Wiestler, Otmar D and Kleihues,
              Paul and Ellison, David W",
  abstract = "The 2016 World Health Organization Classification of Tumors of
              the Central Nervous System is both a conceptual and practical
              advance over its 2007 predecessor. For the first time, the WHO
              classification of CNS tumors uses molecular parameters in
              addition to histology to define many tumor entities, thus
              formulating a concept for how CNS tumor diagnoses should be
              structured in the molecular era. As such, the 2016 CNS WHO
              presents major restructuring of the diffuse gliomas,
              medulloblastomas and other embryonal tumors, and incorporates new
              entities that are defined by both histology and molecular
              features, including glioblastoma, IDH-wildtype and glioblastoma,
              IDH-mutant; diffuse midline glioma, H3 K27M-mutant; RELA
              fusion-positive ependymoma; medulloblastoma, WNT-activated and
              medulloblastoma, SHH-activated; and embryonal tumour with
              multilayered rosettes, C19MC-altered. The 2016 edition has added
              newly recognized neoplasms, and has deleted some entities,
              variants and patterns that no longer have diagnostic and/or
              biological relevance. Other notable changes include the addition
              of brain invasion as a criterion for atypical meningioma and the
              introduction of a soft tissue-type grading system for the now
              combined entity of solitary fibrous tumor / hemangiopericytoma-a
              departure from the manner by which other CNS tumors are graded.
              Overall, it is hoped that the 2016 CNS WHO will facilitate
              clinical, experimental and epidemiological studies that will lead
              to improvements in the lives of patients with brain tumors.",
  journal  = "Acta Neuropathol.",
  volume   =  131,
  number   =  6,
  pages    = "803--820",
  month    =  jun,
  year     =  2016,
  keywords = "Neurooncology",
  language = "en"
}

@ARTICLE{Yosinski2014-pi,
  title         = "How transferable are features in deep neural networks?",
  author        = "Yosinski, Jason and Clune, Jeff and Bengio, Yoshua and
                   Lipson, Hod",
  abstract      = "Many deep neural networks trained on natural images exhibit
                   a curious phenomenon in common: on the first layer they
                   learn features similar to Gabor filters and color blobs.
                   Such first-layer features appear not to be specific to a
                   particular dataset or task, but general in that they are
                   applicable to many datasets and tasks. Features must
                   eventually transition from general to specific by the last
                   layer of the network, but this transition has not been
                   studied extensively. In this paper we experimentally
                   quantify the generality versus specificity of neurons in
                   each layer of a deep convolutional neural network and report
                   a few surprising results. Transferability is negatively
                   affected by two distinct issues: (1) the specialization of
                   higher layer neurons to their original task at the expense
                   of performance on the target task, which was expected, and
                   (2) optimization difficulties related to splitting networks
                   between co-adapted neurons, which was not expected. In an
                   example network trained on ImageNet, we demonstrate that
                   either of these two issues may dominate, depending on
                   whether features are transferred from the bottom, middle, or
                   top of the network. We also document that the
                   transferability of features decreases as the distance
                   between the base task and target task increases, but that
                   transferring features even from distant tasks can be better
                   than using random features. A final surprising result is
                   that initializing a network with transferred features from
                   almost any number of layers can produce a boost to
                   generalization that lingers even after fine-tuning to the
                   target dataset.",
  month         =  nov,
  year          =  2014,
  keywords      = "Classic\_papers",
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "1411.1792"
}

@INPROCEEDINGS{Deng2009-hr,
  title     = "{ImageNet}: A large-scale hierarchical image database",
  booktitle = "2009 {IEEE} Conference on Computer Vision and Pattern
               Recognition",
  author    = "Deng, J and Dong, W and Socher, R and Li, L and Li, Kai and
               Fei-Fei, Li",
  abstract  = "The explosion of image data on the Internet has the potential to
               foster more sophisticated and robust models and algorithms to
               index, retrieve, organize and interact with images and
               multimedia data. But exactly how such data can be harnessed and
               organized remains a critical problem. We introduce here a new
               database called ``ImageNet'', a large-scale ontology of images
               built upon the backbone of the WordNet structure. ImageNet aims
               to populate the majority of the 80,000 synsets of WordNet with
               an average of 500-1000 clean and full resolution images. This
               will result in tens of millions of annotated images organized by
               the semantic hierarchy of WordNet. This paper offers a detailed
               analysis of ImageNet in its current state: 12 subtrees with 5247
               synsets and 3.2 million images in total. We show that ImageNet
               is much larger in scale and diversity and much more accurate
               than the current image datasets. Constructing such a large-scale
               database is a challenging task. We describe the data collection
               scheme with Amazon Mechanical Turk. Lastly, we illustrate the
               usefulness of ImageNet through three simple applications in
               object recognition, image classification and automatic object
               clustering. We hope that the scale, accuracy, diversity and
               hierarchical structure of ImageNet can offer unparalleled
               opportunities to researchers in the computer vision community
               and beyond.",
  pages     = "248--255",
  month     =  jun,
  year      =  2009,
  keywords  = "computer vision;image resolution;image
               retrieval;Internet;multimedia computing;ontologies (artificial
               intelligence);trees (mathematics);very large databases;visual
               databases;ImageNet database;large-scale hierarchical image
               database;Internet;image retrieval;multimedia data;large-scale
               ontology;wordNet structure;image resolution;subtree;computer
               vision;Large-scale systems;Image
               databases;Explosions;Internet;Robustness;Information
               retrieval;Image retrieval;Multimedia
               databases;Ontologies;Spine;Classic\_papers"
}

@INPROCEEDINGS{Abadi2016-bs,
  title     = "Tensorflow: a system for large-scale machine learning",
  booktitle = "{OSDI}",
  author    = "Abadi, Mart{\'\i}n and Barham, Paul and Chen, Jianmin and Chen,
               Zhifeng and Davis, Andy and Dean, Jeffrey and Devin, Matthieu
               and Ghemawat, Sanjay and Irving, Geoffrey and Isard, Michael and
               {Others}",
  volume    =  16,
  pages     = "265--283",
  year      =  2016,
  keywords  = "Software"
}

@ARTICLE{Hou2015-sa,
  title         = "Patch-based Convolutional Neural Network for Whole Slide
                   Tissue Image Classification",
  author        = "Hou, Le and Samaras, Dimitris and Kurc, Tahsin M and Gao, Yi
                   and Davis, James E and Saltz, Joel H",
  abstract      = "Convolutional Neural Networks (CNN) are state-of-the-art
                   models for many image classification tasks. However, to
                   recognize cancer subtypes automatically, training a CNN on
                   gigapixel resolution Whole Slide Tissue Images (WSI) is
                   currently computationally impossible. The differentiation of
                   cancer subtypes is based on cellular-level visual features
                   observed on image patch scale. Therefore, we argue that in
                   this situation, training a patch-level classifier on image
                   patches will perform better than or similar to an
                   image-level classifier. The challenge becomes how to
                   intelligently combine patch-level classification results and
                   model the fact that not all patches will be discriminative.
                   We propose to train a decision fusion model to aggregate
                   patch-level predictions given by patch-level CNNs, which to
                   the best of our knowledge has not been shown before.
                   Furthermore, we formulate a novel Expectation-Maximization
                   (EM) based method that automatically locates discriminative
                   patches robustly by utilizing the spatial relationships of
                   patches. We apply our method to the classification of glioma
                   and non-small-cell lung carcinoma cases into subtypes. The
                   classification accuracy of our method is similar to the
                   inter-observer agreement between pathologists. Although it
                   is impossible to train CNNs on WSIs, we experimentally
                   demonstrate using a comparable non-cancer dataset of smaller
                   images that a patch-based CNN can outperform an image-based
                   CNN.",
  month         =  apr,
  year          =  2015,
  keywords      = "AI\_healthcare",
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1504.07947"
}

@ARTICLE{Hoesli2017-yp,
  title    = "Coherent Raman Scattering Microscopy for Evaluation of Head and
              Neck Carcinoma",
  author   = "Hoesli, Rebecca C and Orringer, Daniel A and McHugh, Jonathan B
              and Spector, Matthew E",
  abstract = "Objective We aim to describe a novel, label-free, real-time
              imaging technique, coherent Raman scattering (CRS) microscopy,
              for histopathological evaluation of head and neck cancer. We
              evaluated the ability of CRS microscopy to delineate between
              tumor and nonneoplastic tissue in tissue samples from patients
              with head and neck cancer. Study Design Prospective case series.
              Setting Tertiary care medical center. Subjects and Methods
              Patients eligible were surgical candidates with biopsy-proven,
              previously untreated head and neck carcinoma and were consented
              preoperatively for participation in this study. Tissue was
              collected from 50 patients, and after confirmation of tumor and
              normal specimens by hematoxylin and eosin (H\&E), there were 42
              tumor samples and 42 normal adjacent controls. Results There were
              42 confirmed carcinoma specimens on H\&E, and CRS microscopy
              identified 37 as carcinoma. Of the 42 normal specimens, CRS
              microscopy identified 40 as normal. This resulted in a
              sensitivity of 88.1\% and specificity of 95.2\% in distinguishing
              between neoplastic and nonneoplastic images. Conclusion CRS
              microscopy is a unique label-free imaging technique that can
              provide rapid, high-resolution images and can accurately
              determine the presence of head and neck carcinoma. This holds
              potential for implementation into standard practice, allowing
              frozen margin evaluation even at institutions without a
              histopathology laboratory.",
  journal  = "Otolaryngol. Head Neck Surg.",
  volume   =  157,
  number   =  3,
  pages    = "448--453",
  month    =  sep,
  year     =  2017,
  keywords = "H\&E stain; coherent Raman scattering microscopy; head and neck
              carcinoma; histopathology",
  language = "en"
}

@ARTICLE{Rezende2014-uz,
  title         = "Stochastic Backpropagation and Approximate Inference in Deep
                   Generative Models",
  author        = "Rezende, Danilo Jimenez and Mohamed, Shakir and Wierstra,
                   Daan",
  abstract      = "We marry ideas from deep neural networks and approximate
                   Bayesian inference to derive a generalised class of deep,
                   directed generative models, endowed with a new algorithm for
                   scalable inference and learning. Our algorithm introduces a
                   recognition model to represent approximate posterior
                   distributions, and that acts as a stochastic encoder of the
                   data. We develop stochastic back-propagation -- rules for
                   back-propagation through stochastic variables -- and use
                   this to develop an algorithm that allows for joint
                   optimisation of the parameters of both the generative and
                   recognition model. We demonstrate on several real-world data
                   sets that the model generates realistic samples, provides
                   accurate imputations of missing data and is a useful tool
                   for high-dimensional data visualisation.",
  month         =  jan,
  year          =  2014,
  keywords      = "Autoencoders;Variational",
  archivePrefix = "arXiv",
  primaryClass  = "stat.ML",
  eprint        = "1401.4082"
}

@ARTICLE{Kingma2013-uf,
  title         = "{Auto-Encoding} Variational Bayes",
  author        = "Kingma, Diederik P and Welling, Max",
  abstract      = "How can we perform efficient inference and learning in
                   directed probabilistic models, in the presence of continuous
                   latent variables with intractable posterior distributions,
                   and large datasets? We introduce a stochastic variational
                   inference and learning algorithm that scales to large
                   datasets and, under some mild differentiability conditions,
                   even works in the intractable case. Our contributions is
                   two-fold. First, we show that a reparameterization of the
                   variational lower bound yields a lower bound estimator that
                   can be straightforwardly optimized using standard stochastic
                   gradient methods. Second, we show that for i.i.d. datasets
                   with continuous latent variables per datapoint, posterior
                   inference can be made especially efficient by fitting an
                   approximate inference model (also called a recognition
                   model) to the intractable posterior using the proposed lower
                   bound estimator. Theoretical advantages are reflected in
                   experimental results.",
  month         =  dec,
  year          =  2013,
  keywords      = "Variational",
  archivePrefix = "arXiv",
  primaryClass  = "stat.ML",
  eprint        = "1312.6114v10"
}

@ARTICLE{Karras2017-fa,
  title         = "Progressive Growing of {GANs} for Improved Quality,
                   Stability, and Variation",
  author        = "Karras, Tero and Aila, Timo and Laine, Samuli and Lehtinen,
                   Jaakko",
  abstract      = "We describe a new training methodology for generative
                   adversarial networks. The key idea is to grow both the
                   generator and discriminator progressively: starting from a
                   low resolution, we add new layers that model increasingly
                   fine details as training progresses. This both speeds the
                   training up and greatly stabilizes it, allowing us to
                   produce images of unprecedented quality, e.g., CelebA images
                   at 1024^2. We also propose a simple way to increase the
                   variation in generated images, and achieve a record
                   inception score of 8.80 in unsupervised CIFAR10.
                   Additionally, we describe several implementation details
                   that are important for discouraging unhealthy competition
                   between the generator and discriminator. Finally, we suggest
                   a new metric for evaluating GAN results, both in terms of
                   image quality and variation. As an additional contribution,
                   we construct a higher-quality version of the CelebA dataset.",
  month         =  oct,
  year          =  2017,
  keywords      = "GANs",
  archivePrefix = "arXiv",
  primaryClass  = "cs.NE",
  eprint        = "1710.10196"
}

@ARTICLE{Radford2015-ej,
  title         = "Unsupervised Representation Learning with Deep Convolutional
                   Generative Adversarial Networks",
  author        = "Radford, Alec and Metz, Luke and Chintala, Soumith",
  abstract      = "In recent years, supervised learning with convolutional
                   networks (CNNs) has seen huge adoption in computer vision
                   applications. Comparatively, unsupervised learning with CNNs
                   has received less attention. In this work we hope to help
                   bridge the gap between the success of CNNs for supervised
                   learning and unsupervised learning. We introduce a class of
                   CNNs called deep convolutional generative adversarial
                   networks (DCGANs), that have certain architectural
                   constraints, and demonstrate that they are a strong
                   candidate for unsupervised learning. Training on various
                   image datasets, we show convincing evidence that our deep
                   convolutional adversarial pair learns a hierarchy of
                   representations from object parts to scenes in both the
                   generator and discriminator. Additionally, we use the
                   learned features for novel tasks - demonstrating their
                   applicability as general image representations.",
  month         =  nov,
  year          =  2015,
  keywords      = "DCGAN",
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "1511.06434"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@INCOLLECTION{Goodfellow2014-gx,
  title     = "Generative Adversarial Nets",
  booktitle = "Advances in Neural Information Processing Systems 27",
  author    = "Goodfellow, Ian and Pouget-Abadie, Jean and Mirza, Mehdi and Xu,
               Bing and Warde-Farley, David and Ozair, Sherjil and Courville,
               Aaron and Bengio, Yoshua",
  editor    = "Ghahramani, Z and Welling, M and Cortes, C and Lawrence, N D and
               Weinberger, K Q",
  abstract  = "We propose a new framework for estimating generative models via
               adversarial nets, in which we simultaneously train two models: a
               generative model G that captures the data distribution, and a
               discriminative model D that estimates the probability that a
               sample came â€¦",
  publisher = "Curran Associates, Inc.",
  pages     = "2672--2680",
  year      =  2014,
  keywords  = "GANs"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@INPROCEEDINGS{Salimans2016-vw,
  title     = "Improved techniques for training gans",
  booktitle = "Advances in Neural Information Processing Systems",
  author    = "Salimans, Tim and Goodfellow, Ian and Zaremba, Wojciech and
               Cheung, Vicki and Radford, Alec and Chen, Xi",
  abstract  = "We present a variety of new architectural features and training
               procedures that we apply to the generative adversarial networks
               (GANs) framework. Using our new techniques, we achieve
               state-of-the-art results in semi-supervised classification on
               MNIST, CIFAR-10 and â€¦",
  publisher = "papers.nips.cc",
  pages     = "2234--2242",
  year      =  2016,
  keywords  = "GANs"
}

@ARTICLE{Yosinski2015-jw,
  title         = "Understanding Neural Networks Through Deep Visualization",
  author        = "Yosinski, Jason and Clune, Jeff and Nguyen, Anh and Fuchs,
                   Thomas and Lipson, Hod",
  abstract      = "Recent years have produced great advances in training large,
                   deep neural networks (DNNs), including notable successes in
                   training convolutional neural networks (convnets) to
                   recognize natural images. However, our understanding of how
                   these models work, especially what computations they perform
                   at intermediate layers, has lagged behind. Progress in the
                   field will be further accelerated by the development of
                   better tools for visualizing and interpreting neural nets.
                   We introduce two such tools here. The first is a tool that
                   visualizes the activations produced on each layer of a
                   trained convnet as it processes an image or video (e.g. a
                   live webcam stream). We have found that looking at live
                   activations that change in response to user input helps
                   build valuable intuitions about how convnets work. The
                   second tool enables visualizing features at each layer of a
                   DNN via regularized optimization in image space. Because
                   previous versions of this idea produced less recognizable
                   images, here we introduce several new regularization methods
                   that combine to produce qualitatively clearer, more
                   interpretable visualizations. Both tools are open source and
                   work on a pre-trained convnet with minimal setup.",
  month         =  jun,
  year          =  2015,
  keywords      = "Visualization\_neuralnets",
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1506.06579"
}

@INCOLLECTION{Robbins1985-lv,
  title     = "A stochastic approximation method",
  booktitle = "Herbert Robbins Selected Papers",
  author    = "Robbins, Herbert and Monro, Sutton",
  publisher = "Springer",
  pages     = "102--109",
  year      =  1985,
  keywords  = "Classic\_papers"
}

@ARTICLE{Freudiger2008-gj,
  title    = "Label-free biomedical imaging with high sensitivity by stimulated
              Raman scattering microscopy",
  author   = "Freudiger, Christian W and Min, Wei and Saar, Brian G and Lu,
              Sijia and Holtom, Gary R and He, Chengwei and Tsai, Jason C and
              Kang, Jing X and Xie, X Sunney",
  abstract = "Label-free chemical contrast is highly desirable in biomedical
              imaging. Spontaneous Raman microscopy provides specific
              vibrational signatures of chemical bonds, but is often hindered
              by low sensitivity. Here we report a three-dimensional
              multiphoton vibrational imaging technique based on stimulated
              Raman scattering (SRS). The sensitivity of SRS imaging is
              significantly greater than that of spontaneous Raman microscopy,
              which is achieved by implementing high-frequency (megahertz)
              phase-sensitive detection. SRS microscopy has a major advantage
              over previous coherent Raman techniques in that it offers
              background-free and readily interpretable chemical contrast. We
              show a variety of biomedical applications, such as
              differentiating distributions of omega-3 fatty acids and
              saturated lipids in living cells, imaging of brain and skin
              tissues based on intrinsic lipid contrast, and monitoring drug
              delivery through the epidermis.",
  journal  = "Science",
  volume   =  322,
  number   =  5909,
  pages    = "1857--1861",
  month    =  dec,
  year     =  2008,
  keywords = "SRS\_imaging",
  language = "en"
}

@ARTICLE{Ji2013-zw,
  title    = "Rapid, label-free detection of brain tumors with stimulated Raman
              scattering microscopy",
  author   = "Ji, Minbiao and Orringer, Daniel A and Freudiger, Christian W and
              Ramkissoon, Shakti and Liu, Xiaohui and Lau, Darryl and Golby,
              Alexandra J and Norton, Isaiah and Hayashi, Marika and Agar,
              Nathalie Y R and Young, Geoffrey S and Spino, Cathie and
              Santagata, Sandro and Camelo-Piragua, Sandra and Ligon, Keith L
              and Sagher, Oren and Xie, X Sunney",
  abstract = "Surgery is an essential component in the treatment of brain
              tumors. However, delineating tumor from normal brain remains a
              major challenge. We describe the use of stimulated Raman
              scattering (SRS) microscopy for differentiating healthy human and
              mouse brain tissue from tumor-infiltrated brain based on
              histoarchitectural and biochemical differences. Unlike
              traditional histopathology, SRS is a label-free technique that
              can be rapidly performed in situ. SRS microscopy was able to
              differentiate tumor from nonneoplastic tissue in an infiltrative
              human glioblastoma xenograft mouse model based on their different
              Raman spectra. We further demonstrated a correlation between SRS
              and hematoxylin and eosin microscopy for detection of glioma
              infiltration ($\kappa$ = 0.98). Finally, we applied SRS
              microscopy in vivo in mice during surgery to reveal tumor margins
              that were undetectable under standard operative conditions. By
              providing rapid intraoperative assessment of brain tissue, SRS
              microscopy may ultimately improve the safety and accuracy of
              surgeries where tumor boundaries are visually indistinct.",
  journal  = "Sci. Transl. Med.",
  volume   =  5,
  number   =  201,
  pages    = "201ra119",
  month    =  sep,
  year     =  2013,
  keywords = "SRS\_imaging",
  language = "en"
}

@ARTICLE{Ji2015-uz,
  title    = "Detection of human brain tumor infiltration with quantitative
              stimulated Raman scattering microscopy",
  author   = "Ji, Minbiao and Lewis, Spencer and Camelo-Piragua, Sandra and
              Ramkissoon, Shakti H and Snuderl, Matija and Venneti, Sriram and
              Fisher-Hubbard, Amanda and Garrard, Mia and Fu, Dan and Wang,
              Anthony C and Heth, Jason A and Maher, Cormac O and Sanai, Nader
              and Johnson, Timothy D and Freudiger, Christian W and Sagher,
              Oren and Xie, Xiaoliang Sunney and Orringer, Daniel A",
  abstract = "Differentiating tumor from normal brain is a major barrier to
              achieving optimal outcome in brain tumor surgery. New imaging
              techniques for visualizing tumor margins during surgery are
              needed to improve surgical results. We recently demonstrated the
              ability of stimulated Raman scattering (SRS) microscopy, a
              nondestructive, label-free optical method, to reveal glioma
              infiltration in animal models. We show that SRS reveals human
              brain tumor infiltration in fresh, unprocessed surgical specimens
              from 22 neurosurgical patients. SRS detects tumor infiltration in
              near-perfect agreement with standard hematoxylin and eosin light
              microscopy ($\kappa$ = 0.86). The unique chemical contrast
              specific to SRS microscopy enables tumor detection by revealing
              quantifiable alterations in tissue cellularity, axonal density,
              and protein/lipid ratio in tumor-infiltrated tissues. To ensure
              that SRS microscopic data can be easily used in brain tumor
              surgery, without the need for expert interpretation, we created a
              classifier based on cellularity, axonal density, and
              protein/lipid ratio in SRS images capable of detecting tumor
              infiltration with 97.5\% sensitivity and 98.5\% specificity.
              Quantitative SRS microscopy detects the spread of tumor cells,
              even in brain tissue surrounding a tumor that appears grossly
              normal. By accurately revealing tumor infiltration, quantitative
              SRS microscopy holds potential for improving the accuracy of
              brain tumor surgery.",
  journal  = "Sci. Transl. Med.",
  volume   =  7,
  number   =  309,
  pages    = "309ra163",
  month    =  oct,
  year     =  2015,
  keywords = "SRS\_imaging",
  language = "en"
}

@ARTICLE{Orringer2017-nn,
  title    = "Rapid intraoperative histology of unprocessed surgical specimens
              via fibre-laser-based stimulated Raman scattering microscopy",
  author   = "Orringer, Daniel A and Pandian, Balaji and Niknafs, Yashar S and
              Hollon, Todd C and Boyle, Julianne and Lewis, Spencer and
              Garrard, Mia and Hervey-Jumper, Shawn L and Garton, Hugh J L and
              Maher, Cormac O and Heth, Jason A and Sagher, Oren and Wilkinson,
              D Andrew and Snuderl, Matija and Venneti, Sriram and Ramkissoon,
              Shakti H and McFadden, Kathryn A and Fisher-Hubbard, Amanda and
              Lieberman, Andrew P and Johnson, Timothy D and Xie, X Sunney and
              Trautman, Jay K and Freudiger, Christian W and Camelo-Piragua,
              Sandra",
  abstract = "Conventional methods for intraoperative histopathologic diagnosis
              are labour- and time-intensive, and may delay decision-making
              during brain-tumour surgery. Stimulated Raman scattering (SRS)
              microscopy, a label-free optical process, has been shown to
              rapidly detect brain-tumour infiltration in fresh, unprocessed
              human tissues. Here, we demonstrate the first application of SRS
              microscopy in the operating room by using a portable
              fibre-laser-based microscope and unprocessed specimens from 101
              neurosurgical patients. We also introduce an image-processing
              method - stimulated Raman histology (SRH) - which leverages SRS
              images to create virtual haematoxylin-and-eosin-stained slides,
              revealing essential diagnostic features. In a simulation of
              intraoperative pathologic consultation in 30 patients, we found a
              remarkable concordance of SRH and conventional histology for
              predicting diagnosis (Cohen's kappa, $\kappa$ > 0.89), with
              accuracy exceeding 92\%. We also built and validated a multilayer
              perceptron based on quantified SRH image attributes that predicts
              brain-tumour subtype with 90\% accuracy. Our findings provide
              insight into how SRH can now be used to improve the surgical care
              of brain tumour patients.",
  journal  = "Nat Biomed Eng",
  volume   =  1,
  month    =  feb,
  year     =  2017,
  keywords = "SRS\_imaging;My\_papers",
  language = "en"
}

@INCOLLECTION{Krizhevsky2012-ik,
  title     = "{ImageNet} Classification with Deep Convolutional Neural
               Networks",
  booktitle = "Advances in Neural Information Processing Systems 25",
  author    = "Krizhevsky, Alex and Sutskever, Ilya and Hinton, Geoffrey E",
  editor    = "Pereira, F and Burges, C J C and Bottou, L and Weinberger, K Q",
  publisher = "Curran Associates, Inc.",
  pages     = "1097--1105",
  year      =  2012,
  keywords  = "ConvNets"
}

@ARTICLE{Liu2017-tb,
  title         = "Detecting Cancer Metastases on Gigapixel Pathology Images",
  author        = "Liu, Yun and Gadepalli, Krishna and Norouzi, Mohammad and
                   Dahl, George E and Kohlberger, Timo and Boyko, Aleksey and
                   Venugopalan, Subhashini and Timofeev, Aleksei and Nelson,
                   Philip Q and Corrado, Greg S and Hipp, Jason D and Peng,
                   Lily and Stumpe, Martin C",
  abstract      = "Each year, the treatment decisions for more than 230,000
                   breast cancer patients in the U.S. hinge on whether the
                   cancer has metastasized away from the breast. Metastasis
                   detection is currently performed by pathologists reviewing
                   large expanses of biological tissues. This process is labor
                   intensive and error-prone. We present a framework to
                   automatically detect and localize tumors as small as 100 x
                   100 pixels in gigapixel microscopy images sized 100,000 x
                   100,000 pixels. Our method leverages a convolutional neural
                   network (CNN) architecture and obtains state-of-the-art
                   results on the Camelyon16 dataset in the challenging
                   lesion-level tumor detection task. At 8 false positives per
                   image, we detect 92.4\% of the tumors, relative to 82.7\% by
                   the previous best automated approach. For comparison, a
                   human pathologist attempting exhaustive search achieved
                   73.2\% sensitivity. We achieve image-level AUC scores above
                   97\% on both the Camelyon16 test set and an independent set
                   of 110 slides. In addition, we discover that two slides in
                   the Camelyon16 training set were erroneously labeled normal.
                   Our approach could considerably reduce false negative rates
                   in metastasis detection.",
  month         =  mar,
  year          =  2017,
  keywords      = "Histology/Pathology",
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1703.02442"
}

@ARTICLE{Ostrom2017-qg,
  title    = "{CBTRUS} Statistical Report: Primary brain and other central
              nervous system tumors diagnosed in the United States in 2010-2014",
  author   = "Ostrom, Quinn T and Gittleman, Haley and Liao, Peter and
              Vecchione-Koval, Toni and Wolinsky, Yingli and Kruchko, Carol and
              Barnholtz-Sloan, Jill S",
  journal  = "Neuro. Oncol.",
  volume   =  19,
  number   = "suppl\_5",
  pages    = "v1--v88",
  month    =  nov,
  year     =  2017,
  keywords = "Neurooncology",
  language = "en"
}

@ARTICLE{Freudiger2014-nw,
  title    = "Stimulated Raman Scattering Microscopy with a Robust Fibre Laser
              Source",
  author   = "Freudiger, Christian W and Yang, Wenlong and Holtom, Gary R and
              Peyghambarian, Nasser and Xie, X Sunney and Kieu, Khanh Q",
  abstract = "Stimulated Raman Scattering microscopy allows label-free chemical
              imaging and has enabled exciting applications in biology,
              material science, and medicine. It provides a major advantage in
              imaging speed over spontaneous Raman scattering and has improved
              image contrast and spectral fidelity compared to coherent
              anti-Stokes Raman. Wider adoption of the technique has, however,
              been hindered by the need for a costly and environmentally
              sensitive tunable ultra-fast dual-wavelength source. We present
              the development of an optimized all-fibre laser system based on
              the optical synchronization of two picosecond power amplifiers.
              To circumvent the high-frequency laser noise intrinsic to
              amplified fibre lasers, we have further developed a high-speed
              noise cancellation system based on voltage-subtraction
              autobalanced detection. We demonstrate uncompromised imaging
              performance of our fibre-laser based stimulated Raman scattering
              microscope with shot-noise limited sensitivity and an imaging
              speed up to 1 frame/s.",
  journal  = "Nat. Photonics",
  volume   =  8,
  number   =  2,
  pages    = "153--159",
  month    =  feb,
  year     =  2014,
  keywords = "SRS\_imaging",
  language = "en"
}

@ARTICLE{Coudray2018-mp,
  title    = "Classification and mutation prediction from non--small cell lung
              cancer histopathology images using deep learning",
  author   = "Coudray, Nicolas and Ocampo, Paolo Santiago and Sakellaropoulos,
              Theodore and Narula, Navneet and Snuderl, Matija and Feny{\"o},
              David and Moreira, Andre L and Razavian, Narges and Tsirigos,
              Aristotelis",
  abstract = "Visual inspection of histopathology slides is one of the main
              methods used by pathologists to assess the stage, type and
              subtype of lung tumors. Adenocarcinoma (LUAD) and squamous cell
              carcinoma (LUSC) are the most prevalent subtypes of lung cancer,
              and their distinction requires visual inspection by an
              experienced pathologist. In this study, we trained a deep
              convolutional neural network (inception v3) on whole-slide images
              obtained from The Cancer Genome Atlas to accurately and
              automatically classify them into LUAD, LUSC or normal lung
              tissue. The performance of our method is comparable to that of
              pathologists, with an average area under the curve (AUC) of 0.97.
              Our model was validated on independent datasets of frozen
              tissues, formalin-fixed paraffin-embedded tissues and biopsies.
              Furthermore, we trained the network to predict the ten most
              commonly mutated genes in LUAD. We found that six of
              them---STK11, EGFR, FAT1, SETBP1, KRAS and TP53---can be
              predicted from pathology images, with AUCs from 0.733 to 0.856 as
              measured on a held-out population. These findings suggest that
              deep-learning models can assist pathologists in the detection of
              cancer subtype or gene mutations. Our approach can be applied to
              any cancer type, and the code is available at
              https://github.com/ncoudray/DeepPATH.",
  journal  = "Nat. Med.",
  volume   =  24,
  number   =  10,
  pages    = "1559--1567",
  month    =  oct,
  year     =  2018,
  keywords = "AI\_healthcare"
}

@ARTICLE{Litjens2016-rt,
  title    = "Deep learning as a tool for increased accuracy and efficiency of
              histopathological diagnosis",
  author   = "Litjens, Geert and S{\'a}nchez, Clara I and Timofeeva, Nadya and
              Hermsen, Meyke and Nagtegaal, Iris and Kovacs, Iringo and
              Hulsbergen-van de Kaa, Christina and Bult, Peter and van
              Ginneken, Bram and van der Laak, Jeroen",
  abstract = "Pathologists face a substantial increase in workload and
              complexity of histopathologic cancer diagnosis due to the advent
              of personalized medicine. Therefore, diagnostic protocols have to
              focus equally on efficiency and accuracy. In this paper we
              introduce 'deep learning' as a technique to improve the
              objectivity and efficiency of histopathologic slide analysis.
              Through two examples, prostate cancer identification in biopsy
              specimens and breast cancer metastasis detection in sentinel
              lymph nodes, we show the potential of this new methodology to
              reduce the workload for pathologists, while at the same time
              increasing objectivity of diagnoses. We found that all slides
              containing prostate cancer and micro- and macro-metastases of
              breast cancer could be identified automatically while 30-40\% of
              the slides containing benign and normal tissue could be excluded
              without the use of any additional immunohistochemical markers or
              human intervention. We conclude that 'deep learning' holds great
              promise to improve the efficacy of prostate cancer diagnosis and
              breast cancer staging.",
  journal  = "Sci. Rep.",
  volume   =  6,
  pages    = "26286",
  month    =  may,
  year     =  2016,
  keywords = "AI\_healthcare",
  language = "en"
}

@ARTICLE{Qin2018-ls,
  title    = "How convolutional neural networks see the world --- A survey of
              convolutional neural network visualization methods",
  author   = "Qin, Zhuwei and Yu, Fuxun and Liu, Chenchen and Chen, Xiang and
              {,George Mason University, 4400 University Dr, Fairfax, VA 22030,
              USA} and {,Clarkson University, 8 Clarkson Ave, Potsdam, NY
              13699, USA}",
  journal  = "Mathematical Foundations of Computing",
  volume   =  1,
  number   =  2,
  pages    = "149--180",
  year     =  2018,
  keywords = "Visualization\_neuralnets"
}

@ARTICLE{Ratnavelu2016-ru,
  title    = "Intraoperative frozen section analysis for the diagnosis of early
              stage ovarian cancer in suspicious pelvic masses",
  author   = "Ratnavelu, Nithya D G and Brown, Andrew P and Mallett, Susan and
              Scholten, Rob J P M and Patel, Amit and Founta, Christina and
              Galaal, Khadra and Cross, Paul and Naik, Raj",
  abstract = "BACKGROUND: Women with suspected early-stage ovarian cancer need
              surgical staging which involves taking samples from areas within
              the abdominal cavity and retroperitoneal lymph nodes in order to
              inform further treatment. One potential strategy is to surgically
              stage all women with suspicious ovarian masses, without any
              histological information during surgery. This avoids incomplete
              staging, but puts more women at risk of potential surgical
              over-treatment.A second strategy is to perform a two-stage
              procedure to remove the pelvic mass and subject it to paraffin
              sectioning, which involves formal tissue fixing with formalin and
              paraffin embedding, prior to ultrathin sectioning and multiple
              site sampling of the tumour. Surgeons may then base further
              surgical staging on this histology, reducing the rate of
              over-treatment, but conferring additional surgical and
              anaesthetic morbidity.A third strategy is to perform a rapid
              histological analysis on the ovarian mass during surgery, known
              as 'frozen section'. Tissues are snap frozen to allow fine tissue
              sections to be cut and basic histochemical staining to be
              performed. Surgeons can perform or avoid the full surgical
              staging procedure depending on the results. However, this is a
              relatively crude test compared to paraffin sections, which take
              many hours to perform. With frozen section there is therefore a
              risk of misdiagnosing malignancy and understaging women
              subsequently found to have a presumed early-stage malignancy
              (false negative), or overstaging women without a malignancy
              (false positive). Therefore it is important to evaluate the
              accuracy and usefulness of adding frozen section to the clinical
              decision-making process. OBJECTIVES: To assess the diagnostic
              test accuracy of frozen section (index test) to diagnose
              histopathological ovarian cancer in women with suspicious pelvic
              masses as verified by paraffin section (reference standard).
              SEARCH METHODS: We searched MEDLINE (January 1946 to January
              2015), EMBASE (January 1980 to January 2015) and relevant
              Cochrane registers. SELECTION CRITERIA: Studies that used frozen
              section for intraoperative diagnosis of ovarian masses suspicious
              of malignancy, provided there was sufficient data to construct 2
              x 2 tables. We excluded articles without an available English
              translation. DATA COLLECTION AND ANALYSIS: Authors independently
              assessed the methodological quality of included studies using the
              Quality Assessment of Diagnostic Accuracy Studies tool (QUADAS-2)
              domains: patient selection, index test, reference standard, flow
              and timing. Data extraction converted 3 x 3 tables of per patient
              results presented in articles into 2 x 2 tables, for two index
              test thresholds. MAIN RESULTS: All studies were retrospective,
              and the majority reported consecutive sampling of cases.
              Sensitivity and specificity results were available from 38
              studies involving 11,181 participants (3200 with invasive cancer,
              1055 with borderline tumours and 6926 with benign tumours,
              determined by paraffin section as the reference standard). The
              median prevalence of malignancy was 29\% (interquartile range
              (IQR) 23\% to 36\%, range 11\% to 63\%). We assessed test
              performance using two thresholds for the frozen section test.
              Firstly, we used a test threshold for frozen sections, defining
              positive test results as invasive cancer and negative test
              results as borderline and benign tumours. The average sensitivity
              was 90.0\% (95\% confidence interval (CI) 87.6\% to 92.0\%; with
              most studies typically reporting range of 71\% to 100\%), and
              average specificity was 99.5\% (95\% CI 99.2\% to 99.7\%; range
              96\% to 100\%).Similarly, we analysed sensitivity and specificity
              using a second threshold for frozen section, where both invasive
              cancer and borderline tumours were considered test positive and
              benign cases were classified as negative. Average sensitivity was
              96.5\% (95\% CI 95.5\% to 97.3\%; typical range 83\% to 100\%),
              and average specificity was 89.5\% (95\% CI 86.6\% to 91.9\%;
              typical range 58\% to 99\%).Results were available from the same
              38 studies, including the subset of 3953 participants with a
              frozen section result of either borderline or invasive cancer,
              based on final diagnosis of malignancy. Studies with small
              numbers of disease-negative cases (borderline cases) had more
              variation in estimates of specificity. Average sensitivity was
              94.0\% (95\% CI 92.0\% to 95.5\%; range 73\% to 100\%), and
              average specificity was 95.8\% (95\% CI 92.4\% to 97.8\%; typical
              range 81\% to 100\%).Our additional analyses showed that, if the
              frozen section showed a benign or invasive cancer, the final
              diagnosis would remain the same in, on average, 94\% and 99\% of
              cases, respectively.In cases where the frozen section diagnosis
              was a borderline tumour, on average 21\% of the final diagnoses
              would turn out to be invasive cancer.In three studies, the same
              pathologist interpreted the index and reference standard tests,
              potentially causing bias. No studies reported blinding
              pathologists to index test results when reporting paraffin
              sections.In heterogeneity analyses, there were no statistically
              significant differences between studies with pathologists of
              different levels of expertise. AUTHORS' CONCLUSIONS: In a
              hypothetical population of 1000 patients (290 with cancer and 80
              with a borderline tumour), if a frozen section positive test
              result for invasive cancer alone was used to diagnose cancer, on
              average 261 women would have a correct diagnosis of a cancer, and
              706 women would be correctly diagnosed without a cancer. However,
              4 women would be incorrectly diagnosed with a cancer (false
              positive), and 29 with a cancer would be missed (false
              negative).If a frozen section result of either an invasive cancer
              or a borderline tumour was used as a positive test to diagnose
              cancer, on average 280 women would be correctly diagnosed with a
              cancer and 635 would be correctly diagnosed without. However, 75
              women would be incorrectly diagnosed with a cancer and 10 women
              with a cancer would be missed.The largest discordance is within
              the reporting of frozen section borderline tumours. Investigation
              into factors leading to discordance within centres and
              standardisation of criteria for reporting borderline tumours may
              help improve accuracy. Some centres may choose to perform
              surgical staging in women with frozen section diagnosis of a
              borderline ovarian tumour to reduce the number of false
              positives. In their interpretation of this review, readers should
              evaluate results from studies most typical of their population of
              patients.",
  journal  = "Cochrane Database Syst. Rev.",
  volume   =  3,
  pages    = "CD010360",
  month    =  mar,
  year     =  2016,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{He2016-tr,
  title     = "Deep residual learning for image recognition",
  author    = "He, K and Zhang, X and Ren, S and Sun, J",
  abstract  = "Deeper neural networks are more difficult to train. We present a
               residual learning framework to ease the training of networks
               that are substantially deeper than those used previously. We
               explicitly reformulate the layers as learning residual functions
               with reference to the layer â€¦",
  journal   = "Proc. IAPR Int. Conf. Pattern Recogn.",
  publisher = "cv-foundation.org",
  year      =  2016,
  keywords  = "ConvNets"
}

@ARTICLE{Kohe2017-yo,
  title    = "Immunohistochemical staining of lipid droplets with adipophilin
              in paraffin-embedded glioma tissue identifies an association
              between lipid droplets and tumour grade",
  author   = "Kohe, Sarah and Colmenero, Isabel and McConville, Carmel and
              Peet, Andrew",
  journal  = "J Histol Histopathol",
  volume   =  4,
  number   =  1,
  pages    = "4",
  year     =  2017,
  keywords = "SRS\_imaging"
}

@ARTICLE{Li2017-yn,
  title         = "Visualizing the Loss Landscape of Neural Nets",
  author        = "Li, Hao and Xu, Zheng and Taylor, Gavin and Studer,
                   Christoph and Goldstein, Tom",
  abstract      = "Neural network training relies on our ability to find
                   ``good'' minimizers of highly non-convex loss functions. It
                   is well-known that certain network architecture designs
                   (e.g., skip connections) produce loss functions that train
                   easier, and well-chosen training parameters (batch size,
                   learning rate, optimizer) produce minimizers that generalize
                   better. However, the reasons for these differences, and
                   their effects on the underlying loss landscape, are not well
                   understood. In this paper, we explore the structure of
                   neural loss functions, and the effect of loss landscapes on
                   generalization, using a range of visualization methods.
                   First, we introduce a simple ``filter normalization'' method
                   that helps us visualize loss function curvature and make
                   meaningful side-by-side comparisons between loss functions.
                   Then, using a variety of visualizations, we explore how
                   network architecture affects the loss landscape, and how
                   training parameters affect the shape of minimizers.",
  month         =  dec,
  year          =  2017,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "1712.09913"
}

@ARTICLE{Viola2012-zs,
  title    = "Mohs micrographic surgery and surgical excision for nonmelanoma
              skin cancer treatment in the Medicare population",
  author   = "Viola, Kate V and Jhaveri, Mamta B and Soulos, Pamela R and
              Turner, Ryan B and Tolpinrud, Whitney L and Doshi, Daven and
              Gross, Cary P",
  abstract = "OBJECTIVES: To identify Medicare use rates of Mohs micrographic
              surgery (MMS) and surgical excision for the treatment of
              nonmelanoma skin cancer (NMSC) and to identify patient, lesion,
              and geographic characteristics associated with treatment type.
              DESIGN: A retrospective analysis of Medicare beneficiaries.
              SETTING: Surveillance, Epidemiology, and End Results database.
              PATIENTS: Patients undergoing MMS or other surgical intervention
              for the treatment of NMSC from January 1, 2001, through December
              31, 2006. MAIN OUTCOME MEASURES: Surgical treatment, patient, and
              lesion characteristics. RESULTS: A total of 26,931 operations
              were performed for the treatment of NMSC from 2001 through 2006,
              of which 36.4\% were MMS. Although the rate of surgical excision
              slightly increased during this period (1.8 vs 2.1 per 100
              Medicare beneficiaries), the rate of MMS doubled (0.75 vs 1.5 per
              100 Medicare beneficiaries). In 46.9\% of facial lesions, MMS was
              performed, whereas MMS was used to treat 14.7\% of total body
              lesions. Atlanta, Georgia, had the highest proportion of patients
              treated with MMS (45.1\%); Louisiana had the lowest (11.0\%).
              Age, race, lesion location, and area of country for patient
              treatment were significantly associated with MMS use (all P <
              .001). CONCLUSIONS: Surgical treatment of NMSC increased
              substantially from 2001 through 2006, primarily because of a
              doubling in the rate of MMS procedures. Significant differences
              in surgical rates, depending on patient age, race, lesion
              location, and geographic region, of treatment were found.",
  journal  = "Arch. Dermatol.",
  volume   =  148,
  number   =  4,
  pages    = "473--477",
  month    =  apr,
  year     =  2012,
  language = "en"
}

@ARTICLE{Sottoriva2013-qa,
  title    = "Intratumor heterogeneity in human glioblastoma reflects cancer
              evolutionary dynamics",
  author   = "Sottoriva, Andrea and Spiteri, Inmaculada and Piccirillo, Sara G
              M and Touloumis, Anestis and Collins, V Peter and Marioni, John C
              and Curtis, Christina and Watts, Colin and Tavar{\'e}, Simon",
  abstract = "Glioblastoma (GB) is the most common and aggressive primary brain
              malignancy, with poor prognosis and a lack of effective
              therapeutic options. Accumulating evidence suggests that
              intratumor heterogeneity likely is the key to understanding
              treatment failure. However, the extent of intratumor
              heterogeneity as a result of tumor evolution is still poorly
              understood. To address this, we developed a unique surgical
              multisampling scheme to collect spatially distinct tumor
              fragments from 11 GB patients. We present an integrated genomic
              analysis that uncovers extensive intratumor heterogeneity, with
              most patients displaying different GB subtypes within the same
              tumor. Moreover, we reconstructed the phylogeny of the fragments
              for each patient, identifying copy number alterations in EGFR and
              CDKN2A/B/p14ARF as early events, and aberrations in PDGFRA and
              PTEN as later events during cancer progression. We also
              characterized the clonal organization of each tumor fragment at
              the single-molecule level, detecting multiple coexisting cell
              lineages. Our results reveal the genome-wide architecture of
              intratumor variability in GB across multiple spatial scales and
              patient-specific patterns of cancer evolution, with consequences
              for treatment design.",
  journal  = "Proc. Natl. Acad. Sci. U. S. A.",
  volume   =  110,
  number   =  10,
  pages    = "4009--4014",
  month    =  mar,
  year     =  2013,
  language = "en"
}

@ARTICLE{Dammers2010-wf,
  title    = "Towards improving the safety and diagnostic yield of stereotactic
              biopsy in a single centre",
  author   = "Dammers, Ruben and Schouten, Joost W and Haitsma, Iain K and
              Vincent, Arnaud J P E and Kros, Johan M and Dirven, Clemens M F",
  abstract = "BACKGROUND: Previously, we reported on our single centre results
              regarding the diagnostic yield of stereotactic needle biopsies of
              brain lesions. The yield then (1996-2006) was 89.4\%. In the
              present study, we review and evaluate our experience with
              intraoperative frozen-section histopathologic diagnosis on-demand
              in order to improve the diagnostic yield. METHODS: One hundred
              sixty-four consecutive frameless biopsy procedures in 160
              patients (group 1, 2006-2010) were compared with the historic
              control group (group 2, n = 164 frameless biopsy procedures).
              Diagnostic yield, as well as demographics, morbidity and
              mortality, was compared. Statistical analysis was performed by
              Student's t, Mann-Whitney U, Chi-square test and backward
              logistic regression when appropriate. RESULTS: Demographics were
              comparable. In group 1, a non-diagnostic tissue specimen was
              obtained in 1.8\%, compared to 11.0\% in group 2 (p = 0.001).
              Also, both the operating time and the number of biopsies needed
              were decreased significantly. Procedure-related mortality
              decreased from 3.7\% to 0.6\% (p = 0.121). Multivariate analysis
              only proved operating time (odds ratio (OR), 1.012; 95\%
              confidence interval (CI), 1.000-1.025; p = 0.043), a right-sided
              lesion (OR, 3.183; 95\% CI, 1.217-8.322; p = 0.018) and on-demand
              intraoperative histology (OR, 0.175; 95\% CI, 0.050-0.618; p =
              0.007) important factors predicting non-diagnostic biopsies.
              CONCLUSIONS: The importance of a reliable pathological diagnosis
              as obtained by biopsy must not be underestimated. We believe that
              when performing stereotactic biopsy for intracranial lesions,
              next to minimising morbidity, one should strive for as high a
              positive yield as possible. In the present single centre
              retrospective series, we have shown that using a standardised
              procedure and careful on-demand intraoperative frozen-section
              analysis can improve the diagnostic yield of stereotactic brain
              biopsy procedures as compared to a historical series.",
  journal  = "Acta Neurochir.",
  volume   =  152,
  number   =  11,
  pages    = "1915--1921",
  month    =  nov,
  year     =  2010,
  language = "en"
}

@ARTICLE{Cancer_Genome_Atlas_Research_Network2015-ms,
  title    = "Comprehensive, Integrative Genomic Analysis of Diffuse
              {Lower-Grade} Gliomas",
  author   = "{Cancer Genome Atlas Research Network} and Brat, Daniel J and
              Verhaak, Roel G W and Aldape, Kenneth D and Yung, W K Alfred and
              Salama, Sofie R and Cooper, Lee A D and Rheinbay, Esther and
              Miller, C Ryan and Vitucci, Mark and Morozova, Olena and
              Robertson, A Gordon and Noushmehr, Houtan and Laird, Peter W and
              Cherniack, Andrew D and Akbani, Rehan and Huse, Jason T and
              Ciriello, Giovanni and Poisson, Laila M and Barnholtz-Sloan, Jill
              S and Berger, Mitchel S and Brennan, Cameron and Colen, Rivka R
              and Colman, Howard and Flanders, Adam E and Giannini, Caterina
              and Grifford, Mia and Iavarone, Antonio and Jain, Rajan and
              Joseph, Isaac and Kim, Jaegil and Kasaian, Katayoon and
              Mikkelsen, Tom and Murray, Bradley A and O'Neill, Brian Patrick
              and Pachter, Lior and Parsons, Donald W and Sougnez, Carrie and
              Sulman, Erik P and Vandenberg, Scott R and Van Meir, Erwin G and
              von Deimling, Andreas and Zhang, Hailei and Crain, Daniel and
              Lau, Kevin and Mallery, David and Morris, Scott and Paulauskis,
              Joseph and Penny, Robert and Shelton, Troy and Sherman, Mark and
              Yena, Peggy and Black, Aaron and Bowen, Jay and Dicostanzo, Katie
              and Gastier-Foster, Julie and Leraas, Kristen M and Lichtenberg,
              Tara M and Pierson, Christopher R and Ramirez, Nilsa C and
              Taylor, Cynthia and Weaver, Stephanie and Wise, Lisa and Zmuda,
              Erik and Davidsen, Tanja and Demchok, John A and Eley, Greg and
              Ferguson, Martin L and Hutter, Carolyn M and Mills Shaw, Kenna R
              and Ozenberger, Bradley A and Sheth, Margi and Sofia, Heidi J and
              Tarnuzzer, Roy and Wang, Zhining and Yang, Liming and Zenklusen,
              Jean Claude and Ayala, Brenda and Baboud, Julien and Chudamani,
              Sudha and Jensen, Mark A and Liu, Jia and Pihl, Todd and Raman,
              Rohini and Wan, Yunhu and Wu, Ye and Ally, Adrian and Auman, J
              Todd and Balasundaram, Miruna and Balu, Saianand and Baylin,
              Stephen B and Beroukhim, Rameen and Bootwalla, Moiz S and Bowlby,
              Reanne and Bristow, Christopher A and Brooks, Denise and
              Butterfield, Yaron and Carlsen, Rebecca and Carter, Scott and
              Chin, Lynda and Chu, Andy and Chuah, Eric and Cibulskis, Kristian
              and Clarke, Amanda and Coetzee, Simon G and Dhalla, Noreen and
              Fennell, Tim and Fisher, Sheila and Gabriel, Stacey and Getz, Gad
              and Gibbs, Richard and Guin, Ranabir and Hadjipanayis, Angela and
              Hayes, D Neil and Hinoue, Toshinori and Hoadley, Katherine and
              Holt, Robert A and Hoyle, Alan P and Jefferys, Stuart R and
              Jones, Steven and Jones, Corbin D and Kucherlapati, Raju and Lai,
              Phillip H and Lander, Eric and Lee, Semin and Lichtenstein, Lee
              and Ma, Yussanne and Maglinte, Dennis T and Mahadeshwar, Harshad
              S and Marra, Marco A and Mayo, Michael and Meng, Shaowu and
              Meyerson, Matthew L and Mieczkowski, Piotr A and Moore, Richard A
              and Mose, Lisle E and Mungall, Andrew J and Pantazi, Angeliki and
              Parfenov, Michael and Park, Peter J and Parker, Joel S and Perou,
              Charles M and Protopopov, Alexei and Ren, Xiaojia and Roach,
              Jeffrey and Sabedot, Tha{\'\i}s S and Schein, Jacqueline and
              Schumacher, Steven E and Seidman, Jonathan G and Seth, Sahil and
              Shen, Hui and Simons, Janae V and Sipahimalani, Payal and
              Soloway, Matthew G and Song, Xingzhi and Sun, Huandong and Tabak,
              Barbara and Tam, Angela and Tan, Donghui and Tang, Jiabin and
              Thiessen, Nina and Triche, Jr, Timothy and Van Den Berg, David J
              and Veluvolu, Umadevi and Waring, Scot and Weisenberger, Daniel J
              and Wilkerson, Matthew D and Wong, Tina and Wu, Junyuan and Xi,
              Liu and Xu, Andrew W and Yang, Lixing and Zack, Travis I and
              Zhang, Jianhua and Aksoy, B Arman and Arachchi, Harindra and
              Benz, Chris and Bernard, Brady and Carlin, Daniel and Cho, Juok
              and DiCara, Daniel and Frazer, Scott and Fuller, Gregory N and
              Gao, Jianjiong and Gehlenborg, Nils and Haussler, David and
              Heiman, David I and Iype, Lisa and Jacobsen, Anders and Ju,
              Zhenlin and Katzman, Sol and Kim, Hoon and Knijnenburg, Theo and
              Kreisberg, Richard Bailey and Lawrence, Michael S and Lee,
              William and Leinonen, Kalle and Lin, Pei and Ling, Shiyun and
              Liu, Wenbin and Liu, Yingchun and Liu, Yuexin and Lu, Yiling and
              Mills, Gordon and Ng, Sam and Noble, Michael S and Paull, Evan
              and Rao, Arvind and Reynolds, Sheila and Saksena, Gordon and
              Sanborn, Zack and Sander, Chris and Schultz, Nikolaus and
              Senbabaoglu, Yasin and Shen, Ronglai and Shmulevich, Ilya and
              Sinha, Rileen and Stuart, Josh and Sumer, S Onur and Sun, Yichao
              and Tasman, Natalie and Taylor, Barry S and Voet, Doug and
              Weinhold, Nils and Weinstein, John N and Yang, Da and Yoshihara,
              Kosuke and Zheng, Siyuan and Zhang, Wei and Zou, Lihua and Abel,
              Ty and Sadeghi, Sara and Cohen, Mark L and Eschbacher, Jenny and
              Hattab, Eyas M and Raghunathan, Aditya and Schniederjan, Matthew
              J and Aziz, Dina and Barnett, Gene and Barrett, Wendi and Bigner,
              Darell D and Boice, Lori and Brewer, Cathy and Calatozzolo,
              Chiara and Campos, Benito and Carlotti, Jr, Carlos Gilberto and
              Chan, Timothy A and Cuppini, Lucia and Curley, Erin and Cuzzubbo,
              Stefania and Devine, Karen and DiMeco, Francesco and Duell,
              Rebecca and Elder, J Bradley and Fehrenbach, Ashley and
              Finocchiaro, Gaetano and Friedman, William and Fulop, Jordonna
              and Gardner, Johanna and Hermes, Beth and Herold-Mende, Christel
              and Jungk, Christine and Kendler, Ady and Lehman, Norman L and
              Lipp, Eric and Liu, Ouida and Mandt, Randy and McGraw, Mary and
              Mclendon, Roger and McPherson, Christopher and Neder, Luciano and
              Nguyen, Phuong and Noss, Ardene and Nunziata, Raffaele and
              Ostrom, Quinn T and Palmer, Cheryl and Perin, Alessandro and
              Pollo, Bianca and Potapov, Alexander and Potapova, Olga and
              Rathmell, W Kimryn and Rotin, Daniil and Scarpace, Lisa and
              Schilero, Cathy and Senecal, Kelly and Shimmel, Kristen and
              Shurkhay, Vsevolod and Sifri, Suzanne and Singh, Rosy and Sloan,
              Andrew E and Smolenski, Kathy and Staugaitis, Susan M and Steele,
              Ruth and Thorne, Leigh and Tirapelli, Daniela P C and Unterberg,
              Andreas and Vallurupalli, Mahitha and Wang, Yun and Warnick,
              Ronald and Williams, Felicia and Wolinsky, Yingli and Bell, Sue
              and Rosenberg, Mara and Stewart, Chip and Huang, Franklin and
              Grimsby, Jonna L and Radenbaugh, Amie J and Zhang, Jianan",
  abstract = "BACKGROUND: Diffuse low-grade and intermediate-grade gliomas
              (which together make up the lower-grade gliomas, World Health
              Organization grades II and III) have highly variable clinical
              behavior that is not adequately predicted on the basis of
              histologic class. Some are indolent; others quickly progress to
              glioblastoma. The uncertainty is compounded by interobserver
              variability in histologic diagnosis. Mutations in IDH, TP53, and
              ATRX and codeletion of chromosome arms 1p and 19q (1p/19q
              codeletion) have been implicated as clinically relevant markers
              of lower-grade gliomas. METHODS: We performed genomewide analyses
              of 293 lower-grade gliomas from adults, incorporating exome
              sequence, DNA copy number, DNA methylation, messenger RNA
              expression, microRNA expression, and targeted protein expression.
              These data were integrated and tested for correlation with
              clinical outcomes. RESULTS: Unsupervised clustering of mutations
              and data from RNA, DNA-copy-number, and DNA-methylation platforms
              uncovered concordant classification of three robust,
              nonoverlapping, prognostically significant subtypes of
              lower-grade glioma that were captured more accurately by IDH,
              1p/19q, and TP53 status than by histologic class. Patients who
              had lower-grade gliomas with an IDH mutation and 1p/19q
              codeletion had the most favorable clinical outcomes. Their
              gliomas harbored mutations in CIC, FUBP1, NOTCH1, and the TERT
              promoter. Nearly all lower-grade gliomas with IDH mutations and
              no 1p/19q codeletion had mutations in TP53 (94\%) and ATRX
              inactivation (86\%). The large majority of lower-grade gliomas
              without an IDH mutation had genomic aberrations and clinical
              behavior strikingly similar to those found in primary
              glioblastoma. CONCLUSIONS: The integration of genomewide data
              from multiple platforms delineated three molecular classes of
              lower-grade gliomas that were more concordant with IDH, 1p/19q,
              and TP53 status than with histologic class. Lower-grade gliomas
              with an IDH mutation either had 1p/19q codeletion or carried a
              TP53 mutation. Most lower-grade gliomas without an IDH mutation
              were molecularly and clinically similar to glioblastoma. (Funded
              by the National Institutes of Health.).",
  journal  = "N. Engl. J. Med.",
  volume   =  372,
  number   =  26,
  pages    = "2481--2498",
  month    =  jun,
  year     =  2015,
  language = "en"
}

@ARTICLE{Wu2007-mm,
  title    = "Clinical evaluation and follow-up outcome of diffusion tensor
              imaging-based functional neuronavigation: a prospective,
              controlled study in patients with gliomas involving pyramidal
              tracts",
  author   = "Wu, Jin-Song and Zhou, Liang-Fu and Tang, Wei-Jun and Mao, Ying
              and Hu, Jin and Song, Yan-Yan and Hong, Xun-Ning and Du, Gu-Hong",
  abstract = "OBJECTIVE: To evaluate diffusion tensor imaging (DTI)-based
              functional neuronavigation in surgery of cerebral gliomas with
              pyramidal tract (PT) involvement with respect to both
              perioperative assessment and follow-up outcome. METHODS: A
              prospective, randomized controlled study was conducted between
              2001 and 2005. A consecutive series of 238 eligible patients with
              initial imaging diagnosis of cerebral gliomas involving PTs were
              randomized into study (n = 118) and control (n = 120) groups. The
              study cases underwent DTI and three-dimensional magnetic
              resonance imaging scans. The maps of fractional anisotropy were
              calculated for PT mapping. Both three-dimensional magnetic
              resonance imaging data sets and fractional anisotropy maps were
              integrated by rigid registration, after which the tumor and
              adjacent PT were segmented and reconstructed for presurgical
              planning and intraoperative guidance. The control cases were
              operated on using routine neuronavigation. RESULTS: There was a
              trend for high-grade gliomas (HGGs) in the study group to be more
              likely to achieve gross total resection (74.4 versus 33.3\%, P <
              0.001). There was no significant difference of low-grade gliomas
              resection between the two groups. Postoperative motor
              deterioration occurred in 32.8\% of control cases, whereas it
              occurred in only 15.3\% of the study cases (P < 0.001). The
              6-month Karnofsky Performance Scale score of study cases was
              significantly higher than that of control cases (86 +/- 20 versus
              74 +/- 28 overall, P < 0.001; 93 +/- 10 versus 86 +/- 17 for
              low-grade gliomas, P = 0.013; and 77 +/- 27 versus 53 +/- 32 for
              HGGs, P = 0.001). For 81 HGGs, the median survival of study cases
              was 21.2 months (95\% confidence interval, 14.1-28.3 mo) compared
              with 14.0 months (95\% confidence interval, 10.2-17.8 mo) of
              control cases (P = 0.048). The estimated hazard ratio for the
              effect of DTI-based functional neuronavigation was 0.570,
              representing a 43.0\% reduction in the risk of death. CONCLUSION:
              DTI-based functional neuronavigation contributes to maximal safe
              resection of cerebral gliomas with PT involvement, thereby
              decreasing postoperative motor deficits for both HGGs and
              low-grade gliomas while increasing high-quality survival for
              HGGs.",
  journal  = "Neurosurgery",
  volume   =  61,
  number   =  5,
  pages    = "935--48; discussion 948--9",
  month    =  nov,
  year     =  2007,
  language = "en"
}

@ARTICLE{Kingma2014-qk,
  title         = "Adam: A Method for Stochastic Optimization",
  author        = "Kingma, Diederik P and Ba, Jimmy",
  abstract      = "We introduce Adam, an algorithm for first-order
                   gradient-based optimization of stochastic objective
                   functions, based on adaptive estimates of lower-order
                   moments. The method is straightforward to implement, is
                   computationally efficient, has little memory requirements,
                   is invariant to diagonal rescaling of the gradients, and is
                   well suited for problems that are large in terms of data
                   and/or parameters. The method is also appropriate for
                   non-stationary objectives and problems with very noisy
                   and/or sparse gradients. The hyper-parameters have intuitive
                   interpretations and typically require little tuning. Some
                   connections to related algorithms, on which Adam was
                   inspired, are discussed. We also analyze the theoretical
                   convergence properties of the algorithm and provide a regret
                   bound on the convergence rate that is comparable to the best
                   known results under the online convex optimization
                   framework. Empirical results demonstrate that Adam works
                   well in practice and compares favorably to other stochastic
                   optimization methods. Finally, we discuss AdaMax, a variant
                   of Adam based on the infinity norm.",
  month         =  dec,
  year          =  2014,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "1412.6980"
}

@ARTICLE{Ronneberger2015-um,
  title         = "{U-Net}: Convolutional Networks for Biomedical Image
                   Segmentation",
  author        = "Ronneberger, Olaf and Fischer, Philipp and Brox, Thomas",
  abstract      = "There is large consent that successful training of deep
                   networks requires many thousand annotated training samples.
                   In this paper, we present a network and training strategy
                   that relies on the strong use of data augmentation to use
                   the available annotated samples more efficiently. The
                   architecture consists of a contracting path to capture
                   context and a symmetric expanding path that enables precise
                   localization. We show that such a network can be trained
                   end-to-end from very few images and outperforms the prior
                   best method (a sliding-window convolutional network) on the
                   ISBI challenge for segmentation of neuronal structures in
                   electron microscopic stacks. Using the same network trained
                   on transmitted light microscopy images (phase contrast and
                   DIC) we won the ISBI cell tracking challenge 2015 in these
                   categories by a large margin. Moreover, the network is fast.
                   Segmentation of a 512x512 image takes less than a second on
                   a recent GPU. The full implementation (based on Caffe) and
                   the trained networks are available at
                   http://lmb.informatik.uni-freiburg.de/people/ronneber/u-net
                   .",
  month         =  may,
  year          =  2015,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1505.04597"
}

@ARTICLE{Shelhamer2017-an,
  title    = "Fully Convolutional Networks for Semantic Segmentation",
  author   = "Shelhamer, Evan and Long, Jonathan and Darrell, Trevor",
  abstract = "Convolutional networks are powerful visual models that yield
              hierarchies of features. We show that convolutional networks by
              themselves, trained end-to-end, pixels-to-pixels, improve on the
              previous best result in semantic segmentation. Our key insight is
              to build ``fully convolutional'' networks that take input of
              arbitrary size and produce correspondingly-sized output with
              efficient inference and learning. We define and detail the space
              of fully convolutional networks, explain their application to
              spatially dense prediction tasks, and draw connections to prior
              models. We adapt contemporary classification networks (AlexNet,
              the VGG net, and GoogLeNet) into fully convolutional networks and
              transfer their learned representations by fine-tuning to the
              segmentation task. We then define a skip architecture that
              combines semantic information from a deep, coarse layer with
              appearance information from a shallow, fine layer to produce
              accurate and detailed segmentations. Our fully convolutional
              networks achieve improved segmentation of PASCAL VOC (30\%
              relative improvement to 67.2\% mean IU on 2012), NYUDv2, SIFT
              Flow, and PASCAL-Context, while inference takes one tenth of a
              second for a typical image.",
  journal  = "IEEE Trans. Pattern Anal. Mach. Intell.",
  volume   =  39,
  number   =  4,
  pages    = "640--651",
  month    =  apr,
  year     =  2017,
  language = "en"
}

@ARTICLE{Livermore2019-wy,
  title     = "Rapid intraoperative molecular genetic classification of gliomas
               using Raman spectroscopy",
  author    = "Livermore, Laurent James and Isabelle, Martin and Bell, Ian Mac
               and Scott, Connor and Walsby-Tickle, John and Gannon, Joan and
               Plaha, Puneet and Vallance, Claire and Ansorge, Olaf",
  abstract  = "AbstractBackground. The molecular genetic classification of
               gliomas, particularly the identification of isocitrate
               dehydrogenase (IDH) mutations, is critical f",
  journal   = "Neuro Oncol Adv",
  publisher = "Narnia",
  volume    =  1,
  number    =  1,
  month     =  may,
  year      =  2019,
  keywords  = "genetics, molecular; glioma; intraoperative care; spectrum
               analysis, raman; genetics; neoplasms; mutation;
               oligodendroglioma; astrocytoma; tissue specimen; isocitrate
               dehydrogenase; surgical procedures, operative; cell lines;
               biopsy; neurosurgical procedures"
}

@ARTICLE{Robboy2013-jk,
  title    = "Pathologist workforce in the United States: I. Development of a
              predictive model to examine factors influencing supply",
  author   = "Robboy, Stanley J and Weintraub, Sally and Horvath, Andrew E and
              Jensen, Bradden W and Alexander, C Bruce and Fody, Edward P and
              Crawford, James M and Clark, Jimmy R and Cantor-Weinberg, Julie
              and Joshi, Megha G and Cohen, Michael B and Prystowsky, Michael B
              and Bean, Sarah M and Gupta, Saurabh and Powell, Suzanne Z and
              Speights, Jr, V O and Gross, David J and Black-Schaffer, W
              Stephen",
  abstract = "CONTEXT: Results of prior pathology workforce surveys have varied
              between a state of equilibrium and predictions of shortage.
              OBJECTIVE: To assess the current and future supply of
              pathologists, and apply a dynamic modeling tool for assessing the
              effects of changing market forces and emerging technologies on
              the supply of pathologists' services through 2030. DESIGN: Data
              came from various sources, including the literature, College of
              American Pathologists' internal data, and primary research
              through custom-developed surveys for the membership and for
              pathology practice managers RESULTS: Through 2010, there were
              approximately 18 000 actively practicing pathologists in the
              United States (5.7 per 100 000 population), approximately 93\% of
              whom were board certified. Our model projects that the absolute
              and per capita numbers of practicing pathologists will decrease
              to approximately 14 000 full-time equivalent (FTE) pathologists
              or 3.7 per 100 000 in the coming 2 decades. This projection
              reflects that beginning in 2015, the numbers of pathologists
              retiring will increase precipitously, and is anticipated to peak
              by 2021. Including all types of separation, the net pathologist
              strength will begin falling by year 2015. Unless workforce entry
              or exit rates change, this trend will continue at least through
              2030. These changes reflect the closure of many training programs
              2 to 4 decades ago and the substantially decreased number of
              graduating residents. CONCLUSIONS: This comprehensive analysis
              predicts that pathologist numbers will decline steadily beginning
              in 2015. Anticipated population growth in general and increases
              in disease incidence owing to the aging population, to be
              presented in a companion article on demand, will lead to a net
              deficit in excess of more than 5700 FTE pathologists. To reach
              the projected need in pathologist numbers of nearly 20 000 FTE by
              2030 will require an increase from today of approximately 8.1\%
              more residency positions. We believe a pathologist shortage will
              negatively impact both patient access to laboratory services and
              health care providers' abilities to deliver more effective health
              care to their patient populations.",
  journal  = "Arch. Pathol. Lab. Med.",
  volume   =  137,
  number   =  12,
  pages    = "1723--1732",
  month    =  dec,
  year     =  2013,
  language = "en"
}

@ARTICLE{Gulshan2016-pn,
  title     = "Development and Validation of a Deep Learning Algorithm for
               Detection of Diabetic Retinopathy in Retinal Fundus Photographs",
  author    = "Gulshan, Varun and Peng, Lily and Coram, Marc and Stumpe, Martin
               C and Wu, Derek and Narayanaswamy, Arunachalam and Venugopalan,
               Subhashini and Widner, Kasumi and Madams, Tom and Cuadros, Jorge
               and Kim, Ramasamy and Raman, Rajiv and Nelson, Philip C and
               Mega, Jessica L and Webster, Dale R",
  abstract  = "Importance: Deep learning is a family of computational methods
               that allow an algorithm to program itself by learning from a
               large set of examples that demonstrate the desired behavior,
               removing the need to specify rules explicitly. Application of
               these methods to medical imaging requires further assessment and
               validation. Objective: To apply deep learning to create an
               algorithm for automated detection of diabetic retinopathy and
               diabetic macular edema in retinal fundus photographs. Design and
               Setting: A specific type of neural network optimized for image
               classification called a deep convolutional neural network was
               trained using a retrospective development data set of 128 175
               retinal images, which were graded 3 to 7 times for diabetic
               retinopathy, diabetic macular edema, and image gradability by a
               panel of 54 US licensed ophthalmologists and ophthalmology
               senior residents between May and December 2015. The resultant
               algorithm was validated in January and February 2016 using 2
               separate data sets, both graded by at least 7 US board-certified
               ophthalmologists with high intragrader consistency. Exposure:
               Deep learning-trained algorithm. Main Outcomes and Measures: The
               sensitivity and specificity of the algorithm for detecting
               referable diabetic retinopathy (RDR), defined as moderate and
               worse diabetic retinopathy, referable diabetic macular edema, or
               both, were generated based on the reference standard of the
               majority decision of the ophthalmologist panel. The algorithm
               was evaluated at 2 operating points selected from the
               development set, one selected for high specificity and another
               for high sensitivity. Results: The EyePACS-1 data set consisted
               of 9963 images from 4997 patients (mean age, 54.4 years; 62.2\%
               women; prevalence of RDR, 683/8878 fully gradable images
               [7.8\%]); the Messidor-2 data set had 1748 images from 874
               patients (mean age, 57.6 years; 42.6\% women; prevalence of RDR,
               254/1745 fully gradable images [14.6\%]). For detecting RDR, the
               algorithm had an area under the receiver operating curve of
               0.991 (95\% CI, 0.988-0.993) for EyePACS-1 and 0.990 (95\% CI,
               0.986-0.995) for Messidor-2. Using the first operating cut point
               with high specificity, for EyePACS-1, the sensitivity was 90.3\%
               (95\% CI, 87.5\%-92.7\%) and the specificity was 98.1\% (95\%
               CI, 97.8\%-98.5\%). For Messidor-2, the sensitivity was 87.0\%
               (95\% CI, 81.1\%-91.0\%) and the specificity was 98.5\% (95\%
               CI, 97.7\%-99.1\%). Using a second operating point with high
               sensitivity in the development set, for EyePACS-1 the
               sensitivity was 97.5\% and specificity was 93.4\% and for
               Messidor-2 the sensitivity was 96.1\% and specificity was
               93.9\%. Conclusions and Relevance: In this evaluation of retinal
               fundus photographs from adults with diabetes, an algorithm based
               on deep machine learning had high sensitivity and specificity
               for detecting referable diabetic retinopathy. Further research
               is necessary to determine the feasibility of applying this
               algorithm in the clinical setting and to determine whether use
               of the algorithm could lead to improved care and outcomes
               compared with current ophthalmologic assessment.",
  journal   = "JAMA",
  publisher = "jamanetwork.com",
  volume    =  316,
  number    =  22,
  pages     = "2402--2410",
  month     =  dec,
  year      =  2016,
  language  = "en"
}

@ARTICLE{Lee2018-mq,
  title         = "A Simple Unified Framework for Detecting
                   {Out-of-Distribution} Samples and Adversarial Attacks",
  author        = "Lee, Kimin and Lee, Kibok and Lee, Honglak and Shin, Jinwoo",
  abstract      = "Detecting test samples drawn sufficiently far away from the
                   training distribution statistically or adversarially is a
                   fundamental requirement for deploying a good classifier in
                   many real-world machine learning applications. However, deep
                   neural networks with the softmax classifier are known to
                   produce highly overconfident posterior distributions even
                   for such abnormal samples. In this paper, we propose a
                   simple yet effective method for detecting any abnormal
                   samples, which is applicable to any pre-trained softmax
                   neural classifier. We obtain the class conditional Gaussian
                   distributions with respect to (low- and upper-level)
                   features of the deep models under Gaussian discriminant
                   analysis, which result in a confidence score based on the
                   Mahalanobis distance. While most prior methods have been
                   evaluated for detecting either out-of-distribution or
                   adversarial samples, but not both, the proposed method
                   achieves the state-of-the-art performances for both cases in
                   our experiments. Moreover, we found that our proposed method
                   is more robust in harsh cases, e.g., when the training
                   dataset has noisy labels or small number of samples.
                   Finally, we show that the proposed method enjoys broader
                   usage by applying it to class-incremental learning: whenever
                   out-of-distribution samples are detected, our classification
                   rule can incorporate new classes well without further
                   training deep models.",
  month         =  jul,
  year          =  2018,
  archivePrefix = "arXiv",
  primaryClass  = "stat.ML",
  eprint        = "1807.03888"
}

@INPROCEEDINGS{Zeiler2014-rr,
  title     = "Visualizing and Understanding Convolutional Networks",
  booktitle = "Computer Vision -- {ECCV} 2014",
  author    = "Zeiler, Matthew D and Fergus, Rob",
  abstract  = "Large Convolutional Network models have recently demonstrated
               impressive classification performance on the ImageNet benchmark
               Krizhevsky et al. [18]. However there is no clear understanding
               of why they perform so well, or how they might be improved. In
               this paper we explore both issues. We introduce a novel
               visualization technique that gives insight into the function of
               intermediate feature layers and the operation of the classifier.
               Used in a diagnostic role, these visualizations allow us to find
               model architectures that outperform Krizhevsky et al on the
               ImageNet classification benchmark. We also perform an ablation
               study to discover the performance contribution from different
               model layers. We show our ImageNet model generalizes well to
               other datasets: when the softmax classifier is retrained, it
               convincingly beats the current state-of-the-art results on
               Caltech-101 and Caltech-256 datasets.",
  publisher = "Springer International Publishing",
  pages     = "818--833",
  year      =  2014
}

@ARTICLE{Sanai2011-ae,
  title    = "Intraoperative confocal microscopy in the visualization of
              5-aminolevulinic acid fluorescence in low-grade gliomas",
  author   = "Sanai, Nader and Snyder, Laura A and Honea, Norissa J and Coons,
              Stephen W and Eschbacher, Jennifer M and Smith, Kris A and
              Spetzler, Robert F",
  abstract = "OBJECT: Greater extent of resection (EOR) for patients with
              low-grade glioma (LGG) corresponds with improved clinical
              outcome, yet remains a central challenge to the neurosurgical
              oncologist. Although 5-aminolevulinic acid (5-ALA)-induced tumor
              fluorescence is a strategy that can improve EOR in gliomas, only
              glioblastomas routinely fluoresce following 5-ALA administration.
              Intraoperative confocal microscopy adapts conventional confocal
              technology to a handheld probe that provides real-time
              fluorescent imaging at up to 1000$\times$ magnification. The
              authors report a combined approach in which intraoperative
              confocal microscopy is used to visualize 5-ALA tumor fluorescence
              in LGGs during the course of microsurgical resection. METHODS:
              Following 5-ALA administration, patients with newly diagnosed LGG
              underwent microsurgical resection. Intraoperative confocal
              microscopy was conducted at the following points: 1) initial
              encounter with the tumor; 2) the midpoint of tumor resection; and
              3) the presumed brain-tumor interface. Histopathological analysis
              of these sites correlated tumor infiltration with intraoperative
              cellular tumor fluorescence. RESULTS: Ten consecutive patients
              with WHO Grades I and II gliomas underwent microsurgical
              resection with 5-ALA and intraoperative confocal microscopy.
              Macroscopic tumor fluorescence was not evident in any patient.
              However, in each case, intraoperative confocal microscopy
              identified tumor fluorescence at a cellular level, a finding that
              corresponded to tumor infiltration on matched histological
              analyses. CONCLUSIONS: Intraoperative confocal microscopy can
              visualize cellular 5-ALA-induced tumor fluorescence within LGGs
              and at the brain-tumor interface. To assess the clinical value of
              5-ALA for high-grade gliomas in conjunction with neuronavigation,
              and for LGGs in combination with intraoperative confocal
              microscopy and neuronavigation, a Phase IIIa randomized
              placebo-controlled trial (BALANCE) is underway at the authors'
              institution.",
  journal  = "J. Neurosurg.",
  volume   =  115,
  number   =  4,
  pages    = "740--748",
  month    =  oct,
  year     =  2011,
  language = "en"
}

@ARTICLE{Jermyn2015-hf,
  title    = "Intraoperative brain cancer detection with Raman spectroscopy in
              humans",
  author   = "Jermyn, Michael and Mok, Kelvin and Mercier, Jeanne and
              Desroches, Joannie and Pichette, Julien and Saint-Arnaud, Karl
              and Bernstein, Liane and Guiot, Marie-Christine and Petrecca,
              Kevin and Leblond, Frederic",
  abstract = "Cancers are often impossible to visually distinguish from normal
              tissue. This is critical for brain cancer where residual invasive
              cancer cells frequently remain after surgery, leading to disease
              recurrence and a negative impact on overall survival. No
              preoperative or intraoperative technology exists to identify all
              cancer cells that have invaded normal brain. To address this
              problem, we developed a handheld contact Raman spectroscopy probe
              technique for live, local detection of cancer cells in the human
              brain. Using this probe intraoperatively, we were able to
              accurately differentiate normal brain from dense cancer and
              normal brain invaded by cancer cells, with a sensitivity of 93\%
              and a specificity of 91\%. This Raman-based probe enabled
              detection of the previously undetectable diffusely invasive brain
              cancer cells at cellular resolution in patients with grade 2 to 4
              gliomas. This intraoperative technology may therefore be able to
              classify cell populations in real time, making it an ideal guide
              for surgical resection and decision-making.",
  journal  = "Sci. Transl. Med.",
  volume   =  7,
  number   =  274,
  pages    = "274ra19",
  month    =  feb,
  year     =  2015,
  language = "en"
}

@ARTICLE{Kalkanis2014-hc,
  title    = "Raman spectroscopy to distinguish grey matter, necrosis, and
              glioblastoma multiforme in frozen tissue sections",
  author   = "Kalkanis, Steven N and Kast, Rachel E and Rosenblum, Mark L and
              Mikkelsen, Tom and Yurgelevic, Sally M and Nelson, Katrina M and
              Raghunathan, Aditya and Poisson, Laila M and Auner, Gregory W",
  abstract = "The need exists for a highly accurate, efficient and inexpensive
              tool to distinguish normal brain tissue from glioblastoma
              multiforme (GBM) and necrosis boundaries rapidly, in real-time,
              in the operating room. Raman spectroscopy provides a unique
              biochemical signature of a tissue type, with the potential to
              provide intraoperative identification of tumor and necrosis
              boundaries. We aimed to develop a database of Raman spectra from
              normal brain, GBM, and necrosis, and a methodology for
              distinguishing these pathologies. Raman spectroscopy was used to
              measure 95 regions from 40 frozen tissue sections using 785 nm
              excitation wavelength. Review of adjacent hematoxylin and eosin
              sections confirmed histology of each region. Three regions each
              of normal grey matter, necrosis, and GBM were selected as a
              training set. Ten regions were selected as a validation set, with
              a secondary validation set of tissue regions containing freeze
              artifact. Grey matter contained higher lipid (1061, 1081 cm(-1))
              content, whereas necrosis revealed increased protein and nucleic
              acid content (1003, 1206, 1239, 1255-1266, 1552 cm(-1)). GBM fell
              between these two extremes. Discriminant function analysis showed
              99.6, 97.8, and 77.5\% accuracy in distinguishing tissue types in
              the training, validation, and validation with freeze artifact
              datasets, respectively. Decreased classification in the freeze
              artifact group was due to tissue preparation damage. This study
              shows the potential of Raman spectroscopy to accurately identify
              normal brain, necrosis, and GBM as a tool to augment pathologic
              diagnosis. Future work will develop mapped images of diffuse
              glioma and neoplastic margins toward development of an
              intraoperative surgical tool.",
  journal  = "J. Neurooncol.",
  volume   =  116,
  number   =  3,
  pages    = "477--485",
  month    =  feb,
  year     =  2014,
  language = "en"
}

@ARTICLE{Desroches2018-jb,
  title    = "A new method using Raman spectroscopy for in vivo targeted brain
              cancer tissue biopsy",
  author   = "Desroches, Joannie and Jermyn, Michael and Pinto, Michael and
              Picot, Fabien and Tremblay, Marie-Andr{\'e}e and Obaid, Sami and
              Marple, Eric and Urmey, Kirk and Trudel, Dominique and Soulez,
              Gilles and Guiot, Marie-Christine and Wilson, Brian C and
              Petrecca, Kevin and Leblond, Fr{\'e}d{\'e}ric",
  abstract = "Modern cancer diagnosis requires histological, molecular, and
              genomic tumor analyses. Tumor sampling is often achieved using a
              targeted needle biopsy approach. Targeting errors and cancer
              heterogeneity causing inaccurate sampling are important
              limitations of this blind technique leading to non-diagnostic or
              poor quality samples, and the need for repeated biopsies pose
              elevated patient risk. An optical technology that can analyze the
              molecular nature of the tissue prior to harvesting could improve
              cancer targeting and mitigate patient risk. Here we report on the
              design, development, and validation of an in situ intraoperative,
              label-free, cancer detection system based on high wavenumber
              Raman spectroscopy. This optical detection device was engineered
              into a commercially available biopsy system allowing tumor
              analysis prior to tissue harvesting without disrupting workflow.
              Using a dual validation approach we show that high wavenumber
              Raman spectroscopy can detect human dense cancer with >60\%
              cancer cells in situ during surgery with a sensitivity and
              specificity of 80\% and 90\%, respectively. We also demonstrate
              for the first time the use of this system in a swine brain biopsy
              model. These studies set the stage for the clinical translation
              of this optical molecular imaging method for high yield and safe
              targeted biopsy.",
  journal  = "Sci. Rep.",
  volume   =  8,
  number   =  1,
  pages    = "1792",
  month    =  jan,
  year     =  2018,
  language = "en"
}

@ARTICLE{Kut2015-rl,
  title    = "Detection of human brain cancer infiltration ex vivo and in vivo
              using quantitative optical coherence tomography",
  author   = "Kut, Carmen and Chaichana, Kaisorn L and Xi, Jiefeng and Raza,
              Shaan M and Ye, Xiaobu and McVeigh, Elliot R and Rodriguez,
              Fausto J and Qui{\~n}ones-Hinojosa, Alfredo and Li, Xingde",
  abstract = "More complete brain cancer resection can prolong survival and
              delay recurrence. However, it is challenging to distinguish
              cancer from noncancer tissues intraoperatively, especially at the
              transitional, infiltrative zones. This is especially critical in
              eloquent regions (for example, speech and motor areas). This
              study tested the feasibility of label-free, quantitative optical
              coherence tomography (OCT) for differentiating cancer from
              noncancer in human brain tissues. Fresh ex vivo human brain
              tissues were obtained from 32 patients with grade II to IV brain
              cancer and 5 patients with noncancer brain pathologies. On the
              basis of volumetric OCT imaging data, pathologically confirmed
              brain cancer tissues (both high- and low-grade) had significantly
              lower optical attenuation values at both cancer core and
              infiltrated zones when compared with noncancer white matter, and
              OCT achieved high sensitivity and specificity at an attenuation
              threshold of 5.5 mm(-1) for brain cancer patients. We also used
              this attenuation threshold to confirm the intraoperative
              feasibility of performing in vivo OCT-guided surgery using a
              murine model harboring human brain cancer. Our OCT system was
              capable of processing and displaying a color-coded optical
              property map in real time at a rate of 110 to 215 frames per
              second, or 1.2 to 2.4 s for an 8- to 16-mm(3) tissue volume, thus
              providing direct visual cues for cancer versus noncancer areas.
              Our study demonstrates the translational and practical potential
              of OCT in differentiating cancer from noncancer tissue. Its
              intraoperative use may facilitate safe and extensive resection of
              infiltrative brain cancers and consequently lead to improved
              outcomes when compared with current clinical standards.",
  journal  = "Sci. Transl. Med.",
  volume   =  7,
  number   =  292,
  pages    = "292ra100",
  month    =  jun,
  year     =  2015,
  language = "en"
}

@ARTICLE{Eberlin2012-yt,
  title    = "Classifying human brain tumors by lipid imaging with mass
              spectrometry",
  author   = "Eberlin, Livia S and Norton, Isaiah and Dill, Allison L and
              Golby, Alexandra J and Ligon, Keith L and Santagata, Sandro and
              Cooks, R Graham and Agar, Nathalie Y R",
  abstract = "Brain tissue biopsies are required to histologically diagnose
              brain tumors, but current approaches are limited by tissue
              characterization at the time of surgery. Emerging technologies
              such as mass spectrometry imaging can enable a rapid direct
              analysis of cancerous tissue based on molecular composition.
              Here, we illustrate how gliomas can be rapidly classified by
              desorption electrospray ionization-mass spectrometry (DESI-MS)
              imaging, multivariate statistical analysis, and machine learning.
              DESI-MS imaging was carried out on 36 human glioma samples,
              including oligodendroglioma, astrocytoma, and oligoastrocytoma,
              all of different histologic grades and varied tumor cell
              concentration. Gray and white matter from glial tumors were
              readily discriminated and detailed diagnostic information could
              be provided. Classifiers for subtype, grade, and concentration
              features generated with lipidomic data showed high recognition
              capability with more than 97\% cross-validation. Specimen
              classification in an independent validation set agreed with
              expert histopathology diagnosis for 79\% of tested features.
              Together, our findings offer proof of concept that intraoperative
              examination and classification of brain tissue by mass
              spectrometry can provide surgeons, pathologists, and oncologists
              with critical and previously unavailable information to rapidly
              guide surgical resections that can improve management of patients
              with malignant brain tumors.",
  journal  = "Cancer Res.",
  volume   =  72,
  number   =  3,
  pages    = "645--654",
  month    =  feb,
  year     =  2012,
  language = "en"
}

@ARTICLE{Santagata2014-qj,
  title    = "Intraoperative mass spectrometry mapping of an onco-metabolite to
              guide brain tumor surgery",
  author   = "Santagata, Sandro and Eberlin, Livia S and Norton, Isaiah and
              Calligaris, David and Feldman, Daniel R and Ide, Jennifer L and
              Liu, Xiaohui and Wiley, Joshua S and Vestal, Matthew L and
              Ramkissoon, Shakti H and Orringer, Daniel A and Gill, Kristen K
              and Dunn, Ian F and Dias-Santagata, Dora and Ligon, Keith L and
              Jolesz, Ferenc A and Golby, Alexandra J and Cooks, R Graham and
              Agar, Nathalie Y R",
  abstract = "For many intraoperative decisions surgeons depend on frozen
              section pathology, a technique developed over 150 y ago.
              Technical innovations that permit rapid molecular
              characterization of tissue samples at the time of surgery are
              needed. Here, using desorption electrospray ionization (DESI) MS,
              we rapidly detect the tumor metabolite 2-hydroxyglutarate (2-HG)
              from tissue sections of surgically resected gliomas, under
              ambient conditions and without complex or time-consuming
              preparation. With DESI MS, we identify isocitrate dehydrogenase
              1-mutant tumors with both high sensitivity and specificity within
              minutes, immediately providing critical diagnostic, prognostic,
              and predictive information. Imaging tissue sections with DESI MS
              shows that the 2-HG signal overlaps with areas of tumor and that
              2-HG levels correlate with tumor content, thereby indicating
              tumor margins. Mapping the 2-HG signal onto 3D MRI
              reconstructions of tumors allows the integration of molecular and
              radiologic information for enhanced clinical decision making. We
              also validate the methodology and its deployment in the operating
              room: We have installed a mass spectrometer in our Advanced
              Multimodality Image Guided Operating (AMIGO) suite and
              demonstrate the molecular analysis of surgical tissue during
              brain surgery. This work indicates that metabolite-imaging MS
              could transform many aspects of surgical care.",
  journal  = "Proc. Natl. Acad. Sci. U. S. A.",
  volume   =  111,
  number   =  30,
  pages    = "11121--11126",
  month    =  jul,
  year     =  2014,
  keywords = "IDH1; brain cancer; intrasurgical diagnosis; mass spectrometry
              imaging; oncometabolite",
  language = "en"
}

@ARTICLE{Parry2013-bh,
  title    = "Ambient mass spectrometry for the intraoperative molecular
              diagnosis of human brain tumors",
  author   = "Parry, Phillip V and Engh, Johnathan A",
  journal  = "Neurosurgery",
  volume   =  72,
  number   =  4,
  pages    = "N17--8",
  month    =  apr,
  year     =  2013,
  language = "en"
}

@ARTICLE{Hollon2018-wd,
  title    = "Shedding Light on {IDH1} Mutation in Gliomas",
  author   = "Hollon, Todd C and Orringer, Daniel A",
  abstract = "IDH mutation is of central importance in the diagnosis and
              treatment of gliomas. Fourier-transform infrared spectroscopy, in
              combination with a supervised machine-learning approach, can be
              used to detect metabolic alterations induced by IDH1 mutations in
              a fraction of the time of conventional techniques. Clin Cancer
              Res; 24(11); 2467-9. \copyright{}2018 AACRSee related article by
              Uckermann et al., p. 2530.",
  journal  = "Clin. Cancer Res.",
  volume   =  24,
  number   =  11,
  pages    = "2467--2469",
  month    =  jun,
  year     =  2018,
  keywords = "My\_papers",
  language = "en"
}

@ARTICLE{Uckermann2018-aq,
  title    = "Optical Analysis of Glioma: {Fourier-Transform} Infrared
              Spectroscopy Reveals the {IDH1} Mutation Status",
  author   = "Uckermann, Ortrud and Juratli, Tareq A and Galli, Roberta and
              Conde, Marina and Wiedemuth, Ralf and Krex, Dietmar and Geiger,
              Kathrin and Temme, Achim and Schackert, Gabriele and Koch, Edmund
              and Steiner, Gerald and Kirsch, Matthias",
  abstract = "Purpose: Somatic mutations in the human cytosolic isocitrate
              dehydrogenase 1 (IDH1) gene cause profound changes in cell
              metabolism and are a common feature of gliomas with unprecedented
              predictive and prognostic impact. Fourier-transform infrared
              (FT-IR) spectroscopy addresses the molecular composition of cells
              and tissue and was investigated to deduct the IDH1 mutation
              status.Experimental Design: We tested the technique on human cell
              lines that were transduced with wild-type IDH1 or mutated IDH1
              and on 34 human glioma samples. IR spectra were acquired at 256
              positions from cell pellets or tissue cryosections. Moreover, IR
              spectra were obtained from fresh, unprocessed biopsies of 64
              patients with glioma.Results:IDH1 mutation was linked to changes
              in spectral bands assigned to molecular groups of lipids and
              proteins in cell lines and human glioma. The spectra of
              cryosections of brain tumor samples showed high interpatient
              variability, for example, bands related to calcifications at 1113
              cm-1 However, supervised classification recognized relevant
              spectral regions at 1103, 1362, 1441, 1485, and 1553 cm-1 and
              assigned 88\% of the tumor samples to the correct group. Similar
              spectral positions allowed the classification of spectra of fresh
              biopsies with an accuracy of 86\%.Conclusions: Here, we show that
              vibrational spectroscopy reveals the IDH1 genotype of glioma.
              Because it can provide information in seconds, an implementation
              into the intraoperative workflow might allow simple and rapid
              online diagnosis of the IDH1 genotype. The intraoperative
              confirmation of IDH1 mutation status might guide the decision to
              pursue definitive neurosurgical resection and guide future in
              situ therapies of infiltrative gliomas. Clin Cancer Res; 24(11);
              2530-8. \copyright{}2017 AACRSee related commentary by Hollon and
              Orringer, p. 2467.",
  journal  = "Clin. Cancer Res.",
  volume   =  24,
  number   =  11,
  pages    = "2530--2538",
  month    =  jun,
  year     =  2018,
  keywords = "My\_papers",
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Senft2011-cp,
  title    = "Intraoperative {MRI} guidance and extent of resection in glioma
              surgery: a randomised, controlled trial",
  author   = "Senft, Christian and Bink, Andrea and Franz, Kea and Vatter,
              Hartmut and Gasser, Thomas and Seifert, Volker",
  abstract = "BACKGROUND: Intraoperative MRI is increasingly used in
              neurosurgery, although there is little evidence for its use. We
              aimed to assess efficacy of intraoperative MRI guidance on extent
              of resection in patients with glioma. METHODS: In our
              prospective, randomised, parallel-group trial, we enrolled adults
              ($\geq$18 years) with contrast enhancing gliomas amenable to
              radiologically complete resection who presented to Goethe
              University (Frankfurt, Germany). We randomly assigned patients
              (1:1) with computer-generated blocks of four and a
              sealed-envelope design to undergo intraoperative MRI-guided
              surgery or conventional microsurgery (control group). Surgeons
              and patients were unmasked to treatment group allocation, but an
              independent neuroradiologist was masked during analysis of all
              preoperative and postoperative imaging data. The primary endpoint
              was rate of complete resections as established by early
              postoperative high-field MRI (1Â·5 T or 3Â·0 T). Analysis was done
              per protocol. This study is registered with ClinicalTrials.gov,
              number NCT01394692. FINDINGS: We enrolled 58 patients between Oct
              1, 2007, and July 1, 2010. 24 (83\%) of 29 patients randomly
              allocated to the intraoperative MRI group and 25 (86\%) of 29
              controls were eligible for analysis (four patients in each group
              had metastasis and one patient in the intraoperative MRI group
              withdrew consent after randomisation). More patients in the
              intraoperative MRI group had complete tumour resection (23 [96\%]
              of 24 patients) than did in the control group (17 [68\%] of 25,
              p=0Â·023). Postoperative rates of new neurological deficits did
              not differ between patients in the intraoperative MRI group
              (three [13\%] of 24) and controls (two [8\%] of 25, p=1Â·0). No
              patient for whom use of intraoperative MRI led to continued
              resection of residual tumour had neurological deterioration. One
              patient in the control group died before 6 months.
              INTERPRETATION: Our study provides evidence for the use of
              intraoperative MRI guidance in glioma surgery: such imaging helps
              surgeons provide the optimum extent of resection. FUNDING: None.",
  journal  = "Lancet Oncol.",
  volume   =  12,
  number   =  11,
  pages    = "997--1003",
  month    =  oct,
  year     =  2011,
  language = "en"
}

@ARTICLE{Stummer2006-ua,
  title    = "Fluorescence-guided surgery with 5-aminolevulinic acid for
              resection of malignant glioma: a randomised controlled
              multicentre phase {III} trial",
  author   = "Stummer, Walter and Pichlmeier, Uwe and Meinel, Thomas and
              Wiestler, Otmar Dieter and Zanella, Friedhelm and Reulen,
              Hans-J{\"u}rgen and {ALA-Glioma Study Group}",
  abstract = "BACKGROUND: 5-Aminolevulinic acid is a non-fluorescent prodrug
              that leads to intracellular accumulation of fluorescent
              porphyrins in malignant gliomas-a finding that is under
              investigation for intraoperative identification and resection of
              these tumours. We aimed to assess the effect of
              fluorescence-guided resection with 5-aminolevulinic acid on
              surgical radicality, progression-free survival, overall survival,
              and morbidity. METHODS: 322 patients aged 23-73 years with
              suspected malignant glioma amenable to complete resection of
              contrast-enhancing tumour were randomly assigned to 20 mg/kg
              bodyweight 5-aminolevulinic acid for fluorescence-guided
              resection (n=161) or to conventional microsurgery with white
              light (n=161). The primary endpoints were the number of patients
              without contrast-enhancing tumour on early MRI (ie, that obtained
              within 72 h after surgery) and 6-month progression-free survival
              as assessed by MRI. Secondary endpoints were volume of residual
              tumour on postoperative MRI, overall survival, neurological
              deficit, and toxic effects. We report the results of an interim
              analysis with 270 patients in the full-analysis population (139
              assigned 5-aminolevulinic acid, 131 assigned white light), which
              excluded patients with ineligible histological and radiological
              findings as assessed by central reviewers who were masked as to
              treatment allocation; the interim analysis resulted in
              termination of the study as defined by the protocol. Primary and
              secondary endpoints were analysed by intention to treat in the
              full-analysis population. The study is registered at
              http://www.clinicaltrials.gov as NCT00241670. FINDINGS: Median
              follow-up was 35.4 months (95\% CI 1.0-56.7). Contrast-enhancing
              tumour was resected completely in 90 (65\%) of 139 patients
              assigned 5-aminolevulinic acid compared with 47 (36\%) of 131
              assigned white light (difference between groups 29\% [95\% CI
              17-40], p<0.0001). Patients allocated 5-aminolevulinic acid had
              higher 6-month progression free survival than did those allocated
              white light (41.0\% [32.8-49.2] vs 21.1\% [14.0-28.2]; difference
              between groups 19.9\% [9.1-30.7], p=0.0003, Z test). Groups did
              not differ in the frequency of severe adverse events or adverse
              events in any organ system class reported within 7 days after
              surgery. INTERPRETATION: Tumour fluorescence derived from
              5-aminolevulinic acid enables more complete resections of
              contrast-enhancing tumour, leading to improved progression-free
              survival in patients with malignant glioma.",
  journal  = "Lancet Oncol.",
  volume   =  7,
  number   =  5,
  pages    = "392--401",
  month    =  may,
  year     =  2006,
  language = "en"
}

@ARTICLE{Mahboob2016-gt,
  title     = "Intraoperative {Ultrasound-Guided} Resection of Gliomas: A
               {Meta-Analysis} and Review of the Literature",
  author    = "Mahboob, Syed and McPhillips, Rachael and Qiu, Zhen and Jiang,
               Yun and Meggs, Carl and Schiavone, Giuseppe and Button, Tim and
               Desmulliez, Marc and Demore, Christine and Cochran, Sandy and
               Eljamel, Sam",
  abstract  = "BACKGROUND: Image-guided surgery has become standard practice
               during surgical resection, using preoperative magnetic resonance
               imaging. Intraoperative ultrasound (IoUS) has attracted interest
               because of its perceived safety, portability, and real-time
               imaging. This report is a meta-analysis of intraoperative
               ultrasound in gliomas. METHODS: Critical literature review and
               meta-analyses, using the MEDLINE/PubMed service. The list of
               references in each article was double-checked for any missing
               references. We included all studies that reported the use of
               ultrasound to guide glioma-surgery. The meta-analyses were
               conducted according to statistical heterogeneity between the
               studies using Open MetaAnalyst Software. If there was no
               heterogeneity, fixed effects model was used for meta-analysis;
               otherwise, a random effect model was used. Statistical
               heterogeneity was explored by $\chi$(2) and inconsistency (I(2))
               statistics; an I(2) value of 50\% or more represented
               substantial heterogeneity. RESULTS: A wide search yielded 19,109
               studies that might be relevant, of which 4819 were ultrasound in
               neurosurgery; 756 studies used ultrasound in cranial surgery, of
               which 24 studies used intraoperative ultrasound to guide
               surgical resection and 74 studies used it to guide biopsy.
               Fifteen studies fulfilled our stringent inclusion criteria,
               giving a total of 739 patients. The estimated average gross
               total resection rate was 77\%. Furthermore, the relationship
               between extent of surgical resection and study population was
               not linear. Gross total resection was more likely under IoUS
               when the lesion was solitary and subcortical, with no history of
               surgery or radiotherapy. IoUS image quality, sensitivity,
               specificity, and positive and negative predictive values
               deteriorated as surgical resection proceeded. CONCLUSION:
               IoUS-guided surgical resection of gliomas is a useful tool for
               guiding the resection and for improving the extent of resection.
               IoUS can be used in conjunction with other complementary
               technologies that can improve anatomic orientation during
               surgery. Real-time imaging, improved image quality, small probe
               sizes, repeatability, portability, and relatively low cost make
               IoUS a realistic, cost-effective tool that complements any
               existing tools in any neurosurgical operating environment.",
  journal   = "World Neurosurg.",
  publisher = "Elsevier",
  volume    =  92,
  pages     = "255--263",
  month     =  aug,
  year      =  2016,
  keywords  = "Glioma; Image-guided surgery; Intraoperative ultrasound;
               Neuronavigation",
  language  = "en"
}

@ARTICLE{Saar2010-ae,
  title    = "Video-rate molecular imaging in vivo with stimulated Raman
              scattering",
  author   = "Saar, Brian G and Freudiger, Christian W and Reichman, Jay and
              Stanley, C Michael and Holtom, Gary R and Xie, X Sunney",
  abstract = "Optical imaging in vivo with molecular specificity is important
              in biomedicine because of its high spatial resolution and
              sensitivity compared with magnetic resonance imaging. Stimulated
              Raman scattering (SRS) microscopy allows highly sensitive optical
              imaging based on vibrational spectroscopy without adding toxic or
              perturbative labels. However, SRS imaging in living animals and
              humans has not been feasible because light cannot be collected
              through thick tissues, and motion-blur arises from slow imaging
              based on backscattered light. In this work, we enable in vivo SRS
              imaging by substantially enhancing the collection of the
              backscattered signal and increasing the imaging speed by three
              orders of magnitude to video rate. This approach allows
              label-free in vivo imaging of water, lipid, and protein in skin
              and mapping of penetration pathways of topically applied drugs in
              mice and humans.",
  journal  = "Science",
  volume   =  330,
  number   =  6009,
  pages    = "1368--1370",
  month    =  dec,
  year     =  2010,
  language = "en"
}

@ARTICLE{Jermyn2016-vw,
  title    = "Neural networks improve brain cancer detection with Raman
              spectroscopy in the presence of operating room light artifacts",
  author   = "Jermyn, Michael and Desroches, Joannie and Mercier, Jeanne and
              Tremblay, Marie-Andr{\'e}e and St-Arnaud, Karl and Guiot,
              Marie-Christine and Petrecca, Kevin and Leblond, Frederic",
  abstract = "Invasive brain cancer cells cannot be visualized during surgery
              and so they are often not removed. These residual cancer cells
              give rise to recurrences. <italic<In vivo</italic< Raman
              spectroscopy can detect these invasive cancer cells in patients
              with grade 2 to 4 gliomas. The robustness of this Raman signal
              can be dampened by spectral artifacts generated by lights in the
              operating room. We found that artificial neural networks (ANNs)
              can overcome these spectral artifacts using nonparametric and
              adaptive models to detect complex nonlinear spectral
              characteristics. Coupling ANN with Raman spectroscopy simplifies
              the intraoperative use of Raman spectroscopy by limiting changes
              required to the standard neurosurgical workflow. The ability to
              detect invasive brain cancer under these conditions may reduce
              residual cancer remaining after surgery and improve patient
              survival.",
  journal  = "J. Biomed. Opt.",
  volume   =  21,
  number   =  9,
  pages    = "94002",
  month    =  sep,
  year     =  2016,
  language = "en"
}

@ARTICLE{Hollon2016-kz,
  title    = "Improving the accuracy of brain tumor surgery via Raman-based
              technology",
  author   = "Hollon, Todd and Lewis, Spencer and Freudiger, Christian W and
              Sunney Xie, X and Orringer, Daniel A",
  abstract = "Despite advances in the surgical management of brain tumors,
              achieving optimal surgical results and identification of tumor
              remains a challenge. Raman spectroscopy, a laser-based technique
              that can be used to nondestructively differentiate molecules
              based on the inelastic scattering of light, is being applied
              toward improving the accuracy of brain tumor surgery. Here, the
              authors systematically review the application of Raman
              spectroscopy for guidance during brain tumor surgery. Raman
              spectroscopy can differentiate normal brain from necrotic and
              vital glioma tissue in human specimens based on chemical
              differences, and has recently been shown to differentiate
              tumor-infiltrated tissues from noninfiltrated tissues during
              surgery. Raman spectroscopy also forms the basis for coherent
              Raman scattering (CRS) microscopy, a technique that amplifies
              spontaneous Raman signals by 10,000-fold, enabling real-time
              histological imaging without the need for tissue processing,
              sectioning, or staining. The authors review the relevant basic
              and translational studies on CRS microscopy as a means of
              providing real-time intraoperative guidance. Recent studies have
              demonstrated how CRS can be used to differentiate
              tumor-infiltrated tissues from noninfiltrated tissues and that it
              has excellent agreement with traditional histology. Under
              simulated operative conditions, CRS has been shown to identify
              tumor margins that would be undetectable using standard
              bright-field microscopy. In addition, CRS microscopy has been
              shown to detect tumor in human surgical specimens with
              near-perfect agreement to standard H \& E microscopy. The authors
              suggest that as the intraoperative application and
              instrumentation for Raman spectroscopy and imaging matures, it
              will become an essential component in the neurosurgical
              armamentarium for identifying residual tumor and improving the
              surgical management of brain tumors.",
  journal  = "Neurosurg. Focus",
  volume   =  40,
  number   =  3,
  pages    = "E9",
  month    =  mar,
  year     =  2016,
  keywords = "CARS = coherent anti-Stokes Raman scattering; CRS = coherent
              Raman scattering; Raman spectroscopy; SRS = stimulated Raman
              scattering; brain metastasis; brain/tumor margin; coherent Raman
              scattering microscopy; glioma; primary brain tumors;My\_papers",
  language = "en"
}

@ARTICLE{Zhang2017-xk,
  title    = "Accuracy of Raman spectroscopy in differentiating brain tumor
              from normal brain tissue",
  author   = "Zhang, Jing and Fan, Yimeng and He, Min and Ma, Xuelei and Song,
              Yanlin and Liu, Ming and Xu, Jianguo",
  abstract = "Raman spectroscopy could be applied to distinguish tumor from
              normal tissues. This meta-analysis was conducted to assess the
              accuracy of Raman spectroscopy in differentiating brain tumor
              from normal brain tissue. PubMed and Embase were searched to
              identify suitable studies prior to Jan 1st, 2016. We estimated
              the pooled sensitivity, specificity, positive and negative
              likelihood ratios (LR), diagnostic odds ratio (DOR), and
              constructed summary receiver operating characteristics (SROC)
              curves to identity the accuracy of Raman spectroscopy in
              differentiating brain tumor from normal brain tissue. A total of
              six studies with 1951 spectra were included. For glioma, the
              pooled sensitivity and specificity of Raman spectroscopy were
              0.96 (95\% CI 0.94-0.97) and 0.99 (95\% CI 0.98-0.99),
              respectively. The area under the curve (AUC) was 0.9831. For
              meningioma, the pooled sensitivity and specificity were 0.98
              (95\% CI 0.94-1.00) and 1.00 (95\% CI 0.98-1.00), respectively.
              The AUC was 0.9955. This meta-analysis suggested that Raman
              spectroscopy could be an effective and accurate tool for
              differentiating glioma and meningioma from normal brain tissue,
              which would help us both avoid removal of normal tissue and
              minimize the volume of residual tumor.",
  journal  = "Oncotarget",
  volume   =  8,
  number   =  22,
  pages    = "36824--36831",
  month    =  may,
  year     =  2017,
  keywords = "Raman spectroscopy; brain tumors; diagnosis; meta-analysis",
  language = "en"
}

@ARTICLE{Zhou2014-lv,
  title         = "Object Detectors Emerge in Deep Scene {CNNs}",
  author        = "Zhou, Bolei and Khosla, Aditya and Lapedriza, Agata and
                   Oliva, Aude and Torralba, Antonio",
  abstract      = "With the success of new computational architectures for
                   visual processing, such as convolutional neural networks
                   (CNN) and access to image databases with millions of labeled
                   examples (e.g., ImageNet, Places), the state of the art in
                   computer vision is advancing rapidly. One important factor
                   for continued progress is to understand the representations
                   that are learned by the inner layers of these deep
                   architectures. Here we show that object detectors emerge
                   from training CNNs to perform scene classification. As
                   scenes are composed of objects, the CNN for scene
                   classification automatically discovers meaningful objects
                   detectors, representative of the learned scene categories.
                   With object detectors emerging as a result of learning to
                   recognize scenes, our work demonstrates that the same
                   network can perform both scene recognition and object
                   localization in a single forward-pass, without ever having
                   been explicitly taught the notion of objects.",
  month         =  dec,
  year          =  2014,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1412.6856"
}

@ARTICLE{Metter2019-yy,
  title    = "Trends in the {US} and Canadian Pathologist Workforces From 2007
              to 2017",
  author   = "Metter, David M and Colgan, Terence J and Leung, Stanley T and
              Timmons, Charles F and Park, Jason Y",
  abstract = "Importance: The current state of the US pathologist workforce is
              uncertain, with deficits forecast over the next 2 decades.
              Objective: To examine the trends in the US pathology workforce
              from 2007 to 2017. Design, Setting, and Participants: A
              cross-sectional study was conducted comparing the number of US
              and Canadian physicians from 2007 to 2017 with a focus on
              pathologists, radiologists, and anesthesiologists. For the United
              States, the number of physicians was examined at the state
              population level with a focus on pathologists. New cancer
              diagnoses per pathologist were compared between the United States
              and Canada. These data from the American Association of Medical
              Colleges Center for Workforce Studies' Physician Specialty Data
              Books and the Canadian Medical Association Masterfile were
              analyzed from January 4, 2019, through March 26, 2019. Main
              Outcomes and Measures: Numbers of pathologists were compared with
              overall physician numbers as well as numbers of radiologists and
              anesthesiologists in the United States and Canada. Results:
              Between 2007 and 2017, the number of active pathologists in the
              United States decreased from 15 568 to 12 839 (-17.53\%). In
              contrast, Canadian data showed an increase from 1467 to 1767
              pathologists during the same period (+20.45\%). When adjusted for
              each country's population, the number of pathologists per 100 000
              population showed a decline from 5.16 to 3.94 in the United
              States and an increase from 4.46 to 4.81 in Canada. As a
              percentage of total US physicians, pathologists have decreased
              from 2.03\% in 2007 to 1.43\% in 2017. The distribution of US
              pathologists varied widely by state; per 100 000 population,
              Idaho had the fewest (1.37) and the District of Columbia had the
              most (15.71). When adjusted by new cancer cases per year, the
              diagnostic workload per US pathologist has risen by 41.73\%;
              during the same period, the Canadian diagnostic workload
              increased by 7.06\%. Conclusions and Relevance: The US
              pathologist workforce decreased in both absolute and
              population-adjusted numbers from 2007 to 2017. The current trends
              suggest a shortage of US pathologists.",
  journal  = "JAMA Netw Open",
  volume   =  2,
  number   =  5,
  pages    = "e194337",
  month    =  may,
  year     =  2019,
  language = "en"
}

@ARTICLE{Price2013-db,
  title    = "Cytomegalovirus contributes to glioblastoma in the context of
              tumor suppressor mutations",
  author   = "Price, Richard L and Song, Jieun and Bingmer, Katherine and Kim,
              Tae Hyong and Yi, Ji-Yeun and Nowicki, Michal O and Mo, Xiaokui
              and Hollon, Todd and Murnan, Eric and Alvarez-Breckenridge,
              Christopher and Fernandez, Soledad and Kaur, Balveen and Rivera,
              Andreana and Oglesbee, Michael and Cook, Charles and Chiocca, E
              Antonio and Kwon, Chang-Hyuk",
  abstract = "To study the controversial role of cytomegalovirus (CMV) in
              glioblastoma, we assessed the effects of murine CMV (MCMV)
              perinatal infection in a GFAP-cre; Nf1(loxP/+); Trp53(-/+)
              genetic mouse model of glioma (Mut3 mice). Early on after
              infection, MCMV antigen was predominantly localized in CD45+
              lymphocytes in the brain with active viral replication and local
              areas of inflammation, but, by 7 weeks, there was a generalized
              loss of MCMV in brain, confirmed by bioluminescent imaging.
              MCMV-infected Mut3 mice exhibited a shorter survival time from
              their gliomas than control Mut3 mice perinatally infected with
              mock or with a different neurotropic virus. Animal survival was
              also significantly shortened when orthotopic gliomas were
              implanted in mice perinatally infected with MCMV versus controls.
              MCMV infection increased phosphorylated STAT3 (p-STAT3) levels in
              neural stem cells (NSC) harvested from Mut3 mice subventricular
              zone, and, in vivo, there was increased p-STAT3 in NSCs in
              MCMV-infected compared with control mice. Of relevance, human CMV
              (HCMV) also increased p-STAT3 and proliferation of
              patient-derived glioblastoma neurospheres, whereas a STAT3
              inhibitor reversed this effect in vitro and in vivo. These
              findings thus associate CMV infection to a STAT3-dependent
              modulatory role in glioma formation/progression in the context of
              tumor suppressor mutations in mice and possibly in humans.",
  journal  = "Cancer Res.",
  volume   =  73,
  number   =  11,
  pages    = "3441--3450",
  month    =  jun,
  year     =  2013,
  keywords = "My\_papers",
  language = "en"
}

@ARTICLE{Hollon2013-vw,
  title    = "Mutations in glioblastoma oncosuppressive pathways pave the way
              for oncomodulatory activity of cytomegalovirus",
  author   = "Hollon, Todd C and Price, Richard L and Kwon, Chang-Hyuk and
              Chiocca, E Antonio",
  abstract = "Over the last decade, cytomegalovirus (CMV) has been suggested to
              promote the development of glioblastoma multiforme (GBM). Recent
              evidence demonstrates that CMV contributes to the progression of
              GBM in the context of oncosuppressor gene mutations. This finding
              provides further insights into the mechanisms whereby CMV
              exacerbates the malignancy of GBM.",
  journal  = "Oncoimmunology",
  volume   =  2,
  number   =  9,
  pages    = "e25620",
  month    =  sep,
  year     =  2013,
  keywords = "brain tumor; glioma; rhabdomyosarcoma; tumor suppressor genes;
              viral oncology;My\_papers",
  language = "en"
}

@ARTICLE{Hollon2015-bf,
  title    = "Advances in the Surgical Management of {Low-Grade} Glioma",
  author   = "Hollon, Todd and Hervey-Jumper, Shawn L and Sagher, Oren and
              Orringer, Daniel A",
  abstract = "Over the past 2 decades, extent of resection has emerged as a
              significant prognostic factor in patients with low-grade gliomas
              (LGGs). Greater extent of resection has been shown to improve
              overall survival, progression-free survival, and time to
              malignant transformation. The operative goal in most LGG cases is
              to maximize extent of resection, while avoiding postoperative
              neurologic deficits. Several advanced surgical techniques have
              been developed in an attempt to better achieve maximal safe
              resection. Intraoperative magnetic resonance imaging,
              fluorescence-guided surgery, intraoperative functional pathway
              mapping, and neuronavigation are some of the most commonly used
              techniques with multiple studies to support their efficacy in
              glioma surgery. By using these techniques either alone or in
              combination, patients harboring LGGs have a better prognosis with
              less surgical morbidity following tumor resection.",
  journal  = "Semin. Radiat. Oncol.",
  volume   =  25,
  number   =  3,
  pages    = "181--188",
  month    =  jul,
  year     =  2015,
  keywords = "My\_papers",
  language = "en"
}

@ARTICLE{Hollon2016-gq,
  title    = "Supratentorial hemispheric ependymomas: an analysis of 109 adults
              for survival and prognostic factors",
  author   = "Hollon, Todd and Nguyen, Vincent and Smith, Brandon W and Lewis,
              Spencer and Junck, Larry and Orringer, Daniel A",
  abstract = "OBJECTIVE Survival rates and prognostic factors for
              supratentorial hemispheric ependymomas have not been determined.
              The authors therefore designed a retrospective study to determine
              progression-free survival (PFS), overall survival (OS), and
              prognostic factors for hemispheric ependymomas. METHODS The study
              population consisted of 8 patients from our institution and 101
              patients from the literature with disaggregated survival
              information (n = 109). Patient age, sex, tumor side, tumor
              location, extent of resection (EOR), tumor grade, postoperative
              chemotherapy, radiation, time to recurrence, and survival were
              recorded. Kaplan-Meier survival analyses and Cox proportional
              hazard models were completed to determine survival rates and
              prognostic factors. RESULTS Anaplastic histology/WHO Grade III
              tumors were identified in 62\% of cases and correlated with older
              age. Three-, 5-, and 10-year PFS rates were 57\%, 51\%, and 42\%,
              respectively. Three-, 5-, and 10-year OS rates were 77\%, 71\%,
              and 58\%, respectively. EOR and tumor grade were identified on
              both Kaplan-Meier log-rank testing and univariate Cox
              proportional hazard models as prognostic for PFS and OS. Both EOR
              and tumor grade remained prognostic on multivariate analysis.
              Subtotal resection (STR) predicted a worse PFS (hazard ratio [HR]
              4.764, p = 0.001) and OS (HR 4.216, p = 0.008). Subgroup survival
              analysis of patients with STR demonstrated a 5- and 10-year OS of
              28\% and 0\%, respectively. WHO Grade III tumors also had worse
              PFS (HR 10.2, p = 0.004) and OS (HR 9.1, p = 0.035). Patients
              with WHO Grade III tumors demonstrated 5- and 10-year OS of 61\%
              and 46\%, respectively. Postoperative radiation was not
              prognostic for PFS or OS. CONCLUSIONS A high incidence of
              anaplastic histology was found in hemispheric ependymomas and was
              associated with older age. EOR and tumor grade were prognostic
              factors for PFS and OS on multivariate analysis. STR or WHO Grade
              III pathology, or both, predicted worse overall prognosis in
              patients with hemispheric ependymoma.",
  journal  = "J. Neurosurg.",
  volume   =  125,
  number   =  2,
  pages    = "410--418",
  month    =  aug,
  year     =  2016,
  keywords = "EOR = extent of resection; GTR = gross total resection; OS =
              overall survival; PFS = progression-free survival; STR = subtotal
              resection; brain tumor; ependymoma; glioma; oncology; prognosis;
              survival;My\_papers",
  language = "en"
}

@ARTICLE{Hollon2016-uk,
  title    = "Improving the accuracy of brain tumor surgery via Raman-based
              technology",
  author   = "Hollon, Todd and Lewis, Spencer and Freudiger, Christian W and
              Sunney Xie, X and Orringer, Daniel A",
  abstract = "Despite advances in the surgical management of brain tumors,
              achieving optimal surgical results and identification of tumor
              remains a challenge. Raman spectroscopy, a laser-based technique
              that can be used to nondestructively differentiate molecules
              based on the inelastic scattering of light, is being applied
              toward improving the accuracy of brain tumor surgery. Here, the
              authors systematically review the application of Raman
              spectroscopy for guidance during brain tumor surgery. Raman
              spectroscopy can differentiate normal brain from necrotic and
              vital glioma tissue in human specimens based on chemical
              differences, and has recently been shown to differentiate
              tumor-infiltrated tissues from noninfiltrated tissues during
              surgery. Raman spectroscopy also forms the basis for coherent
              Raman scattering (CRS) microscopy, a technique that amplifies
              spontaneous Raman signals by 10,000-fold, enabling real-time
              histological imaging without the need for tissue processing,
              sectioning, or staining. The authors review the relevant basic
              and translational studies on CRS microscopy as a means of
              providing real-time intraoperative guidance. Recent studies have
              demonstrated how CRS can be used to differentiate
              tumor-infiltrated tissues from noninfiltrated tissues and that it
              has excellent agreement with traditional histology. Under
              simulated operative conditions, CRS has been shown to identify
              tumor margins that would be undetectable using standard
              bright-field microscopy. In addition, CRS microscopy has been
              shown to detect tumor in human surgical specimens with
              near-perfect agreement to standard H \& E microscopy. The authors
              suggest that as the intraoperative application and
              instrumentation for Raman spectroscopy and imaging matures, it
              will become an essential component in the neurosurgical
              armamentarium for identifying residual tumor and improving the
              surgical management of brain tumors.",
  journal  = "Neurosurg. Focus",
  volume   =  40,
  number   =  3,
  pages    = "E9",
  month    =  mar,
  year     =  2016,
  keywords = "CARS = coherent anti-Stokes Raman scattering; CRS = coherent
              Raman scattering; Raman spectroscopy; SRS = stimulated Raman
              scattering; brain metastasis; brain/tumor margin; coherent Raman
              scattering microscopy; glioma; primary brain tumors;My\_papers",
  language = "en"
}

@ARTICLE{Guan2016-sk,
  title    = "Delayed Sciatic Nerve Injury Resulting From Myositis Ossificans
              Traumatica",
  author   = "Guan, Zhe and Wilson, Thomas J and Jacobson, Jon A and Hollon,
              Todd C and Yang, Lynda J-S",
  abstract = "A motorcyclist sustained multiple-system trauma, including a left
              buttock hematoma requiring decompression and evacuation.
              Presentation for severe hip pain and lower extremity weakness was
              delayed. Imaging revealed myositis ossificans traumatica
              compressing the sciatic nerve in the buttock. The patient
              underwent sciatic nerve decompression with resection of
              heterotopic calcification, resulting in improvement in pain and
              left lower extremity function. This case illustrates the contrast
              in differential diagnosis of peripheral nerve injury immediately
              posttrauma and that occurring in a slow, delayed fashion
              posttrauma. Myositis ossificans may be an underrecognized
              complication of trauma but should be considered in cases of
              delayed peripheral nerve injury after trauma.",
  journal  = "PM R",
  volume   =  8,
  number   =  5,
  pages    = "484--487",
  month    =  may,
  year     =  2016,
  keywords = "My\_papers",
  language = "en"
}

@ARTICLE{Hollon2018-lr,
  title    = "Shedding Light on {IDH1} Mutation in Gliomas",
  author   = "Hollon, Todd C and Orringer, Daniel A",
  abstract = "IDH mutation is of central importance in the diagnosis and
              treatment of gliomas. Fourier-transform infrared spectroscopy, in
              combination with a supervised machine-learning approach, can be
              used to detect metabolic alterations induced by IDH1 mutations in
              a fraction of the time of conventional techniques. Clin Cancer
              Res; 24(11); 2467-9. \copyright{}2018 AACRSee related article by
              Uckermann et al., p. 2530.",
  journal  = "Clin. Cancer Res.",
  volume   =  24,
  number   =  11,
  pages    = "2467--2469",
  month    =  jun,
  year     =  2018,
  keywords = "My\_papers",
  language = "en"
}

@ARTICLE{Guan2015-ee,
  title    = "Ruptured pediatric cerebellopontine angle epidermoid cyst: a case
              report detailing radiographic evolution and clinical course",
  author   = "Guan, Zhe and Hollon, Todd and Bentley, J Nicole and Garton, Hugh
              J L",
  abstract = "Epidermoid cysts (ECs) are uncommon pediatric tumors that often
              occur in the cerebellopontine angle. Although cyst rupture is a
              recognized complication, the radiographic evolution of an EC
              following rupture and the resultant parenchymal brainstem edema
              have not been reported. The authors present the case of a
              13-year-old female with a newly diagnosed cerebellopontine angle
              EC who presented with worsening headaches, photophobia, and
              emesis. Magnetic resonance imaging demonstrated significant
              pericystic brainstem edema and mass effect with effacement of the
              fourth ventricle. Refractory symptoms prompted repeat imaging,
              revealing cyst enlargement and dense rim enhancement. Resection
              of the EC resolved both her symptoms and the brainstem edema.
              This case documents the radiographic evolution of EC rupture and
              subsequent clinical course.",
  journal  = "J. Neurosurg. Pediatr.",
  volume   =  16,
  number   =  5,
  pages    = "574--578",
  month    =  nov,
  year     =  2015,
  keywords = "CN = cranial nerve; CPA = cerebellopontine angle; EC = epidermoid
              cyst; ED = emergency department; cerebellopontine angle tumor;
              chemical meningitis; cyst rupture; epidermoid cyst;
              oncology;My\_papers",
  language = "en"
}

@ARTICLE{Hollon2015-io,
  title    = "Skull fracture mimicking eosinophilic granuloma",
  author   = "Hollon, Todd and McKeever, Paul E and Garton, Hugh J L and Maher,
              Cormac O",
  abstract = "BACKGROUND: Delayed swelling after skull fractures is an uncommon
              complication following head trauma in children. Classically,
              growing skull fractures typically present in patients under 3
              years of age with progressive subcutaneous fluid collections, or
              occasionally with neurologic symptoms. We present the case of a
              healthy 2-year-old boy with a lytic ``punched-out'' frontal skull
              lesion. The child presented 2 months after a minor forehead
              injury for which no medical attention was sought. METHODS: The
              skull defect had no associated leptomeningeal cyst or brain
              herniation. Imaging and presentation were thought to be
              consistent with eosinophilic granuloma. Histologic findings
              demonstrated a healing skull fracture. RESULTS: Cranioplasty was
              performed, and the patient had an uncomplicated postoperative
              course. CONCLUSIONS: In this report, we describe our experience
              with this atypical presentation of a healing skull fracture
              mimicking a typical eosinophilic granuloma.",
  journal  = "Childs. Nerv. Syst.",
  volume   =  31,
  number   =  7,
  pages    = "1171--1174",
  month    =  jul,
  year     =  2015,
  language = "en"
}

@ARTICLE{Hollon2015-ll,
  title    = "Skull fracture mimicking eosinophilic granuloma",
  author   = "Hollon, Todd and McKeever, Paul E and Garton, Hugh J L and Maher,
              Cormac O",
  abstract = "BACKGROUND: Delayed swelling after skull fractures is an uncommon
              complication following head trauma in children. Classically,
              growing skull fractures typically present in patients under 3
              years of age with progressive subcutaneous fluid collections, or
              occasionally with neurologic symptoms. We present the case of a
              healthy 2-year-old boy with a lytic ``punched-out'' frontal skull
              lesion. The child presented 2 months after a minor forehead
              injury for which no medical attention was sought. METHODS: The
              skull defect had no associated leptomeningeal cyst or brain
              herniation. Imaging and presentation were thought to be
              consistent with eosinophilic granuloma. Histologic findings
              demonstrated a healing skull fracture. RESULTS: Cranioplasty was
              performed, and the patient had an uncomplicated postoperative
              course. CONCLUSIONS: In this report, we describe our experience
              with this atypical presentation of a healing skull fracture
              mimicking a typical eosinophilic granuloma.",
  journal  = "Childs. Nerv. Syst.",
  volume   =  31,
  number   =  7,
  pages    = "1171--1174",
  month    =  jul,
  year     =  2015,
  language = "en"
}

@ARTICLE{Hollon2018-bf,
  title    = "A machine learning approach to predict early outcomes after
              pituitary adenoma surgery",
  author   = "Hollon, Todd C and Parikh, Adish and Pandian, Balaji and Tarpeh,
              Jamaal and Orringer, Daniel A and Barkan, Ariel L and McKean,
              Erin L and Sullivan, Stephen E",
  abstract = "OBJECTIVEPituitary adenomas occur in a heterogeneous patient
              population with diverse perioperative risk factors,
              endocrinopathies, and other tumor-related comorbidities. This
              heterogeneity makes predicting postoperative outcomes challenging
              when using traditional scoring systems. Modern machine learning
              algorithms can automatically identify the most predictive risk
              factors and learn complex risk-factor interactions using training
              data to build a robust predictive model that can generalize to
              new patient cohorts. The authors sought to build a predictive
              model using supervised machine learning to accurately predict
              early outcomes of pituitary adenoma surgery.METHODSA
              retrospective cohort of 400 consecutive pituitary adenoma
              patients was used. Patient variables/predictive features were
              limited to common patient characteristics to improve model
              implementation. Univariate and multivariate odds ratio analysis
              was performed to identify individual risk factors for common
              postoperative complications and to compare risk factors with
              model predictors. The study population was split into 300
              training/validation patients and 100 testing patients to train
              and evaluate four machine learning models using binary
              classification accuracy for predicting early outcomes.RESULTSThe
              study included a total of 400 patients. The mean $\pm$ SD patient
              age was 53.9 $\pm$ 16.3 years, 59.8\% of patients had
              nonfunctioning adenomas and 84.7\% had macroadenomas, and the
              mean body mass index (BMI) was 32.6 $\pm$ 7.8 (58.0\% obesity
              rate). Multivariate odds ratio analysis demonstrated that age <
              40 years was associated with a 2.86 greater odds of postoperative
              diabetes insipidus and that nonobese patients (BMI < 30) were 2.2
              times more likely to develop postoperative hyponatremia. Using
              broad criteria for a poor early postoperative outcome-major
              medical and early surgical complications, extended length of
              stay, emergency department admission, inpatient readmission, and
              death-31.0\% of patients met criteria for a poor early outcome.
              After model training, a logistic regression model with elastic
              net (LR-EN) regularization best predicted early postoperative
              outcomes of pituitary adenoma surgery on the 100-patient testing
              set-sensitivity 68.0\%, specificity 93.3\%, overall accuracy
              87.0\%. The receiver operating characteristic and
              precision-recall curves for the LR-EN model had areas under the
              curve of 82.7 and 69.5, respectively. The most important
              predictive variables were lowest perioperative sodium, age, BMI,
              highest perioperative sodium, and Cushing's
              disease.CONCLUSIONSEarly postoperative outcomes of pituitary
              adenoma surgery can be predicted with 87\% accuracy using a
              machine learning approach. These results provide insight into how
              predictive modeling using machine learning can be used to improve
              the perioperative management of pituitary adenoma patients.",
  journal  = "Neurosurg. Focus",
  volume   =  45,
  number   =  5,
  pages    = "E8",
  month    =  nov,
  year     =  2018,
  keywords = "AUC = area under the curve; BMI = body mass index; DVT = deep
              vein thrombosis; LR-EN = logistic regression with elastic net; PE
              = pulmonary embolism; PR = precision recall; ROC = receiver
              operating characteristic; machine learning; obesity; outcome
              prediction; pituitary adenoma; predictive modeling; risk
              stratification;My\_papers",
  language = "en"
}

@ARTICLE{Wertz2018-vh,
  title    = "Surgical Treatment of Olfactory Neuroblastoma: Major Complication
              Rates, Progression Free and Overall Survival",
  author   = "Wertz, Aileen and Hollon, Todd and Marentette, Lawrence J and
              Sullivan, Stephen E and McHugh, Jonathan B and McKean, Erin L",
  abstract = "Objective We aimed to compare major complication rates in
              patients undergoing open versus endoscopic resection of olfactory
              neuroblastoma (ONB) and to determine the prognostic utility of
              the Kadish staging and Hyams grading systems with respect to
              progression-free survival (PFS) and overall survival (OS).
              Methods It is a retrospective review of experience in treating
              ONB at a single tertiary care hospital from 1987 through 2015.
              Major complications were defined as cerebrospinal fluid (CSF)
              leak, meningitis, osteomyelitis, tracheostomy, and severe
              neurologic injury. Results Forty-one patients were included. An
              open approach was used in 34 (83\%), endoscopic in 6 (15\%), and
              combined in 1 (2\%) case. Rates of major complications by
              surgical approach were 17\% after endoscopic versus 31\% after
              open ( p = 0.65). There was no significant difference in PFS or
              OS based on Kadish B versus C (PFS, p = 0.28; OS, p = 0.11) or
              Hyams grade 1 and 2 versus Hyams grade 3 and 4 (PFS, p = 0.53;
              OS, p = 0.38). Conclusions There was no significant difference in
              major complications between open and endoscopic approaches for
              the treatment of ONB. Patient stratification using the Kadish
              staging and Hyams grading systems did not show significant
              differences in PFS or OS. Further research is needed to determine
              if a different staging system would better predict patient
              outcomes.",
  journal  = "J. Neurol. Surg. B Skull Base",
  volume   =  79,
  number   =  2,
  pages    = "151--155",
  month    =  apr,
  year     =  2018,
  keywords = "Hyams; Kadish; complication; endoscopic; olfactory neuroblastoma;
              recurrence; survival",
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Orringer2016-ws,
  title     = "{SURG-13}. Stimulated Raman scattering microscopy provides
               diagnostic intraoperative histopathologic images in brain tumor
               patients",
  author    = "Orringer, D A and Pandian, B and Hollon, T C and Niknafs, Y S
               and {others}",
  abstract  = "Accurate histologic information is essential to decision-making
               during brain tumor surgery. Current methods of intraoperative
               histopathologic diagnosis are labor intensive, prone to
               artifacts that complicate interpretation, and may delay surgical
               care. Stimulated Raman â€¦",
  publisher = "academic.oup.com",
  year      =  2016
}

@ARTICLE{Chandler2016-mj,
  title     = "Outcome of Transsphenoidal Surgery for Cushing Disease: A
               {Single-Center} Experience Over 32 Years",
  author    = "Chandler, William F and Barkan, Ariel L and Hollon, Todd and
               Sakharova, Alla and Sack, Jayson and Brahma, Barunashish and
               Schteingart, David E",
  abstract  = "BACKGROUND: Transsphenoidal surgery is the standard approach for
               treating Cushing disease. Evidence is needed to document
               effectiveness. OBJECTIVE: To analyze results of transsphenoidal
               surgery in 276 consecutive patients, including 19 children.
               METHODS: Medical records were reviewed for patients treated
               initially with surgery for Cushing disease from 1980 to 2012.
               Radiographic features, pathology, remissions, recurrences, and
               complications were recorded. Patients were categorized for
               statistical analysis based on tumor size (microadenomas,
               macroadenomas, and negative imaging) and remission type (type 1
               = morning cortisol $\leq$3 $\mu$g/dL; type 2 = morning cortisol
               normal). RESULTS: Females comprised 78\% of patients and were
               older than men. Imaging showed 50\% microadenomas, 13\%
               macroadenomas, and 37\% negative for tumor. Remission rates for
               microadenomas, macroadenomas, and negative imaging were 89\%,
               66\%, and 71\%, respectively. Patients with microadenomas were
               more likely to have type 1 remission. Pathology showed
               adrenocorticotropic hormone-secreting adenomas in 82\% of
               microadenomas, in 100\% of macroadenomas, and in 43\% of
               negative imaging. The incidence of hyperplasia was 8\%. The
               finding of hyperplasia or no tumor on pathology predicted
               treatment failure. The recurrence rate was 17\%, with an average
               time to recurrence of 4.0 years. Patients with type 1 remission
               had a lower rate of recurrence (13\% type 1 vs 50\% type 2) and
               a longer time to recurrence. Children had similar imaging
               findings, remission rates, and pathology. There were no
               operative deaths. CONCLUSION: Transsphenoidal surgery provides a
               safe and effective treatment for Cushing disease. For both
               adults and children, the best outcomes occurred in patients with
               microadenomas and/or those with type 1 remission.",
  journal   = "Neurosurgery",
  publisher = "academic.oup.com",
  volume    =  78,
  number    =  2,
  pages     = "216--223",
  month     =  feb,
  year      =  2016,
  language  = "en"
}

@ARTICLE{Kirsch2010-yp,
  title    = "Raman spectroscopic imaging for in vivo detection of cerebral
              brain metastases",
  author   = "Kirsch, Matthias and Schackert, Gabriele and Salzer, Reiner and
              Krafft, Christoph",
  abstract = "We report for the first time a proof-of-concept experiment
              employing Raman spectroscopy to detect intracerebral tumors in
              vivo by brain surface mapping. Raman spectroscopy is a
              non-destructive biophotonic method which probes molecular
              vibrations. It provides a specific fingerprint of the biochemical
              composition and structure of tissue without using any labels.
              Here, the Raman system was coupled to a fiber-optic probe.
              Metastatic brain tumors were induced by injection of murine
              melanoma cells into the carotid artery of mice, which led to
              subcortical and cortical tumor growth within 14 days. Before data
              acquisition, the cortex was exposed by creating a bony window
              covered by a calcium fluoride window. Spectral contributions were
              assigned to proteins, lipids, blood, water, bone, and melanin.
              Based on the spectral information, Raman images enabled the
              localization of cortical and subcortical tumor cell aggregates
              with accuracy of roughly 250 $\mu$m. This study demonstrates the
              prospects of Raman spectroscopy as an intravital tool to detect
              cerebral pathologies and opens the field for biophotonic imaging
              of the living brain. Future investigations aim to reduce the
              exposure time from minutes to seconds and improve the lateral
              resolution.",
  journal  = "Anal. Bioanal. Chem.",
  volume   =  398,
  number   =  4,
  pages    = "1707--1713",
  month    =  oct,
  year     =  2010,
  language = "en"
}

@ARTICLE{Uckermann2014-at,
  title    = "Label-free delineation of brain tumors by coherent anti-Stokes
              Raman scattering microscopy in an orthotopic mouse model and
              human glioblastoma",
  author   = "Uckermann, Ortrud and Galli, Roberta and Tamosaityte, Sandra and
              Leipnitz, Elke and Geiger, Kathrin D and Schackert, Gabriele and
              Koch, Edmund and Steiner, Gerald and Kirsch, Matthias",
  abstract = "BACKGROUND: Coherent anti-Stokes Raman scattering (CARS)
              microscopy provides fine resolution imaging and displays
              morphochemical properties of unstained tissue. Here, we evaluated
              this technique to delineate and identify brain tumors. METHODS:
              Different human tumors (glioblastoma, brain metastases of
              melanoma and breast cancer) were induced in an orthotopic mouse
              model. Cryosections were investigated by CARS imaging tuned to
              probe C-H molecular vibrations, thereby addressing the lipid
              content of the sample. Raman microspectroscopy was used as
              reference. Histopathology provided information about the tumor's
              localization, cell proliferation and vascularization. RESULTS:
              The morphochemical contrast of CARS images enabled identifying
              brain tumors irrespective of the tumor type and properties: All
              tumors were characterized by a lower CARS signal intensity than
              the normal parenchyma. On this basis, tumor borders and
              infiltrations could be identified with cellular resolution.
              Quantitative analysis revealed that the tumor-related reduction
              of CARS signal intensity was more pronounced in glioblastoma than
              in metastases. Raman spectroscopy enabled relating the CARS
              intensity variation to the decline of total lipid content in the
              tumors. The analysis of the immunohistochemical stainings
              revealed no correlation between tumor-induced cytological changes
              and the extent of CARS signal intensity reductions. The results
              were confirmed on samples of human glioblastoma. CONCLUSIONS:
              CARS imaging enables label-free, rapid and objective
              identification of primary and secondary brain tumors. Therefore,
              it is a potential tool for diagnostic neuropathology as well as
              for intraoperative tumor delineation.",
  journal  = "PLoS One",
  volume   =  9,
  number   =  9,
  pages    = "e107115",
  month    =  sep,
  year     =  2014,
  language = "en"
}

@ARTICLE{Camp2014-cl,
  title    = "{High-Speed} Coherent Raman Fingerprint Imaging of Biological
              Tissues",
  author   = "Camp, Jr, Charles H and Lee, Young Jong and Heddleston, John M
              and Hartshorn, Christopher M and Hight Walker, Angela R and Rich,
              Jeremy N and Lathia, Justin D and Cicerone, Marcus T",
  abstract = "An imaging platform based on broadband coherent anti-Stokes Raman
              scattering (BCARS) has been developed which provides an
              advantageous combination of speed, sensitivity and spectral
              breadth. The system utilizes a configuration of laser sources
              that probes the entire biologically-relevant Raman window (500
              cm-1 to 3500 cm-1) with high resolution (< 10 cm-1). It strongly
              and efficiently stimulates Raman transitions within the typically
              weak ``fingerprint'' region using intrapulse 3-colour excitation,
              and utilizes the nonresonant background (NRB) to heterodyne
              amplify weak Raman signals. We demonstrate high-speed chemical
              imaging in two- and three-dimensional views of healthy murine
              liver and pancreas tissues and interfaces between xenograft brain
              tumours and the surrounding healthy brain matter.",
  journal  = "Nat. Photonics",
  volume   =  8,
  pages    = "627--634",
  year     =  2014,
  language = "en"
}

@ARTICLE{Sijens1996-ge,
  title     = "{1H} {MR} spectroscopy detection of lipids and lactate in
               metastatic brain tumors",
  author    = "Sijens, P E and Levendag, P C and Vecht, C J and van Dijk, P and
               Oudkerk, M",
  abstract  = "1H MR spectroscopy was used to correlate the metabolite signals
               in 66 untreated metastatic brain tumors with the results of
               Gd-DTPA enhanced MRI. Cubic volumes containing brain metastases
               of lung cancer (n = 17), mammary carcinoma (n = 24), melanoma (n
               = 12) and those originating from other tumors (n = 13) were
               examined using the double spin echo technique with CHESS pulses
               for water suppression and TE = 135 ms. Apart from trends toward
               reduced signals of choline-containing compounds (Cho) and
               reduced post-Gd MRI contrast in lung cancer compared with the
               other pathology groups, the four tumor groups had similar MRI
               and MRS characteristics. Metastases without lipid or lactate
               (Lact) signal in the 1H MR spectra were comparatively small in
               size with homogeneous post-Gd MRI enhancement (33 +/- 5\%, means
               +/- SEM; n = 24) and elevated Cho signals compared with normal
               contralateral brain tissue (70 +/- 5\% of contralateral N-acetyl
               aspartate signal; p < 0.001). The other metastases showed either
               unambiguous lipid signals (n = 30) or MRS detectable Lact (n =
               12) and were heterogeneous on MRI with divergent signals of
               Gd-enhancement (49 +/- 5\% vs 14 +/- 8\%, p < 0.001) and Cho (88
               +/- 10 vs 47 +/- 8\% of contralateral NAA; p = 0.02). Those with
               Lact were significantly larger compared with both other groups
               (p < 0.02, both). It is concluded that brain metastases can be
               categorized into early stage (Cho), intermediate stage (lipid,
               higher Cho) and late stage metastases (Lact, lower Cho).",
  journal   = "NMR Biomed.",
  publisher = "Wiley Online Library",
  volume    =  9,
  number    =  2,
  pages     = "65--71",
  month     =  apr,
  year      =  1996,
  language  = "en"
}

@ARTICLE{Le2009-av,
  title    = "Coherent anti-Stokes Raman scattering imaging of lipids in cancer
              metastasis",
  author   = "Le, Thuc T and Huff, Terry B and Cheng, Ji-Xin",
  abstract = "BACKGROUND: Lipid-rich tumours have been associated with
              increased cancer metastasis and aggressive clinical behaviours.
              Nonetheless, pathologists cannot classify lipid-rich tumours as a
              clinically distinctive form of carcinoma due to a lack of
              mechanistic understanding on the roles of lipids in cancer
              development. METHODS: Coherent anti-Stokes Raman scattering
              (CARS) microscopy is employed to study cancer cell behaviours in
              excess lipid environments in vivo and in vitro. The impacts of a
              high fat diet on cancer development are evaluated in a Balb/c
              mice cancer model. Intravital flow cytometry and histology are
              employed to enumerate cancer cell escape to the bloodstream and
              metastasis to lung tissues, respectively. Cancer cell motility
              and tissue invasion capability are also evaluated in excess lipid
              environments. RESULTS: CARS imaging reveals intracellular lipid
              accumulation is induced by excess free fatty acids (FFAs). Excess
              FFAs incorporation onto cancer cell membrane induces membrane
              phase separation, reduces cell-cell contact, increases surface
              adhesion, and promotes tissue invasion. Increased plasma FFAs
              level and visceral adiposity are associated with early rise in
              circulating tumour cells and increased lung metastasis.
              Furthermore, CARS imaging reveals FFAs-induced lipid accumulation
              in primary, circulating, and metastasized cancer cells.
              CONCLUSION: Lipid-rich tumours are linked to cancer metastasis
              through FFAs-induced physical perturbations on cancer cell
              membrane. Most importantly, the revelation of lipid-rich
              circulating tumour cells suggests possible development of CARS
              intravital flow cytometry for label-free detection of early-stage
              cancer metastasis.",
  journal  = "BMC Cancer",
  volume   =  9,
  pages    = "42",
  month    =  jan,
  year     =  2009,
  language = "en"
}

@ARTICLE{Livermore2019-fb,
  title    = "Rapid intraoperative molecular genetic classification of gliomas
              using Raman spectroscopy",
  author   = "Livermore, Laurent James and Isabelle, Martin and Bell, Ian Mac
              and Scott, Connor and Walsby-Tickle, John and Gannon, Joan and
              Plaha, Puneet and Vallance, Claire and Ansorge, Olaf",
  abstract = "Background: The molecular genetic classification of gliomas,
              particularly the identification of isocitrate dehydrogenase (IDH)
              mutations, is critical for clinical and surgical decision-making.
              Raman spectroscopy probes the unique molecular vibrations of a
              sample to accurately characterize its molecular composition. No
              sample processing is required allowing for rapid analysis of
              tissue. The aim of this study was to evaluate the ability of
              Raman spectroscopy to rapidly identify the common molecular
              genetic subtypes of diffuse glioma in the neurosurgical setting
              using fresh biopsy tissue. In addition, classification models
              were built using cryosections, formalin-fixed paraffin-embedded
              (FFPE) sections and LN-18 (IDH-mutated and wild-type parental
              cell) glioma cell lines. Methods: Fresh tissue, straight from
              neurosurgical theatres, underwent Raman analysis and
              classification into astrocytoma, IDH-wild-type; astrocytoma,
              IDH-mutant; or oligodendroglioma. The genetic subtype was
              confirmed on a parallel section using immunohistochemistry and
              targeted genetic sequencing. Results: Fresh tissue samples from
              62 patients were collected (36 astrocytoma, IDH-wild-type; 21
              astrocytoma, IDH-mutated; 5 oligodendroglioma). A principal
              component analysis fed linear discriminant analysis
              classification model demonstrated 79\%-94\% sensitivity and
              90\%-100\% specificity for predicting the 3 glioma genetic
              subtypes. For the prediction of IDH mutation alone, the model
              gave 91\% sensitivity and 95\% specificity. Seventy-nine
              cryosections, 120 FFPE samples, and LN18 cells were also
              successfully classified. Meantime for Raman data collection was
              9.5 min in the fresh tissue samples, with the process from
              intraoperative biopsy to genetic classification taking under 15
              min. Conclusion: These data demonstrate that Raman spectroscopy
              can be used for the rapid, intraoperative, classification of
              gliomas into common genetic subtypes.",
  journal  = "Neurooncol Adv",
  volume   =  1,
  number   =  1,
  pages    = "vdz008",
  month    =  may,
  year     =  2019,
  keywords = "Raman spectroscopy; brain tumor; intraoperative; isocitrate
              hydrogenase; personalized medicine",
  language = "en"
}

@ARTICLE{Anna2017-mk,
  title    = "Novel strategies of Raman imaging for brain tumor research",
  author   = "Anna, Imiela and Bartosz, Polis and Lech, Polis and Halina,
              Abramczyk",
  abstract = "Raman diagnostics and imaging have been shown to be an effective
              tool for the analysis and discrimination of human brain tumors
              from normal structures. Raman spectroscopic methods have
              potential to be applied in clinical practice as they allow for
              identification of tumor margins during surgery. In this study, we
              investigate medulloblastoma (grade IV WHO) (n= 5), low-grade
              astrocytoma (grades I-II WHO) (n =4), ependymoma (n=3) and
              metastatic brain tumors (n= 1) and the tissue from the negative
              margins used as normal controls. We compare a high grade
              medulloblastoma, low grade astrocytoma and non-tumor samples from
              human central nervous system (CNS) tissue. Based on the
              properties of the Raman vibrational features and Raman images we
              provide a real-time feedback method that is label-free to monitor
              tumor metabolism that reveals reprogramming of biosynthesis of
              lipids, proteins, DNA and RNA. Our results indicate marked
              metabolic differences between low and high grade brain tumors. We
              discuss molecular mechanisms causing these metabolic changes,
              particularly lipid alterations in malignant medulloblastoma and
              low grade gliomas that may shed light on the mechanisms driving
              tumor recurrence thereby revealing new approaches for the
              treatment of malignant glioma. We have found that the high-grade
              tumors of central nervous system (medulloblastoma) exhibit
              enhanced level of $\beta$-sheet conformation and down-regulated
              level of $\alpha$-helix conformation when comparing against
              normal tissue. We have found that almost all tumors studied in
              the paper have increased Raman signals of nucleic acids. This
              increase can be interpreted as increased DNA/RNA turnover in
              brain tumors. We have shown that the ratio of Raman intensities
              I2930/I2845 at 2930 and 2845 cm-1 is a good source of information
              on the ratio of lipid and protein contents. We have found that
              the ratio reflects the different lipid and protein contents of
              cancerous brain tissue compared to the non-tumor tissue. We found
              that levels of the saturated fatty acids were significantly
              reduced in the high grade medulloblastoma samples compared with
              non-tumor brain samples and low grade astrocytoma. Differences
              were also noted in the n-6/n-3 polyunsaturated fatty acids (PUFA)
              content between medulloblastoma and non-tumor brain samples. The
              content of the oleic acid (OA) was significantly smaller in
              almost all brain high grade brain tumors than that observed in
              the control samples. It indicates that the fatty acid composition
              of human brain tumors differs from that found in non-tumor brain
              tissue. The iodine number NI for the normal brain tissue is 60.
              For comparison OA has 87, docosahexaenoic acid (DHA) 464,
              $\alpha$-linolenic acid (ALA) 274. The high grade tumors have the
              iodine numbers between that for palmitic acid, stearic acid,
              arachidic acid (NI=0) and oleic acid (NI=87). Most low grade
              tumors have NI similar to that of OA. The iodine number for
              arachidonic acid (AA) (NI=334) is much higher than those observed
              for all studied samples.",
  journal  = "Oncotarget",
  volume   =  8,
  number   =  49,
  pages    = "85290--85310",
  month    =  oct,
  year     =  2017,
  keywords = "CNS; Raman imaging; Raman spectroscopy; brain tumor; iodine
              number",
  language = "en"
}

@ARTICLE{Zhou2019-ix,
  title    = "Optical biopsy identification and grading of gliomas using
              label-free visible resonance Raman spectroscopy",
  author   = "Zhou, Yan and Liu, Cheng-Hui and Wu, Binlin and Yu, Xinguang and
              Cheng, Gangge and Zhu, Ke and Wang, Kai and Zhang, Chunyuan and
              Zhao, Mingyue and Zong, Rui and Zhang, Lin and Shi, Lingyan and
              Alfano, Robert R",
  abstract = "Glioma is one of the most refractory types of brain tumor.
              Accurate tumor boundary identification and complete resection of
              the tumor are essential for glioma removal during brain surgery.
              We present a method based on visible resonance Raman (VRR)
              spectroscopy to identify glioma margins and grades. A set of
              diagnostic spectral biomarkers features are presented based on
              tissue composition changes revealed by VRR. The Raman spectra
              include molecular vibrational fingerprints of carotenoids,
              tryptophan, amide I/II/III, proteins, and lipids. These basic in
              situ spectral biomarkers are used to identify the tissue from the
              interface between brain cancer and normal tissue and to evaluate
              glioma grades. The VRR spectra are also analyzed using principal
              component analysis for dimension reduction and feature detection
              and support vector machine for classification. The
              cross-validated sensitivity, specificity, and accuracy are found
              to be 100\%, 96.3\%, and 99.6\% to distinguish glioma tissues
              from normal brain tissues, respectively. The area under the
              receiver operating characteristic curve for the classification is
              about 1.0. The accuracies to distinguish normal, low grade
              (grades I and II), and high grade (grades III and IV) gliomas are
              found to be 96.3\%, 53.7\%, and 84.1\% for the three groups,
              respectively, along with a total accuracy of 75.1\%. A set of
              criteria for differentiating normal human brain tissues from
              normal control tissues is proposed and used to identify brain
              cancer margins, yielding a diagnostic sensitivity of 100\% and
              specificity of 71\%. Our study demonstrates the potential of VRR
              as a label-free optical molecular histopathology method used for
              in situ boundary line judgment for brain surgery in the margins.",
  journal  = "J. Biomed. Opt.",
  volume   =  24,
  number   =  9,
  pages    = "1--12",
  month    =  sep,
  year     =  2019,
  keywords = "biomarkers; brain; carotenoids; glioblastoma; gliomas;
              histopathology; label-free; tryptophan",
  language = "en"
}

@ARTICLE{Shi2018-sr,
  title    = "Optical imaging of metabolic dynamics in animals",
  author   = "Shi, Lingyan and Zheng, Chaogu and Shen, Yihui and Chen, Zhixing
              and Silveira, Edilson S and Zhang, Luyuan and Wei, Mian and Liu,
              Chang and de Sena-Tomas, Carmen and Targoff, Kimara and Min, Wei",
  abstract = "Direct visualization of metabolic dynamics in living animals with
              high spatial and temporal resolution is essential to
              understanding many biological processes. Here we introduce a
              platform that combines deuterium oxide (D2O) probing with
              stimulated Raman scattering (DO-SRS) microscopy to image in situ
              metabolic activities. Enzymatic incorporation of D2O-derived
              deuterium into macromolecules generates carbon-deuterium (C-D)
              bonds, which track biosynthesis in tissues and can be imaged by
              SRS in situ. Within the broad vibrational spectra of C-D bonds,
              we discover lipid-, protein-, and DNA-specific Raman shifts and
              develop spectral unmixing methods to obtain C-D signals with
              macromolecular selectivity. DO-SRS microscopy enables us to probe
              de novo lipogenesis in animals, image protein biosynthesis
              without tissue bias, and simultaneously visualize lipid and
              protein metabolism and reveal their different dynamics. DO-SRS
              microscopy, being noninvasive, universally applicable, and
              cost-effective, can be adapted to a broad range of biological
              systems to study development, tissue homeostasis, aging, and
              tumor heterogeneity.",
  journal  = "Nat. Commun.",
  volume   =  9,
  number   =  1,
  pages    = "2995",
  month    =  aug,
  year     =  2018,
  language = "en"
}

@ARTICLE{Hu2016-wj,
  title    = "Bioorthogonal chemical imaging of metabolic activities in live
              mammalian hippocampal tissues with stimulated Raman scattering",
  author   = "Hu, Fanghao and Lamprecht, Michael R and Wei, Lu and Morrison,
              Barclay and Min, Wei",
  abstract = "Brain is an immensely complex system displaying dynamic and
              heterogeneous metabolic activities. Visualizing cellular
              metabolism of nucleic acids, proteins, and lipids in brain with
              chemical specificity has been a long-standing challenge. Recent
              development in metabolic labeling of small biomolecules allows
              the study of these metabolisms at the global level. However,
              these techniques generally require nonphysiological sample
              preparation for either destructive mass spectrometry imaging or
              secondary labeling with relatively bulky fluorescent labels. In
              this study, we have demonstrated bioorthogonal chemical imaging
              of DNA, RNA, protein and lipid metabolism in live rat brain
              hippocampal tissues by coupling stimulated Raman scattering
              microscopy with integrated deuterium and alkyne labeling.
              Heterogeneous metabolic incorporations for different molecular
              species and neurogenesis with newly-incorporated DNA were
              observed in the dentate gyrus of hippocampus at the single cell
              level. We further applied this platform to study metabolic
              responses to traumatic brain injury in hippocampal slice
              cultures, and observed marked upregulation of protein and lipid
              metabolism particularly in the hilus region of the hippocampus
              within days of mechanical injury. Thus, our method paves the way
              for the study of complex metabolic profiles in live brain tissue
              under both physiological and pathological conditions with
              single-cell resolution and minimal perturbation.",
  journal  = "Sci. Rep.",
  volume   =  6,
  pages    = "39660",
  month    =  dec,
  year     =  2016,
  language = "en"
}

@ARTICLE{Jermyn2017-vg,
  title     = "Highly Accurate Detection of Cancer In Situ with Intraoperative,
               {Label-Free}, Multimodal Optical Spectroscopy",
  author    = "Jermyn, Michael and Mercier, Jeanne and Aubertin, Kelly and
               Desroches, Joannie and Urmey, Kirk and Karamchandiani, Jason and
               Marple, Eric and Guiot, Marie-Christine and Leblond, Frederic
               and Petrecca, Kevin",
  abstract  = "Effectiveness of surgery as a cancer treatment is reduced when
               all cancer cells are not detected during surgery, leading to
               recurrences that negatively impact survival. To maximize cancer
               cell detection during cancer surgery, we designed an in situ
               intraoperative, label-free, optical cancer detection system that
               combines intrinsic fluorescence spectroscopy, diffuse
               reflectance spectroscopy, and Raman spectroscopy. Using this
               multimodal optical cancer detection system, we found that brain,
               lung, colon, and skin cancers could be detected in situ during
               surgery with an accuracy, sensitivity, and specificity of 97\%,
               100\%, and 93\%, respectively. This highly sensitive optical
               molecular imaging approach can profoundly impact a wide range of
               surgical and noninvasive interventional oncology procedures by
               improving cancer detection capabilities, thereby reducing cancer
               burden and improving survival and quality of life. Cancer Res;
               77(14); 3942-50. \copyright{}2017 AACR.",
  journal   = "Cancer Res.",
  publisher = "AACR",
  volume    =  77,
  number    =  14,
  pages     = "3942--3950",
  month     =  jul,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Raman1928-cj,
  title    = "A New Type of Secondary Radiation",
  author   = "Raman, C V and Krishnan, K S",
  abstract = "IF we assume that the X-ray scattering of the `unmodified' type
              observed by Prof. Compton corresponds to the normal or average
              state of the atoms and molecules, while the `modified' scattering
              of altered wave-length corresponds to their fluctuations from
              that state, it would follow that we should expect also in the
              case of ordinary light two types of scattering, one determined by
              the normal optical properties of the atoms or molecules, and
              another representing the effect of their fluctuations from their
              normal state. It accordingly becomes necessary to test whether
              this is actually the case. The experiments we have made have
              confirmed this anticipation, and shown that in every case in
              which light is scattered by the molecules in dust-free liquids or
              gases, the diffuse radiation of the ordinary kind, having the
              same wave-length as the incident beam, is accompanied by a
              modified scattered radiation of degraded frequency.",
  journal  = "Nature",
  volume   =  121,
  number   =  3048,
  pages    = "501--502",
  month    =  mar,
  year     =  1928
}

@ARTICLE{Desroches2015-ak,
  title    = "Characterization of a Raman spectroscopy probe system for
              intraoperative brain tissue classification",
  author   = "Desroches, Joannie and Jermyn, Michael and Mok, Kelvin and
              Lemieux-Leduc, C{\'e}dric and Mercier, Jeanne and St-Arnaud, Karl
              and Urmey, Kirk and Guiot, Marie-Christine and Marple, Eric and
              Petrecca, Kevin and Leblond, Fr{\'e}d{\'e}ric",
  abstract = "A detailed characterization study is presented of a Raman
              spectroscopy system designed to maximize the volume of resected
              cancer tissue in glioma surgery based on in vivo molecular tissue
              characterization. It consists of a hand-held probe system
              measuring spectrally resolved inelastically scattered light
              interacting with tissue, designed and optimized for in vivo
              measurements. Factors such as linearity of the signal with
              integration time and laser power, and their impact on signal to
              noise ratio, are studied leading to optimal data acquisition
              parameters. The impact of ambient light sources in the operating
              room is assessed and recommendations made for optimal operating
              conditions. In vivo Raman spectra of normal brain, cancer and
              necrotic tissue were measured in 10 patients, demonstrating that
              real-time inelastic scattering measurements can distinguish
              necrosis from vital tissue (including tumor and normal brain
              tissue) with an accuracy of 87\%, a sensitivity of 84\% and a
              specificity of 89\%.",
  journal  = "Biomed. Opt. Express",
  volume   =  6,
  number   =  7,
  pages    = "2380--2397",
  month    =  jul,
  year     =  2015,
  keywords = "(170.5660) Raman spectroscopy; (170.6510) Spectroscopy, tissue
              diagnostics",
  language = "en"
}

@ARTICLE{Fu2014-hg,
  title    = "Imaging the intracellular distribution of tyrosine kinase
              inhibitors in living cells with quantitative hyperspectral
              stimulated Raman scattering",
  author   = "Fu, Dan and Zhou, Jing and Zhu, Wenjing Suzanne and Manley, Paul
              W and Wang, Y Karen and Hood, Tami and Wylie, Andrew and Xie, X
              Sunney",
  abstract = "ABL1 tyrosine-kinase inhibitors (TKI) are front-line therapy for
              chronic myelogenous leukaemia and are among the best-known
              examples of targeted cancer therapeutics. However, the dynamic
              uptake into cells of TKIs of low molecular weight and their
              intracellular behaviour is unknown because of the difficulty of
              observing non-fluorescent small molecules at subcellular
              resolution. Here we report the direct label-free visualization
              and quantification of two TKI drugs (imatinib and nilotinib)
              inside living cells using hyperspectral stimulated Raman
              scattering imaging. Concentrations of both drugs were enriched
              over 1,000-fold in lysosomes as a result of their lysosomotropic
              properties. In addition, low solubility appeared to contribute
              significantly to the surprisingly large accumulation of
              nilotinib. We further show that the lysosomal trapping of
              imatinib was reduced more than tenfold when chloroquine is used
              simultaneously, which suggests that chloroquine may increase the
              efficacy of TKIs through lysosome-mediated drug-drug interaction
              in addition to the commonly proposed autophagy-inhibition
              mechanism.",
  journal  = "Nat. Chem.",
  volume   =  6,
  number   =  7,
  pages    = "614--622",
  month    =  jul,
  year     =  2014,
  language = "en"
}

@ARTICLE{Krafft2005-ig,
  title    = "Near infrared Raman spectra of human brain lipids",
  author   = "Krafft, Christoph and Neudert, Lars and Simat, Thomas and Salzer,
              Reiner",
  abstract = "Human brain tissue, in particular white matter, contains high
              lipid content. These brain lipids can be divided into three
              principal classes: neutral lipids including the steroid
              cholesterol, phospholipids and sphingolipids. Major lipids in
              normal human brain tissue are phosphatidylcholine,
              phosphatidylethanolamine, phosphatidylserine,
              phosphatidylinositol, phosphatidic acid, sphingomyelin,
              galactocerebrosides, gangliosides, sulfatides and cholesterol.
              Minor lipids are cholesterolester and triacylglycerides. During
              transformation from normal brain tissue to tumors, composition
              and concentration of lipids change in a specific way. Therefore,
              analysis of lipids might be used as a diagnostic parameter to
              distinguish normal tissue from tumors and to determine the tumor
              type and tumor grade. Raman spectroscopy has been suggested as an
              analytical tool to detect these changes even under
              intra-operative conditions. We recorded Raman spectra of the 12
              major and minor brain lipids with 785 nm excitation in order to
              identify their spectral fingerprints for qualitative and
              quantitative analyses.",
  journal  = "Spectrochim. Acta A Mol. Biomol. Spectrosc.",
  volume   =  61,
  number   =  7,
  pages    = "1529--1535",
  month    =  may,
  year     =  2005,
  language = "en"
}

@ARTICLE{Kohler2009-wm,
  title    = "Characterization of lipid extracts from brain tissue and tumors
              using Raman spectroscopy and mass spectrometry",
  author   = "K{\"o}hler, Milena and Machill, Susanne and Salzer, Reiner and
              Krafft, Christoph",
  abstract = "Brain tissue is characterized by high lipid content. The amount
              of lipids decreases, and its composition changes in the most
              frequent primary brain tumor, the glioma. Scope of the current
              paper was to extract quantitatively lipids from porcine and human
              brain tissue as well as from five human gliomas using a modified
              protocol according to Folch. The lipid extracts were studied by
              Raman spectroscopy with 785 nm excitation and by mass
              spectrometry with electron impact ionization. Porcine and human
              brain tissues have similar water and lipid content and show
              similar Raman and mass spectra. In contrast, gliomas are
              characterized by increased water content and decreased lipid
              content. Elevated phosphatidylcholine to cholesterol ratios in
              lipid extracts of gliomas were indicated by Raman bands of the
              choline group and cholesterol. Due to its higher sensitivity,
              mass spectrometry detected increased levels of cholesterol ester
              relative to cholesterol in lipid extracts of gliomas. For
              comparison, thin tissue sections were prepared from the glioma
              specimens before lipid extraction; infrared spectroscopic images
              were recorded and analyzed by a supervised classification model.
              This study demonstrates how to improve the analysis of brain
              tumors and to complement the diagnosis of brain pathologies using
              a multimodal approach.",
  journal  = "Anal. Bioanal. Chem.",
  volume   =  393,
  number   =  5,
  pages    = "1513--1520",
  month    =  mar,
  year     =  2009,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Kast2014-co,
  title    = "Raman molecular imaging of brain frozen tissue sections",
  author   = "Kast, Rachel E and Auner, Gregory W and Rosenblum, Mark L and
              Mikkelsen, Tom and Yurgelevic, Sally M and Raghunathan, Aditya
              and Poisson, Laila M and Kalkanis, Steven N",
  abstract = "Raman spectroscopy provides a molecular signature of the region
              being studied. It is ideal for neurosurgical applications because
              it is non-destructive, label-free, not impacted by water
              concentration, and can map an entire region of tissue. The
              objective of this paper is to demonstrate the meaningful spatial
              molecular information provided by Raman spectroscopy for
              identification of regions of normal brain, necrosis, diffusely
              infiltrating glioma and solid glioblastoma (GBM). Five frozen
              section tissues (1 normal, 1 necrotic, 1 GBM, and 2 infiltrating
              glioma) were mapped in their entirety using a 300-Âµm-square step
              size. Smaller regions of interest were also mapped using a 25-Âµm
              step size. The relative concentrations of relevant biomolecules
              were mapped across all tissues and compared with adjacent
              hematoxylin and eosin-stained sections, allowing identification
              of normal, GBM, and necrotic regions. Raman peaks and peak ratios
              mapped included 1003, 1313, 1431, 1585, and 1659 cm(-1). Tissue
              maps identified boundaries of grey and white matter, necrosis,
              GBM, and infiltrating tumor. Complementary information, including
              relative concentration of lipids, protein, nucleic acid, and
              hemoglobin, was presented in a manner which can be easily adapted
              for in vivo tissue mapping. Raman spectroscopy can successfully
              provide label-free imaging of tissue characteristics with high
              accuracy. It can be translated to a surgical or laboratory tool
              for rapid, non-destructive imaging of tumor margins.",
  journal  = "J. Neurooncol.",
  volume   =  120,
  number   =  1,
  pages    = "55--62",
  month    =  oct,
  year     =  2014,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Kast2015-vp,
  title    = "Identification of regions of normal grey matter and white matter
              from pathologic glioblastoma and necrosis in frozen sections
              using Raman imaging",
  author   = "Kast, Rachel and Auner, Gregory and Yurgelevic, Sally and
              Broadbent, Brandy and Raghunathan, Aditya and Poisson, Laila M
              and Mikkelsen, Tom and Rosenblum, Mark L and Kalkanis, Steven N",
  abstract = "In neurosurgical applications, a tool capable of distinguishing
              grey matter, white matter, and areas of tumor and/or necrosis in
              near-real time could greatly aid in tumor resection decision
              making. Raman spectroscopy is a non-destructive spectroscopic
              technique which provides molecular information about the tissue
              under examination based on the vibrational properties of the
              constituent molecules. With careful measurement and data
              processing, a spatial step and repeat acquisition of Raman
              spectra can be used to create Raman images. Forty frozen brain
              tissue sections were imaged in their entirety using a
              300-Âµm-square measurement grid, and two or more regions of
              interest within each tissue were also imaged using a 25 Âµm-square
              step size. Molecular correlates for histologic features of
              interest were identified within the Raman spectra, and novel
              imaging algorithms were developed to compare molecular features
              across multiple tissues. In previous work, the relative
              concentration of individual biomolecules was imaged. Here, the
              relative concentrations of 1004, 1300:1344, and 1660 cm(-1),
              which correspond primarily to protein and lipid content, were
              simultaneously imaged across all tissues. This provided simple
              interpretation of boundaries between grey matter, white matter,
              and diseased tissue, and corresponded with findings from adjacent
              hematoxylin and eosin-stained sections. This novel, yet simple,
              multi-channel imaging technique allows clinically-relevant
              resolution with straightforward molecular interpretation of Raman
              images not possible by imaging any single peak. This method can
              be applied to either surgical or laboratory tools for rapid,
              non-destructive imaging of grey and white matter.",
  journal  = "J. Neurooncol.",
  volume   =  125,
  number   =  2,
  pages    = "287--295",
  month    =  nov,
  year     =  2015,
  keywords = "Grey matter; Raman imaging; Raman spectroscopy; White matter",
  language = "en"
}

@ARTICLE{Chen2019-qi,
  title    = "An augmented reality microscope with real-time artificial
              intelligence integration for cancer diagnosis",
  author   = "Chen, Po-Hsuan Cameron and Gadepalli, Krishna and MacDonald,
              Robert and Liu, Yun and Kadowaki, Shiro and Nagpal, Kunal and
              Kohlberger, Timo and Dean, Jeffrey and Corrado, Greg S and Hipp,
              Jason D and Mermel, Craig H and Stumpe, Martin C",
  abstract = "The microscopic assessment of tissue samples is instrumental for
              the diagnosis and staging of cancer, and thus guides therapy.
              However, these assessments demonstrate considerable variability
              and many regions of the world lack access to trained
              pathologists. Though artificial intelligence (AI) promises to
              improve the access and quality of healthcare, the costs of image
              digitization in pathology and difficulties in deploying AI
              solutions remain as barriers to real-world use. Here we propose a
              cost-effective solution: the augmented reality microscope (ARM).
              The ARM overlays AI-based information onto the current view of
              the sample in real time, enabling seamless integration of AI into
              routine workflows. We demonstrate the utility of ARM in the
              detection of metastatic breast cancer and the identification of
              prostate cancer, with latency compatible with real-time use. We
              anticipate that the ARM will remove barriers towards the use of
              AI designed to improve the accuracy and efficiency of cancer
              diagnosis.",
  journal  = "Nat. Med.",
  volume   =  25,
  number   =  9,
  pages    = "1453--1457",
  month    =  sep,
  year     =  2019,
  language = "en"
}

@ARTICLE{noauthor_2018-vd,
  title    = "Evaluation of Complications and Costs During Overlapping
              Transsphenoidal Surgery in the Treatment of Pituitary Adenoma",
  journal  = "Neurosurgery",
  volume   =  83,
  number   =  4,
  pages    = "845",
  month    =  oct,
  year     =  2018,
  language = "en"
}

@ARTICLE{Duchi2011-qi,
  title   = "Adaptive Subgradient Methods for Online Learning and Stochastic
             Optimization",
  author  = "Duchi, John",
  journal = "J. Mach. Learn. Res.",
  volume  =  12,
  pages   = "2121--2159",
  year    =  2011
}

@ARTICLE{Thust2018-wz,
  title    = "Pseudoprogression of brain tumors",
  author   = "Thust, Stefanie C and van den Bent, Martin J and Smits, Marion",
  abstract = "This review describes the definition, incidence, clinical
              implications, and magnetic resonance imaging (MRI) findings of
              pseudoprogression of brain tumors, in particular, but not limited
              to, high-grade glioma. Pseudoprogression is an important clinical
              problem after brain tumor treatment, interfering not only with
              day-to-day patient care but also the execution and interpretation
              of clinical trials. Radiologically, pseudoprogression is defined
              as a new or enlarging area(s) of contrast agent enhancement, in
              the absence of true tumor growth, which subsides or stabilizes
              without a change in therapy. The clinical definitions of
              pseudoprogression have been quite variable, which may explain
              some of the differences in reported incidences, which range from
              9-30\%. Conventional structural MRI is insufficient for
              distinguishing pseudoprogression from true progressive disease,
              and advanced imaging is needed to obtain higher levels of
              diagnostic certainty. Perfusion MRI is the most widely used
              imaging technique to diagnose pseudoprogression and has high
              reported diagnostic accuracy. Diagnostic performance of MR
              spectroscopy (MRS) appears to be somewhat higher, but MRS is less
              suitable for the routine and universal application in brain tumor
              follow-up. The combination of MRS and diffusion-weighted imaging
              and/or perfusion MRI seems to be particularly powerful, with
              diagnostic accuracy reaching up to or even greater than 90\%.
              While diagnostic performance can be high with appropriate
              implementation and interpretation, even a combination of
              techniques, however, does not provide 100\% accuracy. It should
              also be noted that most studies to date are small, heterogeneous,
              and retrospective in nature. Future improvements in diagnostic
              accuracy can be expected with harmonization of acquisition and
              postprocessing, quantitative MRI and computer-aided diagnostic
              technology, and meticulous evaluation with clinical and
              pathological data. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage
              2 J. Magn. Reson. Imaging 2018.",
  journal  = "J. Magn. Reson. Imaging",
  month    =  may,
  year     =  2018,
  keywords = "MRI; brain neoplasms; diffusion; glioma; magnetic resonance
              imaging; perfusion weighted; proton magnetic resonance
              spectroscopy",
  language = "en"
}

@ARTICLE{Bergstra2012-mr,
  title    = "Random Search for {Hyper-Parameter} Optimization",
  author   = "Bergstra, James and Bengio, Yoshua",
  journal  = "J. Mach. Learn. Res.",
  volume   =  13,
  number   = "Feb",
  pages    = "281--305",
  year     =  2012
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Thust2018-hw,
  title    = "Glioma imaging in Europe: A survey of 220 centres and
              recommendations for best clinical practice",
  author   = "Thust, S C and Heiland, S and Falini, A and J{\"a}ger, H R and
              Waldman, A D and Sundgren, P C and Godi, C and Katsaros, V K and
              Ramos, A and Bargallo, N and Vernooij, M W and Yousry, T and
              Bendszus, M and Smits, M",
  abstract = "OBJECTIVES: At a European Society of Neuroradiology (ESNR) Annual
              Meeting 2015 workshop, commonalities in practice, current
              controversies and technical hurdles in glioma MRI were discussed.
              We aimed to formulate guidance on MRI of glioma and determine its
              feasibility, by seeking information on glioma imaging practices
              from the European Neuroradiology community. METHODS: Invitations
              to a structured survey were emailed to ESNR members (n=1,662) and
              associates (n=6,400), European national radiologists' societies
              and distributed via social media. RESULTS: Responses were
              received from 220 institutions (59\% academic). Conventional
              imaging protocols generally include T2w, T2-FLAIR, DWI, and pre-
              and post-contrast T1w. Perfusion MRI is used widely (85.5\%),
              while spectroscopy seems reserved for specific indications.
              Reasons for omitting advanced imaging modalities include lack of
              facility/software, time constraints and no requests. Early
              postoperative MRI is routinely carried out by 74\% within 24-72
              h, but only 17\% report a percent measure of resection. For
              follow-up, most sites (60\%) issue qualitative reports, while
              27\% report an assessment according to the RANO criteria. A
              minority of sites use a reporting template (23\%). CONCLUSION:
              Clinical best practice recommendations for glioma imaging
              assessment are proposed and the current role of advanced MRI
              modalities in routine use is addressed. KEY POINTS: â€¢ We
              recommend the EORTC-NBTS protocol as the clinical standard glioma
              protocol. â€¢ Perfusion MRI is recommended for diagnosis and
              follow-up of glioma. â€¢ Use of advanced imaging could be promoted
              with increased education activities. â€¢ Most response assessment
              is currently performed qualitatively. â€¢ Reporting templates are
              not widely used, and could facilitate standardisation.",
  journal  = "Eur. Radiol.",
  volume   =  28,
  number   =  8,
  pages    = "3306--3317",
  month    =  aug,
  year     =  2018,
  keywords = "Brain neoplasms; Glioma; Guideline; Magnetic resonance imaging;
              Surveys and questionnaires",
  language = "en"
}

@ARTICLE{Abbasi2018-au,
  title    = "Incidence of Tumour Progression and Pseudoprogression in
              {High-Grade} Gliomas: a Systematic Review and {Meta-Analysis}",
  author   = "Abbasi, Abdul W and Westerlaan, Henriette E and Holtman, Gea A
              and Aden, Kamal M and van Laar, Peter Jan and van der Hoorn,
              Anouk",
  abstract = "BACKGROUND: High-grade gliomas are the most common primary brain
              tumours. Pseudoprogression describes the false appearance of
              radiation-induced progression on MRI. A distinction should be
              made from true tumour progression to correctly plan treatment.
              However, there is wide variation of reported pseudoprogression.
              We thus aimed to establish the incidence of pseudoprogression and
              tumour progression in high-grade glioma patients with a
              systematic review and meta-analysis. METHODS: We searched PubMed,
              Embase and Web of Science on the incidence of pseudoprogression
              and tumour progression in adult high-grade glioma patients from
              2005, the latest on 8 October 2014. Histology or imaging
              follow-up was used as reference standard. Extracted data included
              number of patients with worsening of imaging findings on T1
              postcontrast or T2/FLAIR, pseudoprogression and tumour
              progression. Study quality was assessed. Heterogeneity was tested
              with I 2 . Pooling of the results was done with random models
              using Metaprop in STATA (StataCorp. Stata Statistical Software.
              College Station, TX: StataCorp LP). RESULTS: We identified 73
              studies. MRI progression occurred in 2603 patients. Of these,
              36\% (95\% confidence interval [CI] 33-40\%) demonstrated
              pseudoprogression, 60\% (95\%CI 56-64\%) tumour progression and
              unknown outcome was present in the remaining 4\% of the patients
              (range 1-37\%). CONCLUSION: This meta-analysis demonstrated for
              the first time a notably high pooled incidence of
              pseudoprogression in patients with a form of progression across
              the available literature. This highlighted the full extent of the
              problem of the currently conventional MRI-based Response
              Assessment in Neuro-Oncology (RANO) criteria for treatment
              evaluation in high-grade gliomas. This underscores the need for
              more accurate treatment evaluation using advanced imaging to
              improve diagnostic accuracy and therapeutic approach.",
  journal  = "Clin. Neuroradiol.",
  volume   =  28,
  number   =  3,
  pages    = "401--411",
  month    =  sep,
  year     =  2018,
  keywords = "High-grade gliomas; Incidence; Meta-analysis; Pseudoprogression;
              Treatment response assessment",
  language = "en"
}

@ARTICLE{Ramakrishna2015-fz,
  title    = "Outcomes in Reoperated {Low-Grade} Gliomas",
  author   = "Ramakrishna, Rohan and Hebb, Adam and Barber, Jason and
              Rostomily, Robert and Silbergeld, Daniel",
  abstract = "BACKGROUND: Low-grade gliomas (LGGs) comprise a diverse set of
              intrinsic brain tumors that correlate strongly with survival.
              Data on the effect of reoperation are sparse. OBJECTIVE: To
              evaluate the effect of reoperation on patients with LGG. METHODS:
              Fifty-two consecutive patients with reoperated LGGs treated at
              the University of Washington between 1986 and 2004 were
              identified and evaluated in a retrospective analysis. RESULTS:
              The average overall survival (OS) for this cohort was 12.95 $\pm$
              0.96 years. The overall 10-year survival rate was 57\%. The
              absence of any residual tumor at either the first or second
              operation was associated with significantly increased OS.
              Negative prognostic variables for OS included the use of upfront
              radiation and pathology at recurrence. The average overall
              progression-free survival to the first recurrence (PFS1) was 6.23
              $\pm$ 0.51 years. Positive prognostic factors for improved PFS1
              included the use of upfront radiation therapy. Variables not
              associated with differences in PFS1 included the use of upfront
              chemotherapy, enhancement, pathology, extent of resection, the
              presence of residual tumor, and Karnofsky Performance Scale score
              <80. The average overall progression-free survival to the second
              recurrence was 2.73 $\pm$ 0.39 years. Pathology at recurrence was
              associated with significant differences in progression-free
              survival to the second recurrence, as was extent of resection at
              time of first recurrence, and Karnofsky Performance Scale score
              <80. CONCLUSION: This is among the largest studies to assess
              variables associated with outcome in patients with reoperated
              LGG. Reresection appears to provide significant benefit, and
              extent of resection remains the strongest predictor of OS.",
  journal  = "Neurosurgery",
  volume   =  77,
  number   =  2,
  pages    = "175--84; discussion 184",
  month    =  aug,
  year     =  2015,
  language = "en"
}

@INPROCEEDINGS{He2015-ta,
  title     = "Delving Deep into Rectifiers: Surpassing {Human-Level}
               Performance on {ImageNet} Classification",
  booktitle = "Proceedings of the 2015 {IEEE} International Conference on
               Computer Vision ({ICCV})",
  author    = "He, Kaiming and Zhang, Xiangyu and Ren, Shaoqing and Sun, Jian",
  publisher = "IEEE Computer Society",
  pages     = "1026--1034",
  series    = "ICCV '15",
  year      =  2015,
  address   = "Washington, DC, USA"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Erhan2009-ti,
  title     = "Visualizing higher-layer features of a deep network",
  author    = "Erhan, D and Bengio, Y and Courville, A and Vincent, P",
  abstract  = "Deep architectures have demonstrated state-of-the-art results in
               a variety of settings, especially with vision datasets. Beyond
               the model definitions and the quantitative analyses, there is a
               need for qualitative comparisons of the solutions learned by
               various deep architectures. The goal of this paper is to find
               good qualitative interpretations of high level features
               represented by such models. To this end, we contrast and compare
               several techniques applied on Stacked Denoising Autoencoders and
               Deep Belief Networks, trained â€¦",
  journal   = "University of Montreal",
  publisher = "researchgate.net",
  year      =  2009
}

@INPROCEEDINGS{Hou2016-fq,
  title     = "{Patch-Based} Convolutional Neural Network for Whole Slide
               Tissue Image Classification",
  booktitle = "2016 {IEEE} Conference on Computer Vision and Pattern
               Recognition ({CVPR})",
  author    = "Hou, L and Samaras, D and Kurc, T M and Gao, Y and Davis, J E
               and Saltz, J H",
  abstract  = "Convolutional Neural Networks (CNN) are state-of-theart models
               for many image classification tasks. However, to recognize
               cancer subtypes automatically, training a CNN on gigapixel
               resolution Whole Slide Tissue Images (WSI) is currently
               computationally impossible. The differentiation of cancer
               subtypes is based on cellular-level visual features observed on
               image patch scale. Therefore, we argue that in this situation,
               training a patch-level classifier on image patches will perform
               better than or similar to an image-level classifier. The
               challenge becomes how to intelligently combine patch-level
               classification results and model the fact that not all patches
               will be discriminative. We propose to train a decision fusion
               model to aggregate patch-level predictions given by patch-level
               CNNs, which to the best of our knowledge has not been shown
               before. Furthermore, we formulate a novel
               Expectation-Maximization (EM) based method that automatically
               locates discriminative patches robustly by utilizing the spatial
               relationships of patches. We apply our method to the
               classification of glioma and non-small-cell lung carcinoma cases
               into subtypes. The classification accuracy of our method is
               similar to the inter-observer agreement between pathologists.
               Although it is impossible to train CNNs on WSIs, we
               experimentally demonstrate using a comparable non-cancer dataset
               of smaller images that a patch-based CNN can outperform an
               image-based CNN.",
  pages     = "2424--2433",
  month     =  jun,
  year      =  2016,
  keywords  = "cancer;image classification;learning (artificial
               intelligence);medical image processing;neural
               nets;optimisation;patch-based convolutional neural
               network;patch-based CNN;whole slide tissue image
               classification;WSI;CNN training;cancer subtype
               differentiation;cellular-level visual features;image patch
               scale;patch-level classifier;decision fusion model
               training;patch-level prediction aggregation;patch-level
               CNN;expectation-maximization based method;EM based
               method;discriminative patch automatic location;patch spatial
               relationships;glioma classification;nonsmall-cell lung
               carcinoma;Cancer;Training;Image resolution;Robustness;Predictive
               models;Neural networks;Visualization"
}

@ARTICLE{Oppenlander2014-sg,
  title    = "An extent of resection threshold for recurrent glioblastoma and
              its risk for neurological morbidity",
  author   = "Oppenlander, Mark E and Wolf, Andrew B and Snyder, Laura A and
              Bina, Robert and Wilson, Jeffrey R and Coons, Stephen W and
              Ashby, Lynn S and Brachman, David and Nakaji, Peter and Porter,
              Randall W and Smith, Kris A and Spetzler, Robert F and Sanai,
              Nader",
  abstract = "OBJECT: Despite improvements in the medical and surgical
              management of patients with glioblastoma, tumor recurrence
              remains inevitable. For recurrent glioblastoma, however, the
              clinical value of a second resection remains uncertain.
              Specifically, what proportion of contrast-enhancing recurrent
              glioblastoma tissue must be removed to improve overall survival
              and what is the neurological cost of incremental resection beyond
              this threshold? METHODS: The authors identified 170 consecutive
              patients with recurrent supratentorial glioblastomas treated at
              the Barrow Neurological Institute from 2001 to 2011. All patients
              previously had a de novo glioblastoma and following their initial
              resection received standard temozolomide and fractionated
              radiotherapy. RESULTS: The mean clinical follow-up was 22.6
              months and no patient was lost to follow-up. At the time of
              recurrence, the median preoperative tumor volume was 26.1 cm(3).
              Following re-resection, median postoperative tumor volume was 3.1
              cm(3), equating to an 87.4\% extent of resection (EOR). The
              median overall survival was 19.0 months, with a median
              progression-free survival following re-resection of 5.2 months.
              Using Cox proportional hazards analysis, the variables of age,
              Karnofsky Performance Scale (KPS) score, and EOR were predictive
              of survival following repeat resection (p = 0.0001).
              Interestingly, a significant survival advantage was noted with as
              little as 80\% EOR. Recursive partitioning analysis validated
              these findings and provided additional risk stratification at the
              highest levels of EOR. Overall, at 7 days after surgery, a
              deterioration in the NIH stroke scale score by 1 point or more
              was observed in 39.1\% of patients with EOR $\geq$ 80\% as
              compared with 16.7\% for those with EOR < 80\% (p = 0.0049). This
              disparity in neurological morbidity, however, did not endure
              beyond 30 days postoperatively (p = 0.1279). CONCLUSIONS: For
              recurrent glioblastomas, an improvement in overall survival can
              be attained beyond an 80\% EOR. This survival benefit must be
              balanced against the risk of neurological morbidity, which does
              increase with more aggressive cytoreduction, but only in the
              early postoperative period. Interestingly, this putative EOR
              threshold closely approximates that reported for newly diagnosed
              glioblastomas, suggesting that for a subset of patients, the
              survival benefit of microsurgical resection does not diminish
              despite biological progression.",
  journal  = "J. Neurosurg.",
  volume   =  120,
  number   =  4,
  pages    = "846--853",
  month    =  apr,
  year     =  2014,
  language = "en"
}

@ARTICLE{Liau2018-jc,
  title    = "First results on survival from a large Phase 3 clinical trial of
              an autologous dendritic cell vaccine in newly diagnosed
              glioblastoma",
  author   = "Liau, Linda M and Ashkan, Keyoumars and Tran, David D and
              Campian, Jian L and Trusheim, John E and Cobbs, Charles S and
              Heth, Jason A and Salacz, Michael and Taylor, Sarah and D'Andre,
              Stacy D and Iwamoto, Fabio M and Dropcho, Edward J and Moshel,
              Yaron A and Walter, Kevin A and Pillainayagam, Clement P and
              Aiken, Robert and Chaudhary, Rekha and Goldlust, Samuel A and
              Bota, Daniela A and Duic, Paul and Grewal, Jai and Elinzano,
              Heinrich and Toms, Steven A and Lillehei, Kevin O and Mikkelsen,
              Tom and Walbert, Tobias and Abram, Steven R and Brenner, Andrew J
              and Brem, Steven and Ewend, Matthew G and Khagi, Simon and
              Portnow, Jana and Kim, Lyndon J and Loudon, William G and
              Thompson, Reid C and Avigan, David E and Fink, Karen L and
              Geoffroy, Francois J and Lindhorst, Scott and Lutzky, Jose and
              Sloan, Andrew E and Schackert, Gabriele and Krex, Dietmar and
              Meisel, Hans-Jorg and Wu, Julian and Davis, Raphael P and Duma,
              Christopher and Etame, Arnold B and Mathieu, David and Kesari,
              Santosh and Piccioni, David and Westphal, Manfred and Baskin,
              David S and New, Pamela Z and Lacroix, Michel and May, Sven-Axel
              and Pluard, Timothy J and Tse, Victor and Green, Richard M and
              Villano, John L and Pearlman, Michael and Petrecca, Kevin and
              Schulder, Michael and Taylor, Lynne P and Maida, Anthony E and
              Prins, Robert M and Cloughesy, Timothy F and Mulholland, Paul and
              Bosch, Marnix L",
  abstract = "BACKGROUND: Standard therapy for glioblastoma includes surgery,
              radiotherapy, and temozolomide. This Phase 3 trial evaluates the
              addition of an autologous tumor lysate-pulsed dendritic cell
              vaccine (DCVax\textregistered{}-L) to standard therapy for newly
              diagnosed glioblastoma. METHODS: After surgery and
              chemoradiotherapy, patients were randomized (2:1) to receive
              temozolomide plus DCVax-L (n = 232) or temozolomide and placebo
              (n = 99). Following recurrence, all patients were allowed to
              receive DCVax-L, without unblinding. The primary endpoint was
              progression free survival (PFS); the secondary endpoint was
              overall survival (OS). RESULTS: For the intent-to-treat (ITT)
              population (n = 331), median OS (mOS) was 23.1 months from
              surgery. Because of the cross-over trial design, nearly 90\% of
              the ITT population received DCVax-L. For patients with methylated
              MGMT (n = 131), mOS was 34.7 months from surgery, with a 3-year
              survival of 46.4\%. As of this analysis, 223 patients are $\geq$
              30 months past their surgery date; 67 of these (30.0\%) have
              lived $\geq$ 30 months and have a Kaplan-Meier (KM)-derived mOS
              of 46.5 months. 182 patients are $\geq$ 36 months past surgery;
              44 of these (24.2\%) have lived $\geq$ 36 months and have a
              KM-derived mOS of 88.2 months. A population of extended survivors
              (n = 100) with mOS of 40.5 months, not explained by known
              prognostic factors, will be analyzed further. Only 2.1\% of ITT
              patients (n = 7) had a grade 3 or 4 adverse event that was deemed
              at least possibly related to the vaccine. Overall adverse events
              with DCVax were comparable to standard therapy alone.
              CONCLUSIONS: Addition of DCVax-L to standard therapy is feasible
              and safe in glioblastoma patients, and may extend survival. Trial
              registration Funded by Northwest Biotherapeutics;
              Clinicaltrials.gov number: NCT00045968;
              https://clinicaltrials.gov/ct2/show/NCT00045968?term=NCT00045968\&rank=1
              ; initially registered 19 September 2002.",
  journal  = "J. Transl. Med.",
  volume   =  16,
  number   =  1,
  pages    = "142",
  month    =  may,
  year     =  2018,
  keywords = "Dendritic cell; Glioblastoma; Immunotherapy; Vaccine",
  language = "en"
}

@ARTICLE{Lau2014-ly,
  title    = "Molecularly targeted therapies for recurrent glioblastoma:
              current and future targets",
  author   = "Lau, Darryl and Magill, Stephen T and Aghi, Manish K",
  abstract = "OBJECT: Glioblastoma is the most aggressive and diffusely
              infiltrative primary brain tumor. Recurrence is expected and is
              extremely difficult to treat. Over the past decade, the
              accumulation of knowledge regarding the molecular and genetic
              profile of glioblastoma has led to numerous molecularly targeted
              therapies. This article aims to review the literature and
              highlight the mechanisms and efficacies of molecularly targeted
              therapies for recurrent glioblastoma. METHODS: A systematic
              search was performed with the phrase ``(name of particular agent)
              and glioblastoma'' as a search term in PubMed to identify all
              articles published up until 2014 that included this phrase in the
              title and/or abstract. The references of systematic reviews were
              also reviewed for additional sources. The review included
              clinical studies that comprised at least 20 patients and reported
              results for the treatment of recurrent glioblastoma with
              molecular targeted therapies. RESULTS: A total of 42 articles
              were included in this review. In the treatment of recurrent
              glioblastoma, various targeted therapies have been tested over
              the past 10-15 years. The targets of interest include epidermal
              growth factor receptor, vascular endothelial growth factor
              receptor, platelet-derived growth factor receptor, Ras pathway,
              protein kinase C, mammalian target of rapamycin, histone
              acetylation, and integrins. Unfortunately, the clinical responses
              to most available targeted therapies are modest at best.
              Radiographic responses generally range in the realm of 5\%-20\%.
              Progression-free survival at 6 months and overall survival were
              also modest with the majority of studies reporting a 10\%-20\%
              6-month progression-free survival and 5- to 8-month overall
              survival. There have been several clinical trials evaluating the
              use of combination therapy for molecularly targeted treatments.
              In general, the outcomes for combination therapy tend to be
              superior to single-agent therapy, regardless of the specific
              agent studied. CONCLUSIONS: Recurrent glioblastoma remains very
              difficult to treat, even with molecular targeted therapies and
              anticancer agents. The currently available targeted therapy
              regimens have poor to modest activity against recurrent
              glioblastoma. As newer agents are actively being developed,
              combination regimens have provided the most promising results for
              improving outcomes. Targeted therapies matched to molecular
              profiles of individual tumors are predicted to be a critical
              component necessary for improving efficacy in future trials.",
  journal  = "Neurosurg. Focus",
  volume   =  37,
  number   =  6,
  pages    = "E15",
  month    =  dec,
  year     =  2014,
  keywords = "BBB = blood-brain barrier; CR = complete response; EGFR =
              epidermal growth factor receptor; MGMT = methyguanine DNA
              methyltransferase; OS = overall survival; PD = progressive
              disease; PDGFR = platelet-derived growth factor receptor; PFS =
              progression-free survival; PKC = protein kinase C; PR = partial
              response; RTK = receptor tyrosine kinase; RTKI = RTK inhibitor;
              SD = stable disease; TCGA = The Cancer Genome Atlas; VEGF =
              vascular endothelial growth factor; VEGFR = VEGF receptor;
              combination treatment; glioblastoma; mTOR = mammalian target of
              rapamycin; molecular therapy; overall survival; progression-free
              survival; recurrent",
  language = "en"
}

@ARTICLE{Szerlip2012-rp,
  title    = "Intratumoral heterogeneity of receptor tyrosine kinases {EGFR}
              and {PDGFRA} amplification in glioblastoma defines subpopulations
              with distinct growth factor response",
  author   = "Szerlip, Nicholas J and Pedraza, Alicia and Chakravarty, Debyani
              and Azim, Mohammad and McGuire, Jeremy and Fang, Yuqiang and
              Ozawa, Tatsuya and Holland, Eric C and Huse, Jason T and Jhanwar,
              Suresh and Leversha, Margaret A and Mikkelsen, Tom and Brennan,
              Cameron W",
  abstract = "Glioblastoma (GBM) is distinguished by a high degree of
              intratumoral heterogeneity, which extends to the pattern of
              expression and amplification of receptor tyrosine kinases (RTKs).
              Although most GBMs harbor RTK amplifications, clinical trials of
              small-molecule inhibitors targeting individual RTKs have been
              disappointing to date. Activation of multiple RTKs within
              individual GBMs provides a theoretical mechanism of resistance;
              however, the spectrum of functional RTK dependence among tumor
              cell subpopulations in actual tumors is unknown. We investigated
              the pattern of heterogeneity of RTK amplification and functional
              RTK dependence in GBM tumor cell subpopulations. Analysis of The
              Cancer Genome Atlas GBM dataset identified 34 of 463 cases
              showing independent focal amplification of two or more RTKs, most
              commonly platelet-derived growth factor receptor $\alpha$
              (PDGFRA) and epidermal growth factor receptor (EGFR). Dual-color
              fluorescence in situ hybridization was performed on eight samples
              with EGFR and PDGFRA amplification, revealing distinct tumor cell
              subpopulations amplified for only one RTK; in all cases these
              predominated over cells amplified for both. Cell lines derived
              from coamplified tumors exhibited genotype selection under
              RTK-targeted ligand stimulation or pharmacologic inhibition in
              vitro. Simultaneous inhibition of both EGFR and PDGFR was
              necessary for abrogation of PI3 kinase pathway activity in the
              mixed population. DNA sequencing of isolated subpopulations
              establishes a common clonal origin consistent with late or
              ongoing divergence of RTK genotype. This phenomenon is especially
              common among tumors with PDGFRA amplification: overall, 43\% of
              PDGFRA-amplified GBM were found to have amplification of EGFR or
              the hepatocyte growth factor receptor gene (MET) as well.",
  journal  = "Proc. Natl. Acad. Sci. U. S. A.",
  volume   =  109,
  number   =  8,
  pages    = "3041--3046",
  month    =  feb,
  year     =  2012,
  language = "en"
}

@ARTICLE{Patel2014-lo,
  title    = "Single-cell {RNA-seq} highlights intratumoral heterogeneity in
              primary glioblastoma",
  author   = "Patel, Anoop P and Tirosh, Itay and Trombetta, John J and Shalek,
              Alex K and Gillespie, Shawn M and Wakimoto, Hiroaki and Cahill,
              Daniel P and Nahed, Brian V and Curry, William T and Martuza,
              Robert L and Louis, David N and Rozenblatt-Rosen, Orit and
              Suv{\`a}, Mario L and Regev, Aviv and Bernstein, Bradley E",
  abstract = "Human cancers are complex ecosystems composed of cells with
              distinct phenotypes, genotypes, and epigenetic states, but
              current models do not adequately reflect tumor composition in
              patients. We used single-cell RNA sequencing (RNA-seq) to profile
              430 cells from five primary glioblastomas, which we found to be
              inherently variable in their expression of diverse
              transcriptional programs related to oncogenic signaling,
              proliferation, complement/immune response, and hypoxia. We also
              observed a continuum of stemness-related expression states that
              enabled us to identify putative regulators of stemness in vivo.
              Finally, we show that established glioblastoma subtype
              classifiers are variably expressed across individual cells within
              a tumor and demonstrate the potential prognostic implications of
              such intratumoral heterogeneity. Thus, we reveal previously
              unappreciated heterogeneity in diverse regulatory programs
              central to glioblastoma biology, prognosis, and therapy.",
  journal  = "Science",
  volume   =  344,
  number   =  6190,
  pages    = "1396--1401",
  month    =  jun,
  year     =  2014,
  language = "en"
}

@ARTICLE{Aum2014-wj,
  title    = "Molecular and cellular heterogeneity: the hallmark of
              glioblastoma",
  author   = "Aum, Diane J and Kim, David H and Beaumont, Thomas L and
              Leuthardt, Eric C and Dunn, Gavin P and Kim, Albert H",
  abstract = "There has been increasing awareness that glioblastoma, which may
              seem histopathologically similar across many tumors, actually
              represents a group of molecularly distinct tumors. Emerging
              evidence suggests that cells even within the same tumor exhibit
              wide-ranging molecular diversity. Parallel to the discoveries of
              molecular heterogeneity among tumors and their individual cells,
              intense investigation of the cellular biology of glioblastoma has
              revealed that not all cancer cells within a given tumor behave
              the same. The identification of a subpopulation of brain tumor
              cells termed ``glioblastoma cancer stem cells'' or
              ``tumor-initiating cells'' has implications for the management of
              glioblastoma. This focused review will therefore summarize
              emerging concepts on the molecular and cellular heterogeneity of
              glioblastoma and emphasize that we should begin to consider each
              individual glioblastoma to be an ensemble of molecularly distinct
              subclones that reflect a spectrum of dynamic cell states.",
  journal  = "Neurosurg. Focus",
  volume   =  37,
  number   =  6,
  pages    = "E11",
  month    =  dec,
  year     =  2014,
  keywords = "2-HG = 2-hydroxyglutarate; G-CIMP = glioma CpG island methylator
              phenotype; H3K27Ac = histone H3 Lysine27 acetylation; IDH1; RTK =
              receptor tyrosine kinase; SCNA = somatic copy number alteration;
              TCGA = The Cancer Genome Atlas; TIC = tumor-initiating cell;
              genomic; glioblastoma; glioma; heterogeneity",
  language = "en"
}

@ARTICLE{Haider2019-ml,
  title    = "{Towards a standard pathological and molecular characterization
              of recurrent glioma in adults: a {RANO} effort}",
  author   = "Haider, Ali S and van den Bent, Martin and Wen, Patrick Y and
              Vogelbaum, Michael A and Chang, Susan and Canoll, Peter D and
              Horbinski, Craig M and Huse, Jason T",
  abstract = "Regardless of subtype, diffuse gliomas of adulthood are
              characterized by inexorable progression through treatment. Cancer
              recurrence in the context of therapy is by no means unique to
              gliomas. For many tumors residing outside the central nervous
              system (CNS), tissue-based analyses are routinely employed to
              document the molecular and cellular features of disease
              recurrence. Such interventions are inconsistently applied for
              gliomas, however, and lack rigorous standardization when they
              are. While many of the reasons underlying these discrepancies
              reflect pragmatic realities inherent to CNS disease, the
              suboptimal employment of histological and molecular assessment at
              recurrence nevertheless represents a missed opportunity to
              proactively guide patient management and increase knowledge.
              Herein, we address this quandary by pairing a succinct
              description of the histological, biological, and molecular
              characteristics of recurrent glioma with recommendations for how
              to better standardize and implement quality pathological
              assessment into patient management. We hope this review will
              prompt thoughtful revision of standard operating procedures to
              maximize the utility of glioma re-biopsy.",
  journal  = "Neuro. Oncol.",
  month    =  dec,
  year     =  2019,
  keywords = "Glioma; adult; pathology; pseudo-progression; recurrence",
  language = "en"
}

@ARTICLE{Johnson2014-rf,
  title    = "Mutational analysis reveals the origin and therapy-driven
              evolution of recurrent glioma",
  author   = "Johnson, Brett E and Mazor, Tali and Hong, Chibo and Barnes,
              Michael and Aihara, Koki and McLean, Cory Y and Fouse, Shaun D
              and Yamamoto, Shogo and Ueda, Hiroki and Tatsuno, Kenji and
              Asthana, Saurabh and Jalbert, Llewellyn E and Nelson, Sarah J and
              Bollen, Andrew W and Gustafson, W Clay and Charron, Elise and
              Weiss, William A and Smirnov, Ivan V and Song, Jun S and Olshen,
              Adam B and Cha, Soonmee and Zhao, Yongjun and Moore, Richard A
              and Mungall, Andrew J and Jones, Steven J M and Hirst, Martin and
              Marra, Marco A and Saito, Nobuhito and Aburatani, Hiroyuki and
              Mukasa, Akitake and Berger, Mitchel S and Chang, Susan M and
              Taylor, Barry S and Costello, Joseph F",
  abstract = "Tumor recurrence is a leading cause of cancer mortality.
              Therapies for recurrent disease may fail, at least in part,
              because the genomic alterations driving the growth of recurrences
              are distinct from those in the initial tumor. To explore this
              hypothesis, we sequenced the exomes of 23 initial low-grade
              gliomas and recurrent tumors resected from the same patients. In
              43\% of cases, at least half of the mutations in the initial
              tumor were undetected at recurrence, including driver mutations
              in TP53, ATRX, SMARCA4, and BRAF; this suggests that recurrent
              tumors are often seeded by cells derived from the initial tumor
              at a very early stage of their evolution. Notably, tumors from 6
              of 10 patients treated with the chemotherapeutic drug
              temozolomide (TMZ) followed an alternative evolutionary path to
              high-grade glioma. At recurrence, these tumors were hypermutated
              and harbored driver mutations in the RB (retinoblastoma) and
              Akt-mTOR (mammalian target of rapamycin) pathways that bore the
              signature of TMZ-induced mutagenesis.",
  journal  = "Science",
  volume   =  343,
  number   =  6167,
  pages    = "189--193",
  month    =  jan,
  year     =  2014,
  language = "en"
}

@ARTICLE{Tzeng2015-ma,
  title         = "Simultaneous Deep Transfer Across Domains and Tasks",
  author        = "Tzeng, Eric and Hoffman, Judy and Darrell, Trevor and
                   Saenko, Kate",
  abstract      = "Recent reports suggest that a generic supervised deep CNN
                   model trained on a large-scale dataset reduces, but does not
                   remove, dataset bias. Fine-tuning deep models in a new
                   domain can require a significant amount of labeled data,
                   which for many applications is simply not available. We
                   propose a new CNN architecture to exploit unlabeled and
                   sparsely labeled target domain data. Our approach
                   simultaneously optimizes for domain invariance to facilitate
                   domain transfer and uses a soft label distribution matching
                   loss to transfer information between tasks. Our proposed
                   adaptation method offers empirical performance which exceeds
                   previously published results on two standard benchmark
                   visual domain adaptation tasks, evaluated across supervised
                   and semi-supervised adaptation settings.",
  month         =  oct,
  year          =  2015,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1510.02192"
}

@ARTICLE{Jaeger2018-as,
  title         = "Retina {U-Net}: Embarrassingly Simple Exploitation of
                   Segmentation Supervision for Medical Object Detection",
  author        = "Jaeger, Paul F and Kohl, Simon A A and Bickelhaupt,
                   Sebastian and Isensee, Fabian and Kuder, Tristan Anselm and
                   Schlemmer, Heinz-Peter and Maier-Hein, Klaus H",
  abstract      = "The task of localizing and categorizing objects in medical
                   images often remains formulated as a semantic segmentation
                   problem. This approach, however, only indirectly solves the
                   coarse localization task by predicting pixel-level scores,
                   requiring ad-hoc heuristics when mapping back to
                   object-level scores. State-of-the-art object detectors on
                   the other hand, allow for individual object scoring in an
                   end-to-end fashion, while ironically trading in the ability
                   to exploit the full pixel-wise supervision signal. This can
                   be particularly disadvantageous in the setting of medical
                   image analysis, where data sets are notoriously small. In
                   this paper, we propose Retina U-Net, a simple architecture,
                   which naturally fuses the Retina Net one-stage detector with
                   the U-Net architecture widely used for semantic segmentation
                   in medical images. The proposed architecture recaptures
                   discarded supervision signals by complementing object
                   detection with an auxiliary task in the form of semantic
                   segmentation without introducing the additional complexity
                   of previously proposed two-stage detectors. We evaluate the
                   importance of full segmentation supervision on two medical
                   data sets, provide an in-depth analysis on a series of toy
                   experiments and show how the corresponding performance gain
                   grows in the limit of small data sets. Retina U-Net yields
                   strong detection performance only reached by its more
                   complex two-staged counterparts. Our framework including all
                   methods implemented for operation on 2D and 3D images is
                   available at github.com/pfjaeger/medicaldetectiontoolkit.",
  month         =  nov,
  year          =  2018,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1811.08661"
}

@ARTICLE{Oktay2018-km,
  title         = "Attention {U-Net}: Learning Where to Look for the Pancreas",
  author        = "Oktay, Ozan and Schlemper, Jo and Le Folgoc, Loic and Lee,
                   Matthew and Heinrich, Mattias and Misawa, Kazunari and Mori,
                   Kensaku and McDonagh, Steven and Hammerla, Nils Y and Kainz,
                   Bernhard and Glocker, Ben and Rueckert, Daniel",
  abstract      = "We propose a novel attention gate (AG) model for medical
                   imaging that automatically learns to focus on target
                   structures of varying shapes and sizes. Models trained with
                   AGs implicitly learn to suppress irrelevant regions in an
                   input image while highlighting salient features useful for a
                   specific task. This enables us to eliminate the necessity of
                   using explicit external tissue/organ localisation modules of
                   cascaded convolutional neural networks (CNNs). AGs can be
                   easily integrated into standard CNN architectures such as
                   the U-Net model with minimal computational overhead while
                   increasing the model sensitivity and prediction accuracy.
                   The proposed Attention U-Net architecture is evaluated on
                   two large CT abdominal datasets for multi-class image
                   segmentation. Experimental results show that AGs
                   consistently improve the prediction performance of U-Net
                   across different datasets and training sizes while
                   preserving computational efficiency. The code for the
                   proposed architecture is publicly available.",
  month         =  apr,
  year          =  2018,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1804.03999"
}

@ARTICLE{Verhaak2010-ak,
  title    = "Integrated genomic analysis identifies clinically relevant
              subtypes of glioblastoma characterized by abnormalities in
              {PDGFRA}, {IDH1}, {EGFR}, and {NF1}",
  author   = "Verhaak, Roel G W and Hoadley, Katherine A and Purdom, Elizabeth
              and Wang, Victoria and Qi, Yuan and Wilkerson, Matthew D and
              Miller, C Ryan and Ding, Li and Golub, Todd and Mesirov, Jill P
              and Alexe, Gabriele and Lawrence, Michael and O'Kelly, Michael
              and Tamayo, Pablo and Weir, Barbara A and Gabriel, Stacey and
              Winckler, Wendy and Gupta, Supriya and Jakkula, Lakshmi and
              Feiler, Heidi S and Hodgson, J Graeme and James, C David and
              Sarkaria, Jann N and Brennan, Cameron and Kahn, Ari and Spellman,
              Paul T and Wilson, Richard K and Speed, Terence P and Gray, Joe W
              and Meyerson, Matthew and Getz, Gad and Perou, Charles M and
              Hayes, D Neil and {Cancer Genome Atlas Research Network}",
  abstract = "The Cancer Genome Atlas Network recently cataloged recurrent
              genomic abnormalities in glioblastoma multiforme (GBM). We
              describe a robust gene expression-based molecular classification
              of GBM into Proneural, Neural, Classical, and Mesenchymal
              subtypes and integrate multidimensional genomic data to establish
              patterns of somatic mutations and DNA copy number. Aberrations
              and gene expression of EGFR, NF1, and PDGFRA/IDH1 each define the
              Classical, Mesenchymal, and Proneural subtypes, respectively.
              Gene signatures of normal brain cell types show a strong
              relationship between subtypes and different neural lineages.
              Additionally, response to aggressive therapy differs by subtype,
              with the greatest benefit in the Classical subtype and no benefit
              in the Proneural subtype. We provide a framework that unifies
              transcriptomic and genomic dimensions for GBM molecular
              stratification with important implications for future studies.",
  journal  = "Cancer Cell",
  volume   =  17,
  number   =  1,
  pages    = "98--110",
  month    =  jan,
  year     =  2010,
  language = "en"
}

@ARTICLE{Parsons2008-wr,
  title    = "An integrated genomic analysis of human glioblastoma multiforme",
  author   = "Parsons, D Williams and Jones, Si{\^a}n and Zhang, Xiaosong and
              Lin, Jimmy Cheng-Ho and Leary, Rebecca J and Angenendt, Philipp
              and Mankoo, Parminder and Carter, Hannah and Siu, I-Mei and
              Gallia, Gary L and Olivi, Alessandro and McLendon, Roger and
              Rasheed, B Ahmed and Keir, Stephen and Nikolskaya, Tatiana and
              Nikolsky, Yuri and Busam, Dana A and Tekleab, Hanna and Diaz, Jr,
              Luis A and Hartigan, James and Smith, Doug R and Strausberg,
              Robert L and Marie, Suely Kazue Nagahashi and Shinjo, Sueli Mieko
              Oba and Yan, Hai and Riggins, Gregory J and Bigner, Darell D and
              Karchin, Rachel and Papadopoulos, Nick and Parmigiani, Giovanni
              and Vogelstein, Bert and Velculescu, Victor E and Kinzler,
              Kenneth W",
  abstract = "Glioblastoma multiforme (GBM) is the most common and lethal type
              of brain cancer. To identify the genetic alterations in GBMs, we
              sequenced 20,661 protein coding genes, determined the presence of
              amplifications and deletions using high-density oligonucleotide
              arrays, and performed gene expression analyses using
              next-generation sequencing technologies in 22 human tumor
              samples. This comprehensive analysis led to the discovery of a
              variety of genes that were not known to be altered in GBMs. Most
              notably, we found recurrent mutations in the active site of
              isocitrate dehydrogenase 1 (IDH1) in 12\% of GBM patients.
              Mutations in IDH1 occurred in a large fraction of young patients
              and in most patients with secondary GBMs and were associated with
              an increase in overall survival. These studies demonstrate the
              value of unbiased genomic analyses in the characterization of
              human brain cancer and identify a potentially useful genetic
              alteration for the classification and targeted therapy of GBMs.",
  journal  = "Science",
  volume   =  321,
  number   =  5897,
  pages    = "1807--1812",
  month    =  sep,
  year     =  2008,
  language = "en"
}

@ARTICLE{Christiansen2018-gv,
  title    = "In Silico Labeling: Predicting Fluorescent Labels in Unlabeled
              Images",
  author   = "Christiansen, Eric M and Yang, Samuel J and Ando, D Michael and
              Javaherian, Ashkan and Skibinski, Gaia and Lipnick, Scott and
              Mount, Elliot and O'Neil, Alison and Shah, Kevan and Lee, Alicia
              K and Goyal, Piyush and Fedus, William and Poplin, Ryan and
              Esteva, Andre and Berndl, Marc and Rubin, Lee L and Nelson,
              Philip and Finkbeiner, Steven",
  abstract = "Microscopy is a central method in life sciences. Many popular
              methods, such as antibody labeling, are used to add physical
              fluorescent labels to specific cellular constituents. However,
              these approaches have significant drawbacks, including
              inconsistency; limitations in the number of simultaneous labels
              because of spectral overlap; and necessary perturbations of the
              experiment, such as fixing the cells, to generate the
              measurement. Here, we show that a computational machine-learning
              approach, which we call ``in silico labeling'' (ISL), reliably
              predicts some fluorescent labels from transmitted-light images of
              unlabeled fixed or live biological samples. ISL predicts a range
              of labels, such as those for nuclei, cell type (e.g., neural),
              and cell state (e.g., cell death). Because prediction happens in
              silico, the method is consistent, is not limited by spectral
              overlap, and does not disturb the experiment. ISL generates
              biological measurements that would otherwise be problematic or
              impossible to acquire.",
  journal  = "Cell",
  volume   =  173,
  number   =  3,
  pages    = "792--803.e19",
  month    =  apr,
  year     =  2018,
  keywords = "cancer; computer vision; deep learning; machine learning;
              microscopy; neuroscience; stem cells",
  language = "en"
}

@ARTICLE{Schultz2019-nt,
  title    = "Synthetic high-density lipoprotein nanoparticles for the
              treatment of {Niemann-Pick} diseases",
  author   = "Schultz, Mark L and Fawaz, Maria V and Azaria, Ruth D and Hollon,
              Todd C and Liu, Elaine A and Kunkel, Thaddeus J and Halseth, Troy
              A and Krus, Kelsey L and Ming, Ran and Morin, Emily E and
              McLoughlin, Hayley S and Bushart, David D and Paulson, Henry L
              and Shakkottai, Vikram G and Orringer, Daniel A and Schwendeman,
              Anna S and Lieberman, Andrew P",
  abstract = "BACKGROUND: Niemann-Pick disease type C is a fatal and
              progressive neurodegenerative disorder characterized by the
              accumulation of unesterified cholesterol in late endosomes and
              lysosomes. We sought to develop new therapeutics for this
              disorder by harnessing the body's endogenous cholesterol
              scavenging particle, high-density lipoprotein (HDL). METHODS:
              Here we design, optimize, and define the mechanism of action of
              synthetic HDL (sHDL) nanoparticles. RESULTS: We demonstrate a
              dose-dependent rescue of cholesterol storage that is sensitive to
              sHDL lipid and peptide composition, enabling the identification
              of compounds with a range of therapeutic potency. Peripheral
              administration of sHDL to Npc1 I1061T homozygous mice mobilizes
              cholesterol, reduces serum bilirubin, reduces liver macrophage
              size, and corrects body weight deficits. Additionally, a single
              intraventricular injection into adult Npc1 I1061T brains
              significantly reduces cholesterol storage in Purkinje neurons.
              Since endogenous HDL is also a carrier of sphingomyelin, we
              tested the same sHDL formulation in the sphingomyelin storage
              disease Niemann-Pick type A. Utilizing stimulated Raman
              scattering microscopy to detect endogenous unlabeled lipids, we
              show significant rescue of Niemann-Pick type A lipid storage.
              CONCLUSIONS: Together, our data establish that sHDL nanoparticles
              are a potential new therapeutic avenue for Niemann-Pick diseases.",
  journal  = "BMC Med.",
  volume   =  17,
  number   =  1,
  pages    = "200",
  month    =  nov,
  year     =  2019,
  keywords = "HDL; NPC1; Niemann--Pick A; Niemann--Pick C; SRS;My\_papers",
  language = "en"
}

@INCOLLECTION{Krizhevsky2012-kq,
  title     = "{ImageNet} Classification with Deep Convolutional Neural
               Networks",
  booktitle = "Advances in Neural Information Processing Systems 25",
  author    = "Krizhevsky, Alex and Sutskever, Ilya and Hinton, Geoffrey E",
  editor    = "Pereira, F and Burges, C J C and Bottou, L and Weinberger, K Q",
  publisher = "Curran Associates, Inc.",
  pages     = "1097--1105",
  year      =  2012
}

@ARTICLE{Ostrom2019-pp,
  title    = "{CBTRUS} Statistical Report: Primary Brain and Other Central
              Nervous System Tumors Diagnosed in the United States in 2012-2016",
  author   = "Ostrom, Quinn T and Cioffi, Gino and Gittleman, Haley and Patil,
              Nirav and Waite, Kristin and Kruchko, Carol and Barnholtz-Sloan,
              Jill S",
  abstract = "The Central Brain Tumor Registry of the United States (CBTRUS),
              in collaboration with the Centers for Disease Control and
              Prevention and National Cancer Institute, is the largest
              population-based registry focused exclusively on primary brain
              and other central nervous system (CNS) tumors in the United
              States (US) and represents the entire US population. This report
              contains the most up-to-date population-based data on primary
              brain tumors available and supersedes all previous reports in
              terms of completeness and accuracy. All rates are age-adjusted
              using the 2000 US standard population and presented per 100,000
              population. The average annual age-adjusted incidence rate
              (AAAIR) of all malignant and non-malignant brain and other CNS
              tumors was 23.41 (Malignant AAAIR = 7.08, non-Malignant AAAIR =
              16.33). This rate was higher in females compared to males (25.84
              versus 20.82), Whites compared to Blacks (23.50 versus 23.34),
              and non-Hispanics compared to Hispanics (23.84 versus 21.28). The
              most commonly occurring malignant brain and other CNS tumor was
              glioblastoma (14.6\% of all tumors), and the most common
              non-malignant tumor was meningioma (37.6\% of all tumors).
              Glioblastoma was more common in males, and meningioma was more
              common in females. In children and adolescents (age 0-19 years),
              the incidence rate of all primary brain and other CNS tumors was
              6.06. An estimated 86,010 new cases of malignant and
              non-malignant brain and other CNS tumors are expected to be
              diagnosed in the US in 2019 (25,510 malignant and 60,490
              non-malignant). There were 79,718 deaths attributed to malignant
              brain and other CNS tumors between 2012 and 2016. This represents
              an average annual mortality rate of 4.42. The five-year relative
              survival rate following diagnosis of a malignant brain and other
              CNS tumor was 35.8\%, and the five-year relative survival rate
              following diagnosis of a non-malignant brain and other CNS tumors
              was 91.5\%.",
  journal  = "Neuro. Oncol.",
  volume   =  21,
  number   = "Suppl 5",
  pages    = "v1--v100",
  month    =  nov,
  year     =  2019,
  language = "en"
}

@ARTICLE{Walker2019-hc,
  title    = "Malignant primary brain and other central nervous system tumors
              diagnosed in Canada from 2009 to 2013",
  author   = "Walker, Emily V and Davis, Faith G and {CBTR founding affiliates}",
  abstract = "BACKGROUND: We present a national surveillance report on
              malignant primary brain and other central nervous system (CNS)
              tumors diagnosed in the Canadian population in 2009-2013.
              METHODS: Patients were identified through the Canadian Cancer
              Registry, an administrative dataset that includes cancer
              incidence data from all provinces/territories in Canada. Tumor
              types were classified by site and histology using the definitions
              from the Central Brain Tumor Registry of the United States
              (CBTRUS). Incidence rates (IRs) and 95\% confidence intervals
              (CIs) were calculated per 100000 person-years (py) and
              age-standardized to the 2011 Canadian population for comparisons
              within Canada and to the 2000 United States population for
              comparisons with the US. RESULTS: Overall, 12515 malignant brain
              and other CNS tumors were diagnosed in the Canadian population in
              2009-2013 (IR: 8.71/100000 py; 95\% CI: 8.56, 8.86); 7085 were
              among males (IR: 10.06/100000 py; 95\% CI: 9.82, 10.29) and 5430
              among females (IR: 7.41/100000 py; 95\% CI: 7.22, 7.61). Of
              these, 12115 were classifiable according to histological
              subgroups defined by CBTRUS. The most common histology was
              glioblastoma (IR: 4.06/100000 py; 95\% CI: 3.95, 4.16). Among
              those aged 0-19 years, 1130 malignant brain and CNS tumors were
              diagnosed in 2009-2013 (IR: 3.36/100000 py; 95\% CI: 3.16, 3.56).
              The most common histology among the pediatric population was
              embryonal tumor (IR: 0.74/100000 py; 95\% CI: 0.65, 0.84).
              CONCLUSIONS: These data represent an initial detailed report on
              the frequency and distribution of primary malignant brain and
              other CNS tumors diagnosed in the Canadian population in
              2009-2013. The reported distributions of tumor diagnoses by sex
              and age reflected expected patterns based on the literature from
              similar populations. A report incorporating data on nonmalignant
              primary brain tumors is forthcoming.",
  journal  = "Neuro. Oncol.",
  volume   =  21,
  number   =  3,
  pages    = "360--369",
  month    =  feb,
  year     =  2019,
  keywords = "Canadian surveillance report; epidemiology; malignant brain
              neoplasms; malignant central nervous system neoplasms;
              neuro-oncology",
  language = "en"
}

@ARTICLE{Beiko2014-ex,
  title    = "{IDH1} mutant malignant astrocytomas are more amenable to
              surgical resection and have a survival benefit associated with
              maximal surgical resection",
  author   = "Beiko, Jason and Suki, Dima and Hess, Kenneth R and Fox, Benjamin
              D and Cheung, Vincent and Cabral, Matthew and Shonka, Nicole and
              Gilbert, Mark R and Sawaya, Raymond and Prabhu, Sujit S and
              Weinberg, Jeffrey and Lang, Frederick F and Aldape, Kenneth D and
              Sulman, Erik P and Rao, Ganesh and McCutcheon, Ian E and Cahill,
              Daniel P",
  abstract = "BACKGROUND: IDH1 gene mutations identify gliomas with a distinct
              molecular evolutionary origin. We sought to determine the impact
              of surgical resection on survival after controlling for IDH1
              status in malignant astrocytomas-World Health Organization grade
              III anaplastic astrocytomas and grade IV glioblastoma. METHODS:
              Clinical parameters including volumetric assessment of
              preoperative and postoperative MRI were recorded prospectively on
              335 malignant astrocytoma patients: n = 128 anaplastic
              astrocytomas and n = 207 glioblastoma. IDH1 status was assessed
              by sequencing and immunohistochemistry. RESULTS: IDH1 mutation
              was independently associated with complete resection of enhancing
              disease (93\% complete resections among mutants vs 67\% among
              wild-type, P 5 cc residual vs not reached for <5 cc, P = .025).
              CONCLUSIONS: The survival benefit associated with surgical
              resection differs based on IDH1 genotype in malignant astrocytic
              gliomas. Therapeutic benefit from maximal surgical resection,
              including both enhancing and nonenhancing tumor, may contribute
              to the better prognosis observed in the IDH1 mutant subgroup.
              Thus, individualized surgical strategies for malignant
              astrocytoma may be considered based on IDH1 status.",
  journal  = "Neuro. Oncol.",
  volume   =  16,
  number   =  1,
  pages    = "81--91",
  month    =  jan,
  year     =  2014,
  keywords = "IDH1; anaplastic astrocytoma; glioblastoma; malignant glioma;
              surgical resection",
  language = "en"
}

@ARTICLE{Watanabe2009-ut,
  title    = "{IDH1} mutations are early events in the development of
              astrocytomas and oligodendrogliomas",
  author   = "Watanabe, Takuya and Nobusawa, Sumihito and Kleihues, Paul and
              Ohgaki, Hiroko",
  abstract = "IDH1 encodes isocitrate dehydrogenase 1, which participates in
              the citric acid cycle and was recently reported to be mutated in
              12\% of glioblastomas. We assessed IDH1 mutations in 321 gliomas
              of various histological types and biological behaviors. A total
              of 130 IDH1 mutations was detected, and all were located at amino
              acid residue 132. Of these, 91\% were G-->A mutations
              (Arg-->His). IDH1 mutations were frequent in low-grade diffuse
              astrocytomas (88\%) and in secondary glioblastomas that developed
              through progression from low-grade diffuse or anaplastic
              astrocytoma (82\%). Similarly, high frequencies of IDH1 mutations
              were found in oligodendrogliomas (79\%) and oligoastrocytomas
              (94\%). Analyses of multiple biopsies from the same patient (51
              cases) showed that there were no cases in which an IDH1 mutation
              occurred after the acquisition of either a TP53 mutation or loss
              of 1p/19q, suggesting that IDH1 mutations are very early events
              in gliomagenesis and may affect a common glial precursor cell
              population. IDH1 mutations were co-present with TP53 mutations in
              63\% of low-grade diffuse astrocytomas and with loss of
              heterozygosity 1p/19q in 64\% of oligodendrogliomas; they were
              rare in pilocytic astrocytomas (10\%) and primary glioblastomas
              (5\%) and absent in ependymomas. The frequent presence of IDH1
              mutations in secondary glioblastomas and their near-complete
              absence in primary glioblastomas reinforce the concept that
              despite their histological similarities, these subtypes are
              genetically and clinically distinct entities.",
  journal  = "Am. J. Pathol.",
  volume   =  174,
  number   =  4,
  pages    = "1149--1153",
  month    =  apr,
  year     =  2009,
  language = "en"
}

@ARTICLE{Martinez-Velez2019-qn,
  title    = "The oncolytic virus {Delta-24-RGD} elicits an antitumor effect in
              pediatric glioma and {DIPG} mouse models",
  author   = "Mart{\'\i}nez-V{\'e}lez, Naiara and Garcia-Moure, Marc and
              Marigil, Miguel and Gonz{\'a}lez-Huarriz, Marisol and
              Puigdelloses, Montse and Gallego P{\'e}rez-Larraya, Jaime and
              Zalaca{\'\i}n, Marta and Marrod{\'a}n, Luc{\'\i}a and
              Varela-Guruceaga, Maider and Laspidea, Virginia and Aristu, Jose
              Javier and Ramos, Luis Isaac and Tejada-Sol{\'\i}s, Sonia and
              D{\'\i}ez-Valle, Ricardo and Jones, Chris and Mackay, Alan and
              Mart{\'\i}nez-Climent, Jose A and Garc{\'\i}a-Barchino, Maria
              Jose and Raabe, Eric and Monje, Michelle and Becher, Oren J and
              Junier, Marie Pierre and El-Habr, Elias A and Chneiweiss, Herve
              and Aldave, Guillermo and Jiang, Hong and Fueyo, Juan and
              Pati{\~n}o-Garc{\'\i}a, Ana and Gomez-Manzano, Candelaria and
              Alonso, Marta M",
  abstract = "Pediatric high-grade glioma (pHGG) and diffuse intrinsic pontine
              gliomas (DIPGs) are aggressive pediatric brain tumors in
              desperate need of a curative treatment. Oncolytic virotherapy is
              emerging as a solid therapeutic approach. Delta-24-RGD is a
              replication competent adenovirus engineered to replicate in tumor
              cells with an aberrant RB pathway. This virus has proven to be
              safe and effective in adult gliomas. Here we report that the
              administration of Delta-24-RGD is safe in mice and results in a
              significant increase in survival in immunodeficient and
              immunocompetent models of pHGG and DIPGs. Our results show that
              the Delta-24-RGD antiglioma effect is mediated by the oncolytic
              effect and the immune response elicited against the tumor.
              Altogether, our data highlight the potential of this virus as
              treatment for patients with these tumors. Of clinical
              significance, these data have led to the start of a phase I/II
              clinical trial at our institution for newly diagnosed DIPG
              (NCT03178032).",
  journal  = "Nat. Commun.",
  volume   =  10,
  number   =  1,
  pages    = "2235",
  month    =  may,
  year     =  2019
}

@ARTICLE{Ceccarelli2016-ur,
  title    = "Molecular Profiling Reveals Biologically Discrete Subsets and
              Pathways of Progression in Diffuse Glioma",
  author   = "Ceccarelli, Michele and Barthel, Floris P and Malta, Tathiane M
              and Sabedot, Thais S and Salama, Sofie R and Murray, Bradley A
              and Morozova, Olena and Newton, Yulia and Radenbaugh, Amie and
              Pagnotta, Stefano M and Anjum, Samreen and Wang, Jiguang and
              Manyam, Ganiraju and Zoppoli, Pietro and Ling, Shiyun and Rao,
              Arjun A and Grifford, Mia and Cherniack, Andrew D and Zhang,
              Hailei and Poisson, Laila and Carlotti, Jr, Carlos Gilberto and
              Tirapelli, Daniela Pretti da Cunha and Rao, Arvind and Mikkelsen,
              Tom and Lau, Ching C and Yung, W K Alfred and Rabadan, Raul and
              Huse, Jason and Brat, Daniel J and Lehman, Norman L and
              Barnholtz-Sloan, Jill S and Zheng, Siyuan and Hess, Kenneth and
              Rao, Ganesh and Meyerson, Matthew and Beroukhim, Rameen and
              Cooper, Lee and Akbani, Rehan and Wrensch, Margaret and Haussler,
              David and Aldape, Kenneth D and Laird, Peter W and Gutmann, David
              H and {TCGA Research Network} and Noushmehr, Houtan and Iavarone,
              Antonio and Verhaak, Roel G W",
  abstract = "Therapy development for adult diffuse glioma is hindered by
              incomplete knowledge of somatic glioma driving alterations and
              suboptimal disease classification. We defined the complete set of
              genes associated with 1,122 diffuse grade II-III-IV gliomas from
              The Cancer Genome Atlas and used molecular profiles to improve
              disease classification, identify molecular correlations, and
              provide insights into the progression from low- to high-grade
              disease. Whole-genome sequencing data analysis determined that
              ATRX but not TERT promoter mutations are associated with
              increased telomere length. Recent advances in glioma
              classification based on IDH mutation and 1p/19q co-deletion
              status were recapitulated through analysis of DNA methylation
              profiles, which identified clinically relevant molecular subsets.
              A subtype of IDH mutant glioma was associated with DNA
              demethylation and poor outcome; a group of IDH-wild-type diffuse
              glioma showed molecular similarity to pilocytic astrocytoma and
              relatively favorable survival. Understanding of cohesive disease
              groups may aid improved clinical outcomes.",
  journal  = "Cell",
  volume   =  164,
  number   =  3,
  pages    = "550--563",
  month    =  jan,
  year     =  2016,
  language = "en"
}

@ARTICLE{Eckel-Passow2015-oj,
  title    = "Glioma Groups Based on 1p/19q, {IDH}, and {TERT} Promoter
              Mutations in Tumors",
  author   = "Eckel-Passow, Jeanette E and Lachance, Daniel H and Molinaro,
              Annette M and Walsh, Kyle M and Decker, Paul A and Sicotte,
              Hugues and Pekmezci, Melike and Rice, Terri and Kosel, Matt L and
              Smirnov, Ivan V and Sarkar, Gobinda and Caron, Alissa A and
              Kollmeyer, Thomas M and Praska, Corinne E and Chada, Anisha R and
              Halder, Chandralekha and Hansen, Helen M and McCoy, Lucie S and
              Bracci, Paige M and Marshall, Roxanne and Zheng, Shichun and
              Reis, Gerald F and Pico, Alexander R and O'Neill, Brian P and
              Buckner, Jan C and Giannini, Caterina and Huse, Jason T and
              Perry, Arie and Tihan, Tarik and Berger, Mitchell S and Chang,
              Susan M and Prados, Michael D and Wiemels, Joseph and Wiencke,
              John K and Wrensch, Margaret R and Jenkins, Robert B",
  abstract = "BACKGROUND: The prediction of clinical behavior, response to
              therapy, and outcome of infiltrative glioma is challenging. On
              the basis of previous studies of tumor biology, we defined five
              glioma molecular groups with the use of three alterations:
              mutations in the TERT promoter, mutations in IDH, and codeletion
              of chromosome arms 1p and 19q (1p/19q codeletion). We tested the
              hypothesis that within groups based on these features, tumors
              would have similar clinical variables, acquired somatic
              alterations, and germline variants. METHODS: We scored tumors as
              negative or positive for each of these markers in 1087 gliomas
              and compared acquired alterations and patient characteristics
              among the five primary molecular groups. Using 11,590 controls,
              we assessed associations between these groups and known glioma
              germline variants. RESULTS: Among 615 grade II or III gliomas,
              29\% had all three alterations (i.e., were triple-positive), 5\%
              had TERT and IDH mutations, 45\% had only IDH mutations, 7\% were
              triple-negative, and 10\% had only TERT mutations; 5\% had other
              combinations. Among 472 grade IV gliomas, less than 1\% were
              triple-positive, 2\% had TERT and IDH mutations, 7\% had only IDH
              mutations, 17\% were triple-negative, and 74\% had only TERT
              mutations. The mean age at diagnosis was lowest (37 years) among
              patients who had gliomas with only IDH mutations and was highest
              (59 years) among patients who had gliomas with only TERT
              mutations. The molecular groups were independently associated
              with overall survival among patients with grade II or III gliomas
              but not among patients with grade IV gliomas. The molecular
              groups were associated with specific germline variants.
              CONCLUSIONS: Gliomas were classified into five principal groups
              on the basis of three tumor markers. The groups had different
              ages at onset, overall survival, and associations with germline
              variants, which implies that they are characterized by distinct
              mechanisms of pathogenesis. (Funded by the National Institutes of
              Health and others.).",
  journal  = "N. Engl. J. Med.",
  volume   =  372,
  number   =  26,
  pages    = "2499--2508",
  month    =  jun,
  year     =  2015,
  language = "en"
}

@ARTICLE{Poplin2017-zm,
  title         = "Predicting Cardiovascular Risk Factors from Retinal Fundus
                   Photographs using Deep Learning",
  author        = "Poplin, Ryan and Varadarajan, Avinash V and Blumer, Katy and
                   Liu, Yun and McConnell, Michael V and Corrado, Greg S and
                   Peng, Lily and Webster, Dale R",
  abstract      = "Traditionally, medical discoveries are made by observing
                   associations and then designing experiments to test these
                   hypotheses. However, observing and quantifying associations
                   in images can be difficult because of the wide variety of
                   features, patterns, colors, values, shapes in real data. In
                   this paper, we use deep learning, a machine learning
                   technique that learns its own features, to discover new
                   knowledge from retinal fundus images. Using models trained
                   on data from 284,335 patients, and validated on two
                   independent datasets of 12,026 and 999 patients, we predict
                   cardiovascular risk factors not previously thought to be
                   present or quantifiable in retinal images, such as such as
                   age (within 3.26 years), gender (0.97 AUC), smoking status
                   (0.71 AUC), HbA1c (within 1.39\%), systolic blood pressure
                   (within 11.23mmHg) as well as major adverse cardiac events
                   (0.70 AUC). We further show that our models used distinct
                   aspects of the anatomy to generate each prediction, such as
                   the optic disc or blood vessels, opening avenues of further
                   research.",
  month         =  aug,
  year          =  2017,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1708.09843"
}

@ARTICLE{Buggenthin2017-je,
  title    = "Prospective identification of hematopoietic lineage choice by
              deep learning",
  author   = "Buggenthin, Felix and Buettner, Florian and Hoppe, Philipp S and
              Endele, Max and Kroiss, Manuel and Strasser, Michael and
              Schwarzfischer, Michael and Loeffler, Dirk and Kokkaliaris,
              Konstantinos D and Hilsenbeck, Oliver and Schroeder, Timm and
              Theis, Fabian J and Marr, Carsten",
  abstract = "Differentiation alters molecular properties of stem and
              progenitor cells, leading to changes in their shape and movement
              characteristics. We present a deep neural network that
              prospectively predicts lineage choice in differentiating primary
              hematopoietic progenitors using image patches from brightfield
              microscopy and cellular movement. Surprisingly, lineage choice
              can be detected up to three generations before conventional
              molecular markers are observable. Our approach allows
              identification of cells with differentially expressed
              lineage-specifying genes without molecular labeling.",
  journal  = "Nat. Methods",
  volume   =  14,
  number   =  4,
  pages    = "403--406",
  month    =  apr,
  year     =  2017,
  language = "en"
}

@ARTICLE{Eulenberg2017-mo,
  title     = "Reconstructing cell cycle and disease progression using deep
               learning",
  author    = "Eulenberg, Philipp and K{\"o}hler, Niklas and Blasi, Thomas and
               Filby, Andrew and Carpenter, Anne E and Rees, Paul and Theis,
               Fabian J and Wolf, F Alexander",
  abstract  = "We show that deep convolutional neural networks combined with
               nonlinear dimension reduction enable reconstructing biological
               processes based on raw image data. We demonstrate this by
               reconstructing the cell cycle of Jurkat cells and disease
               progression in diabetic retinopathy. In further analysis of
               Jurkat cells, we detect and separate a subpopulation of dead
               cells in an unsupervised manner and, in classifying discrete
               cell cycle stages, we reach a sixfold reduction in error rate
               compared to a recent approach based on boosting on image
               features. In contrast to previous methods, deep learning based
               predictions are fast enough for on-the-fly analysis in an
               imaging flow cytometer.The interpretation of information-rich,
               high-throughput single-cell data is a challenge requiring
               sophisticated computational tools. Here the authors demonstrate
               a deep convolutional neural network that can classify cell cycle
               status on-the-fly.",
  journal   = "Nat. Commun.",
  publisher = "nature.com",
  volume    =  8,
  number    =  1,
  pages     = "463",
  month     =  sep,
  year      =  2017,
  language  = "en"
}

@ARTICLE{Rivenson2019-hh,
  title     = "Virtual histological staining of unlabelled
               tissue-autofluorescence images via deep learning",
  author    = "Rivenson, Yair and Wang, Hongda and Wei, Zhensong and de Haan,
               Kevin and Zhang, Yibo and Wu, Yichen and G{\"u}nayd{\i}n, Harun
               and Zuckerman, Jonathan E and Chong, Thomas and Sisk, Anthony E
               and Westbrook, Lindsey M and Wallace, W Dean and Ozcan, Aydogan",
  abstract  = "The histological analysis of tissue samples, widely used for
               disease diagnosis, involves lengthy and laborious tissue
               preparation. Here, we show that a convolutional neural network
               trained using a generative adversarial-network model can
               transform wide-field autofluorescence images of unlabelled
               tissue sections into images that are equivalent to the
               bright-field images of histologically stained versions of the
               same samples. A blind comparison, by board-certified
               pathologists, of this virtual staining method and standard
               histological staining using microscopic images of human tissue
               sections of the salivary gland, thyroid, kidney, liver and lung,
               and involving different types of stain, showed no major
               discordances. The virtual-staining method bypasses the typically
               labour-intensive and costly histological staining procedures,
               and could be used as a blueprint for the virtual staining of
               tissue images acquired with other label-free imaging modalities.",
  journal   = "Nat Biomed Eng",
  publisher = "nature.com",
  volume    =  3,
  number    =  6,
  pages     = "466--477",
  month     =  jun,
  year      =  2019,
  language  = "en"
}

@ARTICLE{Xie2016-eb,
  title         = "Aggregated Residual Transformations for Deep Neural Networks",
  author        = "Xie, Saining and Girshick, Ross and Doll{\'a}r, Piotr and
                   Tu, Zhuowen and He, Kaiming",
  abstract      = "We present a simple, highly modularized network architecture
                   for image classification. Our network is constructed by
                   repeating a building block that aggregates a set of
                   transformations with the same topology. Our simple design
                   results in a homogeneous, multi-branch architecture that has
                   only a few hyper-parameters to set. This strategy exposes a
                   new dimension, which we call ``cardinality'' (the size of
                   the set of transformations), as an essential factor in
                   addition to the dimensions of depth and width. On the
                   ImageNet-1K dataset, we empirically show that even under the
                   restricted condition of maintaining complexity, increasing
                   cardinality is able to improve classification accuracy.
                   Moreover, increasing cardinality is more effective than
                   going deeper or wider when we increase the capacity. Our
                   models, named ResNeXt, are the foundations of our entry to
                   the ILSVRC 2016 classification task in which we secured 2nd
                   place. We further investigate ResNeXt on an ImageNet-5K set
                   and the COCO detection set, also showing better results than
                   its ResNet counterpart. The code and models are publicly
                   available online.",
  month         =  nov,
  year          =  2016,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1611.05431"
}

@ARTICLE{Yan2009-gh,
  title    = "{IDH1} and {IDH2} mutations in gliomas",
  author   = "Yan, Hai and Parsons, D Williams and Jin, Genglin and McLendon,
              Roger and Rasheed, B Ahmed and Yuan, Weishi and Kos, Ivan and
              Batinic-Haberle, Ines and Jones, Si{\^a}n and Riggins, Gregory J
              and Friedman, Henry and Friedman, Allan and Reardon, David and
              Herndon, James and Kinzler, Kenneth W and Velculescu, Victor E
              and Vogelstein, Bert and Bigner, Darell D",
  abstract = "BACKGROUND: A recent genomewide mutational analysis of
              glioblastomas (World Health Organization [WHO] grade IV glioma)
              revealed somatic mutations of the isocitrate dehydrogenase 1 gene
              (IDH1) in a fraction of such tumors, most frequently in tumors
              that were known to have evolved from lower-grade gliomas
              (secondary glioblastomas). METHODS: We determined the sequence of
              the IDH1 gene and the related IDH2 gene in 445 central nervous
              system (CNS) tumors and 494 non-CNS tumors. The enzymatic
              activity of the proteins that were produced from normal and
              mutant IDH1 and IDH2 genes was determined in cultured glioma
              cells that were transfected with these genes. RESULTS: We
              identified mutations that affected amino acid 132 of IDH1 in more
              than 70\% of WHO grade II and III astrocytomas and
              oligodendrogliomas and in glioblastomas that developed from these
              lower-grade lesions. Tumors without mutations in IDH1 often had
              mutations affecting the analogous amino acid (R172) of the IDH2
              gene. Tumors with IDH1 or IDH2 mutations had distinctive genetic
              and clinical characteristics, and patients with such tumors had a
              better outcome than those with wild-type IDH genes. Each of four
              tested IDH1 and IDH2 mutations reduced the enzymatic activity of
              the encoded protein. CONCLUSIONS: Mutations of NADP(+)-dependent
              isocitrate dehydrogenases encoded by IDH1 and IDH2 occur in a
              majority of several types of malignant gliomas.",
  journal  = "N. Engl. J. Med.",
  volume   =  360,
  number   =  8,
  pages    = "765--773",
  month    =  feb,
  year     =  2009,
  language = "en"
}

@INPROCEEDINGS{Wang2016-ul,
  title     = "{CNN-RNN}: A Unified Framework for Multi-label Image
               Classification",
  booktitle = "2016 {IEEE} Conference on Computer Vision and Pattern
               Recognition ({CVPR})",
  author    = "Wang, J and Yang, Y and Mao, J and Huang, Z and Huang, C and Xu,
               W",
  abstract  = "While deep convolutional neural networks (CNNs) have shown a
               great success in single-label image classification, it is
               important to note that real world images generally contain
               multiple labels, which could correspond to different objects,
               scenes, actions and attributes in an image. Traditional
               approaches to multi-label image classification learn independent
               classifiers for each category and employ ranking or thresholding
               on the classification results. These techniques, although
               working well, fail to explicitly exploit the label dependencies
               in an image. In this paper, we utilize recurrent neural networks
               (RNNs) to address this problem. Combined with CNNs, the proposed
               CNN-RNN framework learns a joint image-label embedding to
               characterize the semantic label dependency as well as the
               image-label relevance, and it can be trained end-to-end from
               scratch to integrate both information in a unified framework.
               Experimental results on public benchmark datasets demonstrate
               that the proposed architecture achieves better performance than
               the state-of-the-art multi-label classification models.",
  pages     = "2285--2294",
  month     =  jun,
  year      =  2016,
  keywords  = "image classification;recurrent neural nets;CNN-RNN;multilabel
               image classification;convolutional neural networks;recurrent
               neural networks;image-label embedding;semantic label
               dependency;image-label relevance;public benchmark
               datasets;Computational modeling;Hidden Markov models;Logic
               gates;Neurons;Semantics;Redundancy;Recurrent neural networks"
}

@INPROCEEDINGS{Razavian2014-ev,
  title     = "{CNN} Features {Off-the-Shelf}: An Astounding Baseline for
               Recognition",
  booktitle = "2014 {IEEE} Conference on Computer Vision and Pattern
               Recognition Workshops",
  author    = "Razavian, A S and Azizpour, H and Sullivan, J and Carlsson, S",
  abstract  = "Recent results indicate that the generic descriptors extracted
               from the convolutional neural networks are very powerful. This
               paper adds to the mounting evidence that this is indeed the
               case. We report on a series of experiments conducted for
               different recognition tasks using the publicly available code
               and model of the OverFeat network which was trained to perform
               object classification on ILSVRC13. We use features extracted
               from the OverFeat network as a generic image representation to
               tackle the diverse range of recognition tasks of object image
               classification, scene recognition, fine grained recognition,
               attribute detection and image retrieval applied to a diverse set
               of datasets. We selected these tasks and datasets as they
               gradually move further away from the original task and data the
               OverFeat network was trained to solve. Astonishingly, we report
               consistent superior results compared to the highly tuned
               state-of-the-art systems in all the visual classification tasks
               on various datasets. For instance retrieval it consistently
               outperforms low memory footprint methods except for sculptures
               dataset. The results are achieved using a linear SVM classifier
               (or L2 distance in case of retrieval) applied to a feature
               representation of size 4096 extracted from a layer in the net.
               The representations are further modified using simple
               augmentation techniques e.g. jittering. The results strongly
               suggest that features obtained from deep learning with
               convolutional nets should be the primary candidate in most
               visual recognition tasks.",
  pages     = "512--519",
  month     =  jun,
  year      =  2014,
  keywords  = "feature extraction;image classification;image
               representation;image retrieval;learning (artificial
               intelligence);neural nets;support vector machines;CNN
               features;OverFeat network training;ILSVRC13;feature
               extraction;generic image representation;object image
               classification;scene recognition;fine grained
               recognition;attribute detection;image retrieval;visual
               classification tasks;low memory footprint methods;linear SVM
               classifier;feature representation;augmentation techniques;deep
               learning;convolutional neural network;convolutional nets;Feature
               extraction;Training;Birds;Visualization;Support vector
               machines;Vectors;Image recognition"
}

@ARTICLE{Wheeler2016-zk,
  title    = "Phase {II} multicenter study of gene-mediated cytotoxic
              immunotherapy as adjuvant to surgical resection for newly
              diagnosed malignant glioma",
  author   = "Wheeler, Lee A and Manzanera, Andrea G and Bell, Susan D and
              Cavaliere, Robert and McGregor, John M and Grecula, John C and
              Newton, Herbert B and Lo, Simon S and Badie, Behnam and Portnow,
              Jana and Teh, Bin S and Trask, Todd W and Baskin, David S and
              New, Pamela Z and Aguilar, Laura K and Aguilar-Cordova, Estuardo
              and Chiocca, E Antonio",
  abstract = "BACKGROUND: Despite aggressive standard of care (SOC) treatment,
              survival of malignant gliomas remains very poor. This Phase II,
              prospective, matched controlled, multicenter trial was conducted
              to assess the safety and efficacy of aglatimagene besadenovec
              (AdV-tk) plus valacyclovir (gene-mediated cytotoxic immunotherapy
              [GMCI]) in combination with SOC for newly diagnosed malignant
              glioma patients. METHODS: Treatment cohort patients received SOC
              + GMCI and were enrolled at 4 institutions from 2006 to 2010. The
              preplanned, matched-control cohort included all concurrent
              patients meeting protocol criteria and SOC at a fifth
              institution. AdV-tk was administered at surgery followed by SOC
              radiation and temozolomide. Subset analyses were preplanned,
              based on prognostic factors: pathological diagnosis (glioblastoma
              vs others) and extent of resection. RESULTS: Forty-eight patients
              completed SOC + GMCI, and 134 met control cohort criteria. Median
              overall survival (OS) was 17.1 months for GMCI + SOC versus 13.5
              months for SOC alone (P = .0417). Survival at 1, 2, and 3 years
              was 67\%, 35\%, and 19\% versus 57\%, 22\%, and 8\%,
              respectively. The greatest benefit was observed in gross total
              resection patients: median OS of 25 versus 16.9 months (P =
              .0492); 1, 2, and 3-year survival of 90\%, 53\%, and 32\% versus
              64\%, 28\% and 6\%, respectively. There were no dose-limiting
              toxicities; fever, fatigue, and headache were the most common
              GMCI-related symptoms. CONCLUSIONS: GMCI can be safely combined
              with SOC in newly diagnosed malignant gliomas. Survival outcomes
              were most notably improved in patients with minimal residual
              disease after gross total resection. These data should help guide
              future immunotherapy studies and strongly support further
              evaluation of GMCI for malignant gliomas. CLINICAL TRIAL
              REGISTRY: ClinicalTrials.gov NCT00589875.",
  journal  = "Neuro. Oncol.",
  volume   =  18,
  number   =  8,
  pages    = "1137--1145",
  month    =  aug,
  year     =  2016,
  keywords = "gene therapy; glioblastoma; immuno-oncology; immunotherapy;
              malignant glioma",
  language = "en"
}

@ARTICLE{Desjardins2018-kk,
  title    = "Recurrent Glioblastoma Treated with Recombinant Poliovirus",
  author   = "Desjardins, Annick and Gromeier, Matthias and Herndon, 2nd, James
              E and Beaubier, Nike and Bolognesi, Dani P and Friedman, Allan H
              and Friedman, Henry S and McSherry, Frances and Muscat, Andrea M
              and Nair, Smita and Peters, Katherine B and Randazzo, Dina and
              Sampson, John H and Vlahovic, Gordana and Harrison, William T and
              McLendon, Roger E and Ashley, David and Bigner, Darell D",
  abstract = "BACKGROUND: The prognosis of patients with recurrent World Health
              Organization (WHO) grade IV malignant glioma is dismal, and there
              is currently no effective therapy. We conducted a dose-finding
              and toxicity study in this population of patients, evaluating
              convection-enhanced, intratumoral delivery of the recombinant
              nonpathogenic polio-rhinovirus chimera (PVSRIPO). PVSRIPO
              recognizes the poliovirus receptor CD155, which is widely
              expressed in neoplastic cells of solid tumors and in major
              components of the tumor microenvironment. METHODS: We enrolled
              consecutive adult patients who had recurrent supratentorial WHO
              grade IV malignant glioma, confirmed on histopathological
              testing, with measurable disease (contrast-enhancing tumor of
              $\geq$1 cm and $\leq$5.5 cm in the greatest dimension). The study
              evaluated seven doses, ranging between 107 and 1010 50\%
              tissue-culture infectious doses (TCID50), first in a
              dose-escalation phase and then in a dose-expansion phase.
              RESULTS: From May 2012 through May 2017, a total of 61 patients
              were enrolled and received a dose of PVSRIPO. Dose level -1
              (5.0$\times$107 TCID50) was identified as the phase 2 dose. One
              dose-limiting toxic effect was observed; a patient in whom dose
              level 5 (1010 TCID50) was administered had a grade 4 intracranial
              hemorrhage immediately after the catheter was removed. To
              mitigate locoregional inflammation of the infused tumor with
              prolonged glucocorticoid use, dose level 5 was deescalated to
              reach the phase 2 dose. In the dose-expansion phase, 19\% of the
              patients had a PVSRIPO-related adverse event of grade 3 or
              higher. Overall survival among the patients who received PVSRIPO
              reached a plateau of 21\% (95\% confidence interval, 11 to 33) at
              24 months that was sustained at 36 months. CONCLUSIONS:
              Intratumoral infusion of PVSRIPO in patients with recurrent WHO
              grade IV malignant glioma confirmed the absence of neurovirulent
              potential. The survival rate among patients who received PVSRIPO
              immunotherapy was higher at 24 and 36 months than the rate among
              historical controls. (Funded by the Brain Tumor Research Charity
              and others; ClinicalTrials.gov number, NCT01491893 .).",
  journal  = "N. Engl. J. Med.",
  volume   =  379,
  number   =  2,
  pages    = "150--161",
  month    =  jul,
  year     =  2018,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Kamath2019-oi,
  title    = "Glioblastoma Treated With Magnetic Resonance {Imaging-Guided}
              Laser Interstitial Thermal Therapy: Safety, Efficacy, and
              Outcomes",
  author   = "Kamath, Ashwin A and Friedman, Daniel D and Akbari, S Hassan A
              and Kim, Albert H and Tao, Yu and Luo, Jinqin and Leuthardt, Eric
              C",
  abstract = "BACKGROUND: Despite the multitude of available treatments,
              glioblastoma (GBM) remains an aggressive and uniformly fatal
              tumor. Laser interstitial thermal therapy (LITT) is a novel,
              minimally invasive treatment that holds promise for treating
              patients with GBM who are not candidates for traditional open
              craniotomy. However, due to the recent introduction of LITT into
              clinical practice, large series that evaluate safety and
              long-term outcomes after LITT are lacking. OBJECTIVE: To present
              our institution's series of over 50 GBM patients treated with
              LITT, with regard to safety, efficacy, and outcomes. METHODS: We
              performed a retrospective descriptive study of patients with
              histologically proven GBM who underwent LITT. Data collected
              included demographics, tumor location and volume, tumor genetic
              markers, treatment volume, perioperative complications, and
              long-term follow-up data. RESULTS: We performed 58 LITT
              treatments for GBM in 54 patients over 5.5 yr. Forty-one were
              recurrent tumors while 17 were frontline treatments. Forty GBMs
              were lobar in location, while 18 were in deep structures
              (thalamus, insula, corpus callosum). Average tumor volume was
              12.5 $\pm$ 13.4 cm3. Average percentage of tumor treated with the
              yellow thermal damage threshold (TDT) line (dose equivalent of
              43Â°C for 2 min) was 93.3\% $\pm$ 10.6\%, and with the blue TDT
              line (dose equivalent of 43Â°C for 10 min) was 88.0\% $\pm$
              14.2\%. There were 7 perioperative complications (12\%) and 2
              mortalities (3.4\%). Median overall survival after LITT for the
              total cohort was 11.5 mo, and median progression-free survival
              6.6 mo. CONCLUSION: LITT appears to be a safe and effective
              treatment for GBM in properly selected patients.",
  journal  = "Neurosurgery",
  volume   =  84,
  number   =  4,
  pages    = "836--843",
  month    =  apr,
  year     =  2019,
  keywords = "Brain tumors; GBM; Glioblastoma; LITT; Laser ablation; Laser
              interstitial thermal therapy; MRI; Thermoablation",
  language = "en"
}

@ARTICLE{Chiocca2011-nc,
  title    = "Phase {IB} study of gene-mediated cytotoxic immunotherapy
              adjuvant to up-front surgery and intensive timing radiation for
              malignant glioma",
  author   = "Chiocca, E Antonio and Aguilar, Laura K and Bell, Susan D and
              Kaur, Balveen and Hardcastle, Jayson and Cavaliere, Robert and
              McGregor, John and Lo, Simon and Ray-Chaudhuri, Abhik and
              Chakravarti, Arnab and Grecula, John and Newton, Herbert and
              Harris, Kimbra S and Grossman, Robert G and Trask, Todd W and
              Baskin, David S and Monterroso, Carissa and Manzanera, Andrea G
              and Aguilar-Cordova, Estuardo and New, Pamela Z",
  abstract = "PURPOSE: Despite aggressive therapies, median survival for
              malignant gliomas is less than 15 months. Patients with
              unmethylated O(6)-methylguanine-DNA methyltransferase (MGMT) fare
              worse, presumably because of temozolomide resistance. AdV-tk, an
              adenoviral vector containing the herpes simplex virus thymidine
              kinase gene, plus prodrug synergizes with surgery and
              chemoradiotherapy, kills tumor cells, has not shown MGMT
              dependency, and elicits an antitumor vaccine effect. PATIENTS AND
              METHODS: Patients with newly diagnosed malignant glioma received
              AdV-tk at 3 $\times$ 10(10), 1 $\times$ 10(11), or 3 $\times$
              10(11) vector particles (vp) via tumor bed injection at time of
              surgery followed by 14 days of valacyclovir. Radiation was
              initiated within 9 days after AdV-tk injection to overlap with
              AdV-tk activity. Temozolomide was administered after completing
              valacyclovir treatment. RESULTS: Accrual began December 2005 and
              was completed in 13 months. Thirteen patients were enrolled and
              12 completed therapy, three at dose levels 1 and 2 and six at
              dose level 3. There were no dose-limiting or significant added
              toxicities. One patient withdrew before completing prodrug
              because of an unrelated surgical complication. Survival at 2
              years was 33\% and at 3 years was 25\%. Patient-reported quality
              of life assessed with the Functional Assessment of Cancer
              Therapy-Brain (FACT-Br) was stable or improved after treatment. A
              significant CD3(+) T-cell infiltrate was found in four of four
              tumors analyzed after treatment. Three patients with MGMT
              unmethylated glioblastoma multiforme survived 6.5, 8.7, and 46.4
              months. CONCLUSION: AdV-tk plus valacyclovir can be safely
              delivered with surgery and accelerated radiation in newly
              diagnosed malignant gliomas. Temozolomide did not prevent immune
              responses. Although not powered for efficacy, the survival and
              MGMT independence trends are encouraging. A phase II trial is
              ongoing.",
  journal  = "J. Clin. Oncol.",
  volume   =  29,
  number   =  27,
  pages    = "3611--3619",
  month    =  sep,
  year     =  2011,
  language = "en"
}

@ARTICLE{Zhang2016-zi,
  title         = "Understanding deep learning requires rethinking
                   generalization",
  author        = "Zhang, Chiyuan and Bengio, Samy and Hardt, Moritz and Recht,
                   Benjamin and Vinyals, Oriol",
  abstract      = "Despite their massive size, successful deep artificial
                   neural networks can exhibit a remarkably small difference
                   between training and test performance. Conventional wisdom
                   attributes small generalization error either to properties
                   of the model family, or to the regularization techniques
                   used during training. Through extensive systematic
                   experiments, we show how these traditional approaches fail
                   to explain why large neural networks generalize well in
                   practice. Specifically, our experiments establish that
                   state-of-the-art convolutional networks for image
                   classification trained with stochastic gradient methods
                   easily fit a random labeling of the training data. This
                   phenomenon is qualitatively unaffected by explicit
                   regularization, and occurs even if we replace the true
                   images by completely unstructured random noise. We
                   corroborate these experimental findings with a theoretical
                   construction showing that simple depth two neural networks
                   already have perfect finite sample expressivity as soon as
                   the number of parameters exceeds the number of data points
                   as it usually does in practice. We interpret our
                   experimental findings by comparison with traditional models.",
  month         =  nov,
  year          =  2016,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "1611.03530"
}

@INCOLLECTION{Sajjadi2016-bp,
  title     = "Regularization With Stochastic Transformations and Perturbations
               for Deep {Semi-Supervised} Learning",
  booktitle = "Advances in Neural Information Processing Systems 29",
  author    = "Sajjadi, Mehdi and Javanmardi, Mehran and Tasdizen, Tolga",
  editor    = "Lee, D D and Sugiyama, M and Luxburg, U V and Guyon, I and
               Garnett, R",
  publisher = "Curran Associates, Inc.",
  pages     = "1163--1171",
  year      =  2016
}

@ARTICLE{Smith2015-ed,
  title         = "Cyclical Learning Rates for Training Neural Networks",
  author        = "Smith, Leslie N",
  abstract      = "It is known that the learning rate is the most important
                   hyper-parameter to tune for training deep neural networks.
                   This paper describes a new method for setting the learning
                   rate, named cyclical learning rates, which practically
                   eliminates the need to experimentally find the best values
                   and schedule for the global learning rates. Instead of
                   monotonically decreasing the learning rate, this method lets
                   the learning rate cyclically vary between reasonable
                   boundary values. Training with cyclical learning rates
                   instead of fixed values achieves improved classification
                   accuracy without a need to tune and often in fewer
                   iterations. This paper also describes a simple way to
                   estimate ``reasonable bounds'' -- linearly increasing the
                   learning rate of the network for a few epochs. In addition,
                   cyclical learning rates are demonstrated on the CIFAR-10 and
                   CIFAR-100 datasets with ResNets, Stochastic Depth networks,
                   and DenseNets, and the ImageNet dataset with the AlexNet and
                   GoogLeNet architectures. These are practical tools for
                   everyone who trains neural networks.",
  month         =  jun,
  year          =  2015,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1506.01186"
}

@INPROCEEDINGS{Hu2018-eg,
  title     = "{Squeeze-and-Excitation} Networks",
  booktitle = "2018 {IEEE/CVF} Conference on Computer Vision and Pattern
               Recognition",
  author    = "Hu, J and Shen, L and Sun, G",
  abstract  = "Convolutional neural networks are built upon the convolution
               operation, which extracts informative features by fusing spatial
               and channel-wise information together within local receptive
               fields. In order to boost the representational power of a
               network, several recent approaches have shown the benefit of
               enhancing spatial encoding. In this work, we focus on the
               channel relationship and propose a novel architectural unit,
               which we term the ``Squeeze-and-Excitation'' (SE) block, that
               adaptively recalibrates channel-wise feature responses by
               explicitly modelling interdependencies between channels. We
               demonstrate that by stacking these blocks together, we can
               construct SENet architectures that generalise extremely well
               across challenging datasets. Crucially, we find that SE blocks
               produce significant performance improvements for existing
               state-of-the-art deep architectures at minimal additional
               computational cost. SENets formed the foundation of our ILSVRC
               2017 classification submission which won first place and
               significantly reduced the top-5 error to 2.251\%, achieving a
               25\% relative improvement over the winning entry of 2016. Code
               and models are available at
               https://github.com/hujie-frank/SENet.",
  pages     = "7132--7141",
  month     =  jun,
  year      =  2018,
  keywords  = "convolution;feature extraction;feedforward neural nets;image
               classification;image coding;image fusion;image
               representation;neural net architecture;feature
               extraction;squeeze-and-excitation networks;deep
               architectures;spatial fusion;ILSVRC 2017 classification
               submission;SENets;SE blocks;SENet architectures;channel-wise
               feature responses;Squeeze-and-Excitation block;spatial
               encoding;channel-wise information;convolutional neural
               networks;Computer architecture;Computational
               modeling;Convolution;Task analysis;Convolutional
               codes;Adaptation models;Stacking"
}

@ARTICLE{Westphal2003-fd,
  title    = "A phase 3 trial of local chemotherapy with biodegradable
              carmustine ({BCNU}) wafers (Gliadel wafers) in patients with
              primary malignant glioma",
  author   = "Westphal, Manfred and Hilt, Dana C and Bortey, Enoch and
              Delavault, Patrick and Olivares, Robert and Warnke, Peter C and
              Whittle, Ian R and J{\"a}{\"a}skel{\"a}inen, Juha and Ram, Zvi",
  abstract = "A previous placebo-controlled trial has shown that biodegradable
              1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) wafers (Gliadel
              wafers) prolong survival in patients with recurrent glioblastoma
              multiforme. A previously completed phase 3 trial, also placebo
              controlled, in 32 patients with newly diagnosed malignant glioma
              also demonstrated a survival benefit in those patients treated
              with BCNU wafers. Because of the small number of patients in that
              trial, a larger phase 3 trial was performed to confirm these
              results. Two hundred forty patients were randomized to receive
              either BCNU or placebo wafers at the time of primary surgical
              resection; both groups were treated with external beam radiation
              postoperatively. The two groups were similar for age, sex,
              Karnofsky performance status (KPS), and tumor histology. Median
              survival in the intent-to-treat group was 13.9 months for the
              BCNU wafer-treated group and 11.6 months for the placebo-treated
              group (log-rank P -value stratified by country = 0.03), with a
              29\% reduction in the risk of death in the treatment group. When
              adjusted for factors affecting survival, the treatment effect
              remained positive with a risk reduction of 28\% ( P = 0.03). Time
              to decline in KPS and in 10/11 neuroperformance measures was
              statistically significantly prolonged in the BCNU wafer-treated
              group ( P </= 0.05). Adverse events were comparable for the 2
              groups, except for CSF leak (5\% in the BCNU wafer-treated group
              vs. 0.8\% in the placebo-treated group) and intracranial
              hypertension (9.1\% in the BCNU wafer-treated group vs. 1.7\% in
              the placebo group). This study confirms that local chemotherapy
              with BCNU wafers is well tolerated and offers a survival benefit
              to patients with newly diagnosed malignant glioma.",
  journal  = "Neuro. Oncol.",
  volume   =  5,
  number   =  2,
  pages    = "79--88",
  month    =  apr,
  year     =  2003,
  language = "en"
}

@UNPUBLISHED{Higgins2016-yk,
  title    = "{beta-VAE}: Learning Basic Visual Concepts with a Constrained
              Variational Framework",
  author   = "Higgins, Irina and Matthey, Loic and Pal, Arka and Burgess,
              Christopher and Glorot, Xavier and Botvinick, Matthew and
              Mohamed, Shakir and Lerchner, Alexander",
  abstract = "Learning an interpretable factorised representation of the
              independent data generative factors of the world without
              supervision is an important precursor for the development of
              artificial intelligence that is able to learn and reason in the
              same way that humans do. We introduce beta-VAE, a new
              state-of-the-art framework for automated discovery of
              interpretable factorised latent representations from raw image
              data in a completely unsupervised manner. Our approach is a
              modification of the variational autoencoder (VAE) framework. We
              introduce an adjustable hyperparameter beta that balances latent
              channel capacity and independence constraints with reconstruction
              accuracy. We demonstrate that beta-VAE with appropriately tuned
              beta > 1 qualitatively outperforms VAE (beta = 1), as well as
              state of the art unsupervised (InfoGAN) and semi-supervised
              (DC-IGN) approaches to disentangled factor learning on a variety
              of datasets (celebA, faces and chairs). Furthermore, we devise a
              protocol to quantitatively compare the degree of disentanglement
              learnt by different models, and show that our approach also
              significantly outperforms all baselines quantitatively. Unlike
              InfoGAN, beta-VAE is stable to train, makes few assumptions about
              the data and relies on tuning a single hyperparameter, which can
              be directly optimised through a hyper parameter search using
              weakly labelled data or through heuristic visual inspection for
              purely unsupervised data.",
  month    =  nov,
  year     =  2016
}

@ARTICLE{Xie2015-fy,
  title         = "Unsupervised Deep Embedding for Clustering Analysis",
  author        = "Xie, Junyuan and Girshick, Ross and Farhadi, Ali",
  abstract      = "Clustering is central to many data-driven application
                   domains and has been studied extensively in terms of
                   distance functions and grouping algorithms. Relatively
                   little work has focused on learning representations for
                   clustering. In this paper, we propose Deep Embedded
                   Clustering (DEC), a method that simultaneously learns
                   feature representations and cluster assignments using deep
                   neural networks. DEC learns a mapping from the data space to
                   a lower-dimensional feature space in which it iteratively
                   optimizes a clustering objective. Our experimental
                   evaluations on image and text corpora show significant
                   improvement over state-of-the-art methods.",
  month         =  nov,
  year          =  2015,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "1511.06335"
}

@ARTICLE{Lu2020-ql,
  title         = "Data Efficient and Weakly Supervised Computational Pathology
                   on Whole Slide Images",
  author        = "Lu, Ming Y and Williamson, Drew F K and Chen, Tiffany Y and
                   Chen, Richard J and Barbieri, Matteo and Mahmood, Faisal",
  abstract      = "The rapidly emerging field of computational pathology has
                   the potential to enable objective diagnosis, therapeutic
                   response prediction and identification of new morphological
                   features of clinical relevance. However, deep learning-based
                   computational pathology approaches either require manual
                   annotation of gigapixel whole slide images (WSIs) in
                   fully-supervised settings or thousands of WSIs with
                   slide-level labels in a weakly-supervised setting. Moreover,
                   whole slide level computational pathology methods also
                   suffer from domain adaptation and interpretability issues.
                   These challenges have prevented the broad adaptation of
                   computational pathology for clinical and research purposes.
                   Here we present CLAM - Clustering-constrained attention
                   multiple instance learning, an easy-to-use, high-throughput,
                   and interpretable WSI-level processing and learning method
                   that only requires slide-level labels while being data
                   efficient, adaptable and capable of handling multi-class
                   subtyping problems. CLAM is a deep-learning-based
                   weakly-supervised method that uses attention-based learning
                   to automatically identify sub-regions of high diagnostic
                   value in order to accurately classify the whole slide, while
                   also utilizing instance-level clustering over the
                   representative regions identified to constrain and refine
                   the feature space. In three separate analyses, we
                   demonstrate the data efficiency and adaptability of CLAM and
                   its superior performance over standard weakly-supervised
                   classification. We demonstrate that CLAM models are
                   interpretable and can be used to identify well-known and new
                   morphological features. We further show that models trained
                   using CLAM are adaptable to independent test cohorts, cell
                   phone microscopy images, and biopsies. CLAM is a
                   general-purpose and adaptable method that can be used for a
                   variety of different computational pathology tasks in both
                   clinical and research settings.",
  month         =  apr,
  year          =  2020,
  archivePrefix = "arXiv",
  primaryClass  = "eess.IV",
  eprint        = "2004.09666"
}

@ARTICLE{Djuric2017-qn,
  title    = "Precision histology: how deep learning is poised to revitalize
              histomorphology for personalized cancer care",
  author   = "Djuric, Ugljesa and Zadeh, Gelareh and Aldape, Kenneth and
              Diamandis, Phedias",
  journal  = "NPJ Precis Oncol",
  volume   =  1,
  number   =  1,
  pages    = "22",
  month    =  jun,
  year     =  2017,
  language = "en"
}

@INPROCEEDINGS{Fouad2017-dq,
  title     = "Unsupervised {Superpixel-Based} Segmentation of
               Histopathological Images with Consensus Clustering",
  booktitle = "Medical Image Understanding and Analysis",
  author    = "Fouad, Shereen and Randell, David and Galton, Antony and
               Mehanna, Hisham and Landini, Gabriel",
  abstract  = "We present a framework for adapting consensus clustering methods
               with superpixels to segment oropharyngeal cancer images into
               tissue types (epithelium, stroma and background). The simple
               linear iterative clustering algorithm is initially used to
               split-up the image into binary superpixels which are then used
               as clustering elements. Colour features of the superpixels are
               extracted and fed into several base clustering approaches with
               various parameter initializations. Two consensus clustering
               formulations are then used, the Evidence Accumulation Clustering
               (EAC) and the voting-based function. They both combine the base
               clustering outcomes to obtain a single more robust consensus
               result. Unlike most unsupervised tissue image segmentation
               approaches that depend on individual clustering methods, the
               proposed approach allows for a robust detection of tissue
               compartments. For the voting-based consensus function, we
               introduce a technique based on image processing to generate a
               consistent labelling scheme among the base clustering outcomes.
               Experiments conducted on forty five hand-annotated images of
               oropharyngeal cancer tissue microarray cores show that the
               ensemble algorithm generates more accurate and stable results
               than individual clustering algorithms. The clustering
               performance of the voting-based consensus function using our
               re-labelling technique also outperforms the existing EAC.",
  publisher = "Springer International Publishing",
  pages     = "767--779",
  year      =  2017
}

@ARTICLE{Hanahan2011-cc,
  title    = "Hallmarks of cancer: the next generation",
  author   = "Hanahan, Douglas and Weinberg, Robert A",
  abstract = "The hallmarks of cancer comprise six biological capabilities
              acquired during the multistep development of human tumors. The
              hallmarks constitute an organizing principle for rationalizing
              the complexities of neoplastic disease. They include sustaining
              proliferative signaling, evading growth suppressors, resisting
              cell death, enabling replicative immortality, inducing
              angiogenesis, and activating invasion and metastasis. Underlying
              these hallmarks are genome instability, which generates the
              genetic diversity that expedites their acquisition, and
              inflammation, which fosters multiple hallmark functions.
              Conceptual progress in the last decade has added two emerging
              hallmarks of potential generality to this list-reprogramming of
              energy metabolism and evading immune destruction. In addition to
              cancer cells, tumors exhibit another dimension of complexity:
              they contain a repertoire of recruited, ostensibly normal cells
              that contribute to the acquisition of hallmark traits by creating
              the ``tumor microenvironment.'' Recognition of the widespread
              applicability of these concepts will increasingly affect the
              development of new means to treat human cancer.",
  journal  = "Cell",
  volume   =  144,
  number   =  5,
  pages    = "646--674",
  month    =  mar,
  year     =  2011,
  language = "en"
}

@ARTICLE{Lee2020-pz,
  title         = "{High-Fidelity} Synthesis with Disentangled Representation",
  author        = "Lee, Wonkwang and Kim, Donggyun and Hong, Seunghoon and Lee,
                   Honglak",
  abstract      = "Learning disentangled representation of data without
                   supervision is an important step towards improving the
                   interpretability of generative models. Despite recent
                   advances in disentangled representation learning, existing
                   approaches often suffer from the trade-off between
                   representation learning and generation performance i.e.
                   improving generation quality sacrifices disentanglement
                   performance). We propose an Information-Distillation
                   Generative Adversarial Network (ID-GAN), a simple yet
                   generic framework that easily incorporates the existing
                   state-of-the-art models for both disentanglement learning
                   and high-fidelity synthesis. Our method learns disentangled
                   representation using VAE-based models, and distills the
                   learned representation with an additional nuisance variable
                   to the separate GAN-based generator for high-fidelity
                   synthesis. To ensure that both generative models are aligned
                   to render the same generative factors, we further constrain
                   the GAN generator to maximize the mutual information between
                   the learned latent code and the output. Despite the
                   simplicity, we show that the proposed method is highly
                   effective, achieving comparable image generation quality to
                   the state-of-the-art methods using the disentangled
                   representation. We also show that the proposed decomposition
                   leads to an efficient and stable model design, and we
                   demonstrate photo-realistic high-resolution image synthesis
                   results (1024x1024 pixels) for the first time using the
                   disentangled representations.",
  month         =  jan,
  year          =  2020,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "2001.04296"
}

@ARTICLE{Lee2020-ve,
  title         = "{High-Fidelity} Synthesis with Disentangled Representation",
  author        = "Lee, Wonkwang and Kim, Donggyun and Hong, Seunghoon and Lee,
                   Honglak",
  abstract      = "Learning disentangled representation of data without
                   supervision is an important step towards improving the
                   interpretability of generative models. Despite recent
                   advances in disentangled representation learning, existing
                   approaches often suffer from the trade-off between
                   representation learning and generation performance i.e.
                   improving generation quality sacrifices disentanglement
                   performance). We propose an Information-Distillation
                   Generative Adversarial Network (ID-GAN), a simple yet
                   generic framework that easily incorporates the existing
                   state-of-the-art models for both disentanglement learning
                   and high-fidelity synthesis. Our method learns disentangled
                   representation using VAE-based models, and distills the
                   learned representation with an additional nuisance variable
                   to the separate GAN-based generator for high-fidelity
                   synthesis. To ensure that both generative models are aligned
                   to render the same generative factors, we further constrain
                   the GAN generator to maximize the mutual information between
                   the learned latent code and the output. Despite the
                   simplicity, we show that the proposed method is highly
                   effective, achieving comparable image generation quality to
                   the state-of-the-art methods using the disentangled
                   representation. We also show that the proposed decomposition
                   leads to an efficient and stable model design, and we
                   demonstrate photo-realistic high-resolution image synthesis
                   results (1024x1024 pixels) for the first time using the
                   disentangled representations.",
  month         =  jan,
  year          =  2020,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "2001.04296"
}

@ARTICLE{noauthor_undated-ll,
  title = "[{PDF}] The lateralization accuracy of inferior petrosal sinus .."
}

@ARTICLE{Van_den_Oord2017-lk,
  title         = "Neural Discrete Representation Learning",
  author        = "van den Oord, Aaron and Vinyals, Oriol and Kavukcuoglu,
                   Koray",
  abstract      = "Learning useful representations without supervision remains
                   a key challenge in machine learning. In this paper, we
                   propose a simple yet powerful generative model that learns
                   such discrete representations. Our model, the Vector
                   Quantised-Variational AutoEncoder (VQ-VAE), differs from
                   VAEs in two key ways: the encoder network outputs discrete,
                   rather than continuous, codes; and the prior is learnt
                   rather than static. In order to learn a discrete latent
                   representation, we incorporate ideas from vector
                   quantisation (VQ). Using the VQ method allows the model to
                   circumvent issues of ``posterior collapse'' -- where the
                   latents are ignored when they are paired with a powerful
                   autoregressive decoder -- typically observed in the VAE
                   framework. Pairing these representations with an
                   autoregressive prior, the model can generate high quality
                   images, videos, and speech as well as doing high quality
                   speaker conversion and unsupervised learning of phonemes,
                   providing further evidence of the utility of the learnt
                   representations.",
  month         =  nov,
  year          =  2017,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "1711.00937"
}

@ARTICLE{Spratt2017-in,
  title    = "An integrated multidisciplinary algorithm for the management of
              spinal metastases: an International Spine Oncology Consortium
              report",
  author   = "Spratt, Daniel E and Beeler, Whitney H and de Moraes, Fabio Y and
              Rhines, Laurence D and Gemmete, Joseph J and Chaudhary, Neeraj
              and Shultz, David B and Smith, Sean R and Berlin, Alejandro and
              Dahele, Max and Slotman, Ben J and Younge, Kelly C and Bilsky,
              Mark and Park, Paul and Szerlip, Nicholas J",
  abstract = "Spinal metastases are becoming increasingly common because
              patients with metastatic disease are living longer. The close
              proximity of the spinal cord to the vertebral column limits many
              conventional therapeutic options that can otherwise be used to
              treat cancer. In response to this problem, an innovative
              multidisciplinary approach has been developed for the management
              of spinal metastases, leveraging the capabilities of image-guided
              stereotactic radiosurgery, separation surgery, vertebroplasty,
              and minimally invasive local ablative approaches. In this Review,
              we discuss the variables that should be considered during the
              management of these patients and review the role of each
              discipline and their respective management options to provide
              optimal care. This work is synthesised into a practical algorithm
              to aid clinicians in the management of patients with spinal
              metastasis.",
  journal  = "Lancet Oncol.",
  volume   =  18,
  number   =  12,
  pages    = "e720--e730",
  month    =  dec,
  year     =  2017,
  language = "en"
}

@ARTICLE{Karsy2019-xg,
  title    = "{EQ-5D} {Quality-of-Life} Analysis and {Cost-Effectiveness} After
              Skull Base Meningioma Resection",
  author   = "Karsy, Michael and Jensen, Michael R and Guan, Jian and Ravindra,
              Vijay M and Bisson, Erica F and Couldwell, William T",
  abstract = "BACKGROUND: Skull base meningioma management is complicated by
              their proximity to intracranial neurovascular structures because
              complete resection may pose a risk of worsening morbidity.
              OBJECTIVE: To assess the influence of clinical outcomes and
              surgical management on patient-perceived quality-of-life
              outcomes, value, and cost-effectiveness. METHODS: Patients who
              underwent resection of a skull base meningioma, had adequate
              clinical follow-up, and completed EQ-5D-3L questionnaires
              preoperatively and at 1 mo and 1 yr postoperatively were
              identified in a retrospective review. Cost data from the Value
              Driven Outcomes database were analyzed. RESULTS: A total of 52
              patients (83.0\% women, mean age 51.9 yr) were categorized by
              worsened (n = 7), unchanged (n = 24), or improved (n = 21)
              EQ-5D-3L index scores at 1-mo follow-up. No difference in
              subcategory cost contribution or total cost was seen in the 3
              groups. Patients with improved scores showed a steady improvement
              through each follow-up period, whereas those with unchanged or
              worsened scores did not. Mean quality-adjusted life years (QALYs)
              and cost per QALY improved for all groups but at a higher rate
              for patients with better outcomes at 30-d follow-up. Female sex,
              absence of proptosis, nonfrontotemporal approaches, no optic
              nerve decompression, and absence of surgical complications
              demonstrated improved EQ-5D-3L scores at 1-yr follow-up. A mean
              cost per QALY of \$27 731.06 $\pm$ 22 050.58 was observed for the
              whole group and did not significantly differ among patient groups
              (P = .1). CONCLUSION: Patients undergoing resection of skull base
              meningiomas and who experience an immediate improvement in EQ-5D
              are likely to show continued improvement at 1 yr, with improved
              QALY and reduced cost per QALY.",
  journal  = "Neurosurgery",
  volume   =  85,
  number   =  3,
  pages    = "E543--E552",
  month    =  sep,
  year     =  2019,
  keywords = "Cost-effectiveness; EQ-5D; Meningioma; Outcomes; Quality of life;
              Quality-adjusted life years; Skull base; Value",
  language = "en"
}

@ARTICLE{Magill2018-lm,
  title    = "Tuberculum sellae meningiomas: grading scale to assess surgical
              outcomes using the transcranial versus transsphenoidal approach",
  author   = "Magill, Stephen T and Morshed, Ramin A and Lucas, Calixto-Hope G
              and Aghi, Manish K and Theodosopoulos, Philip V and Berger,
              Mitchel S and de Divitiis, Oreste and Solari, Domenico and
              Cappabianca, Paolo and Cavallo, Luigi M and McDermott, Michael W",
  abstract = "OBJECTIVE Tuberculum sellae meningiomas (TSMs) are surgically
              challenging tumors that can severely impair vision. Debate exists
              regarding whether the transcranial (TC) or endoscopic
              transsphenoidal (TS) approach is best for resecting these tumors,
              and there are few large series comparing these approaches.
              METHODS A retrospective chart review was performed at 2 academic
              centers comparing TC and TS approaches with respect to vision,
              extent of resection, recurrence, and complications. The authors
              report surgical outcomes and propose a simple preoperative tumor
              grading scale that scores tumor size (1-2), optic canal invasion
              (0-2), and arterial encasement (0-2). The authors performed
              univariate, multivariate, and recursive partitioning analysis
              (RPA) to evaluate outcomes. RESULTS The TSMs were resected in 139
              patients. The median follow-up was 29 months. Ninety-five (68\%)
              cases were resected via a TC and 44 (32\%) via a TS approach.
              Tumors treated via a TC approach had a higher tumor (p = 0.0007),
              artery (p < 0.0001), and total score (p = 0.0012) on the grading
              scale. Preoperative visual deficits were present in 87\% of
              patients. Vision improved in 47\%, stayed the same in 35\%,
              declined in 10\%, and was not recorded in 8\%. The extent of
              resection was 65\% gross-total resection, 23\% near-total
              resection (95\%-99\% resection), and 12\% subtotal resection (<
              95\%). A lower tumor score was significantly associated with
              better or stable vision postoperatively (p = 0.0052). The RPA
              confirmed low tumor score as the key predictor of postoperative
              visual improvement or stability. Multivariate analysis and RPA
              demonstrate that lower canal score (p < 0.0001) and TC approach
              (p = 0.0019) are associated with gross-total resection.
              Complications occurred in 20 (14\%) patients, including CSF leak
              (5\%) and infection (4\%). There was no difference in overall
              complication rates between TC and TS approaches; however, the TS
              approach had more CSF leaks (OR 5.96, 95\% CI 1.10-32.04). The
              observed recurrence rate was 10\%, and there was no difference
              between the TC and TS approaches. CONCLUSIONS Tuberculum sellae
              meningiomas can be resected using either a TC or TS approach,
              with low morbidity and good visual outcomes in appropriately
              selected patients. The simple proposed grading scale provides a
              standard preoperative method to evaluate TSMs and can serve as a
              starting point for selection of the surgical approach. Higher
              scores were associated with worsened visual outcomes and subtotal
              resection, regardless of approach. The authors plan a multicenter
              review of this grading scale to further evaluate its utility.",
  journal  = "Neurosurg. Focus",
  volume   =  44,
  number   =  4,
  pages    = "E9",
  month    =  apr,
  year     =  2018,
  keywords = "ACA = anterior cerebral artery; EOR = extent of resection; GTR =
              gross-total resection; ICA = internal carotid artery; NTR =
              near-total resection; RPA = recursive partitioning analysis; STR
              = subtotal resection; TC = transcranial; TS = transsphenoidal;
              TSM = tuberculum sellae meningioma; UCSF = University of
              California, San Francisco; complications; endoscopic; expanded
              endonasal approach; grading scale; meningioma; outcomes; sella;
              sellae; transsphenoidal; tuberculum",
  language = "en"
}

@ARTICLE{Muller2011-mm,
  title    = "Post-operative hypothalamic lesions and obesity in childhood
              craniopharyngioma: results of the multinational prospective trial
              {KRANIOPHARYNGEOM} 2000 after 3-year follow-up",
  author   = "M{\"u}ller, Hermann L and Gebhardt, Ursel and Teske, Carmen and
              Faldum, Andreas and Zwiener, Isabella and Warmuth-Metz, Monika
              and Pietsch, Torsten and Pohl, Fabian and S{\"o}rensen, Niels and
              Calaminus, Gabriele and {Study Committee of KRANIOPHARYNGEOM
              2000}",
  abstract = "BACKGROUND: Hypothalamic obesity has major impact on prognosis
              and quality of life (QoL) in childhood craniopharyngioma.
              PATIENTS AND METHODS: For this study, 120 patients were
              prospectively recruited during 2001 and 2007 and evaluated after
              3 years of follow-up (KRANIOPHARYNGEOM 2000). Body mass index
              (BMI) and QoL at diagnosis and 36 months after diagnosis were
              analysed based on the reference assessment of tumour localisation
              and post-surgical hypothalamic lesions. Treatment was analysed
              based on the neurosurgical strategy of 50 participating
              neurosurgical centres, the centre size based on the patient load.
              RESULTS: BMI SDS at diagnosis was similar in patients with or
              without hypothalamic involvement. Surgical lesions of anterior
              and posterior hypothalamic areas were associated with higher
              increase in BMI SDS during 36 months post-diagnosis compared with
              patients without or only anterior lesion (+1.8 BMISD, P=0.033,
              +2.1 BMISD; P=0.011), negative impact on QoL in patients with
              posterior hypothalamic lesions. Surgical strategies varied among
              the 50 neurosurgical centres (three large-sized, 24 middle-sized
              and 23 small-sized centres). Patients treated in small-sized
              centres presented with a higher rate of hypothalamic involvement
              compared with those treated in the middle- and large-sized
              centres. Treatment in large-sized centres was less radical, and
              the rates of complete resection and hypothalamic surgical lesions
              were lower in large-sized centres than those of the middle- and
              small-sized centres. However, a multivariable analysis showed
              that pre-operative hypothalamic involvement was the only
              independent risk factor for severe obesity (P=0.002).
              CONCLUSIONS: Radical neurosurgical strategies leading to
              posterior hypothalamic lesions are not recommended due to the
              potential to exacerbate hypothalamic obesity and impaired QoL.
              Treatment should be confined to experienced multidisciplinary
              teams.",
  journal  = "Eur. J. Endocrinol.",
  volume   =  165,
  number   =  1,
  pages    = "17--24",
  month    =  jul,
  year     =  2011,
  language = "en"
}

@ARTICLE{Zweckberger2017-rb,
  title    = "Prospective analysis of neuropsychological deficits following
              resection of benign skull base meningiomas",
  author   = "Zweckberger, Klaus and Hallek, Eveline and Vogt, Lidia and Giese,
              Henrik and Schick, Uta and Unterberg, Andreas W",
  abstract = "OBJECTIVE Resection of skull base tumors is challenging. The
              introduction of alternative treatment options, such as
              radiotherapy, has sparked discussion regarding outcome in terms
              of quality of life and neuropsychological deficits. So far,
              however, no prospective data are available on this topic. METHODS
              A total of 58 patients with skull base meningiomas who underwent
              surgery for the first time were enrolled in this prospective
              single-center trial. The average age of the patients was 56.4
              $\pm$ 12.5 years. Seventy-nine percent of the tumors were located
              within the anterior skull base. Neurological examinations and
              neuropsychological testing were performed at 3 time points: 1 day
              prior to surgery (T1), 3-5 months after surgery (T2), and 9-12
              months after surgery (T3). The average follow-up duration was
              13.8 months. Neuropsychological assessment consisted of quality
              of life, depression and anxiety, verbal learning and memory,
              cognitive speed, attention and concentration, figural memory, and
              visual-motor speed. RESULTS Following surgery, 23\% of patients
              showed transient neurological deficits and 12\% showed permanent
              new neurological deficits with varying grades of manifestation.
              Postoperative quality of life, however, remained stable and was
              slightly improved at follow-up examinations at T3 (60.6 $\pm$
              21.5 vs 63.6 $\pm$ 24.1 points), and there was no observed effect
              on anxiety and depression. Long-term verbal memory, working
              memory, and executive functioning were slightly affected within
              the first months following surgery and appeared to be the most
              vulnerable to impairment by the tumor or the resection but were
              stable or improved in the majority of patients at long-term
              follow-up examinations after 1 year. CONCLUSIONS This report
              describes the first prospective study of neuropsychological
              outcomes following resection of skull base meningiomas and, as
              such, contributes to a better understanding of postoperative
              impairment in these patients. Despite deterioration in a minority
              of patients on subscales of the measures used, the majority
              demonstrated stable or improved outcome at follow-up assessments.",
  journal  = "J. Neurosurg.",
  volume   =  127,
  number   =  6,
  pages    = "1242--1248",
  month    =  dec,
  year     =  2017,
  keywords = "EORTC = European Organization for Research and Treatment of
              Cancer; FM = figural memory; FSRT = fractionated stereotactic
              radiotherapy; GTR = gross-total resection; HAD-S = Hospital
              Anxiety and Depression Scale; HAWIE-R = Hamburger Wechsler
              Intelligence Test for Adults--Revised; IMRT = intensity-modulated
              radiotherapy; STR = subtotal resection; TMT-B = Trail Making
              Test, version B; VLMT = Verbal Learning and Memory Test; WMS-R =
              Wechsler Memory Scale, revised version; neurocognitive
              functioning; neuropsychological assessment; oncology; quality of
              life; resection; skull base meningioma",
  language = "en"
}

@ARTICLE{Liouta2016-bf,
  title    = "Effects of intracranial meningioma location, size, and surgery on
              neurocognitive functions: a 3-year prospective study",
  author   = "Liouta, Evangelia and Koutsarnakis, Christos and Liakos, Faidon
              and Stranjalis, George",
  abstract = "OBJECT Current recommendations stress the need for cognitive
              parameters to be integrated in the evaluation of outcomes for
              intracranial meningioma surgery. The aim of this prospective
              study was to examine neurocognitive function in meningioma
              patients pre- and postoperatively. METHODS Patients with skull
              base (anterior and middle fossa) and convexity (anterior and
              posterior) meningiomas (n = 54) underwent neuropsychological
              examination prior to and 1 year after surgery. A control group (n
              = 52) of healthy volunteers matched for age, sex, and education
              underwent the same examination. Assessments included executive,
              memory, and motor functions with standardized testing. Patients
              with convexity meningiomas were clinically assessed for parietal
              association cortex functions. RESULTS All patients performed
              significantly worse (p 4 cm) had more severe neurocognitive
              deficits than those with a small tumor (< 4 cm). Postoperatively,
              patients showed no deterioration in neurocognitive function.
              Instead, significant improvement (p < 0.05) was observed in some
              executive, motor, and parietal association cortex functions.
              CONCLUSIONS According to the authors' findings, intracranial
              meningiomas may cause neurocognitive deficits in patients.
              Surgery does not cause a deterioration in cognitive function;
              instead, it may lead to improvements in some functions. Permanent
              neuropsychological postoperative deficits should be interpreted
              as tumor-induced rather than due to surgery.",
  journal  = "J. Neurosurg.",
  volume   =  124,
  number   =  6,
  pages    = "1578--1584",
  month    =  jun,
  year     =  2016,
  keywords = "COWAT = Controlled Oral Word Association Test; DWI =
              diffusion-weighted imaging; RBMT = Rivermead Behavioural Memory
              Test Extended Version; TMT = Trail Making Test; cognition;
              convexity meningioma; oncology; prospective study; skull base
              meningioma; surgery",
  language = "en"
}

@ARTICLE{Zwagerman2018-cc,
  title     = "Does lumbar drainage reduce postoperative cerebrospinal fluid
               leak after endoscopic endonasal skull base surgery? A
               prospective, randomized controlled trial",
  author    = "Zwagerman, Nathan T and Wang, Eric W and Shin, Samuel S and
               Chang, Yue-Fang and Fernandez-Miranda, Juan C and Snyderman,
               Carl H and Gardner, Paul A",
  abstract  = "OBJECTIVE: Based on a null hypothesis that the use of short-term
               lumbar drainage (LD) after endoscopic endonasal surgery (EES)
               for intradural pathology does not prevent postoperative CSF
               leaks, a trial was conducted to assess the effect of
               postoperative LD on postoperative CSF leak following standard
               reconstruction. METHODS: A prospective, randomized controlled
               trial of lumbar drain placement after endoscopic endonasal skull
               base surgery was performed from February 2011 to March 2015. All
               patients had 3-month follow-up data. Surgeons were blinded to
               which patients would or would not receive the drain until after
               closure was completed. An a priori power analysis calculation
               assuming 80\% of power, 5\% postoperative CSF leak rate in the
               no-LD group, and 16\% in the LD group determined a planned
               sample size of 186 patients. A routine data and safety check was
               performed with every 50 patients being recruited to ensure the
               efficacy of randomization and safety. These interim tests were
               run by a statistician who was not blinded to the arms they were
               evaluating. This study accrued 230 consecutive adult patients
               with skull base pathology who were eligible for endoscopic
               endonasal resection. Inclusion criteria (high-flow leak) were
               dural defect greater than 1 cm2 (mandatory), extensive arachnoid
               dissection, and/or dissection into a ventricle or cistern. Sixty
               patients were excluded because they did not meet the inclusion
               criteria. One hundred seventy patients were randomized to either
               receive or not receive a lumbar drain. RESULTS: One hundred
               seventy patients were randomized, with a mean age of 51.6 years
               (range 19-86 years) and 38\% were male. The mean BMI for the
               entire cohort was 28.1 kg/m2. The experimental cohort with
               postoperative LD had an 8.2\% rate of CSF leak compared to a
               21.2\% rate in the control group (odds ratio 3.0, 95\%
               confidence interval 1.2-7.6, p = 0.017). In 106 patients in whom
               defect size was measured intraoperatively, a larger defect was
               associated with postoperative CSF leak (6.2 vs 2.9 cm2, p =
               0.03). No significant difference was identified in BMI between
               those with (mean 28.4 $\pm$ 4.3 kg/m2) and without (mean 28.1
               $\pm$ 5.6 kg/m2) postoperative CSF leak (p = 0.79). Furthermore,
               when patients were grouped based on BMI 30 kg/m2, no difference
               was noted in the rates of CSF fistula (p = 0.97). CONCLUSIONS:
               Among patients undergoing intradural EES judged to be at high
               risk for CSF leak as defined by the study's inclusion criteria,
               perioperative LD used in the context of vascularized nasoseptal
               flap closure significantly reduced the rate of postoperative CSF
               leaks.Clinical trial registration no.: NCT03163134
               (clinicaltrials.gov).",
  journal   = "J. Neurosurg.",
  publisher = "thejns.org",
  pages     = "1--7",
  month     =  oct,
  year      =  2018,
  keywords  = "CI = confidence interval; CSF leak; DVT = deep vein thrombosis;
               EES = endoscopic endonasal surgery; LD = lumbar drainage; OR =
               odds ratio; PE = pulmonary emboli; endoscopic endonasal
               approach; lumbar drain; nasoseptal flap; pituitary surgery;
               skull base",
  language  = "en"
}

@ARTICLE{Kellman2001-dp,
  title    = "The transglabellar/subcranial approach to the anterior skull
              base: a review of 72 cases",
  author   = "Kellman, R M and Marentette, L",
  abstract = "OBJECTIVES: To describe the transglabellar/subcranial approach to
              the anterior skull base and to compare it with more traditional
              approaches to craniofacial resection. DESIGN: A retrospective
              analysis of 72 cases at 2 academic medical centers. The main
              parameters analyzed were the disease entities treated, the
              average operating room time, the average amount of blood loss,
              the number of transfusions, the length of intensive care unit and
              hospital stays, and complication rates. These were compared with
              published data for traditional craniofacial approaches. SETTING:
              All patients were operated on by the authors in collaboration
              with neurosurgical teams at the State University of New York
              Upstate Medical University, Syracuse, and the University of
              Michigan Hospital, Ann Arbor. PATIENTS: The
              transglabellar/subcranial approach was performed 72 times in 69
              patients in this series. Forty-two procedures in 40 patients were
              performed for malignant disease and 30 procedures in 29 patients
              were performed for benign entities. Patients' ages ranged from 2
              to 78 years. Follow-up ranged from 6 months to 4 years, with a
              minimum follow-up of 1 year for survivors. RESULTS: There were no
              operative mortalities. Operating time, average amount of blood
              loss, length of hospital and intensive care unit stays, and
              complication rates compared favorably with published results of
              traditional craniofacial resections. CONCLUSIONS: The
              transglabellar/subcranial approach to the anterior skull base may
              be a reasonable technique for the surgical management of lesions
              in the region of the anterior skull base. It provides excellent
              exposure of the nasal cavity, the orbits, and the ethmoid and
              sphenoid sinuses, while allowing wide access to the anterior
              fossa with a minimum amount of frontal lobe retraction.",
  journal  = "Arch. Otolaryngol. Head. Neck Surg.",
  volume   =  127,
  number   =  6,
  pages    = "687--690",
  month    =  jun,
  year     =  2001,
  language = "en"
}

@ARTICLE{Kunimatsu2017-nz,
  title    = "Skull Base Tumors and {Tumor-Like} Lesions: A Pictorial Review",
  author   = "Kunimatsu, Akira and Kunimatsu, Natsuko",
  abstract = "A number of tumors and tumor-like non-neoplastic lesions with
              different cell types on histology occur in the skull base. A wide
              variety in disease and lesion appearance often complicates the
              process of radiological diagnosis. The main role of radiographic
              imaging is the detection and characterization of skull base
              lesions, with evaluation of the extent of invasion or
              preservation of adjacent critical organs. Evaluation of the skull
              base anatomy and surgical planning by using image guidance are
              also important for surgeons. Computed tomography (CT) and
              magnetic resonance (MR) imaging are the preferred modalities for
              the evaluation of skull base lesions. CT and MR are used for
              lesion detection, tissue characterization and assessment of
              neurovascular and bone involvement by the lesions. Both
              modalities provide useful information, one sometimes of greater
              value than the other. T1-weighted MR imaging is useful in
              detecting skull base lesions, typically surrounded by abundant
              fatty bone marrow. T2-weighted MR imaging is generally useful for
              tumor tissue characterization. CT surpasses MR imaging in
              evaluating intratumoral calcification and bone destruction or
              hyperostosis. To date, imaging features have been well-reported
              in individual skull base tumors; however, correct diagnosis by
              imaging alone still presents a challenge. Knowledge of clinical
              issues and awareness of variants of skull base tumors are of help
              in making a diagnosis. The purpose of this article is to review
              pertinent clinical issues, typical imaging appearances and
              certain imaging variations of common skull base lesions.",
  journal  = "Pol. J. Radiol.",
  volume   =  82,
  pages    = "398--409",
  month    =  jul,
  year     =  2017,
  keywords = "Magnetic Resonance Imaging; Skull Base Neoplasms; Tomography,
              Spiral Computed",
  language = "en"
}

@ARTICLE{Simonyan2013-jx,
  title         = "Deep Inside Convolutional Networks: Visualising Image
                   Classification Models and Saliency Maps",
  author        = "Simonyan, Karen and Vedaldi, Andrea and Zisserman, Andrew",
  abstract      = "This paper addresses the visualisation of image
                   classification models, learnt using deep Convolutional
                   Networks (ConvNets). We consider two visualisation
                   techniques, based on computing the gradient of the class
                   score with respect to the input image. The first one
                   generates an image, which maximises the class score [Erhan
                   et al., 2009], thus visualising the notion of the class,
                   captured by a ConvNet. The second technique computes a class
                   saliency map, specific to a given image and class. We show
                   that such maps can be employed for weakly supervised object
                   segmentation using classification ConvNets. Finally, we
                   establish the connection between the gradient-based ConvNet
                   visualisation methods and deconvolutional networks [Zeiler
                   et al., 2013].",
  month         =  dec,
  year          =  2013,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1312.6034"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@INPROCEEDINGS{Shen2020-dn,
  title     = "Interpreting the latent space of gans for semantic face editing",
  booktitle = "Proceedings of the {IEEE/CVF} Conference on Computer Vision and
               Pattern Recognition",
  author    = "Shen, Yujun and Gu, Jinjin and Tang, Xiaoou and Zhou, Bolei",
  abstract  = "Despite the recent advance of Generative Adversarial Networks
               (GANs) in high-fidelity image synthesis, there lacks enough
               understanding of how GANs are able to map a latent code sampled
               from a random distribution to a photo-realistic image. Previous
               work assumes the latent space learned by GANs follows a
               distributed representation but observes the vector arithmetic
               phenomenon. In this work, we propose a novel framework, called
               InterFaceGAN, for semantic face editing by interpreting the
               latent semantics learned by â€¦",
  publisher = "openaccess.thecvf.com",
  pages     = "9243--9252",
  year      =  2020
}

@ARTICLE{Chen2020-uz,
  title         = "A Simple Framework for Contrastive Learning of Visual
                   Representations",
  author        = "Chen, Ting and Kornblith, Simon and Norouzi, Mohammad and
                   Hinton, Geoffrey",
  abstract      = "This paper presents SimCLR: a simple framework for
                   contrastive learning of visual representations. We simplify
                   recently proposed contrastive self-supervised learning
                   algorithms without requiring specialized architectures or a
                   memory bank. In order to understand what enables the
                   contrastive prediction tasks to learn useful
                   representations, we systematically study the major
                   components of our framework. We show that (1) composition of
                   data augmentations plays a critical role in defining
                   effective predictive tasks, (2) introducing a learnable
                   nonlinear transformation between the representation and the
                   contrastive loss substantially improves the quality of the
                   learned representations, and (3) contrastive learning
                   benefits from larger batch sizes and more training steps
                   compared to supervised learning. By combining these
                   findings, we are able to considerably outperform previous
                   methods for self-supervised and semi-supervised learning on
                   ImageNet. A linear classifier trained on self-supervised
                   representations learned by SimCLR achieves 76.5\% top-1
                   accuracy, which is a 7\% relative improvement over previous
                   state-of-the-art, matching the performance of a supervised
                   ResNet-50. When fine-tuned on only 1\% of the labels, we
                   achieve 85.8\% top-5 accuracy, outperforming AlexNet with
                   100X fewer labels.",
  month         =  feb,
  year          =  2020,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "2002.05709"
}

@ARTICLE{Khosla2020-hy,
  title         = "Supervised Contrastive Learning",
  author        = "Khosla, Prannay and Teterwak, Piotr and Wang, Chen and
                   Sarna, Aaron and Tian, Yonglong and Isola, Phillip and
                   Maschinot, Aaron and Liu, Ce and Krishnan, Dilip",
  abstract      = "Cross entropy is the most widely used loss function for
                   supervised training of image classification models. In this
                   paper, we propose a novel training methodology that
                   consistently outperforms cross entropy on supervised
                   learning tasks across different architectures and data
                   augmentations. We modify the batch contrastive loss, which
                   has recently been shown to be very effective at learning
                   powerful representations in the self-supervised setting. We
                   are thus able to leverage label information more effectively
                   than cross entropy. Clusters of points belonging to the same
                   class are pulled together in embedding space, while
                   simultaneously pushing apart clusters of samples from
                   different classes. In addition to this, we leverage key
                   ingredients such as large batch sizes and normalized
                   embeddings, which have been shown to benefit self-supervised
                   learning. On both ResNet-50 and ResNet-200, we outperform
                   cross entropy by over 1\%, setting a new state of the art
                   number of 78.8\% among methods that use AutoAugment data
                   augmentation. The loss also shows clear benefits for
                   robustness to natural corruptions on standard benchmarks on
                   both calibration and accuracy. Compared to cross entropy,
                   our supervised contrastive loss is more stable to
                   hyperparameter settings such as optimizers or data
                   augmentations.",
  month         =  apr,
  year          =  2020,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "2004.11362"
}

@INPROCEEDINGS{Larochelle2011-mi,
  title     = "The neural autoregressive distribution estimator",
  booktitle = "Proceedings of the Fourteenth International Conference on
               Artificial Intelligence and Statistics",
  author    = "Larochelle, Hugo and Murray, Iain",
  pages     = "29--37",
  year      =  2011
}

@INPROCEEDINGS{Germain2015-kv,
  title      = "{MADE}: Masked Autoencoder for Distribution Estimation",
  booktitle  = "International Conference on Machine Learning",
  author     = "Germain, Mathieu and Gregor, Karol and Murray, Iain and
                Larochelle, Hugo",
  abstract   = "There has been a lot of recent interest in designing neural
                network models to estimate a distribution from a set of
                examples. We introduce a simple modification for autoencoder
                neural networks that...",
  publisher  = "PMLR",
  pages      = "881--889",
  month      =  jun,
  year       =  2015,
  language   = "en",
  conference = "International Conference on Machine Learning"
}

@ARTICLE{Van_den_Oord2016-ep,
  title         = "Pixel Recurrent Neural Networks",
  author        = "van den Oord, Aaron and Kalchbrenner, Nal and Kavukcuoglu,
                   Koray",
  abstract      = "Modeling the distribution of natural images is a landmark
                   problem in unsupervised learning. This task requires an
                   image model that is at once expressive, tractable and
                   scalable. We present a deep neural network that sequentially
                   predicts the pixels in an image along the two spatial
                   dimensions. Our method models the discrete probability of
                   the raw pixel values and encodes the complete set of
                   dependencies in the image. Architectural novelties include
                   fast two-dimensional recurrent layers and an effective use
                   of residual connections in deep recurrent networks. We
                   achieve log-likelihood scores on natural images that are
                   considerably better than the previous state of the art. Our
                   main results also provide benchmarks on the diverse ImageNet
                   dataset. Samples generated from the model appear crisp,
                   varied and globally coherent.",
  month         =  jan,
  year          =  2016,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1601.06759"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@INCOLLECTION{Van_den_Oord2016-zr,
  title     = "Conditional Image Generation with {PixelCNN} Decoders",
  booktitle = "Advances in Neural Information Processing Systems 29",
  author    = "van den Oord, Aaron and Kalchbrenner, Nal and Espeholt, Lasse
               and Kavukcuoglu, Koray and Vinyals, Oriol and Graves, Alex",
  editor    = "Lee, D D and Sugiyama, M and Luxburg, U V and Guyon, I and
               Garnett, R",
  abstract  = "This work explores conditional image generation with a new image
               density model based on the PixelCNN architecture. The model can
               be conditioned on any vector, including descriptive labels or
               tags, or latent embeddings created by other networks. When
               conditioned on class labels from the ImageNet database, the
               model is able to generate diverse, realistic scenes representing
               distinct animals, objects, landscapes and structures. When
               conditioned on an embedding produced by a convolutional network
               given a single â€¦",
  publisher = "Curran Associates, Inc.",
  pages     = "4790--4798",
  year      =  2016
}

@ARTICLE{Zhang2018-kh,
  title         = "The Unreasonable Effectiveness of Deep Features as a
                   Perceptual Metric",
  author        = "Zhang, Richard and Isola, Phillip and Efros, Alexei A and
                   Shechtman, Eli and Wang, Oliver",
  abstract      = "While it is nearly effortless for humans to quickly assess
                   the perceptual similarity between two images, the underlying
                   processes are thought to be quite complex. Despite this, the
                   most widely used perceptual metrics today, such as PSNR and
                   SSIM, are simple, shallow functions, and fail to account for
                   many nuances of human perception. Recently, the deep
                   learning community has found that features of the VGG
                   network trained on ImageNet classification has been
                   remarkably useful as a training loss for image synthesis.
                   But how perceptual are these so-called ``perceptual
                   losses''? What elements are critical for their success? To
                   answer these questions, we introduce a new dataset of human
                   perceptual similarity judgments. We systematically evaluate
                   deep features across different architectures and tasks and
                   compare them with classic metrics. We find that deep
                   features outperform all previous metrics by large margins on
                   our dataset. More surprisingly, this result is not
                   restricted to ImageNet-trained VGG features, but holds
                   across different deep architectures and levels of
                   supervision (supervised, self-supervised, or even
                   unsupervised). Our results suggest that perceptual
                   similarity is an emergent property shared across deep visual
                   representations.",
  month         =  jan,
  year          =  2018,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1801.03924"
}

@ARTICLE{Monti2003-bo,
  title    = "Consensus Clustering: A {Resampling-Based} Method for Class
              Discovery and Visualization of Gene Expression Microarray Data",
  author   = "Monti, Stefano and Tamayo, Pablo and Mesirov, Jill and Golub,
              Todd",
  abstract = "In this paper we present a new methodology of class discovery and
              clustering validation tailored to the task of analyzing gene
              expression data. The method can best be thought of as an analysis
              approach, to guide and assist in the use of any of a wide range
              of available clustering algorithms. We call the new methodology
              consensus clustering, and in conjunction with resampling
              techniques, it provides for a method to represent the consensus
              across multiple runs of a clustering algorithm and to assess the
              stability of the discovered clusters. The method can also be used
              to represent the consensus over multiple runs of a clustering
              algorithm with random restart (such as K-means, model-based
              Bayesian clustering, SOM, etc.), so as to account for its
              sensitivity to the initial conditions. Finally, it provides for a
              visualization tool to inspect cluster number, membership, and
              boundaries. We present the results of our experiments on both
              simulated data and real gene expression data aimed at evaluating
              the effectiveness of the methodology in discovering biologically
              meaningful clusters.",
  journal  = "Mach. Learn.",
  volume   =  52,
  number   =  1,
  pages    = "91--118",
  month    =  jul,
  year     =  2003
}

@ARTICLE{Altshuler2021-dj,
  title    = "Imaging Errors in Distinguishing Pituitary Adenomas From Other
              Sellar Lesions",
  author   = "Altshuler, David B and Andrews, Chris A and Parmar, Hemant A and
              Sullivan, Stephen E and Trobe, Jonathan D",
  abstract = "BACKGROUND: Pituitary adenomas and nonadenomatous lesions in the
              sellar region may be difficult to distinguish by imaging yet that
              distinction is critical in guiding management. The nature of the
              diagnostic errors in this setting has not been well documented.
              METHODS: Two neurosurgeons and 2 neuroradiologists of differing
              experience levels viewed deidentified MRIs of 18 nonadenomatous
              sellar lesions and 21 adenomas. They recorded their diagnoses,
              the imaging features they used to make those diagnoses, and their
              confidence in making those diagnoses. RESULTS: Among the 18
              nonadenoma cases, 11 (61\%) were incorrectly diagnosed as adenoma
              by at least 1 reader, including Rathke cleft cyst, plasmacytoma,
              aneurysm, craniopharyngioma, chordoma, Langerhans cell
              histiocytosis, metastasis, and undifferentiated sinonasal
              carcinoma. Among the 21 adenoma cases, 8 (38\%) were incorrectly
              diagnosed by at least 1 reader as craniopharyngioma, Rathke cleft
              cyst, sinonasal carcinoma, hemangioblastoma, and pituitary
              hyperplasia. Incorrect imaging diagnoses were made with high
              confidence in 13\% of readings. Avoidable errors among the
              nonadenomatous cases occurred when readers failed to appreciate
              that the lesion was separate from the pituitary gland.
              Unavoidable errors in those cases occurred when the lesions were
              so large that the pituitary gland had been obliterated or the
              imaging features of a nonadenomatous lesion resembled those of a
              cystic pituitary adenoma. Avoidable errors in misdiagnosis of
              adenomas as nonadenomas occurred when readers failed to
              appreciate features highly characteristic of adenomas. An
              unavoidable error occurred because a cystic adenoma had features
              correctly associated with craniopharyngioma. CONCLUSIONS: Errors
              in imaging differentiation of pituitary adenoma from
              nonadenomatous lesions occurred often and sometimes with high
              confidence among a small sample of neurosurgeons and
              neuroradiologists. In the misdiagnosis of nonadenomatous lesions
              as adenomas, errors occurred largely from failure to appreciate a
              separate pituitary gland, but unavoidable errors occurred when
              large lesions had obliterated this distinguishing feature. In the
              misdiagnosis of adenomas as nonadenomatous lesions, avoidable
              errors occurred because readers failed to recognize imaging
              features more characteristic of adenomas and because cystic
              adenomas share features with craniopharyngiomas and Rathke cleft
              cysts. Awareness of these errors should lead to improved
              management of sellar lesions.",
  journal  = "J. Neuroophthalmol.",
  month    =  feb,
  year     =  2021,
  language = "en"
}

@ARTICLE{Ezzat2004-fu,
  title     = "The prevalence of pituitary adenomas: a systematic review",
  author    = "Ezzat, Shereen and Asa, Sylvia L and Couldwell, William T and
               Barr, Charles E and Dodge, William E and Vance, Mary Lee and
               McCutcheon, Ian E",
  abstract  = "BACKGROUND: Pituitary adenomas display an array of hormonal and
               proliferative activity. Once primarily classified according to
               size (microadenomas, or = 1 cm), these tumors are now further
               classified according to immunohistochemistry and functional
               status. With these additional classifications in mind, the goals
               of the current study were to determine the prevalence of
               pituitary adenomas and to explore the clinical relevance of the
               findings. METHODS: The authors conducted a metaanalysis of all
               existing English-language articles in MEDLINE. They used the
               search string (pituitary adenoma or pituitary tumor) and
               prevalence and selected relevant autopsy and imaging evaluation
               studies for inclusion. RESULTS: The authors found an overall
               estimated prevalence of pituitary adenomas of 16.7\% (14.4\% in
               autopsy studies and 22.5\% in radiologic studies). CONCLUSIONS:
               Given the high frequency of pituitary adenomas and their
               potential for causing clinical pathologies, the findings of the
               current study suggest that early diagnosis and treatment of
               pituitary adenomas should have far-reaching benefits.",
  journal   = "Cancer",
  publisher = "Wiley Online Library",
  volume    =  101,
  number    =  3,
  pages     = "613--619",
  month     =  aug,
  year      =  2004,
  language  = "en"
}

@ARTICLE{Vitale2017-na,
  title    = "Pituitary magnetic resonance imaging in Cushing's disease",
  author   = "Vitale, Giovanni and Tortora, Fabio and Baldelli, Roberto and
              Cocchiara, Francesco and Paragliola, Rosa Maria and Sbardella,
              Emilia and Simeoli, Chiara and Caranci, Ferdinando and Pivonello,
              Rosario and Colao, Annamaria and {A.B.C. Group}",
  abstract = "Adrenocorticotropin-secreting pituitary tumor represents about 10
              \% of pituitary adenomas and at the time of diagnosis most of
              them are microadenomas. Transsphenoidal surgery is the first-line
              treatment of Cushing's disease and accurate localization of the
              tumor within the gland is essential for selectively removing the
              lesion and preserving normal pituitary function. Magnetic
              resonance imaging is the best imaging modality for the detection
              of pituitary tumors, but adrenocorticotropin-secreting pituitary
              microadenomas are not correctly identified in 30-50 \% of cases,
              because of their size, location, and enhancing characteristics.
              Several recent studies were performed with the purpose of better
              localizing the adrenocorticotropin-secreting microadenomas
              through the use in magnetic resonance imaging of specific
              sequences, reduced contrast medium dose and high-field
              technology. Therefore, an improved imaging technique for
              pituitary disease is mandatory in the suspect of Cushing's
              disease. The aims of this paper are to present an overview of
              pituitary magnetic resonance imaging in the diagnosis of
              Cushing's disease and to provide a magnetic resonance imaging
              protocol to be followed in case of suspicion
              adrenocorticotropin-secreting pituitary adenoma.",
  journal  = "Endocrine",
  volume   =  55,
  number   =  3,
  pages    = "691--696",
  month    =  mar,
  year     =  2017,
  keywords = "Cushing's disease; Imaging; MRI; Pituitary microadenoma",
  language = "en"
}

@ARTICLE{Bashari2019-fy,
  title    = "Modern imaging of pituitary adenomas",
  author   = "Bashari, Waiel A and Senanayake, Russell and Fern{\'a}ndez-Pombo,
              Ant{\'\i}a and Gillett, Daniel and Koulouri, Olympia and Powlson,
              Andrew S and Matys, Tomasz and Scoffings, Daniel and Cheow, Heok
              and Mendichovszky, Iosif and Gurnell, Mark",
  abstract = "Decision-making in pituitary disease is critically dependent on
              high quality imaging of the sella and parasellar region. Magnetic
              resonance imaging (MRI) is the investigation of choice and, for
              the majority of patients, combined T1 and T2 weighted sequences
              provide the information required to allow surgery, radiotherapy
              (RT) and/or medical therapy to be planned and long-term outcomes
              to be monitored. However, in some cases standard clinical MR
              sequences are indeterminate and additional information is needed
              to help inform the choice of therapy for a pituitary adenoma
              (PA). This article reviews current recommendations for imaging of
              PA, examines the potential added value that alternative MR
              sequences and/or CT can offer, and considers how the use of
              functional/molecular imaging might allow definitive treatment to
              be recommended for a subset of patients who would otherwise be
              deemed unsuitable for (further) surgery and/or RT.",
  journal  = "Best Pract. Res. Clin. Endocrinol. Metab.",
  volume   =  33,
  number   =  2,
  pages    = "101278",
  month    =  apr,
  year     =  2019,
  keywords = "CT; MRI; PET; functional imaging; molecular imaging; pituitary",
  language = "en"
}

@ARTICLE{Oldfield2011-gt,
  title     = "Surgical Management of Cushing's Disease: A Personal Perspective",
  author    = "Oldfield, Edward H",
  abstract  = "What about Cushing's disease differs from the other types of
               pituitary tumors? There are several differences, of course, but
               one of the principal differences is",
  journal   = "Neurosurgery",
  publisher = "Oxford Academic",
  volume    =  58,
  number    = "CN\_suppl\_1",
  pages     = "13--26",
  month     =  sep,
  year      =  2011,
  keywords  = "surgical procedures, operative; neoplasms; pituitary gland;
               pituitary-dependent cushing's disease; cushing syndrome;
               magnetic resonance imaging; adenoma",
  language  = "en"
}

@ARTICLE{noauthor_undated-vx,
  title = "[{PDF}] Acromegaly without imaging evidence of pituitary .."
}

@ARTICLE{Lonser2010-hb,
  title    = "Acromegaly without imaging evidence of pituitary adenoma",
  author   = "Lonser, Russell R and Kindzelski, Bogdan A and Mehta, Gautam U
              and Jane, Jr, John A and Oldfield, Edward H",
  abstract = "CONTEXT: GH-secreting pituitary adenomas are nearly always
              visible on conventional magnetic resonance (MR) imaging. However,
              management and outcome of acromegalic patients lacking imaging
              evidence of GH-secreting pituitary adenomas are undefined.
              OBJECTIVE: The aim was to evaluate surgical exploration for
              MR-invisible GH-secreting pituitary adenomas. DESIGN AND SETTING:
              We conducted a retrospective review at two tertiary care centers.
              PATIENTS OR OTHER PARTICIPANTS: Consecutive acromegalic patients
              without imaging evidence of a pituitary adenoma on pre- and
              postcontrast, spin echo T1-weighted MR imaging and who lacked
              evidence of an ectopic (nonpituitary) source causing GH excess
              were included. INTERVENTIONS: Surgical exploration with
              identification and resection of a pituitary adenoma was
              performed. MAIN OUTCOME MEASURES: Laboratory values (GH, IGF-I),
              surgical findings, and clinical outcome were analyzed. RESULTS:
              Six patients (three males, three females; 3\% of all patients)
              with suspected GH-secreting adenomas did not demonstrate imaging
              evidence of pituitary adenoma on conventional MR imaging. Three
              patients underwent a postcontrast, volumetric interpolated
              breath-hold examination MR-imaging sequence (1.2-mm slice
              thickness), which revealed a 4-mm pituitary adenoma not seen on
              the spin echo T1-weighted MR imaging in one patient. A pituitary
              adenoma was identified and removed in all patients (mean
              diameter, 5.6 mm; range, 5 to 6.7 mm). Histological analysis
              confirmed that the lesions were GH-secreting adenomas. All
              patients achieved biochemical remission after surgical resection.
              CONCLUSION: Acromegaly can be caused by GH-secreting pituitary
              adenomas that are not evident on conventional MR imaging.
              Adenomas in some of these patients become evident using
              volumetric interpolated breath-hold examination MR imaging.
              Surgical exploration of the pituitary gland in acromegalic
              patients with endocrine findings consistent with a GH-secreting
              adenoma but negative MR imaging can lead to identification and
              removal of an adenoma.",
  journal  = "J. Clin. Endocrinol. Metab.",
  volume   =  95,
  number   =  9,
  pages    = "4192--4196",
  month    =  sep,
  year     =  2010,
  language = "en"
}

@ARTICLE{Wind2013-qp,
  title    = "The lateralization accuracy of inferior petrosal sinus sampling
              in 501 patients with Cushing's disease",
  author   = "Wind, Joshua J and Lonser, Russell R and Nieman, Lynnette K and
              DeVroom, Hetty L and Chang, Richard and Oldfield, Edward H",
  abstract = "CONTEXT: It is often difficult to find an adenoma in patients
              with Cushing's disease (CD) whose preoperative magnetic resonance
              imaging (MRI) is normal. Better localizing modalities are needed.
              OBJECTIVE: The aim of this study was to determine the accuracy of
              inferior petrosal sinus sampling (IPSS) in predicting adenoma
              lateralization. DESIGN AND SETTING: We conducted a prospective
              observational study at a tertiary care clinical research center.
              PATIENTS: A total of 501 consecutive patients (363 female) with
              confirmed ACTH adenomas and IPSS were included. MAIN OUTCOME
              MEASURE: We measured the accuracy of IPSS to predict the
              intrasellar location of an adenoma. RESULTS: IPSS confirmed a
              pituitary source of ACTH secretion in 491 patients (98\%). All 10
              patients with false-negative results had peak IPSS ACTH
              concentrations (before or after CRH) of < 400 pg/ml.
              Interpetrosal (side-to-side) ratios were $\geq$ 1.4 in 491
              patients (98\%). This ratio correctly predicted lateralization in
              273 of 396 patients (positive predictive value = 69\%) with a
              lateral adenoma. Left-sided IPSS lateralization (P = .008) and
              consistent lateralization before and after CRH administration (P
              = .02) were associated with enhanced accuracy. When positive,
              preoperative MRI correlated with adenoma location in 171 of 201
              patients (positive predictive value = 86\%). CONCLUSIONS:
              Potential false-negative results, the most common type of
              diagnostic error with IPSS for the differential diagnosis of CS,
              can be identified by peak IPSS ACTH values < 400 pg/ml. When MRI
              is normal, IPSS can be used to guide surgical exploration in
              patients with negative preoperative imaging. However, because of
              the limited accuracy of lateralization, thorough exploration of
              the pituitary gland is required when an adenoma is not readily
              discovered based on predicted location.",
  journal  = "J. Clin. Endocrinol. Metab.",
  volume   =  98,
  number   =  6,
  pages    = "2285--2293",
  month    =  jun,
  year     =  2013,
  language = "en"
}

@ARTICLE{noauthor_undated-eq,
  title = "[{PDF}] Mortality in patients with Cushing's disease more than .."
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Clayton2016-sg,
  title    = "Mortality in patients with Cushing's disease more than 10 years
              after remission: a multicentre, multinational, retrospective
              cohort study",
  author   = "Clayton, Richard N and Jones, Peter W and Reulen, Raoul C and
              Stewart, Paul M and Hassan-Smith, Zaki K and Ntali, Georgia and
              Karavitaki, Niki and Dekkers, Olaf M and Pereira, Alberto M and
              Bolland, Mark and Holdaway, Ian and Lindholm, Jorgen",
  abstract = "BACKGROUND: No agreement has been reached on the long-term
              survival prospects for patients with Cushing's disease. We
              studied life expectancy in patients who had received curative
              treatment and whose hypercortisolism remained in remission for
              more than 10 years, and identified factors determining their
              survival. METHODS: We did a multicentre, multinational,
              retrospective cohort study using individual case records from
              specialist referral centres in the UK, Denmark, the Netherlands,
              and New Zealand. Inclusion criteria for participants, who had all
              been in studies reported previously in peer-reviewed
              publications, were diagnosis and treatment of Cushing's disease,
              being cured of hypercortisolism for a minimum of 10 years at
              study entry, and continuing to be cured with no relapses until
              the database was frozen or death. We identified the number and
              type of treatments used to achieve cure, and used mortality as
              our primary endpoint. We compared mortality rates between
              patients with Cushing's disease and the general population, and
              expressed them as standardised mortality ratios (SMRs). We
              analysed survival data with multivariate analysis (Cox
              regression) with no corrections for multiple testing. FINDINGS:
              The census dates on which the data were frozen ranged from Dec
              31, 2009, to Dec 1, 2014. We obtained data for 320 patients with
              3790 person-years of follow-up from 10 years after cure
              (female:male ratio of 3:1). The median patient follow-up was 11Â·8
              years (IQR 17-26) from study entry and did not differ between
              countries. There were no significant differences in demographic
              characteristics, duration of follow-up, comorbidities, treatment
              number, or type of treatment between women and men, so we pooled
              data from both sexes for survival analysis. 51 (16\%) of the
              cohort died during follow-up from study entry (10 years after
              cure). Median survival from study entry was similar for women (31
              years; IQR 19-38) and men (28 years; 24-42), and about 40 years
              (IQR 30-48) from remission. The overall SMR for all-cause
              mortality was 1Â·61 (95\% CI 1Â·23-2Â·12; p=0Â·0001). The SMR for
              circulatory disease was increased at 2Â·72 (1Â·88-3Â·95; p<0Â·0001),
              but deaths from cancer were not higher than expected (0Â·79,
              0Â·41-1Â·51). Presence of diabetes, but not hypertension, was an
              independent risk factor for mortality (hazard ratio 2Â·82, 95\% CI
              1Â·29-6Â·17; p=0Â·0095). We noted a step-wise reduction in survival
              with increasing number of treatments. Patients cured by pituitary
              surgery alone had long-term survival similar to that of the
              general population (SMR 0Â·95, 95\% CI 0Â·58-1Â·55) compared with
              those who were not (2Â·53, 1Â·82-3Â·53; p<0Â·0001). INTERPRETATION:
              Patients with Cushing's disease who have been in remission for
              more than 10 years are at increased risk of overall mortality
              compared with the general population, particularly from
              circulatory disease. However, median survival from cure is
              excellent at about 40 years of remission. Treatment complexity
              and an increased number of treatments, reflecting disease that is
              more difficult to control, appears to negatively affect survival.
              Pituitary surgery alone is the preferred treatment to secure an
              optimum outcome, and should be done in a centre of surgical
              excellence. FUNDING: None.",
  journal  = "Lancet Diabetes Endocrinol",
  volume   =  4,
  number   =  7,
  pages    = "569--576",
  month    =  jul,
  year     =  2016,
  language = "en"
}

@ARTICLE{Carr2018-vj,
  title    = "Negative surgical exploration in patients with Cushing's disease:
              benefit of two-thirds gland resection on remission rate and a
              review of the literature",
  author   = "Carr, Steven B and Kleinschmidt-DeMasters, Bette K and Kerr,
              Janice M and Kiseljak-Vassiliades, Katja and Wierman, Margaret E
              and Lillehei, Kevin O",
  abstract = "OBJECTIVEThe authors report their single-institution experience
              with the pathological findings, rates of remission, and
              complications in patients with presumed Cushing's disease (CD)
              who underwent a two-thirds pituitary gland resection when no
              adenoma was identified at the time of transsphenoidal surgery
              (TSS). The authors also review the literature on patients with
              CD, negative surgical exploration, and histological
              findings.METHODSThis study is a retrospective analysis of cases
              found in neurosurgery and pathology department databases between
              1989 and 2011. In all cases, patients had been operated on by the
              same neurosurgeon (K.O.L.). Twenty-two (13.6\%) of 161 patients
              who underwent TSS for CD had no adenoma identified
              intraoperatively after systematic exploration of the entire
              gland; these patients all underwent a two-thirds pituitary gland
              resection. A chart review was performed to assess treatment data
              points as well as clinical and biochemical remission
              status.RESULTSOf the 22 patients who underwent two-thirds gland
              resection, 6 (27.3\%) ultimately had lesions found on final
              pathology. All 6 patients were found to have a distinct
              adrenocorticotropic hormone (ACTH) cell adenoma. Sixteen (72.7\%)
              of the patients had no tumor identified, with 3 of these patients
              suspected of having ACTH cell hyperplasia. The follow-up duration
              for the entire group was between 14 and 315 months (mean 98.9
              months, median 77 months). Remission rates were 100\% (6/6
              patients) for the ACTH cell adenoma group and 75\% (12/16) for
              the group without adenoma. Overall, 18 (81.8\%) of the 22
              patients had no evidence of hypercortisolism at last follow-up,
              and 4 patients (18\%) had persistent hypercortisolism, defined as
              a postoperative cortisol level > 5 $\mu$g/dl. Of these 4
              patients, 1 was suspected of harboring a cavernous sinus adenoma,
              2 were found to have lung tumors secreting ACTH, and 1 remained
              with an undiagnosed etiology. Rates of postoperative
              complications were low.CONCLUSIONSThe diagnosis and treatment of
              CD can be challenging for neurosurgeons, endocrinologists, and
              pathologists alike. Failure to find a discrete adenoma at the
              time of surgery occurs in at least 10\%-15\% of cases, even in
              experienced centers. The current literature provides little
              guidance regarding rational intraoperative approaches in such
              cases. The authors' experience with 161 patients with CD, when no
              intraoperative tumor was localized, demonstrates the utility of a
              two-thirds pituitary gland resection with a novel and effective
              surgical strategy, as suggested by a high initial remission rate
              and a low operative morbidity.",
  journal  = "J. Neurosurg.",
  volume   =  129,
  number   =  5,
  pages    = "1260--1267",
  month    =  nov,
  year     =  2018,
  keywords = "ACTH = adrenocorticotropic hormone; CD = Cushing's disease; CRH =
              corticotropin-releasing hormone; Cushing's disease; DST =
              dexamethasone suppression test; EOR = extent of resection; HPA =
              hypothalamic-pituitary-adrenocortical; IPSS = inferior petrosal
              sinus sampling; TSS = transsphenoidal surgery; adenoma; outcome;
              pituitary surgery; resection; transsphenoidal",
  language = "en"
}

@ARTICLE{McKinney2020-lq,
  title    = "International evaluation of an {AI} system for breast cancer
              screening",
  author   = "McKinney, Scott Mayer and Sieniek, Marcin and Godbole, Varun and
              Godwin, Jonathan and Antropova, Natasha and Ashrafian, Hutan and
              Back, Trevor and Chesus, Mary and Corrado, Greg S and Darzi, Ara
              and Etemadi, Mozziyar and Garcia-Vicente, Florencia and Gilbert,
              Fiona J and Halling-Brown, Mark and Hassabis, Demis and Jansen,
              Sunny and Karthikesalingam, Alan and Kelly, Christopher J and
              King, Dominic and Ledsam, Joseph R and Melnick, David and
              Mostofi, Hormuz and Peng, Lily and Reicher, Joshua Jay and
              Romera-Paredes, Bernardino and Sidebottom, Richard and Suleyman,
              Mustafa and Tse, Daniel and Young, Kenneth C and De Fauw, Jeffrey
              and Shetty, Shravya",
  abstract = "Screening mammography aims to identify breast cancer at earlier
              stages of the disease, when treatment can be more successful1.
              Despite the existence of screening programmes worldwide, the
              interpretation of mammograms is affected by high rates of false
              positives and false negatives2. Here we present an artificial
              intelligence (AI) system that is capable of surpassing human
              experts in breast cancer prediction. To assess its performance in
              the clinical setting, we curated a large representative dataset
              from the UK and a large enriched dataset from the USA. We show an
              absolute reduction of 5.7\% and 1.2\% (USA and UK) in false
              positives and 9.4\% and 2.7\% in false negatives. We provide
              evidence of the ability of the system to generalize from the UK
              to the USA. In an independent study of six radiologists, the AI
              system outperformed all of the human readers: the area under the
              receiver operating characteristic curve (AUC-ROC) for the AI
              system was greater than the AUC-ROC for the average radiologist
              by an absolute margin of 11.5\%. We ran a simulation in which the
              AI system participated in the double-reading process that is used
              in the UK, and found that the AI system maintained non-inferior
              performance and reduced the workload of the second reader by
              88\%. This robust assessment of the AI system paves the way for
              clinical trials to improve the accuracy and efficiency of breast
              cancer screening.",
  journal  = "Nature",
  volume   =  577,
  number   =  7788,
  pages    = "89--94",
  month    =  jan,
  year     =  2020
}

@ARTICLE{Di2021-wk,
  title    = "Rapid Intraoperative Diagnosis of Meningiomas using Stimulated
              Raman Histology",
  author   = "Di, Long and Eichberg, Daniel G and Park, You Jeong and Shah,
              Ashish H and Jamshidi, Aria M and Luther, Evan M and Lu, Victor M
              and Komotar, Ricardo J and Ivan, Michael E and Gultekin, Sakir H",
  abstract = "BACKGROUND: Frozen section is a time- and labor-intensive method
              for intraoperative pathologic diagnosis. As a result, there
              exists a need to expedite and streamline the acquisition and
              interpretation of diagnostic histologic data to inform surgical
              decision making. Stimulated Raman histology (SRH) is an emerging
              technology that may serve to expedite the acquisition and
              interpretation of histologic data in the operating room. METHODS:
              A blinded, prospective cohort study of 82 patients undergoing
              resection for tumors of the central nervous system was performed.
              Twenty-six patients with diagnoses of meningioma on SRH, frozen,
              or permanent section were included in this subanalysis.
              Diagnostic time and accuracy of stimulated SRH histology images
              were compared with the gold standard (frozen section). Agreement
              of SRH and frozen section diagnosis with permanent section (true)
              diagnosis was also compared. RESULTS: Mean time-to-diagnosis was
              significantly shorter for SRH-mediated diagnosis compared with
              frozen section (9.2 vs. 35.8, P < 0.0001). Diagnostic accuracy
              was not significantly different between methods (P = 0.15).
              Diagnostic agreement was not significantly different between SRH
              versus frozen, SRH versus permanent, or frozen versus permanent
              section methods (P = 0.5, P = 0.5, P = 1.00). CONCLUSIONS: SRH is
              a promising adjuvant technology that may expedite intraoperative
              neuropathologic consult without sacrificing diagnostic accuracy.",
  journal  = "World Neurosurg.",
  volume   =  150,
  pages    = "e108--e116",
  month    =  jun,
  year     =  2021,
  keywords = "Brain tumor; Frozen section; Meningioma; Pathology; Permanent
              section; Stimulated Raman histology",
  language = "en"
}

@ARTICLE{Eichberg2019-rd,
  title    = "Stimulated Raman histology for rapid and accurate intraoperative
              diagnosis of {CNS} tumors: prospective blinded study",
  author   = "Eichberg, Daniel G and Shah, Ashish H and Di, Long and Semonche,
              Alexa M and Jimsheleishvili, George and Luther, Evan M and
              Sarkiss, Christopher A and Levi, Allan D and Gultekin, Sakir H
              and Komotar, Ricardo J and Ivan, Michael E",
  abstract = "OBJECTIVE: In some centers where brain tumor surgery is
              performed, the opportunity for expert intraoperative
              neuropathology consultation is lacking. Consequently, surgeons
              may not have access to the highest quality diagnostic
              histological data to inform surgical decision-making. Stimulated
              Raman histology (SRH) is a novel technology that allows for rapid
              acquisition of diagnostic histological images at the bedside.
              METHODS: The authors performed a prospective blinded cohort study
              of 82 consecutive patients undergoing resection of CNS tumors to
              compare diagnostic time and accuracy of SRH simulation to the
              gold standard, i.e., frozen and permanent section diagnosis.
              Diagnostic accuracy was determined by concordance of
              SRH-simulated intraoperative pathology consultation with a
              blinded board-certified neuropathologist, with official frozen
              section and permanent section results. RESULTS: Overall, the mean
              time to diagnosis was 30.5 $\pm$ 13.2 minutes faster (p < 0.0001)
              for SRH simulation than for frozen section, with similar
              diagnostic correlation: 91.5\% ($\kappa$ = 0.834, p < 0.0001)
              between SRH simulation and permanent section, and 91.5\% between
              frozen and permanent section ($\kappa$ = 0.894, p < 0.0001).
              CONCLUSIONS: SRH-simulated intraoperative pathology consultation
              was significantly faster and equally accurate as frozen section.",
  journal  = "J. Neurosurg.",
  pages    = "1--7",
  month    =  dec,
  year     =  2019,
  keywords = "CI = confidence interval; HGG = high-grade glioma; LGG =
              low-grade glioma; NPV = negative predictive value; PPV = positive
              predictive value; SRH = stimulated Raman histology; TTD = time to
              diagnosis; brain tumor; frozen section; oncology; pathology;
              permanent section; stimulated Raman histology",
  language = "en"
}

@INPROCEEDINGS{Milletari2016-jn,
  title     = "{V-Net}: Fully Convolutional Neural Networks for Volumetric
               Medical Image Segmentation",
  booktitle = "2016 Fourth International Conference on {3D} Vision ({3DV})",
  author    = "Milletari, F and Navab, N and Ahmadi, S",
  abstract  = "Convolutional Neural Networks (CNNs) have been recently employed
               to solve problems from both the computer vision and medical
               image analysis fields. Despite their popularity, most approaches
               are only able to process 2D images while most medical data used
               in clinical practice consists of 3D volumes. In this work we
               propose an approach to 3D image segmentation based on a
               volumetric, fully convolutional, neural network. Our CNN is
               trained end-to-end on MRI volumes depicting prostate, and learns
               to predict segmentation for the whole volume at once. We
               introduce a novel objective function, that we optimise during
               training, based on Dice coefficient. In this way we can deal
               with situations where there is a strong imbalance between the
               number of foreground and background voxels. To cope with the
               limited number of annotated volumes available for training, we
               augment the data applying random non-linear transformations and
               histogram matching. We show in our experimental evaluation that
               our approach achieves good performances on challenging test data
               while requiring only a fraction of the processing time needed by
               other previous methods.",
  pages     = "565--571",
  month     =  oct,
  year      =  2016,
  keywords  = "biomedical MRI;image segmentation;medical image
               processing;neural nets;V-Net;fully convolutional neural
               networks;volumetric medical image segmentation;CNN;computer
               vision;medical image analysis;clinical practice;3D image
               segmentation;MRI volumes;magnetic resonance imaging;Dice
               coefficient;foreground voxel;background voxel;random nonlinear
               transformations;histogram matching;Image segmentation;Feature
               extraction;Biomedical imaging;Three-dimensional displays;Neural
               networks;Magnetic resonance imaging;Two dimensional
               displays;Deep learning;segmentation;prostate;machine
               learning;convolutional neural networks"
}

@ARTICLE{noauthor_undated-kv,
  title = "[{PDF}] {Grad-CAM}: Visual Explanations from Deep Networks via .."
}

@ARTICLE{Selvaraju2020-ui,
  title    = "{Grad-CAM}: Visual Explanations from Deep Networks via
              {Gradient-Based} Localization",
  author   = "Selvaraju, Ramprasaath R and Cogswell, Michael and Das, Abhishek
              and Vedantam, Ramakrishna and Parikh, Devi and Batra, Dhruv",
  abstract = "We propose a technique for producing `visual explanations' for
              decisions from a large class of Convolutional Neural Network
              (CNN)-based models, making them more transparent and explainable.
              Our approach---Gradient-weighted Class Activation Mapping
              (Grad-CAM), uses the gradients of any target concept (say `dog'
              in a classification network or a sequence of words in captioning
              network) flowing into the final convolutional layer to produce a
              coarse localization map highlighting the important regions in the
              image for predicting the concept. Unlike previous approaches,
              Grad-CAM is applicable to a wide variety of CNN model-families:
              (1) CNNs with fully-connected layers (e.g.VGG), (2) CNNs used for
              structured outputs (e.g.captioning), (3) CNNs used in tasks with
              multi-modal inputs (e.g.visual question answering) or
              reinforcement learning, all without architectural changes or
              re-training. We combine Grad-CAM with existing fine-grained
              visualizations to create a high-resolution class-discriminative
              visualization, Guided Grad-CAM, and apply it to image
              classification, image captioning, and visual question answering
              (VQA) models, including ResNet-based architectures. In the
              context of image classification models, our visualizations (a)
              lend insights into failure modes of these models (showing that
              seemingly unreasonable predictions have reasonable explanations),
              (b) outperform previous methods on the ILSVRC-15
              weakly-supervised localization task, (c) are robust to
              adversarial perturbations, (d) are more faithful to the
              underlying model, and (e) help achieve model generalization by
              identifying dataset bias. For image captioning and VQA, our
              visualizations show that even non-attention based models learn to
              localize discriminative regions of input image. We devise a way
              to identify important neurons through Grad-CAM and combine it
              with neuron names (Bau et al. in Computer vision and pattern
              recognition, 2017) to provide textual explanations for model
              decisions. Finally, we design and conduct human studies to
              measure if Grad-CAM explanations help users establish appropriate
              trust in predictions from deep networks and show that Grad-CAM
              helps untrained users successfully discern a `stronger' deep
              network from a `weaker' one even when both make identical
              predictions. Our code is available at
              https://github.com/ramprs/grad-cam/, along with a demo on CloudCV
              (Agrawal et al., in: Mobile cloud visual media computing, pp
              265--290. Springer, 2015) (http://gradcam.cloudcv.org) and a
              video at http://youtu.be/COjUB9Izk6E.",
  journal  = "Int. J. Comput. Vis.",
  volume   =  128,
  number   =  2,
  pages    = "336--359",
  month    =  feb,
  year     =  2020
}

@INPROCEEDINGS{Zhou2016-ui,
  title     = "Learning deep features for discriminative localization",
  booktitle = "Proceedings of the {IEEE} conference on computer vision and
               pattern recognition",
  author    = "Zhou, Bolei and Khosla, Aditya and Lapedriza, Agata and Oliva,
               Aude and Torralba, Antonio",
  pages     = "2921--2929",
  year      =  2016
}

@ARTICLE{Liu2020-wh,
  title     = "Reporting guidelines for clinical trial reports for
               interventions involving artificial intelligence: the
               {CONSORT-AI} extension",
  author    = "Liu, Xiaoxuan and Rivera, Samantha Cruz and Moher, David and
               Calvert, Melanie J and Denniston, Alastair K",
  abstract  = "The CONSORT 2010 statement provides minimum guidelines for
               reporting randomized trials. Its widespread use has been
               instrumental in ensuring transparency in the evaluation of new
               interventions. More recently, there has been a growing
               recognition that interventions involving artificial intelligence
               (AI) need to undergo rigorous, prospective evaluation to
               demonstrate impact on health outcomes. The CONSORT-AI
               (Consolidated Standards of Reporting Trials--Artificial
               Intelligence) extension is a new reporting guideline for
               clinical trials evaluating interventions with an AI component.
               It was developed in parallel with its companion statement for
               clinical trial protocols: SPIRIT-AI (Standard Protocol Items:
               Recommendations for Interventional Trials--Artificial
               Intelligence). Both guidelines were developed through a staged
               consensus process involving literature review and expert
               consultation to generate 29 candidate items, which were assessed
               by an international multi-stakeholder group in a two-stage
               Delphi survey (103 stakeholders), agreed upon in a two-day
               consensus meeting (31 stakeholders) and refined through a
               checklist pilot (34 participants). The CONSORT-AI extension
               includes 14 new items that were considered sufficiently
               important for AI interventions that they should be routinely
               reported in addition to the core CONSORT 2010 items. CONSORT-AI
               recommends that investigators provide clear descriptions of the
               AI intervention, including instructions and skills required for
               use, the setting in which the AI intervention is integrated, the
               handling of inputs and outputs of the AI intervention, the
               human--AI interaction and provision of an analysis of error
               cases. CONSORT-AI will help promote transparency and
               completeness in reporting clinical trials for AI interventions.
               It will assist editors and peer reviewers, as well as the
               general readership, to understand, interpret and critically
               appraise the quality of clinical trial design and risk of bias
               in the reported outcomes. The CONSORT-AI and SPIRIT-AI
               extensions improve the transparency of clinical trial design and
               trial protocol reporting for artificial intelligence
               interventions.",
  journal   = "Nat. Med.",
  publisher = "Nature Publishing Group",
  volume    =  26,
  number    =  9,
  pages     = "1364--1374",
  month     =  sep,
  year      =  2020,
  language  = "en"
}

@ARTICLE{Karremann2018-dr,
  title    = "Diffuse high-grade gliomas with {H3} {K27M} mutations carry a
              dismal prognosis independent of tumor location",
  author   = "Karremann, Michael and Gielen, Gerrit H and Hoffmann, Marion and
              Wiese, Maria and Colditz, Niclas and Warmuth-Metz, Monika and
              Bison, Brigitte and Claviez, Alexander and van Vuurden, Dannis G
              and von Bueren, Andr{\'e} O and Gessi, Marco and K{\"u}hnle,
              Ingrid and Hans, Volkmar H and Benesch, Martin and Sturm, Dominik
              and Kortmann, Rolf-Dieter and Waha, Andreas and Pietsch, Torsten
              and Kramm, Christof M",
  abstract = "Background: The novel entity of ``diffuse midline glioma, H3
              K27M-mutant'' has been defined in the 2016 revision of the World
              Health Organization (WHO) classification of tumors of the central
              nervous system (CNS). Tumors of this entity arise in CNS midline
              structures of predominantly pediatric patients and are associated
              with an overall dismal prognosis. They are defined by K27M
              mutations in H3F3A or HIST1H3B/C, encoding for histone 3 variants
              H3.3 and H3.1, respectively, which are considered hallmark events
              driving gliomagenesis. Methods: Here, we characterized 85
              centrally reviewed diffuse gliomas on midline locations enrolled
              in the nationwide pediatric German HIT-HGG registry regarding
              tumor site, histone 3 mutational status, WHO grade, age, sex, and
              extent of tumor resection. Results: We found 56 H3.3 K27M-mutant
              tumors (66\%), 6 H3.1 K27M-mutant tumors (7\%), and 23
              H3-wildtype tumors (27\%). H3 K27M-mutant gliomas shared an
              aggressive clinical course independent of their anatomic
              location. Multivariate regression analysis confirmed the
              significant impact of the H3 K27M mutation as the only
              independent parameter predictive of overall survival (P = 0.009).
              In H3 K27M-mutant tumors, neither anatomic midline location nor
              histopathological grading nor extent of tumor resection had an
              influence on survival. Conclusion: These results substantiate the
              clinical significance of considering diffuse midline glioma, H3
              K27M-mutant, as a distinct entity corresponding to WHO grade IV,
              carrying a universally fatal prognosis.",
  journal  = "Neuro. Oncol.",
  volume   =  20,
  number   =  1,
  pages    = "123--131",
  month    =  jan,
  year     =  2018,
  keywords = "K27M mutation; children; diffuse midline glioma; high-grade
              glioma; histone H3",
  language = "en"
}

@ARTICLE{Sturm2012-nn,
  title    = "Hotspot mutations in {H3F3A} and {IDH1} define distinct
              epigenetic and biological subgroups of glioblastoma",
  author   = "Sturm, Dominik and Witt, Hendrik and Hovestadt, Volker and
              Khuong-Quang, Dong-Anh and Jones, David T W and Konermann,
              Carolin and Pfaff, Elke and T{\"o}njes, Martje and Sill, Martin
              and Bender, Sebastian and Kool, Marcel and Zapatka, Marc and
              Becker, Natalia and Zucknick, Manuela and Hielscher, Thomas and
              Liu, Xiao-Yang and Fontebasso, Adam M and Ryzhova, Marina and
              Albrecht, Steffen and Jacob, Karine and Wolter, Marietta and
              Ebinger, Martin and Schuhmann, Martin U and van Meter, Timothy
              and Fr{\"u}hwald, Michael C and Hauch, Holger and Pekrun, Arnulf
              and Radlwimmer, Bernhard and Niehues, Tim and von Komorowski,
              Gregor and D{\"u}rken, Matthias and Kulozik, Andreas E and
              Madden, Jenny and Donson, Andrew and Foreman, Nicholas K and
              Drissi, Rachid and Fouladi, Maryam and Scheurlen, Wolfram and von
              Deimling, Andreas and Monoranu, Camelia and Roggendorf, Wolfgang
              and Herold-Mende, Christel and Unterberg, Andreas and Kramm,
              Christof M and Felsberg, J{\"o}rg and Hartmann, Christian and
              Wiestler, Benedikt and Wick, Wolfgang and Milde, Till and Witt,
              Olaf and Lindroth, Anders M and Schwartzentruber, Jeremy and
              Faury, Damien and Fleming, Adam and Zakrzewska, Magdalena and
              Liberski, Pawel P and Zakrzewski, Krzysztof and Hauser, Peter and
              Garami, Miklos and Klekner, Almos and Bognar, Laszlo and
              Morrissy, Sorana and Cavalli, Florence and Taylor, Michael D and
              van Sluis, Peter and Koster, Jan and Versteeg, Rogier and
              Volckmann, Richard and Mikkelsen, Tom and Aldape, Kenneth and
              Reifenberger, Guido and Collins, V Peter and Majewski, Jacek and
              Korshunov, Andrey and Lichter, Peter and Plass, Christoph and
              Jabado, Nada and Pfister, Stefan M",
  abstract = "Glioblastoma (GBM) is a brain tumor that carries a dismal
              prognosis and displays considerable heterogeneity. We have
              recently identified recurrent H3F3A mutations affecting two
              critical amino acids (K27 and G34) of histone H3.3 in one-third
              of pediatric GBM. Here, we show that each H3F3A mutation defines
              an epigenetic subgroup of GBM with a distinct global methylation
              pattern, and that they are mutually exclusive with IDH1
              mutations, which characterize a third mutation-defined subgroup.
              Three further epigenetic subgroups were enriched for hallmark
              genetic events of adult GBM and/or established transcriptomic
              signatures. We also demonstrate that the two H3F3A mutations give
              rise to GBMs in separate anatomic compartments, with differential
              regulation of transcription factors OLIG1, OLIG2, and FOXG1,
              possibly reflecting different cellular origins.",
  journal  = "Cancer Cell",
  volume   =  22,
  number   =  4,
  pages    = "425--437",
  month    =  oct,
  year     =  2012,
  language = "en"
}

@ARTICLE{Williams2020-ub,
  title    = "Progress in diffuse intrinsic pontine glioma: advocating for
              stereotactic biopsy in the standard of care",
  author   = "Williams, John R and Young, Christopher C and Vitanza, Nicholas A
              and McGrath, Margaret and Feroze, Abdullah H and Browd, Samuel R
              and Hauptman, Jason S",
  abstract = "Diffuse intrinsic pontine glioma (DIPG) is a universally fatal
              pediatric brainstem tumor affecting approximately 300 children in
              the US annually. Median survival is less than 1 year, and
              radiation therapy has been the mainstay of treatment for decades.
              Recent advances in the biological understanding of the disease
              have identified the H3K27M mutation in nearly 80\% of DIPGs,
              leading to the 2016 WHO classification of diffuse midline glioma
              H3K27M-mutant, a grade IV brainstem tumor. Developments in
              epigenetic targeting of transcriptional tendencies have yielded
              potential molecular targets for clinical trials. Chimeric antigen
              receptor T cell therapy has also shown preclinical promise.
              Recent clinical studies, including prospective trials, have
              demonstrated the safety and feasibility of pediatric brainstem
              biopsy in the setting of DIPG and other brainstem tumors. Given
              developments in the ability to analyze DIPG tumor tissue to
              deepen biological understanding of this disease and develop new
              therapies for treatment, together with the increased safety of
              stereotactic brainstem biopsy, the authors present a case for
              offering biopsy to all children with suspected DIPG. They also
              present their standard operative techniques for image-guided,
              frameless stereotactic biopsy.",
  journal  = "Neurosurg. Focus",
  volume   =  48,
  number   =  1,
  pages    = "E4",
  month    =  jan,
  year     =  2020,
  keywords = "CAR = chimeric antigen receptor; DIPG = diffuse intrinsic pontine
              glioma; DMG = diffuse midline glioma; EGFR = epidermal growth
              factor receptor; biopsy; brainstem cancer; diffuse intrinsic
              pontine glioma; diffuse midline glioma; pediatric cancer",
  language = "en"
}

@ARTICLE{Vitanza2019-mk,
  title    = "Diffuse Intrinsic Pontine Glioma: From Diagnosis to
              {Next-Generation} Clinical Trials",
  author   = "Vitanza, Nicholas A and Monje, Michelle",
  abstract = "PURPOSE OF REVIEW: This review of diffuse intrinsic pontine
              glioma (DIPG) provides clinical background, a systematic approach
              to diagnosis and initial care, and synthesizes historical,
              modern, and future directions for treatment. We present evidence
              supporting neurosurgical biopsy, early palliative care
              involvement, limitation of glucocorticoid use, and the leveraging
              of preclinical DIPG models as a pipeline to next-generation
              clinical trials. RECENT FINDINGS: New molecular understanding of
              pediatric high-grade gliomas has led to the reclassification of
              DIPG as one member of a family of diffuse gliomas occurring in
              the midline of the central nervous system that exhibit
              pathognomonic mutations in genes encoding histone 3 (H3 K27M).
              DIPG remains a clinically relevant term, though diagnostically
              the 80\% of DIPG cases that exhibit the H3 K27M mutation have
              been reclassified as diffuse midline glioma, H3 K27M-mutant.
              Re-irradiation has been shown to be well-tolerated and of
              potential benefit. Epigenetic targeting of transcriptional
              dependencies in preclinical models is fueling molecularly
              targeted clinical trials. Chimeric antigen receptor T cell
              immunotherapy has also demonstrated efficacy in preclinical
              models and provides a promising new clinical strategy. DIPG is a
              universally fatal, epigenetically driven tumor of the pons that
              is considered part of a broader class of diffuse midline gliomas
              sharing H3 K27M mutations. Radiation remains the standard of
              care, single-agent temozolomide is not recommended, and
              glucocorticoids should be used only sparingly. A rapid evolution
              of understanding in the chromatin, signaling, and immunological
              biology of DIPG may soon result in clinical breakthroughs.",
  journal  = "Curr. Treat. Options Neurol.",
  volume   =  21,
  number   =  8,
  pages    = "37",
  month    =  jul,
  year     =  2019,
  keywords = "DIPG; DMG; Diffuse intrinsic pontine glioma; Diffuse midline
              glioma; H3 K27M mutation",
  language = "en"
}

@ARTICLE{Liu2020-cl,
  title     = "Isocitrate dehydrogenase ({IDH}) status prediction in
               histopathology images of gliomas using deep learning",
  author    = "Liu, Sidong and Shah, Zubair and Sav, Aydin and Russo, Carlo and
               Berkovsky, Shlomo and Qian, Yi and Coiera, Enrico and Di Ieva,
               Antonio",
  abstract  = "Mutations in isocitrate dehydrogenase genes IDH1 and IDH2 are
               frequently found in diffuse and anaplastic astrocytic and
               oligodendroglial tumours as well as in secondary glioblastomas.
               As IDH is a very important prognostic, diagnostic and
               therapeutic biomarker for glioma, it is of paramount importance
               to determine its mutational status. The haematoxylin and eosin
               (H\&E) staining is a valuable tool in precision oncology as it
               guides histopathology-based diagnosis and proceeding patient's
               treatment. However, H\&E staining alone does not determine the
               IDH mutational status of a tumour. Deep learning methods applied
               to MRI data have been demonstrated to be a useful tool in IDH
               status prediction, however the effectiveness of deep learning on
               H\&E slides in the clinical setting has not been investigated so
               far. Furthermore, the performance of deep learning methods in
               medical imaging has been practically limited by small sample
               sizes currently available. Here we propose a data augmentation
               method based on the Generative Adversarial Networks (GAN) deep
               learning methodology, to improve the prediction performance of
               IDH mutational status using H\&E slides. The H\&E slides were
               acquired from 266 grade II-IV glioma patients from a mixture of
               public and private databases, including 130 IDH-wildtype and 136
               IDH-mutant patients. A baseline deep learning model without data
               augmentation achieved an accuracy of 0.794 (AUC = 0.920). With
               GAN-based data augmentation, the accuracy of the IDH mutational
               status prediction was improved to 0.853 (AUC = 0.927) when the
               3,000 GAN generated training samples were added to the original
               training set (24,000 samples). By integrating also patients' age
               into the model, the accuracy improved further to 0.882 (AUC =
               0.931). Our findings show that deep learning methodology,
               enhanced by GAN data augmentation, can support physicians in
               gliomas' IDH status prediction.",
  journal   = "Sci. Rep.",
  publisher = "Nature Publishing Group",
  volume    =  10,
  number    =  1,
  pages     = "1--11",
  month     =  may,
  year      =  2020,
  language  = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@INPROCEEDINGS{Heusel2017-ci,
  title     = "{GANs} Trained by a Two {Time-Scale} Update Rule Converge to a
               Local Nash Equilibrium",
  booktitle = "Advances in Neural Information Processing Systems",
  author    = "Heusel, Martin and Ramsauer, Hubert and Unterthiner, Thomas and
               Nessler, Bernhard and Hochreiter, Sepp",
  editor    = "Guyon, I and Luxburg, U V and Bengio, S and Wallach, H and
               Fergus, R and Vishwanathan, S and Garnett, R",
  abstract  = "Abstract Generative Adversarial Networks (GANs) excel at
               creating realistic images with complex models for which maximum
               likelihood is infeasible. However, the convergence of GAN
               training has still not been proved. We propose a two time-scale
               update rule (TTUR) for training GANs with stochastic gradient
               descent on arbitrary GAN loss functions. TTUR has an individual
               learning rate for both the discriminator and the generator.
               Using the theory of stochastic approximation, we prove that the
               TTUR converges under mild assumptions to a â€¦",
  publisher = "Curran Associates, Inc.",
  volume    =  30,
  pages     = "6626--6637",
  year      =  2017
}

@ARTICLE{Nunez2020-qg,
  title    = "Genetically Engineered Mouse Model of Brainstem {High-Grade}
              Glioma",
  author   = "Nunez, Fernando M and Gauss, Jessica C and Mendez, Flor M and
              Haase, Santiago and Lowenstein, Pedro R and Castro, Maria G",
  abstract = "Summary Brainstem gliomas are aggressive tumors that are more
              prevalent in pediatric patients. The location of these tumors
              makes them inoperable, and currently there is no effective
              treatment. Recent genomic data revealed the unique biology of
              these tumors. The following protocol provides a method to
              incorporate these specific genetic lesions in a mouse glioma
              model. Using this model, the effects of these mutations in tumor
              progression and response to treatments can be studied within a
              relevant in vivo context. For complete details on the use and
              execution of this protocol, please refer to Mendez et al. (2020).",
  journal  = "STAR Protocols",
  volume   =  1,
  number   =  3,
  pages    = "100165",
  month    =  dec,
  year     =  2020,
  keywords = "Cell Biology; Cell culture; Cell isolation; Cancer; Neuroscience"
}

@ARTICLE{Mosaab2020-kw,
  title    = "Histone {H3K27M} Mutation Overrides Histological Grading in
              Pediatric Gliomas",
  author   = "Mosaab, Amal and El-Ayadi, Moatasem and Khorshed, Eman N and
              Amer, Nada and Refaat, Amal and El-Beltagy, Mohamed and Hassan,
              Zeinab and Soror, Sameh H and Zaghloul, Mohamed Saad and
              El-Naggar, Shahenda",
  abstract = "Pediatric high-grade gliomas (HGG) are rare aggressive tumors
              that present a prognostic and therapeutic challenge. Diffuse
              midline glioma, H3K27M-mutant is a new entity introduced to HGG
              in the latest WHO classification. In this study we evaluated the
              presence of H3K27M mutation in 105 tumor samples histologically
              classified into low-grade gliomas (LGG) (n = 45), and HGG (n =
              60). Samples were screened for the mutation in histone H3.3 and
              H3.1 variants to examine its prevalence, prognostic impact, and
              assess its potential clinical value in limited resource settings.
              H3K27M mutation was detected in 28 of 105 (26.7\%) samples, and
              its distribution was significantly associated with midline
              locations (p-value < 0.0001) and HGG (p-value = 0.003). Overall
              and event- free survival (OS and EFS, respectively) of patients
              with mutant tumors did not differ significantly, neither
              according to histologic grade (OS p-value = 0.736, EFS p-value =
              0.75) nor across anatomical sites (OS p-value = 0.068, EFS
              p-value = 0.153). Detection of H3K27M mutation in pediatric
              gliomas provides more precise risk stratification compared to
              traditional histopathological techniques. Hence, mutation
              detection should be pursued in all pediatric gliomas. Meanwhile,
              focusing on midline LGG can be an alternative in
              lower-middle-income countries to maximally optimize patients'
              treatment options.",
  journal  = "Sci. Rep.",
  volume   =  10,
  number   =  1,
  pages    = "8368",
  month    =  may,
  year     =  2020,
  language = "en"
}

@ARTICLE{Heindl2015-xt,
  title    = "Mapping spatial heterogeneity in the tumor microenvironment: a
              new era for digital pathology",
  author   = "Heindl, Andreas and Nawaz, Sidra and Yuan, Yinyin",
  abstract = "The emergent field of digital pathology employing automated image
              analysis techniques is to revolutionize traditional pathology at
              the center of clinical diagnostics. Histological images provide
              important tumor features unavailable in molecular profiling or
              omics data- the spatial context of tumor and stromal cells at
              single-cell resolution. Methods to map the spatial and
              morphological patterns of cancer and normal cells can contribute
              to a more comprehensive understanding of the highly heterogeneous
              tumor microenvironment. This review focuses on methods that help
              expand our knowledge of intra-tumoral spatial heterogeneity of
              the tumor microenvironment and their potential synergies with
              molecular profiling technologies.",
  journal  = "Lab. Invest.",
  volume   =  95,
  number   =  4,
  pages    = "377--384",
  month    =  apr,
  year     =  2015,
  language = "en"
}

@ARTICLE{Clark2013-tx,
  title    = "The Cancer Imaging Archive ({TCIA)}: maintaining and operating a
              public information repository",
  author   = "Clark, Kenneth and Vendt, Bruce and Smith, Kirk and Freymann,
              John and Kirby, Justin and Koppel, Paul and Moore, Stephen and
              Phillips, Stanley and Maffitt, David and Pringle, Michael and
              Tarbox, Lawrence and Prior, Fred",
  abstract = "The National Institutes of Health have placed significant
              emphasis on sharing of research data to support secondary
              research. Investigators have been encouraged to publish their
              clinical and imaging data as part of fulfilling their grant
              obligations. Realizing it was not sufficient to merely ask
              investigators to publish their collection of imaging and clinical
              data, the National Cancer Institute (NCI) created the open source
              National Biomedical Image Archive software package as a mechanism
              for centralized hosting of cancer related imaging. NCI has
              contracted with Washington University in Saint Louis to create
              The Cancer Imaging Archive (TCIA)-an open-source, open-access
              information resource to support research, development, and
              educational initiatives utilizing advanced medical imaging of
              cancer. In its first year of operation, TCIA accumulated 23
              collections (3.3 million images). Operating and maintaining a
              high-availability image archive is a complex challenge involving
              varied archive-specific resources and driven by the needs of both
              image submitters and image consumers. Quality archives of any
              type (traditional library, PubMed, refereed journals) require
              management and customer service. This paper describes the
              management tasks and user support model for TCIA.",
  journal  = "J. Digit. Imaging",
  volume   =  26,
  number   =  6,
  pages    = "1045--1057",
  month    =  dec,
  year     =  2013,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Pantanowitz2020-qn,
  title    = "An artificial intelligence algorithm for prostate cancer
              diagnosis in whole slide images of core needle biopsies: a
              blinded clinical validation and deployment study",
  author   = "Pantanowitz, Liron and Quiroga-Garza, Gabriela M and Bien, Lilach
              and Heled, Ronen and Laifenfeld, Daphna and Linhart, Chaim and
              Sandbank, Judith and Albrecht Shach, Anat and Shalev, Varda and
              Vecsler, Manuela and Michelow, Pamela and Hazelhurst, Scott and
              Dhir, Rajiv",
  abstract = "BACKGROUND: There is high demand to develop computer-assisted
              diagnostic tools to evaluate prostate core needle biopsies
              (CNBs), but little clinical validation and a lack of clinical
              deployment of such tools. We report here on a blinded clinical
              validation study and deployment of an artificial intelligence
              (AI)-based algorithm in a pathology laboratory for routine
              clinical use to aid prostate diagnosis. METHODS: An AI-based
              algorithm was developed using haematoxylin and eosin
              (H\&E)-stained slides of prostate CNBs digitised with a Philips
              scanner, which were divided into training (1 357 480 image
              patches from 549 H\&E-stained slides) and internal test (2501
              H\&E-stained slides) datasets. The algorithm provided slide-level
              scores for probability of cancer, Gleason score 7-10 (vs Gleason
              score 6 or atypical small acinar proliferation [ASAP]), Gleason
              pattern 5, and perineural invasion and calculation of cancer
              percentage present in CNB material. The algorithm was
              subsequently validated on an external dataset of 100 consecutive
              cases (1627 H\&E-stained slides) digitised on an Aperio AT2
              scanner. In addition, the AI tool was implemented in a pathology
              laboratory within routine clinical workflow as a second read
              system to review all prostate CNBs. Algorithm performance was
              assessed with area under the receiver operating characteristic
              curve (AUC), specificity, and sensitivity, as well as Pearson's
              correlation coefficient (Pearson's r) for cancer percentage.
              FINDINGS: The algorithm achieved an AUC of 0Â·997 (95\% CI 0Â·995
              to 0Â·998) for cancer detection in the internal test set and 0Â·991
              (0Â·979 to 1Â·00) in the external validation set. The AUC for
              distinguishing between a low-grade (Gleason score 6 or ASAP) and
              high-grade (Gleason score 7-10) cancer diagnosis was 0Â·941 (0Â·905
              to 0Â·977) and the AUC for detecting Gleason pattern 5 was 0Â·971
              (0Â·943 to 0Â·998) in the external validation set. Cancer
              percentage calculated by pathologists and the algorithm showed
              good agreement (r=0Â·882, 95\% CI 0Â·834 to 0Â·915; p<0Â·0001) with a
              mean bias of -4Â·14\% (-6Â·36 to -1Â·91). The algorithm achieved an
              AUC of 0Â·957 (0Â·930 to 0Â·985) for perineural invasion. In routine
              practice, the algorithm was used to assess 11 429 H\&E-stained
              slides pertaining to 941 cases leading to 90 Gleason score 7-10
              alerts and 560 cancer alerts. 51 (9\%) cancer alerts led to
              additional cuts or stains being ordered, two (4\%) of which led
              to a third opinion request. We report on the first case of missed
              cancer that was detected by the algorithm. INTERPRETATION: This
              study reports the successful development, external clinical
              validation, and deployment in clinical practice of an AI-based
              algorithm to accurately detect, grade, and evaluate clinically
              relevant findings in digitised slides of prostate CNBs. FUNDING:
              Ibex Medical Analytics.",
  journal  = "Lancet Digit Health",
  volume   =  2,
  number   =  8,
  pages    = "e407--e416",
  month    =  aug,
  year     =  2020,
  language = "en"
}

@ARTICLE{Chang2018-qd,
  title    = "Residual Convolutional Neural Network for the Determination of
              {IDH} Status in Low- and {High-Grade} Gliomas from {MR} Imaging",
  author   = "Chang, Ken and Bai, Harrison X and Zhou, Hao and Su, Chang and
              Bi, Wenya Linda and Agbodza, Ena and Kavouridis, Vasileios K and
              Senders, Joeky T and Boaro, Alessandro and Beers, Andrew and
              Zhang, Biqi and Capellini, Alexandra and Liao, Weihua and Shen,
              Qin and Li, Xuejun and Xiao, Bo and Cryan, Jane and Ramkissoon,
              Shakti and Ramkissoon, Lori and Ligon, Keith and Wen, Patrick Y
              and Bindra, Ranjit S and Woo, John and Arnaout, Omar and
              Gerstner, Elizabeth R and Zhang, Paul J and Rosen, Bruce R and
              Yang, Li and Huang, Raymond Y and Kalpathy-Cramer, Jayashree",
  abstract = "Purpose: Isocitrate dehydrogenase (IDH) mutations in glioma
              patients confer longer survival and may guide treatment decision
              making. We aimed to predict the IDH status of gliomas from MR
              imaging by applying a residual convolutional neural network to
              preoperative radiographic data.Experimental Design: Preoperative
              imaging was acquired for 201 patients from the Hospital of
              University of Pennsylvania (HUP), 157 patients from Brigham and
              Women's Hospital (BWH), and 138 patients from The Cancer Imaging
              Archive (TCIA) and divided into training, validation, and testing
              sets. We trained a residual convolutional neural network for each
              MR sequence (FLAIR, T2, T1 precontrast, and T1 postcontrast) and
              built a predictive model from the outputs. To increase the size
              of the training set and prevent overfitting, we augmented the
              training set images by introducing random rotations,
              translations, flips, shearing, and zooming.Results: With our
              neural network model, we achieved IDH prediction accuracies of
              82.8\% (AUC = 0.90), 83.0\% (AUC = 0.93), and 85.7\% (AUC = 0.94)
              within training, validation, and testing sets, respectively. When
              age at diagnosis was incorporated into the model, the training,
              validation, and testing accuracies increased to 87.3\% (AUC =
              0.93), 87.6\% (AUC = 0.95), and 89.1\% (AUC = 0.95),
              respectively.Conclusions: We developed a deep learning technique
              to noninvasively predict IDH genotype in grade II-IV glioma using
              conventional MR imaging using a multi-institutional data set.
              Clin Cancer Res; 24(5); 1073-81. \copyright{}2017 AACR.",
  journal  = "Clin. Cancer Res.",
  volume   =  24,
  number   =  5,
  pages    = "1073--1081",
  month    =  mar,
  year     =  2018,
  language = "en"
}

@ARTICLE{Bangalore_Yogananda2020-lp,
  title    = "A novel fully automated {MRI-based} deep-learning method for
              classification of {IDH} mutation status in brain gliomas",
  author   = "Bangalore Yogananda, Chandan Ganesh and Shah, Bhavya R and
              Vejdani-Jahromi, Maryam and Nalawade, Sahil S and Murugesan,
              Gowtham K and Yu, Frank F and Pinho, Marco C and Wagner, Benjamin
              C and Mickey, Bruce and Patel, Toral R and Fei, Baowei and
              Madhuranthakam, Ananth J and Maldjian, Joseph A",
  abstract = "BACKGROUND: Isocitrate dehydrogenase (IDH) mutation status has
              emerged as an important prognostic marker in gliomas. Currently,
              reliable IDH mutation determination requires invasive surgical
              procedures. The purpose of this study was to develop a highly
              accurate, MRI-based, voxelwise deep-learning IDH classification
              network using T2-weighted (T2w) MR images and compare its
              performance to a multicontrast network. METHODS: Multiparametric
              brain MRI data and corresponding genomic information were
              obtained for 214 subjects (94 IDH-mutated, 120 IDH wild-type)
              from The Cancer Imaging Archive and The Cancer Genome Atlas. Two
              separate networks were developed, including a T2w image-only
              network (T2-net) and a multicontrast (T2w, fluid attenuated
              inversion recovery, and T1 postcontrast) network (TS-net) to
              perform IDH classification and simultaneous single label tumor
              segmentation. The networks were trained using 3D Dense-UNets.
              Three-fold cross-validation was performed to generalize the
              networks' performance. Receiver operating characteristic analysis
              was also performed. Dice scores were computed to determine tumor
              segmentation accuracy. RESULTS: T2-net demonstrated a mean
              cross-validation accuracy of 97.14\% $\pm$ 0.04 in predicting IDH
              mutation status, with a sensitivity of 0.97 $\pm$ 0.03,
              specificity of 0.98 $\pm$ 0.01, and an area under the curve (AUC)
              of 0.98 $\pm$ 0.01. TS-net achieved a mean cross-validation
              accuracy of 97.12\% $\pm$ 0.09, with a sensitivity of 0.98 $\pm$
              0.02, specificity of 0.97 $\pm$ 0.001, and an AUC of 0.99 $\pm$
              0.01. The mean whole tumor segmentation Dice scores were 0.85
              $\pm$ 0.009 for T2-net and 0.89 $\pm$ 0.006 for TS-net.
              CONCLUSION: We demonstrate high IDH classification accuracy using
              only T2-weighted MR images. This represents an important
              milestone toward clinical translation.",
  journal  = "Neuro. Oncol.",
  volume   =  22,
  number   =  3,
  pages    = "402--411",
  month    =  mar,
  year     =  2020,
  keywords = "CNN; IDH; MRI; deep learning; glioma",
  language = "en"
}

@ARTICLE{Chang2018-jp,
  title    = "{Deep-Learning} Convolutional Neural Networks Accurately Classify
              Genetic Mutations in Gliomas",
  author   = "Chang, P and Grinband, J and Weinberg, B D and Bardis, M and Khy,
              M and Cadena, G and Su, M-Y and Cha, S and Filippi, C G and Bota,
              D and Baldi, P and Poisson, L M and Jain, R and Chow, D",
  abstract = "BACKGROUND AND PURPOSE: The World Health Organization has
              recently placed new emphasis on the integration of genetic
              information for gliomas. While tissue sampling remains the
              criterion standard, noninvasive imaging techniques may provide
              complimentary insight into clinically relevant genetic mutations.
              Our aim was to train a convolutional neural network to
              independently predict underlying molecular genetic mutation
              status in gliomas with high accuracy and identify the most
              predictive imaging features for each mutation. MATERIALS AND
              METHODS: MR imaging data and molecular information were
              retrospectively obtained from The Cancer Imaging Archives for 259
              patients with either low- or high-grade gliomas. A convolutional
              neural network was trained to classify isocitrate dehydrogenase 1
              (IDH1) mutation status, 1p/19q codeletion, and
              O6-methylguanine-DNA methyltransferase (MGMT) promotor
              methylation status. Principal component analysis of the final
              convolutional neural network layer was used to extract the key
              imaging features critical for successful classification. RESULTS:
              Classification had high accuracy: IDH1 mutation status, 94\%;
              1p/19q codeletion, 92\%; and MGMT promotor methylation status,
              83\%. Each genetic category was also associated with distinctive
              imaging features such as definition of tumor margins, T1 and
              FLAIR suppression, extent of edema, extent of necrosis, and
              textural features. CONCLUSIONS: Our results indicate that for The
              Cancer Imaging Archives dataset, machine-learning approaches
              allow classification of individual genetic mutations of both low-
              and high-grade gliomas. We show that relevant MR imaging features
              acquired from an added dimensionality-reduction technique
              demonstrate that neural networks are capable of learning key
              imaging components without prior feature selection or
              human-directed training.",
  journal  = "AJNR Am. J. Neuroradiol.",
  volume   =  39,
  number   =  7,
  pages    = "1201--1207",
  month    =  jul,
  year     =  2018,
  language = "en"
}

@ARTICLE{Schoenfeld2012-ud,
  title    = "The superiority of conservative resection and adjuvant radiation
              for craniopharyngiomas",
  author   = "Schoenfeld, Adam and Pekmezci, Melike and Barnes, Michael J and
              Tihan, Tarik and Gupta, Nalin and Lamborn, Kathleen R and
              Banerjee, Anu and Mueller, Sabine and Chang, Susan and Berger,
              Mitchel S and Haas-Kogan, Daphne",
  abstract = "The purpose of this study is to evaluate the roles of resection
              extent and adjuvant radiation in the treatment of
              craniopharyngiomas. We reviewed the records of 122 patients ages
              11-52 years who received primary treatment for craniopharyngioma
              between 1980 and 2009 at the University of California, San
              Francisco (UCSF). Primary endpoints were progression free
              survival (PFS) and overall survival (OS). Secondary endpoints
              were development of panhypopituitarism, diabetes insipidus (DI),
              and visual field defects. Of 122 patients, 30 (24\%) were treated
              with gross total resection (GTR) without radiation therapy (RT),
              3 (3\%) with GTR + RT, 41 (33.6\%) with subtotal resection (STR)
              without RT, and 48 (39.3\%) with STR + RT. Median age at
              diagnosis was 30 years, with 46 patients 18 years or younger.
              Median follow-up for all patients was 56.4 months (interquartile
              range 18.9-144.2 months) and 47 months (interquartile range
              12.3-121.8 months) for the 60 patients without progression. Fifty
              six patients progressed, 10 have died, 6 without progression.
              Median PFS was 61.1 months for all patients. PFS rate at 2 years
              was 61.5\% (95\% CI: 52.1-70.9). OS rate at 10 years was 91.1\%
              (95\% CI 84.3-97.9). There was no significant difference in PFS
              and OS between patients treated with GTR vs. STR + XRT (PFS; p =
              0.544, OS; p = 0.735), but STR alone resulted in significantly
              shortened PFS compared to STR + RT or GTR (p < 0.001 for both).
              STR was associated with significantly shortened OS compared to
              STR + RT (p = 0.050) and trended to shorter OS compared to GTR (p
              = 0.066). GTR was associated with significantly greater risk of
              developing DI (56.3 vs. 13.3\% with STR + XRT, p < 0.001) and
              panhypopituitarism (54.8 vs. 26.7\% with STR + XRT, p = 0.014).
              In conclusion, for patients with craniopharyngioma, STR + RT may
              provide superior clinical outcome, achieving better disease
              control than STR and limiting side effects associated with
              aggressive surgical resection.",
  journal  = "J. Neurooncol.",
  volume   =  108,
  number   =  1,
  pages    = "133--139",
  month    =  may,
  year     =  2012,
  language = "en"
}

@ARTICLE{Beer-Furlan2020-ne,
  title    = "Improving Function in Cavernous Sinus Meningiomas: A Modern
              Treatment Algorithm",
  author   = "Beer-Furlan, Andr{\'e} and Priddy, Blake H and Jamshidi, Ali O
              and Shaikhouni, Ammar and Prevedello, Luciano M and Ditzel Filho,
              Leo and Otto, Bradley A and Carrau, Ricardo L and Prevedello,
              Daniel M",
  abstract = "Background: The efficacy and safety of radiosurgery led to
              paradigm shift in the management of cavernous sinus meningiomas.
              Nevertheless, patients are still significantly affected by
              cranial nerve deficits related to the mass effect of these
              tumors. Our management strategy involves the combination of a
              functional surgical decompression followed by radiation therapy.
              Methods: We reviewed a single institution's cohort of patients
              who underwent endoscopic endonasal decompression (EED) for
              symptomatic meningiomas primarily involving the cavernous sinus
              (CS) from 2010 to 2016. The preoperative neuro-ophthalmological
              exam was compared to the 1- and 6-month postoperative exams. The
              patient's length of hospital stay, complications, and
              radiological and clinical follow-up were noted. Results: A total
              of 17 patients underwent EED for CS meningiomas that fit our
              radiological criteria. The final outcome at the 6-month visit
              showed five patients (62.5\%) with normalization of deficit and
              three patients (37.5\%) with partial improvement of the CNII
              deficit. Out of the 12 patients who had cavernous sinus cranial
              nerves (CSCN) deficits, the final outcome at the 6-month visit
              showed four patients (33.33\%) with normalization of deficit,
              seven patients (58.3\%) with partial improvement, and one patient
              (8.33\%) with no improvement. There were no intraoperative
              complications. Conclusion: The EED for CS meningiomas is a
              valuable technique when addressing acute/subacute CNII and CSCN
              deficits. This conservative surgical approach showed good
              functional outcomes, low morbidity, and low complication rates.
              However, it does not exempt the need for radiosurgery/radiation
              therapy for control of tumor growth.",
  journal  = "Front. Neurol.",
  volume   =  11,
  pages    = "652",
  month    =  jul,
  year     =  2020,
  keywords = "cavernous sinus; endoscopic endonasal; meningioma; parasellar;
              skull base",
  language = "en"
}

@ARTICLE{Abou-Al-Shaar2020-gr,
  title    = "{Cranio-Orbital} and Orbitocranial Approaches to Orbital and
              Intracranial Disease: {Eye-Opening} Approaches for Neurosurgeons",
  author   = "Abou-Al-Shaar, Hussam and Krisht, Khaled M and Cohen, Michael A
              and Abunimer, Abdullah M and Neil, Jayson A and Karsy, Michael
              and Alzhrani, Gmaan and Couldwell, William T",
  abstract = "Orbital approaches for targeting intracranial, orbital, and
              infratemporal disease have evolved over the years in an effort to
              discover safe, reliable, effective, and cosmetically satisfying
              surgical corridors. The surgical goals of these approaches
              balance important factors such as proximity of the lesion to the
              optic nerve, the degree of anticipated manipulation and required
              space for surgical maneuverability, and the type of disease. The
              authors provide a comprehensive review of the most commonly used
              periorbital approaches in the management of intra- and
              extracranial disease, with emphasis on the advantages and
              limitations of each approach.",
  journal  = "Front Surg",
  volume   =  7,
  pages    = "1",
  month    =  feb,
  year     =  2020,
  keywords = "cranio-orbital; endoscopic; intraconal; intracranial; keyhole;
              total lateral orbitotomy; transconjunctival; zygoma",
  language = "en"
}

@ARTICLE{Lanchantin2020-mz,
  title         = "General Multi-label Image Classification with Transformers",
  author        = "Lanchantin, Jack and Wang, Tianlu and Ordonez, Vicente and
                   Qi, Yanjun",
  abstract      = "Multi-label image classification is the task of predicting a
                   set of labels corresponding to objects, attributes or other
                   entities present in an image. In this work we propose the
                   Classification Transformer (C-Tran), a general framework for
                   multi-label image classification that leverages Transformers
                   to exploit the complex dependencies among visual features
                   and labels. Our approach consists of a Transformer encoder
                   trained to predict a set of target labels given an input set
                   of masked labels, and visual features from a convolutional
                   neural network. A key ingredient of our method is a label
                   mask training objective that uses a ternary encoding scheme
                   to represent the state of the labels as positive, negative,
                   or unknown during training. Our model shows state-of-the-art
                   performance on challenging datasets such as COCO and Visual
                   Genome. Moreover, because our model explicitly represents
                   the uncertainty of labels during training, it is more
                   general by allowing us to produce improved results for
                   images with partial or extra label annotations during
                   inference. We demonstrate this additional capability in the
                   COCO, Visual Genome, News500, and CUB image datasets.",
  month         =  nov,
  year          =  2020,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "2011.14027"
}

@UNPUBLISHED{Comba2021-dr,
  title    = "Spatiotemporal analysis of glioma heterogeneity reveals {Col1A1}
              as an actionable 1 target to disrupt tumor mesenchymal
              differentiation, invasion and malignancy",
  author   = "Comba, Andrea and Motsch, Sebastien and Dunn, Patrick J and
              Hollon, Todd C and Argento, Anna E and Zamler, Daniel B and Kish,
              Phillips E and Kahana, Alon and Kleer, Celina G and Castro, Maria
              Graciela and Lowenstein, Pedro R",
  abstract = "Intra-tumoral heterogeneity and diffuse infiltration are
              hallmarks of glioblastoma that challenge 18 treatment efficacy.
              However, the mechanisms that set up both tumor heterogeneity and
              invasion 19 remain poorly understood. Herein, we present a
              comprehensive spatiotemporal study that aligns 20 distinctive
              intra-tumoral histopathological structures, oncostreams, with
              dynamic properties and 21 a unique, actionable, spatial
              transcriptomic signature. Oncostreams are dynamic multicellular
              22 fascicles of spindle-like and aligned cells with mesenchymal
              properties. Their density correlates 23 with tumor aggressiveness
              in genetically engineered mouse glioma models, and high grade 24
              human gliomas. Oncostreams facilitate the intra-tumoral
              distribution of tumoral and non-25 tumoral cells, and the
              invasion of the normal brain. These fascicles are defined by a
              specific 26 molecular signature that regulates their organization
              and function. Oncostreams structure and 27 function depend on
              overexpression of COL1A1. COL1A1 is a central gene in the dynamic
              28 organization of glioma mesenchymal transformation, and a
              powerful regulator of glioma 29 malignant behavior. Inhibition of
              COL1A1 eliminated oncostreams, reprogramed the malignant 30
              histopathological phenotype, reduced expression of the
              mesenchymal associated genes, and 31 prolonged animal survival.
              Oncostreams represent a novel pathological marker of potential
              value 32 for diagnosis, prognosis, and treatment. \#\#\#
              Competing Interest Statement The authors have declared no
              competing interest.",
  journal  = "bioRxiv",
  pages    = "2020.12.01.404970",
  month    =  may,
  year     =  2021,
  language = "en"
}

@ARTICLE{Hollon2020-oj,
  title    = "Rapid, label-free detection of diffuse glioma recurrence using
              intraoperative stimulated Raman histology and deep neural
              networks",
  author   = "Hollon, Todd C and Pandian, Balaji and Urias, Esteban and Save,
              Akshay V and Adapa, Arjun R and Srinivasan, Sudharsan and
              Jairath, Neil K and Farooq, Zia and Marie, Tamara and Al-Holou,
              Wajd N and Eddy, Karen and Heth, Jason A and Khalsa, Siri Sahib S
              and Conway, Kyle and Sagher, Oren and Bruce, Jeffrey N and
              Canoll, Peter and Freudiger, Christian W and Camelo-Piragua,
              Sandra and Lee, Honglak and Orringer, Daniel A",
  abstract = "BACKGROUND: Detection of glioma recurrence remains a challenge in
              modern neuro-oncology. Noninvasive radiographic imaging is unable
              to definitively differentiate true recurrence versus
              pseudoprogression. Even in biopsied tissue, it can be challenging
              to differentiate recurrent tumor and treatment effect. We
              hypothesized that intraoperative stimulated Raman histology (SRH)
              and deep neural networks can be used to improve the
              intraoperative detection of glioma recurrence. METHODS: We used
              fiber-laser-based SRH, a label-free, non-consumptive,
              high-resolution microscopy method (<60 secs per 1 x 1 mm2) to
              image a cohort of patients (n = 35) with suspected recurrent
              gliomas who underwent biopsy or resection. The SRH images were
              then used to train a convolutional neural network (CNN) and
              develop an inference algorithm to detect viable recurrent glioma.
              Following network training, the performance of the CNN was tested
              for diagnostic accuracy in a retrospective cohort (n = 48).
              RESULTS: Using patch-level CNN predictions, the inference
              algorithm returned a single Bernoulli distribution for the
              probability of tumor recurrence for each surgical specimen or
              patient. The external SRH validation dataset consisted of 48
              patients (recurrent, 30; pseudoprogression, 18), and we achieved
              a diagnostic accuracy of 95.8\%. CONCLUSION: SRH with CNN-based
              diagnosis can be used to improve the intraoperative detection of
              glioma recurrence in near-real time. Our results provide insight
              into how optical imaging and computer vision can be combined to
              augment conventional diagnostic methods and improve the quality
              of specimen sampling at glioma recurrence.",
  journal  = "Neuro. Oncol.",
  month    =  jul,
  year     =  2020,
  keywords = "deep learning; frozen section; intraoperative pathology;
              label-free imaging; neural networks; stimulated Raman histology",
  language = "en"
}

@ARTICLE{Magill2021-ij,
  title     = "International Tuberculum Sellae Meningioma Study: Surgical
               Outcomes and Management Trends",
  author    = "Magill, Stephen T and Schwartz, Theodore H and Couldwell,
               William T and Gardner, Paul A and Heilman, Carl B and Sen,
               Chandra N and Akagami, Ryojo and Cappabianca, Paolo and
               Prevedello, Daniel M and McDermott, Michael W and {The
               International Tuberculum Sellae Meningioma Authors}",
  abstract  = "AbstractINTRODUCTION. Tuberculum sellae meningiomas (TSM) can be
               resected via transcranial (TCA) or transsphenoidal (TSA)
               approaches, but comparative outcomes d",
  journal   = "Neurosurgery",
  publisher = "Oxford Academic",
  volume    =  67,
  number    = "Supplement\_1",
  month     =  feb,
  year      =  2021,
  keywords  = "world health organization; tuberculum sellae meningioma;
               recurrence risk; surgical outcome; cerebrospinal fluid leak;
               mortality; neoplasms; blindness; follow-up; vision"
}

@ARTICLE{Goldbrunner2016-mt,
  title     = "{EANO} guidelines for the diagnosis and treatment of meningiomas",
  author    = "Goldbrunner, Roland and Minniti, Giuseppe and Preusser, Matthias
               and Jenkinson, Michael D and Sallabanda, Kita and Houdart,
               Emmanuel and von Deimling, Andreas and Stavrinou, Pantelis and
               Lefranc, Florence and Lund-Johansen, Morten and Moyal, Elizabeth
               Cohen-Jonathan and Brandsma, Dieta and Henriksson, Roger and
               Soffietti, Riccardo and Weller, Michael",
  abstract  = "Although meningiomas are the most common intracranial tumours,
               the level of evidence to provide recommendations for the
               diagnosis and treatment of meningiomas is low compared with
               other tumours such as high-grade gliomas. The meningioma task
               force of the European Association of Neuro-Oncology (EANO)
               assessed the scientific literature and composed a framework of
               the best possible evidence-based recommendations for health
               professionals. The provisional diagnosis of meningioma is mainly
               made by MRI. Definitive diagnosis, including histological
               classification, grading, and molecular profiling, requires a
               surgical procedure to obtain tumour tissue. Therefore, in many
               elderly patients, observation is the best therapeutic option. If
               therapy is deemed necessary, the standard treatment is gross
               total surgical resection including the involved dura. As an
               alternative, radiosurgery can be done for small tumours, or
               fractionated radiotherapy in large or previously treated
               tumours. Treatment concepts combining surgery and radiosurgery
               or fractionated radiotherapy, which enable treatment of the
               complete tumour volume with low morbidity, are being developed.
               Pharmacotherapy for meningiomas has remained largely
               experimental. However, antiangiogenic drugs, peptide receptor
               radionuclide therapy, and targeted agents are promising
               candidates for future pharmacological approaches to treat
               refractory meningiomas across all WHO grades.",
  journal   = "Lancet Oncol.",
  publisher = "Elsevier",
  volume    =  17,
  number    =  9,
  pages     = "e383--91",
  month     =  sep,
  year      =  2016,
  language  = "en"
}

@ARTICLE{Lemee2019-rz,
  title    = "Extent of Resection in Meningioma: Predictive Factors and
              Clinical Implications",
  author   = "Lem{\'e}e, Jean-Michel and Corniola, Marco V and Da Broi, Michele
              and Joswig, Holger and Scheie, David and Schaller, Karl and
              Helseth, Eirik and Meling, Torstein R",
  abstract = "Meningiomas present as intracranial extra-axial lesions with
              dural attachment, which are primarily managed surgically. The
              extent of resection (EOR) may vary depending on patient- and
              tumor-related factors. The aim of this study is to identify
              preoperative predictive factors of EOR and to propose an
              estimation of the predicted gross total resection (GTR) based of
              patient- and tumor-characteristics. 1469 patients from a
              retrospectively (1990 to 2002) and prospectively managed (2003 to
              2010) databank of Oslo University Hospital, Norway, totalling
              11,414 patient-years of follow-up were included. Patients had a
              mean age at surgery of 64 $\pm$ 20.1 years with a female-to-male
              ratio was 2.4:1 and a mean KPS of 81.2 $\pm$ 12.1. Skull-base
              meningiomas represented 47\% of all cases. WHO grades were I in
              92.3\%, II in 5.2\%, and III in 2.2\%. Bone infiltration was
              described in 18.7\% of cases. 39.3\% of patients had Simpson I
              resection, 34.3\% had Simpson II, 5.4\% had Simpson III, 20.6\%
              had Simpson IV, and 0.5\% had Simpson V. The risk factors for
              incomplete resection were: symptomatic presentation (OR 0.56
              [0.43-0.72]), skull-base location (OR 0.79 [0.70-0.88]), and bone
              invasion (OR 0.85 [0.73-0.99]). Using a recursive partitioning
              analysis, we propose a classification-tree for the prediction of
              GTR rate based on preoperatively determinable patient- and tumor
              characteristics. The identification of preoperative predictors of
              poor GTR rate may aid clinicians managing meningioma patients. In
              selected cases were the predicted GTR rate is low, staged
              treatment with surgical debulking followed by adjuvant therapy
              may be favored in order to minimize postoperative morbidity and
              mortality.",
  journal  = "Sci. Rep.",
  volume   =  9,
  number   =  1,
  pages    = "5944",
  month    =  apr,
  year     =  2019,
  language = "en"
}

@ARTICLE{Goldbrunner2020-zc,
  title    = "{EANO} guideline on the diagnosis and treatment of vestibular
              schwannoma",
  author   = "Goldbrunner, Roland and Weller, Michael and Regis, Jean and
              Lund-Johansen, Morten and Stavrinou, Pantelis and Reuss, David
              and Evans, D Gareth and Lefranc, Florence and Sallabanda, Kita
              and Falini, Andrea and Axon, Patrick and Sterkers, Olivier and
              Fariselli, Laura and Wick, Wolfgang and Tonn, Joerg-Christian",
  abstract = "The level of evidence to provide treatment recommendations for
              vestibular schwannoma is low compared with other intracranial
              neoplasms. Therefore, the vestibular schwannoma task force of the
              European Association of Neuro-Oncology assessed the data
              available in the literature and composed a set of recommendations
              for health care professionals. The radiological diagnosis of
              vestibular schwannoma is made by magnetic resonance imaging.
              Histological verification of the diagnosis is not always
              required. Current treatment options include observation, surgical
              resection, fractionated radiotherapy, and radiosurgery. The
              choice of treatment depends on clinical presentation, tumor size,
              and expertise of the treating center. In small tumors,
              observation has to be weighed against radiosurgery, in large
              tumors surgical decompression is mandatory, potentially followed
              by fractionated radiotherapy or radiosurgery. Except for
              bevacizumab in neurofibromatosis type 2, there is no role for
              pharmacotherapy.",
  journal  = "Neuro. Oncol.",
  volume   =  22,
  number   =  1,
  pages    = "31--45",
  month    =  jan,
  year     =  2020,
  keywords = "diagnosis; radiotherapy; surgery; treatment; vestibular
              schwannoma",
  language = "en"
}

@ARTICLE{Wang2020-cy,
  title    = "A new scoring system for predicting extent of resection in medial
              sphenoid wing meningiomas based on three-dimensional
              multimodality fusion imaging",
  author   = "Wang, Zilan and Liang, Xiaolong and Yang, Yanbo and Gao, Bixi and
              Wang, Ling and You, Wanchun and Chen, Zhouqing and Wang, Zhong",
  abstract = "BACKGROUND: Three-dimensional (3D) fusion imaging has been proved
              to be a promising neurosurgical tool for presurgical evaluation
              of tumor removal. We aim to develop a scoring system based on
              this new tool to predict the resection grade of medial sphenoid
              wing meningiomas (mSWM) intuitively. METHODS: We included 46
              patients treated for mSWM from 2014 to 2019 to evaluate their
              tumors' location, volume, cavernous sinus involvement, vascular
              encasement, and bone invasion by 3D multimodality fusion imaging.
              A scoring system based on the significant parameters detected by
              statistical analysis was created and evaluated. RESULTS: The
              tumor volumes ranged from 0.8 cm3 to 171.9 cm3. A total of 39
              (84.8\%) patients had arterial involvement. Cavernous sinus (CS)
              involvement was observed in 23 patients (50.0\%) and bone
              invasion was noted in 10 patients (21.7\%). Simpson I resection
              was achieved in 10 patients (21.7\%) and Simpson II resection was
              achieved in 17 patients (37.0\%). Fifteen patients (32.6\%)
              underwent Simpson III resection and 4 patients (8.7\%) underwent
              Simpson IV resections. A scoring system was created. The score
              ranged from 1 to 10 and the mean score of our patients was 5.3
              $\pm$ 2.8. Strong positive monotonic correlation existed between
              the score and resection grade (Rs = 0.772, P < 0.001). The
              scoring system had good predictive capacity with an accuracy of
              69.60\%. CONCLUSIONS: We described a scoring system that enabled
              neurosurgeons to predict extent of resection and outcomes for
              mSWM preoperatively with 3D multimodality fusion imaging. TRIAL
              REGISTRATION: Retrospectively registered.",
  journal  = "Chin Neurosurg J",
  volume   =  6,
  number   =  1,
  pages    = "35",
  month    =  nov,
  year     =  2020,
  keywords = "3D reconstruction; Brain tumor; Fusion imaging; Scoring system;
              Sphenoid wing meningioma",
  language = "en"
}

@ARTICLE{Hirsch1993-gk,
  title    = "Meningiomas involving the cavernous sinus: value of imaging for
              predicting surgical complications",
  author   = "Hirsch, W L and Sekhar, L N and Lanzino, G and Pomonis, S and
              Sen, C N",
  abstract = "OBJECTIVES: The purpose of this study was to determine if it is
              possible to predict complications of surgery on cavernous sinus
              meningiomas on the basis of preoperative MR and CT findings.
              MATERIALS AND METHODS: We retrospectively reviewed the CT, MR,
              and postoperative clinical findings in 65 consecutive patients
              with pathologically proved cavernous sinus meningiomas who had
              surgery during the period 1985-1991. Tumors were categorized on
              the basis of their relationship to the cavernous carotid artery.
              The presence of tumor in three anatomic sites (the sella, the
              sphenoid sinus, and the orbital apex) was also correlated with
              surgical complications. RESULTS: Category 1 tumors, which do not
              completely encircle the cavernous carotid artery, were dissected
              without injury, sacrifice, or grafting of the artery in 91\% of
              cases. Category 2 lesions completely encircle the artery but do
              not narrow its lumen; they could be dissected from the cavernous
              carotid artery without arterial injury in 61\% of cases, but
              imaging failed to discriminate differences within this group.
              Category 3 lesions, which completely encircle and narrow the
              cavernous carotid artery, are usually difficult to dissect free
              from the artery. The categories also correlated with recovery of
              extraocular motility; 84\% of category 1 lesions compared with
              only 36\% of category 2 or 3 lesions will recover to good or
              excellent extraocular motility after cavernous sinus surgery.
              Tumor involvement of the sella, orbital apex, and sphenoid sinus
              correlated with postoperative endocrine dysfunction, decreased
              visual acuity, and CSF leak, respectively. CONCLUSION: Imaging
              studies can frequently predict the difficulty of resecting
              cavernous sinus meningiomas from the cavernous carotid artery and
              the likelihood of permanent loss of extraocular motility after
              surgery on these lesions. This information is helpful in
              appropriate preoperative planning and in providing information to
              patients about to undergo such surgery.",
  journal  = "AJR Am. J. Roentgenol.",
  volume   =  160,
  number   =  5,
  pages    = "1083--1088",
  month    =  may,
  year     =  1993,
  language = "en"
}

@ARTICLE{Yashar2012-bz,
  title    = "Extent of resection and early postoperative outcomes following
              removal of cystic vestibular schwannomas: surgical experience
              over a decade and review of the literature",
  author   = "Yashar, Parham and Zada, Gabriel and Harris, Brianna and
              Giannotta, Steven L",
  abstract = "OBJECT: Vestibular schwannomas (VSs) are benign tumors of the
              eighth cranial nerve sheath, representing approximately 6\%-8\%
              of all newly diagnosed brain tumors, with an annual incidence of
              2000-2500 cases in the US. Although most of these lesions are
              solid, cystic vestibular schwannomas (CVSs) compose 4\%-20\% of
              all VSs and are commonly larger at the time of presentation. The
              authors present their experience with the operative management of
              CVSs, including surgical approach, extent of resection, and
              postoperative facial nerve outcomes. The literature pertaining to
              clinical and histopathological differences between CVSs and their
              solid counterparts is reviewed. METHODS: The University of
              Southern California Department of Neurosurgery database was
              retrospectively reviewed to identify patients who had undergone
              resection of a VS between 2000 and 2010. One hundred seventy-nine
              patients with VS were identified. Patients with CVSs were the
              subject of the present analysis. Diagnosis of a CVS was made
              based on MRI findings. Clinical and neuroimaging data, including
              pre- and postoperative assessments and operative notes, were
              collected and reviewed. RESULTS: Twenty-three patients, 14 men
              (61\%) and 9 women (39\%), underwent 24 operations for CVSs.
              These patients composed 12.8\% of all cases of VS. Patient ages
              ranged from 28 to 78 years (mean 55 years), and the mean maximal
              tumor diameter was 3.6 cm (range 2.0-4.0 cm). Patients most
              frequently presented with headache, hearing loss, vertigo, and
              dizziness. Preoperative facial numbness was reported in 44\% of
              patients. Among the 24 cases, 13 were treated with retrosigmoid
              craniotomy and 11 via a translabyrinthine approach. Complete
              resection was achieved in 11 patients (48\%), subtotal resection
              (STR) in 8 patients (35\%), and near-total resection (NTR) in 4
              patients (17\%). Facial nerve outcomes were available in all
              except one case. Good facial nerve outcomes (House-Brackmann [HB]
              Grades I-III) were achieved in 82\% of the patients who had
              undergone either NTR or STR, as compared with 73\% of patients
              who had undergone gross-total resection (GTR; p > 0.05, Fisher
              exact test). In comparison, 83\% of patients with solid VSs had a
              good HB grade (p = 0.38, Fisher exact test), although this
              finding did not reach statistical significance. Complications
              included wound infection (2 patients), delayed CSF leakage (1
              patient), and a delayed temporal encephalocele following a
              translabyrinthine approach and requiring surgical repair (1
              patient). CONCLUSIONS: Cystic vestibular schwannoma represents a
              clinical and surgical entity separate from its solid counterpart,
              as demonstrated by its more rapid clinical course and early
              surgical outcomes. Facial nerve grades may correlate with the
              degree of tumor resection, trending toward poorer grades with
              more significant resections. Although GTR is recommended whenever
              possible, performing an STR when facial nerve preservation is in
              jeopardy to improve facial nerve outcomes is the preferred
              strategy at the authors' institution.",
  journal  = "Neurosurg. Focus",
  volume   =  33,
  number   =  3,
  pages    = "E13",
  month    =  sep,
  year     =  2012,
  language = "en"
}

@ARTICLE{Zada2013-em,
  title    = "A proposed grading system for standardizing tumor consistency of
              intracranial meningiomas",
  author   = "Zada, Gabriel and Yashar, Parham and Robison, Aaron and Winer,
              Jesse and Khalessi, Alexander and Mack, William J and Giannotta,
              Steven L",
  abstract = "OBJECT: Tumor consistency plays an important and underrecognized
              role in the surgeon's ability to resect meningiomas, especially
              with evolving trends toward minimally invasive and keyhole
              surgical approaches. Aside from descriptors such as ``hard'' or
              ``soft,'' no objective criteria exist for grading, studying, and
              conveying the consistency of meningiomas. METHODS: The authors
              designed a practical 5-point scale for intraoperative grading of
              meningiomas based on the surgeon's ability to internally debulk
              the tumor and on the subsequent resistance to folding of the
              tumor capsule. Tumor consistency grades and features are as
              follows: 1) extremely soft tumor, internal debulking with suction
              only; 2) soft tumor, internal debulking mostly with suction, and
              remaining fibrous strands resected with easily folded capsule; 3)
              average consistency, tumor cannot be freely suctioned and
              requires mechanical debulking, and the capsule then folds with
              relative ease; 4) firm tumor, high degree of mechanical debulking
              required, and capsule remains difficult to fold; and 5) extremely
              firm, calcified tumor, approaches density of bone, and capsule
              does not fold. Additional grading categories included tumor
              heterogeneity (with minimum and maximum consistency scores) and a
              3-point vascularity score. This grading system was prospectively
              assessed in 50 consecutive patients undergoing craniotomy for
              meningioma resection by 2 surgeons in an independent fashion.
              Grading scores were subjected to a linear weighted kappa analysis
              for interuser reliability. RESULTS: Fifty patients (100 scores)
              were included in the analysis. The mean maximal tumor diameter
              was 4.3 cm. The distribution of overall tumor consistency scores
              was as follows: Grade 1, 4\%; Grade 2, 9\%; Grade 3, 43\%; Grade
              4, 44\%; and Grade 5, 0\%. Regions of Grade 5 consistency were
              reported only focally in 14\% of heterogeneous tumors. Tumors
              were designated as homogeneous in 68\% and heterogeneous in 32\%
              of grades. The kappa analysis score for overall tumor consistency
              grade was 0.87 (SE 0.06, 95\% CI 0.76-0.99), with 90\% user
              agreement. Kappa analysis scores for minimum and maximum grades
              of tumor regions were 0.69 (agreement 72\%) and 0.75 (agreement
              78\%), respectively. The kappa analysis score for tumor
              vascularity grading was 0.56 (agreement 76\%). Overall
              consistency did not correlate with patient age, tumor location,
              or tumor size. A higher tumor vascularity grade was associated
              with a larger tumor diameter (p = 0.045) and with skull base
              location (p = 0.02). CONCLUSIONS: The proposed grading system
              provides a reliable, practical, and objective assessment of
              meningioma consistency and facilitates communication among
              providers. This system also accounts for heterogeneity in tumor
              consistency. With the proposed scale, meningioma consistency can
              be standardized as groundwork for future studies relating to
              surgical outcomes, predictability of consistency and vascularity
              using neuroimaging techniques, and effectiveness of various
              surgical instruments.",
  journal  = "Neurosurg. Focus",
  volume   =  35,
  number   =  6,
  pages    = "E1",
  month    =  dec,
  year     =  2013,
  language = "en"
}

@ARTICLE{Itamura2018-zl,
  title    = "Prospective clinical validation of a meningioma consistency
              grading scheme: association with surgical outcomes and extent of
              tumor resection",
  author   = "Itamura, Kyohei and Chang, Ki-Eun and Lucas, Joshua and Donoho,
              Daniel A and Giannotta, Steven and Zada, Gabriel",
  abstract = "OBJECTIVEThe present study aims to assess the clinical utility of
              a previously validated intraoperative meningioma consistency
              grading scale and its association with extent of resection (EOR)
              and various surgical outcomes.METHODSThe previously validated
              grading system was prospectively assessed in 127 consecutive
              patients undergoing open craniotomy for meningioma by multiple
              neurosurgeons at two high-volume academic hospitals from 2013 to
              2016. Consistency grading scores ranging from 1 (soft) to 5
              (firm/calcified) were retrospectively analyzed to test for
              association with surgical outcomes and EOR, categorized as
              gross-total resection (GTR) or subtotal resection, defined by
              postoperative MRI.RESULTSOne hundred twenty-seven patients were
              included in the analysis with a tumor consistency distribution as
              follows: grade 1, 3.1\%; grade 2, 14.2\%; grade 3, 44.1\%; grade
              4, 32.3\%; and grade 5, 6.3\%. The mean tumor diameter was 3.6
              $\pm$ 1.7 cm. Tumor consistency grades were grouped into soft
              (grades 1 and 2), average (grade 3), and firm (grades 4 and 5)
              groups for statistical analysis with distributions of 17.3\%,
              44.1\%, and 38.6\%, respectively. There was no association
              between meningioma consistency and maximal tumor diameter, or
              location. Mean duration of surgery was longer for tumors with
              higher consistency: grades 1 and 2, 186 minutes; grade 3, 219
              minutes; and grades 4 and 5, 299 minutes (p = 0.000028). There
              was a trend toward higher perioperative complication rates for
              tumors of increased consistency: grades 1 and 2, 4.5\%; grade 3,
              7.0\%; and grades 4 and 5, 20.8\% (p = 0.047). The proportion of
              GTR for each consistency group was as follows: grades 1 and 2,
              77\%; grade 3, 68\%; and grades 4 and 5, 43\% (p =
              0.0062).CONCLUSIONSIn addition to other important meningioma
              characteristics such as invasiveness, tumor consistency is a key
              determinant of surgical outcomes, including operative duration
              and EOR. Future studies predicting tumor consistency based on
              preoperative neuroimaging will help considerably with
              preoperative planning for meningiomas.",
  journal  = "J. Neurosurg.",
  pages    = "1--5",
  month    =  dec,
  year     =  2018,
  keywords = "EOR = extent of resection; GTR = gross-total resection; USC =
              University of Southern California; clinical validation;
              consistency; extent of resection; grading scale; meningioma;
              oncology",
  language = "en"
}

@ARTICLE{Simpson1957-oe,
  title    = "The recurrence of intracranial meningiomas after surgical
              treatment",
  author   = "Simpson, D",
  journal  = "J. Neurol. Neurosurg. Psychiatry",
  volume   =  20,
  number   =  1,
  pages    = "22--39",
  month    =  feb,
  year     =  1957,
  keywords = "MENINGIOMA",
  language = "en"
}

@ARTICLE{Knosp1993-qa,
  title     = "Pituitary Adenomas with Invasion of the Cavernous Sinus Space: A
               Magnetic Resonance Imaging Classification Compared with Surgical
               Findings",
  author    = "Knosp, Engelbert and Steiner, Erich and Kitz, Klaus and Matula,
               Christian",
  abstract  = "ABSTRACT. WE PRESENT 25 pituitary adenomas that were confirmed
               surgically to have invaded the cavernous sinus space. The
               surgical results are compared with the",
  journal   = "Neurosurgery",
  publisher = "Oxford Academic",
  volume    =  33,
  number    =  4,
  pages     = "610--618",
  month     =  oct,
  year      =  1993,
  keywords  = "cavernous sinus; neoplasms",
  language  = "en"
}

@ARTICLE{Staartjes2018-vu,
  title     = "Utility of deep neural networks in predicting gross-total
               resection after transsphenoidal surgery for pituitary adenoma: a
               pilot study",
  author    = "Staartjes, Victor E and Serra, Carlo and Muscas, Giovanni and
               Maldaner, Nicolai and Akeret, Kevin and van Niftrik, Christiaan
               H B and Fierstra, Jorn and Holzmann, David and Regli, Luca",
  abstract  = "OBJECTIVEGross-total resection (GTR) is often the primary
               surgical goal in transsphenoidal surgery for pituitary adenoma.
               Existing classifications are effective at predicting GTR but are
               often hampered by limited discriminatory ability in moderate
               cases and by poor interrater agreement. Deep learning, a subset
               of machine learning, has recently established itself as highly
               effective in forecasting medical outcomes. In this pilot study,
               the authors aimed to evaluate the utility of using deep learning
               to predict GTR after transsphenoidal surgery for pituitary
               adenoma.METHODSData from a prospective registry were used. The
               authors trained a deep neural network to predict GTR from 16
               preoperatively available radiological and procedural variables.
               Class imbalance adjustment, cross-validation, and random dropout
               were applied to prevent overfitting and ensure robustness of the
               predictive model. The authors subsequently compared the deep
               learning model to a conventional logistic regression model and
               to the Knosp classification as a gold standard.RESULTSOverall,
               140 patients who underwent endoscopic transsphenoidal surgery
               were included. GTR was achieved in 95 patients (68\%), with a
               mean extent of resection of 96.8\% $\pm$ 10.6\%. Intraoperative
               high-field MRI was used in 116 (83\%) procedures. The deep
               learning model achieved excellent area under the curve (AUC;
               0.96), accuracy (91\%), sensitivity (94\%), and specificity
               (89\%). This represents an improvement in comparison with the
               Knosp classification (AUC: 0.87, accuracy: 81\%, sensitivity:
               92\%, specificity: 70\%) and a statistically significant
               improvement in comparison with logistic regression (AUC: 0.86,
               accuracy: 82\%, sensitivity: 81\%, specificity: 83\%) (all p <
               0.001).CONCLUSIONSIn this pilot study, the authors demonstrated
               the utility of applying deep learning to preoperatively predict
               the likelihood of GTR with excellent performance. Further
               training and validation in a prospective multicentric cohort
               will enable the development of an easy-to-use interface for use
               in clinical practice.",
  journal   = "Neurosurg. Focus",
  publisher = "thejns.org",
  volume    =  45,
  number    =  5,
  pages     = "E12",
  month     =  nov,
  year      =  2018,
  keywords  = "3T-iMRI = 3-T intraoperative MRI; AUC = area under the curve;
               CSS = cavernous sinus space; EOR = extent of resection; GTR =
               gross-total resection; ICD = intercarotid distance; NPV =
               negative predictive value; PA = pituitary adenoma; PPV =
               positive predictive value; deep learning; deep neural network;
               outcome prediction; pituitary adenoma; pituitary surgery;
               transsphenoidal surgery",
  language  = "en"
}

@ARTICLE{Mooney2019-yk,
  title    = "Proposal and Validation of a Simple Grading Scale ({TRANSSPHER}
              Grade) for Predicting Gross Total Resection of Nonfunctioning
              Pituitary Macroadenomas After Transsphenoidal Surgery",
  author   = "Mooney, Michael A and Sarris, Christina E and Zhou, James J and
              Barkhoudarian, Garni and Chicoine, Michael R and
              Fernandez-Miranda, Juan C and Gardner, Paul A and Hardesty,
              Douglas A and Jahnke, Heidi and Kelly, Daniel F and Liebelt,
              Brandon D and Mayberg, Marc R and Prevedello, Daniel M and
              Sfondouris, John and Sheehy, John P and Chandler, James P and
              Yuen, Kevin C J and White, William L and Little, Andrew S and
              {TRANSSPHER Study Group}",
  abstract = "BACKGROUND: A simple, reliable grading scale to better
              characterize nonfunctioning pituitary adenomas (NFPAs)
              preoperatively has potential for research and clinical
              applications. OBJECTIVE: To develop a grading scale from a
              prospective multicenter cohort of patients that accurately and
              reliably predicts the likelihood of gross total resection (GTR)
              after transsphenoidal NFPA surgery. METHODS: Extent-of-resection
              (EOR) data from a prospective multicenter study in
              transsphenoidal NFPA surgery were analyzed (TRANSSPHER study;
              ClinicalTrials.gov NCT02357498). Sixteen preoperative
              radiographic magnetic resonance imaging (MRI) tumor
              characteristics (eg, tumor size, invasion measures, tumor signal
              characteristics, and parameters impacting surgical access) were
              evaluated to determine EOR predictors, to calculate
              receiver-operating characteristic curves, and to develop a
              grading scale. A separate validation cohort (n = 165) was
              examined to assess the scale's performance and inter-rater
              reliability. RESULTS: Data for 222 patients from 7 centers
              treated by 15 surgeons were analyzed. Approximately one-fifth of
              patients (18.5\%; 41 of 222) underwent subtotal resection (STR).
              Maximum tumor diameter > 40 mm; nodular tumor extension through
              the diaphragma into the frontal lobe, temporal lobe, posterior
              fossa, or ventricle; and Knosp grades 3 to 4 were identified as
              independent STR predictors. A grading scale (TRANSSPHER grade)
              based on a combination of these 3 features outperformed
              individual variables in predicting GTR (AUC, 0.732). In a
              validation cohort, the scale exhibited high sensitivity and
              specificity (AUC, 0.779) and strong inter-rater reliability
              (kappa coefficient, 0.617). CONCLUSION: This simple, reliable
              grading scale based on preoperative MRI characteristics can be
              used to better characterize NFPAs for clinical and research
              purposes and to predict the likelihood of achieving GTR.",
  journal  = "Oper Neurosurg (Hagerstown)",
  volume   =  17,
  number   =  5,
  pages    = "460--469",
  month    =  nov,
  year     =  2019,
  keywords = "Adenoma; Extent of resection; Grading scale; Pituitary; Residual;
              Transsphenoidal",
  language = "en"
}

@ARTICLE{Mooney2017-pb,
  title    = "Interrater and intrarater reliability of the Knosp scale for
              pituitary adenoma grading",
  author   = "Mooney, Michael A and Hardesty, Douglas A and Sheehy, John P and
              Bird, Robert and Chapple, Kristina and White, William L and
              Little, Andrew S",
  abstract = "OBJECTIVE The goal of this study was to determine the interrater
              and intrarater reliability of the Knosp grading scale for
              predicting pituitary adenoma cavernous sinus (CS) involvement.
              METHODS Six independent raters (3 neurosurgery residents, 2
              pituitary surgeons, and 1 neuroradiologist) participated in the
              study. Each rater scored 50 unique pituitary MRI scans (with
              contrast) of biopsy-proven pituitary adenoma. Reliabilities for
              the full scale were determined 3 ways: 1) using all 50 scans, 2)
              using scans with midrange scores versus end scores, and 3) using
              a dichotomized scale that reflects common clinical practice. The
              performance of resident raters was compared with that of faculty
              raters to assess the influence of training level on reliability.
              RESULTS Overall, the interrater reliability of the Knosp scale
              was ``strong'' (0.73, 95\% CI 0.56-0.84). However, the percent
              agreement for all 6 reviewers was only 10\% (26\% for faculty
              members, 30\% for residents). The reliability of the middle
              scores (i.e., average rated Knosp Grades 1 and 2) was ``very
              weak'' (0.18, 95\% CI -0.27 to 0.56) and the percent agreement
              for all reviewers was only 5\%. When the scale was dichotomized
              into tumors unlikely to have intraoperative CS involvement
              (Grades 0, 1, and 2) and those likely to have CS involvement
              (Grades 3 and 4), the reliability was ``strong'' (0.60, 95\% CI
              0.39-0.75) and the percent agreement for all raters improved to
              60\%. There was no significant difference in reliability between
              residents and faculty (residents 0.72, 95\% CI 0.55-0.83 vs
              faculty 0.73, 95\% CI 0.56-0.84). Intrarater reliability was
              moderate to strong and increased with the level of experience.
              CONCLUSIONS Although these findings suggest that the Knosp
              grading scale has acceptable interrater reliability overall, it
              raises important questions about the ``very weak'' reliability of
              the scale's middle grades. By dichotomizing the scale into
              clinically useful groups, the authors were able to address the
              poor reliability and percent agreement of the intermediate grades
              and to isolate the most important grades for use in surgical
              decision making (Grades 3 and 4). Authors of future pituitary
              surgery studies should consider reporting Knosp grades as
              dichotomized results rather than as the full scale to optimize
              the reliability of the scale.",
  journal  = "J. Neurosurg.",
  volume   =  126,
  number   =  5,
  pages    = "1714--1719",
  month    =  may,
  year     =  2017,
  keywords = "CS = cavernous sinus; ICA = internal carotid artery; Knosp
              classification; cavernous sinus; interrater reliability;
              intrarater reliability; pituitary adenoma; pituitary surgery",
  language = "en"
}

@ARTICLE{Nanda2017-yh,
  title    = "Relevance of Simpson grading system and recurrence-free survival
              after surgery for World Health Organization Grade {I} meningioma",
  author   = "Nanda, Anil and Bir, Shyamal C and Maiti, Tanmoy K and Konar,
              Subhas K and Missios, Symeon and Guthikonda, Bharat",
  abstract = "OBJECTIVE The clinical significance of the Simpson system for
              grading the extent of meningioma resection and its role as a
              predictor of the recurrence of World Health Organization (WHO)
              Grade I meningiomas have been questioned in the past, echoing
              changes in meningioma surgery over the years. The authors
              reviewed their experience in resecting WHO Grade I meningiomas
              and assessed the association between extent of resection, as
              evaluated using the Simpson classification, and recurrence-free
              survival (RFS) of patients after meningioma surgery. METHODS
              Clinical and radiological information for patients with WHO Grade
              I meningiomas who had undergone resective surgery over the past
              20 years was retrospectively reviewed. Simpson and Shinshu
              grading scales were used to evaluate the extent of resection.
              Statistical analysis was conducted using Kaplan-Meier curves and
              Cox proportional-hazards regression. RESULTS Four hundred
              fifty-eight patients were eligible for analysis. Overall tumor
              recurrence rates for Simpson resection Grades I, II, III, and IV
              were 5\%, 22\%, 31\%, and 35\%, respectively. After Cox
              regression analysis, Simpson Grade I (extensive resection) was
              revealed as a significant predictor of RFS (p = 0.003). Patients
              undergoing Simpson Grade I and II resections showed significant
              improvement in RFS compared with patients undergoing Grade III
              and IV resections (p = 0.005). Extent of resection had a
              significant effect on recurrence rates for both skull base (p =
              0.047) and convexity (p = 0.012) meningiomas. Female sex and a
              Karnofsky Performance Scale score > 70 were also identified as
              independent predictors of RFS after resection of WHO Grade I
              meningioma. CONCLUSIONS In this patient cohort, a significant
              association was noted between extent of resection and rates of
              tumor recurrence. In the authors' experience the Simpson grading
              system maintains its relevance and prognostic value and can serve
              an important role for patient education. Even though complete
              tumor resection is the goal, surgery should be tailored to each
              patient according to the risks and surgical morbidity.",
  journal  = "J. Neurosurg.",
  volume   =  126,
  number   =  1,
  pages    = "201--211",
  month    =  jan,
  year     =  2017,
  keywords = "KPS = Karnofsky Performance Scale; RFS = recurrence-free
              survival; Simpson grade; WHO grade; meningioma; oncology;
              recurrence",
  language = "en"
}

@ARTICLE{Sughrue2010-aj,
  title    = "The relevance of Simpson Grade {I} and {II} resection in modern
              neurosurgical treatment of World Health Organization Grade {I}
              meningiomas",
  author   = "Sughrue, Michael E and Kane, Ari J and Shangari, Gopal and
              Rutkowski, Martin J and McDermott, Michael W and Berger, Mitchel
              S and Parsa, Andrew T",
  abstract = "OBJECT: In 1957, Simpson published a seminal paper defining the
              risk factors for recurrence following surgical treatment of
              intracranial meningiomas. Given that Simpson's study was
              published more than 50 years ago, preceding image guidance
              technology and MR imaging, the authors reviewed their own
              experience with surgical treatment of Grade I meningiomas to
              determine if Simpson's grading scale is still relevant to modern
              neurosurgical practice. METHODS: From this cohort, the authors
              evaluated all patients undergoing craniotomy for resection of a
              histologically proven WHO Grade I meningioma as their initial
              therapy. Clinical information was retrospectively reconstructed
              using patient medical records and radiological data. Recurrence
              analysis was performed using the Kaplan-Meier method. RESULTS:
              The 5-year recurrence/progression-free survival for all patients
              receiving a Simpson Grade I, II, III, or IV resection was 95, 85,
              88, and 81\%, respectively (p = not significant, log-rank test).
              Kaplan-Meier analysis revealed no significant difference in
              recurrence-free survival between patients receiving a Simpson
              Grade I, II, III, or IV resection. Analysis limited to
              meningiomas arising from the skull base (excluding the cavernous
              sinus) similarly found no significant benefit to Simpson Grade I
              or II resection, and the survival curves were nearly
              superimposed. CONCLUSIONS: In this study of a cohort of patients
              undergoing surgery for WHO Grade I meningiomas, the authors
              demonstrate that the benefit of more aggressive attempts to
              resect the tumor with dura and underlying bone was negligible
              compared with simply removing the entire tumor, or even leaving
              small amounts of tumor attached to critical structures. The
              authors believe that these data reflect an evolution in the
              nature of meningioma surgery over the past 2 decades, and bring
              into question the relevance of using Simpson's grading system as
              the sole predictor of recurrence.",
  journal  = "J. Neurosurg.",
  volume   =  113,
  number   =  5,
  pages    = "1029--1035",
  month    =  nov,
  year     =  2010,
  language = "en"
}

@ARTICLE{Hasseleid2012-ci,
  title    = "Surgery for convexity meningioma: Simpson Grade {I} resection as
              the goal: clinical article",
  author   = "Hasseleid, Bernt Filip and Meling, Torstein R and R{\o}nning,
              P{\aa}l and Scheie, David and Helseth, Eirik",
  abstract = "OBJECT: Recently the relevance of Simpson resection grade as a
              prognostic factor for recurrence of WHO Grade I meningiomas was
              challenged, contradicting many previous scientific reports and
              traditional neurosurgical teaching. The objective of this study
              was to determine whether the predictive value of Simpson
              resection grade is outdated or remains valid with respect to
              meningioma recurrence and overall survival. METHODS: All patients
              at least 16 years old who underwent primary craniotomies for
              convexity meningiomas at Oslo University-affiliated hospitals
              (Rikshospitalet and Ullev{\aa}l University Hospitals) in the
              period between January 1, 1990, and January 27, 2011, were
              included. Overall survival and retreatment-free survival rates
              were correlated with patient- and surgery-specific factors.
              RESULTS: Three hundred ninety-one consecutive patients were
              included in the study. The median patient age was 60.1 years
              (range 19-92 years). The female-to-male ratio was 2.1:1. The WHO
              grades were Grade I in 353 (90.3\%), Grade II in 22 (5.6\%), and
              Grade III in 16 (4.1\%). The follow-up rate was 100\%. Median
              follow-up time was 7.1 years (range 0.0-20.9 years) and total
              observation time was 3147 patient-years. The 1-, 5-, and 10-year
              overall survival rates were 96\%, 89\%, and 78\%, respectively.
              Age, sex, WHO grade, and Simpson grade were significantly
              associated with overall survival. The 1-, 5-, and 10-year
              retreatment-free survival rates were 99\%, 94\%, and 90\%,
              respectively. Simpson resection grade and WHO grade were
              significantly associated with retreatment-free survival. The
              hazard ratios for retreatment after combined Simpson resection
              Grades II+III and IV+V were 4.9- and 13.2-times higher than after
              Simpson Grade I resection, respectively. CONCLUSIONS: Simpson
              Grade I resection should continue to be the goal for convexity
              meningiomas.",
  journal  = "J. Neurosurg.",
  volume   =  117,
  number   =  6,
  pages    = "999--1006",
  month    =  dec,
  year     =  2012,
  language = "en"
}

@ARTICLE{Levine1999-bj,
  title    = "Proposed grading system to predict the extent of resection and
              outcomes for cranial base meningiomas",
  author   = "Levine, Z T and Buchanan, R I and Sekhar, L N and Rosen, C L and
              Wright, D C",
  abstract = "OBJECTIVE: This investigation was performed to construct a
              grading system for cranial base meningiomas that augments the
              current system of topographic labeling. This new system
              classifies cranial base meningiomas based on predicted surgical
              resection and patient outcomes. METHODS: Two hundred thirty-two
              consecutive patients with cranial base meningiomas were
              surgically treated by the two senior authors between April 1993
              and August 1997. Using standard statistical tests, a large number
              of preoperative, intraoperative, and follow-up findings were
              analyzed for correlation with the extent of resection. These
              included the presence of previous radiotherapy, Cranial Nerve
              III, V, and VI palsies, multiple fossa involvement, and vessel
              encasement. RESULTS: Analysis revealed that each variable tested
              was independently and inversely correlated with total tumor
              resection (P < 0.002). We were able to construct a grading system
              based on these variables; when more variables are present, the
              grade is higher. With the grading system, lower-grade tumors were
              correlated with increased probabilities of total resection (r2 =
              0.9947) and better patient outcomes, as measured by Karnofsky
              performance scale scores (r = 0.9291). We also found that, as a
              group, patients who underwent subtotal resection exhibited worse
              Karnofsky performance scale scores and had longer hospital stays.
              CONCLUSION: The current system of classifying cranial base
              meningiomas provides no information regarding the tumor except
              location and no information concerning patient prognosis. We
              present a more useful system to categorize these tumors. Our
              scheme must be tested at other centers to corroborate our
              findings. This new grading system should serve to guide surgical
              treatment, inform patients, and improve communication among
              surgeons.",
  journal  = "Neurosurgery",
  volume   =  45,
  number   =  2,
  pages    = "221--230",
  month    =  aug,
  year     =  1999,
  language = "en"
}

@ARTICLE{Clark2013-jv,
  title    = "Genomic analysis of {non-NF2} meningiomas reveals mutations in
              {TRAF7}, {KLF4}, {AKT1}, and {SMO}",
  author   = "Clark, Victoria E and Erson-Omay, E Zeynep and Serin, Akdes and
              Yin, Jun and Cotney, Justin and Ozduman, Koray and Av{\c s}ar,
              Timu{\c c}in and Li, Jie and Murray, Phillip B and Henegariu,
              Octavian and Yilmaz, Saliha and G{\"u}nel, Jennifer Moliterno and
              Carri{\'o}n-Grant, Geneive and Yilmaz, Baran and Grady, Conor and
              Tanrikulu, Bahattin and Bakircio{\u g}lu, Mehmet and Kaymak{\c
              c}alan, Hande and Caglayan, Ahmet Okay and Sencar, Leman and
              Ceyhun, Emre and Atik, A Fatih and Bayri, Ya{\c s}ar and Bai,
              Hanwen and Kolb, Luis E and Hebert, Ryan M and Omay, S Bulent and
              Mishra-Gorur, Ketu and Choi, Murim and Overton, John D and
              Holland, Eric C and Mane, Shrikant and State, Matthew W and
              Bilg{\"u}var, Kaya and Baehring, Joachim M and Gutin, Philip H
              and Piepmeier, Joseph M and Vortmeyer, Alexander and Brennan,
              Cameron W and Pamir, M Necmettin and Kili{\c c}, T{\"u}rker and
              Lifton, Richard P and Noonan, James P and Yasuno, Katsuhito and
              G{\"u}nel, Murat",
  abstract = "We report genomic analysis of 300 meningiomas, the most common
              primary brain tumors, leading to the discovery of mutations in
              TRAF7, a proapoptotic E3 ubiquitin ligase, in nearly one-fourth
              of all meningiomas. Mutations in TRAF7 commonly occurred with a
              recurrent mutation (K409Q) in KLF4, a transcription factor known
              for its role in inducing pluripotency, or with AKT1(E17K), a
              mutation known to activate the PI3K pathway. SMO mutations, which
              activate Hedgehog signaling, were identified in ~5\% of non-NF2
              mutant meningiomas. These non-NF2 meningiomas were clinically
              distinctive-nearly always benign, with chromosomal stability, and
              originating from the medial skull base. In contrast, meningiomas
              with mutant NF2 and/or chromosome 22 loss were more likely to be
              atypical, showing genomic instability, and localizing to the
              cerebral and cerebellar hemispheres. Collectively, these findings
              identify distinct meningioma subtypes, suggesting avenues for
              targeted therapeutics.",
  journal  = "Science",
  volume   =  339,
  number   =  6123,
  pages    = "1077--1080",
  month    =  mar,
  year     =  2013,
  language = "en"
}

@ARTICLE{Mansouri2016-jx,
  title    = "Surgically resected skull base meningiomas demonstrate a
              divergent postoperative recurrence pattern compared with
              non-skull base meningiomas",
  author   = "Mansouri, Alireza and Klironomos, George and Taslimi, Shervin and
              Kilian, Alex and Gentili, Fred and Khan, Osaama H and Aldape,
              Kenneth and Zadeh, Gelareh",
  abstract = "OBJECTIVE The objective of this study was to identify the natural
              history and clinical predictors of postoperative recurrence of
              skull base and non-skull base meningiomas. METHODS The authors
              performed a retrospective hospital-based study of all patients
              with meningioma referred to their institution from September 1993
              to January 2014. The cohort constituted both patients with a
              first-time presentation and those with evidence of recurrence.
              Kaplan-Meier curves were constructed for analysis of recurrence
              and differences were assessed using the log-rank test. Cox
              proportional hazard regression was used to identify potential
              predictors of recurrence. RESULTS Overall, 398 intracranial
              meningiomas were reviewed, including 269 (68\%) non-skull base
              and 129 (32\%) skull base meningiomas (median follow-up 30.2
              months, interquartile range [IQR] 8.5-76 months). The 10-year
              recurrence-free survival rates for patients with gross-total
              resection (GTR) and subtotal resection (STR) were 90\% and 43\%,
              respectively. Skull base tumors were associated with a lower
              proliferation index (0.041 vs 0.062, p = 0.001), higher
              likelihood of WHO Grade I (85.3\% vs 69.1\%, p = 0.003), and
              younger patient age (55.2 vs 58.3 years, p = 0.01). Meningiomas
              in all locations demonstrated an average recurrence rate of 30\%
              at 100 months of follow-up. Subsequently, the recurrence of skull
              base meningiomas plateaued whereas non-skull base lesions had an
              80\% recurrence rate at 230 months follow-up (p = 0.02). On
              univariate analysis, a prior history of recurrence (p < 0.001),
              initial WHO grade following resection (p < 0.001), and the
              inability to obtain GTR (p < 0.001) were predictors of future
              recurrence. On multivariate analysis a prior history of
              recurrence (p = 0.02) and an STR (p < 0.01) were independent
              predictors of a recurrence. Assessing only patients with primary
              presentations, STR and WHO Grades II and III were independent
              predictors of recurrence (p < 0.001 for both). CONCLUSIONS
              Patients with skull base meningiomas present at a younger age and
              have less aggressive lesions overall. Extent of resection is a
              key predictor of recurrence and long-term follow-up of
              meningiomas is necessary, especially for non-skull base tumors.
              In skull base meningiomas, recurrence risk plateaus approximately
              100 months after surgery, suggesting that for this specific
              cohort, follow-up after 100 months can be less frequent.",
  journal  = "J. Neurosurg.",
  volume   =  125,
  number   =  2,
  pages    = "431--440",
  month    =  aug,
  year     =  2016,
  keywords = "CI = confidence interval; EOR = extent of resection; GTR =
              gross-total resection; IQR = interquartile range; NF2 =
              neurofibromatosis Type 2; OR = odds ratio; PR = progesterone
              receptor; STR = subtotal resection; meningioma; postoperative
              period; recurrence; skull base",
  language = "en"
}

@ARTICLE{Iannella2017-gg,
  title    = "Subtotal resection of vestibular schwannoma: Evaluation with
              Ki-67 measurement, magnetic resonance imaging, and long-term
              observation",
  author   = "Iannella, Giannicola and de Vincentiis, Marco and Di Gioia, Cira
              and Carletti, Raffaella and Pasquariello, Benedetta and Manno,
              Alessandra and Angeletti, Diletta and Savastano, Ersilia and
              Magliulo, Giuseppe",
  abstract = "Purpose The aim of this study was to compare the postoperative
              clinical and radiological data of patients with vestibular
              schwannomas who were initially managed by near total resection
              (NTR) or subtotal resection (STR). The Ki-67 analysis results
              were compared with tumor regrowth to determine the presence of a
              correlation between this proliferative index and postoperative
              tumor regrowth. Study Design Seventeen adult patients (7 male, 10
              female) were retrospectively reviewed. Nine (52.9\%) and eight
              (47.1\%) patients underwent NTR and STR, respectively.
              Postoperative clinical and radiological data associated with
              vestibular schwannoma growth were compared with the Ki-67
              immunohistochemical analysis results. Results Evidence of
              clinically significant regrowth was observed in four (23.5\%)
              patients. Patients who underwent NTR had a lower rate/incidence
              of tumor regrowth than did patients who underwent STR. Patients
              with a higher Ki-67 index had the highest tumor regrowth rates.
              Conclusions Our study indicates that assessment of the Ki-67
              index may be useful for determining the probability of regrowth
              of vestibular schwannomas when only partial removal is
              accomplished.",
  journal  = "J. Int. Med. Res.",
  volume   =  45,
  number   =  3,
  pages    = "1061--1073",
  month    =  jun,
  year     =  2017,
  keywords = "Ki-67 index; Vestibular schwannoma; facial paralysis; near total
              resection; subtotal resection",
  language = "en"
}

@ARTICLE{Tauziede-Espariat2016-nj,
  title    = "Prognostic and Therapeutic Markers in Chordomas: A Study of 287
              Tumors",
  author   = "Tauzi{\'e}de-Espariat, Arnault and Bresson, Damien and Polivka,
              Marc and Bouazza, Schahrazed and Labrousse, Fran{\c c}ois and
              Aronica, Eleonora and Pretet, Jean-Luc and Projetti, Fabrice and
              Herman, Philippe and Salle, Henri and Monnien, Franck and
              Valmary-Degano, S{\'e}verine and Laquerri{\`e}re, Annie and
              Pocard, Marc and Chaigneau, Lo{\"\i}c and Isambert, Nicolas and
              Aubriot-Lorton, Marie-H{\'e}l{\`e}ne and Feuvret, Lo{\"\i}c and
              George, Bernard and Froelich, S{\'e}bastien and Adle-Biassette,
              Homa",
  abstract = "Chordomas are slow-growing malignant neoplasms. Determination of
              histopathologic prognostic factors using a large cohort study has
              been limited by their low incidence. In this retrospective study,
              we investigated the clinical, histopathologic, and
              immunohistochemical prognostic factors in 287 chordomas from 111
              patients assessed by central pathologic review. Expression
              patterns of a variety of markers, including vascular endothelial
              growth factor (VEGF), mTOR pathway, c-kit, HER2, epidermal growth
              factor receptor (EGFR) and STAT3, and KRAS, BRAF, EGFR, and
              PIK3CA mutations were analyzed. On univariate analysis, the
              results confirm surgery as the best treatment, as judged by
              patient progression-free survival (PFS) and overall survival
              (OS). Proton therapy, the presence of a dedifferentiated
              component, mitotic figures, and Ki67 and p53 labeling indices
              correlated with PFS . Necrosis and apoptosis correlated with OS.
              Based on these findings, we propose a histopathologic grading
              system that correlates with PFS and OS. On multivariate analysis,
              extent of resection, tumor grade, and proton therapy were
              independent prognostic factors of PFS; extent of resection, tumor
              location, and grade were independent prognostic factors of OS.
              Based on the expression of EGFR, pSTAT3, VEGF, and mTOR pathway
              proteins, (in 85.9\%, 79.1\%, 85.7\%, and 46\% of chordomas,
              respectively), and 2 new mutations in the PIK3CA gene, we also
              provide evidence for potential therapeutic targets.",
  journal  = "J. Neuropathol. Exp. Neurol.",
  volume   =  75,
  number   =  2,
  pages    = "111--120",
  month    =  feb,
  year     =  2016,
  language = "en"
}

@ARTICLE{Zhai2019-mn,
  title    = "A nomogram to predict the progression-free survival of clival
              chordoma",
  author   = "Zhai, Yixuan and Bai, Jiwei and Li, Mingxuan and Wang, Shuai and
              Li, Chuzhong and Wei, Xinting and Zhang, Yazhuo",
  abstract = "OBJECTIVE: Chordoma shows poor patient prognosis because of its
              high recurrence rate. Even though many clinical factors and
              biomarkers are reported to be associated with prognosis, no
              prediction model has been applied clinically. Thus, the authors
              aim to derive and validate a prognostic nomogram to predict
              progression-free survival (PFS) of chordoma. METHODS: A total of
              201 patients were randomly divided into a derivation group (151
              cases) and a validation group (50 cases). The expression levels
              of biomarkers were quantified using tissue microarray analysis. A
              nomogram was established via univariate and multivariate Cox
              regression analysis in the derivation group. The predictive
              performance of the nomogram was then tested in the validation
              group. RESULTS: The mean follow-up interval was 57 months (range
              26-107 months). One clinical factor and 3 biomarkers were
              confirmed to be associated with PFS, including degree of
              resection, E-cadherin, Ki-67, and VEGFA. The nomogram with these
              prognostic factors had areas under the receiver operating
              characteristic curve of 0.87 and 0.95 in the derivation group at
              3 years and 5 years, respectively, compared with 0.87 and 0.84 in
              the validation group. Calibration and score-stratified survival
              curve were good in the derivation group and validation group,
              respectively. CONCLUSIONS: The established nomogram performs well
              for predicting the PFS of chordoma and for risk stratification,
              which could facilitate prognostic evaluation and follow-up.",
  journal  = "J. Neurosurg.",
  pages    = "1--9",
  month    =  dec,
  year     =  2019,
  keywords = "AUC = area under the ROC curve; GTR = gross-total resection; HR =
              hazard ratio; OS = overall survival; PFS = progression-free
              survival; PI = prognostic index; PR = partial resection; ROC =
              receiver operating characteristic; STR = subtotal resection; TMA
              = tissue microarray; chordoma; nomogram; oncology;
              progression-free survival",
  language = "en"
}

@ARTICLE{Rajkomar2018-qz,
  title     = "Scalable and accurate deep learning with electronic health
               records",
  author    = "Rajkomar, Alvin and Oren, Eyal and Chen, Kai and Dai, Andrew M
               and Hajaj, Nissan and Hardt, Michaela and Liu, Peter J and Liu,
               Xiaobing and Marcus, Jake and Sun, Mimi and Sundberg, Patrik and
               Yee, Hector and Zhang, Kun and Zhang, Yi and Flores, Gerardo and
               Duggan, Gavin E and Irvine, Jamie and Le, Quoc and Litsch, Kurt
               and Mossin, Alexander and Tansuwan, Justin and Wang, De and
               Wexler, James and Wilson, Jimbo and Ludwig, Dana and
               Volchenboum, Samuel L and Chou, Katherine and Pearson, Michael
               and Madabushi, Srinivasan and Shah, Nigam H and Butte, Atul J
               and Howell, Michael D and Cui, Claire and Corrado, Greg S and
               Dean, Jeffrey",
  abstract  = "Predictive modeling with electronic health record (EHR) data is
               anticipated to drive personalized medicine and improve
               healthcare quality. Constructing predictive statistical models
               typically requires extraction of curated predictor variables
               from normalized EHR data, a labor-intensive process that
               discards the vast majority of information in each patient's
               record. We propose a representation of patients' entire raw EHR
               records based on the Fast Healthcare Interoperability Resources
               (FHIR) format. We demonstrate that deep learning methods using
               this representation are capable of accurately predicting
               multiple medical events from multiple centers without
               site-specific data harmonization. We validated our approach
               using de-identified EHR data from two US academic medical
               centers with 216,221 adult patients hospitalized for at least 24
               h. In the sequential format we propose, this volume of EHR data
               unrolled into a total of 46,864,534,945 data points, including
               clinical notes. Deep learning models achieved high accuracy for
               tasks such as predicting: in-hospital mortality (area under the
               receiver operator curve [AUROC] across sites 0.93--0.94), 30-day
               unplanned readmission (AUROC 0.75--0.76), prolonged length of
               stay (AUROC 0.85--0.86), and all of a patient's final discharge
               diagnoses (frequency-weighted AUROC 0.90). These models
               outperformed traditional, clinically-used predictive models in
               all cases. We believe that this approach can be used to create
               accurate and scalable predictions for a variety of clinical
               scenarios. In a case study of a particular prediction, we
               demonstrate that neural networks can be used to identify
               relevant information from the patient's chart. Artificial
               intelligence outperforms traditional statistical models at
               predicting a range of clinical outcomes from a patient's entire
               raw electronic health record (EHR). A team led by Alvin Rajkomar
               and Eyal Oren from Google in Mountain View, California, USA,
               developed a data processing pipeline for transforming EHR files
               into a standardized format. They then applied deep learning
               models to data from 216,221 adult patients hospitalized for at
               least 24 h each at two academic medical centers, and showed that
               their algorithm could accurately predict risk of mortality,
               hospital readmission, prolonged hospital stay and discharge
               diagnosis. In all cases, the method proved more accurate than
               previously published models. The authors provide a case study to
               serve as a proof-of-concept of how such an algorithm could be
               used in routine clinical practice in the future.",
  journal   = "npj Digital Medicine",
  publisher = "Nature Publishing Group",
  volume    =  1,
  number    =  1,
  pages     = "1--10",
  month     =  may,
  year      =  2018,
  language  = "en"
}

@ARTICLE{Zhu2020-vq,
  title    = "Suprasellar pituitary adenomas: a 10-year experience in a single
              tertiary medical center and a literature review",
  author   = "Zhu, Jianyu and Wang, Zhicheng and Zhang, Yi and Liu, Jie and Li,
              Xiaoxu and Deng, Kan and Lu, Lin and Yao, Yong",
  abstract = "BACKGROUND: Suprasellar pituitary adenomas (SPAs) are a special
              type of pituitary adenoma. Although dozens of SPA cases have been
              reported, the exact definition and the characteristics of SPA
              have not been exhaustively discussed before. METHODS: In a
              retrospective electronic medical records review, 13 patients with
              SPA were identified in our hospital between January 2010 and
              December 2019. A literature review was performed by searching the
              online database PubMed, and 39 cases conformed to the criteria
              based on the previous literature. Data regarding clinical
              symptoms, imaging manifestations, surgical information and
              follow-ups were analyzed. RESULTS: The mean age at diagnosis of
              52 patients with SPA was 36.73 years, and most of the patients
              were female (61.5\%). The most common hormone-secreting subtypes
              of SPA were nonfunctioning (36.5\%) and ACTH-secreting (34.6\%)
              SPA. Macroadenomas (68.9\%) were more common than microadenomas
              (31.1\%). The origins of the SPAs included the intrasellar
              pituitary gland (type I), the subdiaphragmatic (type IIa) and
              supradiaphragmatic (type IIb) part of the pituitary stalk, and
              the suprasellar peri-infundibular region (type III). The most
              common anatomic subtype of SPA was type III, and type IIb was
              also common. The most common presentations of SPA were visual
              symptoms, especially for type III SPA. In addition, 64.7\% and
              73.1\% of type IIb and III SPAs, respectively, were suspected to
              be of suprasellar origin based on presurgical imaging
              examination. Patients with tumors of suspected suprasellar origin
              were more likely to receive transcranial surgery (TCS) initially
              than those with tumors of suspected intrasellar origin (70.6\%
              vs. 22.2\%, p = 0.0013). The intact rate for the pituitary stalk
              after surgery for type II SPA was lower than that for type I and
              III SPA (52.6\% vs. 92.6\%, p = 0.0036). More patients with type
              II SPA experienced postoperative central diabetes insipidus (CDI)
              than those with type I and III SPA (57.9\% vs. 11.1\%, p =
              0.0011). There was no significant difference in the incidence of
              postoperative CDI between transsphenoidal surgery (TSS) and TCS
              (p = 0.1304). Nine patients in our hospital received extended
              endoscopic TSS; only one experienced tumor recurrence, and no
              severe complications occurred after surgery. CONCLUSIONS: SPAs
              could be defined as pituitary adenomas completely or partially
              located in the suprasellar region. There were both similarities
              and differences among the different anatomic subtypes of SPA. For
              patients who were suspected of having SPAs, visual field tests,
              pituitary hormone evaluation and MRI were necessary. Because
              imaging examination is not a reliable method, surgery is the only
              way to confirm the tumor origin. Extended endoscopic TSS might be
              a safe and efficient approach to remove these tumors, but more
              studies are needed to verify this conclusion. For type II SPA,
              the pituitary stalk should be carefully protected during surgery,
              and postoperative CDI should be monitored.",
  journal  = "Pituitary",
  volume   =  23,
  number   =  4,
  pages    = "367--380",
  month    =  aug,
  year     =  2020,
  keywords = "Anatomic origin; Ectopic; Suprasellar; Suprasellar pituitary
              adenoma",
  language = "en"
}

@ARTICLE{Lu2021-xi,
  title    = "{AI-based} pathology predicts origins for cancers of unknown
              primary",
  author   = "Lu, Ming Y and Chen, Tiffany Y and Williamson, Drew F K and Zhao,
              Melissa and Shady, Maha and Lipkova, Jana and Mahmood, Faisal",
  abstract = "Cancer of unknown primary (CUP) origin is an enigmatic group of
              diagnoses in which the primary anatomical site of tumour origin
              cannot be determined1,2. This poses a considerable challenge, as
              modern therapeutics are predominantly specific to the primary
              tumour3. Recent research has focused on using genomics and
              transcriptomics to identify the origin of a tumour4-9. However,
              genomic testing is not always performed and lacks clinical
              penetration in low-resource settings. Here, to overcome these
              challenges, we present a deep-learning-based algorithm-Tumour
              Origin Assessment via Deep Learning (TOAD)-that can provide a
              differential diagnosis for the origin of the primary tumour using
              routinely acquired histology slides. We used whole-slide images
              of tumours with known primary origins to train a model that
              simultaneously identifies the tumour as primary or metastatic and
              predicts its site of origin. On our held-out test set of tumours
              with known primary origins, the model achieved a top-1 accuracy
              of 0.83 and a top-3 accuracy of 0.96, whereas on our external
              test set it achieved top-1 and top-3 accuracies of 0.80 and 0.93,
              respectively. We further curated a dataset of 317 cases of CUP
              for which a differential diagnosis was assigned. Our model
              predictions resulted in concordance for 61\% of cases and a top-3
              agreement of 82\%. TOAD can be used as an assistive tool to
              assign a differential diagnosis to complicated cases of
              metastatic tumours and CUPs and could be used in conjunction with
              or in lieu of ancillary tests and extensive diagnostic work-ups
              to reduce the occurrence of CUP.",
  journal  = "Nature",
  volume   =  594,
  number   =  7861,
  pages    = "106--110",
  month    =  jun,
  year     =  2021,
  language = "en"
}

@ARTICLE{Elliott2018-vz,
  title    = "Genome-wide association studies of brain imaging phenotypes in
              {UK} Biobank",
  author   = "Elliott, Lloyd T and Sharp, Kevin and Alfaro-Almagro, Fidel and
              Shi, Sinan and Miller, Karla L and Douaud, Gwena{\"e}lle and
              Marchini, Jonathan and Smith, Stephen M",
  abstract = "The genetic architecture of brain structure and function is
              largely unknown. To investigate this, we carried out genome-wide
              association studies of 3,144 functional and structural brain
              imaging phenotypes from UK Biobank (discovery dataset 8,428
              subjects). Here we show that many of these phenotypes are
              heritable. We identify 148 clusters of associations between
              single nucleotide polymorphisms and imaging phenotypes that
              replicate at P < 0.05, when we would expect 21 to replicate by
              chance. Notable significant, interpretable associations include:
              iron transport and storage genes, related to magnetic
              susceptibility of subcortical brain tissue; extracellular matrix
              and epidermal growth factor genes, associated with white matter
              micro-structure and lesions; genes that regulate mid-line axon
              development, associated with organization of the pontine crossing
              tract; and overall 17 genes involved in development, pathway
              signalling and plasticity. Our results provide insights into the
              genetic architecture of the brain that are relevant to
              neurological and psychiatric disorders, brain development and
              ageing.",
  journal  = "Nature",
  volume   =  562,
  number   =  7726,
  pages    = "210--216",
  month    =  oct,
  year     =  2018,
  language = "en"
}

@ARTICLE{Louis2021-vd,
  title    = "The 2021 {WHO} Classification of Tumors of the Central Nervous
              System: a summary",
  author   = "Louis, David N and Perry, Arie and Wesseling, Pieter and Brat,
              Daniel J and Cree, Ian A and Figarella-Branger, Dominique and
              Hawkins, Cynthia and Ng, H K and Pfister, Stefan M and
              Reifenberger, Guido and Soffietti, Riccardo and von Deimling,
              Andreas and Ellison, David W",
  abstract = "The fifth edition of the WHO Classification of Tumors of the
              Central Nervous System (CNS), published in 2021, is the sixth
              version of the international standard for the classification of
              brain and spinal cord tumors. Building on the 2016 updated fourth
              edition and the work of the Consortium to Inform Molecular and
              Practical Approaches to CNS Tumor Taxonomy, the 2021 fifth
              edition introduces major changes that advance the role of
              molecular diagnostics in CNS tumor classification. At the same
              time, it remains wedded to other established approaches to tumor
              diagnosis such as histology and immunohistochemistry. In doing
              so, the fifth edition establishes some different approaches to
              both CNS tumor nomenclature and grading and it emphasizes the
              importance of integrated diagnoses and layered reports. New tumor
              types and subtypes are introduced, some based on novel diagnostic
              technologies such as DNA methylome profiling. The present review
              summarizes the major general changes in the 2021 fifth edition
              classification and the specific changes in each taxonomic
              category. It is hoped that this summary provides an overview to
              facilitate more in-depth exploration of the entire fifth edition
              of the WHO Classification of Tumors of the Central Nervous
              System.",
  journal  = "Neuro. Oncol.",
  month    =  jun,
  year     =  2021,
  keywords = "World Health Organization; brain tumor; central nervous system;
              classification; diagnosis",
  language = "en"
}

@ARTICLE{Grill2020-at,
  title         = "Bootstrap your own latent: A new approach to self-supervised
                   Learning",
  author        = "Grill, Jean-Bastien and Strub, Florian and Altch{\'e},
                   Florent and Tallec, Corentin and Richemond, Pierre H and
                   Buchatskaya, Elena and Doersch, Carl and Pires, Bernardo
                   Avila and Guo, Zhaohan Daniel and Azar, Mohammad Gheshlaghi
                   and Piot, Bilal and Kavukcuoglu, Koray and Munos, R{\'e}mi
                   and Valko, Michal",
  abstract      = "We introduce Bootstrap Your Own Latent (BYOL), a new
                   approach to self-supervised image representation learning.
                   BYOL relies on two neural networks, referred to as online
                   and target networks, that interact and learn from each
                   other. From an augmented view of an image, we train the
                   online network to predict the target network representation
                   of the same image under a different augmented view. At the
                   same time, we update the target network with a slow-moving
                   average of the online network. While state-of-the art
                   methods rely on negative pairs, BYOL achieves a new state of
                   the art without them. BYOL reaches $74.3\%$ top-1
                   classification accuracy on ImageNet using a linear
                   evaluation with a ResNet-50 architecture and $79.6\%$ with a
                   larger ResNet. We show that BYOL performs on par or better
                   than the current state of the art on both transfer and
                   semi-supervised benchmarks. Our implementation and
                   pretrained models are given on GitHub.",
  month         =  jun,
  year          =  2020,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "2006.07733"
}

@ARTICLE{Zbontar2021-ot,
  title         = "Barlow Twins: {Self-Supervised} Learning via Redundancy
                   Reduction",
  author        = "Zbontar, Jure and Jing, Li and Misra, Ishan and LeCun, Yann
                   and Deny, St{\'e}phane",
  abstract      = "Self-supervised learning (SSL) is rapidly closing the gap
                   with supervised methods on large computer vision benchmarks.
                   A successful approach to SSL is to learn embeddings which
                   are invariant to distortions of the input sample. However, a
                   recurring issue with this approach is the existence of
                   trivial constant solutions. Most current methods avoid such
                   solutions by careful implementation details. We propose an
                   objective function that naturally avoids collapse by
                   measuring the cross-correlation matrix between the outputs
                   of two identical networks fed with distorted versions of a
                   sample, and making it as close to the identity matrix as
                   possible. This causes the embedding vectors of distorted
                   versions of a sample to be similar, while minimizing the
                   redundancy between the components of these vectors. The
                   method is called Barlow Twins, owing to neuroscientist H.
                   Barlow's redundancy-reduction principle applied to a pair of
                   identical networks. Barlow Twins does not require large
                   batches nor asymmetry between the network twins such as a
                   predictor network, gradient stopping, or a moving average on
                   the weight updates. Intriguingly it benefits from very
                   high-dimensional output vectors. Barlow Twins outperforms
                   previous methods on ImageNet for semi-supervised
                   classification in the low-data regime, and is on par with
                   current state of the art for ImageNet classification with a
                   linear classifier head, and for transfer tasks of
                   classification and object detection.",
  month         =  mar,
  year          =  2021,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "2103.03230"
}

@ARTICLE{Brennan2013-hx,
  title    = "The somatic genomic landscape of glioblastoma",
  author   = "Brennan, Cameron W and Verhaak, Roel G W and McKenna, Aaron and
              Campos, Benito and Noushmehr, Houtan and Salama, Sofie R and
              Zheng, Siyuan and Chakravarty, Debyani and Sanborn, J Zachary and
              Berman, Samuel H and Beroukhim, Rameen and Bernard, Brady and Wu,
              Chang-Jiun and Genovese, Giannicola and Shmulevich, Ilya and
              Barnholtz-Sloan, Jill and Zou, Lihua and Vegesna, Rahulsimham and
              Shukla, Sachet A and Ciriello, Giovanni and Yung, W K and Zhang,
              Wei and Sougnez, Carrie and Mikkelsen, Tom and Aldape, Kenneth
              and Bigner, Darell D and Van Meir, Erwin G and Prados, Michael
              and Sloan, Andrew and Black, Keith L and Eschbacher, Jennifer and
              Finocchiaro, Gaetano and Friedman, William and Andrews, David W
              and Guha, Abhijit and Iacocca, Mary and O'Neill, Brian P and
              Foltz, Greg and Myers, Jerome and Weisenberger, Daniel J and
              Penny, Robert and Kucherlapati, Raju and Perou, Charles M and
              Hayes, D Neil and Gibbs, Richard and Marra, Marco and Mills,
              Gordon B and Lander, Eric and Spellman, Paul and Wilson, Richard
              and Sander, Chris and Weinstein, John and Meyerson, Matthew and
              Gabriel, Stacey and Laird, Peter W and Haussler, David and Getz,
              Gad and Chin, Lynda and {TCGA Research Network}",
  abstract = "We describe the landscape of somatic genomic alterations based on
              multidimensional and comprehensive characterization of more than
              500 glioblastoma tumors (GBMs). We identify several novel mutated
              genes as well as complex rearrangements of signature receptors,
              including EGFR and PDGFRA. TERT promoter mutations are shown to
              correlate with elevated mRNA expression, supporting a role in
              telomerase reactivation. Correlative analyses confirm that the
              survival advantage of the proneural subtype is conferred by the
              G-CIMP phenotype, and MGMT DNA methylation may be a predictive
              biomarker for treatment response only in classical subtype GBM.
              Integrative analysis of genomic and proteomic profiles challenges
              the notion of therapeutic inhibition of a pathway as an
              alternative to inhibition of the target itself. These data will
              facilitate the discovery of therapeutic and diagnostic target
              candidates, the validation of research and clinical observations
              and the generation of unanticipated hypotheses that can advance
              our molecular understanding of this lethal cancer.",
  journal  = "Cell",
  volume   =  155,
  number   =  2,
  pages    = "462--477",
  month    =  oct,
  year     =  2013,
  language = "en"
}

@ARTICLE{Hollon2020-rq,
  title    = "An automated tissue-to-diagnosis pipeline using intraoperative
              stimulated Raman histology and deep learning",
  author   = "Hollon, Todd C and Orringer, Daniel A",
  abstract = "We recently developed and validated a bedside tissue-to-diagnosis
              pipeline using stimulated Raman histology (SRH), a label-free
              optical imaging method, and deep convolutional neural networks
              (CNN) in prospective clinical trial. Our CNN learned a hierarchy
              of interpretable histologic features found in the most common
              brain tumors and was able to accurately segment cancerous regions
              in SRH images.",
  journal  = "Mol Cell Oncol",
  volume   =  7,
  number   =  3,
  pages    = "1736742",
  month    =  apr,
  year     =  2020,
  keywords = "Stimulated Raman histology; convolutional neural networks; deep
              learning; label-free imaging",
  language = "en"
}

@ARTICLE{Stupp2005-by,
  title    = "Radiotherapy plus concomitant and adjuvant temozolomide for
              glioblastoma",
  author   = "Stupp, Roger and Mason, Warren P and van den Bent, Martin J and
              Weller, Michael and Fisher, Barbara and Taphoorn, Martin J B and
              Belanger, Karl and Brandes, Alba A and Marosi, Christine and
              Bogdahn, Ulrich and Curschmann, J{\"u}rgen and Janzer, Robert C
              and Ludwin, Samuel K and Gorlia, Thierry and Allgeier, Anouk and
              Lacombe, Denis and Cairncross, J Gregory and Eisenhauer,
              Elizabeth and Mirimanoff, Ren{\'e} O and {European Organisation
              for Research and Treatment of Cancer Brain Tumor and Radiotherapy
              Groups} and {National Cancer Institute of Canada Clinical Trials
              Group}",
  abstract = "BACKGROUND: Glioblastoma, the most common primary brain tumor in
              adults, is usually rapidly fatal. The current standard of care
              for newly diagnosed glioblastoma is surgical resection to the
              extent feasible, followed by adjuvant radiotherapy. In this trial
              we compared radiotherapy alone with radiotherapy plus
              temozolomide, given concomitantly with and after radiotherapy, in
              terms of efficacy and safety. METHODS: Patients with newly
              diagnosed, histologically confirmed glioblastoma were randomly
              assigned to receive radiotherapy alone (fractionated focal
              irradiation in daily fractions of 2 Gy given 5 days per week for
              6 weeks, for a total of 60 Gy) or radiotherapy plus continuous
              daily temozolomide (75 mg per square meter of body-surface area
              per day, 7 days per week from the first to the last day of
              radiotherapy), followed by six cycles of adjuvant temozolomide
              (150 to 200 mg per square meter for 5 days during each 28-day
              cycle). The primary end point was overall survival. RESULTS: A
              total of 573 patients from 85 centers underwent randomization.
              The median age was 56 years, and 84 percent of patients had
              undergone debulking surgery. At a median follow-up of 28 months,
              the median survival was 14.6 months with radiotherapy plus
              temozolomide and 12.1 months with radiotherapy alone. The
              unadjusted hazard ratio for death in the
              radiotherapy-plus-temozolomide group was 0.63 (95 percent
              confidence interval, 0.52 to 0.75; P<0.001 by the log-rank test).
              The two-year survival rate was 26.5 percent with radiotherapy
              plus temozolomide and 10.4 percent with radiotherapy alone.
              Concomitant treatment with radiotherapy plus temozolomide
              resulted in grade 3 or 4 hematologic toxic effects in 7 percent
              of patients. CONCLUSIONS: The addition of temozolomide to
              radiotherapy for newly diagnosed glioblastoma resulted in a
              clinically meaningful and statistically significant survival
              benefit with minimal additional toxicity.",
  journal  = "N. Engl. J. Med.",
  volume   =  352,
  number   =  10,
  pages    = "987--996",
  month    =  mar,
  year     =  2005,
  language = "en"
}

@ARTICLE{He2015-ac,
  title         = "Delving Deep into Rectifiers: Surpassing {Human-Level}
                   Performance on {ImageNet} Classification",
  author        = "He, Kaiming and Zhang, Xiangyu and Ren, Shaoqing and Sun,
                   Jian",
  abstract      = "Rectified activation units (rectifiers) are essential for
                   state-of-the-art neural networks. In this work, we study
                   rectifier neural networks for image classification from two
                   aspects. First, we propose a Parametric Rectified Linear
                   Unit (PReLU) that generalizes the traditional rectified
                   unit. PReLU improves model fitting with nearly zero extra
                   computational cost and little overfitting risk. Second, we
                   derive a robust initialization method that particularly
                   considers the rectifier nonlinearities. This method enables
                   us to train extremely deep rectified models directly from
                   scratch and to investigate deeper or wider network
                   architectures. Based on our PReLU networks (PReLU-nets), we
                   achieve 4.94\% top-5 test error on the ImageNet 2012
                   classification dataset. This is a 26\% relative improvement
                   over the ILSVRC 2014 winner (GoogLeNet, 6.66\%). To our
                   knowledge, our result is the first to surpass human-level
                   performance (5.1\%, Russakovsky et al.) on this visual
                   recognition challenge.",
  month         =  feb,
  year          =  2015,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1502.01852"
}

@ARTICLE{Horbinski2019-ig,
  title    = "The medical necessity of advanced molecular testing in the
              diagnosis and treatment of brain tumor patients",
  author   = "Horbinski, Craig and Ligon, Keith L and Brastianos, Priscilla and
              Huse, Jason T and Venere, Monica and Chang, Susan and Buckner,
              Jan and Cloughesy, Timothy and Jenkins, Robert B and Giannini,
              Caterina and Stupp, Roger and Nabors, L Burt and Wen, Patrick Y
              and Aldape, Kenneth J and Lukas, Rimas V and Galanis, Evanthia
              and Eberhart, Charles G and Brat, Daniel J and Sarkaria, Jann N",
  abstract = "Accurate pathologic diagnoses and molecularly informed treatment
              decisions for a wide variety of cancers depend on robust clinical
              molecular testing that uses genomic, epigenomic, and
              transcriptomic-based tools. Nowhere is this more essential than
              in the workup of brain tumors, as emphasized by the incorporation
              of molecular criteria into the 2016 World Health Organization
              classification of central nervous system tumors and the updated
              official guidelines of the National Comprehensive Cancer Network.
              Despite the medical necessity of molecular testing in brain
              tumors, access to and utilization of molecular diagnostics is
              still highly variable across institutions, and a lack of
              reimbursement for such testing remains a significant obstacle.
              The objectives of this review are (i) to identify barriers to
              adoption of molecular testing in brain tumors, (ii) to describe
              the current molecular tools recommended for the clinical
              evaluation of brain tumors, and (iii) to summarize how molecular
              data are interpreted to guide clinical care, so as to improve
              understanding and justification for their coverage in the routine
              workup of adult and pediatric brain tumor cases.",
  journal  = "Neuro. Oncol.",
  volume   =  21,
  number   =  12,
  pages    = "1498--1508",
  month    =  dec,
  year     =  2019,
  keywords = "embryona; ependymoma; glioma; meningioma; molecular",
  language = "en"
}

@ARTICLE{Louis2019-ti,
  title    = "{cIMPACT-NOW}: a practical summary of diagnostic points from
              Round 1 updates",
  author   = "Louis, David N and Ellison, David W and Brat, Daniel J and
              Aldape, Kenneth and Capper, David and Hawkins, Cynthia and
              Paulus, Werner and Perry, Arie and Reifenberger, Guido and
              Figarella-Branger, Dominique and von Deimling, Andreas and
              Wesseling, Pieter",
  abstract = "cIMPACT-NOW (the Consortium to Inform Molecular and Practical
              Approaches to CNS Tumor Taxonomy) was established to provide a
              forum to evaluate and recommend proposed changes to future CNS
              tumor classifications. From 2016 to 2019 (Round 1), cIMPACT
              published four updates. Update 1 clarified the use of the term
              NOS (Not Otherwise Specified) and proposed use of the additional
              term NEC (Not Elsewhere Classified). Update 2 issued
              clarifications regarding two diagnoses: Diffuse Midline Glioma,
              H3 K27M-mutant and Diffuse Astrocytoma/Anaplastic Astrocytoma,
              IDH-mutant. Update 3 proposed molecular criteria that could be
              used in the setting of an IDH-wildtype diffuse or anaplastic
              astrocytic glioma without histological features of glioblastoma
              to infer that the tumor would behave similarly to a grade IV
              glioblastoma. Update 4 suggested that, in children and young
              adults, subtypes of IDH-wildtype/H3-wildtype diffuse gliomas may
              have distinct clinical features in the setting of a BRAFV600E
              mutation, FGFR1 alteration, other MAPK pathway alteration, or a
              MYB or MYBL1 rearrangement. The practical diagnostic relevance of
              these cIMPACT proposals is highlighted in this summary.",
  journal  = "Brain Pathol.",
  volume   =  29,
  number   =  4,
  pages    = "469--472",
  month    =  jul,
  year     =  2019,
  language = "en"
}

@ARTICLE{Paszke2019-hj,
  title         = "{PyTorch}: An Imperative Style, {High-Performance} Deep
                   Learning Library",
  author        = "Paszke, Adam and Gross, Sam and Massa, Francisco and Lerer,
                   Adam and Bradbury, James and Chanan, Gregory and Killeen,
                   Trevor and Lin, Zeming and Gimelshein, Natalia and Antiga,
                   Luca and Desmaison, Alban and K{\"o}pf, Andreas and Yang,
                   Edward and DeVito, Zach and Raison, Martin and Tejani,
                   Alykhan and Chilamkurthy, Sasank and Steiner, Benoit and
                   Fang, Lu and Bai, Junjie and Chintala, Soumith",
  abstract      = "Deep learning frameworks have often focused on either
                   usability or speed, but not both. PyTorch is a machine
                   learning library that shows that these two goals are in fact
                   compatible: it provides an imperative and Pythonic
                   programming style that supports code as a model, makes
                   debugging easy and is consistent with other popular
                   scientific computing libraries, while remaining efficient
                   and supporting hardware accelerators such as GPUs. In this
                   paper, we detail the principles that drove the
                   implementation of PyTorch and how they are reflected in its
                   architecture. We emphasize that every aspect of PyTorch is a
                   regular Python program under the full control of its user.
                   We also explain how the careful and pragmatic implementation
                   of the key components of its runtime enables them to work
                   together to achieve compelling performance. We demonstrate
                   the efficiency of individual subsystems, as well as the
                   overall speed of PyTorch on several common benchmarks.",
  month         =  dec,
  year          =  2019,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "1912.01703"
}

@ARTICLE{Jiang2021-kf,
  title         = "Contrastive Representation Learning for Rapid Intraoperative
                   Diagnosis of Skull Base Tumors Imaged Using Stimulated Raman
                   Histology",
  author        = "Jiang, Cheng and Bhattacharya, Abhishek and Linzey, Joseph
                   and Joshi, Rushikesh and Cha, Sung Jik and Srinivasan,
                   Sudharsan and Alber, Daniel and Kondepudi, Akhil and Urias,
                   Esteban and Pandian, Balaji and Al-Holou, Wajd and Sullivan,
                   Steve and Gregory Thompson, B and Heth, Jason and Freudiger,
                   Chris and Khalsa, Siri and Pacione, Donato and Golfinos,
                   John G and Camelo-Piragua, Sandra and Orringer, Daniel A and
                   Lee, Honglak and Hollon, Todd",
  abstract      = "Background: Accurate diagnosis of skull base tumors is
                   essential for providing personalized surgical treatment
                   strategies. Intraoperative diagnosis can be challenging due
                   to tumor diversity and lack of intraoperative pathology
                   resources. Objective: To develop an independent and parallel
                   intraoperative pathology workflow that can provide rapid and
                   accurate skull base tumor diagnoses using label-free optical
                   imaging and artificial intelligence (AI). Method: We used a
                   fiber laser-based, label-free, non-consumptive,
                   high-resolution microscopy method ($<$ 60 sec per 1 $\times$
                   1 mm$^\text\{2\}$), called stimulated Raman histology (SRH),
                   to image a consecutive, multicenter cohort of skull base
                   tumor patients. SRH images were then used to train a
                   convolutional neural network (CNN) model using three
                   representation learning strategies: cross-entropy,
                   self-supervised contrastive learning, and supervised
                   contrastive learning. Our trained CNN models were tested on
                   a held-out, multicenter SRH dataset. Results: SRH was able
                   to image the diagnostic features of both benign and
                   malignant skull base tumors. Of the three representation
                   learning strategies, supervised contrastive learning most
                   effectively learned the distinctive and diagnostic SRH image
                   features for each of the skull base tumor types. In our
                   multicenter testing set, cross-entropy achieved an overall
                   diagnostic accuracy of 91.5\%, self-supervised contrastive
                   learning 83.9\%, and supervised contrastive learning 96.6\%.
                   Our trained model was able to identify tumor-normal margins
                   and detect regions of microscopic tumor infiltration in
                   whole-slide SRH images. Conclusion: SRH with AI models
                   trained using contrastive representation learning can
                   provide rapid and accurate intraoperative diagnosis of skull
                   base tumors.",
  month         =  aug,
  year          =  2021,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "2108.03555"
}

@ARTICLE{Wang2016-da,
  title         = "{CNN-RNN}: A Unified Framework for Multi-label Image
                   Classification",
  author        = "Wang, Jiang and Yang, Yi and Mao, Junhua and Huang, Zhiheng
                   and Huang, Chang and Xu, Wei",
  abstract      = "While deep convolutional neural networks (CNNs) have shown a
                   great success in single-label image classification, it is
                   important to note that real world images generally contain
                   multiple labels, which could correspond to different
                   objects, scenes, actions and attributes in an image.
                   Traditional approaches to multi-label image classification
                   learn independent classifiers for each category and employ
                   ranking or thresholding on the classification results. These
                   techniques, although working well, fail to explicitly
                   exploit the label dependencies in an image. In this paper,
                   we utilize recurrent neural networks (RNNs) to address this
                   problem. Combined with CNNs, the proposed CNN-RNN framework
                   learns a joint image-label embedding to characterize the
                   semantic label dependency as well as the image-label
                   relevance, and it can be trained end-to-end from scratch to
                   integrate both information in a unified framework.
                   Experimental results on public benchmark datasets
                   demonstrate that the proposed architecture achieves better
                   performance than the state-of-the-art multi-label
                   classification model",
  month         =  apr,
  year          =  2016,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1604.04573"
}

@ARTICLE{Amraei2017-ao,
  title    = "A Comparison between the Diagnostic Accuracy of Frozen Section
              and Permanent Section Analyses in Central Nervous System",
  author   = "Amraei, Razie and Moradi, Afshin and Zham, Hanieh and Ahadi,
              Mahsa and Baikpour, Maryam and Rakhshan, Azadeh",
  abstract = "Objective: Using diagnostic pathological methods during surgery
              is a valuable means of determining the appropriate management for
              patients. Application of Frozen Section in CNS surgeries might
              face challenges due to friability of brain tissue and its
              relative inaccessibility. Various studies have evaluated the
              diagnostic acuity of frozen section compared to gold standard but
              results have been quite inconsistent. We conducted the present
              study to evaluate the accuracy of cryostat in diagnosing central
              nervous system tumors compared to the Gold Standard method.
              Methods: In this descriptive retrospective study, patients with
              definite diagnosis of central nervous system tumors made through
              histopathological evaluations were identified by reviewing the
              archives of pathology reports during 1996-2013. Demographic data,
              clinical history, radiologic findings and results of pathologic
              evaluations were extracted from the medical records and entered
              into SPSS statistical software v.22 for analysis. Results: A
              total of 405 patients diagnosed with CNS tumors were identified,
              of which 16 patients were not eligible and eventually 389
              patients were included in the study. Regarding tumor category,
              subtype and grade, the results of the two methods were totally
              compatible in 303 patients (77.9\%) and discrepant in 22.1\% of
              cases. The tumors located in the middle fossa (p=0.031; OR=2.27;
              95\% CI: 1.08-4.79) and the posterior fossa (p=0.021; OR=2.46;
              95\% CI: 1.15-5.26) and the tumors biopsied using the
              stereotactic method (p=0.050; OR=2.42; 95\% CI: 1.001-5.83) were
              associated with an increased chance of discrepant results between
              the two methods. Conclusion: Frozen section can correctly
              diagnose and affect the management of CNS lesions in 77.9\% of
              cases. Finding ways to increase the sensitivity and specificity
              of this method and providing surgeons with more definite and
              exact intra-operative diagnosis can improve management of central
              nervous system lesions to a considerable degree.",
  journal  = "Asian Pac. J. Cancer Prev.",
  volume   =  18,
  number   =  3,
  pages    = "659--666",
  month    =  mar,
  year     =  2017,
  keywords = "Central nervous system tumors; frozen section analysis; permanent
              section analysis; compatibility",
  language = "en"
}

@ARTICLE{Jiang2021-nn,
  title         = "Contrastive Representation Learning for Rapid Intraoperative
                   Diagnosis of Skull Base Tumors Imaged Using Stimulated Raman
                   Histology",
  author        = "Jiang, Cheng and Bhattacharya, Abhishek and Linzey, Joseph
                   and Joshi, Rushikesh and Cha, Sung Jik and Srinivasan,
                   Sudharsan and Alber, Daniel and Kondepudi, Akhil and Urias,
                   Esteban and Pandian, Balaji and Al-Holou, Wajd and Sullivan,
                   Steve and Gregory Thompson, B and Heth, Jason and Freudiger,
                   Chris and Khalsa, Siri and Pacione, Donato and Golfinos,
                   John G and Camelo-Piragua, Sandra and Orringer, Daniel A and
                   Lee, Honglak and Hollon, Todd",
  abstract      = "Background: Accurate diagnosis of skull base tumors is
                   essential for providing personalized surgical treatment
                   strategies. Intraoperative diagnosis can be challenging due
                   to tumor diversity and lack of intraoperative pathology
                   resources. Objective: To develop an independent and parallel
                   intraoperative pathology workflow that can provide rapid and
                   accurate skull base tumor diagnoses using label-free optical
                   imaging and artificial intelligence (AI). Method: We used a
                   fiber laser-based, label-free, non-consumptive,
                   high-resolution microscopy method ($<$ 60 sec per 1 $\times$
                   1 mm$^\text\{2\}$), called stimulated Raman histology (SRH),
                   to image a consecutive, multicenter cohort of skull base
                   tumor patients. SRH images were then used to train a
                   convolutional neural network (CNN) model using three
                   representation learning strategies: cross-entropy,
                   self-supervised contrastive learning, and supervised
                   contrastive learning. Our trained CNN models were tested on
                   a held-out, multicenter SRH dataset. Results: SRH was able
                   to image the diagnostic features of both benign and
                   malignant skull base tumors. Of the three representation
                   learning strategies, supervised contrastive learning most
                   effectively learned the distinctive and diagnostic SRH image
                   features for each of the skull base tumor types. In our
                   multicenter testing set, cross-entropy achieved an overall
                   diagnostic accuracy of 91.5\%, self-supervised contrastive
                   learning 83.9\%, and supervised contrastive learning 96.6\%.
                   Our trained model was able to identify tumor-normal margins
                   and detect regions of microscopic tumor infiltration in
                   whole-slide SRH images. Conclusion: SRH with AI models
                   trained using contrastive representation learning can
                   provide rapid and accurate intraoperative diagnosis of skull
                   base tumors.",
  month         =  aug,
  year          =  2021,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "2108.03555"
}

@INPROCEEDINGS{Agostinelli2013-wb,
  title     = "Adaptive {Multi-Column} Deep Neural Networks with Application to
               Robust Image Denoising",
  booktitle = "Advances in Neural Information Processing Systems",
  author    = "Agostinelli, Forest and Anderson, Michael R and Lee, Honglak",
  editor    = "Burges, C J C and Bottou, L and Welling, M and Ghahramani, Z and
               Weinberger, K Q",
  publisher = "Curran Associates, Inc.",
  volume    =  26,
  year      =  2013
}

@ARTICLE{Chen2021-li,
  title         = "An Empirical Study of Training {Self-Supervised} Vision
                   Transformers",
  author        = "Chen, Xinlei and Xie, Saining and He, Kaiming",
  abstract      = "This paper does not describe a novel method. Instead, it
                   studies a straightforward, incremental, yet must-know
                   baseline given the recent progress in computer vision:
                   self-supervised learning for Vision Transformers (ViT).
                   While the training recipes for standard convolutional
                   networks have been highly mature and robust, the recipes for
                   ViT are yet to be built, especially in the self-supervised
                   scenarios where training becomes more challenging. In this
                   work, we go back to basics and investigate the effects of
                   several fundamental components for training self-supervised
                   ViT. We observe that instability is a major issue that
                   degrades accuracy, and it can be hidden by apparently good
                   results. We reveal that these results are indeed partial
                   failure, and they can be improved when training is made more
                   stable. We benchmark ViT results in MoCo v3 and several
                   other self-supervised frameworks, with ablations in various
                   aspects. We discuss the currently positive evidence as well
                   as challenges and open questions. We hope that this work
                   will provide useful data points and experience for future
                   research.",
  month         =  apr,
  year          =  2021,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "2104.02057"
}

@INPROCEEDINGS{Khosla2010-ee,
  title     = "An integrated machine learning approach to stroke prediction",
  booktitle = "In {KDD}",
  author    = "Khosla, Aditya and Chiu, Hsu-Kuang and Cao, Yu and Hu, Junling
               and Lin, Cliff Chiung-Yu and Lee, Honglak",
  abstract  = "CiteSeerX - Document Details (Isaac Councill, Lee Giles, Pradeep
               Teregowda): Stroke is the third leading cause of death and the
               principal cause of serious long-term disability in the United
               States. Accurate prediction of stroke is highly valuable for
               early intervention and treatment. In this study, we compare the
               Cox proportional hazards model with a machine learning approach
               for stroke prediction on the Cardiovascular Health Study (CHS)
               dataset. Specifically, we consider the common problems of data
               imputation, feature selection, and prediction in medical
               datasets. We propose a novel automatic feature selection
               algorithm that selects robust features based on our proposed
               heuristic: conservative mean. Combined with Support Vector
               Machines (SVMs), our proposed feature selection algorithm
               achieves a greater area under the ROC curve (AUC) as compared to
               the Cox proportional hazards",
  year      =  2010
}

@ARTICLE{Bengio2012-pq,
  title         = "Representation Learning: A Review and New Perspectives",
  author        = "Bengio, Yoshua and Courville, Aaron and Vincent, Pascal",
  abstract      = "The success of machine learning algorithms generally depends
                   on data representation, and we hypothesize that this is
                   because different representations can entangle and hide more
                   or less the different explanatory factors of variation
                   behind the data. Although specific domain knowledge can be
                   used to help design representations, learning with generic
                   priors can also be used, and the quest for AI is motivating
                   the design of more powerful representation-learning
                   algorithms implementing such priors. This paper reviews
                   recent work in the area of unsupervised feature learning and
                   deep learning, covering advances in probabilistic models,
                   auto-encoders, manifold learning, and deep networks. This
                   motivates longer-term unanswered questions about the
                   appropriate objectives for learning good representations,
                   for computing representations (i.e., inference), and the
                   geometrical connections between representation learning,
                   density estimation and manifold learning.",
  month         =  jun,
  year          =  2012,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "1206.5538"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{GBD_2016_Brain_and_Other_CNS_Cancer_Collaborators2019-jl,
  title    = "Global, regional, and national burden of brain and other {CNS}
              cancer, 1990-2016: a systematic analysis for the Global Burden of
              Disease Study 2016",
  author   = "{GBD 2016 Brain and Other CNS Cancer Collaborators}",
  abstract = "BACKGROUND: Brain and CNS cancers (collectively referred to as
              CNS cancers) are a source of mortality and morbidity for which
              diagnosis and treatment require extensive resource allocation and
              sophisticated diagnostic and therapeutic technology. Previous
              epidemiological studies are limited to specific geographical
              regions or time periods, making them difficult to compare on a
              global scale. In this analysis, we aimed to provide a comparable
              and comprehensive estimation of the global burden of brain cancer
              between 1990 and 2016. METHODS: We report means and 95\%
              uncertainty intervals (UIs) for incidence, mortality, and
              disability-adjusted life-years (DALYs) estimates for CNS cancers
              (according to the International Classification of Diseases tenth
              revision: malignant neoplasm of meninges, malignant neoplasm of
              brain, and malignant neoplasm of spinal cord, cranial nerves, and
              other parts of CNS) from the Global Burden of Diseases, Injuries,
              and Risk Factors Study 2016. Data sources include vital
              registration and cancer registry data. Mortality was modelled
              using an ensemble model approach. Incidence was estimated by
              dividing the final mortality estimates by mortality to incidence
              ratios. DALYs were estimated by summing years of life lost and
              years lived with disability. Locations were grouped into
              quintiles based on the Socio-demographic Index (SDI), a summary
              indicator of income per capita, years of schooling, and total
              fertility rate. FINDINGS: In 2016, there were 330 000 (95\% UI
              299 000 to 349 000) incident cases of CNS cancer and 227 000 (205
              000 to 241 000) deaths globally, and age-standardised incidence
              rates of CNS cancer increased globally by 17Â·3\% (95\% UI 11Â·4 to
              26Â·9) between 1990 and 2016 (2016 age-standardised incidence rate
              4Â·63 per 100 000 person-years [4Â·17 to 4Â·90]). The highest
              age-standardised incidence rate was in the highest quintile of
              SDI (6Â·91 [5Â·71 to 7Â·53]). Age-standardised incidence rates
              increased with each SDI quintile. East Asia was the region with
              the most incident cases of CNS cancer for both sexes in 2016 (108
              000 [95\% UI 98 000 to 122 000]), followed by western Europe (49
              000 [37 000 to 54 000]), and south Asia (31 000 [29 000 to 37
              000]). The top three countries with the highest number of
              incident cases were China, the USA, and India. CNS cancer was
              responsible for 7Â·7 million (95\% UI 6Â·9 to 8Â·3) DALYs globally,
              a non-significant change in age-standardised DALY rate of -10Â·0\%
              (-16Â·4 to 2Â·6) between 1990 and 2016. The age-standardised DALY
              rate decreased in the high SDI quintile (-10Â·0\% [-27Â·1 to -0Â·1])
              and high-middle SDI quintile (-10Â·5\% [-18Â·4 to -1Â·4]) over time
              but increased in the low SDI quintile (22Â·5\% [11Â·2 to 50Â·5]).
              INTERPRETATION: CNS cancer is responsible for substantial
              morbidity and mortality worldwide, and incidence increased
              between 1990 and 2016. Significant geographical and regional
              variation in the incidence of CNS cancer might be reflective of
              differences in diagnoses and reporting practices or unknown
              environmental and genetic risk factors. Future efforts are needed
              to analyse CNS cancer burden by subtype. FUNDING: Bill \& Melinda
              Gates Foundation.",
  journal  = "Lancet Neurol.",
  volume   =  18,
  number   =  4,
  pages    = "376--393",
  month    =  apr,
  year     =  2019,
  language = "en"
}

@ARTICLE{Ostrom2020-vy,
  title    = "{CBTRUS} Statistical Report: Primary Brain and Other Central
              Nervous System Tumors Diagnosed in the United States in 2013-2017",
  author   = "Ostrom, Quinn T and Patil, Nirav and Cioffi, Gino and Waite,
              Kristin and Kruchko, Carol and Barnholtz-Sloan, Jill S",
  abstract = "The Central Brain Tumor Registry of the United States (CBTRUS),
              in collaboration with the Centers for Disease Control (CDC) and
              National Cancer Institute (NCI), is the largest population-based
              registry focused exclusively on primary brain and other central
              nervous system (CNS) tumors in the United States (US) and
              represents the entire US population. This report contains the
              most up-to-date population-based data on primary brain tumors
              (malignant and non-malignant) and supersedes all previous CBTRUS
              reports in terms of completeness and accuracy. All rates
              (incidence and mortality) are age-adjusted using the 2000 US
              standard population and presented per 100,000 population. The
              average annual age-adjusted incidence rate (AAAIR) of all
              malignant and non-malignant brain and other CNS tumors was 23.79
              (Malignant AAAIR=7.08, non-Malignant AAAIR=16.71). This rate was
              higher in females compared to males (26.31 versus 21.09), Blacks
              compared to Whites (23.88 versus 23.83), and non-Hispanics
              compared to Hispanics (24.23 versus 21.48). The most commonly
              occurring malignant brain and other CNS tumor was glioblastoma
              (14.5\% of all tumors), and the most common non-malignant tumor
              was meningioma (38.3\% of all tumors). Glioblastoma was more
              common in males, and meningioma was more common in females. In
              children and adolescents (age 0-19 years), the incidence rate of
              all primary brain and other CNS tumors was 6.14. An estimated
              83,830 new cases of malignant and non-malignant brain and other
              CNS tumors are expected to be diagnosed in the US in 2020 (24,970
              malignant and 58,860 non-malignant). There were 81,246 deaths
              attributed to malignant brain and other CNS tumors between 2013
              and 2017. This represents an average annual mortality rate of
              4.42. The 5-year relative survival rate following diagnosis of a
              malignant brain and other CNS tumor was 23.5\% and for a
              non-malignant brain and other CNS tumor was 82.4\%.",
  journal  = "Neuro. Oncol.",
  volume   =  22,
  number   = "12 Suppl 2",
  pages    = "iv1--iv96",
  month    =  oct,
  year     =  2020,
  language = "en"
}

@ARTICLE{Damodaran2015-gq,
  title    = "Clinical tumor sequencing: opportunities and challenges for
              precision cancer medicine",
  author   = "Damodaran, Senthilkumar and Berger, Michael F and Roychowdhury,
              Sameek",
  abstract = "Advances in tumor genome sequencing have enabled discovery of
              actionable alterations leading to novel therapies. Currently,
              there are approved targeted therapies across various tumors that
              can be matched to genomic alterations, such as point mutations,
              gene amplification, and translocations. Tools to detect these
              genomic alterations have emerged as a result of decreasing costs
              and improved throughput enabled by next-generation sequencing
              (NGS) technologies. NGS has been successfully utilized for
              developing biomarkers to assess susceptibility, diagnosis,
              prognosis, and treatment of cancers. However, clinical
              application presents some potential challenges in terms of tumor
              specimen acquisition, analysis, privacy, interpretation, and drug
              development in rare cancer subsets. Although whole-genome
              sequencing offers the most complete strategy for tumor analysis,
              its present utility in clinical care is limited. Consequently,
              targeted gene capture panels are more commonly employed by
              academic institutions and commercial vendors for clinical grade
              cancer genomic testing to assess molecular eligibility for
              matching therapies, whereas whole-exome and transcriptome
              (RNASeq) sequencing are being utilized for discovery research.
              This review discusses the strategies, clinical challenges, and
              opportunities associated with the application of cancer genomic
              testing for precision cancer medicine.",
  journal  = "Am Soc Clin Oncol Educ Book",
  pages    = "e175--82",
  year     =  2015,
  language = "en"
}

@ARTICLE{Van_der_Maaten2008-eh,
  title    = "Visualizing Data using {t-SNE}",
  author   = "van der Maaten, Laurens and Hinton, Geoffrey",
  journal  = "J. Mach. Learn. Res.",
  volume   =  9,
  number   =  86,
  pages    = "2579--2605",
  year     =  2008
}

@ARTICLE{Gusev2018-xt,
  title    = "The {REMBRANDT} study, a large collection of genomic data from
              brain cancer patients",
  author   = "Gusev, Yuriy and Bhuvaneshwar, Krithika and Song, Lei and
              Zenklusen, Jean-Claude and Fine, Howard and Madhavan, Subha",
  abstract = "The Rembrandt brain cancer dataset includes 671 patients
              collected from 14 contributing institutions from 2004-2006. It is
              accessible for conducting clinical translational research using
              the open access Georgetown Database of Cancer (G-DOC) platform.
              In addition, the raw and processed genomics and transcriptomics
              data have also been made available via the public NCBI GEO
              repository as a super series GSE108476. Such combined datasets
              would provide researchers with a unique opportunity to conduct
              integrative analysis of gene expression and copy number changes
              in patients alongside clinical outcomes (overall survival) using
              this large brain cancer study.",
  journal  = "Sci Data",
  volume   =  5,
  pages    = "180158",
  month    =  aug,
  year     =  2018,
  language = "en"
}

@INPROCEEDINGS{Pennington2014-dx,
  title      = "Glove: Global vectors for word representation",
  booktitle  = "Proceedings of the 2014 Conference on Empirical Methods in
                Natural Language Processing ({EMNLP})",
  author     = "Pennington, Jeffrey and Socher, Richard and Manning,
                Christopher",
  publisher  = "Association for Computational Linguistics",
  year       =  2014,
  address    = "Stroudsburg, PA, USA",
  conference = "Proceedings of the 2014 Conference on Empirical Methods in
                Natural Language Processing (EMNLP)",
  location   = "Doha, Qatar"
}

@ARTICLE{noauthor_undated-vw,

}

@INPROCEEDINGS{Vaswani2017-in,
  title     = "Attention is All you Need",
  booktitle = "Advances in Neural Information Processing Systems",
  author    = "Vaswani, Ashish and Shazeer, Noam and Parmar, Niki and
               Uszkoreit, Jakob and Jones, Llion and Gomez, Aidan N and Kaiser,
               {\L} Ukasz and Polosukhin, Illia",
  editor    = "Guyon, I and Luxburg, U V and Bengio, S and Wallach, H and
               Fergus, R and Vishwanathan, S and Garnett, R",
  publisher = "Curran Associates, Inc.",
  volume    =  30,
  year      =  2017
}

@ARTICLE{Gonzalez_Castro2021-rw,
  title    = "The {cIMPACT-NOW} updates and their significance to current
              neuro-oncology practice",
  author   = "Gonzalez Castro, L Nicolas and Wesseling, Pieter",
  abstract = "Over the past 4 years, advances in molecular pathology have
              enhanced our understanding of CNS tumors, providing new elements
              to refine their classification and improve the 2016 World Health
              Organization (WHO) Classification of CNS tumors. The Consortium
              to Inform Molecular and Practical Approaches to CNS Tumor
              Taxonomy-Not Official WHO (cIMPACT-NOW) was formed in late 2016
              by a group of neuropathology and neuro-oncology experts to
              provide practical recommendations (published as cIMPACT-NOW
              updates) to improve the diagnosis and classification of CNS
              tumors, in advance of the publication of a new WHO Classification
              of CNS tumors. Here we review the content of all the available
              cIMPACT-NOW updates and discuss the implications of each update
              for the diagnosis and management of patients with CNS tumors.",
  journal  = "Neurooncol Pract",
  volume   =  8,
  number   =  1,
  pages    = "4--10",
  month    =  feb,
  year     =  2021,
  keywords = "IDH-mutant gliomas; brain tumor classification; cIMPACT-NOW;
              glioblastoma; molecular pathology",
  language = "en"
}

@ARTICLE{Cheah2018-tu,
  title     = "Cost Analysis of Operating an Anatomic Pathology Laboratory in a
               {Middle-Income} Country",
  author    = "Cheah, Phaik-Leng and Looi, Lai Meng and Horton, Susan",
  abstract  = "AbstractObjective. To examine the cost of operating an anatomic
               pathology laboratory in a teaching hospital in Malaysia. Once
               the cost is determined, compare it",
  journal   = "Am. J. Clin. Pathol.",
  publisher = "Oxford Academic",
  volume    =  149,
  number    =  1,
  pages     = "1--7",
  month     =  jan,
  year      =  2018,
  keywords  = "budgets"
}

@ARTICLE{Yadav2021-dj,
  title     = "Availability of essential diagnostics in ten low-income and
               middle-income countries: results from national health facility
               surveys",
  author    = "Yadav, Harika and Shah, Devanshi and Sayed, Shahin and Horton,
               Susan and Schroeder, Lee F",
  abstract  = "BackgroundPathology and laboratory medicine diagnostics and
               diagnostic imaging are crucial to achieving universal health
               coverage. We analysed Service Provision Assessments (SPAs) from
               ten low-income and middle-income countries to benchmark
               diagnostic availability.",
  journal   = "The Lancet Global Health",
  publisher = "Elsevier",
  month     =  oct,
  year      =  2021
}

@ARTICLE{Horton2018-fd,
  title    = "Delivering modern, high-quality, affordable pathology and
              laboratory medicine to low-income and middle-income countries: a
              call to action",
  author   = "Horton, Susan and Sullivan, Richard and Flanigan, John and
              Fleming, Kenneth A and Kuti, Modupe A and Looi, Lai Meng and Pai,
              Sanjay A and Lawler, Mark",
  abstract = "Modern, affordable pathology and laboratory medicine (PALM)
              systems are essential to achieve the 2030 Sustainable Development
              Goals for health in low-income and middle-income countries
              (LMICs). In this last in a Series of three papers about PALM in
              LMICs, we discuss the policy environment and emphasise three
              crucial high-level actions that are needed to deliver universal
              health coverage. First, nations need national strategic
              laboratory plans; second, these plans require adequate financing
              for implementation; and last, pathologists themselves need to
              take on leadership roles to advocate for the centrality of PALM
              to achieve the Sustainable Development Goals for health. The
              national strategic laboratory plan should deliver a tiered,
              networked laboratory system as a central element. Appropriate
              financing should be provided, at a level of at least 4\% of
              health expenditure. Financing of new technologies such as
              molecular diagnostics is challenging for LMICs, even though many
              of these tests are cost-effective. Point-of-care testing can
              substantially reduce test-reporting time, but this benefit must
              be balanced with higher costs. Our research analysis highlights a
              considerable deficiency in advocacy for PALM; pathologists have
              been invisible in national and international health discourse and
              leadership. Embedding PALM in LMICs can only be achieved if
              pathologists advocate for these services, and undertake
              leadership roles, both nationally and internationally. We
              articulate eight key recommendations to address the current
              barriers identified in this Series and issue a call to action for
              all stakeholders to come together in a global alliance to ensure
              the effective provision of PALM services in resource-limited
              settings.",
  journal  = "Lancet",
  volume   =  391,
  number   =  10133,
  pages    = "1953--1964",
  month    =  may,
  year     =  2018,
  language = "en"
}

@ARTICLE{De_Almeida2011-pd,
  title    = "Functional outcomes for endoscopic and open skull base surgery:
              an evidence-based review",
  author   = "de Almeida, John R and Witterick, Ian J and Vescan, Allan D",
  abstract = "The goals of treatment of skull base neoplasms are to maximize
              oncologic outcomes and optimize functional outcomes. Several
              studies have investigated the former, but fewer examine the
              latter. This article reviews the available evidence for several
              functional outcomes, including endocrine, nasal, neurologic,
              visual, and quality of life outcomes for both endoscopic and open
              approaches. The quality of evidence for each outcome is compared
              for endoscopic and open approaches using the Oxford Centre for
              Evidence-based Medicine guidelines, and recommendations are made.
              Future longitudinal comparative outcome studies are needed to
              better delineate the functional status of patients undergoing
              skull base surgery.",
  journal  = "Otolaryngol. Clin. North Am.",
  volume   =  44,
  number   =  5,
  pages    = "1185--1200",
  month    =  oct,
  year     =  2011,
  language = "en"
}

@ARTICLE{Wang2019-um,
  title    = "International consensus statement on endoscopic skull-base
              surgery: executive summary",
  author   = "Wang, Eric W and Gardner, Paul A and Zanation, Adam M",
  abstract = "BACKGROUND: Endoscopic skull-base surgery (ESBS) is a rapidly
              growing discipline that often combines the expertise of
              otolaryngology-head and neck surgeons and neurosurgeons to
              provide care for these challenging conditions. As the field has
              grown, so too has the literature evaluating this surgical
              approach and the challenges and complications associated with
              these interventions. An international, multidisciplinary effort
              to critically evaluate and grade the current literature on ESBS
              has resulted in the International Consensus Statement on
              Endoscopic Skull Base Surgery (ICAR:SB). This Executive Summary
              highlights the key findings of the ICAR:SB document. METHODS:
              Following the prior methodology of the ICAR statements, the
              ICAR:SB document consists of 98 topics in ESBS that underwent a
              systematic review. When sufficient evidence exists, an
              evidence-based review with recommendation (EBRR) or
              evidence-based review (EBR) was created and then underwent an
              iterative review process until consensus was achieved. This
              Executive Summary recapitulates these findings. RESULTS: This
              summary complies the EBR and EBRR from the ICAR:SB document in
              the management of numerous skull-base pathologies including
              cerebrospinal fluid rhinorrhea, intradural tumors, sinonasal
              malignancies, and clival tumors, as well as the key issues of
              reconstruction after and the complications associated with ESBS.
              CONCLUSION: The ICAR:SB Executive Summary recaps the
              evidenced-based recommendations concerning the advantages,
              limitations and challenges of ESBS in the management of diverse
              skull-base pathologies. Although multifactorial in nature, the
              overall level of evidence in ESBS is modest. This represents an
              opportunity to address these knowledge gaps moving forward.",
  journal  = "Int. Forum Allergy Rhinol.",
  volume   =  9,
  number   = "S3",
  pages    = "S127--S144",
  month    =  jul,
  year     =  2019,
  keywords = "CSF rhinorrhea; angiofibroma; clival chordoma; craniopharyngioma;
              endoscopic endonasal approach; endoscopic endonasal skull-base
              surgery; esthesioneuroblastoma; evidence-based medicine;
              meningioma; nasoseptal flap reconstruction; olfactory
              neuroblastoma; pituitary adenoma; squamous cell carcinoma",
  language = "en"
}

@ARTICLE{Shankar2015-cw,
  title    = "Rapid Intraoperative Molecular Characterization of Glioma",
  author   = "Shankar, Ganesh M and Francis, Joshua M and Rinne, Mikael L and
              Ramkissoon, Shakti H and Huang, Franklin W and Venteicher, Andrew
              S and Akama-Garren, Elliot H and Kang, Yun Jee and Lelic, Nina
              and Kim, James C and Brown, Loreal E and Charbonneau, Sarah K and
              Golby, Alexandra J and Sekhar Pedamallu, Chandra and Hoang, Mai P
              and Sullivan, Ryan J and Cherniack, Andrew D and Garraway, Levi A
              and Stemmer-Rachamimov, Anat and Reardon, David A and Wen,
              Patrick Y and Brastianos, Priscilla K and Curry, William T and
              Barker, 2nd, Fred G and Hahn, William C and Nahed, Brian V and
              Ligon, Keith L and Louis, David N and Cahill, Daniel P and
              Meyerson, Matthew",
  abstract = "IMPORTANCE: Conclusive intraoperative pathologic confirmation of
              diffuse infiltrative glioma guides the decision to pursue
              definitive neurosurgical resection. Establishing the
              intraoperative diagnosis by histologic analysis can be difficult
              in low-cellularity infiltrative gliomas. Therefore, we developed
              a rapid and sensitive genotyping assay to detect somatic
              single-nucleotide variants in the telomerase reverse
              transcriptase (TERT) promoter and isocitrate dehydrogenase 1
              (IDH1). OBSERVATIONS: This assay was applied to tissue samples
              from 190 patients with diffuse gliomas, including archived fixed
              and frozen specimens and tissue obtained intraoperatively.
              Results demonstrated 96\% sensitivity (95\% CI, 90\%-99\%) and
              100\% specificity (95\% CI, 95\%-100\%) for World Health
              Organization grades II and III gliomas. In a series of live
              cases, glioma-defining mutations could be identified within 60
              minutes, which could facilitate the diagnosis in an
              intraoperative timeframe. CONCLUSIONS AND RELEVANCE: The
              genotyping method described herein can establish the diagnosis of
              low-cellularity tumors like glioma and could be adapted to the
              point-of-care diagnosis of other lesions that are similarly
              defined by highly recurrent somatic mutations.",
  journal  = "JAMA Oncol",
  volume   =  1,
  number   =  5,
  pages    = "662--667",
  month    =  aug,
  year     =  2015,
  language = "en"
}

@INPROCEEDINGS{Frome2013-pd,
  title     = "{DeViSE}: A Deep {Visual-Semantic} Embedding Model",
  booktitle = "Advances in Neural Information Processing Systems",
  author    = "Frome, Andrea and Corrado, Greg S and Shlens, Jon and Bengio,
               Samy and Dean, Jeff and Ranzato,
               Marc\textquotesingle Aurelio and Mikolov, Tomas",
  editor    = "Burges, C J C and Bottou, L and Welling, M and Ghahramani, Z and
               Weinberger, K Q",
  publisher = "Curran Associates, Inc.",
  volume    =  26,
  year      =  2013
}

@ARTICLE{Zhang2019-ag,
  title    = "The International Cancer Genome Consortium Data Portal",
  author   = "Zhang, Junjun and Bajari, Rosita and Andric, Dusan and
              Gerthoffert, Francois and Lepsa, Alexandru and Nahal-Bose,
              Hardeep and Stein, Lincoln D and Ferretti, Vincent",
  journal  = "Nat. Biotechnol.",
  volume   =  37,
  number   =  4,
  pages    = "367--369",
  month    =  apr,
  year     =  2019,
  language = "en"
}

@ARTICLE{Jonsson2019-eu,
  title    = "Genomic Correlates of Disease Progression and Treatment Response
              in Prospectively Characterized Gliomas",
  author   = "Jonsson, Philip and Lin, Andrew L and Young, Robert J and
              DiStefano, Natalie M and Hyman, David M and Li, Bob T and Berger,
              Michael F and Zehir, Ahmet and Ladanyi, Marc and Solit, David B
              and Arnold, Angela G and Stadler, Zsofia K and Mandelker, Diana
              and Goldberg, Michael E and Chmielecki, Juliann and Pourmaleki,
              Maryam and Ogilvie, Shahiba Q and Chavan, Shweta S and McKeown,
              Andrew T and Manne, Malbora and Hyde, Allison and Beal, Kathryn
              and Yang, T Jonathan and Nolan, Craig P and Pentsova, Elena and
              Omuro, Antonio and Gavrilovic, Igor T and Kaley, Thomas J and
              Diamond, Eli L and Stone, Jacqueline B and Grommes, Christian and
              Boire, Adrienne and Daras, Mariza and Piotrowski, Anna F and
              Miller, Alexandra M and Gutin, Philip H and Chan, Timothy A and
              Tabar, Viviane S and Brennan, Cameron W and Rosenblum, Marc and
              DeAngelis, Lisa M and Mellinghoff, Ingo K and Taylor, Barry S",
  abstract = "PURPOSE: The genomic landscape of gliomas has been characterized
              and now contributes to disease classification, yet the
              relationship between molecular profile and disease progression
              and treatment response remain poorly understood.Experimental
              Design: We integrated prospective clinical sequencing of 1,004
              primary and recurrent tumors from 923 glioma patients with
              clinical and treatment phenotypes. RESULTS: Thirteen percent of
              glioma patients harbored a pathogenic germline variant, including
              a subset associated with heritable genetic syndromes and variants
              mediating DNA repair dysfunctions (29\% of the total) that were
              associated with somatic biallelic inactivation and
              mechanism-specific somatic phenotypes. In astrocytomas, genomic
              alterations in effectors of cell-cycle progression correlated
              with aggressive disease independent of IDH mutation status, arose
              preferentially in enhancing tumors (44\% vs. 8\%, P < 0.001),
              were associated with rapid disease progression following tumor
              recurrence (HR = 2.6, P = 0.02), and likely preceded the
              acquisition of alkylating therapy-associated somatic
              hypermutation. Thirty-two percent of patients harbored a
              potentially therapeutically actionable lesion, of whom 11\%
              received targeted therapies. In BRAF-mutant gliomas, response to
              agents targeting the RAF/MEK/ERK signaling axis was influenced by
              the type of mutation, its clonality, and its cellular and genomic
              context. CONCLUSIONS: These data reveal genomic correlates of
              disease progression and treatment response in diverse types of
              glioma and highlight the potential utility of incorporating
              genomic information into the clinical decision-making for
              patients with glioma.",
  journal  = "Clin. Cancer Res.",
  volume   =  25,
  number   =  18,
  pages    = "5537--5547",
  month    =  sep,
  year     =  2019,
  language = "en"
}

@ARTICLE{Du2019-yw,
  title    = "Gene2vec: distributed representation of genes based on
              co-expression",
  author   = "Du, Jingcheng and Jia, Peilin and Dai, Yulin and Tao, Cui and
              Zhao, Zhongming and Zhi, Degui",
  abstract = "BACKGROUND: Existing functional description of genes are
              categorical, discrete, and mostly through manual process. In this
              work, we explore the idea of gene embedding, distributed
              representation of genes, in the spirit of word embedding.
              RESULTS: From a pure data-driven fashion, we trained a
              200-dimension vector representation of all human genes, using
              gene co-expression patterns in 984 data sets from the GEO
              databases. These vectors capture functional relatedness of genes
              in terms of recovering known pathways - the average inner product
              (similarity) of genes within a pathway is 1.52X greater than that
              of random genes. Using t-SNE, we produced a gene co-expression
              map that shows local concentrations of tissue specific genes. We
              also illustrated the usefulness of the embedded gene vectors,
              laden with rich information on gene co-expression patterns, in
              tasks such as gene-gene interaction prediction. CONCLUSIONS: We
              proposed a machine learning method that utilizes
              transcriptome-wide gene co-expression to generate a distributed
              representation of genes. We further demonstrated the utility of
              our distribution by predicting gene-gene interaction based solely
              on gene names. The distributed representation of genes could be
              useful for more bioinformatics applications.",
  journal  = "BMC Genomics",
  volume   =  20,
  number   = "Suppl 1",
  pages    = "82",
  month    =  feb,
  year     =  2019,
  keywords = "Distributed representation; Embedding; Gene co-expression;
              Gene-gene interaction; Gene2Vec; Word2vec",
  language = "en"
}

@ARTICLE{DeWitt2017-ju,
  title    = "Cost-effectiveness of {IDH} testing in diffuse gliomas according
              to the 2016 {WHO} classification of tumors of the central nervous
              system recommendations",
  author   = "DeWitt, John C and Jordan, Justin T and Frosch, Matthew P and
              Samore, Wesley R and Iafrate, A John and Louis, David N and
              Lennerz, Jochen K",
  abstract = "Background: Due to the decreasing prevalence of IDH1 mutations in
              older patients, the 2016 World Health Organization (WHO)
              classification of brain tumors proposed not to perform sequencing
              for isocitrate dehydrogenase (IDH) in glioblastoma patients
              $\geq$55 years old. We present a cost-effectiveness analysis to
              estimate the financial impact of these guidelines. Methods: From
              2010 to 2015 we performed 1023 IDH tests in gliomas, amounting to
              ~$1.09 million in direct laboratory test costs. Samples were
              tested using R132H-specific immunohistochemistry, DNA sequencing
              validated for detection of noncanonical IDH1/2 mutations, or both
              methods. Results: In cases tested by DNA sequencing, the fraction
              of non-R132H mutations was 5.4\%, which included only 2
              high-grade gliomas in patients \geq{}55 years (0.9\%). When
              remodeling the optimal age cutoff in our patient population using
              5-year age-binning, we found a 10-times higher pretest
              probability for the presence of a noncanonical IDH1 mutation in
              the setting of a negative IDH1-R132H immunohistochemistry result
              in patients <55 years. Applying the independently confirmed age
              cutoff of 55 years to glioblastoma patients (64\%) would result
              in $403200 saved (43\%). By not performing sequencing in patients
              $\geq$55 years, the turn-around time to final integrated
              neuropathological diagnosis is reduced by 53\%, allowing these
              patients to gain earlier benefits from personalized genomic
              medicine. Conclusion: The negligible prevalence of noncanonical
              IDH mutations in glioblastoma patients $\geq$55 years argues
              against universal IDH sequencing in this population. We predict
              that adoption of this age-based sequencing cutoff recommendation
              from the 2016 WHO guidelines will result in significant cost and
              time savings throughout the global health care system.",
  journal  = "Neuro. Oncol.",
  volume   =  19,
  number   =  12,
  pages    = "1640--1650",
  month    =  nov,
  year     =  2017,
  keywords = "IDH testing; biomarker; cost-effectiveness; reimbursement;
              turn-around time",
  language = "en"
}

@ARTICLE{Kather2020-fg,
  title    = "Pan-cancer image-based detection of clinically actionable genetic
              alterations",
  author   = "Kather, Jakob Nikolas and Heij, Lara R and Grabsch, Heike I and
              Loeffler, Chiara and Echle, Amelie and Muti, Hannah Sophie and
              Krause, Jeremias and Niehues, Jan M and Sommer, Kai A J and
              Bankhead, Peter and Kooreman, Loes F S and Schulte, Jefree J and
              Cipriani, Nicole A and Buelow, Roman D and Boor, Peter and
              Ortiz-Br{\"u}chle, Nadi-Na and Hanby, Andrew M and Speirs,
              Valerie and Kochanny, Sara and Patnaik, Akash and
              Srisuwananukorn, Andrew and Brenner, Hermann and Hoffmeister,
              Michael and van den Brandt, Piet A and J{\"a}ger, Dirk and
              Trautwein, Christian and Pearson, Alexander T and Luedde, Tom",
  abstract = "Molecular alterations in cancer can cause phenotypic changes in
              tumor cells and their micro-environment. Routine histopathology
              tissue slides - which are ubiquitously available - can reflect
              such morphological changes. Here, we show that deep learning can
              consistently infer a wide range of genetic mutations, molecular
              tumor subtypes, gene expression signatures and standard pathology
              biomarkers directly from routine histology. We developed,
              optimized, validated and publicly released a one-stop-shop
              workflow and applied it to tissue slides of more than 5000
              patients across multiple solid tumors. Our findings show that a
              single deep learning algorithm can be trained to predict a wide
              range of molecular alterations from routine, paraffin-embedded
              histology slides stained with hematoxylin and eosin. These
              predictions generalize to other populations and are spatially
              resolved. Our method can be implemented on mobile hardware,
              potentially enabling point-of-care diagnostics for personalized
              cancer treatment. More generally, this approach could elucidate
              and quantify genotype-phenotype links in cancer.",
  journal  = "Nat Cancer",
  volume   =  1,
  number   =  8,
  pages    = "789--799",
  month    =  aug,
  year     =  2020,
  language = "en"
}

@ARTICLE{Devlin2018-ck,
  title         = "{BERT}: Pre-training of Deep Bidirectional Transformers for
                   Language Understanding",
  author        = "Devlin, Jacob and Chang, Ming-Wei and Lee, Kenton and
                   Toutanova, Kristina",
  abstract      = "We introduce a new language representation model called
                   BERT, which stands for Bidirectional Encoder Representations
                   from Transformers. Unlike recent language representation
                   models, BERT is designed to pre-train deep bidirectional
                   representations from unlabeled text by jointly conditioning
                   on both left and right context in all layers. As a result,
                   the pre-trained BERT model can be fine-tuned with just one
                   additional output layer to create state-of-the-art models
                   for a wide range of tasks, such as question answering and
                   language inference, without substantial task-specific
                   architecture modifications. BERT is conceptually simple and
                   empirically powerful. It obtains new state-of-the-art
                   results on eleven natural language processing tasks,
                   including pushing the GLUE score to 80.5\% (7.7\% point
                   absolute improvement), MultiNLI accuracy to 86.7\% (4.6\%
                   absolute improvement), SQuAD v1.1 question answering Test F1
                   to 93.2 (1.5 point absolute improvement) and SQuAD v2.0 Test
                   F1 to 83.1 (5.1 point absolute improvement).",
  month         =  oct,
  year          =  2018,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CL",
  eprint        = "1810.04805"
}

@ARTICLE{Wang2020-ij,
  title         = "Understanding Contrastive Representation Learning through
                   Alignment and Uniformity on the Hypersphere",
  author        = "Wang, Tongzhou and Isola, Phillip",
  abstract      = "Contrastive representation learning has been outstandingly
                   successful in practice. In this work, we identify two key
                   properties related to the contrastive loss: (1) alignment
                   (closeness) of features from positive pairs, and (2)
                   uniformity of the induced distribution of the (normalized)
                   features on the hypersphere. We prove that, asymptotically,
                   the contrastive loss optimizes these properties, and analyze
                   their positive effects on downstream tasks. Empirically, we
                   introduce an optimizable metric to quantify each property.
                   Extensive experiments on standard vision and language
                   datasets confirm the strong agreement between both metrics
                   and downstream task performance. Remarkably, directly
                   optimizing for these two metrics leads to representations
                   with comparable or better performance at downstream tasks
                   than contrastive learning. Project Page:
                   https://ssnl.github.io/hypersphere Code:
                   https://github.com/SsnL/align\_uniform ,
                   https://github.com/SsnL/moco\_align\_uniform",
  month         =  may,
  year          =  2020,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "2005.10242"
}

@ARTICLE{Hirahara2021-jl,
  title     = "Effect of the pixel interpolation method for downsampling
               medical images on deep learning accuracy",
  author    = "Hirahara, Daisuke and Takaya, Eichi and Kadowaki, Mizuki and
               Kobayashi, Yasuyuki and Ueda, Takuya",
  journal   = "J. Comput. Commun.",
  publisher = "Scientific Research Publishing, Inc.",
  volume    =  09,
  number    =  11,
  pages     = "150--156",
  year      =  2021
}

@INCOLLECTION{Yin2019-dc,
  title     = "A fourier perspective on model robustness in computer vision",
  booktitle = "Proceedings of the 33rd International Conference on Neural
               Information Processing Systems",
  author    = "Yin, Dong and Lopes, Raphael Gontijo and Shlens, Jonathon and
               Cubuk, Ekin D and Gilmer, Justin",
  abstract  = "Achieving robustness to distributional shift is a longstanding
               and challenging goal of computer vision. Data augmentation is a
               commonly used approach for improving robustness, however
               robustness gains are typically not uniform across corruption
               types. Indeed increasing performance in the presence of random
               noise is often met with reduced performance on other corruptions
               such as contrast change. Understanding when and why these sorts
               of trade-offs occur is a crucial step towards mitigating them.
               Towards this end, we investigate recently observed tradeoffs
               caused by Gaussian data augmentation and adversarial training.
               We find that both methods improve robustness to corruptions that
               are concentrated in the high frequency domain while reducing
               robustness to corruptions that are concentrated in the low
               frequency domain. This suggests that one way to mitigate these
               trade-offs via data augmentation is to use a more diverse set of
               augmentations. Towards this end we observe that AutoAugment [6],
               a recently proposed data augmentation policy optimized for clean
               accuracy, achieves state-of-the-art robustness on the CIFAR-10-C
               [17] benchmark.",
  publisher = "Curran Associates Inc.",
  pages     = "13276--13286",
  month     =  dec,
  year      =  2019,
  address   = "Red Hook, NY, USA"
}

@INPROCEEDINGS{Rezende2015-oh,
  title     = "Variational Inference with Normalizing Flows",
  booktitle = "Proceedings of the 32nd International Conference on Machine
               Learning",
  author    = "Rezende, Danilo and Mohamed, Shakir",
  editor    = "Bach, Francis and Blei, David",
  abstract  = "The choice of the approximate posterior distribution is one of
               the core problems in variational inference. Most applications of
               variational inference employ simple families of posterior
               approximations in order to allow for efficient inference,
               focusing on mean-field or other simple structured
               approximations. This restriction has a significant impact on the
               quality of inferences made using variational methods. We
               introduce a new approach for specifying flexible, arbitrarily
               complex and scalable approximate posterior distributions. Our
               approximations are distributions constructed through a
               normalizing flow, whereby a simple initial density is
               transformed into a more complex one by applying a sequence of
               invertible transformations until a desired level of complexity
               is attained. We use this view of normalizing flows to develop
               categories of finite and infinitesimal flows and provide a
               unified view of approaches for constructing rich posterior
               approximations. We demonstrate that the theoretical advantages
               of having posteriors that better match the true posterior,
               combined with the scalability of amortized variational
               approaches, provides a clear improvement in performance and
               applicability of variational inference.",
  publisher = "PMLR",
  volume    =  37,
  pages     = "1530--1538",
  series    = "Proceedings of Machine Learning Research",
  year      =  2015,
  address   = "Lille, France"
}

@INPROCEEDINGS{Peng2019-ig,
  title           = "To what extent does downsampling, compression, and data
                     scarcity impact renal image analysis?",
  booktitle       = "2019 Digital Image Computing: Techniques and Applications
                     ({DICTA})",
  author          = "Peng, Can and Zhao, Kun and Wiliem, Arnold and Zhang, Teng
                     and Hobson, Peter and Jennings, Anthony and Lovell, Brian
                     C",
  abstract        = "This paper shows that the image file size of 40 $\chi$ WSI
                     images can be reduced by a factor of over 6000 with
                     negligible loss of glomerulus detection accuracy, and
                     examines the impact of image downsampling rates and
                     compression on detection accuracy. The condition of the
                     Glomeruli, or filter sacks, in renal Direct
                     Immunofluorescence (DIF) specimens is a critical indicator
                     for diagnosing kidney diseases. A digital pathology system
                     which digitizes a glass histology slide into a Whole Slide
                     Image (WSI) and then automatically detects and zooms in on
                     the glomeruli with a higher magnification objective will
                     be extremely helpful for pathologists. In this paper,
                     using glomerulus detection as the study case, we provide
                     analysis and observations on several important issues to
                     help with the development of Computer Aided Diagnostic
                     (CAD) systems to process WSIs. Large image resolution,
                     large file size, and data scarcity are always challenging
                     to deal with. To this end, we first examine image
                     downsampling rates in terms of their effect on detection
                     accuracy. Second, we examine the impact of image
                     compression. Third, we examine the relationship between
                     the size of the training set and detection accuracy. To
                     understand the above issues, experiments are performed on
                     the state-of-the-art detectors: Faster R-CNN, R-FCN, Mask
                     R-CNN and SSD. Critical findings are observed: (1) The
                     best balance between detection accuracy, detection speed
                     and file size is achieved at 8 times downsampling captured
                     with a 40 $\chi$ objective; (2) compression which reduces
                     the file size dramatically, does not necessarily have an
                     adverse effect on overall accuracy; (3) reducing the
                     amount of training data to some extents causes a drop in
                     precision but has a negligible impact on the recall; (4)
                     in most cases, Faster R-CNN achieves the best accuracy in
                     the glomerulus detection task. We show that the image file
                     size of 40 $\chi$ WSI images can be reduced by a factor of
                     over 6000 with negligible loss of glomerulus detection
                     accuracy.",
  publisher       = "IEEE",
  month           =  dec,
  year            =  2019,
  language        = "en",
  conference      = "2019 Digital Image Computing: Techniques and Applications
                     (DICTA)",
  location        = "Perth, Australia"
}

@ARTICLE{Wu2018-pd,
  title    = "In-vivo optical imaging in head and neck oncology: basic
              principles, clinical applications and future directions",
  author   = "Wu, Chenzhou and Gleysteen, John and Teraphongphom, Nutte Tarn
              and Li, Yi and Rosenthal, Eben",
  abstract = "Head and neck cancers become a severe threat to human's health
              nowadays and represent the sixth most common cancer worldwide.
              Surgery remains the first-line choice for head and neck cancer
              patients. Limited resectable tissue mass and complicated anatomy
              structures in the head and neck region put the surgeons in a
              dilemma between the extensive resection and a better quality of
              life for the patients. Early diagnosis and treatment of the
              pre-malignancies, as well as real-time in vivo detection of
              surgical margins during en bloc resection, could be leveraged to
              minimize the resection of normal tissues. With the understanding
              of the head and neck oncology, recent advances in optical
              hardware and reagents have provided unique opportunities for
              real-time pre-malignancies and cancer imaging in the clinic or
              operating room. Optical imaging in the head and neck has been
              reported using autofluorescence imaging, targeted fluorescence
              imaging, high-resolution microendoscopy, narrow band imaging and
              the Raman spectroscopy. In this study, we reviewed the basic
              theories and clinical applications of optical imaging for the
              diagnosis and treatment in the field of head and neck oncology
              with the goal of identifying limitations and facilitating future
              advancements in the field.",
  journal  = "Int. J. Oral Sci.",
  volume   =  10,
  number   =  2,
  pages    = "10",
  month    =  mar,
  year     =  2018,
  language = "en"
}

@ARTICLE{Kho2019-qe,
  title    = "Hyperspectral Imaging for Resection Margin Assessment during
              Cancer Surgery",
  author   = "Kho, Esther and de Boer, Lisanne L and Van de Vijver, Koen K and
              van Duijnhoven, Frederieke and Vrancken Peeters, Marie-Jeanne T F
              D and Sterenborg, Henricus J C M and Ruers, Theo J M",
  abstract = "PURPOSE: Complete tumor removal during cancer surgery remains
              challenging due to the lack of accurate techniques for
              intraoperative margin assessment. This study evaluates the use of
              hyperspectral imaging for margin assessment by reporting its use
              in fresh human breast specimens. EXPERIMENTAL DESIGN:
              Hyperspectral data were first acquired on tissue slices from 18
              patients after gross sectioning of the resected breast specimen.
              This dataset, which contained over 22,000 spectra, was well
              correlated with histopathology and was used to develop a support
              vector machine classification algorithm and test the
              classification performance. In addition, we evaluated
              hyperspectral imaging in clinical practice by imaging the
              resection surface of six lumpectomy specimens. With the developed
              classification algorithm, we determined if hyperspectral imaging
              could detect malignancies in the resection surface. RESULTS: The
              diagnostic performance of hyperspectral imaging on the tissue
              slices was high; invasive carcinoma, ductal carcinoma in situ,
              connective tissue, and adipose tissue were correctly classified
              as tumor or healthy tissue with accuracies of 93\%, 84\%, 70\%,
              and 99\%, respectively. These accuracies increased with the size
              of the area, consisting of one tissue type. The entire resection
              surface was imaged within 10 minutes, and data analysis was
              performed fast, without the need of an experienced operator. On
              the resection surface, hyperspectral imaging detected 19 of 20
              malignancies that, according to the available histopathology
              information, were located within 2 mm of the resection surface.
              CONCLUSIONS: These findings show the potential of using
              hyperspectral imaging for margin assessment during
              breast-conserving surgery to improve surgical outcome.",
  journal  = "Clin. Cancer Res.",
  volume   =  25,
  number   =  12,
  pages    = "3572--3580",
  month    =  jun,
  year     =  2019,
  language = "en"
}

@ARTICLE{Olde_Heuvel2021-in,
  title    = "State-of-the-art Intraoperative Imaging Technologies for Prostate
              Margin Assessment: A Systematic Review",
  author   = "Olde Heuvel, Judith and de Wit-van der Veen, Berlind J and
              Huizing, Daphne M V and van der Poel, Henk G and van Leeuwen, Pim
              J and Bhairosing, Patrick A and Stokkel, Marcel P M and Slump,
              Cornelis H",
  abstract = "CONTEXT: The main challenge in radical prostatectomy is complete
              excision of malignant tissue, while preserving continence and
              erectile function. Positive surgical margins (PSMs) occur in up
              to 38\% of cases, are associated with tumour recurrences, and may
              result in debilitating additional therapies. Despite surgical
              developments for prostate cancer (PCa), no technology is yet
              implemented to assess surgical margins of the entire prostatic
              surface intraoperatively. OBJECTIVE: The aim of this systematic
              review is to provide an overview of novel imaging methods
              developed for intraoperative margin assessment in PCa surgery,
              which are compared with standard postoperative histopathology.
              EVIDENCE ACQUISITION: A literature search of the last 10 yr was
              conducted in the Scopus, PubMed, and Embase (Ovid) databases.
              Eligible articles had to report the PSM rate according to their
              intraoperative margin assessment technology in comparison with
              standard histopathology. EVIDENCE SYNTHESIS: The search resulted
              in 616 original articles, of which 11 were included for full-text
              review. The main technical developments in PCa margin assessment
              included optical coherence tomography, photodynamic diagnosis
              with 5-aminolevulinic acid, spectroscopy, and enhanced
              microscopy. These techniques are described and their main
              advantages, limitations, and applications in the clinical setting
              are discussed. CONCLUSIONS: Several imaging methods are suggested
              in literature for the detection of positive margins during PCa
              surgery. Despite promising qualifications of the mentioned
              technologies, many struggle to find implementation in the clinic.
              Surgical conditions hampering the signal, long imaging times, and
              comparison with histopathology are mutual challenges. The next
              step towards reduction of PSMs in PCa surgery includes evaluation
              of these technologies in large clinical trials. PATIENT SUMMARY:
              In this review, new technologies are reported that can assist the
              surgeon by detecting insufficient removal of all tumorous tissue
              during surgery, instead of the standard postoperative
              histopathological assessment. Currently, it is not clear whether
              these technologies improve the patient outcome directly; however,
              the review shows potential future implementations.",
  journal  = "Eur Urol Focus",
  volume   =  7,
  number   =  4,
  pages    = "733--741",
  month    =  jul,
  year     =  2021,
  keywords = "Imaging technologies; Intraoperative; Margin assessment; Prostate
              cancer",
  language = "en"
}

@ARTICLE{Jradi2010-lx,
  title    = "The 20-core prostate biopsy as an initial strategy: impact on the
              detection of prostatic cancer",
  author   = "Jradi, Mohamed Amine and Dridi, Mohamed and Teyeb, Mourad and
              Mohamed, Mokhtar Ould Sidi and Khiary, Ramzi and Ghozzi, Samir
              and Ben Rais, Nawfel",
  abstract = "INTRODUCTION: To increase the detection rate of prostate cancer
              in recent years, we examined the increase in the number of cores
              taken at initial prostate biopsy. We hypothesized that an
              increasing number of cores may undermine the accuracy of models
              predicting the presence of prostate cancer at initial biopsy in
              patients submitted to 20-core initial biopsy. METHODS: A total of
              232 consecutive patients with prostate-specific antigen (PSA)
              between 4 and 20 ng/mL and/or abnormal digital rectal examination
              (DRE) underwent 12-core prostate biopsy protocol (group 1) or
              20-core prostate biopsy protocol (group 2). The patients were
              divided into subgroups according to the results of their serum
              PSA and prostate volume. We evaluated the cancer detection rate
              overall and in each subgroup. Clinical data were analyzed using
              chi-square analysis and the unpaired t-test or 1-way ANOVA with
              significance considered at 0.05. RESULTS: The 2 groups of
              patients were not significantly different with regard to
              parameters (age, abnormal DRE and serum PSA), although median
              prostate volume in group 1 (57.76 +/- 26.94 cc) were slighter
              greater than in group 2. Cancer detection rate for patients
              submitted to 20 prostate biopsy was higher than patients
              submitted to 12 prostate biopsy (35.2\% vs. 25\%, p = 0.095).
              Breakdown to PSA level showed a benefit to 20 prostate biopsy for
              PSA <6 ng/mL (37.1\% vs. 12.9\%, p = 0.005). Stratifying results
              by prostate volume, we found that the improvement of cancer
              detection rate with 20 prostate biopsy was significant in
              patients with a prostate volume greater than 60 cc (55\% in 20
              prostate biopsy vs. 11.3\% p < 0.05). Morbidity rates were
              identical in groups 1 and 2 with no statistically significant
              difference. There appeared to be no greater risk of infection and
              bleeding with 20 prostate biopsy protocol. CONCLUSION: The
              20-core biopsy protocol was more efficient than the 12-core
              biopsy protocol, especially in patients with prostate specific
              antigen <6 ng/mL and prostate volume greater than 60 cc.",
  journal  = "Can. Urol. Assoc. J.",
  volume   =  4,
  number   =  2,
  pages    = "100--104",
  month    =  apr,
  year     =  2010,
  language = "en"
}

@ARTICLE{Jo2017-yp,
  title         = "Measuring the tendency of {CNNs} to Learn Surface
                   Statistical Regularities",
  author        = "Jo, Jason and Bengio, Yoshua",
  abstract      = "Deep CNNs are known to exhibit the following peculiarity: on
                   the one hand they generalize extremely well to a test set,
                   while on the other hand they are extremely sensitive to
                   so-called adversarial perturbations. The extreme sensitivity
                   of high performance CNNs to adversarial examples casts
                   serious doubt that these networks are learning high level
                   abstractions in the dataset. We are concerned with the
                   following question: How can a deep CNN that does not learn
                   any high level semantics of the dataset manage to generalize
                   so well? The goal of this article is to measure the tendency
                   of CNNs to learn surface statistical regularities of the
                   dataset. To this end, we use Fourier filtering to construct
                   datasets which share the exact same high level abstractions
                   but exhibit qualitatively different surface statistical
                   regularities. For the SVHN and CIFAR-10 datasets, we present
                   two Fourier filtered variants: a low frequency variant and a
                   randomly filtered variant. Each of the Fourier filtering
                   schemes is tuned to preserve the recognizability of the
                   objects. Our main finding is that CNNs exhibit a tendency to
                   latch onto the Fourier image statistics of the training
                   dataset, sometimes exhibiting up to a 28\% generalization
                   gap across the various test sets. Moreover, we observe that
                   significantly increasing the depth of a network has a very
                   marginal impact on closing the aforementioned generalization
                   gap. Thus we provide quantitative evidence supporting the
                   hypothesis that deep CNNs tend to learn surface statistical
                   regularities in the dataset rather than higher-level
                   abstract concepts.",
  month         =  nov,
  year          =  2017,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "1711.11561"
}

@INPROCEEDINGS{Razavian2014-vw,
  title           = "{CNN} features off-the-shelf: An astounding baseline for
                     recognition",
  booktitle       = "2014 {IEEE} Conference on Computer Vision and Pattern
                     Recognition Workshops",
  author          = "Razavian, Ali Sharif and Azizpour, Hossein and Sullivan,
                     Josephine and Carlsson, Stefan",
  abstract        = "A series of experiments conducted for different
                     recognition tasks using the publicly available code and
                     model of the OverFeat network which was trained to perform
                     object classification on ILSVRC13 suggest that features
                     obtained from deep learning with convolutional nets should
                     be the primary candidate in most visual recognition tasks.
                     Recent results indicate that the generic descriptors
                     extracted from the convolutional neural networks are very
                     powerful. This paper adds to the mounting evidence that
                     this is indeed the case. We report on a series of
                     experiments conducted for different recognition tasks
                     using the publicly available code and model of the
                     OverFeat network which was trained to perform object
                     classification on ILSVRC13. We use features extracted from
                     the OverFeat network as a generic image representation to
                     tackle the diverse range of recognition tasks of object
                     image classification, scene recognition, fine grained
                     recognition, attribute detection and image retrieval
                     applied to a diverse set of datasets. We selected these
                     tasks and datasets as they gradually move further away
                     from the original task and data the OverFeat network was
                     trained to solve. Astonishingly, we report consistent
                     superior results compared to the highly tuned
                     state-of-the-art systems in all the visual classification
                     tasks on various datasets. For instance retrieval it
                     consistently outperforms low memory footprint methods
                     except for sculptures dataset. The results are achieved
                     using a linear SVM classifier (or L2 distance in case of
                     retrieval) applied to a feature representation of size
                     4096 extracted from a layer in the net. The
                     representations are further modified using simple
                     augmentation techniques e.g. jittering. The results
                     strongly suggest that features obtained from deep learning
                     with convolutional nets should be the primary candidate in
                     most visual recognition tasks.",
  publisher       = "IEEE",
  month           =  jun,
  year            =  2014,
  language        = "en",
  conference      = "2014 IEEE Conference on Computer Vision and Pattern
                     Recognition Workshops (CVPRW)",
  location        = "Columbus, OH, USA"
}

@ARTICLE{Arjovsky2017-ma,
  title         = "Wasserstein {GAN}",
  author        = "Arjovsky, Martin and Chintala, Soumith and Bottou, L{\'e}on",
  abstract      = "We introduce a new algorithm named WGAN, an alternative to
                   traditional GAN training. In this new model, we show that we
                   can improve the stability of learning, get rid of problems
                   like mode collapse, and provide meaningful learning curves
                   useful for debugging and hyperparameter searches.
                   Furthermore, we show that the corresponding optimization
                   problem is sound, and provide extensive theoretical work
                   highlighting the deep connections to other distances between
                   distributions.",
  month         =  jan,
  year          =  2017,
  archivePrefix = "arXiv",
  primaryClass  = "stat.ML",
  eprint        = "1701.07875"
}

@UNPUBLISHED{Dosovitskiy2020-xs,
  title    = "An Image is Worth 16x16 Words: Transformers for Image Recognition
              at Scale",
  author   = "Dosovitskiy, Alexey and Beyer, Lucas and Kolesnikov, Alexander
              and Weissenborn, Dirk and Zhai, Xiaohua and Unterthiner, Thomas
              and Dehghani, Mostafa and Minderer, Matthias and Heigold, Georg
              and Gelly, Sylvain and Uszkoreit, Jakob and Houlsby, Neil",
  abstract = "While the Transformer architecture has become the de-facto
              standard for natural language processing tasks, its applications
              to computer vision remain limited. In vision, attention is either
              applied in conjunction with convolutional networks, or used to
              replace certain components of convolutional networks while
              keeping their overall structure in place. We show that this
              reliance on CNNs is not necessary and a pure transformer applied
              directly to sequences of image patches can perform very well on
              image classification tasks. When pre-trained on large amounts of
              data and transferred to multiple mid-sized or small image
              recognition benchmarks (ImageNet, CIFAR-100, VTAB, etc.), Vision
              Transformer (ViT) attains excellent results compared to
              state-of-the-art convolutional networks while requiring
              substantially fewer computational resources to train.",
  month    =  sep,
  year     =  2020
}

@ARTICLE{Loshchilov2017-qa,
  title         = "Decoupled Weight Decay Regularization",
  author        = "Loshchilov, Ilya and Hutter, Frank",
  abstract      = "L$_2$ regularization and weight decay regularization are
                   equivalent for standard stochastic gradient descent (when
                   rescaled by the learning rate), but as we demonstrate this
                   is \emph{not} the case for adaptive gradient
                   algorithms, such as Adam. While common implementations of
                   these algorithms employ L$_2$ regularization (often calling
                   it ``weight decay'' in what may be misleading due to the
                   inequivalence we expose), we propose a simple modification
                   to recover the original formulation of weight decay
                   regularization by \emph{decoupling} the
                   weight decay from the optimization steps taken w.r.t. the
                   loss function. We provide empirical evidence that our
                   proposed modification (i) decouples the optimal choice of
                   weight decay factor from the setting of the learning rate
                   for both standard SGD and Adam and (ii) substantially
                   improves Adam's generalization performance, allowing it to
                   compete with SGD with momentum on image classification
                   datasets (on which it was previously typically outperformed
                   by the latter). Our proposed decoupled weight decay has
                   already been adopted by many researchers, and the community
                   has implemented it in TensorFlow and PyTorch; the complete
                   source code for our experiments is available at
                   https://github.com/loshchil/AdamW-and-SGDW",
  month         =  nov,
  year          =  2017,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "1711.05101"
}

@INPROCEEDINGS{Ramesh2021-cv,
  title     = "{Zero-Shot} {Text-to-Image} Generation",
  booktitle = "Proceedings of the 38th International Conference on Machine
               Learning",
  author    = "Ramesh, Aditya and Pavlov, Mikhail and Goh, Gabriel and Gray,
               Scott and Voss, Chelsea and Radford, Alec and Chen, Mark and
               Sutskever, Ilya",
  editor    = "Meila, Marina and Zhang, Tong",
  abstract  = "Text-to-image generation has traditionally focused on finding
               better modeling assumptions for training on a fixed dataset.
               These assumptions might involve complex architectures, auxiliary
               losses, or side information such as object part labels or
               segmentation masks supplied during training. We describe a
               simple approach for this task based on a transformer that
               autoregressively models the text and image tokens as a single
               stream of data. With sufficient data and scale, our approach is
               competitive with previous domain-specific models when evaluated
               in a zero-shot fashion.",
  publisher = "PMLR",
  volume    =  139,
  pages     = "8821--8831",
  series    = "Proceedings of Machine Learning Research",
  year      =  2021
}

@ARTICLE{Weller2021-vh,
  title    = "{EANO} guidelines on the diagnosis and treatment of diffuse
              gliomas of adulthood",
  author   = "Weller, Michael and van den Bent, Martin and Preusser, Matthias
              and Le Rhun, Emilie and Tonn, J{\"o}rg C and Minniti, Giuseppe
              and Bendszus, Martin and Balana, Carmen and Chinot, Olivier and
              Dirven, Linda and French, Pim and Hegi, Monika E and Jakola,
              Asgeir S and Platten, Michael and Roth, Patrick and Rud{\`a},
              Roberta and Short, Susan and Smits, Marion and Taphoorn, Martin J
              B and von Deimling, Andreas and Westphal, Manfred and Soffietti,
              Riccardo and Reifenberger, Guido and Wick, Wolfgang",
  abstract = "In response to major changes in diagnostic algorithms and the
              publication of mature results from various large clinical trials,
              the European Association of Neuro-Oncology (EANO) recognized the
              need to provide updated guidelines for the diagnosis and
              management of adult patients with diffuse gliomas. Through these
              evidence-based guidelines, a task force of EANO provides
              recommendations for the diagnosis, treatment and follow-up of
              adult patients with diffuse gliomas. The diagnostic component is
              based on the 2016 update of the WHO Classification of Tumors of
              the Central Nervous System and the subsequent recommendations of
              the Consortium to Inform Molecular and Practical Approaches to
              CNS Tumour Taxonomy - Not Officially WHO (cIMPACT-NOW). With
              regard to therapy, we formulated recommendations based on the
              results from the latest practice-changing clinical trials and
              also provide guidance for neuropathological and neuroradiological
              assessment. In these guidelines, we define the role of the major
              treatment modalities of surgery, radiotherapy and systemic
              pharmacotherapy, covering current advances and cognizant that
              unnecessary interventions and expenses should be avoided. This
              document is intended to be a source of reference for
              professionals involved in the management of adult patients with
              diffuse gliomas, for patients and caregivers, and for health-care
              providers.",
  journal  = "Nat. Rev. Clin. Oncol.",
  volume   =  18,
  number   =  3,
  pages    = "170--186",
  month    =  mar,
  year     =  2021,
  language = "en"
}

@ARTICLE{Louis2017-zj,
  title    = "{cIMPACT-NOW} (the consortium to inform molecular and practical
              approaches to {CNS} tumor taxonomy): a new initiative in
              advancing nervous system tumor classification",
  author   = "Louis, David N and Aldape, Ken and Brat, Daniel J and Capper,
              David and Ellison, David W and Hawkins, Cynthia and Paulus,
              Werner and Perry, Arie and Reifenberger, Guido and
              Figarella-Branger, Dominique and Wesseling, Pieter and Batchelor,
              Tracy T and Gregory Cairncross, J and Pfister, Stefan M and
              Rutkowski, Stefan and Weller, Michael and Wick, Wolfgang and von
              Deimling, Andreas",
  journal  = "Brain Pathol.",
  volume   =  27,
  number   =  6,
  pages    = "851--852",
  month    =  nov,
  year     =  2017,
  language = "en"
}

@ARTICLE{Ramesh2021-jw,
  title         = "{Zero-Shot} {Text-to-Image} Generation",
  author        = "Ramesh, Aditya and Pavlov, Mikhail and Goh, Gabriel and
                   Gray, Scott and Voss, Chelsea and Radford, Alec and Chen,
                   Mark and Sutskever, Ilya",
  abstract      = "Text-to-image generation has traditionally focused on
                   finding better modeling assumptions for training on a fixed
                   dataset. These assumptions might involve complex
                   architectures, auxiliary losses, or side information such as
                   object part labels or segmentation masks supplied during
                   training. We describe a simple approach for this task based
                   on a transformer that autoregressively models the text and
                   image tokens as a single stream of data. With sufficient
                   data and scale, our approach is competitive with previous
                   domain-specific models when evaluated in a zero-shot
                   fashion.",
  month         =  feb,
  year          =  2021,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "2102.12092"
}

@ARTICLE{Van_den_Oord2018-dk,
  title         = "Representation Learning with Contrastive Predictive Coding",
  author        = "van den Oord, Aaron and Li, Yazhe and Vinyals, Oriol",
  abstract      = "While supervised learning has enabled great progress in many
                   applications, unsupervised learning has not seen such
                   widespread adoption, and remains an important and
                   challenging endeavor for artificial intelligence. In this
                   work, we propose a universal unsupervised learning approach
                   to extract useful representations from high-dimensional
                   data, which we call Contrastive Predictive Coding. The key
                   insight of our model is to learn such representations by
                   predicting the future in latent space by using powerful
                   autoregressive models. We use a probabilistic contrastive
                   loss which induces the latent space to capture information
                   that is maximally useful to predict future samples. It also
                   makes the model tractable by using negative sampling. While
                   most prior work has focused on evaluating representations
                   for a particular modality, we demonstrate that our approach
                   is able to learn useful representations achieving strong
                   performance on four distinct domains: speech, images, text
                   and reinforcement learning in 3D environments.",
  month         =  jul,
  year          =  2018,
  archivePrefix = "arXiv",
  primaryClass  = "cs.LG",
  eprint        = "1807.03748"
}

@ARTICLE{Kather2019-ip,
  title    = "Deep learning can predict microsatellite instability directly
              from histology in gastrointestinal cancer",
  author   = "Kather, Jakob Nikolas and Pearson, Alexander T and Halama, Niels
              and J{\"a}ger, Dirk and Krause, Jeremias and Loosen, Sven H and
              Marx, Alexander and Boor, Peter and Tacke, Frank and Neumann, Ulf
              Peter and Grabsch, Heike I and Yoshikawa, Takaki and Brenner,
              Hermann and Chang-Claude, Jenny and Hoffmeister, Michael and
              Trautwein, Christian and Luedde, Tom",
  abstract = "Microsatellite instability determines whether patients with
              gastrointestinal cancer respond exceptionally well to
              immunotherapy. However, in clinical practice, not every patient
              is tested for MSI, because this requires additional genetic or
              immunohistochemical tests. Here we show that deep residual
              learning can predict MSI directly from H\&E histology, which is
              ubiquitously available. This approach has the potential to
              provide immunotherapy to a much broader subset of patients with
              gastrointestinal cancer.",
  journal  = "Nat. Med.",
  volume   =  25,
  number   =  7,
  pages    = "1054--1056",
  month    =  jul,
  year     =  2019,
  language = "en"
}

@ARTICLE{Fu2020-cn,
  title    = "Pan-cancer computational histopathology reveals mutations, tumor
              composition and prognosis",
  author   = "Fu, Yu and Jung, Alexander W and Torne, Ramon Vi{\~n}as and
              Gonzalez, Santiago and V{\"o}hringer, Harald and Shmatko, Artem
              and Yates, Lucy R and Jimenez-Linan, Mercedes and Moore, Luiza
              and Gerstung, Moritz",
  abstract = "We use deep transfer learning to quantify histopathological
              patterns across 17,355 hematoxylin and eosin-stained
              histopathology slide images from 28 cancer types and correlate
              these with matched genomic, transcriptomic and survival data.
              This approach accurately classifies cancer types and provides
              spatially resolved tumor and normal tissue distinction.
              Automatically learned computational histopathological features
              correlate with a large range of recurrent genetic aberrations
              across cancer types. This includes whole-genome duplications,
              which display universal features across cancer types, individual
              chromosomal aneuploidies, focal amplifications and deletions, as
              well as driver gene mutations. There are widespread associations
              between bulk gene expression levels and histopathology, which
              reflect tumor composition and enable the localization of
              transcriptomically defined tumor-infiltrating lymphocytes.
              Computational histopathology augments prognosis based on
              histopathological subtyping and grading, and highlights
              prognostically relevant areas such as necrosis or lymphocytic
              aggregates. These findings show the remarkable potential of
              computer vision in characterizing the molecular basis of tumor
              histopathology.",
  journal  = "Nat Cancer",
  volume   =  1,
  number   =  8,
  pages    = "800--810",
  month    =  aug,
  year     =  2020,
  language = "en"
}

@ARTICLE{Nagpal2019-xc,
  title    = "Development and validation of a deep learning algorithm for
              improving Gleason scoring of prostate cancer",
  author   = "Nagpal, Kunal and Foote, Davis and Liu, Yun and Chen, Po-Hsuan
              Cameron and Wulczyn, Ellery and Tan, Fraser and Olson, Niels and
              Smith, Jenny L and Mohtashamian, Arash and Wren, James H and
              Corrado, Greg S and MacDonald, Robert and Peng, Lily H and Amin,
              Mahul B and Evans, Andrew J and Sangoi, Ankur R and Mermel, Craig
              H and Hipp, Jason D and Stumpe, Martin C",
  abstract = "For prostate cancer patients, the Gleason score is one of the
              most important prognostic factors, potentially determining
              treatment independent of the stage. However, Gleason scoring is
              based on subjective microscopic examination of tumor morphology
              and suffers from poor reproducibility. Here we present a deep
              learning system (DLS) for Gleason scoring whole-slide images of
              prostatectomies. Our system was developed using 112 million
              pathologist-annotated image patches from 1226 slides, and
              evaluated on an independent validation dataset of 331 slides.
              Compared to a reference standard provided by genitourinary
              pathology experts, the mean accuracy among 29 general
              pathologists was 0.61 on the validation set. The DLS achieved a
              significantly higher diagnostic accuracy of 0.70 (p = 0.002) and
              trended towards better patient risk stratification in
              correlations to clinical follow-up data. Our approach could
              improve the accuracy of Gleason scoring and subsequent therapy
              decisions, particularly where specialist expertise is
              unavailable. The DLS also goes beyond the current Gleason system
              to more finely characterize and quantitate tumor morphology,
              providing opportunities for refinement of the Gleason system
              itself.",
  journal  = "NPJ Digit Med",
  volume   =  2,
  pages    = "48",
  month    =  jun,
  year     =  2019,
  keywords = "Prostate cancer",
  language = "en"
}

@ARTICLE{Mobadersany2018-lj,
  title    = "Predicting cancer outcomes from histology and genomics using
              convolutional networks",
  author   = "Mobadersany, Pooya and Yousefi, Safoora and Amgad, Mohamed and
              Gutman, David A and Barnholtz-Sloan, Jill S and Vel{\'a}zquez
              Vega, Jos{\'e} E and Brat, Daniel J and Cooper, Lee A D",
  abstract = "Cancer histology reflects underlying molecular processes and
              disease progression and contains rich phenotypic information that
              is predictive of patient outcomes. In this study, we show a
              computational approach for learning patient outcomes from digital
              pathology images using deep learning to combine the power of
              adaptive machine learning algorithms with traditional survival
              models. We illustrate how these survival convolutional neural
              networks (SCNNs) can integrate information from both histology
              images and genomic biomarkers into a single unified framework to
              predict time-to-event outcomes and show prediction accuracy that
              surpasses the current clinical paradigm for predicting the
              overall survival of patients diagnosed with glioma. We use
              statistical sampling techniques to address challenges in learning
              survival from histology images, including tumor heterogeneity and
              the need for large training cohorts. We also provide insights
              into the prediction mechanisms of SCNNs, using heat map
              visualization to show that SCNNs recognize important structures,
              like microvascular proliferation, that are related to prognosis
              and that are used by pathologists in grading. These results
              highlight the emerging role of deep learning in precision
              medicine and suggest an expanding utility for computational
              analysis of histology in the future practice of pathology.",
  journal  = "Proc. Natl. Acad. Sci. U. S. A.",
  volume   =  115,
  number   =  13,
  pages    = "E2970--E2979",
  month    =  mar,
  year     =  2018,
  keywords = "artificial intelligence; cancer; deep learning; digital
              pathology; machine learning",
  language = "en"
}

@ARTICLE{Straehle2022-on,
  title    = "Neuropathological interpretation of stimulated Raman histology
              images of brain and spine tumors: part {B}",
  author   = "Straehle, Jakob and Erny, Daniel and Neidert, Nicolas and
              Heiland, Dieter Henrik and El Rahal, Amir and Sacalean, Vlad and
              Steybe, David and Schmelzeisen, Rainer and Vlachos, Andreas and
              Mizaikoff, Boris and Reinacher, Peter Christoph and Coenen,
              Volker Arnd and Prinz, Marco and Beck, J{\"u}rgen and Schnell,
              Oliver",
  abstract = "Intraoperative histopathological examinations are routinely
              performed to provide neurosurgeons with information about the
              entity of tumor tissue. Here, we quantified the neuropathological
              interpretability of stimulated Raman histology (SRH) acquired
              using a Raman laser imaging system in a routine clinical setting
              without any specialized training or prior experience. Stimulated
              Raman scattering microscopy was performed on 117 samples of
              pathological tissue from 73 cases of brain and spine tumor
              surgeries. A board-certified neuropathologist --- novice in the
              interpretation of SRH --- assessed image quality by scoring
              subjective tumor infiltration and stated a diagnosis based on the
              SRH images. The diagnostic accuracy was determined by comparison
              to frozen hematoxylin--eosin (H\&E)-stained sections and the
              ground truth defined as the definitive neuropathological
              diagnosis. The overall SRH imaging quality was rated high with
              the detection of tumor cells classified as inconclusive in only
              4.2\% of all images. The accuracy of neuropathological diagnosis
              based on SRH images was 87.7\% and was non-inferior to the
              current standard of fast frozen H\&E-stained sections (87.3 vs.
              88.9\%, p = 0.783). We found a substantial diagnostic correlation
              between SRH-based neuropathological diagnosis and H\&E-stained
              frozen sections ($\kappa$ = 0.8). The interpretability of
              intraoperative SRH imaging was demonstrated to be equivalent to
              the current standard method of H\&E-stained frozen sections.
              Further research using this label-free innovative alternative vs.
              conventional staining is required to determine to which extent
              SRH-based intraoperative decision-making can be streamlined in
              order to facilitate the advancement of surgical neurooncology.",
  journal  = "Neurosurg. Rev.",
  volume   =  45,
  number   =  2,
  pages    = "1721--1729",
  month    =  apr,
  year     =  2022
}

@ARTICLE{Neidert2022-ku,
  title    = "Stimulated Raman histology in the neurosurgical workflow of a
              major European neurosurgical center - part A",
  author   = "Neidert, Nicolas and Straehle, Jakob and Erny, Daniel and
              Sacalean, Vlad and El Rahal, Amir and Steybe, David and
              Schmelzeisen, Rainer and Vlachos, Andreas and Reinacher, Peter
              Christoph and Coenen, Volker Arnd and Mizaikoff, Boris and
              Heiland, Dieter Henrik and Prinz, Marco and Beck, J{\"u}rgen and
              Schnell, Oliver",
  abstract = "Histopathological diagnosis is the current standard for the
              classification of brain and spine tumors. Raman spectroscopy has
              been reported to allow fast and easy intraoperative tissue
              analysis. Here, we report data on the intraoperative
              implementation of a stimulated Raman histology (SRH) as an
              innovative strategy offering intraoperative near real-time
              histopathological analysis. A total of 429 SRH images from 108
              patients were generated and analyzed by using a Raman imaging
              system (Invenio Imaging Inc.). We aimed at establishing a
              dedicated workflow for SRH serving as an intraoperative
              diagnostic, research, and quality control tool in the
              neurosurgical operating room (OR). First experiences with this
              novel imaging modality were reported and analyzed suggesting
              process optimization regarding tissue collection, preparation,
              and imaging. The Raman imaging system was rapidly integrated into
              the surgical workflow of a large neurosurgical center. Within a
              few minutes of connecting the device, the first high-quality
              images could be acquired in a ``plug-and-play'' manner. We did
              not encounter relevant obstacles and the learning curve was
              steep. However, certain prerequisites regarding quality and
              acquisition of tissue samples, data processing and
              interpretation, and high throughput adaptions must be considered.
              Intraoperative SRH can easily be integrated into the workflow of
              neurosurgical tumor resection. Considering few process
              optimizations that can be implemented rapidly, high-quality
              images can be obtained near real time. Hence, we propose SRH as a
              complementary tool for the diagnosis of tumor entity, analysis of
              tumor infiltration zones, online quality and safety control and
              as a research tool in the neurosurgical OR.",
  journal  = "Neurosurg. Rev.",
  volume   =  45,
  number   =  2,
  pages    = "1731--1739",
  month    =  apr,
  year     =  2022,
  keywords = "Extent of resection; Neurooncolocy; Neurosurgery; Stimulated
              Raman histology; Tissue imaging",
  language = "en"
}

@ARTICLE{Li2020-ug,
  title         = "Prototypical Contrastive Learning of Unsupervised
                   Representations",
  author        = "Li, Junnan and Zhou, Pan and Xiong, Caiming and Hoi, Steven
                   C H",
  abstract      = "This paper presents Prototypical Contrastive Learning (PCL),
                   an unsupervised representation learning method that
                   addresses the fundamental limitations of instance-wise
                   contrastive learning. PCL not only learns low-level features
                   for the task of instance discrimination, but more
                   importantly, it implicitly encodes semantic structures of
                   the data into the learned embedding space. Specifically, we
                   introduce prototypes as latent variables to help find the
                   maximum-likelihood estimation of the network parameters in
                   an Expectation-Maximization framework. We iteratively
                   perform E-step as finding the distribution of prototypes via
                   clustering and M-step as optimizing the network via
                   contrastive learning. We propose ProtoNCE loss, a
                   generalized version of the InfoNCE loss for contrastive
                   learning, which encourages representations to be closer to
                   their assigned prototypes. PCL outperforms state-of-the-art
                   instance-wise contrastive learning methods on multiple
                   benchmarks with substantial improvement in low-resource
                   transfer learning. Code and pretrained models are available
                   at https://github.com/salesforce/PCL.",
  month         =  may,
  year          =  2020,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "2005.04966"
}

@INPROCEEDINGS{Wang2021-dy,
  title           = "Understanding the behaviour of contrastive loss",
  booktitle       = "2021 {IEEE/CVF} Conference on Computer Vision and Pattern
                     Recognition ({CVPR})",
  author          = "Wang, Feng and Liu, Huaping",
  publisher       = "IEEE",
  month           =  jun,
  year            =  2021,
  conference      = "2021 IEEE/CVF Conference on Computer Vision and Pattern
                     Recognition (CVPR)",
  location        = "Nashville, TN, USA"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{noauthor_undated-rc,
  title   = "Understanding Contrastive Representation Learning through",
  journal = "http://proceedings.mlr.press â€º ...http://proceedings.mlr.press â€º
             ..."
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Netzer2011-fc,
  title     = "Reading digits in natural images with unsupervised feature
               learning",
  author    = "Netzer, Yuval and Wang, Tao and Coates, Adam and Bissacco,
               Alessandro and Wu, Bo and Ng, Andrew Y",
  abstract  = "Detecting and reading text from natural images is a hard
               computer vision task that is central to a variety of emerging
               applications. Related problems like document character
               recognition have been widely studied by computer vision and
               machine learning researchers and are virtually solved for
               practical applications like reading handwritten digits. Reliably
               recognizing characters in more complex scenes like photographs,
               however, is far more difficult: the best existing methods lag
               well behind human performance on the same tasks. In this paper
               we â€¦",
  publisher = "research.google",
  year      =  2011
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Ringwald2021-ik,
  title     = "Adaptiope: A modern benchmark for unsupervised domain adaptation",
  author    = "{Ringwald} and {Stiefelhagen}",
  abstract  = "Unsupervised domain adaptation (UDA) deals with the adaptation
               process of a given source domain with labeled training data to a
               target domain for which only unannotated data is available. This
               is a challenging task as the domain shift leads to degraded
               performance on the target domain data if not addressed. In this
               paper, we analyze commonly used UDA classification datasets and
               discover systematic problems with regard to dataset setup,
               ground truth ambiguity and annotation quality. We manually clean
               the most popular UDA â€¦",
  journal   = "Proceedings of the IEEE/CVF",
  publisher = "openaccess.thecvf.com",
  year      =  2021
}

@INPROCEEDINGS{Saenko2010-mm,
  title     = "Adapting Visual Category Models to New Domains",
  booktitle = "Computer Vision -- {ECCV} 2010",
  author    = "Saenko, Kate and Kulis, Brian and Fritz, Mario and Darrell,
               Trevor",
  abstract  = "Domain adaptation is an important emerging topic in computer
               vision. In this paper, we present one of the first studies of
               domain shift in the context of object recognition. We introduce
               a method that adapts object models acquired in a particular
               visual domain to new imaging conditions by learning a
               transformation that minimizes the effect of domain-induced
               changes in the feature distribution. The transformation is
               learned in a supervised manner and can be applied to categories
               for which there are no labeled examples in the new domain. While
               we focus our evaluation on object recognition tasks, the
               transform-based adaptation technique we develop is general and
               could be applied to non-image data. Another contribution is a
               new multi-domain object database, freely available for download.
               We experimentally demonstrate the ability of our method to
               improve recognition on categories with few or no target domain
               labels and moderate to large changes in the imaging conditions.",
  publisher = "Springer Berlin Heidelberg",
  pages     = "213--226",
  year      =  2010
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Peng2019-sw,
  title     = "Moment matching for multi-source domain adaptation",
  author    = "{Peng} and {Bai} and {Xia} and {Huang} and {others}",
  abstract  = "Conventional unsupervised domain adaptation (UDA) assumes that
               training data are sampled from a single domain. This neglects
               the more practical scenario where training data are collected
               from multiple sources, requiring multi-source domain adaptation.
               We make three major contributions towards addressing this
               problem. First, we collect and annotate by far the largest UDA
               dataset, called DomainNet, which contains six domains and about
               0.6 million images distributed among 345 categories, addressing
               the gap in data availability for â€¦",
  journal   = "Proc. Estonian Acad. Sci. Biol. Ecol.",
  publisher = "openaccess.thecvf.com",
  year      =  2019
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Eisenhardt1930-pe,
  title     = "Diagnosis of Intracranial Tumors by Supravital Technique",
  author    = "Eisenhardt, L and Cushing, H",
  abstract  = "In any method of quickdiagnosis, the rapidity depends upon
               familiarity with a given procedure, the experience of the
               observer and the nature of the tissue. The morphological
               diagnosis of a tumor is occasionally very difficult whatever the
               method of prepara-tion, and long and exhaustive study may be
               necessary before the final dassification of the growth is
               possible. Technique: The method, as stated, is that described in
               detail by Sabin 8 in her studies of living human blood cells.
               Its application to the more solid tissue of intracranial â€¦",
  journal   = "Am. J. Pathol.",
  publisher = "ncbi.nlm.nih.gov",
  volume    =  6,
  number    =  5,
  pages     = "541--552.7",
  month     =  sep,
  year      =  1930,
  language  = "en"
}

@ARTICLE{Pekmezci2021-et,
  title     = "Detection of glioma infiltration at the tumor margin using
               quantitative stimulated Raman scattering histology",
  author    = "Pekmezci, Melike and Morshed, Ramin A and Chunduru, Pranathi and
               Pandian, Balaji and Young, Jacob and Villanueva-Meyer, Javier E
               and Tihan, Tarik and Sloan, Emily A and Aghi, Manish K and
               Molinaro, Annette M and Berger, Mitchel S and Hervey-Jumper,
               Shawn L",
  abstract  = "In the management of diffuse gliomas, the identification and
               removal of tumor at the infiltrative margin remains a central
               challenge. Prior work has demonstrated that fluorescence
               labeling tools and radiographic imaging are useful surgical
               adjuvants with macroscopic resolution. However, they lose
               sensitivity at the tumor margin and have limited clinical
               utility for lower grade histologies. Fiber-laser based
               stimulated Raman histology (SRH) is an optical imaging technique
               that provides microscopic tissue characterization of unprocessed
               tissues. It remains unknown whether SRH of tissues taken from
               the infiltrative glioma margin will identify microscopic
               residual disease. Here we acquired glioma margin specimens for
               SRH, histology, and tumor specific tissue characterization.
               Generalized linear mixed models were used to evaluate agreement.
               We find that SRH identified residual tumor in 82 of 167 margin
               specimens (49\%), compared to IHC confirming residual tumor in
               72 of 128 samples (56\%), and H\&E confirming residual tumor in
               82 of 169 samples (49\%). Intraobserver agreements between all 3
               modalities were confirmed. These data demonstrate that SRH
               detects residual microscopic tumor at the infiltrative glioma
               margin and may be a promising tool to enhance extent of
               resection.",
  journal   = "Sci. Rep.",
  publisher = "Nature Publishing Group",
  volume    =  11,
  number    =  1,
  pages     = "1--11",
  month     =  jun,
  year      =  2021,
  language  = "en"
}

@ARTICLE{Farahani2015-cs,
  title     = "Whole slide imaging in pathology: advantages, limitations, and
               emerging perspectives",
  author    = "Farahani, Navid and Parwani, Anil V and Pantanowitz, Liron",
  abstract  = "Whole slide imaging in pathology: advantages, limitations, and
               emerging perspectives Navid Farahani,1 Anil V Parwani,2 Liron
               Pantanowitz2 1Department of Pathology and Laboratory Medicine,
               Cedars-Sinai Medical Center, Los Angeles, CA, USA; 2Department
               of Pathology, University of Pittsburgh School of Medicine,
               Pittsburgh, PA, USA Abstract: Significant technologic gains have
               led to the adoption of innovative digital imaging solutions in
               pathology. Whole slide imaging (WSI), which refers to scanning
               of conventional glass slides in order to produce digital slides,
               is the most recent imaging modality being employed by pathology
               departments worldwide. WSI continues to gain traction among
               pathologists for diagnostic, educational, and research purposes.
               This article provides a technologic review of WSI platforms and
               covers clinical and nonclinical pathology applications of these
               imaging systems. Barriers to adoption of WSI include limiting
               technology, image quality, problems with scanning all materials
               (eg, cytology slides), cost, digital slide storage, inability to
               handle high-throughput routine work, regulatory barriers,
               ergonomics, and pathologists' reluctance. Emerging issues
               related to clinical validation, standardization, and forthcoming
               advances in the field are also addressed. Keywords: digital,
               imaging, microscopy, pathology, validation, whole slide image,
               telepathology",
  journal   = "Pathol. Lab. Med. Int.",
  publisher = "Dove Press",
  volume    =  7,
  pages     = "23--33",
  month     =  jun,
  year      =  2015,
  language  = "en"
}

@ARTICLE{Lecun1998-ye,
  title    = "Gradient-based learning applied to document recognition",
  author   = "Lecun, Y and Bottou, L and Bengio, Y and Haffner, P",
  abstract = "Multilayer neural networks trained with the back-propagation
              algorithm constitute the best example of a successful gradient
              based learning technique. Given an appropriate network
              architecture, gradient-based learning algorithms can be used to
              synthesize a complex decision surface that can classify
              high-dimensional patterns, such as handwritten characters, with
              minimal preprocessing. This paper reviews various methods applied
              to handwritten character recognition and compares them on a
              standard handwritten digit recognition task. Convolutional neural
              networks, which are specifically designed to deal with the
              variability of 2D shapes, are shown to outperform all other
              techniques. Real-life document recognition systems are composed
              of multiple modules including field extraction, segmentation
              recognition, and language modeling. A new learning paradigm,
              called graph transformer networks (GTN), allows such multimodule
              systems to be trained globally using gradient-based methods so as
              to minimize an overall performance measure. Two systems for
              online handwriting recognition are described. Experiments
              demonstrate the advantage of global training, and the flexibility
              of graph transformer networks. A graph transformer network for
              reading a bank cheque is also described. It uses convolutional
              neural network character recognizers combined with global
              training techniques to provide record accuracy on business and
              personal cheques. It is deployed commercially and reads several
              million cheques per day.",
  journal  = "Proc. IEEE",
  volume   =  86,
  number   =  11,
  pages    = "2278--2324",
  month    =  nov,
  year     =  1998,
  keywords = "Neural networks;Pattern recognition;Machine learning;Optical
              character recognition software;Character recognition;Feature
              extraction;Multi-layer neural network;Optical computing;Hidden
              Markov models;Principal component analysis"
}

@ARTICLE{Scott2013-ol,
  title    = "A systematic approach to the diagnosis of suspected central
              nervous system lymphoma",
  author   = "Scott, Brian J and Douglas, Vanja C and Tihan, Tarik and
              Rubenstein, James L and Josephson, S Andrew",
  abstract = "Central nervous system (CNS) lymphoma can present a diagnostic
              challenge. Currently, there is no consensus regarding what
              presurgical evaluation is warranted or how to proceed when
              lesions are not surgically accessible. We conducted a review of
              the literature on CNS lymphoma diagnosis (1966 to October 2011)
              to determine whether a common diagnostic algorithm can be
              generated. We extracted data regarding the usefulness of brain
              and body imaging, serum and cerebrospinal fluid (CSF) studies,
              ophthalmologic examination, and tissue biopsy in the diagnosis of
              CNS lymphoma. Contrast enhancement on imaging is highly sensitive
              at the time of diagnosis: 98.9\% in immunocompetent lymphoma and
              96.1\% in human immunodeficiency virus-related CNS lymphoma. The
              sensitivity of CSF cytology is low (2\%-32\%) but increases when
              combined with flow cytometry. Cerebrospinal fluid lactate
              dehydrogenase isozyme 5, $\beta$2-microglobulin, and
              immunoglobulin heavy chain rearrangement studies have improved
              sensitivity over CSF cytology (58\%-85\%) but have only moderate
              specificity (85\%). New techniques of proteomics and microRNA
              analysis have more than 95\% specificity in the diagnosis of CNS
              lymphoma. Positive CSF cytology, vitreous biopsy, or
              brain/leptomeningeal biopsy remain the current standard for
              diagnosis. A combined stepwise systematic approach outlined here
              may facilitate an expeditious, comprehensive presurgical
              evaluation for cases of suspected CNS lymphoma.",
  journal  = "JAMA Neurol.",
  volume   =  70,
  number   =  3,
  pages    = "311--319",
  month    =  mar,
  year     =  2013,
  language = "en"
}

@ARTICLE{Ehteshami_Bejnordi2017-fb,
  title    = "Diagnostic Assessment of Deep Learning Algorithms for Detection
              of Lymph Node Metastases in Women With Breast Cancer",
  author   = "Ehteshami Bejnordi, Babak and Veta, Mitko and Johannes van Diest,
              Paul and van Ginneken, Bram and Karssemeijer, Nico and Litjens,
              Geert and van der Laak, Jeroen A W M and {the CAMELYON16
              Consortium} and Hermsen, Meyke and Manson, Quirine F and
              Balkenhol, Maschenka and Geessink, Oscar and Stathonikos,
              Nikolaos and van Dijk, Marcory Crf and Bult, Peter and Beca,
              Francisco and Beck, Andrew H and Wang, Dayong and Khosla, Aditya
              and Gargeya, Rishab and Irshad, Humayun and Zhong, Aoxiao and
              Dou, Qi and Li, Quanzheng and Chen, Hao and Lin, Huang-Jing and
              Heng, Pheng-Ann and Ha{\ss}, Christian and Bruni, Elia and Wong,
              Quincy and Halici, Ugur and {\"O}ner, Mustafa {\"U}mit and
              Cetin-Atalay, Rengul and Berseth, Matt and Khvatkov, Vitali and
              Vylegzhanin, Alexei and Kraus, Oren and Shaban, Muhammad and
              Rajpoot, Nasir and Awan, Ruqayya and Sirinukunwattana, Korsuk and
              Qaiser, Talha and Tsang, Yee-Wah and Tellez, David and
              Annuscheit, Jonas and Hufnagl, Peter and Valkonen, Mira and
              Kartasalo, Kimmo and Latonen, Leena and Ruusuvuori, Pekka and
              Liimatainen, Kaisa and Albarqouni, Shadi and Mungal, Bharti and
              George, Ami and Demirci, Stefanie and Navab, Nassir and Watanabe,
              Seiryo and Seno, Shigeto and Takenaka, Yoichi and Matsuda, Hideo
              and Ahmady Phoulady, Hady and Kovalev, Vassili and Kalinovsky,
              Alexander and Liauchuk, Vitali and Bueno, Gloria and
              Fernandez-Carrobles, M Milagro and Serrano, Ismael and Deniz,
              Oscar and Racoceanu, Daniel and Ven{\^a}ncio, Rui",
  abstract = "Importance: Application of deep learning algorithms to
              whole-slide pathology images can potentially improve diagnostic
              accuracy and efficiency. Objective: Assess the performance of
              automated deep learning algorithms at detecting metastases in
              hematoxylin and eosin-stained tissue sections of lymph nodes of
              women with breast cancer and compare it with pathologists'
              diagnoses in a diagnostic setting. Design, Setting, and
              Participants: Researcher challenge competition (CAMELYON16) to
              develop automated solutions for detecting lymph node metastases
              (November 2015-November 2016). A training data set of whole-slide
              images from 2 centers in the Netherlands with (n = 110) and
              without (n = 160) nodal metastases verified by
              immunohistochemical staining were provided to challenge
              participants to build algorithms. Algorithm performance was
              evaluated in an independent test set of 129 whole-slide images
              (49 with and 80 without metastases). The same test set of
              corresponding glass slides was also evaluated by a panel of 11
              pathologists with time constraint (WTC) from the Netherlands to
              ascertain likelihood of nodal metastases for each slide in a
              flexible 2-hour session, simulating routine pathology workflow,
              and by 1 pathologist without time constraint (WOTC). Exposures:
              Deep learning algorithms submitted as part of a challenge
              competition or pathologist interpretation. Main Outcomes and
              Measures: The presence of specific metastatic foci and the
              absence vs presence of lymph node metastasis in a slide or image
              using receiver operating characteristic curve analysis. The 11
              pathologists participating in the simulation exercise rated their
              diagnostic confidence as definitely normal, probably normal,
              equivocal, probably tumor, or definitely tumor. Results: The area
              under the receiver operating characteristic curve (AUC) for the
              algorithms ranged from 0.556 to 0.994. The top-performing
              algorithm achieved a lesion-level, true-positive fraction
              comparable with that of the pathologist WOTC (72.4\% [95\% CI,
              64.3\%-80.4\%]) at a mean of 0.0125 false-positives per normal
              whole-slide image. For the whole-slide image classification task,
              the best algorithm (AUC, 0.994 [95\% CI, 0.983-0.999]) performed
              significantly better than the pathologists WTC in a diagnostic
              simulation (mean AUC, 0.810 [range, 0.738-0.884]; P < .001). The
              top 5 algorithms had a mean AUC that was comparable with the
              pathologist interpreting the slides in the absence of time
              constraints (mean AUC, 0.960 [range, 0.923-0.994] for the top 5
              algorithms vs 0.966 [95\% CI, 0.927-0.998] for the pathologist
              WOTC). Conclusions and Relevance: In the setting of a challenge
              competition, some deep learning algorithms achieved better
              diagnostic performance than a panel of 11 pathologists
              participating in a simulation exercise designed to mimic routine
              pathology workflow; algorithm performance was comparable with an
              expert pathologist interpreting whole-slide images without time
              constraints. Whether this approach has clinical utility will
              require evaluation in a clinical setting.",
  journal  = "JAMA",
  volume   =  318,
  number   =  22,
  pages    = "2199--2210",
  month    =  dec,
  year     =  2017,
  language = "en"
}

@ARTICLE{Raghu2019-yt,
  title         = "Transfusion: Understanding Transfer Learning for Medical
                   Imaging",
  author        = "Raghu, Maithra and Zhang, Chiyuan and Kleinberg, Jon and
                   Bengio, Samy",
  abstract      = "Transfer learning from natural image datasets, particularly
                   ImageNet, using standard large models and corresponding
                   pretrained weights has become a de-facto method for deep
                   learning applications to medical imaging. However, there are
                   fundamental differences in data sizes, features and task
                   specifications between natural image classification and the
                   target medical tasks, and there is little understanding of
                   the effects of transfer. In this paper, we explore
                   properties of transfer learning for medical imaging. A
                   performance evaluation on two large scale medical imaging
                   tasks shows that surprisingly, transfer offers little
                   benefit to performance, and simple, lightweight models can
                   perform comparably to ImageNet architectures. Investigating
                   the learned representations and features, we find that some
                   of the differences from transfer learning are due to the
                   over-parametrization of standard models rather than
                   sophisticated feature reuse. We isolate where useful feature
                   reuse occurs, and outline the implications for more
                   efficient model exploration. We also explore feature
                   independent benefits of transfer arising from weight
                   scalings.",
  month         =  feb,
  year          =  2019,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "1902.07208"
}

@ARTICLE{Steiner2021-wz,
  title         = "How to train your {ViT}? Data, Augmentation, and
                   Regularization in Vision Transformers",
  author        = "Steiner, Andreas and Kolesnikov, Alexander and Zhai, Xiaohua
                   and Wightman, Ross and Uszkoreit, Jakob and Beyer, Lucas",
  abstract      = "Vision Transformers (ViT) have been shown to attain highly
                   competitive performance for a wide range of vision
                   applications, such as image classification, object detection
                   and semantic image segmentation. In comparison to
                   convolutional neural networks, the Vision Transformer's
                   weaker inductive bias is generally found to cause an
                   increased reliance on model regularization or data
                   augmentation (``AugReg'' for short) when training on smaller
                   training datasets. We conduct a systematic empirical study
                   in order to better understand the interplay between the
                   amount of training data, AugReg, model size and compute
                   budget. As one result of this study we find that the
                   combination of increased compute and AugReg can yield models
                   with the same performance as models trained on an order of
                   magnitude more training data: we train ViT models of various
                   sizes on the public ImageNet-21k dataset which either match
                   or outperform their counterparts trained on the larger, but
                   not publicly available JFT-300M dataset.",
  month         =  jun,
  year          =  2021,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "2106.10270"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@INPROCEEDINGS{Kolesnikov2019-zw,
  title     = "Revisiting self-supervised visual representation learning",
  booktitle = "Proceedings of the {IEEE/CVF} conference on computer vision and
               pattern recognition",
  author    = "Kolesnikov, Alexander and Zhai, Xiaohua and Beyer, Lucas",
  abstract  = "Unsupervised visual representation learning remains a largely
               unsolved problem in computer vision research. Among a big body
               of recently proposed approaches for unsupervised learning of
               visual representations, a class of self-supervised techniques
               achieves superior performance on many challenging benchmarks. A
               large number of the pretext tasks for self-supervised learning
               have been studied, but other important aspects, such as the
               choice of convolutional neural networks (CNN), has not received
               equal â€¦",
  publisher = "openaccess.thecvf.com",
  pages     = "1920--1929",
  year      =  2019
}

@ARTICLE{Campanella2019-oc,
  title    = "Clinical-grade computational pathology using weakly supervised
              deep learning on whole slide images",
  author   = "Campanella, Gabriele and Hanna, Matthew G and Geneslaw, Luke and
              Miraflor, Allen and Werneck Krauss Silva, Vitor and Busam, Klaus
              J and Brogi, Edi and Reuter, Victor E and Klimstra, David S and
              Fuchs, Thomas J",
  abstract = "The development of decision support systems for pathology and
              their deployment in clinical practice have been hindered by the
              need for large manually annotated datasets. To overcome this
              problem, we present a multiple instance learning-based deep
              learning system that uses only the reported diagnoses as labels
              for training, thereby avoiding expensive and time-consuming
              pixel-wise manual annotations. We evaluated this framework at
              scale on a dataset of 44,732 whole slide images from 15,187
              patients without any form of data curation. Tests on prostate
              cancer, basal cell carcinoma and breast cancer metastases to
              axillary lymph nodes resulted in areas under the curve above 0.98
              for all cancer types. Its clinical application would allow
              pathologists to exclude 65-75\% of slides while retaining 100\%
              sensitivity. Our results show that this system has the ability to
              train accurate classification models at unprecedented scale,
              laying the foundation for the deployment of computational
              decision support systems in clinical practice.",
  journal  = "Nat. Med.",
  volume   =  25,
  number   =  8,
  pages    = "1301--1309",
  month    =  aug,
  year     =  2019,
  language = "en"
}

@ARTICLE{Lu2021-vn,
  title    = "Data-efficient and weakly supervised computational pathology on
              whole-slide images",
  author   = "Lu, Ming Y and Williamson, Drew F K and Chen, Tiffany Y and Chen,
              Richard J and Barbieri, Matteo and Mahmood, Faisal",
  abstract = "Deep-learning methods for computational pathology require either
              manual annotation of gigapixel whole-slide images (WSIs) or large
              datasets of WSIs with slide-level labels and typically suffer
              from poor domain adaptation and interpretability. Here we report
              an interpretable weakly supervised deep-learning method for
              data-efficient WSI processing and learning that only requires
              slide-level labels. The method, which we named
              clustering-constrained-attention multiple-instance learning
              (CLAM), uses attention-based learning to identify subregions of
              high diagnostic value to accurately classify whole slides and
              instance-level clustering over the identified representative
              regions to constrain and refine the feature space. By applying
              CLAM to the subtyping of renal cell carcinoma and non-small-cell
              lung cancer as well as the detection of lymph node metastasis, we
              show that it can be used to localize well-known morphological
              features on WSIs without the need for spatial labels, that it
              overperforms standard weakly supervised classification algorithms
              and that it is adaptable to independent test cohorts, smartphone
              microscopy and varying tissue content.",
  journal  = "Nat Biomed Eng",
  volume   =  5,
  number   =  6,
  pages    = "555--570",
  month    =  jun,
  year     =  2021,
  language = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@UNPUBLISHED{Shao2021-sj,
  title    = "{TransMIL}: Transformer based Correlated Multiple Instance
              Learning for Whole Slide Image Classification",
  author   = "Shao, Zhuchen and Bian, Hao and Chen, Yang and Wang, Yifeng and
              Zhang, Jian and Ji, Xiangyang and Zhang, Yongbing",
  abstract = "Multiple instance learning (MIL) is a powerful tool to solve the
              weakly supervised classification in whole slide image (WSI) based
              pathology diagnosis. However, the current MIL methods are usually
              based on independent and identical distribution hypothesis, thus
              neglect the correlation among different instances. To address
              this problem, we proposed a new framework, called correlated MIL,
              and provided a proof for convergence. Based on this framework, we
              devised a Transformer based MIL (TransMIL), which explored both
              morphological and spatial information. The proposed TransMIL can
              effectively deal with unbalanced/balanced and binary/multiple
              classification with great visualization and interpretability. We
              conducted various experiments for three different computational
              pathology problems and achieved better performance and faster
              convergence compared with state-of-the-art methods. The test AUC
              for the binary tumor classification can be up to 93.09\% over
              CAMELYON16 dataset. And the AUC over the cancer subtypes
              classification can be up to 96.03\% and 98.82\% over TCGA-NSCLC
              dataset and TCGA-RCC dataset, respectively. Implementation is
              available at: https://github.com/szc19990412/TransMIL.",
  journal  = "https://openreview.net â€º forumhttps://openreview.net â€º forum",
  month    =  may,
  year     =  2021
}

@INPROCEEDINGS{Ilse2018-ix,
  title     = "Attention-based Deep Multiple Instance Learning",
  booktitle = "Proceedings of the 35th International Conference on Machine
               Learning",
  author    = "Ilse, Maximilian and Tomczak, Jakub and Welling, Max",
  editor    = "Dy, Jennifer and Krause, Andreas",
  abstract  = "Multiple instance learning (MIL) is a variation of supervised
               learning where a single class label is assigned to a bag of
               instances. In this paper, we state the MIL problem as learning
               the Bernoulli distribution of the bag label where the bag label
               probability is fully parameterized by neural networks.
               Furthermore, we propose a neural network-based
               permutation-invariant aggregation operator that corresponds to
               the attention mechanism. Notably, an application of the proposed
               attention-based operator provides insight into the contribution
               of each instance to the bag label. We show empirically that our
               approach achieves comparable performance to the best MIL methods
               on benchmark MIL datasets and it outperforms other methods on a
               MNIST-based MIL dataset and two real-life histopathology
               datasets without sacrificing interpretability.",
  publisher = "PMLR",
  volume    =  80,
  pages     = "2127--2136",
  series    = "Proceedings of Machine Learning Research",
  year      =  2018
}

@ARTICLE{Vanderbeek2018-ba,
  title    = "The clinical trials landscape for glioblastoma: is it adequate to
              develop new treatments?",
  author   = "Vanderbeek, Alyssa M and Rahman, Rifaquat and Fell, Geoffrey and
              Ventz, Steffen and Chen, Tianqi and Redd, Robert and Parmigiani,
              Giovanni and Cloughesy, Timothy F and Wen, Patrick Y and Trippa,
              Lorenzo and Alexander, Brian M",
  abstract = "Background: There have been few treatment advances for patients
              with glioblastoma (GBM) despite increasing scientific
              understanding of the disease. While factors such as intrinsic
              tumor biology and drug delivery are challenges to developing
              efficacious therapies, it is unclear whether the current clinical
              trial landscape is optimally evaluating new therapies and
              biomarkers. Methods: We queried ClinicalTrials.gov for
              interventional clinical trials for patients with GBM initiated
              between January 2005 and December 2016 and abstracted data
              regarding phase, status, start and end dates, testing locations,
              endpoints, experimental interventions, sample size, clinical
              presentation/indication, and design to better understand the
              clinical trials landscape. Results: Only approximately 8\%-11\%
              of patients with newly diagnosed GBM enroll on clinical trials
              with a similar estimate for all patients with GBM. Trial duration
              was similar across phases with median time to completion between
              3 and 4 years. While 93\% of clinical trials were in phases I-II,
              26\% of the overall clinical trial patient population was
              enrolled on phase III studies. Of the 8 completed phase III
              trials, only 1 reported positive results. Although 58\% of the
              phase III trials were supported by phase II data with a similar
              endpoint, only 25\% of these phase II trials were randomized.
              Conclusions: The clinical trials landscape for GBM is
              characterized by long development times, inadequate dissemination
              of information, suboptimal go/no-go decision making, and low
              patient participation.",
  journal  = "Neuro. Oncol.",
  volume   =  20,
  number   =  8,
  pages    = "1034--1043",
  month    =  jul,
  year     =  2018,
  language = "en"
}

@ARTICLE{Cahill2021-yn,
  title    = "Extent of Resection of Glioblastoma: A Critical Evaluation in the
              Molecular Era",
  author   = "Cahill, Daniel P",
  abstract = "The work of modern neurosurgical glioma practice combines
              securing accurate diagnoses, under the 2016 revised World Health
              Organization (WHO) Classification of Tumors of the Central
              Nervous System, with an aggressive and safe surgical pursuit of
              tumor removal. The evidence base that drives clinical
              decision-making has undergone a critical reevaluation with the
              incorporation of molecular classifiers into the updated WHO
              diagnoses including the 3 most common diffuse gliomas in adults:
              glioblastoma IDH wild-type, astrocytoma IDH mutant, and
              oligodendroglioma IDH mutant 1p/19q codeleted. The studies that
              form the foundation of modern practice, and the areas for future
              inquiry are reviewed.",
  journal  = "Neurosurg. Clin. N. Am.",
  volume   =  32,
  number   =  1,
  pages    = "23--29",
  month    =  jan,
  year     =  2021,
  keywords = "Glioma; IDH1 mutation; Surgery",
  language = "en"
}

@ARTICLE{Capper2018-al,
  title    = "{DNA} methylation-based classification of central nervous system
              tumours",
  author   = "Capper, David and Jones, David T W and Sill, Martin and
              Hovestadt, Volker and Schrimpf, Daniel and Sturm, Dominik and
              Koelsche, Christian and Sahm, Felix and Chavez, Lukas and Reuss,
              David E and Kratz, Annekathrin and Wefers, Annika K and Huang,
              Kristin and Pajtler, Kristian W and Schweizer, Leonille and
              Stichel, Damian and Olar, Adriana and Engel, Nils W and
              Lindenberg, Kerstin and Harter, Patrick N and Braczynski, Anne K
              and Plate, Karl H and Dohmen, Hildegard and Garvalov, Boyan K and
              Coras, Roland and H{\"o}lsken, Annett and Hewer, Ekkehard and
              Bewerunge-Hudler, Melanie and Schick, Matthias and Fischer, Roger
              and Beschorner, Rudi and Schittenhelm, Jens and Staszewski, Ori
              and Wani, Khalida and Varlet, Pascale and Pages, Melanie and
              Temming, Petra and Lohmann, Dietmar and Selt, Florian and Witt,
              Hendrik and Milde, Till and Witt, Olaf and Aronica, Eleonora and
              Giangaspero, Felice and Rushing, Elisabeth and Scheurlen, Wolfram
              and Geisenberger, Christoph and Rodriguez, Fausto J and Becker,
              Albert and Preusser, Matthias and Haberler, Christine and
              Bjerkvig, Rolf and Cryan, Jane and Farrell, Michael and Deckert,
              Martina and Hench, J{\"u}rgen and Frank, Stephan and Serrano,
              Jonathan and Kannan, Kasthuri and Tsirigos, Aristotelis and
              Br{\"u}ck, Wolfgang and Hofer, Silvia and Brehmer, Stefanie and
              Seiz-Rosenhagen, Marcel and H{\"a}nggi, Daniel and Hans, Volkmar
              and Rozsnoki, Stephanie and Hansford, Jordan R and Kohlhof,
              Patricia and Kristensen, Bjarne W and Lechner, Matt and Lopes,
              Beatriz and Mawrin, Christian and Ketter, Ralf and Kulozik,
              Andreas and Khatib, Ziad and Heppner, Frank and Koch, Arend and
              Jouvet, Anne and Keohane, Catherine and M{\"u}hleisen, Helmut and
              Mueller, Wolf and Pohl, Ute and Prinz, Marco and Benner, Axel and
              Zapatka, Marc and Gottardo, Nicholas G and Driever, Pablo
              Hern{\'a}iz and Kramm, Christof M and M{\"u}ller, Hermann L and
              Rutkowski, Stefan and von Hoff, Katja and Fr{\"u}hwald, Michael C
              and Gnekow, Astrid and Fleischhack, Gudrun and Tippelt, Stephan
              and Calaminus, Gabriele and Monoranu, Camelia-Maria and Perry,
              Arie and Jones, Chris and Jacques, Thomas S and Radlwimmer,
              Bernhard and Gessi, Marco and Pietsch, Torsten and Schramm,
              Johannes and Schackert, Gabriele and Westphal, Manfred and
              Reifenberger, Guido and Wesseling, Pieter and Weller, Michael and
              Collins, Vincent Peter and Bl{\"u}mcke, Ingmar and Bendszus,
              Martin and Debus, J{\"u}rgen and Huang, Annie and Jabado, Nada
              and Northcott, Paul A and Paulus, Werner and Gajjar, Amar and
              Robinson, Giles W and Taylor, Michael D and Jaunmuktane, Zane and
              Ryzhova, Marina and Platten, Michael and Unterberg, Andreas and
              Wick, Wolfgang and Karajannis, Matthias A and Mittelbronn, Michel
              and Acker, Till and Hartmann, Christian and Aldape, Kenneth and
              Sch{\"u}ller, Ulrich and Buslei, Rolf and Lichter, Peter and
              Kool, Marcel and Herold-Mende, Christel and Ellison, David W and
              Hasselblatt, Martin and Snuderl, Matija and Brandner, Sebastian
              and Korshunov, Andrey and von Deimling, Andreas and Pfister,
              Stefan M",
  abstract = "Accurate pathological diagnosis is crucial for optimal management
              of patients with cancer. For the approximately 100 known tumour
              types of the central nervous system, standardization of the
              diagnostic process has been shown to be particularly
              challenging-with substantial inter-observer variability in the
              histopathological diagnosis of many tumour types. Here we present
              a comprehensive approach for the DNA methylation-based
              classification of central nervous system tumours across all
              entities and age groups, and demonstrate its application in a
              routine diagnostic setting. We show that the availability of this
              method may have a substantial impact on diagnostic precision
              compared to standard methods, resulting in a change of diagnosis
              in up to 12\% of prospective cases. For broader accessibility, we
              have designed a free online classifier tool, the use of which
              does not require any additional onsite data processing. Our
              results provide a blueprint for the generation of
              machine-learning-based tumour classifiers across other cancer
              entities, with the potential to fundamentally transform tumour
              pathology.",
  journal  = "Nature",
  volume   =  555,
  number   =  7697,
  pages    = "469--474",
  month    =  mar,
  year     =  2018,
  language = "en"
}

@ARTICLE{Saharia2022-kp,
  title         = "Photorealistic {Text-to-Image} Diffusion Models with Deep
                   Language Understanding",
  author        = "Saharia, Chitwan and Chan, William and Saxena, Saurabh and
                   Li, Lala and Whang, Jay and Denton, Emily and Ghasemipour,
                   Seyed Kamyar Seyed and Ayan, Burcu Karagol and Sara Mahdavi,
                   S and Lopes, Rapha Gontijo and Salimans, Tim and Ho,
                   Jonathan and Fleet, David J and Norouzi, Mohammad",
  abstract      = "We present Imagen, a text-to-image diffusion model with an
                   unprecedented degree of photorealism and a deep level of
                   language understanding. Imagen builds on the power of large
                   transformer language models in understanding text and hinges
                   on the strength of diffusion models in high-fidelity image
                   generation. Our key discovery is that generic large language
                   models (e.g. T5), pretrained on text-only corpora, are
                   surprisingly effective at encoding text for image synthesis:
                   increasing the size of the language model in Imagen boosts
                   both sample fidelity and image-text alignment much more than
                   increasing the size of the image diffusion model. Imagen
                   achieves a new state-of-the-art FID score of 7.27 on the
                   COCO dataset, without ever training on COCO, and human
                   raters find Imagen samples to be on par with the COCO data
                   itself in image-text alignment. To assess text-to-image
                   models in greater depth, we introduce DrawBench, a
                   comprehensive and challenging benchmark for text-to-image
                   models. With DrawBench, we compare Imagen with recent
                   methods including VQ-GAN+CLIP, Latent Diffusion Models, and
                   DALL-E 2, and find that human raters prefer Imagen over
                   other models in side-by-side comparisons, both in terms of
                   sample quality and image-text alignment. See
                   https://imagen.research.google/ for an overview of the
                   results.",
  month         =  may,
  year          =  2022,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "2205.11487"
}

@ARTICLE{Bhandari2021-yi,
  title    = "Noninvasive Determination of {IDH} and 1p19q Status of
              Lower-grade Gliomas Using {MRI} Radiomics: A Systematic Review",
  author   = "Bhandari, A P and Liong, R and Koppen, J and Murthy, S V and
              Lasocki, A",
  abstract = "BACKGROUND: Determination of isocitrate dehydrogenase (IDH)
              status and, if IDH-mutant, assessing 1p19q codeletion are an
              important component of diagnosis of World Health Organization
              grades II/III or lower-grade gliomas. This has led to research
              into noninvasively correlating imaging features (``radiomics'')
              with genetic status. PURPOSE: Our aim was to perform a diagnostic
              test accuracy systematic review for classifying IDH and 1p19q
              status using MR imaging radiomics, to provide future directions
              for integration into clinical radiology. DATA SOURCES: Ovid
              (MEDLINE), Scopus, and the Web of Science were searched in
              accordance with the Preferred Reporting Items for Systematic
              Reviews and Meta-Analyses for Diagnostic Test Accuracy
              guidelines. STUDY SELECTION: Fourteen journal articles were
              selected that included 1655 lower-grade gliomas classified by
              their IDH and/or 1p19q status from MR imaging radiomic features.
              DATA ANALYSIS: For each article, the classification of IDH and/or
              1p19q status using MR imaging radiomics was evaluated using the
              area under curve or descriptive statistics. Quality assessment
              was performed with the Quality Assessment of Diagnostic Accuracy
              Studies 2 tool and the radiomics quality score. DATA SYNTHESIS:
              The best classifier of IDH status was with conventional radiomics
              in combination with convolutional neural network-derived features
              (area under the curve = 0.95, 94.4\% sensitivity, 86.7\%
              specificity). Optimal classification of 1p19q status occurred
              with texture-based radiomics (area under the curve = 0.96, 90\%
              sensitivity, 89\% specificity). LIMITATIONS: A meta-analysis
              showed high heterogeneity due to the uniqueness of radiomic
              pipelines. CONCLUSIONS: Radiogenomics is a potential alternative
              to standard invasive biopsy techniques for determination of IDH
              and 1p19q status in lower-grade gliomas but requires
              translational research for clinical uptake.",
  journal  = "AJNR Am. J. Neuroradiol.",
  volume   =  42,
  number   =  1,
  pages    = "94--101",
  month    =  jan,
  year     =  2021,
  language = "en"
}

@ARTICLE{Chen2014-wj,
  title    = "Predicting the likelihood of an isocitrate dehydrogenase 1 or 2
              mutation in diagnoses of infiltrative glioma",
  author   = "Chen, Li and Voronovich, Zoya and Clark, Kenneth and Hands, Isaac
              and Mannas, Jonathan and Walsh, Meggen and Nikiforova, Marina N
              and Durbin, Eric B and Weiss, Heidi and Horbinski, Craig",
  abstract = "BACKGROUND: Several variables are associated with the likelihood
              of isocitrate dehydrogenase 1 or 2 (IDH1/2) mutation in gliomas,
              though no guidelines yet exist for when testing is warranted,
              especially when an R132H IDH1 immunostain is negative. METHODS: A
              cohort of 89 patients was used to build IDH1/2 mutation
              prediction models in World Health Organization grades II-IV
              gliomas, and an external cohort of 100 patients was used for
              validation. Logistic regression and backward model selection with
              the Akaike information criterion were used to develop prediction
              models. RESULTS: A multivariable model, incorporating patient
              age, glioblastoma multiforme diagnosis, and prior history of
              grade II or III glioma, was developed to predict IDH1/2 mutation
              probability. This model generated an area under the curve (AUC)
              of 0.934 (95\% CI: 0.878, 0.978) in the external validation
              cohort and 0.941 (95\% CI: 0.918, 0.962) in the cohort of The
              Cancer Genome Atlas. When R132H IDH1 immunostain information was
              added, AUC increased to 0.986 (95\% CI: 0.967, 0.998). This model
              had an AUC of 0.947 (95\% CI: 0.891, 0.995) in predicting whether
              an R132H IDH1 immunonegative case harbored a less common IDH1 or
              IDH2 mutation. The models were also 94\% accurate in predicting
              IDH1/2 mutation status in gliomas from The Cancer Genome Atlas.
              An interactive web-based application for calculating the
              probability of an IDH1/2 mutation is now available using these
              models. CONCLUSIONS: We have integrated multiple variables to
              generate a probability of an IDH1/2 mutation. The associated
              web-based application can help triage diffuse gliomas that would
              benefit from mutation testing in both clinical and research
              settings.",
  journal  = "Neuro. Oncol.",
  volume   =  16,
  number   =  11,
  pages    = "1478--1483",
  month    =  nov,
  year     =  2014,
  keywords = "IDH1; IDH2; glioma",
  language = "en"
}

@ARTICLE{Brat2022-ve,
  title    = "Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas",
  author   = "Brat, Daniel J and Aldape, Kenneth and Bridge, Julia A and
              Canoll, Peter and Colman, Howard and Hameed, Meera R and Harris,
              Brent T and Hattab, Eyas M and Huse, Jason T and Jenkins, Robert
              B and Lopez-Terrada, Dolores H and McDonald, William C and
              Rodriguez, Fausto J and Souter, Lesley H and Colasacco, Carol and
              Thomas, Nicole E and Yount, Michelle Hawks and van den Bent,
              Martin J and Perry, Arie",
  abstract = "CONTEXT.---: The diagnosis and clinical management of patients
              with diffuse gliomas (DGs) have evolved rapidly over the past
              decade with the emergence of molecular biomarkers that are used
              to classify, stratify risk, and predict treatment response for
              optimal clinical care. OBJECTIVE.---: To develop evidence-based
              recommendations for informing molecular biomarker testing for
              pediatric and adult patients with DGs and provide guidance for
              appropriate laboratory test and biomarker selection for optimal
              diagnosis, risk stratification, and prediction. DESIGN.---: The
              College of American Pathologists convened an expert panel to
              perform a systematic review of the literature and develop
              recommendations. A systematic review of literature was conducted
              to address the overarching question, ``What ancillary tests are
              needed to classify DGs and sufficiently inform the clinical
              management of patients?'' Recommendations were derived from
              quality of evidence, open comment feedback, and expert panel
              consensus. RESULTS.---: Thirteen recommendations and 3 good
              practice statements were established to guide pathologists and
              treating physicians on the most appropriate methods and molecular
              biomarkers to include in laboratory testing to inform clinical
              management of patients with DGs. CONCLUSIONS.---: Evidence-based
              incorporation of laboratory results from molecular biomarker
              testing into integrated diagnoses of DGs provides reproducible
              and clinically meaningful information for patient management.",
  journal  = "Arch. Pathol. Lab. Med.",
  volume   =  146,
  number   =  5,
  pages    = "547--574",
  month    =  may,
  year     =  2022,
  language = "en"
}

@ARTICLE{Horbinski2022-ue,
  title    = "Clinical implications of the 2021 edition of the {WHO}
              classification of central nervous system tumours",
  author   = "Horbinski, Craig and Berger, Tamar and Packer, Roger J and Wen,
              Patrick Y",
  abstract = "A new edition of the WHO classification of tumours of the CNS was
              published in 2021. Although the previous edition of this
              classification was published just 5 years earlier, in 2016, rapid
              advances in our understanding of the molecular underpinnings of
              CNS tumours, including the diversity of clinically relevant
              molecular types and subtypes, necessitated a new classification
              system. Compared with the 2016 scheme, the new classification
              incorporates even more molecular alterations into the diagnosis
              of many tumours and reorganizes gliomas into adult-type diffuse
              gliomas, paediatric-type diffuse low-grade and high-grade
              gliomas, circumscribed astrocytic gliomas, and ependymal tumours.
              A number of new entities are incorporated into the 2021
              classification, especially tumours that preferentially or
              exclusively arise in the paediatric population. Such a
              substantial revision of the WHO scheme will have major
              implications for the diagnosis and treatment of patients with CNS
              tumours. In this Perspective, we summarize the main changes in
              the classification of diffuse and circumscribed gliomas,
              ependymomas, embryonal tumours and meningiomas, and discuss how
              each change will influence post-surgical treatment, clinical
              trial enrolment and cooperative studies. Although the 2021 WHO
              classification of CNS tumours is a major conceptual advance, its
              implementation on a routine clinical basis presents some
              challenges that will require innovative solutions.",
  journal  = "Nat. Rev. Neurol.",
  month    =  jun,
  year     =  2022,
  language = "en"
}

@ARTICLE{Radford2021-kp,
  title         = "Learning Transferable Visual Models From Natural Language
                   Supervision",
  author        = "Radford, Alec and Kim, Jong Wook and Hallacy, Chris and
                   Ramesh, Aditya and Goh, Gabriel and Agarwal, Sandhini and
                   Sastry, Girish and Askell, Amanda and Mishkin, Pamela and
                   Clark, Jack and Krueger, Gretchen and Sutskever, Ilya",
  abstract      = "State-of-the-art computer vision systems are trained to
                   predict a fixed set of predetermined object categories. This
                   restricted form of supervision limits their generality and
                   usability since additional labeled data is needed to specify
                   any other visual concept. Learning directly from raw text
                   about images is a promising alternative which leverages a
                   much broader source of supervision. We demonstrate that the
                   simple pre-training task of predicting which caption goes
                   with which image is an efficient and scalable way to learn
                   SOTA image representations from scratch on a dataset of 400
                   million (image, text) pairs collected from the internet.
                   After pre-training, natural language is used to reference
                   learned visual concepts (or describe new ones) enabling
                   zero-shot transfer of the model to downstream tasks. We
                   study the performance of this approach by benchmarking on
                   over 30 different existing computer vision datasets,
                   spanning tasks such as OCR, action recognition in videos,
                   geo-localization, and many types of fine-grained object
                   classification. The model transfers non-trivially to most
                   tasks and is often competitive with a fully supervised
                   baseline without the need for any dataset specific training.
                   For instance, we match the accuracy of the original
                   ResNet-50 on ImageNet zero-shot without needing to use any
                   of the 1.28 million training examples it was trained on. We
                   release our code and pre-trained model weights at
                   https://github.com/OpenAI/CLIP.",
  month         =  feb,
  year          =  2021,
  archivePrefix = "arXiv",
  primaryClass  = "cs.CV",
  eprint        = "2103.00020"
}

@ARTICLE{Hollon2022-kr,
  title     = "{AI-based} molecular classification of diffuse gliomas using
               rapid, label-free optical imaging",
  author    = "Hollon, Todd and Jiang, Cheng and Chowdury, Asadur and
               Nasir-Moin, Mustafa and Kondepudi, Akhil and Aabedi, Alexander
               and Adapa, Arjun and Al-Holou, Wajd and Heth, Jason and Sagher,
               Oren and Lowenstein, Pedro and Castro, Maria and Wadiura, Lisa
               and Widhalm, Georg and Neuschmelting, Volker and Reinecke, David
               and von Spreckelsen, Niklas and Berger, Mitchell and
               Hervey-Jumper, Shawn and Golfinos, John and Snuderl, Matija and
               Camelo-Piragua, Sandra and Freudiger, Christian and Lee, Honglak
               and Orringer, Daniel",
  abstract  = "Abstract Molecular classification has transformed the management
               of brain tumors by enabling more accurate prognostication and
               personalized treatment. However, timely molecular diagnostic
               testing for brain tumor patients is limited [1--3], complicating
               surgical and adjuvant treatment and obstructing clinical trial
               enrollment [4]. Here, we developed DeepGlioma, a rapid (",
  journal   = "In Review at Nature, Preprint available at Research Square",
  publisher = "Research Square Platform LLC",
  month     =  aug,
  year      =  2022
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@UNPUBLISHED{Jiang2022-bk,
  title    = "{OpenSRH}: optimizing brain tumor surgery using intraoperative
              stimulated Raman histology",
  author   = "Jiang, Cheng and Chowdury, Asadur Zaman and Hou, Xinhai and
              Kondepudi, Akhil and Freudiger, Christian and Conway, Kyle
              Stephen and Camelo-Piragua, Sandra and Orringer, Daniel A and
              Lee, Honglak and Hollon, Todd",
  journal  = "https://openreview.net â€º forumhttps://openreview.net â€º
              forumhttps://openreview.net â€º profile â€º
              id=~Todd\_Hollon1https://openreview.net â€º profile â€º
              id=~Todd\_Hollon1",
  month    =  jun,
  year     =  2022
}

@ARTICLE{Lander2001-fn,
  title    = "Initial sequencing and analysis of the human genome",
  author   = "Lander, E S and Linton, L M and Birren, B and Nusbaum, C and
              Zody, M C and Baldwin, J and Devon, K and Dewar, K and Doyle, M
              and FitzHugh, W and Funke, R and Gage, D and Harris, K and
              Heaford, A and Howland, J and Kann, L and Lehoczky, J and LeVine,
              R and McEwan, P and McKernan, K and Meldrim, J and Mesirov, J P
              and Miranda, C and Morris, W and Naylor, J and Raymond, C and
              Rosetti, M and Santos, R and Sheridan, A and Sougnez, C and
              Stange-Thomann, Y and Stojanovic, N and Subramanian, A and Wyman,
              D and Rogers, J and Sulston, J and Ainscough, R and Beck, S and
              Bentley, D and Burton, J and Clee, C and Carter, N and Coulson, A
              and Deadman, R and Deloukas, P and Dunham, A and Dunham, I and
              Durbin, R and French, L and Grafham, D and Gregory, S and
              Hubbard, T and Humphray, S and Hunt, A and Jones, M and Lloyd, C
              and McMurray, A and Matthews, L and Mercer, S and Milne, S and
              Mullikin, J C and Mungall, A and Plumb, R and Ross, M and
              Shownkeen, R and Sims, S and Waterston, R H and Wilson, R K and
              Hillier, L W and McPherson, J D and Marra, M A and Mardis, E R
              and Fulton, L A and Chinwalla, A T and Pepin, K H and Gish, W R
              and Chissoe, S L and Wendl, M C and Delehaunty, K D and Miner, T
              L and Delehaunty, A and Kramer, J B and Cook, L L and Fulton, R S
              and Johnson, D L and Minx, P J and Clifton, S W and Hawkins, T
              and Branscomb, E and Predki, P and Richardson, P and Wenning, S
              and Slezak, T and Doggett, N and Cheng, J F and Olsen, A and
              Lucas, S and Elkin, C and Uberbacher, E and Frazier, M and Gibbs,
              R A and Muzny, D M and Scherer, S E and Bouck, J B and Sodergren,
              E J and Worley, K C and Rives, C M and Gorrell, J H and Metzker,
              M L and Naylor, S L and Kucherlapati, R S and Nelson, D L and
              Weinstock, G M and Sakaki, Y and Fujiyama, A and Hattori, M and
              Yada, T and Toyoda, A and Itoh, T and Kawagoe, C and Watanabe, H
              and Totoki, Y and Taylor, T and Weissenbach, J and Heilig, R and
              Saurin, W and Artiguenave, F and Brottier, P and Bruls, T and
              Pelletier, E and Robert, C and Wincker, P and Smith, D R and
              Doucette-Stamm, L and Rubenfield, M and Weinstock, K and Lee, H M
              and Dubois, J and Rosenthal, A and Platzer, M and Nyakatura, G
              and Taudien, S and Rump, A and Yang, H and Yu, J and Wang, J and
              Huang, G and Gu, J and Hood, L and Rowen, L and Madan, A and Qin,
              S and Davis, R W and Federspiel, N A and Abola, A P and Proctor,
              M J and Myers, R M and Schmutz, J and Dickson, M and Grimwood, J
              and Cox, D R and Olson, M V and Kaul, R and Raymond, C and
              Shimizu, N and Kawasaki, K and Minoshima, S and Evans, G A and
              Athanasiou, M and Schultz, R and Roe, B A and Chen, F and Pan, H
              and Ramser, J and Lehrach, H and Reinhardt, R and McCombie, W R
              and de la Bastide, M and Dedhia, N and Bl{\"o}cker, H and
              Hornischer, K and Nordsiek, G and Agarwala, R and Aravind, L and
              Bailey, J A and Bateman, A and Batzoglou, S and Birney, E and
              Bork, P and Brown, D G and Burge, C B and Cerutti, L and Chen, H
              C and Church, D and Clamp, M and Copley, R R and Doerks, T and
              Eddy, S R and Eichler, E E and Furey, T S and Galagan, J and
              Gilbert, J G and Harmon, C and Hayashizaki, Y and Haussler, D and
              Hermjakob, H and Hokamp, K and Jang, W and Johnson, L S and
              Jones, T A and Kasif, S and Kaspryzk, A and Kennedy, S and Kent,
              W J and Kitts, P and Koonin, E V and Korf, I and Kulp, D and
              Lancet, D and Lowe, T M and McLysaght, A and Mikkelsen, T and
              Moran, J V and Mulder, N and Pollara, V J and Ponting, C P and
              Schuler, G and Schultz, J and Slater, G and Smit, A F and Stupka,
              E and Szustakowki, J and Thierry-Mieg, D and Thierry-Mieg, J and
              Wagner, L and Wallis, J and Wheeler, R and Williams, A and Wolf,
              Y I and Wolfe, K H and Yang, S P and Yeh, R F and Collins, F and
              Guyer, M S and Peterson, J and Felsenfeld, A and Wetterstrand, K
              A and Patrinos, A and Morgan, M J and de Jong, P and Catanese, J
              J and Osoegawa, K and Shizuya, H and Choi, S and Chen, Y J and
              Szustakowki, J and {International Human Genome Sequencing
              Consortium}",
  abstract = "The human genome holds an extraordinary trove of information
              about human development, physiology, medicine and evolution. Here
              we report the results of an international collaboration to
              produce and make freely available a draft sequence of the human
              genome. We also present an initial analysis of the data,
              describing some of the insights that can be gleaned from the
              sequence.",
  journal  = "Nature",
  volume   =  409,
  number   =  6822,
  pages    = "860--921",
  month    =  feb,
  year     =  2001,
  language = "en"
}

@ARTICLE{Di2021-kg,
  title    = "Stimulated Raman Histology for Rapid Intraoperative Diagnosis of
              Gliomas",
  author   = "Di, Long and Eichberg, Daniel G and Huang, Kevin and Shah, Ashish
              H and Jamshidi, Aria M and Luther, Evan M and Lu, Victor M and
              Komotar, Ricardo J and Ivan, Michael E and Gultekin, Sakir H",
  abstract = "BACKGROUND: Intraoperative pathologic diagnosis traditionally
              involves frozen section histopathology, which may be labor and
              time intensive. Indeed, a technique that streamlines the
              acquisition and evaluation of intraoperative histologic data may
              expedite surgical decision-making and shorten operative time.
              Stimulated Raman histology (SRH) is an emerging technology that
              allows for more rapid acquisition and interpretation of
              intraoperative histopathologic data. METHODS: A blinded,
              prospective cohort study was performed for 82 patients undergoing
              resection for a central nervous system tumor. Of these, 21
              patients were diagnosed with glioma either intraoperatively or
              postoperatively on permanent section histology and included in
              this study. Time to diagnosis (TTD) and diagnostic accuracy
              relative to permanent section (the gold standard) were compared
              between SRH-based diagnosis and conventional frozen section
              histology. Diagnostic concordance with permanent section was also
              compared between frozen histopathology and SRH diagnosis.
              RESULTS: Diagnostic accuracy was not significantly different
              between methods (P = 1.00). Diagnostic concordance was not
              significantly different between methods when comparing 95\%
              confidence intervals for kappa values ($\kappa$ = 0.215; $\kappa$
              = 0.297; $\kappa$ = 0.369). Lastly, mean TTD was significantly
              shorter with SRH-based diagnosis compared with frozen section (43
              vs. 9.7 minutes, P < 0.0001). SRH was able to identify key
              features associated with varying glioma types. CONCLUSIONS: SRH
              allows for rapid intraoperative diagnosis without sacrificing
              diagnostic accuracy. SRH may serve as a promising adjuvant to
              conventional histopathology to expedite intraoperative pathology
              consultation and surgical decision-making.",
  journal  = "World Neurosurg.",
  volume   =  150,
  pages    = "e135--e143",
  month    =  jun,
  year     =  2021,
  keywords = "Brain tumor; Frozen section; Glioma; Pathology; Permanent
              section; Stimulated Raman histology",
  language = "en"
}

@ARTICLE{Liu2022-gc,
  title    = "Instant diagnosis of gastroscopic biopsy via deep-learned
              single-shot femtosecond stimulated Raman histology",
  author   = "Liu, Zhijie and Su, Wei and Ao, Jianpeng and Wang, Min and Jiang,
              Qiuli and He, Jie and Gao, Hua and Lei, Shu and Nie, Jinshan and
              Yan, Xuefeng and Guo, Xiaojing and Zhou, Pinghong and Hu, Hao and
              Ji, Minbiao",
  abstract = "Gastroscopic biopsy provides the only effective method for
              gastric cancer diagnosis, but the gold standard histopathology is
              time-consuming and incompatible with gastroscopy. Conventional
              stimulated Raman scattering (SRS) microscopy has shown promise in
              label-free diagnosis on human tissues, yet it requires the tuning
              of picosecond lasers to achieve chemical specificity at the cost
              of time and complexity. Here, we demonstrate that single-shot
              femtosecond SRS (femto-SRS) reaches the maximum speed and
              sensitivity with preserved chemical resolution by integrating
              with U-Net. Fresh gastroscopic biopsy is imaged in 96\%. We
              further demonstrate semantic segmentation of intratumor
              heterogeneity and evaluation of resection margins of endoscopic
              submucosal dissection (ESD) tissues to simulate rapid and
              automated intraoperative diagnosis. Our method holds potential
              for synchronizing gastroscopy and histopathological diagnosis.",
  journal  = "Nat. Commun.",
  volume   =  13,
  number   =  1,
  pages    = "4050",
  month    =  jul,
  year     =  2022,
  language = "en"
}
